data_2mzu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mzu _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.876 0.369 . . . . 55.42 111.126 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -103.75 152.15 38.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.659 0.742 . . . . 74.52 110.839 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 146.7 60.82 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.661 2.24 . . . . 74.02 112.359 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -131.89 141.28 49.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 74.24 111.178 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.46 ' HA ' HD22 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -135.69 144.26 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 74.54 111.14 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 18.7 p90 -101.94 165.22 11.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 75.15 110.873 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -146.95 91.99 2.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 71.41 110.873 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.99 101.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.888 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.7 mm -82.07 119.17 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 71.2 111.078 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -107.71 157.79 17.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 71.2 111.144 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.26 95.98 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 70.51 111.08 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.49 31.48 10.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 73.0 110.872 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.57 -22.6 38.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.711 -0.757 . . . . 70.32 112.469 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -94.7 115.41 65.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.638 0.732 . . . . 72.14 110.902 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.72 123.62 10.3 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.656 2.238 . . . . 71.33 112.381 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.407 ' HB3' HD11 ' A' ' 138' ' ' ILE . 13.8 mt -67.07 -39.54 86.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 64.42 110.953 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.4 -131.15 2.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.825 -0.702 . . . . 73.34 112.522 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.54 137.04 54.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.818 0.342 . . . . 72.51 110.867 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.1 99.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 73.52 111.132 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -107.87 173.28 6.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 70.42 110.844 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.42 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -145.94 134.47 22.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 75.23 110.892 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -83.78 98.47 9.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 74.22 110.879 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 mt -79.63 115.88 19.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 73.53 110.942 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -76.0 64.97 1.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 74.13 110.855 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.63 -22.54 23.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 65.13 111.103 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -66.5 -35.68 80.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 72.14 110.886 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.62 -28.87 12.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 74.33 110.926 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.14 66.52 60.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.616 0.722 . . . . 65.43 111.111 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -37.2 9.56 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.737 2.291 . . . . 73.2 112.335 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -63.48 -38.17 90.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 65.02 110.882 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 m -85.9 -41.29 15.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 75.34 111.153 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.22 -44.78 82.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 75.34 111.139 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -49.55 -30.23 8.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.01 110.881 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -67.68 -68.92 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 73.42 110.88 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -55.27 -25.62 34.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 75.43 110.94 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.52 -55.57 5.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 74.51 110.885 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.76 -34.66 28.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 63.1 111.12 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 mt -75.8 -61.98 1.74 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 70.11 110.91 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.0 m -51.92 -33.92 39.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 73.35 110.858 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.3 p -76.51 -31.99 58.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 72.12 111.113 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.01 -15.55 60.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 72.34 112.528 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -19.16 45.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.869 0.366 . . . . 71.01 110.888 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.41 -28.94 14.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 74.42 110.941 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.05 -25.25 6.13 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.739 -0.743 . . . . 60.42 112.453 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -158.08 -47.68 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.894 0.378 . . . . 75.32 110.907 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.61 -145.88 47.13 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.72 -0.752 . . . . 75.21 112.467 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -179.75 92.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.925 0.393 . . . . 73.02 110.956 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.22 85.45 6.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 74.42 110.911 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.2 -66.14 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.736 -0.745 . . . . 74.42 112.523 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m 49.05 -166.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 75.4 110.9 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.8 147.64 16.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 74.12 110.892 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -128.73 120.58 26.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 62.44 110.876 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -144.61 42.98 1.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 74.04 110.864 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.408 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.69 72.88 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 75.54 110.88 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.8 mt -112.59 113.35 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 74.44 111.134 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 28.9 mt -104.58 103.05 37.81 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.712 . . . . 73.04 111.121 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.441 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 53.4 Cg_endo -69.85 89.56 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.691 2.261 . . . . 71.13 112.329 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.92 -19.45 1.97 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.71 -0.757 . . . . 53.35 112.445 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.78 -54.08 1.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 73.52 110.841 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 173.27 171.35 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 74.32 110.883 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.1 m -111.28 -154.16 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 72.24 110.846 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 55' ' ' ARG . 54.6 tp60 -134.68 163.38 29.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 70.54 110.893 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.757 -0.735 . . . . 70.12 112.488 -179.983 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.1 pt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.779 0.323 . . . . 73.11 111.085 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -174.31 58.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 74.32 110.892 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.54 -160.41 53.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.784 -0.722 . . . . 61.33 112.51 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.26 -40.88 59.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 73.45 110.902 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.443 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 173.45 -177.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 74.12 110.878 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.35 -165.94 1.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 72.42 110.869 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.83 165.51 12.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 65.5 110.884 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -51.44 119.38 4.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 74.44 110.927 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -91.59 -69.16 0.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 72.01 110.857 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -177.25 177.14 1.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 74.52 110.909 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.42 36.89 3.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 73.42 110.892 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 mt -48.15 -33.63 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 72.24 111.128 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 22.1 mt -106.83 89.28 2.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 72.51 110.901 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.25 139.23 37.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 73.41 110.911 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -49.71 101.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 74.35 110.851 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 74.2 p -115.88 28.38 8.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 72.53 111.121 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.32 178.01 24.81 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 74.33 112.5 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 173.5 10.81 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.677 2.251 . . . . 75.24 112.338 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.12 32.8 85.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 75.34 112.496 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.5 mm -105.91 137.55 35.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.84 0.352 . . . . 74.1 111.159 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.438 ' HB2' ' C ' ' A' ' 130' ' ' GLY . 0.8 OUTLIER -105.16 144.86 31.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 73.33 110.958 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.58 -163.05 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 74.23 110.846 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.12 140.92 52.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.497 . . . . 72.2 110.859 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.55 34.85 2.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 71.23 111.083 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.43 -19.08 63.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 71.23 110.923 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 176.64 -31.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 60.32 111.101 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.63 -89.28 0.49 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 73.44 112.495 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 117.24 4.97 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.638 2.226 . . . . 75.1 112.353 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 45.11 54.61 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 73.53 110.867 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.1 p -157.96 60.46 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.21 111.123 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.48 ' O ' ' C ' ' A' ' 109' ' ' GLY . 2.1 m-20 -66.05 -30.71 71.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 72.03 110.887 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 30.52 -116.14 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.749 . . . . 74.34 112.519 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.0 p -167.17 40.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.837 0.351 . . . . 62.43 110.85 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -108.86 50.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 74.44 110.916 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -54.49 -176.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 75.51 110.857 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -160.87 91.7 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 74.34 110.951 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 113' ' ' PHE . 3.0 mt -33.28 105.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 74.21 111.116 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 41.8 t -69.59 100.51 1.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 72.03 110.914 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.1 p -83.94 11.31 7.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 74.44 111.146 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.49 ' O ' ' C ' ' A' ' 118' ' ' LYS . . . 177.37 124.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 73.23 111.072 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 117' ' ' ALA . 1.0 OUTLIER -30.22 105.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 74.1 110.879 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.412 ' CG2' ' CZ2' ' A' ' 121' ' ' TRP . 71.0 p -87.75 73.51 9.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.5 111.144 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -69.8 -27.09 64.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 63.24 110.889 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.412 ' CZ2' ' CG2' ' A' ' 119' ' ' THR . 17.6 p90 -55.86 -22.47 25.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 70.5 110.906 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.2 mt -77.95 -55.91 4.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 74.44 110.878 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 53.48 95.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 75.12 110.827 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 43.17 37.78 3.34 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 74.31 112.517 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.62 -11.48 48.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 74.42 110.863 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -148.46 -163.79 1.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 73.54 110.838 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 25.0 t -122.09 116.03 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 73.44 111.139 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.19 134.48 27.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 72.13 111.149 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -157.2 54.79 0.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 74.32 110.891 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.438 ' C ' ' HB2' ' A' ' 98' ' ' LEU . . . 169.92 176.29 39.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.764 -0.731 . . . . 72.34 112.486 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 132' ' ' VAL . 10.1 pttt -178.89 131.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.792 0.329 . . . . 74.43 110.905 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 131' ' ' LYS . 48.0 t -36.08 108.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 75.23 111.13 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -59.33 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 75.13 110.897 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -152.93 158.35 41.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 65.12 110.896 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.16 30.94 24.11 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 73.01 112.475 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.93 -29.42 12.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 72.24 110.853 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.67 -33.8 35.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 73.22 110.876 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.407 HD11 ' HB3' ' A' ' 17' ' ' LEU . 44.5 mm -66.06 -44.34 92.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 73.23 111.131 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.9 t -63.96 -26.34 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 63.35 111.129 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.5 -30.72 47.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 73.42 110.857 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.92 -43.39 68.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 60.14 111.103 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 27.9 mtm -58.58 -43.98 89.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 73.14 110.859 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.441 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 8.7 tm-20 -54.25 -26.65 30.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 71.33 110.897 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -28.45 52.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 72.12 110.893 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -103.16 31.61 4.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 73.34 110.862 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -120.05 152.86 16.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 70.43 112.499 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.3 t -103.03 144.29 31.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.886 0.374 . . . . 74.24 110.865 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -73.57 65.28 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 72.31 110.832 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -175.35 -34.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 61.23 110.883 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.21 -70.9 0.34 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 61.15 112.482 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.21 170.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 75.13 110.882 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.4 t -159.48 158.85 32.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 73.14 111.113 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 86.0 p -75.38 -53.92 7.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.01 110.859 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -73.01 155.52 39.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 75.33 110.924 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -109.2 109.36 20.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 61.41 110.921 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 3.6 mp -90.81 123.06 42.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.447 . . . . 74.34 111.155 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.77 162.53 32.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 71.51 111.123 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.4 mt -95.69 120.76 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 72.35 111.142 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.32 -49.39 8.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 62.41 111.087 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -146.23 156.31 43.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 73.54 110.88 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.404 ' HA ' ' CE1' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -165.55 144.95 6.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 65.4 110.901 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.46 171.68 42.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 60.13 112.493 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -65.35 141.74 58.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 71.12 110.864 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.54 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.1 mm? -93.48 -56.47 2.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 74.33 110.892 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 75.43 110.874 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.458 -0.052 0 CA-C-O 120.838 0.351 . . . . 75.31 111.125 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 -103.13 152.67 38.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.629 0.728 . . . . 63.31 110.911 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 146.54 60.22 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.641 2.227 . . . . 73.34 112.356 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -133.05 141.58 48.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 75.51 111.165 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.467 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.0 OUTLIER -134.24 143.21 38.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 74.23 111.16 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.566 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 16.6 p90 -100.94 166.37 10.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 75.4 110.871 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -146.67 87.29 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 73.21 110.895 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -50.59 102.45 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 75.41 110.834 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.9 mm -80.59 128.89 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 71.53 111.121 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -122.39 154.24 37.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 74.11 111.129 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.5 t -132.44 94.24 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 75.35 111.109 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.15 31.37 13.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 72.5 110.905 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.88 -24.77 27.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.754 . . . . 75.32 112.513 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -91.44 114.57 62.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.62 0.724 . . . . 54.24 110.916 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.71 122.91 9.59 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.729 2.286 . . . . 64.55 112.34 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.26 -38.7 82.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 73.33 110.949 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.97 -128.21 2.11 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.727 -0.749 . . . . 71.45 112.49 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.47 136.86 53.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 74.34 110.861 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.35 102.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 64.31 111.18 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.0 OUTLIER -109.06 174.77 5.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 71.22 110.841 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.438 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.9 OUTLIER -144.85 132.66 21.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 72.12 110.924 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -86.63 97.35 10.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 74.21 110.878 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.69 119.74 23.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 74.34 110.91 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -78.35 65.19 3.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 74.1 110.868 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.45 -23.49 10.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 71.2 111.1 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -66.85 -31.92 72.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 74.1 110.827 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -101.82 -31.63 10.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.871 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.48 66.27 69.69 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.588 0.709 . . . . 65.24 111.169 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -39.85 6.1 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.669 2.246 . . . . 72.52 112.348 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -36.45 70.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 75.34 110.942 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.2 m -91.33 -47.91 7.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 71.04 111.151 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.4 -46.66 80.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 62.44 111.085 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -54.66 -26.05 30.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 61.34 110.864 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.48 -65.31 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 64.13 110.931 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.95 -24.38 64.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 74.13 110.918 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -80.34 -53.15 6.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 75.22 110.858 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.04 -34.79 22.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 71.53 111.075 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 mt -79.52 -59.5 2.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 73.14 110.944 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.6 m -52.65 -32.16 40.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 52.23 110.907 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.3 p -77.51 -52.65 8.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 74.44 111.19 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.23 -17.86 7.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.741 . . . . 70.34 112.497 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -33.83 37.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.923 0.392 . . . . 72.15 110.869 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -58.52 -29.42 66.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 71.34 110.908 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.16 -13.18 60.36 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.781 -0.723 . . . . 74.32 112.486 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -160.05 -166.03 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.887 0.375 . . . . 74.33 110.903 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.54 -140.97 7.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 74.42 112.468 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -157.73 50.77 0.43 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.971 0.415 . . . . 72.24 110.912 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 142.16 21.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 75.25 110.899 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.86 21.22 73.12 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.71 -0.757 . . . . 71.45 112.464 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.11 -26.68 28.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.829 0.347 . . . . 71.33 110.85 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 68.38 155.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 75.23 110.915 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -95.18 138.65 32.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 72.13 110.916 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -119.38 30.46 7.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 63.03 110.842 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -176.34 117.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 72.11 110.897 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.3 mt -146.11 114.1 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 71.25 111.135 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.6 mt -106.59 103.05 44.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.69 0.757 . . . . 74.4 111.149 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 76.71 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.672 2.248 . . . . 64.02 112.374 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.04 -26.47 0.32 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.755 -0.736 . . . . 53.03 112.483 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.414 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -117.56 -57.47 2.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 73.51 110.853 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.414 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER 176.24 170.55 0.43 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.851 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 13.2 m -112.98 -177.51 3.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 71.12 110.869 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -170.6 140.39 1.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 75.14 110.922 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.752 -0.737 . . . . 71.11 112.482 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.8 pt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.779 0.323 . . . . 75.41 111.07 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -130.77 -67.49 0.72 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 74.42 110.903 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -137.81 -65.25 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.749 . . . . 71.04 112.503 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -145.21 -40.06 0.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.887 0.375 . . . . 72.22 110.918 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.429 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.58 179.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 75.14 110.899 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.61 177.73 8.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 71.11 110.891 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.04 169.47 17.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 74.13 110.908 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -49.94 163.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 71.54 110.852 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -120.94 -74.5 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 73.53 110.854 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -165.22 169.4 16.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 72.43 110.902 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.42 37.63 3.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 73.21 110.883 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -50.22 -29.37 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.488 . . . . 65.35 111.111 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 34.7 mt -111.97 80.52 1.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.898 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.76 153.16 43.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 75.22 110.915 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -60.44 94.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 75.15 110.848 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 p -105.75 25.12 11.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 74.33 111.134 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.66 179.48 24.62 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.761 -0.733 . . . . 75.42 112.499 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 171.09 15.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.681 2.254 . . . . 73.12 112.351 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.23 29.28 70.46 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.687 -0.768 . . . . 61.32 112.499 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.1 mm -102.82 138.38 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.861 0.362 . . . . 73.31 111.137 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -109.32 144.2 37.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 74.14 110.926 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.84 -168.75 2.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 65.44 110.828 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.8 mtp -105.81 99.97 9.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.497 . . . . 75.42 110.854 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.64 50.11 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 71.11 111.082 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -86.59 -78.28 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 75.1 110.886 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -146.53 34.01 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 73.11 111.108 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.36 -111.7 4.39 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.788 -0.72 . . . . 74.42 112.466 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 111.43 2.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.701 2.267 . . . . 73.34 112.339 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 72.09 163.72 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 75.01 110.867 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 p 67.27 29.57 7.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 74.34 111.125 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.37 78.29 8.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 73.41 110.849 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -72.35 -71.97 1.0 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 62.01 112.526 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.7 p 177.29 49.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.783 0.325 . . . . 74.04 110.86 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 1.8 mm-40 -64.02 -31.1 72.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 71.14 110.922 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.468 ' HB3' ' O ' ' A' ' 111' ' ' GLN . 8.2 t80 67.71 139.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 74.22 110.877 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.554 ' CD1' ' C ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -161.08 123.14 3.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 74.22 110.894 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.9 mt -86.4 126.59 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 74.13 111.094 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.05 101.07 13.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 71.34 110.897 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.9 p -86.99 20.98 2.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 73.1 111.151 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 175.59 146.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 72.21 111.092 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 98.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 75.33 110.851 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 32.8 p -106.51 46.69 0.91 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 74.34 111.163 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -26.51 64.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 74.3 110.88 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.3 p90 -49.5 -25.42 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 75.11 110.951 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 18.1 mt -45.72 -32.19 2.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 74.04 110.936 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.5 m-20 59.47 77.21 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 75.23 110.848 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.15 42.23 0.78 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.793 -0.718 . . . . 74.52 112.46 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -26.39 37.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.831 0.348 . . . . 74.01 110.906 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -136.21 169.03 18.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.41 110.853 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 50.0 t -102.43 118.53 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 54.44 111.155 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.02 133.72 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 74.2 111.129 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -156.25 33.91 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 65.44 110.918 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.89 176.11 44.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.712 -0.756 . . . . 73.05 112.471 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -175.71 135.06 0.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.833 0.349 . . . . 73.53 110.913 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 70.2 t -39.7 107.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 74.11 111.15 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.62 -59.13 3.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 74.04 110.908 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -152.78 157.79 41.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 60.13 110.879 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.64 42.95 9.52 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.731 -0.747 . . . . 73.41 112.472 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -29.04 70.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.328 . . . . 74.12 110.882 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.86 -31.95 42.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 65.54 110.867 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.9 mm -65.21 -40.0 87.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 72.14 111.099 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.49 -27.75 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 73.45 111.129 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -80.13 -28.46 38.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 75.54 110.868 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.02 -38.72 63.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 74.42 111.122 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 28.2 mtm -60.7 -52.63 64.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 72.24 110.894 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.51 -26.32 30.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 54.45 110.95 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.412 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.37 -23.98 63.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 73.03 110.857 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.412 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 64.8 m-85 -107.66 16.11 24.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 75.13 110.839 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -110.67 168.55 13.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 61.31 112.497 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.8 m -113.71 146.71 39.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 65.2 110.847 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -75.72 66.43 2.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.091 -0.504 . . . . 74.14 110.883 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -171.11 -37.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 73.22 110.863 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 159.13 -63.15 0.3 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 63.23 112.472 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.49 175.52 0.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.377 . . . . 75.14 110.879 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.7 p -145.12 176.69 9.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 70.53 111.127 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.24 -60.66 1.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.33 110.853 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.21 -175.77 5.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 75.22 110.918 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.96 108.73 15.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 71.24 110.901 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 4.1 mp -83.74 117.96 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 74.42 111.103 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.12 165.87 18.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 74.53 111.186 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.0 mt -103.87 106.08 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 75.35 111.142 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.49 -44.96 85.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 73.44 111.144 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -161.45 158.04 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 74.3 110.845 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.2 148.27 16.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 73.04 110.876 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.09 171.77 41.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.713 -0.756 . . . . 73.51 112.466 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -65.19 142.45 58.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.871 0.367 . . . . 74.41 110.888 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.565 HD22 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -94.54 -58.75 2.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 73.33 110.918 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.932 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.3 t . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.795 0.331 . . . . 74.2 111.136 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -108.62 146.31 33.42 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.621 0.724 . . . . 72.42 110.885 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 146.45 60.42 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.673 2.249 . . . . 74.45 112.373 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 m -133.19 140.22 47.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 74.02 111.139 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.469 ' HA ' HD21 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -134.21 144.67 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 70.45 111.108 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 17.8 p90 -103.13 168.43 9.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 72.22 110.897 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -148.22 87.71 1.61 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 72.52 110.891 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -51.34 103.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 74.44 110.888 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.7 mm -81.96 135.81 24.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 73.41 111.099 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -128.19 155.05 45.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.01 111.084 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -135.54 96.17 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 75.34 111.092 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 66.86 30.76 7.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 73.51 110.908 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.57 -23.74 33.09 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 73.11 112.517 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -91.99 117.3 67.65 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.639 0.733 . . . . 75.42 110.922 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.4 Cg_endo -69.79 124.45 11.08 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.661 2.241 . . . . 72.44 112.324 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.431 ' HB3' HD11 ' A' ' 138' ' ' ILE . 12.0 mt -68.98 -38.82 79.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 65.44 110.878 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.96 -129.38 2.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 75.24 112.447 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.41 137.05 54.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 74.34 110.891 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -146.26 100.21 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 74.14 111.128 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.4 t -108.67 175.26 5.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 73.22 110.811 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.442 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -146.34 130.47 17.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 74.44 110.874 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -83.5 100.78 10.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 73.01 110.892 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 mt -82.84 123.57 29.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 74.41 110.907 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -82.26 63.55 6.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 75.15 110.911 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.86 -23.44 12.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 54.02 111.079 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -64.48 -37.95 89.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 70.3 110.854 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.59 -29.06 13.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 75.41 110.875 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.7 64.92 73.14 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.6 0.714 . . . . 70.25 111.181 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -38.18 8.14 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.664 2.243 . . . . 74.22 112.344 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.36 -37.98 79.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 72.25 110.903 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.5 m -88.61 -45.07 10.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 70.32 111.137 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.03 -47.01 86.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 75.03 111.147 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -50.56 -31.08 14.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 74.45 110.891 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.81 -62.85 1.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 74.35 110.907 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.19 -22.61 61.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.33 110.865 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -83.08 -56.94 3.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 73.04 110.875 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.35 -29.69 10.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 73.44 111.156 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.9 mt -80.13 -60.89 2.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 73.43 110.908 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.0 m -55.3 -36.01 65.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 73.14 110.831 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.1 p -69.23 -31.97 70.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 74.3 111.135 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.15 -18.11 58.03 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.775 -0.726 . . . . 71.23 112.492 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.54 -32.33 40.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 63.53 110.871 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -60.78 -28.22 68.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 74.5 110.923 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.19 -15.17 56.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.749 . . . . 62.42 112.478 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -158.31 -165.4 1.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.877 0.37 . . . . 75.1 110.927 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.62 -166.74 33.42 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.723 -0.751 . . . . 70.31 112.468 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -103.73 15.06 29.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.974 0.416 . . . . 74.32 110.955 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.53 140.05 2.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 65.25 110.913 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.64 28.85 60.5 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.699 -0.762 . . . . 52.41 112.483 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 m -79.45 -177.16 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.383 . . . . 71.41 110.814 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.0 p -139.73 127.76 22.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 70.13 110.846 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -75.66 128.77 35.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 74.11 110.856 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -128.8 37.3 4.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 73.43 110.872 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.04 81.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 73.02 110.918 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.6 mt -117.9 117.97 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 75.12 111.127 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 28.8 mt -112.27 103.88 55.65 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.613 0.72 . . . . 75.12 111.104 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 53.2 Cg_endo -69.79 92.0 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.678 2.252 . . . . 72.43 112.304 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.74 -17.4 2.81 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 71.51 112.505 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.9 -53.96 1.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 74.04 110.874 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.65 174.21 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.911 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 9.3 m -113.04 -162.4 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 73.42 110.881 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 174.51 143.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 72.23 110.941 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 71.22 112.485 -179.953 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.837 0.351 . . . . 73.55 111.143 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -76.2 -34.64 59.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 64.22 110.969 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.16 -113.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 72.43 112.487 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -78.95 -44.18 23.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.91 0.386 . . . . 72.01 110.907 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.4 170.29 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 73.14 110.925 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.73 166.25 13.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 75.45 110.913 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.75 166.34 18.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 74.22 110.875 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -54.23 145.73 16.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 74.2 110.833 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -104.91 -69.98 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 72.24 110.922 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -176.38 177.35 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 71.24 110.918 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.28 37.11 3.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 71.13 110.892 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.22 -34.61 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 74.24 111.132 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.7 mt -112.02 78.03 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 72.1 110.904 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -70.1 144.16 52.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 73.42 110.936 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -51.03 99.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 62.42 110.816 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.7 p -111.8 28.96 8.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 74.2 111.138 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.45 179.64 26.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.701 -0.762 . . . . 65.2 112.507 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 163.99 36.22 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.653 2.235 . . . . 73.22 112.384 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.29 37.85 54.13 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 74.33 112.466 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.2 mm -110.19 139.9 31.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.914 0.388 . . . . 75.43 111.071 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.66 146.09 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 73.31 110.87 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.81 -158.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 75.32 110.865 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -130.4 136.83 49.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 75.41 110.89 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -120.52 100.4 7.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 62.51 111.069 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -151.16 -41.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 71.5 110.928 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -178.86 34.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 72.15 111.078 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.13 -109.99 1.77 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 72.11 112.492 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 115.19 3.98 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.708 2.272 . . . . 63.01 112.313 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 73.24 169.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 71.12 110.921 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 65.86 27.16 11.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 61.22 111.187 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -75.78 144.37 41.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.871 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.32 -100.33 0.63 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.731 -0.747 . . . . 74.42 112.471 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.9 p -158.09 37.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.839 0.352 . . . . 75.42 110.873 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.22 58.71 0.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 73.42 110.854 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -58.19 -171.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 74.3 110.88 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.549 ' O ' ' C ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -160.88 78.36 0.6 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 74.35 110.874 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.549 ' C ' ' O ' ' A' ' 113' ' ' PHE . 4.9 mt -25.1 105.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 73.04 111.119 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 37.3 t -70.29 101.57 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 75.22 110.89 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 47.9 p -90.53 21.98 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 72.13 111.185 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' A' ' 118' ' ' LYS . . . 173.25 127.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 74.5 111.16 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 117' ' ' ALA . 2.1 tttt -36.77 108.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 74.53 110.956 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 61.4 p -95.06 71.33 3.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 72.35 111.155 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -68.62 -26.61 65.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 72.25 110.873 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 17.9 p90 -56.28 -19.99 16.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 75.32 110.907 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 82.9 mt -80.81 -54.66 5.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 74.12 110.897 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 52.47 95.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 65.23 110.88 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 42.29 41.91 4.12 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.768 -0.73 . . . . 74.33 112.478 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -91.21 -9.95 43.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.828 0.347 . . . . 70.1 110.898 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -146.73 -169.99 3.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 65.23 110.827 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.6 t -115.56 109.83 29.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 72.43 111.085 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 t -88.64 136.05 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 74.53 111.112 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -157.93 40.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 72.41 110.878 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -176.32 175.47 47.48 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.701 -0.761 . . . . 62.01 112.465 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -176.1 136.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 75.31 110.929 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.3 t -38.62 108.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 72.54 111.155 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.69 -58.88 3.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 73.12 110.867 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -153.51 158.76 41.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 73.03 110.919 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.63 31.94 28.75 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.737 -0.744 . . . . 72.52 112.522 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -33.51 39.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.775 0.322 . . . . 73.24 110.901 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -34.29 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 73.25 110.876 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 17' ' ' LEU . 40.2 mm -63.81 -41.63 93.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 72.13 111.135 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.8 t -64.48 -24.87 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 74.34 111.175 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -81.62 -28.85 33.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 71.04 110.855 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.68 -38.9 64.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 74.2 111.094 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.0 mtm -59.04 -52.9 63.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 72.32 110.892 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -55.42 -25.51 36.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 74.44 110.92 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.416 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -70.02 -23.76 63.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 73.12 110.833 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.416 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 62.1 m-85 -108.24 20.8 18.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 74.13 110.879 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.01 164.96 12.35 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.789 -0.719 . . . . 62.4 112.499 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.1 m -107.41 146.93 31.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.86 0.362 . . . . 74.34 110.855 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.7 mmm-85 -74.28 69.93 1.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 75.21 110.861 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -174.44 -36.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 74.41 110.914 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 150.58 -52.22 0.51 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 65.35 112.433 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.45 -176.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.912 0.387 . . . . 72.01 110.89 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -164.93 155.97 14.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.445 . . . . 73.32 111.127 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 80.7 p -82.49 -54.75 4.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 75.31 110.905 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -79.12 177.34 8.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 75.3 110.908 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -121.41 108.55 13.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 74.31 110.882 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 4.2 mp -86.01 116.65 29.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 75.03 111.139 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.67 162.72 25.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 74.24 111.092 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.7 mt -101.86 116.02 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 63.14 111.109 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.88 -47.91 27.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 72.34 111.105 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -159.69 157.08 28.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 75.24 110.837 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.0 146.83 17.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 65.31 110.873 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.4 172.98 44.17 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.801 -0.714 . . . . 72.21 112.533 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -64.97 142.51 58.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 74.12 110.938 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.558 HD23 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -93.22 -59.93 1.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 75.51 110.883 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 74.54 110.909 179.951 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 N--CA 1.458 -0.051 0 CA-C-O 120.847 0.356 . . . . 63.24 111.119 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -110.63 154.0 43.34 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.615 0.721 . . . . 75.11 110.885 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 146.35 60.02 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.719 2.279 . . . . 73.54 112.316 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.6 m -128.6 127.8 42.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 62.14 111.179 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.63 177.84 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 74.33 111.164 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.532 ' HB3' HD22 ' A' ' 164' ' ' LEU . 2.2 p90 -160.61 178.27 9.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 75.12 110.867 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -155.96 95.25 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 73.1 110.901 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -45.37 108.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 71.11 110.839 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.9 mm -79.38 129.34 37.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 74.42 111.097 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -121.96 137.46 54.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 73.5 111.133 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -120.73 93.25 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 64.34 111.1 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.46 36.3 6.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 73.55 110.908 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.91 -16.4 61.24 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.71 -0.757 . . . . 64.21 112.474 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -102.33 109.56 60.68 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.646 0.736 . . . . 64.44 110.904 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.7 Cg_endo -69.78 127.03 13.99 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.653 2.235 . . . . 75.32 112.324 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.403 ' HB3' HD11 ' A' ' 138' ' ' ILE . 9.9 mt -67.34 -39.03 85.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 74.23 110.913 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.45 -120.82 0.97 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 64.41 112.44 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -134.91 140.86 46.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 75.01 110.907 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.43 93.12 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 74.3 111.124 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.4 t -95.35 174.19 7.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 73.13 110.833 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.434 ' N ' ' OG ' ' A' ' 21' ' ' SER . 56.5 m-85 -147.33 143.21 27.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 73.1 110.856 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -96.5 95.74 8.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 74.55 110.863 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.0 mt -78.85 124.93 28.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 75.5 110.906 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.91 63.11 7.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 75.24 110.872 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.39 -23.65 10.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 71.21 111.098 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -62.68 -39.89 95.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 62.13 110.846 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -98.27 -28.7 13.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 71.13 110.887 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.05 63.89 71.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.64 0.733 . . . . 75.32 111.1 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -36.55 10.73 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.707 2.272 . . . . 75.32 112.385 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -38.73 92.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 74.31 110.918 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.5 m -85.22 -42.3 14.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 75.11 111.13 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.67 -42.84 95.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 74.15 111.097 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -49.36 -30.59 7.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 72.11 110.922 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -68.58 -70.4 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 74.33 110.905 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.09 -32.12 21.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 75.32 110.862 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.36 -54.51 6.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 73.44 110.856 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.93 -37.3 43.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 74.53 111.115 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 mt -79.19 -58.54 3.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 75.41 110.919 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.8 m -50.13 -35.22 24.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 72.01 110.857 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.4 p -79.07 -54.39 6.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 75.51 111.145 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.28 -16.14 7.18 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.748 . . . . 74.42 112.453 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -53.86 -27.43 29.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 65.12 110.907 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.28 -17.38 41.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 73.3 110.939 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.07 -11.93 70.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 74.13 112.53 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -163.34 -168.33 1.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 75.11 110.907 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.51 -137.51 5.38 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 33.15 112.476 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -168.07 88.59 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.909 0.385 . . . . 75.53 110.949 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -79.98 82.87 5.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.079 -0.51 . . . . 71.31 110.884 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.58 -62.02 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 53.34 112.488 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 m 51.11 -169.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.816 0.341 . . . . 73.32 110.889 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.6 p -176.09 122.75 0.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 71.42 110.882 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -91.4 108.19 19.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 72.54 110.936 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -113.68 28.25 8.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.14 110.822 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.413 ' NH2' ' HZ2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -166.04 95.39 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 72.32 110.875 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mt -126.29 116.38 45.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 63.25 111.127 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.6 mt -108.57 104.84 55.57 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.616 0.722 . . . . 71.31 111.129 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 53.8 Cg_endo -69.82 88.31 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.24 . . . . 71.04 112.356 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.98 -18.67 1.96 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 70.14 112.491 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.0 -55.18 1.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 74.2 110.846 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 173.4 172.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 74.15 110.907 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 11.4 m -108.57 -160.46 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 75.11 110.918 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 176.49 140.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 73.22 110.913 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.813 -0.708 . . . . 74.41 112.54 -179.951 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 40.4 pt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.827 0.346 . . . . 74.54 111.166 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -165.72 51.27 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 71.22 110.892 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.54 -173.24 55.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.751 -0.738 . . . . 72.51 112.481 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -53.41 -24.67 13.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.398 . . . . 75.45 110.921 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.528 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -174.7 176.97 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 74.33 110.861 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -151.83 179.95 7.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 74.23 110.904 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.79 171.02 11.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.895 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -87.55 171.85 10.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 74.5 110.854 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -119.7 -59.45 1.81 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.468 . . . . 73.31 110.839 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.4 p30 -177.45 177.01 1.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 64.5 110.852 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.3 35.27 3.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 75.2 110.892 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mt -50.48 -32.64 10.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 73.43 111.133 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.3 mt -111.03 74.95 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 75.41 110.922 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp -70.32 147.02 50.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 63.45 110.874 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -50.88 99.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.449 . . . . 75.44 110.819 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 77.0 p -112.66 27.62 9.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 64.31 111.125 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 147.85 -179.26 24.86 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.714 -0.755 . . . . 44.42 112.467 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 170.48 16.53 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.657 2.238 . . . . 71.32 112.337 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.4 34.28 79.35 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.74 . . . . 75.14 112.494 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.5 mm -106.49 139.43 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.915 0.388 . . . . 74.41 111.083 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.415 ' CD2' ' HB2' ' A' ' 112' ' ' PHE . 0.4 OUTLIER -106.85 146.57 30.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 75.53 110.915 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.06 -156.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 72.12 110.852 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.4 mmt -131.73 127.61 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.077 -0.51 . . . . 72.44 110.898 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 111' ' ' GLN . . . -86.88 129.35 34.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 72.23 111.145 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 172.23 -168.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 73.34 110.888 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.435 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -47.47 -50.58 22.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 64.44 111.113 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 123.53 -66.89 0.5 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 55.24 112.447 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.435 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.8 Cg_endo -69.75 112.84 3.18 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.62 2.214 . . . . 74.33 112.39 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.8 OUTLIER 36.88 47.3 0.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 72.4 110.857 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.3 p -144.54 39.31 1.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 74.33 111.132 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -76.64 140.38 40.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 74.21 110.88 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.32 -131.06 3.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 54.1 112.485 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 p -138.07 29.92 2.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.805 0.336 . . . . 74.22 110.839 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.402 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 9.3 mm-40 -116.83 72.69 0.83 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 72.3 110.939 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.415 ' HB2' ' CD2' ' A' ' 98' ' ' LEU . 34.7 p90 -57.24 -174.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 75.51 110.897 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.552 ' O ' ' C ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -159.54 78.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 72.44 110.858 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.552 ' C ' ' O ' ' A' ' 113' ' ' PHE . 3.0 mt -23.38 107.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.492 . . . . 74.53 111.171 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 34.9 t -73.01 99.4 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 64.34 110.875 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 48.9 p -88.55 20.66 3.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 73.05 111.171 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 118' ' ' LYS . . . 174.17 127.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 74.14 111.13 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 117' ' ' ALA . 3.4 tttt -36.35 107.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 61.03 110.912 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.42 ' HA ' ' CZ2' ' A' ' 121' ' ' TRP . 49.5 p -94.36 72.86 3.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 75.23 111.135 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -71.45 -26.92 62.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 74.33 110.876 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.42 ' CZ2' ' HA ' ' A' ' 119' ' ' THR . 15.7 p90 -54.35 -22.02 11.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.168 -0.469 . . . . 73.44 110.913 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.1 mt -78.66 -53.12 7.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 75.33 110.881 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 54.43 95.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 72.32 110.862 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 40.43 39.88 1.81 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.76 -0.733 . . . . 64.11 112.493 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -87.07 -12.15 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 74.55 110.903 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -145.17 -164.88 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 62.15 110.82 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.8 t -121.6 111.67 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 73.0 111.104 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.1 136.85 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 73.22 111.13 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -159.48 42.43 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.12 110.856 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -175.03 178.17 46.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.81 -0.71 . . . . 71.53 112.547 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -179.39 135.35 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.82 0.343 . . . . 72.14 110.906 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.7 t -40.63 111.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 61.03 111.166 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.14 -59.93 2.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 75.34 110.878 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -151.05 165.9 32.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 74.24 110.9 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.76 34.53 48.4 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 63.2 112.485 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.43 -23.3 15.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 71.14 110.869 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.96 -31.2 62.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.433 . . . . 74.32 110.865 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.403 HD11 ' HB3' ' A' ' 17' ' ' LEU . 37.4 mm -65.89 -38.3 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 75.55 111.1 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.3 t -66.58 -27.83 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 74.12 111.089 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -80.88 -30.64 35.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 73.12 110.88 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.15 -38.52 69.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 74.24 111.088 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 38.9 mtm -62.66 -54.0 46.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 72.24 110.894 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -55.52 -24.57 32.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 75.51 110.87 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.408 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.77 -25.04 61.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 71.32 110.867 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.408 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 72.0 m-85 -108.34 19.96 19.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 75.45 110.919 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.48 163.4 12.17 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.758 -0.734 . . . . 74.33 112.449 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.3 t -112.01 146.59 37.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 73.45 110.845 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -75.06 67.96 1.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 74.21 110.856 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -172.68 -36.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 75.53 110.88 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 156.11 -93.74 0.14 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.715 -0.755 . . . . 52.44 112.461 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.413 ' HZ2' ' NH2' ' A' ' 55' ' ' ARG . 6.1 mttp -51.85 165.51 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.808 0.337 . . . . 72.32 110.919 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.5 p -143.53 -171.7 3.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 71.14 111.115 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.5 p -88.44 -62.64 1.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 75.14 110.838 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -66.06 178.06 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 74.41 110.885 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.76 107.58 10.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 74.24 110.834 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 4.9 mp -91.36 108.46 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 74.05 111.118 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.24 162.87 23.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 74.11 111.115 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 19.9 mt -97.58 128.38 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 74.51 111.092 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -93.85 -56.13 2.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 75.32 111.076 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -135.11 155.15 51.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 73.41 110.854 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.83 146.11 11.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 63.33 110.944 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.39 165.83 31.49 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.72 -0.752 . . . . 64.51 112.444 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -61.33 107.87 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 73.1 110.934 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 7' ' ' PHE . 2.7 mm? -49.75 -49.7 47.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 73.43 110.922 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 72.22 110.877 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.458 -0.033 0 CA-C-O 120.824 0.345 . . . . 72.25 111.13 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 62.42 157.64 0.12 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.619 0.723 . . . . 75.13 110.921 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 146.4 59.99 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.679 2.253 . . . . 71.52 112.373 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -132.7 141.78 48.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 73.55 111.155 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.439 ' HA ' HD21 ' A' ' 164' ' ' LEU . 1.1 m -133.21 143.52 38.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.33 111.133 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.561 ' HB3' HD23 ' A' ' 164' ' ' LEU . 15.4 p90 -103.13 159.79 15.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 73.14 110.872 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -143.52 87.94 1.97 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 74.45 110.847 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -50.95 106.09 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 74.25 110.857 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.5 mm -81.18 130.57 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 71.3 111.133 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -121.28 146.89 46.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 73.21 111.102 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.0 t -130.59 94.4 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 75.53 111.128 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 67.44 32.95 5.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 75.11 110.865 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.76 -19.02 56.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.707 -0.759 . . . . 71.22 112.475 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -99.28 113.68 64.97 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.63 0.729 . . . . 70.21 110.884 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.6 Cg_endo -69.81 127.01 13.93 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.67 2.247 . . . . 54.2 112.328 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.3 mt -68.4 -38.28 81.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 73.52 110.949 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.78 -125.32 1.49 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.755 -0.736 . . . . 73.3 112.497 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.92 136.42 53.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 73.33 110.908 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.1 t -144.81 99.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 63.22 111.145 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -109.95 172.58 6.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 64.51 110.84 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -144.48 142.56 30.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 73.13 110.901 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.444 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 47.6 tt0 -98.22 99.58 10.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 71.24 110.9 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.487 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 2.2 mt -80.25 122.46 26.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 72.11 110.936 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -75.59 65.53 1.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 63.44 110.911 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.55 -22.6 13.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 72.21 111.102 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -63.61 -46.21 86.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 60.33 110.883 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -91.06 -30.38 16.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.43 110.88 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.03 67.11 80.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.653 0.74 . . . . 64.01 111.14 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -39.61 6.28 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.652 2.234 . . . . 75.44 112.346 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -37.05 85.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 75.41 110.878 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 m -85.15 -40.81 16.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 72.41 111.168 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.9 -48.59 68.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 63.01 111.088 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -49.52 -32.91 13.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 75.44 110.854 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.04 -50.62 69.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 73.11 110.902 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -69.55 -44.29 71.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 71.45 110.829 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -63.96 -35.47 80.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 74.34 110.898 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.97 92.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 53.14 111.107 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mt -74.39 -45.94 43.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 63.22 110.903 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 m -57.49 -45.31 85.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 75.41 110.855 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 74.8 p -72.15 -48.64 41.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.104 -0.498 . . . . 64.35 111.11 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.74 -13.67 10.72 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.707 -0.759 . . . . 63.3 112.52 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -50.46 -34.57 25.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.856 0.36 . . . . 72.32 110.88 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -53.36 -27.97 26.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.882 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.87 -11.29 60.76 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 71.02 112.488 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -162.36 -165.79 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 72.12 110.88 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.95 -133.57 3.65 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.696 -0.764 . . . . 43.12 112.435 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -175.33 91.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.955 0.407 . . . . 75.51 110.906 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -80.68 78.02 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 75.42 110.864 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 158' ' ' ILE . . . 179.39 -66.66 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 74.13 112.502 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m 49.19 -167.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 75.12 110.818 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.46 129.36 1.03 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 70.22 110.857 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -94.52 106.84 18.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.447 . . . . 73.35 110.864 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.0 27.29 9.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 73.12 110.856 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.97 91.71 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 75.43 110.909 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.0 mt -125.86 113.04 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 75.02 111.123 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.1 mt -105.12 102.36 35.83 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.596 0.712 . . . . 75.43 111.094 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 79.32 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.665 2.244 . . . . 63.2 112.35 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.45 -25.56 0.52 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 53.04 112.477 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.33 -57.67 2.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.809 0.338 . . . . 74.43 110.867 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.44 156.77 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 73.54 110.851 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.9 m -93.11 -167.81 1.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 74.11 110.915 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 177.61 146.93 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 72.32 110.887 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.721 -0.752 . . . . 72.32 112.451 -179.983 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.827 0.346 . . . . 73.5 111.16 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -72.37 -34.28 67.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 75.21 110.879 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.25 -140.72 6.44 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.763 -0.732 . . . . 75.34 112.49 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -64.26 -35.27 80.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.935 0.398 . . . . 73.44 110.882 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.472 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.5 168.0 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.909 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -141.12 179.81 6.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 73.14 110.859 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.07 160.09 33.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 75.44 110.902 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.9 152.64 45.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 72.13 110.894 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -100.24 -75.81 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 70.12 110.913 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.4 p30 -166.91 173.94 8.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 65.02 110.919 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.86 34.75 3.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 72.4 110.908 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -51.03 -29.41 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 74.1 111.14 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 24.6 mt -99.99 91.7 4.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 74.41 110.878 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.9 mppp? -80.96 140.16 35.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 64.53 110.878 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -50.33 101.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 70.14 110.883 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.7 p -111.01 25.39 11.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.45 111.146 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 151.38 178.74 26.45 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 72.54 112.453 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 175.91 7.46 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.662 2.241 . . . . 75.41 112.332 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.86 37.11 93.81 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.69 -0.767 . . . . 70.44 112.474 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.1 mm -109.51 134.91 50.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.849 0.357 . . . . 73.52 111.118 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.452 HD21 ' CD1' ' A' ' 112' ' ' PHE . 2.8 mt -99.69 165.17 11.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 63.24 110.959 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.492 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 9.8 t -163.73 -128.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 63.21 110.83 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 28.8 mtm -150.24 143.15 24.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 74.24 110.844 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.58 104.13 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 63.13 111.06 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 179.8 174.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 75.2 110.896 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -50.57 -26.27 5.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 71.11 111.098 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.59 -82.93 0.33 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.709 -0.758 . . . . 75.23 112.499 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 95.06 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.687 2.258 . . . . 71.32 112.386 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 72.73 171.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 72.21 110.923 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.2 p 66.46 28.9 9.41 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 64.01 111.106 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -96.57 160.64 14.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 75.45 110.902 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.88 -132.42 3.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 72.15 112.488 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.9 t -104.48 -47.13 4.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.833 0.349 . . . . 75.53 110.86 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -47.36 109.28 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 74.2 110.906 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.492 ' HB3' ' O ' ' A' ' 99' ' ' SER . 0.1 OUTLIER -111.04 -164.1 0.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 75.24 110.898 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.412 ' H ' ' HB2' ' A' ' 112' ' ' PHE . 3.5 p90 -143.81 153.0 41.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 72.54 110.859 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.0 mt -98.09 120.36 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 74.24 111.148 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 17.4 m -89.51 95.77 10.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 70.54 110.88 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 p -68.14 -8.46 38.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 75.14 111.135 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -147.33 154.03 40.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 73.12 111.05 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -56.66 93.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 74.33 110.894 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.2 p -95.74 45.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 64.2 111.114 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -25.75 67.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 72.54 110.888 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.4 p90 -48.18 -29.75 3.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.119 -0.491 . . . . 75.02 110.864 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.8 mt -45.51 -36.41 4.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 74.01 110.891 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.32 80.47 0.21 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 63.41 110.866 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 37.95 42.11 1.07 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.701 -0.762 . . . . 75.35 112.507 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.69 -14.66 47.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.824 0.345 . . . . 73.01 110.905 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -146.43 -176.47 5.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.871 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.4 t -113.91 115.86 50.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 75.45 111.107 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 22.4 t -92.27 132.26 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 74.32 111.133 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -157.1 44.78 0.38 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 75.53 110.94 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -179.34 174.76 46.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.724 -0.751 . . . . 75.13 112.474 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.02 143.43 0.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 73.31 110.886 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.5 t -44.3 113.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 74.4 111.12 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.444 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -77.43 -59.82 2.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 75.24 110.906 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -152.53 155.23 37.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 74.3 110.902 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.99 36.91 10.56 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.739 . . . . 72.4 112.472 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -27.52 62.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.785 0.326 . . . . 75.54 110.87 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.85 -32.22 60.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 74.45 110.866 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.2 mm -66.17 -39.19 83.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 74.14 111.153 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.1 t -64.71 -26.62 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 74.22 111.165 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -81.04 -29.36 35.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 64.51 110.875 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.2 -39.5 65.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 61.24 111.092 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 35.0 mtm -61.22 -53.5 56.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 73.22 110.876 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.45 -25.41 36.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 75.31 110.934 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.413 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -70.23 -23.81 62.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 72.31 110.882 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.413 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 66.7 m-85 -108.89 20.73 18.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.4 110.863 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -111.3 171.74 14.57 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 61.32 112.482 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 t -127.9 143.29 51.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 75.32 110.868 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -71.48 79.22 0.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 65.44 110.933 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -178.91 -34.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 74.42 110.89 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.92 -83.1 0.18 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.741 . . . . 74.33 112.504 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.44 169.22 3.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 71.31 110.941 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.9 p -144.61 -171.58 3.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 73.23 111.146 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.8 p -88.64 -63.79 1.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 74.41 110.83 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -64.6 -179.68 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 74.43 110.916 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -127.71 108.81 11.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 75.35 110.899 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.14 116.54 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 74.11 111.16 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.69 164.93 24.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 65.1 111.112 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.402 ' O ' ' HA2' ' A' ' 50' ' ' GLY . 3.7 mt -102.75 126.48 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.434 . . . . 73.23 111.123 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.76 -57.67 2.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 65.34 111.085 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -135.79 152.86 51.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.442 . . . . 60.21 110.849 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.32 144.38 10.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.198 -0.456 . . . . 75.43 110.924 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.18 171.28 40.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.71 -0.757 . . . . 52.05 112.518 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -63.56 141.96 58.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 75.05 110.872 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.561 HD23 ' HB3' ' A' ' 7' ' ' PHE . 1.1 mm? -94.82 -59.61 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 72.44 110.906 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 73.13 110.872 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.781 0.324 . . . . 74.23 111.177 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -122.45 156.06 61.48 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.627 0.727 . . . . 74.43 110.891 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 146.14 59.21 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.674 2.249 . . . . 74.43 112.322 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -134.12 104.37 6.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 74.21 111.133 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -100.38 172.28 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.192 -0.458 . . . . 72.31 111.134 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.501 ' HB3' HD21 ' A' ' 164' ' ' LEU . 0.5 OUTLIER -160.16 172.98 16.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 75.41 110.9 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.4 ' HA ' ' HB3' ' A' ' 161' ' ' CYS . 32.1 m-85 -153.39 95.29 1.91 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 75.33 110.926 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.2 104.59 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 70.22 110.884 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.7 mm -76.17 138.21 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 74.2 111.188 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.11 168.81 16.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 75.3 111.148 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.5 t -144.82 99.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 63.01 111.154 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.42 25.01 7.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 65.43 110.846 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.42 -28.3 12.0 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.725 -0.75 . . . . 70.31 112.479 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.64 125.79 70.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.73 . . . . 75.33 110.894 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 120.4 7.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.641 2.228 . . . . 74.41 112.358 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.5 mt -66.2 -42.02 89.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 72.33 110.922 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.423 ' HA3' HD12 ' A' ' 138' ' ' ILE . . . 160.88 -130.99 2.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 65.44 112.478 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.26 136.55 52.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 71.53 110.893 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -143.01 100.53 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 74.25 111.179 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -109.51 172.84 6.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 71.23 110.872 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.407 ' N ' ' OG ' ' A' ' 21' ' ' SER . 43.6 m-85 -145.64 144.56 30.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 75.11 110.902 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -100.28 97.89 8.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 75.32 110.865 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.438 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 2.3 mt -82.37 128.65 34.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 75.4 110.924 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -87.16 67.3 9.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 75.42 110.932 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.57 -22.48 33.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 74.04 111.117 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -65.08 -34.16 77.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 74.31 110.882 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.2 mmtp -101.46 -31.27 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 75.42 110.927 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.78 65.64 74.72 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.588 0.708 . . . . 74.42 111.105 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -37.49 9.03 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.669 2.246 . . . . 74.43 112.321 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.15 -36.5 77.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 75.44 110.891 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.9 m -90.59 -41.32 11.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 65.04 111.143 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.69 -48.9 75.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 74.12 111.131 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -49.86 -34.29 19.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 74.15 110.922 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -65.25 -65.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 64.21 110.915 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -55.38 -36.51 66.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 75.54 110.875 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -68.61 -49.61 57.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 73.54 110.906 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.29 -25.15 32.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 75.3 111.084 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.24 -58.3 3.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 74.23 110.96 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.41 -38.4 83.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 72.04 110.872 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 42.8 p -62.59 -39.36 93.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 75.12 111.146 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.32 -19.52 31.74 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 74.15 112.493 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.71 -30.58 22.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.929 0.395 . . . . 75.13 110.905 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -31.35 69.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 74.15 110.909 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.64 -8.97 68.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 74.12 112.458 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -169.81 -165.68 0.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.963 0.411 . . . . 73.2 110.834 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.37 -142.37 12.0 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.75 -0.738 . . . . 73.2 112.46 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -115.12 21.61 14.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.896 0.379 . . . . 74.11 110.875 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.4 125.26 12.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 75.42 110.86 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.05 36.96 93.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 75.32 112.53 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -117.3 141.11 48.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.36 . . . . 73.44 110.823 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.5 p -51.99 170.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 73.0 110.88 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.24 -173.77 4.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 75.44 110.885 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -106.56 -69.75 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 73.13 110.826 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.0 ttm-85 -137.26 160.72 38.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 74.44 110.884 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.5 mt -148.49 107.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 75.02 111.16 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.1 mt -106.08 104.78 51.16 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.624 0.726 . . . . 63.43 111.077 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 79.29 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.67 2.247 . . . . 72.13 112.351 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.45 -26.53 0.27 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.749 . . . . 75.4 112.477 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.428 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.1 OUTLIER -120.61 -59.1 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 74.1 110.879 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.428 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER 170.91 156.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 74.34 110.9 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 6.6 m -85.78 -166.72 1.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 72.43 110.879 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -162.97 118.34 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 75.11 110.866 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.739 . . . . 72.05 112.495 180.0 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.8 pt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.815 0.34 . . . . 75.41 111.108 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.36 26.73 9.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.931 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.18 -70.07 2.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 63.42 112.476 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -125.42 -56.2 1.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.403 . . . . 74.55 110.909 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.36 -178.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 72.13 110.907 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -146.25 179.78 7.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 72.2 110.877 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.7 166.74 11.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 73.45 110.908 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -45.51 148.32 0.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 73.2 110.881 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -107.96 -74.66 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 75.45 110.856 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -162.11 170.47 19.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 70.41 110.89 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.22 37.95 3.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 75.42 110.925 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.37 -30.13 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 75.3 111.152 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 13.6 mt -110.02 84.59 1.95 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 73.15 110.92 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -71.77 146.83 47.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 64.03 110.926 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -51.69 103.23 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 73.25 110.862 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 44.2 p -124.87 38.92 4.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 64.33 111.156 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.85 166.65 12.44 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.752 . . . . 71.25 112.49 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 160.11 50.91 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.698 2.265 . . . . 72.54 112.324 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.95 -14.53 58.53 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.69 -0.767 . . . . 65.32 112.465 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.6 mm -55.36 134.73 18.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.838 0.351 . . . . 73.31 111.131 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mt -102.07 167.46 10.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 74.54 110.945 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.24 -147.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 71.24 110.878 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.3 mmt -145.17 124.88 13.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 71.51 110.902 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -115.31 76.36 1.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 63.52 111.109 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -114.12 -40.75 3.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 72.3 110.894 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.25 25.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 75.15 111.121 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.71 -140.82 16.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.728 -0.748 . . . . 61.31 112.505 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 106' ' ' ASN . 54.0 Cg_endo -69.73 59.32 1.6 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.668 2.245 . . . . 72.2 112.355 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER 166.02 160.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 73.21 110.885 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.2 p 56.71 34.19 24.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 74.22 111.185 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.17 64.83 1.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 70.52 110.889 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -62.82 -77.85 0.2 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.748 -0.739 . . . . 75.11 112.434 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 44.0 t -164.43 43.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.342 . . . . 71.55 110.868 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -101.39 39.46 1.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 74.12 110.903 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -55.29 -178.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 75.13 110.84 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -157.58 -175.88 5.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.118 -0.492 . . . . 75.01 110.834 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mt -121.73 93.5 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 72.44 111.151 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 61' ' ' MET . 43.9 m -69.94 87.64 0.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 62.1 110.866 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.0 p -60.91 -14.88 25.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 74.22 111.118 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -143.26 153.16 42.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 73.1 111.103 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -54.51 93.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 73.54 110.862 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.9 p -93.82 52.74 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 72.22 111.149 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -24.24 65.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 73.32 110.862 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -48.95 -29.91 5.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 75.52 110.883 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 17.9 mt -47.2 -33.52 5.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 71.35 110.924 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.5 m-20 57.85 80.36 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 74.23 110.903 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.23 43.44 0.7 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 73.11 112.502 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.72 -16.29 51.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.849 0.357 . . . . 72.42 110.956 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -143.02 -167.75 2.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 73.2 110.884 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.2 t -120.34 115.14 46.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 63.21 111.142 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.4 t -86.91 133.76 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 74.23 111.078 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -154.82 41.42 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.51 110.906 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . 179.38 175.99 46.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.803 -0.713 . . . . 61.03 112.507 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -175.2 142.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 75.21 110.946 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.5 t -45.61 112.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 73.34 111.128 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.13 -61.02 2.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 73.52 110.893 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -155.68 147.14 22.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 63.23 110.883 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.82 38.57 4.88 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.728 -0.749 . . . . 65.42 112.495 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -30.36 70.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.805 0.336 . . . . 74.31 110.878 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.47 -37.57 49.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 63.4 110.881 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.423 HD12 ' HA3' ' A' ' 18' ' ' GLY . 33.0 mm -61.89 -38.54 80.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 65.43 111.091 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 74.6 t -67.11 -24.21 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 73.04 111.109 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.72 -28.77 28.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 72.53 110.869 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.13 -39.01 63.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 71.51 111.108 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 28.1 mtm -58.95 -52.42 65.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 70.53 110.866 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.26 -26.69 30.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 73.25 110.886 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.428 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.81 -24.46 63.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 74.1 110.873 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.428 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 63.1 m-85 -107.78 14.07 25.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 73.22 110.853 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -113.61 167.52 12.34 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.763 -0.732 . . . . 63.23 112.505 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.55 133.95 51.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 75.11 110.867 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -54.38 -22.69 13.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.496 . . . . 75.13 110.873 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -31.27 64.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.452 . . . . 74.01 110.895 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 141.49 -40.69 1.3 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.749 -0.739 . . . . 75.45 112.53 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.57 -177.43 0.43 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 74.31 110.909 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.3 p -146.27 159.63 43.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 72.54 111.117 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.69 -58.47 2.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 65.44 110.844 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -89.48 -177.17 5.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 73.25 110.846 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -112.21 108.17 17.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 71.21 110.87 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.0 mp -84.65 117.73 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 64.43 111.165 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.12 164.18 22.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 74.43 111.2 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.2 mt -101.32 130.74 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 75.22 111.08 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.17 -53.45 4.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 74.12 111.098 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -148.33 145.69 28.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 74.01 110.847 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.4 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -149.93 146.57 27.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 71.42 110.886 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.52 161.81 21.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.714 -0.755 . . . . 73.43 112.472 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -58.13 107.1 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 71.22 110.908 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.501 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.2 mm? -49.04 -54.88 13.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 74.03 110.921 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 75.02 110.864 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.859 0.361 . . . . 75.33 111.101 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -100.73 146.07 31.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.69 0.757 . . . . 65.22 110.854 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 152.48 69.17 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.702 2.268 . . . . 75.41 112.328 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -135.92 135.15 39.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 70.43 111.15 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.449 ' HA ' HD21 ' A' ' 164' ' ' LEU . 1.4 m -129.43 143.2 41.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 74.22 111.133 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 7.0 p90 -104.66 165.21 11.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 72.24 110.889 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -147.29 86.4 1.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 72.12 110.896 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -46.76 107.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 74.44 110.855 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.3 mm -85.38 119.78 34.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 71.21 111.115 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -113.43 149.85 33.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 72.44 111.095 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.2 t -133.28 98.42 2.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.451 . . . . 73.22 111.147 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.69 32.93 10.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 75.52 110.875 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.46 -18.59 57.11 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.717 -0.754 . . . . 73.14 112.486 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -98.5 114.84 65.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.651 0.739 . . . . 74.2 110.862 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.75 125.36 12.06 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.68 2.253 . . . . 73.51 112.337 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.6 mt -67.91 -39.05 83.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 73.13 110.873 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.19 -129.31 2.28 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.761 -0.733 . . . . 63.12 112.476 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -121.36 134.74 55.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 75.25 110.92 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.7 t -145.11 103.19 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 75.2 111.086 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.589 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -114.73 173.75 6.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 75.12 110.864 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.425 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.8 OUTLIER -143.57 136.8 27.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 75.11 110.922 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -91.52 98.28 11.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 75.04 110.855 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mt -80.15 125.87 30.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 64.14 110.906 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -83.58 63.17 7.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 72.24 110.933 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.64 -23.73 7.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 74.4 111.105 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.6 -35.1 76.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 73.2 110.855 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.51 -30.87 13.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 72.42 110.868 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.04 66.58 68.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.656 0.741 . . . . 73.44 111.126 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -32.71 18.04 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.664 2.243 . . . . 70.34 112.351 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -40.62 95.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 72.43 110.893 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.4 m -86.83 -44.91 11.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 73.04 111.157 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.26 82.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 72.25 111.074 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -47.62 -40.66 20.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 73.53 110.87 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -64.01 -63.33 1.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 74.31 110.882 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.43 -23.32 24.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 71.04 110.865 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.481 ' NH2' ' HG2' ' A' ' 163' ' ' GLN . 0.0 OUTLIER -74.54 -59.31 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 73.53 110.894 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.43 -30.3 62.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 73.1 111.126 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.3 mt -75.75 -58.29 3.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 74.53 110.869 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.6 m -49.64 -46.69 49.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 75.31 110.863 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.6 p -74.69 -28.81 60.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 62.0 111.172 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.58 -8.44 76.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.775 -0.726 . . . . 74.34 112.457 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -63.23 -15.82 58.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.874 0.368 . . . . 75.31 110.866 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HE3' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -49.48 -28.84 5.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 72.05 110.859 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.29 -25.83 5.64 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.696 -0.764 . . . . 73.13 112.431 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -160.25 -46.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 75.34 110.861 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.52 -146.22 21.48 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.766 -0.731 . . . . 53.13 112.466 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -175.44 92.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.99 0.424 . . . . 74.44 110.884 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.47 141.02 29.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 74.35 110.922 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.91 39.66 74.92 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.754 -0.736 . . . . 71.31 112.479 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.09 28.83 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 72.13 110.848 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 3.9 m 51.16 -170.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 70.14 110.885 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -105.06 -174.27 2.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 71.11 110.875 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -120.3 -72.78 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 74.02 110.808 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 45.2 ttm-85 -138.91 156.41 47.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 75.32 110.815 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.0 mt -147.87 113.27 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 74.14 111.143 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.5 mt -113.12 104.13 55.71 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.601 0.715 . . . . 71.54 111.178 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.4 Cg_endo -69.77 77.35 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.729 2.286 . . . . 72.01 112.327 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.01 -27.1 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.741 . . . . 72.13 112.46 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.01 -54.67 2.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 74.32 110.869 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 168.87 165.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 74.31 110.834 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.6 m -92.45 -161.25 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 63.32 110.861 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -179.57 129.58 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 72.01 110.919 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.677 -0.773 . . . . 72.43 112.43 -179.947 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.418 ' HB ' ' HE3' ' A' ' 44' ' ' LYS . 31.1 pt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.866 0.365 . . . . 74.44 111.103 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -157.38 47.79 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 75.32 110.927 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.95 -128.29 8.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.711 -0.757 . . . . 64.5 112.508 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -118.52 -27.0 6.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 72.51 110.855 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.472 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 177.32 167.58 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 74.4 110.893 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -139.6 177.51 7.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 73.4 110.894 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.16 157.17 37.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 75.31 110.878 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -52.73 136.24 33.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 72.14 110.899 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -91.18 -76.27 0.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 72.23 110.888 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -165.49 167.89 17.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 73.1 110.91 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.55 37.76 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 72.11 110.913 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.38 -29.91 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 74.14 111.169 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 13.8 mt -108.95 79.17 1.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 74.43 110.914 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 150.33 47.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 71.44 110.896 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -59.31 96.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 62.53 110.829 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.9 p -104.53 25.53 10.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 65.23 111.167 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 144.93 -179.08 22.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 44.15 112.487 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 171.82 13.75 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.715 2.277 . . . . 73.2 112.339 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.78 23.0 78.6 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 54.12 112.464 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.1 mm -99.04 142.7 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.891 0.377 . . . . 75.13 111.14 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.36 140.91 47.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 74.03 110.943 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.14 -167.15 2.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 72.54 110.858 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -100.24 104.95 16.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 74.41 110.863 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.419 ' CB ' ' HB3' ' A' ' 113' ' ' PHE . . . -78.42 52.37 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 74.33 111.117 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.34 -169.14 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 72.44 110.854 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -46.45 -47.59 19.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 71.34 111.074 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.67 -74.79 0.31 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.761 -0.733 . . . . 61.32 112.495 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 111.32 2.79 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.659 2.239 . . . . 71.31 112.311 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 41.35 56.64 3.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 73.35 110.924 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.0 p -153.68 44.8 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 70.4 111.178 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.33 125.15 28.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 74.51 110.893 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.24 -91.84 0.52 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.74 . . . . 74.14 112.492 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.7 t -178.73 49.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.816 0.341 . . . . 73.54 110.814 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -74.69 -40.26 61.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 74.2 110.936 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 66.25 141.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 73.44 110.873 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.551 ' CD1' ' C ' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -161.99 135.85 6.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 74.2 110.912 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mt -85.9 119.32 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 72.25 111.134 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.08 98.97 10.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 73.4 110.899 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 76.7 p -86.1 18.48 3.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 64.1 111.145 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 177.31 142.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 71.31 111.071 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -51.65 99.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 75.02 110.919 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.419 ' CG2' ' CZ2' ' A' ' 121' ' ' TRP . 41.4 p -104.12 53.62 0.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 62.55 111.111 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.67 -27.32 68.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 73.35 110.894 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.419 ' CZ2' ' CG2' ' A' ' 119' ' ' THR . 6.6 p90 -48.29 -26.74 2.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.947 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 23.8 mt -44.48 -37.41 3.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 75.2 110.923 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 124' ' ' GLY . 5.5 m-20 59.16 80.98 0.17 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 62.02 110.857 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.63 41.67 0.88 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.742 -0.742 . . . . 70.11 112.473 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.12 -21.4 36.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.85 0.357 . . . . 73.44 110.909 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -144.75 -169.44 3.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 74.01 110.832 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.8 t -124.58 123.46 66.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 64.3 111.099 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 t -88.84 132.58 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 71.02 111.096 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -154.93 36.64 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 73.54 110.889 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -174.12 177.77 46.22 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.753 -0.736 . . . . 62.43 112.509 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -177.9 138.81 0.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.861 0.362 . . . . 75.41 110.905 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 77.2 t -41.94 106.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 74.44 111.123 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -59.91 2.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 73.35 110.878 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -153.46 150.0 28.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 72.43 110.91 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.8 48.25 4.23 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.729 . . . . 73.33 112.496 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -32.01 73.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.719 0.295 . . . . 75.1 110.849 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.99 -33.22 37.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 71.22 110.916 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.2 mm -64.92 -36.47 77.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 71.41 111.077 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 63.5 t -65.8 -27.59 41.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 75.44 111.144 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -81.03 -27.51 35.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 73.35 110.827 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.04 -39.89 60.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 74.51 111.116 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 33.9 mtm -60.69 -52.92 63.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 75.31 110.886 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -53.55 -27.6 27.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 74.53 110.889 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.425 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.28 -24.48 63.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 74.23 110.896 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.425 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 59.7 m-85 -109.08 21.47 17.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 73.1 110.892 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -114.54 168.14 12.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 70.04 112.466 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 m -104.73 129.84 52.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 72.52 110.891 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -54.97 -26.12 34.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 74.01 110.89 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -77.71 -28.81 51.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 74.43 110.882 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.27 -39.43 1.24 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.765 -0.731 . . . . 63.4 112.47 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -178.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 75.02 110.876 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 10.6 p -144.64 133.58 22.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 62.54 111.161 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.7 m -69.09 -41.17 77.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 73.12 110.889 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.5 -177.15 3.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 74.53 110.899 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -115.92 108.54 16.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 73.23 110.885 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 4.9 mp -92.0 119.2 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 74.1 111.12 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.0 163.7 24.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 74.22 111.145 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.5 mt -96.23 105.56 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 73.55 111.106 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.7 76.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 71.51 111.083 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -162.98 160.95 25.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 71.43 110.87 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -167.98 148.16 4.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 71.42 110.882 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.5 -173.02 44.27 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.739 -0.743 . . . . 75.24 112.492 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.481 ' HG2' ' NH2' ' A' ' 37' ' ' ARG . 3.8 mt-30 -80.93 129.59 34.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 75.1 110.91 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.549 HD23 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -83.87 -57.78 3.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 75.44 110.972 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 74.4 110.871 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.863 0.363 . . . . 75.04 111.121 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -72.09 149.8 92.19 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.646 0.736 . . . . 73.01 110.876 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 146.32 59.61 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.689 2.259 . . . . 64.22 112.351 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -136.29 140.53 43.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 72.45 111.127 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.455 ' HA ' HD22 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -132.84 147.62 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 71.33 111.136 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 16.5 p90 -106.64 166.48 10.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 74.12 110.849 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -144.47 90.38 2.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.4 110.914 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -51.04 117.69 2.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 64.21 110.892 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.2 mm -90.43 116.65 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 71.35 111.134 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -113.47 124.26 51.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 70.34 111.093 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 t -109.22 101.34 12.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 72.23 111.158 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.31 44.26 25.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 73.31 110.833 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.08 -2.0 87.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.734 . . . . 73.3 112.491 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -109.56 99.49 37.71 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.677 0.751 . . . . 64.24 110.883 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.71 101.29 0.89 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.703 2.269 . . . . 72.13 112.378 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.11 -35.73 82.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 71.12 110.89 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.59 -145.1 9.04 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.745 -0.741 . . . . 73.15 112.497 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.56 153.2 51.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 73.04 110.89 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.8 t -144.89 101.46 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 75.41 111.116 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 2.4 t -92.33 176.44 6.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 71.31 110.83 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.455 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -146.26 116.2 7.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 74.12 110.882 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -67.64 96.99 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 70.02 110.88 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.43 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 1.8 mt -80.16 134.32 36.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 75.41 110.885 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -94.4 66.93 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 71.44 110.849 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.95 -23.65 33.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 75.42 111.089 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.39 -29.16 67.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 63.51 110.888 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -103.11 -30.13 10.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 73.44 110.885 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.86 63.89 60.18 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.609 0.719 . . . . 75.44 111.131 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -5.85 17.19 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.689 2.259 . . . . 74.51 112.388 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.72 -45.25 11.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 74.55 110.907 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 44.2 m -92.76 -48.8 6.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 64.12 111.126 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.99 -41.89 68.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 73.33 111.109 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -58.88 -44.52 91.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 75.53 110.933 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -54.2 -50.03 68.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 74.52 110.922 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -61.53 -43.61 98.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 64.0 110.856 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -63.06 -44.01 97.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 73.52 110.907 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.85 -37.75 66.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 54.02 111.089 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 28.8 mt -71.97 -54.7 9.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 65.11 110.903 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -44.7 81.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 64.5 110.857 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.1 p -65.32 -47.0 78.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 73.21 111.118 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.09 -18.28 16.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 75.35 112.484 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -52.89 -29.06 26.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.914 0.388 . . . . 72.2 110.881 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -19.0 37.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 74.3 110.894 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.2 -13.07 40.52 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.683 -0.77 . . . . 62.31 112.476 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -176.78 -170.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.869 0.366 . . . . 73.41 110.855 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -177.83 173.15 45.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 71.25 112.466 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -117.93 60.29 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.961 0.41 . . . . 73.54 110.931 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -78.01 57.56 1.8 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.491 . . . . 75.14 110.863 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 169.76 59.06 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 63.34 112.447 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.57 151.62 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 75.12 110.852 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.9 p -96.07 129.23 43.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 63.51 110.856 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -84.39 133.95 34.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 75.24 110.885 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -132.62 40.59 3.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 73.2 110.897 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 tpp85 -162.58 71.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 75.23 110.882 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.4 mt -123.66 113.76 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.42 111.153 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.7 mt -112.91 109.59 52.44 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.618 0.723 . . . . 75.03 111.12 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 76.92 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.67 2.247 . . . . 65.03 112.319 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.79 -27.15 0.21 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 74.35 112.457 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.412 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.0 OUTLIER -115.26 -60.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 75.43 110.858 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.412 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER 172.68 173.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 65.12 110.866 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.2 m -108.83 -177.71 3.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 75.21 110.866 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -150.92 154.63 37.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 72.2 110.894 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.746 -0.74 . . . . 64.14 112.499 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.4 pt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.848 0.356 . . . . 74.13 111.144 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -164.74 -64.6 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 72.25 110.91 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -136.61 161.85 25.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 70.25 112.509 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -47.84 -32.1 5.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.904 0.383 . . . . 70.42 110.863 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.445 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.31 170.22 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 74.1 110.864 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.46 -179.9 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.886 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.85 160.0 26.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 75.44 110.888 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -52.1 151.67 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 63.13 110.823 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -100.62 -78.34 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 71.42 110.861 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -158.01 172.49 18.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 64.25 110.888 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.8 37.48 4.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 74.12 110.898 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mt -50.61 -29.35 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 64.35 111.089 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 15.1 mt -108.87 88.33 2.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 72.54 110.874 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -71.6 151.97 43.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 73.32 110.921 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -64.85 87.39 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 75.23 110.842 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.21 -51.38 11.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 75.03 111.154 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . -147.86 -164.46 11.31 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.772 -0.728 . . . . 64.41 112.477 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 173.8 10.44 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.659 2.24 . . . . 65.33 112.331 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.52 28.09 73.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.777 -0.725 . . . . 63.43 112.472 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.8 mm -100.85 140.69 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.893 0.377 . . . . 75.14 111.145 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.45 138.97 47.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 74.1 110.93 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.62 -168.1 3.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 71.52 110.863 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -94.23 103.91 15.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 75.01 110.902 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.424 ' CB ' ' HB3' ' A' ' 113' ' ' PHE . . . -75.64 69.77 2.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 64.32 111.115 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -131.71 -175.17 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 74.13 110.896 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.93 -27.15 2.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 75.15 111.112 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.4 -89.23 0.49 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.715 -0.755 . . . . 64.54 112.506 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 90.86 0.52 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.737 2.292 . . . . 74.42 112.316 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 76.07 168.53 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 64.4 110.897 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 p 69.86 28.96 4.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 73.53 111.174 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -109.28 106.65 16.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 64.4 110.879 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -90.23 -65.58 1.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 62.32 112.457 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.5 p 179.64 49.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.806 0.336 . . . . 74.45 110.836 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -62.39 -34.95 77.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 75.33 110.963 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 68.58 137.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 73.31 110.89 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -154.06 127.55 8.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 74.23 110.849 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.7 mt -83.95 125.32 40.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 74.23 111.164 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -91.15 103.48 16.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 75.2 110.894 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 69.4 p -88.42 20.75 3.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.32 111.117 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 174.87 146.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 70.01 111.13 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.411 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 1.2 tttt -54.43 99.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 74.22 110.906 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 42.2 p -105.87 46.66 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 72.21 111.125 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -25.73 65.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 75.14 110.879 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 5.6 p90 -50.12 -25.46 3.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.474 . . . . 75.24 110.905 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.9 mt -45.04 -35.72 3.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 74.21 110.888 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.0 m-20 60.74 80.45 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 65.33 110.853 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.3 42.66 0.9 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 63.2 112.52 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? -82.23 -25.49 34.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.834 0.35 . . . . 73.32 110.897 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -141.46 179.23 6.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 63.31 110.876 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.4 t -114.8 124.31 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 65.31 111.096 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.45 131.92 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 74.3 111.119 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -149.23 31.58 0.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 64.33 110.911 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -175.8 175.69 47.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.804 -0.713 . . . . 73.03 112.494 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' A' ' 132' ' ' VAL . 1.5 pttp -173.12 127.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.81 0.338 . . . . 75.45 110.885 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.471 ' C ' ' O ' ' A' ' 131' ' ' LYS . 53.8 t -32.12 106.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 74.43 111.107 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -57.16 4.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 71.13 110.895 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -157.06 157.51 34.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 75.41 110.905 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.33 32.05 10.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 65.3 112.507 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -24.23 66.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 71.43 110.848 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -39.4 79.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 71.44 110.893 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 25.9 mm -66.56 -37.7 80.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 72.13 111.134 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.17 -30.54 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 73.23 111.129 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -73.09 -30.86 63.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 74.43 110.898 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.79 -37.19 70.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 72.34 111.111 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 16.0 mtm -57.97 -53.79 54.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 62.24 110.869 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.87 -28.12 34.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 71.22 110.866 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.418 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -67.81 -24.44 65.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 64.54 110.854 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.418 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 58.5 m-85 -108.71 20.68 18.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 70.11 110.915 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.41 166.25 12.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 52.34 112.514 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.5 t -123.34 148.79 45.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.864 0.364 . . . . 62.2 110.866 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.9 mmm-85 -75.34 70.51 2.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 63.12 110.92 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -174.79 -35.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.3 110.889 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.42 -42.72 0.88 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 70.04 112.483 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.38 165.63 20.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.864 0.364 . . . . 74.32 110.854 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.8 p -145.67 154.5 42.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 75.01 111.133 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 m -71.32 -48.16 52.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 75.33 110.849 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -96.87 -178.53 4.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 74.2 110.921 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -124.05 108.86 12.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 74.33 110.887 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.76 123.12 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 70.43 111.126 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.83 158.57 40.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 71.03 111.136 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.7 mt -91.1 108.44 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 75.51 111.15 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.85 -48.4 31.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 73.34 111.099 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -151.93 162.74 40.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 62.44 110.872 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.11 148.19 4.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.901 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 176.81 172.51 41.52 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 74.33 112.498 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -63.84 140.4 58.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.836 0.351 . . . . 74.14 110.91 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.56 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -92.49 -56.19 3.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 73.33 110.894 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 73.43 110.864 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.6 t . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.82 0.343 . . . . 62.14 111.159 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -102.44 153.51 38.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.617 0.722 . . . . 72.11 110.877 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 146.72 61.0 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.672 2.248 . . . . 75.32 112.316 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -133.28 140.05 47.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 74.12 111.18 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.417 ' HA ' HD21 ' A' ' 164' ' ' LEU . 1.6 m -133.3 143.02 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 64.21 111.14 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.558 ' HB3' HD23 ' A' ' 164' ' ' LEU . 15.7 p90 -103.4 161.07 14.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 75.54 110.92 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -142.55 88.08 2.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 72.54 110.868 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -52.13 107.49 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 72.54 110.888 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 32.3 mm -78.9 131.39 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 61.34 111.117 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -126.87 123.58 37.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 62.32 111.102 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 t -108.28 94.55 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 74.13 111.156 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.1 t0 58.96 46.76 13.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 74.24 110.899 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.34 -4.37 84.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.738 -0.744 . . . . 72.51 112.477 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -111.28 102.63 53.5 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.681 0.753 . . . . 73.51 110.87 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.82 124.34 10.96 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.628 2.218 . . . . 74.01 112.33 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.1 mt -70.14 -38.76 75.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 73.24 110.926 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.39 -127.17 1.7 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.76 -0.733 . . . . 72.02 112.534 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.49 138.37 54.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.856 0.36 . . . . 75.3 110.851 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.4 t -145.04 100.05 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.12 111.083 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -108.78 175.24 5.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 70.54 110.885 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.454 ' N ' ' OG ' ' A' ' 21' ' ' SER . 1.8 m-85 -146.23 137.2 24.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 74.41 110.827 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -92.12 101.55 14.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 71.3 110.892 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -83.15 119.06 24.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 75.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -76.55 65.68 2.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 74.12 110.88 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.7 -22.77 25.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 44.13 111.099 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -65.87 -33.94 76.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 71.05 110.881 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -101.56 -29.19 12.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 62.41 110.887 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.22 65.73 64.65 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.594 0.712 . . . . 72.43 111.107 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -34.92 13.54 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.65 2.234 . . . . 73.31 112.37 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -39.55 91.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 75.54 110.909 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.5 m -87.96 -40.4 13.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 72.44 111.139 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.4 95.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 73.5 111.061 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -51.75 -35.78 44.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 73.54 110.87 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -61.37 -54.53 42.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.874 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -65.76 -45.65 81.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 73.45 110.879 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.97 -38.7 86.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 72.53 110.828 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.36 -44.28 97.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 70.21 111.093 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.5 mt -74.03 -47.21 38.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 65.43 110.933 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.1 m -51.92 -44.94 64.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 60.11 110.838 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.6 p -71.75 -34.4 69.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 75.52 111.144 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.59 -6.41 41.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.738 -0.744 . . . . 71.54 112.462 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.75 -25.09 17.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 71.2 110.856 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -32.97 74.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 75.55 110.897 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.54 -28.88 4.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 73.31 112.487 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -141.51 -39.97 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.885 0.374 . . . . 74.11 110.91 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.13 -163.91 52.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 61.54 112.467 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.54 45.83 1.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.914 0.388 . . . . 75.52 110.937 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 74.33 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 75.33 110.865 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.67 -59.38 0.33 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 73.14 112.49 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 45.8 -163.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.774 0.321 . . . . 63.44 110.909 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.2 p 179.11 116.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 60.13 110.89 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -97.37 75.35 2.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 74.3 110.867 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -73.15 -21.27 60.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 65.24 110.826 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.18 122.51 46.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 75.11 110.887 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.0 mt -150.29 111.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 75.34 111.125 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 42.8 mt -105.78 103.0 41.82 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.615 0.722 . . . . 75.43 111.179 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 83.11 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.706 2.271 . . . . 72.15 112.341 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 153.19 -20.63 0.75 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 74.34 112.525 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.21 -59.33 1.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.866 0.365 . . . . 64.33 110.859 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -178.14 175.59 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 73.14 110.866 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.4 m -120.47 -170.13 1.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 75.13 110.893 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -177.67 144.13 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 71.44 110.938 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.705 -0.76 . . . . 71.01 112.512 -179.956 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.836 0.35 . . . . 65.44 111.152 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -82.89 -50.49 8.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.454 . . . . 71.3 110.884 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.76 -125.79 0.87 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.786 -0.721 . . . . 74.23 112.517 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -72.46 -33.2 66.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.885 0.374 . . . . 73.15 110.861 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.403 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.52 174.94 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 72.35 110.887 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.74 -168.52 1.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 75.25 110.85 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.28 162.67 14.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 72.23 110.902 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -54.33 115.83 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 73.3 110.881 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -93.85 -74.72 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 75.44 110.878 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -174.88 174.76 2.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 74.14 110.847 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.82 37.94 3.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 74.43 110.887 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -49.6 -30.13 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 73.31 111.131 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.1 mt -112.56 78.18 1.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.168 -0.469 . . . . 71.31 110.886 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -70.55 151.55 44.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 73.41 110.864 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -49.81 102.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 72.4 110.898 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.2 p -113.81 26.94 9.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 64.42 111.098 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.69 -177.78 24.78 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 71.12 112.54 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 174.14 9.94 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.655 2.237 . . . . 72.21 112.372 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.13 44.4 97.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 73.44 112.485 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.0 mm -110.86 140.4 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.844 0.354 . . . . 73.41 111.122 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.456 HD22 ' CD1' ' A' ' 112' ' ' PHE . 2.8 mt -108.29 155.68 20.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 64.5 110.943 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 6.8 t -167.29 -134.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 71.41 110.884 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 9.7 mmt -153.78 143.38 21.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 71.44 110.902 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -128.37 139.8 52.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 73.14 111.095 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 168.5 -31.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 74.3 110.858 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -175.95 -41.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 74.11 111.097 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.84 -77.47 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 70.33 112.484 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 112.0 2.96 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.636 2.224 . . . . 64.44 112.331 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 39.71 61.15 1.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 64.41 110.909 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.3 p -156.17 52.92 0.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 73.22 111.142 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.82 124.94 42.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 71.31 110.876 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.19 -103.48 1.97 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 73.54 112.5 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.19 30.49 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 72.23 110.858 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -112.5 40.48 2.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 73.54 110.933 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.456 ' CD1' HD22 ' A' ' 98' ' ' LEU . 5.7 p90 -58.21 -170.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 73.51 110.89 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -148.58 146.54 28.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 74.45 110.895 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -15.3 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 74.22 111.119 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 49.17 93.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 54.44 110.913 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.3 p -91.17 26.75 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 75.34 111.118 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 178.26 151.76 0.28 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 62.01 111.129 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.74 97.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 75.53 110.881 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.5 p -104.11 46.5 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 63.34 111.148 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -25.38 68.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 72.03 110.842 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -47.32 -28.61 2.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.155 -0.475 . . . . 75.23 110.938 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.6 mt -46.74 -32.82 3.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 75.22 110.865 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 62.52 77.44 0.33 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 73.34 110.869 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 36.54 43.43 0.77 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 72.45 112.45 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -80.85 -13.6 58.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 74.34 110.916 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -144.05 -169.15 3.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 74.43 110.859 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.1 t -120.69 117.39 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 73.44 111.173 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.83 134.14 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 72.15 111.119 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -156.09 37.6 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.839 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -175.4 173.55 46.3 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.772 -0.728 . . . . 70.2 112.486 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.0 pttt -175.59 139.3 0.42 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.797 0.332 . . . . 75.34 110.926 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.1 t -41.17 110.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 73.13 111.132 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.0 -59.29 2.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 71.11 110.868 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -152.12 157.14 41.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 73.3 110.897 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.09 35.54 17.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.742 . . . . 64.2 112.508 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -31.38 63.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.751 0.31 . . . . 71.24 110.909 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.59 -30.23 20.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 71.04 110.887 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 41.4 mm -66.27 -41.29 88.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 75.43 111.092 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.02 -28.29 44.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 74.53 111.152 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -79.34 -28.64 42.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 64.04 110.857 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.32 -38.46 63.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 71.15 111.112 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 28.6 mtm -59.78 -51.8 68.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 72.42 110.894 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.02 -24.69 25.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 73.12 110.903 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.408 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -72.71 -24.11 60.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 75.0 110.925 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.408 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 62.1 m-85 -108.27 16.86 22.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 75.41 110.879 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.98 178.66 17.62 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 61.23 112.491 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -141.3 132.59 26.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 63.52 110.865 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -64.58 84.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 74.51 110.855 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 179.74 -33.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 71.3 110.865 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.21 -92.49 0.15 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.8 -0.714 . . . . 73.01 112.488 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -51.17 156.53 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 73.31 110.895 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.1 p -131.66 156.02 46.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 74.11 111.145 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.63 -35.21 78.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 75.11 110.863 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -101.23 -179.59 4.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 75.52 110.859 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.8 104.55 7.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 71.44 110.846 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.8 mp -90.63 105.56 16.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 71.42 111.081 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.95 166.02 13.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 75.24 111.132 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.5 mm -98.4 119.51 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 74.24 111.118 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.96 -50.56 8.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 71.13 111.117 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -142.81 155.58 44.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 73.04 110.862 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -163.44 148.87 11.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 73.32 110.89 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 172.96 167.64 33.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.783 -0.722 . . . . 73.43 112.511 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -61.83 134.8 57.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.789 0.328 . . . . 65.1 110.927 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.558 HD23 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -85.7 -59.3 2.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 74.23 110.938 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 75.13 110.855 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.822 0.344 . . . . 74.5 111.162 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.46 142.96 29.58 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 74.41 110.889 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 146.84 61.47 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.687 2.258 . . . . 72.31 112.356 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -129.52 135.66 48.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 74.42 111.167 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -133.13 160.56 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 74.45 111.122 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.547 ' HB3' HD23 ' A' ' 164' ' ' LEU . 1.7 p90 -143.36 -179.29 6.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 74.04 110.879 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -155.89 92.99 1.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 74.23 110.896 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -44.05 104.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 74.54 110.925 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.1 mm -77.18 134.79 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.14 111.083 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -127.66 154.12 45.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 73.23 111.068 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.2 t -134.02 95.91 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 64.34 111.106 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.37 31.52 10.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 74.21 110.861 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.63 -23.39 34.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.788 -0.72 . . . . 74.53 112.471 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -92.25 115.09 64.1 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.607 0.718 . . . . 60.04 110.891 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.9 Cg_endo -69.73 123.0 9.69 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.69 2.26 . . . . 75.43 112.374 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.66 -38.66 87.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 73.23 110.909 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.65 -122.95 1.19 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.756 -0.735 . . . . 54.23 112.458 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.05 141.13 46.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 73.33 110.91 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.53 103.99 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 64.24 111.136 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.8 t -110.28 172.95 6.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 71.1 110.834 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.418 ' N ' ' OG ' ' A' ' 21' ' ' SER . 10.1 m-85 -146.29 131.61 18.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 74.32 110.906 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -85.98 98.07 10.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 71.33 110.884 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 mt -83.12 136.39 34.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 74.33 110.888 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -96.27 63.75 2.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 65.21 110.85 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.19 -24.02 16.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 71.52 111.072 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.36 -31.19 70.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 74.21 110.887 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.5 -27.07 13.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.831 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.61 63.52 47.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.577 0.703 . . . . 74.54 111.088 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -41.82 3.89 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.679 2.253 . . . . 73.03 112.354 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -55.32 -37.46 67.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 73.41 110.922 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.0 m -89.19 -53.36 4.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 62.53 111.141 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.26 -36.37 41.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 64.12 111.123 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -49.74 -32.35 13.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 72.22 110.876 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -63.84 0.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 75.04 110.926 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.37 -34.29 68.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 74.52 110.893 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -49.48 69.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.487 . . . . 71.14 110.871 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.87 -31.46 72.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 73.2 111.113 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.9 mt -75.43 -55.95 5.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 74.34 110.96 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.0 m -49.37 -48.92 46.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 73.44 110.873 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.2 p -69.05 -28.08 66.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 71.34 111.132 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.3 -14.51 65.16 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.728 . . . . 75.54 112.459 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -52.29 -25.29 9.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 73.24 110.938 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HE3' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -50.3 -28.26 7.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 75.14 110.868 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.69 -26.08 4.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.766 -0.731 . . . . 71.11 112.501 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -165.45 -47.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 74.5 110.849 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.61 177.72 0.38 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.774 -0.727 . . . . 61.41 112.488 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -94.7 26.71 3.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.004 0.43 . . . . 75.1 110.919 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.19 126.92 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 73.41 110.902 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.18 39.6 92.47 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.763 -0.732 . . . . 73.11 112.484 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -92.02 -178.66 5.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.888 0.375 . . . . 73.22 110.853 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 22.6 m -117.73 153.39 33.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 73.0 110.891 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -101.61 143.54 31.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 74.53 110.888 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -145.25 45.01 1.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 74.11 110.827 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -171.38 70.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 72.14 110.885 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.2 mt -117.39 109.46 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 73.05 111.091 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.417 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 34.6 mt -106.82 102.67 43.51 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.65 0.738 . . . . 75.1 111.148 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.5 Cg_endo -69.82 79.67 0.95 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.683 2.255 . . . . 73.01 112.309 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.19 -25.62 0.54 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 73.12 112.491 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.3 OUTLIER -117.95 -59.17 1.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.332 . . . . 74.51 110.865 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.431 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.2 OUTLIER 176.91 162.63 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 75.34 110.815 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.9 m -104.59 -169.05 1.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 75.1 110.909 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -178.72 146.91 0.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 75.42 110.939 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.728 . . . . 73.24 112.472 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.436 ' HB ' ' HE3' ' A' ' 44' ' ' LYS . 3.9 pt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.857 0.361 . . . . 75.04 111.144 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -135.42 -67.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 63.34 110.933 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.16 -142.65 3.49 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 74.12 112.517 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -50.23 -32.94 17.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.856 0.36 . . . . 74.3 110.889 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.444 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.69 -175.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 73.2 110.883 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -147.32 161.01 41.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 72.2 110.871 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -60.73 166.0 3.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 71.44 110.899 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -82.12 174.94 10.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 75.52 110.852 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -120.09 -76.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 73.22 110.871 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.5 p30 -158.89 176.04 12.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 74.01 110.89 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.03 37.66 3.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 75.43 110.844 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.54 -30.08 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 71.4 111.141 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 20.9 mt -109.99 82.56 1.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 73.34 110.92 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.93 150.48 46.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 71.24 110.875 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -58.03 97.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.5 110.841 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.0 p -104.06 24.09 11.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 74.44 111.122 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 147.19 -178.89 24.52 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.739 -0.743 . . . . 72.0 112.5 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 172.62 12.33 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.651 2.234 . . . . 75.25 112.327 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.92 29.56 72.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 75.45 112.473 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.5 mm -103.07 139.97 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.877 0.37 . . . . 62.51 111.119 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.409 HD23 ' CD2' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -108.86 145.97 34.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 65.23 110.935 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.95 -167.99 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 74.23 110.891 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.443 ' CE ' ' HA ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -98.38 113.71 25.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 74.4 110.859 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.03 130.45 40.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 65.44 111.077 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.544 ' CG ' ' HA3' ' A' ' 109' ' ' GLY . 0.6 OUTLIER 175.5 -70.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 65.22 110.915 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -146.85 -50.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 72.21 111.07 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.35 -70.27 0.51 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.759 -0.734 . . . . 71.44 112.522 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 110.23 2.5 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.672 2.248 . . . . 74.51 112.358 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 39.52 45.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 71.11 110.865 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.513 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 22.1 p -153.77 53.33 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 73.21 111.164 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -50.43 -37.16 36.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 73.21 110.909 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.544 ' HA3' ' CG ' ' A' ' 102' ' ' ASN . . . 77.34 -56.39 3.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 72.1 112.484 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 1.0 OUTLIER 85.73 41.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 74.34 110.839 -179.731 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.433 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 25.5 mm-40 -104.45 -14.91 15.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 75.24 110.925 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.566 ' CD1' ' C ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER 72.91 150.94 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.54 110.876 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.551 ' CD1' ' C ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -159.23 131.11 6.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.849 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 mt -87.85 126.93 41.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 73.53 111.139 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.94 101.02 13.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.35 110.823 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.4 p -86.24 20.45 2.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 74.35 111.101 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 176.25 146.21 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 74.5 111.071 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -56.01 94.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 72.23 110.926 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.453 ' CG2' ' CZ2' ' A' ' 121' ' ' TRP . 33.8 p -100.7 56.64 0.89 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 54.45 111.126 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.04 -26.17 67.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 75.11 110.904 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.453 ' CZ2' ' CG2' ' A' ' 119' ' ' THR . 6.8 p90 -49.17 -26.4 2.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 72.31 110.908 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.7 mt -45.83 -34.16 3.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.26 -0.427 . . . . 75.22 110.926 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.6 m-20 61.93 72.5 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 73.42 110.916 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.65 42.74 0.71 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.691 -0.766 . . . . 75.11 112.519 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.78 -28.47 36.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 72.3 110.885 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -124.83 -173.22 2.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 75.11 110.845 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.11 116.86 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 63.32 111.143 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.34 135.03 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 75.44 111.137 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -160.79 34.82 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 71.34 110.872 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -172.49 176.39 45.43 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.764 -0.731 . . . . 53.12 112.497 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -174.14 136.98 0.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.803 0.335 . . . . 71.42 110.905 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.6 t -40.95 108.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 73.44 111.159 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -57.96 4.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 72.12 110.921 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -157.18 156.83 33.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.54 110.893 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.07 32.61 16.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.789 -0.719 . . . . 72.11 112.505 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -26.22 46.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 74.54 110.888 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -32.39 59.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 55.14 110.867 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.1 mm -65.29 -37.06 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 72.22 111.126 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.1 t -66.31 -28.19 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 72.42 111.104 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.21 -28.64 38.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 73.1 110.901 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.99 -40.0 60.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 64.13 111.112 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 34.6 mtm -61.27 -53.1 61.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 74.14 110.908 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.87 -24.73 24.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 75.11 110.896 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.407 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.66 -24.31 61.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.41 110.857 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.407 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 64.0 m-85 -107.7 13.94 26.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 73.02 110.878 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.1 169.08 13.64 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.732 -0.746 . . . . 72.55 112.482 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.5 p -114.08 146.71 39.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 72.31 110.859 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -73.73 72.92 1.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 73.43 110.888 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -179.53 -34.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 73.33 110.886 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 154.5 -61.3 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.775 -0.726 . . . . 74.14 112.516 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -58.31 174.37 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.35 . . . . 74.0 110.918 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.6 p -146.49 179.84 7.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 75.32 111.133 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.51 -65.19 1.03 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 54.11 110.872 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.96 -175.7 4.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 75.22 110.881 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -115.07 107.06 14.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 71.35 110.874 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.0 mp -84.85 111.36 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 73.33 111.162 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.49 165.48 17.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 72.14 111.161 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.3 mt -104.44 127.78 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 74.34 111.111 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.77 -50.38 6.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 50.33 111.085 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -148.73 150.86 33.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 63.15 110.907 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -156.87 149.54 23.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 75.4 110.835 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 164.49 170.5 29.51 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.809 -0.71 . . . . 72.51 112.535 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.28 127.53 27.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.808 0.337 . . . . 73.1 110.921 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.547 HD23 ' HB3' ' A' ' 7' ' ' PHE . 2.0 mm? -78.31 -47.7 17.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 72.22 110.974 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 63.52 110.929 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.6 t . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.809 0.338 . . . . 44.3 111.172 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -111.81 146.8 35.49 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.613 0.721 . . . . 74.32 110.899 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 146.1 58.67 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.64 2.227 . . . . 72.4 112.37 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -133.94 140.76 46.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 70.03 111.135 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.468 ' HA ' HD21 ' A' ' 164' ' ' LEU . 1.7 m -134.97 142.24 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 74.53 111.142 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.556 ' HB3' HD23 ' A' ' 164' ' ' LEU . 11.7 p90 -102.7 170.88 7.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 74.51 110.917 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -151.18 88.51 1.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 74.22 110.888 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -50.08 105.6 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 72.32 110.869 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.9 mm -84.97 122.12 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 63.54 111.123 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -113.76 150.99 32.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 72.12 111.097 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.1 t -132.39 95.9 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 74.24 111.119 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.66 33.97 8.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 75.51 110.896 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.47 -19.13 55.91 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.719 -0.753 . . . . 71.35 112.516 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -97.01 113.23 62.66 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.629 0.728 . . . . 74.11 110.896 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.72 126.5 13.41 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.72 2.28 . . . . 71.34 112.322 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.6 mt -69.18 -40.02 78.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.439 . . . . 65.42 110.899 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.7 -125.51 1.61 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.785 -0.721 . . . . 72.35 112.542 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -123.36 135.91 54.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 73.14 110.874 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.64 103.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 72.21 111.093 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.5 t -113.47 174.59 5.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 71.1 110.881 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.439 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -145.3 126.14 14.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 75.54 110.906 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -80.59 100.0 8.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 73.55 110.862 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.446 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 1.4 mt -83.14 120.4 25.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 73.51 110.916 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -75.94 68.29 2.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 73.33 110.899 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.2 -22.73 42.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 71.42 111.088 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -67.24 -36.72 82.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 75.12 110.885 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -97.19 -27.28 14.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.86 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.92 67.24 41.43 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.6 0.714 . . . . 73.31 111.146 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -36.05 11.39 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.673 2.249 . . . . 64.31 112.314 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.57 -37.75 82.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 75.24 110.86 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.0 m -88.85 -44.05 10.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 71.44 111.169 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.77 -46.69 89.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 73.12 111.108 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -51.03 -29.47 12.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 74.24 110.896 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.14 -64.64 0.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 75.5 110.891 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -59.05 -30.97 68.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 63.45 110.923 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.54 -51.63 19.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 71.43 110.897 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.63 -33.31 68.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 73.14 111.112 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.0 mt -76.38 -51.86 11.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 75.45 110.921 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.1 m -61.66 -37.05 82.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 72.52 110.863 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.9 p -65.81 -34.64 78.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 72.31 111.125 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.28 -15.8 53.84 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.693 -0.765 . . . . 71.43 112.489 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.89 -27.36 29.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.905 0.383 . . . . 74.01 110.899 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -72.91 -29.29 63.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 74.03 110.862 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.31 -15.37 60.28 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.706 -0.759 . . . . 64.02 112.451 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -157.63 -165.41 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 71.02 110.857 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.05 -136.05 5.4 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 74.4 112.507 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.49 30.61 6.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.932 0.396 . . . . 74.32 110.924 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -87.37 96.44 10.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 74.34 110.945 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 134.47 -38.89 1.77 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.762 -0.733 . . . . 75.52 112.44 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.13 -169.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 63.24 110.848 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.9 p -141.73 175.5 9.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.87 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -107.55 142.72 37.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.897 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -143.46 45.89 1.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 74.14 110.827 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -161.98 60.83 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 75.31 110.889 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.0 mt -104.21 108.86 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 73.03 111.127 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.6 mt -102.0 101.7 20.08 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.635 0.731 . . . . 72.13 111.126 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 89.85 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.245 . . . . 75.31 112.377 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.83 -17.6 1.99 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 61.02 112.497 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.58 -53.11 1.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 74.1 110.834 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.89 166.04 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.32 110.843 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.8 m -101.33 -173.35 2.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 70.14 110.897 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 174.1 150.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 73.05 110.941 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.713 -0.756 . . . . 72.02 112.506 179.993 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.486 HG13 ' CD2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.804 0.335 . . . . 75.42 111.121 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.486 ' CD2' HG13 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -164.59 37.82 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 74.23 110.922 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.15 149.79 6.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.712 -0.756 . . . . 63.22 112.481 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -44.47 -33.53 1.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 72.4 110.876 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.479 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.73 166.08 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 75.22 110.874 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -132.13 177.17 7.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 75.45 110.873 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.08 157.15 28.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 73.42 110.876 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -49.94 153.75 1.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 74.22 110.852 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -104.41 -76.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.457 . . . . 73.32 110.903 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -159.32 177.45 10.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 61.44 110.917 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.29 35.59 3.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 72.2 110.895 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.65 -31.86 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 75.4 111.097 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 mt -102.79 101.79 11.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 72.03 110.884 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -90.93 138.79 31.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 75.14 110.899 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -47.35 105.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 73.51 110.876 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 43.8 p -114.95 30.04 7.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 73.12 111.134 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 144.68 176.45 18.7 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 71.34 112.507 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 178.01 5.0 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.663 2.242 . . . . 64.31 112.347 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.82 21.81 63.65 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 71.53 112.514 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.0 mm -91.75 140.37 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 74.02 111.125 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.496 HD23 ' HB2' ' A' ' 112' ' ' PHE . 0.5 OUTLIER -109.64 149.1 30.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 74.21 110.926 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.68 -164.55 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 73.24 110.892 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.0 mtm -98.71 96.6 8.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 74.4 110.892 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.45 62.09 0.51 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 74.43 111.105 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -125.15 -158.3 0.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 73.34 110.875 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.39 53.25 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 74.22 111.079 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.19 -106.07 0.14 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.713 -0.756 . . . . 75.24 112.509 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 116.65 4.66 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.707 2.271 . . . . 73.25 112.361 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 66.52 174.13 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 73.4 110.901 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 p 67.69 32.98 5.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 73.42 111.15 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.96 146.22 31.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 73.43 110.93 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -148.35 53.79 0.52 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 54.52 112.46 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.0 t 68.83 33.79 3.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 74.23 110.869 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -59.89 -168.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 74.3 110.933 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.496 ' HB2' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -175.72 155.42 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 74.04 110.912 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -168.53 68.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 72.15 110.879 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 113' ' ' PHE . 6.9 mt -33.73 107.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 72.33 111.164 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.6 m -84.6 139.23 32.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 72.4 110.899 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.1 p -105.01 27.12 8.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.172 -0.467 . . . . 72.22 111.17 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 178.65 142.94 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 75.13 111.094 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -52.36 98.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.888 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.9 p -96.13 44.78 1.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 72.42 111.197 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -26.54 65.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 70.33 110.925 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 7.3 p90 -49.68 -27.42 4.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.129 -0.487 . . . . 64.52 110.943 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 23.6 mt -47.02 -34.71 5.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 65.21 110.9 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 61.4 77.95 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 74.45 110.846 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 39.11 44.42 2.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.724 . . . . 60.13 112.436 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -81.69 -25.56 35.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 72.12 110.903 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -136.34 -169.35 2.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 75.22 110.848 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 79.4 t -123.79 112.25 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 74.32 111.158 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.5 t -79.95 131.04 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 71.41 111.138 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -150.26 37.39 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 75.25 110.909 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -175.13 173.57 46.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.707 -0.759 . . . . 70.34 112.46 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 132' ' ' VAL . 6.6 pttp -175.9 134.3 0.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 73.34 110.915 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 131' ' ' LYS . 54.0 t -37.02 105.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 71.14 111.127 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -59.31 3.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 72.51 110.921 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -154.84 158.65 39.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.893 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.29 36.3 15.06 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.731 -0.747 . . . . 73.23 112.5 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.33 -25.23 33.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 74.03 110.87 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.16 -34.19 65.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 75.41 110.866 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.9 mm -66.31 -40.02 85.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 74.51 111.139 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.2 t -63.67 -27.59 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 74.45 111.145 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.57 -30.1 52.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 64.21 110.926 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.01 -45.94 59.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 73.11 111.135 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.3 mtm -57.75 -42.02 83.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 63.02 110.875 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -53.77 -27.53 29.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 73.23 110.918 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -28.9 52.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 73.31 110.917 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -100.2 29.38 4.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 72.23 110.921 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.18 155.66 16.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.752 -0.737 . . . . 62.02 112.477 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.7 t -110.65 149.81 29.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 45.14 110.872 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -76.05 59.83 1.35 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 73.53 110.873 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -176.72 -34.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 74.31 110.889 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.83 -43.23 0.76 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 50.41 112.485 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.75 165.04 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 73.12 110.89 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 27.7 p -147.82 149.21 31.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 75.22 111.129 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.9 m -69.82 -46.08 66.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 72.15 110.828 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.12 -176.22 3.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.082 -0.508 . . . . 74.03 110.904 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -115.09 107.95 16.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 75.05 110.928 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.98 122.12 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 73.23 111.114 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.89 168.43 18.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 62.51 111.159 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 41.0 mm -105.43 114.22 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 73.03 111.084 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.58 -47.8 37.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 71.14 111.122 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -157.44 160.23 38.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.849 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.05 146.09 9.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 62.21 110.875 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.95 173.18 44.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 73.31 112.493 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -63.7 139.55 58.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 65.12 110.902 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -92.18 -56.84 2.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.901 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 72.35 110.901 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.826 0.346 . . . . 75.33 111.156 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -51.65 152.66 4.7 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 74.3 110.905 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 146.03 58.89 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.732 2.288 . . . . 71.24 112.327 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -135.22 141.69 45.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 73.03 111.159 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.448 ' HA ' HD22 ' A' ' 164' ' ' LEU . 1.5 m -134.48 143.8 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 74.53 111.101 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 19.0 p90 -102.03 160.77 14.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 72.22 110.856 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -140.42 95.51 2.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 71.44 110.936 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -58.77 113.84 2.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 65.25 110.847 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.424 HG12 HG22 ' A' ' 20' ' ' VAL . 14.8 mm -86.05 124.45 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 73.54 111.112 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -117.25 123.28 46.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 72.22 111.085 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 t -106.6 94.51 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 71.2 111.162 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 62.18 44.56 7.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.857 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.6 -1.58 88.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 73.12 112.523 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -110.05 98.68 35.9 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.627 0.727 . . . . 71.3 110.896 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.4 Cg_endo -69.81 103.98 1.26 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.737 2.292 . . . . 64.32 112.31 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.7 mp -65.74 -34.95 79.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 73.12 110.856 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.76 -143.09 7.94 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 63.13 112.484 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.08 154.06 47.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 74.33 110.838 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.424 HG22 HG12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -144.91 97.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 73.51 111.094 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -91.2 172.46 8.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 74.34 110.832 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.404 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -145.6 123.48 11.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 74.15 110.89 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.402 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 23.4 tt0 -73.7 97.48 2.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 62.21 110.857 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.419 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 1.7 mt -85.09 118.17 24.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 74.23 110.882 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -79.38 68.98 5.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 73.21 110.887 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.62 -22.22 21.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 72.01 111.122 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -69.59 -28.35 65.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 71.33 110.871 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.91 -29.57 11.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 72.24 110.927 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.18 66.42 38.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.62 0.724 . . . . 73.35 111.122 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -35.21 13.17 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.698 2.265 . . . . 73.01 112.332 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.86 -36.41 72.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 72.33 110.895 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.5 m -94.22 -43.02 8.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 75.21 111.139 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.33 91.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.415 . . . . 73.25 111.085 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -50.42 -35.53 28.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 74.14 110.873 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -64.54 -64.19 0.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 72.41 110.926 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -56.35 -34.15 66.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 75.44 110.913 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -53.26 18.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 73.13 110.904 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.74 -35.42 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 70.21 111.125 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.7 mt -72.09 -58.68 3.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 73.15 110.941 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.9 m -51.4 -41.01 60.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 75.15 110.877 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.9 p -72.23 -28.31 63.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 74.51 111.138 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.64 12.75 71.56 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 72.23 112.465 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.39 -18.42 49.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 73.41 110.861 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 29.78 1.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 75.33 110.867 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.04 -22.92 16.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.759 -0.734 . . . . 75.32 112.491 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -179.02 -169.53 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 65.22 110.914 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.4 -135.84 2.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.801 -0.714 . . . . 72.44 112.547 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.83 57.49 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.937 0.399 . . . . 74.41 110.951 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -87.17 48.8 1.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 73.14 110.876 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 174.48 54.7 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 70.13 112.492 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.83 131.14 46.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.869 0.366 . . . . 74.41 110.82 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.8 p -96.69 121.26 38.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 73.31 110.912 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -80.99 117.21 21.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 74.53 110.87 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -114.03 29.75 7.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 75.22 110.874 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.54 91.6 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 73.43 110.849 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 62' ' ' CYS . 3.1 mt -128.68 116.29 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 64.21 111.166 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.2 mt -107.89 104.47 53.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.567 0.699 . . . . 75.43 111.169 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 79.47 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.7 2.267 . . . . 73.4 112.332 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.7 -24.42 0.56 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.707 -0.759 . . . . 54.45 112.515 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.406 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.1 OUTLIER -117.64 -58.98 1.97 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.86 0.362 . . . . 75.34 110.848 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.406 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER 176.33 157.28 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 64.11 110.906 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.414 ' HB3' HG12 ' A' ' 56' ' ' ILE . 34.7 m -90.7 -167.31 1.79 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 75.42 110.865 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 174.69 142.09 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 72.34 110.937 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 74.22 112.469 -179.928 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.866 0.365 . . . . 65.54 111.119 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.85 -65.44 1.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 72.21 110.952 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.82 -33.17 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 54.55 112.486 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -141.11 -54.92 0.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.93 0.395 . . . . 72.23 110.908 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.408 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.19 -177.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 72.1 110.895 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.89 -167.67 1.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.44 110.872 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -133.37 162.76 30.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 74.55 110.871 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -47.76 104.34 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 74.24 110.854 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -80.79 -67.38 0.78 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 75.34 110.882 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -177.68 173.45 1.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.92 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.19 35.54 4.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 74.11 110.885 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -49.94 -28.91 4.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 74.44 111.153 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 16.0 mt -117.38 68.69 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 74.24 110.854 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -62.28 166.53 4.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 74.24 110.863 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -68.72 83.67 0.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 64.51 110.832 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.4 p -99.86 24.54 8.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 75.53 111.12 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 155.65 177.47 28.91 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.782 -0.723 . . . . 72.3 112.496 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 170.13 17.29 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.704 2.269 . . . . 70.32 112.354 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.12 40.04 96.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 71.43 112.474 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.3 mm -108.9 136.06 45.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.832 0.348 . . . . 74.51 111.144 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.506 HD23 ' CD1' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -103.62 157.39 17.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.446 . . . . 73.41 110.899 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 3.6 t -162.19 -139.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 73.32 110.883 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 13.7 mmt -152.91 147.42 25.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 72.43 110.853 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -123.19 151.34 42.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 75.31 111.074 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 167.71 -50.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 74.45 110.915 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -174.63 29.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 73.41 111.136 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.55 -116.66 4.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 64.01 112.472 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 125.09 11.76 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.661 2.241 . . . . 75.21 112.355 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 70.54 165.76 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 73.03 110.888 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 p 67.13 29.22 7.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 73.04 111.175 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -65.24 90.38 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 74.24 110.898 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -66.52 -131.78 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.743 -0.742 . . . . 72.42 112.477 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.0 p -133.23 24.2 4.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.833 0.349 . . . . 54.24 110.861 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -106.56 55.76 0.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 75.13 110.939 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.506 ' CD1' HD23 ' A' ' 98' ' ' LEU . 4.6 p90 -58.65 -168.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 74.2 110.843 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -152.73 160.63 43.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 73.12 110.827 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 mp -105.1 91.17 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 73.44 111.13 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.5 m -64.28 90.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 75.43 110.896 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.6 p -63.93 -12.89 41.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 65.12 111.141 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -143.22 156.7 44.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 62.22 111.096 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -56.41 95.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 70.35 110.892 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.1 p -97.83 50.11 1.03 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 74.51 111.136 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -24.37 66.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 74.25 110.89 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -48.29 -30.49 4.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 74.1 110.933 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.5 mt -47.44 -34.65 7.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 72.21 110.922 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 124' ' ' GLY . 3.6 m-20 59.03 81.18 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 74.54 110.848 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.61 43.63 0.8 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.709 -0.758 . . . . 74.41 112.47 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -81.66 -16.64 50.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 74.55 110.871 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -144.75 -168.55 2.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 73.55 110.802 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.7 t -120.75 120.97 64.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 64.11 111.125 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.4 t -93.26 136.15 25.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 74.35 111.112 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -156.2 37.54 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 75.23 110.854 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -177.51 174.49 46.97 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 51.41 112.528 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 132' ' ' VAL . 5.1 pttp -172.94 132.96 0.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.347 . . . . 74.43 110.9 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' LYS . 38.2 t -36.44 107.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 72.23 111.149 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.402 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -72.27 -58.92 3.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 74.54 110.903 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -155.86 154.89 31.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 72.14 110.876 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.07 28.79 11.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 45.33 112.512 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -24.04 52.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 64.32 110.881 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.06 -36.94 73.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 75.01 110.932 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 27.4 mm -67.6 -39.57 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 73.23 111.093 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.01 -29.49 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 72.24 111.083 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -74.71 -30.55 61.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 71.3 110.897 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.74 -37.98 70.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 73.22 111.09 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 17.5 mtm -58.71 -53.44 58.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 71.51 110.85 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.85 -26.06 32.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 73.52 110.868 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.423 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.81 -23.74 63.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 65.01 110.9 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.423 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 59.8 m-85 -109.16 17.32 21.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 72.33 110.87 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -107.7 170.33 15.31 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.796 -0.716 . . . . 72.32 112.489 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 t -134.55 142.69 47.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.899 0.381 . . . . 71.53 110.837 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -69.03 82.73 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 75.51 110.846 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -179.33 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 74.43 110.885 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.75 -84.67 0.16 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 61.45 112.506 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.68 175.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 75.43 110.877 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.6 p -143.49 168.99 18.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 73.23 111.184 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.65 -48.08 35.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 70.33 110.842 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -92.29 -179.66 5.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 73.24 110.886 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -124.51 108.32 11.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 74.23 110.841 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.53 109.41 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 72.42 111.123 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.14 161.89 22.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 70.04 111.159 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.0 mm -92.85 120.07 41.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 72.53 111.134 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.15 -56.99 3.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 71.13 111.088 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -137.71 157.37 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 74.1 110.894 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -165.91 146.98 6.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 75.0 110.9 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.11 172.42 44.54 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 64.1 112.472 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -66.2 137.37 56.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.899 0.38 . . . . 62.51 110.871 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.3 mm? -88.76 -58.68 2.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 73.22 110.908 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 71.52 110.906 179.918 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.89 0.376 . . . . 74.34 111.125 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -87.14 144.84 36.85 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.669 0.747 . . . . 62.3 110.879 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 145.01 55.52 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.662 2.241 . . . . 70.34 112.347 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.4 m -130.95 129.75 42.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 55.12 111.14 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.07 170.56 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 73.32 111.141 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.569 ' HB3' HD21 ' A' ' 164' ' ' LEU . 1.5 p90 -153.92 179.5 8.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.949 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.414 ' HA ' ' HB3' ' A' ' 161' ' ' CYS . 97.9 m-85 -155.79 97.37 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 70.41 110.888 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -47.73 106.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 74.12 110.875 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.3 mm -79.03 124.27 37.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 74.12 111.138 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -116.65 134.87 54.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.34 111.085 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.0 t -116.49 96.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 73.53 111.11 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.57 35.52 22.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 61.24 110.85 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.36 -15.78 60.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 71.0 112.517 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -103.32 108.09 57.9 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.663 0.744 . . . . 62.32 110.865 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.75 126.49 13.38 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.698 2.265 . . . . 74.03 112.39 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.409 ' HB3' HD12 ' A' ' 138' ' ' ILE . 9.4 mt -68.1 -38.25 82.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 73.14 110.902 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.96 -138.64 5.89 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.77 -0.729 . . . . 73.44 112.53 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.94 140.36 48.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.811 0.339 . . . . 74.35 110.894 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.87 97.8 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 72.42 111.117 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 2.4 t -103.69 174.33 5.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 72.32 110.848 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.427 ' N ' ' OG ' ' A' ' 21' ' ' SER . 26.6 m-85 -148.12 132.1 17.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 75.21 110.891 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -88.08 98.79 11.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 71.34 110.889 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 mt -80.8 133.43 35.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 75.43 110.896 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -91.25 65.42 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 71.41 110.888 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.26 -23.58 23.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 74.22 111.119 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.77 -40.89 96.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 75.01 110.851 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -95.07 -26.8 15.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 72.25 110.906 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.78 67.44 50.28 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.615 0.721 . . . . 75.14 111.16 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -38.51 7.63 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.655 2.237 . . . . 61.44 112.326 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -38.99 90.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 71.45 110.925 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.7 m -84.76 -42.23 15.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 74.34 111.131 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.99 -48.46 78.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 62.3 111.076 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -53.88 -33.13 55.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 64.03 110.898 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -60.92 -61.71 2.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 75.13 110.888 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -63.96 -41.3 97.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 70.23 110.898 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -63.48 -31.14 72.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 75.43 110.858 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.91 67.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 71.11 111.127 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 mp -67.6 -36.76 81.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 74.21 110.937 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.2 m -69.02 -51.19 41.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 62.14 110.881 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.5 p -64.88 -32.95 74.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 75.23 111.173 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.02 -13.48 55.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 71.05 112.462 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.77 -33.45 23.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.951 0.405 . . . . 72.43 110.913 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -53.45 -27.87 27.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 72.43 110.929 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.46 -5.71 80.48 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.737 -0.744 . . . . 72.44 112.484 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -168.65 -167.58 0.79 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 75.0 110.935 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.26 -137.86 6.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.705 -0.759 . . . . 70.44 112.449 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -151.54 47.15 0.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.001 0.429 . . . . 74.3 110.925 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 139.47 58.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 74.05 110.882 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.03 -22.01 39.69 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.763 -0.732 . . . . 61.14 112.482 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.45 173.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 71.54 110.854 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 17.6 p -122.1 179.68 4.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 74.41 110.862 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -104.47 136.09 44.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 73.41 110.841 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.21 37.16 3.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 70.1 110.856 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -166.95 77.21 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 75.33 110.881 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.9 mt -120.52 111.29 31.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 74.03 111.139 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.4 mt -108.21 103.5 50.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.646 0.736 . . . . 74.22 111.135 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 76.25 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 73.22 112.361 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.99 -26.77 0.25 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.722 -0.751 . . . . 73.03 112.495 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.1 OUTLIER -117.69 -55.33 2.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.86 0.362 . . . . 74.24 110.88 -179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER 171.98 175.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 71.12 110.871 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.3 m -111.83 -168.11 1.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 72.32 110.887 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -173.15 141.98 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.22 110.941 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.791 -0.719 . . . . 74.53 112.45 -179.955 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.878 0.371 . . . . 71.33 111.156 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -79.89 -37.48 34.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 75.15 110.912 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.95 -151.08 13.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.8 -0.714 . . . . 71.55 112.499 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -51.03 -40.14 57.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.948 0.404 . . . . 74.04 110.882 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.45 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.5 167.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 74.4 110.885 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.35 167.17 19.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.898 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.17 150.8 48.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 74.33 110.865 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -52.47 161.03 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 75.01 110.881 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -110.99 -70.77 0.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 74.32 110.858 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -170.55 173.54 5.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 63.42 110.908 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.46 37.34 3.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 74.54 110.831 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.99 -30.28 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.21 111.187 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.1 mt -108.79 80.01 1.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 74.5 110.888 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.65 154.06 34.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 75.24 110.901 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -64.13 88.42 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 75.41 110.831 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.1 p -78.57 -54.29 6.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 74.23 111.134 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.05 -165.94 11.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 72.43 112.468 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 177.91 5.08 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.633 2.222 . . . . 75.01 112.351 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.24 31.13 78.03 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.742 -0.742 . . . . 74.32 112.482 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.2 mm -107.01 140.98 23.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 72.13 111.094 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.26 144.9 35.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 73.42 110.895 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.25 146.61 22.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 75.23 110.903 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -69.74 82.83 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 63.45 110.838 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.44 142.86 42.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 73.34 111.069 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 170.59 -167.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 71.3 110.866 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.456 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -50.46 -51.46 46.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 74.01 111.102 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.14 -69.91 0.37 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 65.23 112.52 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.456 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 54.0 Cg_endo -69.76 99.26 0.73 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.725 2.283 . . . . 75.44 112.327 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 37.87 55.35 1.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 74.23 110.874 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.2 p -159.97 53.33 0.35 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 71.4 111.168 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.28 152.47 31.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 74.2 110.891 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.59 5.37 2.87 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 75.21 112.498 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 74.2 51.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.793 0.33 . . . . 72.24 110.881 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.685 ' O ' ' CB ' ' A' ' 112' ' ' PHE . 0.6 OUTLIER -70.21 -31.64 69.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 71.24 110.935 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.685 ' CB ' ' O ' ' A' ' 111' ' ' GLN . 30.6 t80 99.66 145.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 71.21 110.878 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.507 ' O ' ' CG ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -169.86 114.62 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 75.4 110.91 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.3 mt -80.94 129.07 38.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 63.21 111.119 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -91.34 92.77 8.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.447 . . . . 74.24 110.856 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.2 p -79.23 14.16 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 74.53 111.18 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 178.65 143.77 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.466 . . . . 75.32 111.052 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -50.56 98.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 75.34 110.937 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.437 ' CG2' ' CZ2' ' A' ' 121' ' ' TRP . 35.0 p -104.16 48.93 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 71.55 111.092 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -24.86 67.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 71.41 110.868 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.437 ' CZ2' ' CG2' ' A' ' 119' ' ' THR . 6.2 p90 -50.03 -26.96 4.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 74.52 110.901 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.6 mt -45.63 -35.52 4.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 75.12 110.94 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.7 m-20 61.6 80.2 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 73.43 110.819 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 35.98 43.17 0.62 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.741 -0.742 . . . . 54.44 112.497 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.46 -19.28 33.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.753 0.311 . . . . 74.54 110.908 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -142.86 -165.15 1.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.865 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.7 t -131.29 125.64 57.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 75.24 111.123 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.51 133.2 33.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 73.11 111.162 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -155.3 36.53 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 75.3 110.925 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.72 173.9 45.08 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.705 -0.76 . . . . 64.25 112.446 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -175.88 133.54 0.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 74.12 110.913 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.8 t -39.73 107.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 55.31 111.144 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -58.08 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 75.22 110.922 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -154.75 163.05 40.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 75.54 110.873 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.5 32.67 46.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.69 -0.766 . . . . 54.54 112.471 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.89 -34.05 26.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.744 0.307 . . . . 75.34 110.827 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.6 -32.24 12.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 74.43 110.847 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.409 HD12 ' HB3' ' A' ' 17' ' ' LEU . 41.8 mm -66.31 -43.35 91.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 72.34 111.135 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.75 -26.33 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 74.44 111.113 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.32 -29.73 38.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 73.25 110.864 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.31 -37.61 66.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 60.2 111.08 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 24.4 mtm -57.3 -54.25 48.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 63.5 110.912 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -25.5 34.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 71.33 110.873 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.403 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.91 -23.74 63.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 75.35 110.846 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.403 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 57.1 m-85 -108.79 17.13 22.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 75.55 110.88 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.34 168.37 12.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 62.41 112.5 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.6 m -113.76 148.22 36.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 75.24 110.892 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 -75.24 67.46 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.41 110.898 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -175.11 -35.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 71.45 110.872 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.78 -45.34 0.62 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.728 -0.749 . . . . 60.12 112.442 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.71 171.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 74.35 110.933 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.4 p -145.04 139.58 27.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 74.32 111.134 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.39 -39.89 77.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 73.15 110.826 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.39 -174.93 2.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 74.44 110.885 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.57 107.59 13.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 74.3 110.941 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.68 102.34 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 75.44 111.131 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.93 163.86 13.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 65.44 111.165 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.2 mt -102.94 116.47 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 74.22 111.131 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.72 -52.34 7.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 63.54 111.159 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -148.17 153.75 39.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 62.01 110.865 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -160.84 149.74 16.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 73.21 110.889 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.84 166.38 27.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.798 -0.715 . . . . 74.12 112.505 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -59.4 109.24 0.84 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 74.22 110.876 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.569 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.6 mm? -53.2 -48.19 68.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 75.12 110.934 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 75.32 110.913 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.83 0.348 . . . . 73.45 111.143 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -118.04 146.92 40.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.595 0.712 . . . . 75.24 110.889 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 149.34 66.58 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.676 2.25 . . . . 72.42 112.355 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -136.02 137.7 41.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 73.52 111.181 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.41 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.9 m -131.61 145.64 34.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 74.21 111.113 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.641 ' HB3' HD22 ' A' ' 164' ' ' LEU . 8.2 p90 -101.93 168.04 9.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.923 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -147.81 88.9 1.71 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.893 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.86 105.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 73.13 110.882 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.2 mm -83.97 126.95 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 75.12 111.105 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -121.04 149.54 42.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 51.54 111.077 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 t -130.04 94.94 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 62.41 111.123 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.02 32.66 10.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 74.43 110.893 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.18 -21.59 42.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 70.43 112.489 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -94.18 113.07 59.82 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.644 0.735 . . . . 75.33 110.882 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.7 Cg_endo -69.81 123.32 9.97 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.649 2.233 . . . . 74.3 112.357 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.71 -37.83 79.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 63.03 110.916 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.13 -125.98 1.67 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.75 -0.738 . . . . 73.13 112.497 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.51 138.48 52.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 73.15 110.895 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.71 101.16 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 74.31 111.15 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -108.23 172.77 6.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 75.53 110.829 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.403 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -143.54 133.03 23.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 74.41 110.871 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -85.4 97.38 9.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 74.22 110.926 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 mt -81.78 117.61 22.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 72.43 110.889 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -78.7 64.96 3.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 74.33 110.827 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.79 -24.05 14.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 75.33 111.111 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -67.96 -35.14 77.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 75.2 110.849 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -95.78 -29.2 14.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 70.33 110.908 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.58 65.82 55.77 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.641 0.734 . . . . 73.4 111.129 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -29.32 23.96 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.618 2.212 . . . . 74.11 112.355 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -41.23 96.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 74.4 110.932 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.8 m -88.55 -45.31 10.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 75.31 111.143 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.98 -46.07 82.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 73.2 111.101 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -47.01 -33.66 4.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 72.44 110.911 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -64.57 -65.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 63.25 110.854 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -59.04 -28.58 66.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 73.31 110.887 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -50.6 65.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 72.34 110.847 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.54 -31.71 72.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 62.41 111.069 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 75.1 mt -73.67 -54.54 7.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 75.4 110.927 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.9 m -48.28 -43.94 33.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 65.33 110.844 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.3 p -63.34 -38.42 91.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 72.3 111.186 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.06 -10.84 44.34 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.702 -0.761 . . . . 72.4 112.496 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -28.89 27.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.399 . . . . 74.03 110.893 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -63.83 -29.05 70.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 65.24 110.915 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.35 1.38 90.04 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 74.51 112.508 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -174.89 -165.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.915 0.388 . . . . 75.34 110.865 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.67 -96.22 0.63 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 74.41 112.506 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.67 ' O ' ' C ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -119.19 -70.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.958 0.409 . . . . 73.24 110.894 -179.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.67 ' C ' ' O ' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -6.44 96.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 74.23 110.922 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 120.45 -30.61 5.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.695 -0.764 . . . . 64.22 112.498 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.37 -168.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.808 0.337 . . . . 72.03 110.875 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.1 p -142.84 171.94 13.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 72.43 110.94 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -92.82 139.97 29.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 74.14 110.909 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -123.45 32.57 5.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 74.51 110.821 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.99 114.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.423 . . . . 73.13 110.905 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.2 mt -144.96 112.47 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 72.24 111.125 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.5 mt -105.42 105.07 50.99 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.622 0.725 . . . . 71.35 111.165 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.8 Cg_endo -69.79 56.9 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.644 2.229 . . . . 74.02 112.336 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.16 33.33 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.71 -0.757 . . . . 75.05 112.476 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.43 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.0 OUTLIER -177.12 -59.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.838 0.352 . . . . 75.12 110.882 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.43 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER 174.65 157.92 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 65.21 110.885 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.5 m -97.04 -161.88 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 73.24 110.927 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 177.01 137.96 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 74.21 110.892 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 62.15 112.449 -179.946 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.8 pt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.844 0.354 . . . . 74.23 111.098 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -155.12 -66.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 73.2 110.939 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -132.32 -88.3 0.39 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.709 -0.758 . . . . 73.52 112.486 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -130.91 -37.39 1.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 75.51 110.884 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.437 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.27 170.04 0.31 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 73.12 110.898 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -130.99 179.7 5.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 75.25 110.852 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.1 169.01 19.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 63.31 110.879 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -63.34 156.75 24.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.884 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -108.26 -68.91 0.88 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 64.01 110.853 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -175.94 178.09 1.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 73.22 110.893 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.94 36.5 2.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 74.14 110.901 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -50.61 -29.78 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 74.44 111.101 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 18.8 mt -111.61 74.79 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 71.44 110.896 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.73 153.51 41.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.12 110.859 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -52.87 101.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 73.34 110.866 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.5 p -116.03 29.15 8.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 75.32 111.126 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 151.8 174.15 22.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 62.15 112.438 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 171.33 14.73 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.638 2.225 . . . . 74.23 112.308 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.63 39.7 98.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 62.42 112.479 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.7 mm -106.13 135.28 45.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.88 0.371 . . . . 74.42 111.085 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.475 HD23 ' CD1' ' A' ' 112' ' ' PHE . 1.1 mt -101.05 149.07 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.924 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.424 ' HB2' ' HA ' ' A' ' 128' ' ' VAL . 0.2 OUTLIER 178.81 131.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 75.33 110.833 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.74 162.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 74.55 110.891 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -156.22 36.8 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 62.34 111.128 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -68.18 -35.71 78.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 71.42 110.928 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -174.61 32.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 75.21 111.06 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.04 -114.34 6.31 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.686 -0.769 . . . . 75.51 112.484 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 114.75 3.81 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.658 2.239 . . . . 70.51 112.34 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 71.19 171.86 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 74.43 110.867 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 66.66 25.68 9.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 75.31 111.143 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -80.3 130.53 35.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 71.1 110.909 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.01 -74.85 0.11 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.774 -0.727 . . . . 61.42 112.489 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.8 p -166.43 43.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 73.44 110.857 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -118.36 54.97 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 74.52 110.945 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.475 ' CD1' HD23 ' A' ' 98' ' ' LEU . 1.5 p90 -77.9 -165.91 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 73.14 110.887 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -154.44 174.58 14.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 74.43 110.837 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.0 mt -111.26 90.93 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.496 . . . . 73.34 111.15 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 55.8 m -65.55 93.13 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 74.45 110.899 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.2 p -65.8 -11.26 44.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.46 . . . . 74.45 111.191 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -145.5 154.95 42.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 65.31 111.096 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -55.64 94.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 70.14 110.915 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.7 p -96.74 49.56 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 74.51 111.097 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -26.01 68.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 71.45 110.863 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -48.11 -29.6 3.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 75.41 110.886 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 19.0 mt -46.92 -33.51 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 73.23 110.925 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.4 OUTLIER 60.54 78.17 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.847 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.94 43.81 0.9 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 62.33 112.467 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -16.27 49.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 72.25 110.87 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -141.41 -168.19 2.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 75.33 110.877 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 51.0 t -122.01 124.22 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 75.23 111.12 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.424 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 2.3 t -93.21 135.67 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.21 111.127 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -160.69 35.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 74.31 110.887 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -174.08 174.9 46.54 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.73 -0.748 . . . . 64.54 112.499 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -176.1 137.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 74.33 110.877 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.1 t -40.73 107.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 75.02 111.092 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -59.82 2.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.04 110.928 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -153.78 157.13 38.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 72.53 110.935 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.11 32.9 19.34 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.737 -0.744 . . . . 65.2 112.487 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.01 -29.19 56.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 74.5 110.93 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.26 -31.19 42.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 74.1 110.896 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.8 mm -65.58 -40.71 88.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 74.2 111.147 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.4 t -63.03 -27.36 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 75.41 111.096 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.91 -27.76 36.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 74.32 110.893 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.91 -38.68 61.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 73.41 111.097 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.8 mtm -61.42 -52.18 65.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 73.44 110.859 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -54.05 -29.61 44.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 74.04 110.904 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.429 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -65.8 -23.37 66.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 73.41 110.906 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.429 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 62.2 m-85 -108.95 18.63 20.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 72.52 110.849 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -114.03 168.46 12.58 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.693 -0.765 . . . . 73.31 112.484 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 m -113.07 146.76 38.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 74.24 110.865 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -76.01 64.45 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 75.34 110.873 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -165.48 -38.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 64.41 110.918 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 157.75 -71.39 0.25 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 74.22 112.501 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 170.4 4.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.817 0.341 . . . . 75.15 110.921 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.8 p -145.39 -173.9 4.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 72.5 111.113 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.74 -67.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 75.25 110.841 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -59.93 -179.22 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 75.02 110.903 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.62 107.07 9.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 72.14 110.913 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.1 mp -86.99 116.41 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 75.54 111.156 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.44 169.58 13.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 72.32 111.126 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 11.6 mm -104.83 109.25 27.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 74.24 111.112 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.68 -45.15 72.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 75.31 111.108 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -161.76 160.03 27.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 73.35 110.856 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.9 146.66 9.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 71.54 110.862 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.97 178.81 48.14 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.684 -0.77 . . . . 64.42 112.452 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -63.98 146.24 54.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.854 0.359 . . . . 72.42 110.922 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.641 HD22 ' HB3' ' A' ' 7' ' ' PHE . 3.5 mm? -102.4 -55.66 2.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 75.5 110.904 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 71.23 110.944 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.838 0.352 . . . . 74.23 111.133 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -123.48 156.26 64.43 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.661 0.744 . . . . 74.21 110.855 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 145.83 58.52 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.694 2.263 . . . . 62.35 112.399 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.1 m -129.71 126.88 39.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 73.44 111.106 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.9 m -121.27 170.51 11.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.139 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.513 ' HB3' HD23 ' A' ' 164' ' ' LEU . 0.6 OUTLIER -158.52 176.37 12.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 74.53 110.882 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -153.13 96.21 2.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.864 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -43.22 106.63 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 74.35 110.867 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.1 mm -78.74 137.63 21.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 74.31 111.114 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.25 160.42 34.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 64.3 111.112 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -143.33 103.6 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 74.33 111.119 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.96 24.98 9.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 73.45 110.902 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.11 -25.29 25.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 72.34 112.512 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -90.28 125.17 60.96 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.672 0.748 . . . . 74.3 110.886 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 124.49 11.14 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.653 2.235 . . . . 74.3 112.328 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.7 mt -68.25 -38.15 81.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 75.04 110.941 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.93 -131.17 2.86 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.669 -0.777 . . . . 65.32 112.434 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.67 136.66 53.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 75.24 110.9 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.3 t -142.4 99.46 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 65.15 111.137 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 22' ' ' PHE . 1.5 t -106.36 174.01 6.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 65.32 110.839 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.434 ' N ' ' OG ' ' A' ' 21' ' ' SER . 48.2 m-85 -144.81 132.97 21.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 73.32 110.863 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -89.43 95.95 10.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 75.44 110.893 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.41 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 1.4 mt -81.06 134.61 35.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 62.33 110.896 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -92.18 66.87 4.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 72.34 110.852 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.91 -22.81 27.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 75.23 111.129 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -65.22 -39.44 92.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 71.35 110.813 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -96.58 -27.84 14.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 74.14 110.882 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.54 66.2 63.75 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.612 0.72 . . . . 71.52 111.112 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -45.91 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.703 2.268 . . . . 64.32 112.348 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -54.41 -34.71 61.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.434 . . . . 75.32 110.912 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.5 m -89.64 -54.11 4.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 73.11 111.109 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.92 -42.27 62.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 54.53 111.116 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -56.04 -27.18 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 71.51 110.925 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -66.68 -65.68 0.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 74.4 110.901 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.94 -34.66 70.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 73.45 110.888 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -70.22 -48.27 57.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 74.34 110.894 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.92 -37.18 66.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 73.33 111.118 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mt -76.92 -56.06 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.934 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.0 m -53.6 -32.75 52.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 73.31 110.886 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.6 p -73.42 -53.41 10.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 74.15 111.142 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.54 -13.92 6.49 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 74.11 112.455 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -53.63 -31.01 45.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.373 . . . . 73.41 110.877 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -27.9 60.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 72.45 110.925 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.04 -17.12 53.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 54.41 112.515 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -154.85 -165.18 1.98 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.907 0.385 . . . . 72.31 110.865 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.05 -123.41 1.47 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 73.3 112.473 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -121.7 31.72 6.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.934 0.397 . . . . 74.35 110.905 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.67 114.34 20.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 74.04 110.882 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.48 41.26 94.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 63.12 112.484 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 m -121.45 138.24 54.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.827 0.346 . . . . 74.45 110.845 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 55.9 m -56.34 150.57 14.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 72.33 110.859 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -69.37 -179.86 1.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 73.51 110.89 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -110.9 -72.62 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.15 110.854 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -143.34 157.81 44.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 73.33 110.818 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.9 mt -147.03 111.89 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 73.44 111.105 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.3 mt -109.76 102.28 49.67 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.682 0.753 . . . . 73.23 111.108 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 53.9 Cg_endo -69.77 88.53 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.714 2.276 . . . . 74.32 112.339 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.89 -20.33 1.61 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 50.0 112.46 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.54 -54.38 1.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 71.11 110.865 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 171.03 166.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.914 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.6 m -91.7 -162.08 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 72.11 110.87 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -165.4 112.84 0.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 73.54 110.961 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 72.13 112.506 -179.958 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.875 0.369 . . . . 70.04 111.123 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -135.9 34.63 2.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 73.52 110.946 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.26 -109.73 2.48 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.752 -0.737 . . . . 62.41 112.516 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -111.12 -30.76 7.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.38 . . . . 74.14 110.873 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.421 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.3 179.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 71.12 110.913 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -148.15 164.98 32.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 74.11 110.838 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.61 171.31 15.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 72.24 110.865 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.76 153.88 40.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 75.32 110.877 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -106.63 -78.46 0.58 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 63.25 110.873 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.5 p30 -155.1 172.89 17.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 72.43 110.895 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.9 39.27 3.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 75.23 110.877 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -49.92 -30.26 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 75.14 111.104 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.6 mt -108.05 91.63 3.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 75.41 110.959 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.11 150.87 43.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 71.24 110.867 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -63.42 89.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 63.0 110.858 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.39 -55.3 5.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 63.22 111.102 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . -145.66 -166.73 12.05 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.719 -0.753 . . . . 41.33 112.512 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 172.17 13.17 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.686 2.257 . . . . 74.13 112.3 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.5 12.67 77.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.732 -0.747 . . . . 71.24 112.471 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.7 mm -89.05 143.39 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 75.52 111.129 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.441 HD23 ' HB2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -114.14 143.14 45.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.898 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.5 -165.25 2.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 74.54 110.872 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -95.53 104.94 16.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 73.15 110.856 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.04 77.37 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 43.23 111.141 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 22.1 p-10 -129.14 -172.28 2.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 74.44 110.897 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.22 -18.9 64.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 71.03 111.098 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.5 -82.68 0.33 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.74 -0.743 . . . . 74.42 112.512 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 96.14 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.728 2.285 . . . . 73.43 112.329 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 71.92 166.13 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 74.01 110.874 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 p 66.1 45.48 2.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 61.14 111.159 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 1.9 m-20 -43.81 -31.76 0.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 74.43 110.843 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . 70.58 -64.24 0.83 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 73.0 112.52 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 1.2 t 84.72 58.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.85 0.357 . . . . 74.0 110.849 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -109.93 -15.99 13.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 75.23 110.967 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.613 ' CD1' ' C ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER 73.47 154.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 75.14 110.883 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.563 ' O ' ' C ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -165.08 67.77 0.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 75.31 110.873 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.563 ' C ' ' O ' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -23.67 123.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 74.25 111.093 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 37.2 m -96.28 114.14 25.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 74.32 110.863 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.1 p -93.16 27.39 2.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 63.11 111.163 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 176.38 142.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 63.25 111.131 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.404 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 3.6 tttt -53.42 99.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 74.04 110.893 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 28.8 p -98.89 48.63 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 73.12 111.134 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.39 -25.52 68.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 75.15 110.904 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.8 p90 -48.99 -28.29 3.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 75.1 110.915 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 26.1 mt -48.37 -32.12 7.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 72.25 110.913 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.0 m-20 59.77 76.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.31 110.934 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.98 41.5 0.98 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.74 -0.743 . . . . 75.03 112.509 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.93 -26.4 36.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.822 0.344 . . . . 74.13 110.894 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -129.3 -167.76 1.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 73.5 110.89 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 76.0 t -127.89 118.27 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 74.13 111.139 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.53 129.94 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 70.22 111.134 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -151.2 33.49 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 72.52 110.894 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -172.68 175.28 45.77 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 43.21 112.477 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -175.75 137.28 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.813 0.34 . . . . 72.13 110.938 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.8 t -41.63 105.73 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 73.43 111.142 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -59.95 3.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 70.45 110.898 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -154.28 161.91 41.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 74.42 110.921 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.05 33.66 28.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.721 -0.752 . . . . 55.22 112.498 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -29.45 57.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 74.25 110.862 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.53 -33.02 53.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 73.42 110.885 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.3 mm -65.56 -35.72 75.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 64.12 111.122 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.3 t -67.09 -26.92 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 72.34 111.139 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -82.27 -27.81 32.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 74.24 110.869 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.74 -41.28 60.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.488 . . . . 70.14 111.083 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.3 mtm -62.27 -51.73 66.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 73.31 110.91 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -54.06 -26.01 24.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.452 . . . . 72.34 110.899 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.426 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.34 -24.59 62.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 75.51 110.84 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.426 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 67.6 m-85 -107.58 12.12 27.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 72.14 110.902 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.39 171.64 17.7 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 73.11 112.487 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.68 131.09 55.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.849 0.357 . . . . 73.24 110.876 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -54.56 -28.07 43.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 70.11 110.813 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -72.53 -29.68 63.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 71.53 110.854 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.83 -42.45 1.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 35.34 112.49 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.27 -177.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.873 0.368 . . . . 64.13 110.881 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.5 p -144.78 138.41 27.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.207 -0.451 . . . . 73.31 111.148 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.69 -44.84 63.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 73.52 110.842 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.42 -177.68 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 73.24 110.925 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.78 109.13 18.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 74.23 110.911 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.1 mp -93.46 118.24 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 75.34 111.142 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.26 162.58 26.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 74.22 111.157 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 20.0 mm -101.29 117.16 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 75.03 111.098 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.65 -47.07 20.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 65.02 111.112 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -153.74 157.49 39.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 72.25 110.848 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -160.32 147.48 16.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 75.11 110.904 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.19 161.73 21.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.7 -0.762 . . . . 63.15 112.437 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.62 108.58 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.37 . . . . 72.44 110.933 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.513 HD23 ' HB3' ' A' ' 7' ' ' PHE . 2.1 mm? -50.78 -49.86 57.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.41 110.892 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 72.45 110.915 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 C--O 1.23 0.035 0 CA-C-O 120.849 0.357 . . . . 73.54 111.116 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -106.52 155.83 38.13 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.721 . . . . 74.33 110.884 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 146.95 61.54 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.629 2.22 . . . . 73.32 112.375 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -135.39 142.35 45.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 61.44 111.164 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.44 ' HA ' HD22 ' A' ' 164' ' ' LEU . 1.3 m -133.12 143.4 39.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 73.32 111.094 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 16.1 p90 -104.13 164.12 11.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 72.24 110.861 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -147.4 85.07 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 65.32 110.836 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.66 106.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 74.34 110.846 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.7 mm -85.01 134.58 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 75.24 111.095 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 156' ' ' ILE . . . -124.07 158.65 31.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 55.0 111.11 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.5 t -137.84 94.45 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 74.33 111.17 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.21 32.19 8.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 73.12 110.851 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.23 -24.0 32.55 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.759 -0.734 . . . . 75.12 112.51 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -91.74 115.01 63.74 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.633 0.73 . . . . 65.43 110.902 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.6 Cg_endo -69.76 122.59 9.27 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.682 2.254 . . . . 73.1 112.335 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.6 mt -66.64 -37.86 85.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 64.54 110.964 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.41 -122.29 1.2 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.72 -0.752 . . . . 73.34 112.48 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -130.12 138.22 50.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.853 0.359 . . . . 73.5 110.873 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.6 t -145.14 99.56 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 74.43 111.114 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.1 t -108.16 174.91 5.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 63.51 110.823 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.445 ' N ' ' OG ' ' A' ' 21' ' ' SER . 2.1 m-85 -144.92 131.81 20.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.493 . . . . 75.13 110.909 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.432 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 60.0 tt0 -86.4 97.04 10.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 71.44 110.933 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -77.39 124.43 27.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 74.13 110.925 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -80.64 64.31 5.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 75.11 110.89 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.41 -22.38 12.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 55.45 111.12 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.32 -48.96 77.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 73.05 110.847 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -90.1 -29.64 18.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 73.14 110.892 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.89 67.84 81.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.618 0.723 . . . . 74.31 111.064 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -41.01 4.59 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.713 2.275 . . . . 71.31 112.316 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -35.27 79.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 72.43 110.936 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 48.5 m -84.63 -44.23 13.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 74.34 111.112 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.18 -47.05 78.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 65.21 111.089 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -50.96 -27.03 6.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 72.01 110.889 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -65.81 -63.39 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 75.53 110.892 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -61.11 -34.78 75.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 72.41 110.867 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.78 -47.06 64.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 73.01 110.87 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.87 -39.84 72.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 74.54 111.132 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mt -79.34 -49.46 12.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 74.05 110.957 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.7 m -55.69 -37.84 68.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 74.31 110.846 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.9 p -74.91 -47.14 31.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 73.22 111.126 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.55 -11.95 13.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.738 -0.744 . . . . 73.12 112.505 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -52.07 -37.78 54.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 71.32 110.843 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -58.85 -27.48 65.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 73.53 110.905 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.76 -14.79 56.11 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.718 -0.754 . . . . 75.23 112.46 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -158.68 -166.07 1.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.885 0.374 . . . . 70.15 110.879 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.23 -133.2 2.98 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.681 -0.771 . . . . 64.02 112.446 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -149.72 48.35 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.933 0.397 . . . . 75.12 110.923 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -58.7 125.73 24.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 70.25 110.924 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.11 43.15 17.53 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.776 -0.726 . . . . 74.24 112.478 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.47 -169.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.831 0.348 . . . . 74.14 110.903 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.0 p -125.17 132.29 53.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 72.33 110.886 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -110.7 108.91 18.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 75.15 110.869 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -133.45 37.75 3.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 74.12 110.848 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.46 77.96 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 75.31 110.851 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.6 mt -117.87 109.56 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 75.41 111.15 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.2 mt -97.77 104.51 21.8 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.606 0.717 . . . . 73.24 111.155 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 53.4 Cg_endo -69.76 85.94 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.687 2.258 . . . . 64.23 112.351 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.71 -19.88 1.82 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 65.2 112.489 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.9 -56.6 1.93 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.857 0.36 . . . . 73.54 110.846 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 171.1 165.21 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 74.12 110.862 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 15.6 m -99.79 -161.85 0.9 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.445 . . . . 75.51 110.934 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.4 145.87 22.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 74.04 110.916 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 51.14 112.454 -179.965 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.3 pt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.884 0.373 . . . . 74.33 111.162 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -161.34 -64.29 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 75.24 110.952 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -132.15 166.68 23.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.706 -0.759 . . . . 54.32 112.492 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.14 -26.0 2.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.917 0.389 . . . . 74.0 110.899 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.427 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 176.13 173.47 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 75.12 110.928 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -149.76 167.82 25.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 71.35 110.891 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.75 167.63 20.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 74.52 110.912 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.13 135.02 57.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 73.23 110.852 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -83.33 -77.31 0.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 75.41 110.885 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.1 p30 -156.25 174.42 15.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 75.32 110.939 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.52 36.93 3.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 73.14 110.821 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.09 -32.13 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.2 111.117 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 21.8 mt -109.99 86.96 2.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 72.54 110.932 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -75.1 145.83 41.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 73.25 110.946 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.9 m80 -49.85 103.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 70.51 110.857 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.2 p -114.4 28.4 8.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 74.11 111.117 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.17 175.76 21.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.685 -0.769 . . . . 61.51 112.469 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 175.96 7.35 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.7 2.267 . . . . 74.11 112.34 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.13 26.63 69.43 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 74.33 112.45 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.2 mm -95.9 140.34 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.828 0.347 . . . . 74.32 111.166 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.34 139.25 44.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 73.45 110.861 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.13 156.71 39.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 72.22 110.842 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -59.95 96.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 74.44 110.837 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.4 ' HB3' ' HG2' ' A' ' 111' ' ' GLN . . . -63.99 89.65 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 73.21 111.133 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.71 173.55 11.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 74.01 110.882 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.93 -23.06 6.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 72.51 111.074 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 122.44 -82.16 0.35 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 62.14 112.52 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 91.91 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.696 2.264 . . . . 65.15 112.359 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 73.66 171.8 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 74.15 110.889 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 p 66.0 39.07 4.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 75.23 111.098 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -45.36 -30.48 1.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.838 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.436 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . 51.92 -118.47 7.3 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.777 -0.725 . . . . 62.42 112.491 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 1.5 p 165.4 67.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 72.14 110.882 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.4 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 2.4 tt0 -102.79 -27.51 12.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 73.52 110.923 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.569 ' CD1' ' C ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER 68.09 151.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 75.55 110.861 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -164.39 85.81 0.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 65.42 110.927 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.2 mt -42.06 114.44 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 75.53 111.135 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.8 m -85.87 122.44 29.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 75.12 110.9 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.2 p -91.73 24.04 3.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 73.35 111.139 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 179.34 154.61 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 51.11 111.053 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.2 86.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 74.05 110.91 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 32.6 p -84.16 53.4 2.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 74.35 111.093 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -66.8 -23.14 66.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 74.12 110.909 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -53.75 -25.69 20.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 74.31 110.963 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 38.2 mt -45.6 -33.48 2.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 74.41 110.933 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 124' ' ' GLY . 1.6 m-20 61.95 76.18 0.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 62.2 110.838 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.6 41.54 0.85 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 70.23 112.478 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.67 -21.89 37.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.835 0.35 . . . . 74.14 110.938 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -137.43 -167.23 2.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 74.05 110.861 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.9 t -127.06 122.07 59.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 73.13 111.161 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 t -88.1 133.3 30.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 75.54 111.106 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -156.97 32.55 0.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 74.13 110.852 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -169.44 172.1 43.4 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.727 -0.749 . . . . 54.12 112.47 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 131' ' ' LYS . 1.6 pttt -176.11 132.41 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 73.41 110.916 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 131' ' ' LYS . 97.4 t -37.97 105.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.51 111.163 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.432 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -67.31 -58.69 4.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 75.14 110.94 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -150.99 170.29 19.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 72.22 110.87 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.13 31.0 64.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.735 . . . . 72.43 112.502 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.21 -26.38 11.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.771 0.32 . . . . 75.13 110.893 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.18 -31.89 54.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 74.54 110.886 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.4 mm -64.96 -40.26 88.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 71.24 111.107 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.43 -28.67 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 72.43 111.162 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -78.01 -29.02 49.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 73.42 110.885 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.96 57.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 71.32 111.132 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 35.9 mtm -61.38 -41.9 97.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 74.53 110.844 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.402 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 13.1 tm-20 -53.47 -30.57 41.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 72.42 110.89 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.408 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -73.55 -27.23 61.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 72.32 110.875 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.408 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 61.4 m-85 -105.44 30.01 6.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 75.52 110.81 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.0 151.69 17.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.766 -0.73 . . . . 75.23 112.51 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.5 m -114.37 140.52 48.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 63.22 110.854 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -74.11 70.18 1.55 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.34 110.886 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -179.93 -33.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 63.13 110.88 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 153.96 -100.61 0.2 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.773 -0.727 . . . . 72.4 112.468 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.32 169.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 72.32 110.912 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.6 p -143.65 -171.04 3.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 65.1 111.093 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.1 p -78.39 -55.31 5.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 63.14 110.847 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -81.54 166.66 20.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 74.42 110.877 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -111.95 110.08 20.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 74.01 110.888 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 4.8 mp -89.46 118.18 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 72.34 111.132 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.67 164.36 24.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 75.55 111.127 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.8 mt -98.44 123.04 50.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 73.4 111.073 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.53 -49.05 11.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 63.42 111.118 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -153.4 155.96 37.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 73.25 110.875 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.56 148.97 18.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 73.23 110.902 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 172.42 172.28 38.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.703 -0.76 . . . . 61.13 112.495 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -64.67 142.36 58.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.363 . . . . 63.33 110.867 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -94.86 -59.58 1.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 74.21 110.903 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 74.2 110.913 179.955 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.458 -0.049 0 CA-C-O 120.839 0.352 . . . . 75.3 111.083 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -70.63 117.51 56.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.615 0.721 . . . . 64.41 110.861 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 152.6 69.31 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.653 2.235 . . . . 72.14 112.337 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -137.78 139.64 40.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 65.54 111.145 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.44 ' HA ' HD22 ' A' ' 164' ' ' LEU . 1.4 m -127.38 142.5 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 75.31 111.142 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.59 ' HB3' HD21 ' A' ' 164' ' ' LEU . 7.3 p90 -106.1 155.45 19.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 73.21 110.872 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -143.8 86.72 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 73.13 110.847 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -47.75 125.91 9.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 73.24 110.846 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.5 mm -97.61 111.36 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 74.11 111.168 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -104.62 126.04 51.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 75.03 111.082 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 t -111.13 101.28 12.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 72.23 111.103 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 t0 59.87 43.55 14.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 73.15 110.87 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.58 0.83 88.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.747 -0.739 . . . . 73.11 112.511 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -113.22 102.4 54.74 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.628 0.728 . . . . 75.21 110.91 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.6 Cg_endo -69.81 110.88 2.67 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.626 2.217 . . . . 74.13 112.361 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.3 mp -65.45 -35.27 80.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 75.34 110.915 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.36 -133.72 3.04 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.731 . . . . 74.21 112.499 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -128.36 146.75 50.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 74.25 110.861 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.7 101.44 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 75.25 111.17 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -107.52 170.94 7.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.833 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -143.35 138.05 29.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 74.52 110.858 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.448 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 19.7 tt0 -91.17 99.94 12.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 74.42 110.865 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.406 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 5.5 mt -82.56 123.13 28.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 72.54 110.923 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -79.04 63.5 3.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 75.42 110.86 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.13 -22.32 16.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 74.41 111.062 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.17 -36.27 74.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 75.14 110.868 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.37 -25.31 15.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 72.11 110.919 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.44 65.51 34.04 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.625 0.726 . . . . 75.43 111.107 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -35.77 11.95 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.698 2.265 . . . . 74.21 112.339 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -39.82 89.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 75.32 110.859 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 98.6 m -87.28 -45.3 10.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 71.23 111.165 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.73 91.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 73.02 111.1 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -47.42 -35.15 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 74.32 110.874 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -62.64 -68.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 54.1 110.906 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -56.21 -23.44 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 72.34 110.903 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.463 ' NH2' ' HG2' ' A' ' 163' ' ' GLN . 0.0 OUTLIER -68.17 -54.21 19.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 75.34 110.854 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.57 -26.46 66.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.51 111.103 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.5 mt -79.0 -56.45 4.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 73.42 110.925 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.9 m -49.38 -46.13 46.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 65.44 110.834 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.3 p -72.44 -27.27 62.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 75.23 111.166 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.5 -8.81 74.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.726 -0.75 . . . . 73.11 112.475 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -18.55 50.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 72.21 110.883 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.36 -30.59 12.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 74.42 110.928 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.64 -23.97 6.57 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.763 -0.732 . . . . 74.12 112.509 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -160.59 -50.84 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 73.35 110.867 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.97 163.18 0.17 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.718 -0.753 . . . . 72.34 112.499 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -96.48 26.67 4.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.0 0.429 . . . . 74.35 110.934 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.17 142.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 72.21 110.904 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.83 27.05 74.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.706 -0.759 . . . . 53.32 112.487 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.37 -176.46 0.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.827 0.346 . . . . 72.32 110.844 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.9 p -126.06 122.47 35.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 74.14 110.856 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -86.98 130.61 34.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 75.23 110.877 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -147.33 46.82 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.14 110.889 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -158.94 61.59 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 75.24 110.905 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 13.7 mt -107.92 109.25 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 75.32 111.127 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.6 mt -100.2 103.78 25.23 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.604 0.716 . . . . 73.42 111.093 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.413 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 53.8 Cg_endo -69.75 85.01 0.63 Allowed 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.722 2.281 . . . . 73.53 112.34 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.37 -20.46 1.19 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.731 . . . . 71.43 112.479 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.89 -57.93 1.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.915 0.388 . . . . 72.13 110.911 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 174.19 164.48 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 62.01 110.827 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 10.1 m -100.81 -168.45 1.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 73.53 110.931 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 177.24 146.21 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 73.32 110.887 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.756 . . . . 72.33 112.497 179.991 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.2 pt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.829 0.347 . . . . 74.01 111.145 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -155.88 46.4 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 75.14 110.918 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.34 -133.98 11.51 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 72.12 112.479 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -79.23 -38.94 34.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.939 0.399 . . . . 62.54 110.88 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.429 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.2 176.63 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 75.12 110.893 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.75 -178.18 3.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 72.3 110.858 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -95.34 167.88 11.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.109 -0.496 . . . . 74.21 110.872 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -60.63 154.93 20.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 61.24 110.836 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -112.23 -67.44 1.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.02 110.881 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -176.45 178.11 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 75.43 110.871 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.46 35.99 3.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 74.42 110.918 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.51 -30.16 7.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 72.44 111.123 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.9 mt -111.41 79.52 1.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 73.14 110.916 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -69.89 152.05 44.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 75.5 110.897 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -56.73 97.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 74.3 110.898 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.1 p -108.93 26.31 10.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 74.01 111.145 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.58 178.64 25.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.719 -0.753 . . . . 62.53 112.496 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 171.57 14.16 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.736 2.291 . . . . 74.11 112.335 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.9 37.64 94.54 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 64.24 112.468 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 21.5 mm -108.62 136.99 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.884 0.373 . . . . 74.53 111.163 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.503 HD22 ' CD1' ' A' ' 112' ' ' PHE . 4.2 mt -103.1 162.18 13.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 73.12 110.92 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.16 -160.15 0.31 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 75.43 110.786 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.3 mmt -121.93 138.15 54.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 73.54 110.903 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.452 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -119.05 148.22 43.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 70.42 111.1 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 2.4 m-20 163.73 -50.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 75.02 110.88 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -178.11 30.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 75.13 111.101 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.33 -120.89 5.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 61.15 112.509 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 126.35 13.17 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.629 2.219 . . . . 74.11 112.337 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 69.11 173.02 0.3 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 65.52 110.898 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 p 67.07 26.38 8.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 73.41 111.142 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -72.25 146.63 47.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 74.13 110.853 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.89 -106.88 0.9 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 72.45 112.518 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.6 p -151.43 33.74 0.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.81 0.338 . . . . 70.12 110.9 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -114.42 51.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 72.33 110.902 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.503 ' CD1' HD22 ' A' ' 98' ' ' LEU . 5.4 p90 -56.85 -169.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 62.34 110.892 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.87 164.27 37.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 74.05 110.894 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.4 mt -108.66 90.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 71.42 111.145 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 57.3 m -63.41 91.29 0.05 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 72.04 110.89 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.2 p -61.68 -15.16 37.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 72.34 111.111 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -143.89 156.4 44.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 74.33 111.08 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -56.06 94.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 75.42 110.864 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.7 p -95.49 46.11 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 71.42 111.151 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -23.88 67.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 74.45 110.853 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -49.54 -28.16 5.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 75.1 110.896 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.9 mt -46.77 -34.06 4.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.227 -0.442 . . . . 75.15 110.912 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.4 OUTLIER 63.01 75.18 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 74.11 110.889 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.11 43.71 0.7 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.732 -0.747 . . . . 73.31 112.495 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -80.34 -27.42 38.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 74.34 110.91 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -127.18 -168.65 1.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 72.02 110.856 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.7 t -121.43 110.22 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 65.02 111.114 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.4 t -83.84 134.57 26.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 73.41 111.166 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -158.24 44.85 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 74.14 110.902 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . 179.02 175.25 45.89 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.772 -0.728 . . . . 75.43 112.525 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.2 pttp -174.9 145.19 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 72.13 110.927 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 32.7 t -44.73 113.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 74.23 111.155 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.448 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -78.14 -61.24 2.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 64.05 110.929 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -152.35 151.42 30.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 73.04 110.881 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.77 30.44 9.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.733 . . . . 52.21 112.529 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -26.41 26.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.782 0.325 . . . . 73.23 110.886 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.19 -34.1 68.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 74.11 110.841 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.5 mm -69.39 -38.27 76.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 64.35 111.101 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.21 -28.66 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 75.13 111.152 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -75.75 -31.31 59.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.887 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.07 -41.41 70.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 75.43 111.093 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 21.4 mtm -58.04 -45.36 87.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 72.23 110.902 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 11.3 tm-20 -54.59 -25.3 25.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 72.43 110.909 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.99 -28.87 43.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 72.23 110.9 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -105.26 34.27 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.31 110.865 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.414 ' HA3' HG23 ' A' ' 56' ' ' ILE . . . -113.58 161.01 12.84 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 73.23 112.466 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 t -117.75 143.64 46.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.89 0.376 . . . . 75.14 110.852 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -74.76 63.85 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 75.54 110.906 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -175.45 -34.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 75.44 110.893 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.59 -44.81 0.74 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.746 -0.74 . . . . 71.32 112.478 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -62.65 -169.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 75.54 110.902 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.82 147.97 4.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 74.14 111.167 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.97 -39.61 90.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 73.0 110.864 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.32 171.56 7.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 73.11 110.894 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -114.85 108.72 17.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 75.43 110.924 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.8 mp -93.39 119.52 41.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 75.33 111.121 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.71 163.09 25.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 70.52 111.122 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.5 mt -91.28 109.37 21.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 72.33 111.123 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.03 -43.47 62.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 72.04 111.07 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -162.61 155.0 19.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 75.44 110.864 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.56 148.44 16.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.211 -0.449 . . . . 71.55 110.956 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.26 -174.65 44.72 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.739 -0.743 . . . . 75.2 112.489 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.463 ' HG2' ' NH2' ' A' ' 37' ' ' ARG . 3.1 mt-30 -82.03 131.22 35.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.351 . . . . 71.42 110.897 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.59 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.2 mm? -86.92 -60.79 1.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.945 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 75.33 110.911 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.888 0.375 . . . . 71.43 111.138 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -94.29 154.81 40.35 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.596 0.712 . . . . 60.44 110.883 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 146.09 59.05 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 74.12 112.374 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -133.98 142.97 47.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 73.32 111.15 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.46 ' HA ' HD21 ' A' ' 164' ' ' LEU . 1.8 m -134.23 141.73 42.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 74.24 111.136 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.575 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 13.6 p90 -101.49 168.54 9.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 74.42 110.876 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -148.44 88.9 1.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 73.11 110.87 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -51.25 102.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 60.1 110.873 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.5 mm -80.3 135.95 24.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 74.34 111.164 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -127.71 155.41 44.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 75.0 111.142 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.9 t -136.0 94.09 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 65.21 111.139 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.61 32.01 7.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 75.54 110.873 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.55 -23.63 33.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.753 -0.737 . . . . 52.05 112.481 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -92.3 115.62 65.04 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.615 0.721 . . . . 75.44 110.922 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.4 Cg_endo -69.76 121.26 7.95 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.703 2.269 . . . . 73.23 112.319 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.1 mt -65.64 -37.58 86.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 73.41 110.927 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.43 -125.6 1.69 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 70.3 112.509 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -128.44 136.95 51.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 74.25 110.853 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.24 103.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 75.52 111.146 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -109.42 173.25 6.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 71.31 110.885 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.413 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -143.8 127.9 17.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 74.32 110.87 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -82.89 99.59 9.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 75.24 110.913 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.417 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 1.4 mt -83.18 122.79 28.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 74.23 110.889 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -77.48 67.25 3.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 75.14 110.903 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.45 -20.89 33.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 75.43 111.105 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -68.57 -38.48 80.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 74.53 110.859 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.48 -28.07 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 72.13 110.925 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.68 67.9 58.79 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.627 0.727 . . . . 64.24 111.105 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -36.91 9.89 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.705 2.27 . . . . 75.44 112.338 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.68 -37.68 82.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 73.44 110.907 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.4 m -88.53 -43.21 11.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 65.55 111.173 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.42 -49.38 77.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 75.24 111.136 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -51.29 -27.67 10.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.22 110.903 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.0 -63.83 0.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.33 110.897 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -59.94 -32.75 71.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 74.21 110.883 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -71.72 -47.8 51.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 75.23 110.903 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.3 -36.94 69.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 70.13 111.097 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.5 mt -77.65 -50.69 11.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 75.15 110.9 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.5 m -58.68 -38.13 77.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 73.14 110.873 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.5 p -71.37 -38.6 71.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 72.24 111.144 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.81 -10.8 45.27 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.732 -0.746 . . . . 73.1 112.467 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -30.72 39.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 73.02 110.854 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -65.69 -28.71 69.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 72.23 110.927 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.28 -15.98 58.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.734 . . . . 61.21 112.516 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -155.11 -167.39 2.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.895 0.379 . . . . 75.41 110.866 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.56 -158.43 28.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.749 . . . . 61.43 112.492 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -112.42 21.09 16.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.929 0.395 . . . . 73.54 110.864 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.51 121.43 5.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 74.13 110.919 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.37 44.73 9.3 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.761 -0.733 . . . . 31.45 112.458 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.7 t -92.59 -169.38 2.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.824 0.345 . . . . 63.35 110.873 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 8.1 p -121.14 143.43 49.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 74.32 110.889 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -99.98 141.28 33.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 74.31 110.871 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -151.87 48.26 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 73.02 110.807 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.1 tpp85 -172.95 68.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 75.5 110.894 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.7 mt -116.11 113.3 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 73.3 111.127 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.5 mt -110.26 103.16 53.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.629 0.728 . . . . 73.34 111.156 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 86.24 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.671 2.247 . . . . 74.41 112.353 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.57 -20.77 1.5 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.737 -0.744 . . . . 72.55 112.485 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.87 -52.47 1.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 73.41 110.869 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.51 166.46 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 73.41 110.876 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.7 m -107.34 -169.4 1.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 73.12 110.918 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 173.85 149.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 74.44 110.891 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.67 -0.776 . . . . 71.03 112.497 -179.945 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.873 0.368 . . . . 74.15 111.125 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -127.79 -77.8 0.57 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 74.44 110.951 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -151.24 -76.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.67 -0.776 . . . . 50.12 112.464 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 4.7 mm-40 -117.55 -52.58 2.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.919 0.39 . . . . 75.1 110.909 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER 179.04 152.24 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 74.42 110.908 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -117.32 167.62 11.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 74.32 110.885 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.49 161.53 16.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.494 . . . . 73.33 110.881 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -48.28 151.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 73.44 110.848 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -102.78 -76.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 61.21 110.899 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -158.25 172.8 17.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 72.13 110.934 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.13 38.02 3.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 73.55 110.901 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.31 -31.53 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 65.11 111.156 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.8 mt -107.42 91.94 3.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 75.12 110.908 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -73.36 148.2 43.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 74.32 110.903 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -57.5 96.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 75.31 110.855 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -85.19 -57.93 2.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 75.03 111.129 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -143.26 -164.88 10.46 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.774 -0.727 . . . . 75.32 112.484 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 175.31 8.3 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.667 2.244 . . . . 73.12 112.359 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.07 21.19 69.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.785 -0.721 . . . . 72.03 112.512 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.1 mm -96.19 142.54 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.381 . . . . 65.3 111.144 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -114.49 143.71 44.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 65.11 110.929 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.98 -165.24 2.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 73.44 110.882 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 35.5 mtm -92.22 99.02 11.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 74.23 110.878 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.07 60.33 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.427 . . . . 65.34 111.096 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -118.7 -179.17 3.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.04 110.922 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.07 -24.49 3.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 65.0 111.121 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.96 -80.84 0.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.759 -0.734 . . . . 64.51 112.502 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 89.56 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.664 2.243 . . . . 75.13 112.322 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 66.26 -170.37 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 75.14 110.883 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.2 p 67.32 34.42 4.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 64.32 111.154 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.83 148.47 23.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 63.42 110.913 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.65 59.2 0.44 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.73 -0.747 . . . . 63.44 112.462 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 65.2 36.2 7.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.836 0.35 . . . . 73.02 110.89 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -59.66 -169.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 74.21 110.909 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.464 ' HB2' HD22 ' A' ' 98' ' ' LEU . 0.0 OUTLIER 177.43 149.05 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.92 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -165.49 73.2 0.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 74.22 110.884 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.506 ' C ' ' O ' ' A' ' 113' ' ' PHE . 19.1 mt -28.4 106.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 75.4 111.126 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 35.7 m -80.5 117.84 21.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 73.51 110.888 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.5 p -94.84 26.36 3.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 72.12 111.154 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 176.7 145.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 55.25 111.123 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -54.83 100.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 72.11 110.9 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.9 p -101.19 47.61 0.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 75.21 111.147 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -26.25 68.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 70.44 110.852 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -48.41 -28.62 3.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 74.31 110.942 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 26.0 mt -47.4 -35.82 8.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 74.11 110.914 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 124' ' ' GLY . 1.8 m-20 61.24 81.43 0.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 72.13 110.884 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.05 43.27 0.87 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 74.33 112.497 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.98 -17.86 39.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.785 0.326 . . . . 74.41 110.885 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -143.59 -168.1 2.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 74.22 110.851 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.4 t -126.26 119.32 53.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 73.24 111.115 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.8 t -83.23 129.89 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 75.11 111.107 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -153.86 33.83 0.44 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.862 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -171.96 172.85 44.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.722 . . . . 70.41 112.486 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -175.81 135.18 0.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 73.44 110.914 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.7 t -39.69 104.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 64.03 111.13 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.75 -60.0 2.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 73.51 110.899 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -154.56 160.22 41.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 75.15 110.882 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.59 32.03 28.61 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 74.35 112.528 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -29.59 26.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.747 0.308 . . . . 73.31 110.871 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.44 -32.4 49.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 72.25 110.907 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.0 mm -65.74 -38.85 83.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 74.13 111.091 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.9 t -64.39 -27.22 42.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 74.44 111.163 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.24 -28.49 38.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 61.55 110.876 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.82 -43.2 59.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 64.53 111.096 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 40.7 mtm -60.73 -51.29 69.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 75.32 110.851 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.94 -23.2 30.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 75.2 110.881 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -23.97 61.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 75.44 110.883 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -109.73 19.85 18.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 71.54 110.885 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.5 167.37 12.35 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.773 -0.727 . . . . 72.22 112.47 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.5 m -109.8 148.15 31.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 75.54 110.851 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.4 mmm-85 -76.53 64.21 2.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 72.34 110.875 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -174.13 -36.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 73.43 110.902 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 156.76 -47.65 0.48 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 72.42 112.525 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 168.11 9.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.84 0.352 . . . . 75.43 110.935 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.3 p -144.91 -174.24 4.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 72.23 111.157 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.84 -68.3 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 62.24 110.852 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.28 -176.06 4.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 74.33 110.924 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.85 109.73 18.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 72.32 110.921 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mp -85.04 118.34 31.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 74.22 111.18 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.72 162.34 28.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 74.32 111.15 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.6 mt -101.34 120.89 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 71.41 111.12 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.98 -48.83 12.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 72.01 111.119 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -156.95 158.31 36.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 71.03 110.828 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.89 146.91 13.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 73.23 110.887 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.68 174.04 45.29 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.747 -0.74 . . . . 74.33 112.471 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -65.0 140.57 58.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.853 0.359 . . . . 74.42 110.924 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.568 HD23 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -93.41 -59.39 2.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 73.11 110.923 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 64.33 110.871 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.7 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.834 0.349 . . . . 74.04 111.147 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -123.51 154.19 66.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.605 0.717 . . . . 75.01 110.902 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 145.49 57.11 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.709 2.273 . . . . 72.21 112.341 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.9 m -128.84 128.96 44.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 65.13 111.165 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.52 172.71 11.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 74.11 111.18 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.506 ' HB3' HD21 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -162.0 174.26 13.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.905 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -153.05 97.85 2.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 64.45 110.958 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.34 108.96 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 62.11 110.861 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.2 mm -80.11 133.64 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 73.41 111.136 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -125.82 156.37 39.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 74.15 111.086 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.5 t -134.81 96.39 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 65.02 111.171 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.56 30.56 10.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 72.11 110.883 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.31 -23.8 32.11 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 45.4 112.495 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -91.79 116.03 65.68 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.658 0.742 . . . . 74.12 110.872 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.2 Cg_endo -69.77 126.09 12.9 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.687 2.258 . . . . 62.52 112.324 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.1 mt -70.32 -40.93 73.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 73.31 110.938 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.26 -122.13 1.09 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.729 -0.748 . . . . 65.11 112.493 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -134.32 143.12 47.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 74.05 110.908 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.26 100.31 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 74.33 111.156 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 22' ' ' PHE . 2.1 t -104.52 173.78 6.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 75.53 110.854 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.426 ' N ' ' OG ' ' A' ' 21' ' ' SER . 63.9 m-85 -145.18 130.74 18.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 75.41 110.88 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -86.28 95.2 9.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 74.4 110.878 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.1 134.07 36.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 73.04 110.872 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -93.1 66.58 4.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 72.2 110.849 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.67 -22.71 36.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 60.42 111.086 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -65.68 -35.65 81.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 55.31 110.865 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -99.61 -29.24 12.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 73.34 110.922 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.86 66.06 67.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 74.02 111.106 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -35.32 12.7 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.688 2.259 . . . . 73.34 112.321 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.06 -39.39 81.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 72.44 110.895 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.7 m -89.84 -49.25 6.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 74.04 111.135 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.26 -42.16 63.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 65.13 111.094 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.75 -25.18 62.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 75.25 110.919 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.7 -65.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 73.13 110.85 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -31.14 66.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 73.44 110.891 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -73.15 -52.91 12.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 75.14 110.856 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.05 -33.52 57.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 54.02 111.095 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.6 mt -80.59 -56.07 4.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 74.22 110.914 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.1 m -54.38 -36.05 63.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 63.43 110.83 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.9 p -73.9 -45.29 51.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 75.43 111.147 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.7 -14.93 19.76 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.728 -0.749 . . . . 75.42 112.477 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -32.77 46.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 75.32 110.901 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -63.23 -28.77 70.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 75.12 110.892 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.86 -16.52 50.8 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.785 -0.721 . . . . 64.01 112.518 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -156.35 -165.91 2.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.923 0.392 . . . . 74.55 110.871 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.44 -164.75 33.14 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.721 -0.752 . . . . 74.54 112.452 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -105.74 26.78 9.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.911 0.386 . . . . 64.31 110.929 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.38 129.84 16.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 74.42 110.893 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.95 37.71 88.15 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.786 -0.721 . . . . 71.11 112.483 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.4 p -71.92 -172.56 0.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 74.32 110.819 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 8.1 p -131.45 127.33 37.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 61.42 110.858 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -86.0 115.56 23.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 73.14 110.863 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -124.08 32.55 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 61.31 110.878 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.71 83.04 0.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 73.01 110.865 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.0 mt -123.24 110.67 26.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 73.34 111.153 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.4 mt -104.17 104.24 42.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.676 0.75 . . . . 75.52 111.097 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 81.95 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.684 2.256 . . . . 75.53 112.367 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.77 -21.89 0.8 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 74.4 112.508 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.42 -54.95 2.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 75.33 110.892 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 171.58 168.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 72.44 110.867 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 113' ' ' PHE . 34.7 m -106.4 -165.65 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 74.41 110.864 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.62 130.55 9.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 72.14 110.925 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.721 -0.752 . . . . 73.51 112.457 -179.969 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.878 0.371 . . . . 74.41 111.142 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -140.83 35.54 1.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 64.42 110.911 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.97 -140.51 15.04 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.75 -0.738 . . . . 75.34 112.496 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -78.17 -31.28 49.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.892 0.377 . . . . 72.22 110.891 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.434 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.47 -179.56 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 74.33 110.894 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.66 162.7 35.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 73.55 110.892 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -78.78 167.96 20.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 74.14 110.877 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -59.35 146.02 41.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 74.41 110.85 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -102.59 -77.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 64.32 110.889 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -152.24 171.44 17.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 72.22 110.905 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.55 38.36 3.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 70.44 110.901 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mt -50.42 -30.48 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 73.11 111.131 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.6 mt -108.42 93.33 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.952 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -73.03 148.94 43.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 73.5 110.876 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -59.76 94.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.887 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.04 -59.28 2.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 71.31 111.149 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . -142.83 -166.02 10.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 73.12 112.523 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 172.24 12.98 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.676 2.251 . . . . 75.14 112.331 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.15 20.12 76.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.695 -0.764 . . . . 73.24 112.499 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.2 mm -96.21 142.52 13.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.853 0.359 . . . . 73.53 111.11 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.406 HD22 ' HB2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -112.52 141.04 46.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 75.43 110.891 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.22 165.86 32.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 74.13 110.862 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 11.8 mtm -71.92 87.19 1.01 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 72.02 110.922 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -48.35 124.6 8.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 71.14 111.127 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 24.1 p-10 -170.6 -174.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 74.31 110.912 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.03 -12.53 60.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 74.42 111.171 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.12 -83.3 0.34 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 61.3 112.51 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 96.28 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.666 2.244 . . . . 54.45 112.341 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 71.27 178.38 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 62.23 110.875 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.2 p 58.53 40.13 24.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 75.41 111.139 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.451 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 4.2 m120 -43.19 -35.3 1.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 72.54 110.894 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . 69.83 -62.83 0.69 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.8 -0.714 . . . . 71.33 112.46 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 0.6 OUTLIER 81.96 44.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.844 0.354 . . . . 72.41 110.858 -179.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -92.95 -7.63 45.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 73.31 110.88 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.553 ' CD1' ' C ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER 69.16 149.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 75.43 110.931 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.587 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -163.29 70.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 73.3 110.842 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.527 ' C ' ' O ' ' A' ' 113' ' ' PHE . 0.8 OUTLIER -27.48 124.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 71.33 111.154 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.6 m -96.0 114.08 25.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 72.05 110.909 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.9 p -92.56 28.47 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 74.31 111.114 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 175.95 141.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 74.34 111.062 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.406 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 2.1 tttt -50.63 99.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.905 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 49.6 p -98.99 55.67 1.02 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.218 -0.446 . . . . 71.33 111.125 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -23.87 61.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 73.12 110.882 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 8.1 p90 -49.88 -29.6 8.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.95 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 32.0 mt -49.45 -32.52 12.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 73.24 110.931 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.3 m-20 60.13 76.6 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 73.54 110.814 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.46 42.15 0.89 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.717 -0.754 . . . . 70.22 112.444 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.67 -21.93 32.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.831 0.348 . . . . 73.52 110.914 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -129.18 -166.72 1.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 74.33 110.844 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 79.1 t -128.99 118.76 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.21 111.152 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.82 132.57 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 62.32 111.103 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -155.13 30.1 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 72.24 110.878 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.39 173.99 43.14 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.717 -0.754 . . . . 63.1 112.476 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -175.49 135.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 63.33 110.892 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.2 t -40.58 105.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 75.14 111.114 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -59.36 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 71.33 110.903 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -154.19 -178.72 7.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.887 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.91 31.13 60.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 73.31 112.514 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.09 -24.63 55.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 74.14 110.867 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.41 -30.63 19.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 74.12 110.859 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.0 mm -65.15 -38.85 83.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 65.14 111.113 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 74.6 t -63.44 -30.4 49.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 73.01 111.179 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -76.49 -28.83 56.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 74.1 110.841 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.48 -41.3 60.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 54.45 111.102 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 33.8 mtm -61.35 -51.28 69.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 73.43 110.831 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.66 -25.52 27.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 72.24 110.951 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.84 -25.07 61.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 73.31 110.868 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -105.98 10.47 32.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 72.44 110.895 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.8 165.18 13.32 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.792 -0.718 . . . . 62.44 112.452 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.0 m -108.67 148.02 31.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 74.3 110.841 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 -75.95 60.73 1.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 73.12 110.843 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -163.38 -38.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 74.54 110.875 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 158.38 -50.99 0.41 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.789 -0.72 . . . . 74.12 112.492 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.03 174.14 7.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 71.13 110.886 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.8 p -144.36 -170.39 3.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 65.42 111.181 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 63.4 m -98.23 -67.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 62.22 110.843 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -76.89 -175.88 3.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 74.21 110.896 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.52 109.8 18.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.433 . . . . 75.44 110.879 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 4.2 mp -86.37 114.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 75.1 111.098 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.41 164.4 20.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 70.1 111.173 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.4 mt -103.89 125.65 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 73.3 111.099 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.93 -54.51 4.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 73.45 111.144 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -142.2 150.73 41.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 75.31 110.851 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -156.88 146.75 20.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 74.35 110.878 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.66 164.18 24.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.767 -0.73 . . . . 73.23 112.518 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -57.68 111.43 1.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 71.43 110.882 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.1 mm? -54.36 -51.22 65.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 74.53 110.93 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 71.01 110.872 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.458 -0.031 0 CA-C-O 120.861 0.362 . . . . 73.11 111.151 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -106.08 141.53 22.93 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.608 0.718 . . . . 65.4 110.906 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 147.19 62.49 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.686 2.257 . . . . 74.32 112.322 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -130.96 140.85 50.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 73.24 111.174 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.474 ' HA ' HD22 ' A' ' 164' ' ' LEU . 1.5 m -135.14 142.47 39.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 74.34 111.114 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.556 ' HB3' HD21 ' A' ' 164' ' ' LEU . 11.7 p90 -103.37 161.71 13.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 74.11 110.923 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -144.45 89.18 1.98 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 75.34 110.889 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.17 103.24 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 70.33 110.838 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.8 mm -75.85 136.75 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 72.22 111.126 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -128.16 152.98 47.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.04 111.131 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 t -135.97 94.98 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.438 . . . . 74.11 111.116 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.74 31.27 4.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.44 110.859 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.02 -22.18 40.48 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.714 -0.755 . . . . 75.54 112.492 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -94.23 117.41 67.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.676 0.751 . . . . 74.42 110.859 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.75 124.56 11.2 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.683 2.255 . . . . 64.22 112.364 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.408 ' HB3' HD12 ' A' ' 138' ' ' ILE . 8.9 mt -68.87 -39.13 80.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 73.34 110.953 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.52 -135.93 4.62 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 71.12 112.433 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.32 134.33 55.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 74.12 110.917 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -145.79 102.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 73.21 111.137 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -111.44 172.36 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 75.03 110.852 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.41 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -143.97 130.95 20.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 70.03 110.894 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -84.42 100.38 11.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.52 110.896 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.444 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 1.7 mt -84.99 127.77 34.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 71.1 110.911 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -86.79 68.55 10.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 75.02 110.865 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.76 -23.9 32.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 70.41 111.077 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.5 -34.86 78.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 72.34 110.833 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 -27.45 14.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 75.5 110.901 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.42 66.78 37.18 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.636 0.732 . . . . 71.11 111.096 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -36.66 10.39 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.687 2.258 . . . . 73.33 112.3 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -37.56 80.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 74.45 110.834 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.7 m -88.53 -45.65 9.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 73.11 111.116 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.76 -38.66 82.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 72.31 111.11 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -51.22 -35.26 35.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 75.34 110.917 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -64.21 -63.18 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 75.43 110.888 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -56.93 -39.82 75.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 73.34 110.892 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.51 -47.29 76.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 74.1 110.856 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.68 74.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 75.11 111.129 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.2 mt -77.26 -54.8 6.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 74.15 110.904 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.0 m -51.67 -41.97 61.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 61.02 110.861 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -76.24 -34.44 59.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 75.22 111.103 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.26 -11.45 56.97 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.699 -0.762 . . . . 73.15 112.46 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -59.82 -18.77 46.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 72.1 110.905 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.23 -28.35 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.22 110.859 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.52 -26.03 5.26 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.798 -0.715 . . . . 53.22 112.518 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -158.67 -46.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 74.13 110.862 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.92 -149.8 43.99 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.775 -0.726 . . . . 75.04 112.498 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -179.45 92.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.954 0.407 . . . . 73.22 110.94 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.86 82.64 6.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 72.42 110.946 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 179.06 -68.34 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.71 -0.757 . . . . 64.52 112.511 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 48.36 -166.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 75.52 110.839 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.1 p -176.86 122.56 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 60.44 110.875 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -84.13 128.81 34.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 74.14 110.846 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -129.57 35.55 4.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 74.54 110.84 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.19 100.74 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 74.41 110.87 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.7 mt -140.65 113.98 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.478 . . . . 73.31 111.141 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.8 mt -113.9 113.02 47.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.592 0.711 . . . . 74.24 111.091 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 81.28 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.67 2.247 . . . . 71.21 112.388 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.38 -25.73 0.29 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 73.21 112.461 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.43 -57.37 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.884 0.373 . . . . 70.04 110.914 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 170.0 169.32 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 53.24 110.877 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.0 m -92.51 -165.78 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 74.13 110.893 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 176.49 142.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 62.32 110.968 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.739 . . . . 74.54 112.488 -179.97 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.9 pt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.807 0.337 . . . . 74.34 111.114 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -170.92 55.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 74.14 110.912 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.03 177.83 51.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.744 . . . . 43.51 112.476 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -52.23 -28.3 18.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.954 0.407 . . . . 73.44 110.86 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.558 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 179.84 -175.58 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 74.13 110.905 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.431 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -142.38 -179.06 6.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 75.35 110.935 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.2 168.07 20.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 64.41 110.86 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -70.87 132.45 45.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 75.42 110.899 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -89.39 -70.11 0.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 75.41 110.886 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -172.01 172.79 4.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 73.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.9 36.78 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 73.33 110.829 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -49.64 -30.73 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 73.5 111.146 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 20.6 mt -110.42 68.13 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 74.44 110.893 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.67 156.19 14.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.913 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -61.76 92.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 73.45 110.8 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.4 p -105.35 24.82 11.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 73.23 111.121 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.39 177.93 27.41 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.704 -0.76 . . . . 73.0 112.478 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 172.9 11.74 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.674 2.249 . . . . 73.35 112.357 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.17 38.1 95.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.723 -0.751 . . . . 63.13 112.473 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.1 mm -110.69 134.37 53.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.868 0.366 . . . . 73.22 111.155 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.461 HD21 ' CD1' ' A' ' 112' ' ' PHE . 1.6 mt -100.81 156.6 17.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 72.14 110.921 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 t 175.85 126.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 65.45 110.883 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.7 mmt -50.55 162.06 0.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 73.03 110.888 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -158.0 95.12 1.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 75.21 111.108 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -118.07 -21.94 8.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 71.32 110.884 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -179.0 -32.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 64.24 111.112 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.09 -82.36 0.33 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.705 -0.759 . . . . 71.24 112.478 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 117.32 5.01 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.638 2.225 . . . . 74.3 112.368 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 40.22 41.79 1.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 75.25 110.936 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.2 p -155.73 56.0 0.61 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.165 -0.471 . . . . 74.24 111.075 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -66.1 -42.56 89.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 75.32 110.948 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.78 -152.91 52.82 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.737 -0.744 . . . . 74.31 112.459 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.17 21.42 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.859 0.362 . . . . 63.33 110.877 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.439 ' O ' ' CG ' ' A' ' 111' ' ' GLN . 5.2 tt0 -116.26 87.94 2.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 73.42 110.908 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.461 ' CD1' HD21 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -84.88 -165.15 1.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.43 . . . . 74.5 110.834 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.36 165.69 34.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 75.42 110.896 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.06 90.88 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 73.13 111.124 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 53.2 m -66.08 89.96 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 54.34 110.889 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.3 p -67.68 -8.11 32.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 74.35 111.099 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -145.9 153.3 40.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 75.41 111.138 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -56.57 94.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 63.53 110.918 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.2 p -96.73 45.99 1.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 71.21 111.148 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -24.66 67.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 64.34 110.842 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -48.51 -27.62 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 75.04 110.929 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.6 mt -45.83 -34.42 3.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 74.21 110.919 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 124' ' ' GLY . 1.7 m-20 62.17 78.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 62.01 110.834 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.07 43.07 0.63 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 64.23 112.494 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 -17.28 43.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.773 0.321 . . . . 74.11 110.875 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -143.24 -165.48 2.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 73.41 110.897 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.0 t -126.21 130.22 72.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.432 . . . . 73.33 111.114 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.9 135.86 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 75.42 111.15 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -159.33 38.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 74.21 110.865 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -178.12 173.77 46.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.73 -0.748 . . . . 51.14 112.459 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -174.99 140.0 0.51 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.854 0.359 . . . . 74.22 110.887 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.0 t -40.65 107.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 65.11 111.151 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -59.96 2.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 74.4 110.849 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -154.43 152.33 30.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 65.21 110.911 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.37 41.86 6.39 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.742 -0.742 . . . . 73.02 112.493 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -33.7 72.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.838 0.351 . . . . 63.2 110.902 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -36.31 31.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.439 . . . . 75.15 110.91 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 17' ' ' LEU . 38.3 mm -63.86 -38.97 83.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 74.21 111.088 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.2 t -66.63 -24.34 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 75.41 111.139 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.08 -27.33 30.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 73.32 110.902 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.17 59.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 64.51 111.112 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 31.7 mtm -60.0 -54.11 49.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 73.04 110.888 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.474 ' HA ' ' OE1' ' A' ' 143' ' ' GLU . 10.4 mm-40 -54.84 -28.89 53.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 63.42 110.899 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.43 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -64.22 -24.3 67.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 74.15 110.83 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.43 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 69.0 m-85 -106.85 32.5 4.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.863 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.65 170.63 15.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 73.43 112.471 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.5 t -127.37 146.97 50.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.887 0.375 . . . . 74.31 110.861 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.1 mmm-85 -72.83 77.29 1.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.897 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -174.45 -35.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 72.44 110.891 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.89 -77.5 0.24 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.705 -0.759 . . . . 73.23 112.5 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.17 168.94 9.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 72.13 110.882 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.9 p -144.16 -173.76 4.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 72.42 111.182 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.0 p -86.85 -63.03 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 72.55 110.834 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -66.2 173.54 3.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 75.33 110.86 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -122.79 109.65 14.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 75.35 110.886 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mp -85.86 119.59 34.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 73.24 111.124 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.83 163.61 28.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 74.13 111.156 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.1 mt -102.45 128.35 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 75.1 111.14 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.65 -59.55 2.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 64.31 111.109 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -134.59 155.77 49.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 63.44 110.894 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.66 143.93 4.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 71.41 110.859 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.89 173.23 43.15 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 55.12 112.483 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -64.59 140.63 58.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 73.05 110.888 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.556 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -93.28 -57.68 2.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 75.11 110.938 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 65.22 110.886 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.816 0.341 . . . . 74.42 110.885 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.5 t -140.39 131.94 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 55.42 111.126 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -103.75 152.15 38.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.659 0.742 . . . . 74.52 110.839 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 146.7 60.82 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.661 2.24 . . . . 74.02 112.359 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -131.89 141.28 49.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 74.24 111.178 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.46 ' HA ' HD22 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -135.69 144.26 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 74.54 111.14 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 18.7 p90 -101.94 165.22 11.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 75.15 110.873 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -146.95 91.99 2.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 71.41 110.873 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.99 101.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.888 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.7 mm -82.07 119.17 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 71.2 111.078 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -107.71 157.79 17.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 71.2 111.144 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.26 95.98 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 70.51 111.08 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.49 31.48 10.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 73.0 110.872 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.57 -22.6 38.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.711 -0.757 . . . . 70.32 112.469 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -94.7 115.41 65.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.638 0.732 . . . . 72.14 110.902 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.72 123.62 10.3 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.656 2.238 . . . . 71.33 112.381 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.407 ' HB3' HD11 ' A' ' 138' ' ' ILE . 13.8 mt -67.07 -39.54 86.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 64.42 110.953 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.4 -131.15 2.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.825 -0.702 . . . . 73.34 112.522 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.54 137.04 54.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.818 0.342 . . . . 72.51 110.867 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.1 99.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 73.52 111.132 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -107.87 173.28 6.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 70.42 110.844 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.42 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -145.94 134.47 22.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 75.23 110.892 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -83.78 98.47 9.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 74.22 110.879 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 mt -79.63 115.88 19.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 73.53 110.942 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -76.0 64.97 1.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 74.13 110.855 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.63 -22.54 23.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 65.13 111.103 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -66.5 -35.68 80.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 72.14 110.886 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.62 -28.87 12.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 74.33 110.926 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.14 66.52 60.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.616 0.722 . . . . 65.43 111.111 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -37.2 9.56 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.737 2.291 . . . . 73.2 112.335 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -63.48 -38.17 90.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 65.02 110.882 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 m -85.9 -41.29 15.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 75.34 111.153 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.22 -44.78 82.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 75.34 111.139 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -49.55 -30.23 8.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.01 110.881 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -67.68 -68.92 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 73.42 110.88 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -55.27 -25.62 34.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 75.43 110.94 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.52 -55.57 5.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 74.51 110.885 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.76 -34.66 28.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 63.1 111.12 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 mt -75.8 -61.98 1.74 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 70.11 110.91 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.0 m -51.92 -33.92 39.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 73.35 110.858 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.3 p -76.51 -31.99 58.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 72.12 111.113 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.01 -15.55 60.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 72.34 112.528 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -19.16 45.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.869 0.366 . . . . 71.01 110.888 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.41 -28.94 14.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 74.42 110.941 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.05 -25.25 6.13 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.739 -0.743 . . . . 60.42 112.453 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -158.08 -47.68 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.894 0.378 . . . . 75.32 110.907 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.61 -145.88 47.13 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.72 -0.752 . . . . 75.21 112.467 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -179.75 92.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.925 0.393 . . . . 73.02 110.956 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.22 85.45 6.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 74.42 110.911 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.2 -66.14 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.736 -0.745 . . . . 74.42 112.523 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m 49.05 -166.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 75.4 110.9 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.8 147.64 16.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 74.12 110.892 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -128.73 120.58 26.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 62.44 110.876 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -144.61 42.98 1.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 74.04 110.864 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.408 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.69 72.88 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 75.54 110.88 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.8 mt -112.59 113.35 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 74.44 111.134 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 28.9 mt -104.58 103.05 37.81 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.712 . . . . 73.04 111.121 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.441 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 53.4 Cg_endo -69.85 89.56 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.691 2.261 . . . . 71.13 112.329 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.92 -19.45 1.97 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.71 -0.757 . . . . 53.35 112.445 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.78 -54.08 1.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 73.52 110.841 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 173.27 171.35 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 74.32 110.883 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.1 m -111.28 -154.16 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 72.24 110.846 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 55' ' ' ARG . 54.6 tp60 -134.68 163.38 29.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 70.54 110.893 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.71 -103.24 2.83 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.757 -0.735 . . . . 70.12 112.488 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.05 139.21 5.76 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 75.32 112.5 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.69 146.06 52.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 64.02 110.807 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -167.77 121.58 0.95 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 71.13 110.887 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.38 -57.72 0.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 74.42 111.173 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.43 35.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 74.35 110.917 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.05 -35.77 10.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 75.25 110.802 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -116.62 -35.6 4.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 74.13 110.851 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 132.55 144.0 5.19 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.741 . . . . 61.13 112.494 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.4 p 62.92 30.21 16.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.321 . . . . 72.02 111.143 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.4 -165.54 0.33 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 75.31 112.46 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -151.23 -131.62 1.81 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.698 -0.763 . . . . 53.44 112.481 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -175.11 -167.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.349 . . . . 75.4 110.887 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.404 ' O ' ' CG1' ' A' ' 78' ' ' ILE . 7.3 p -90.16 42.61 1.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.436 . . . . 60.22 110.905 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.404 ' CG1' ' O ' ' A' ' 77' ' ' SER . 4.1 pt 44.51 28.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 73.11 111.085 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -174.31 58.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 74.32 110.892 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.54 -160.41 53.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.784 -0.722 . . . . 61.33 112.51 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.26 -40.88 59.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 73.45 110.902 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.443 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 173.45 -177.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 74.12 110.878 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.35 -165.94 1.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 72.42 110.869 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.83 165.51 12.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 65.5 110.884 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -51.44 119.38 4.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 74.44 110.927 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -91.59 -69.16 0.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 72.01 110.857 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -177.25 177.14 1.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 74.52 110.909 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.42 36.89 3.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 73.42 110.892 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 mt -48.15 -33.63 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 72.24 111.128 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 22.1 mt -106.83 89.28 2.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 72.51 110.901 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.25 139.23 37.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 73.41 110.911 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -49.71 101.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 74.35 110.851 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 74.2 p -115.88 28.38 8.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 72.53 111.121 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.32 178.01 24.81 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 74.33 112.5 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 173.5 10.81 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.677 2.251 . . . . 75.24 112.338 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.12 32.8 85.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 75.34 112.496 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.5 mm -105.91 137.55 35.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.84 0.352 . . . . 74.1 111.159 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.438 ' HB2' ' C ' ' A' ' 130' ' ' GLY . 0.8 OUTLIER -105.16 144.86 31.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 73.33 110.958 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.58 -163.05 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 74.23 110.846 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.12 140.92 52.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.497 . . . . 72.2 110.859 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.55 34.85 2.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 71.23 111.083 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.43 -19.08 63.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 71.23 110.923 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 176.64 -31.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 60.32 111.101 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.63 -89.28 0.49 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 73.44 112.495 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 117.24 4.97 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.638 2.226 . . . . 75.1 112.353 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 45.11 54.61 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 73.53 110.867 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.1 p -157.96 60.46 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.21 111.123 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.48 ' O ' ' C ' ' A' ' 109' ' ' GLY . 2.1 m-20 -66.05 -30.71 71.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 72.03 110.887 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 30.52 -116.14 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.749 . . . . 74.34 112.519 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.0 p -167.17 40.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.837 0.351 . . . . 62.43 110.85 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -108.86 50.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 74.44 110.916 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -54.49 -176.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 75.51 110.857 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -160.87 91.7 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 74.34 110.951 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 113' ' ' PHE . 3.0 mt -33.28 105.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 74.21 111.116 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 41.8 t -69.59 100.51 1.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 72.03 110.914 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.1 p -83.94 11.31 7.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 74.44 111.146 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.49 ' O ' ' C ' ' A' ' 118' ' ' LYS . . . 177.37 124.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 73.23 111.072 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 117' ' ' ALA . 1.0 OUTLIER -30.22 105.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 74.1 110.879 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.412 ' CG2' ' CZ2' ' A' ' 121' ' ' TRP . 71.0 p -87.75 73.51 9.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.5 111.144 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -69.8 -27.09 64.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 63.24 110.889 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.412 ' CZ2' ' CG2' ' A' ' 119' ' ' THR . 17.6 p90 -55.86 -22.47 25.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 70.5 110.906 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.2 mt -77.95 -55.91 4.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 74.44 110.878 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 53.48 95.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 75.12 110.827 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 43.17 37.78 3.34 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 74.31 112.517 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.62 -11.48 48.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 74.42 110.863 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -148.46 -163.79 1.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 73.54 110.838 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 25.0 t -122.09 116.03 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 73.44 111.139 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.19 134.48 27.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 72.13 111.149 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -157.2 54.79 0.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 74.32 110.891 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.438 ' C ' ' HB2' ' A' ' 98' ' ' LEU . . . 169.92 176.29 39.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.764 -0.731 . . . . 72.34 112.486 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 132' ' ' VAL . 10.1 pttt -178.89 131.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.792 0.329 . . . . 74.43 110.905 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 131' ' ' LYS . 48.0 t -36.08 108.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 75.23 111.13 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.46 -59.33 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 75.13 110.897 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -152.93 158.35 41.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 65.12 110.896 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.16 30.94 24.11 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 73.01 112.475 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.93 -29.42 12.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 72.24 110.853 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.67 -33.8 35.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 73.22 110.876 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.407 HD11 ' HB3' ' A' ' 17' ' ' LEU . 44.5 mm -66.06 -44.34 92.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 73.23 111.131 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.9 t -63.96 -26.34 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 63.35 111.129 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.5 -30.72 47.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 73.42 110.857 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.92 -43.39 68.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 60.14 111.103 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 27.9 mtm -58.58 -43.98 89.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 73.14 110.859 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.441 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 8.7 tm-20 -54.25 -26.65 30.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 71.33 110.897 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -28.45 52.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 72.12 110.893 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -103.16 31.61 4.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 73.34 110.862 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -120.05 152.86 16.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 70.43 112.499 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.3 t -103.03 144.29 31.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.886 0.374 . . . . 74.24 110.865 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -73.57 65.28 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 72.31 110.832 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -175.35 -34.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 61.23 110.883 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.21 -70.9 0.34 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 61.15 112.482 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.21 170.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 75.13 110.882 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.4 t -159.48 158.85 32.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 73.14 111.113 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 86.0 p -75.38 -53.92 7.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.01 110.859 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -73.01 155.52 39.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 75.33 110.924 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -109.2 109.36 20.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 61.41 110.921 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 3.6 mp -90.81 123.06 42.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.447 . . . . 74.34 111.155 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.77 162.53 32.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 71.51 111.123 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.4 mt -95.69 120.76 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 72.35 111.142 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.32 -49.39 8.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 62.41 111.087 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -146.23 156.31 43.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 73.54 110.88 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.404 ' HA ' ' CE1' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -165.55 144.95 6.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 65.4 110.901 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.46 171.68 42.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 60.13 112.493 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -65.35 141.74 58.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 71.12 110.864 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.54 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.1 mm? -93.48 -56.47 2.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 74.33 110.892 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 75.43 110.874 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.865 0.364 . . . . 71.11 110.875 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.9 t 61.7 106.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 75.31 111.125 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 -103.13 152.67 38.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.629 0.728 . . . . 63.31 110.911 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 146.54 60.22 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.641 2.227 . . . . 73.34 112.356 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -133.05 141.58 48.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 75.51 111.165 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.467 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.0 OUTLIER -134.24 143.21 38.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 74.23 111.16 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.566 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 16.6 p90 -100.94 166.37 10.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 75.4 110.871 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -146.67 87.29 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 73.21 110.895 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -50.59 102.45 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 75.41 110.834 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.9 mm -80.59 128.89 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 71.53 111.121 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -122.39 154.24 37.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 74.11 111.129 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.5 t -132.44 94.24 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 75.35 111.109 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.15 31.37 13.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 72.5 110.905 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.88 -24.77 27.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.754 . . . . 75.32 112.513 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -91.44 114.57 62.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.62 0.724 . . . . 54.24 110.916 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.71 122.91 9.59 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.729 2.286 . . . . 64.55 112.34 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.26 -38.7 82.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 73.33 110.949 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.97 -128.21 2.11 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.727 -0.749 . . . . 71.45 112.49 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.47 136.86 53.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 74.34 110.861 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.35 102.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 64.31 111.18 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.0 OUTLIER -109.06 174.77 5.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 71.22 110.841 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.438 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.9 OUTLIER -144.85 132.66 21.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 72.12 110.924 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -86.63 97.35 10.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 74.21 110.878 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.69 119.74 23.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 74.34 110.91 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -78.35 65.19 3.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 74.1 110.868 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.45 -23.49 10.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 71.2 111.1 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -66.85 -31.92 72.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 74.1 110.827 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -101.82 -31.63 10.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.871 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.48 66.27 69.69 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.588 0.709 . . . . 65.24 111.169 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -39.85 6.1 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.669 2.246 . . . . 72.52 112.348 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -36.45 70.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 75.34 110.942 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.2 m -91.33 -47.91 7.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 71.04 111.151 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.4 -46.66 80.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 62.44 111.085 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -54.66 -26.05 30.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 61.34 110.864 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.48 -65.31 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 64.13 110.931 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.95 -24.38 64.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 74.13 110.918 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -80.34 -53.15 6.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 75.22 110.858 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.04 -34.79 22.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 71.53 111.075 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 mt -79.52 -59.5 2.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 73.14 110.944 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.6 m -52.65 -32.16 40.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 52.23 110.907 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.3 p -77.51 -52.65 8.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 74.44 111.19 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.23 -17.86 7.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.741 . . . . 70.34 112.497 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -33.83 37.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.923 0.392 . . . . 72.15 110.869 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -58.52 -29.42 66.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 71.34 110.908 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.16 -13.18 60.36 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.781 -0.723 . . . . 74.32 112.486 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -160.05 -166.03 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.887 0.375 . . . . 74.33 110.903 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.54 -140.97 7.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 74.42 112.468 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -157.73 50.77 0.43 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.971 0.415 . . . . 72.24 110.912 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 142.16 21.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 75.25 110.899 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.86 21.22 73.12 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.71 -0.757 . . . . 71.45 112.464 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.11 -26.68 28.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.829 0.347 . . . . 71.33 110.85 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 68.38 155.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 75.23 110.915 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -95.18 138.65 32.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 72.13 110.916 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -119.38 30.46 7.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 63.03 110.842 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -176.34 117.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 72.11 110.897 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.3 mt -146.11 114.1 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 71.25 111.135 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.6 mt -106.59 103.05 44.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.69 0.757 . . . . 74.4 111.149 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 76.71 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.672 2.248 . . . . 64.02 112.374 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.04 -26.47 0.32 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.755 -0.736 . . . . 53.03 112.483 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.414 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -117.56 -57.47 2.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 73.51 110.853 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.414 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER 176.24 170.55 0.43 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.851 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 13.2 m -112.98 -177.51 3.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 71.12 110.869 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -170.6 140.39 1.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 75.14 110.922 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.52 -144.93 4.13 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.752 -0.737 . . . . 71.11 112.482 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 52.46 32.63 38.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.727 -0.749 . . . . 71.24 112.479 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -92.28 113.17 25.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.827 0.346 . . . . 64.32 110.866 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -167.52 28.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 73.51 110.885 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.62 107.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 64.34 111.201 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 70' ' ' HIS . 3.6 mmm180 -116.8 -76.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 75.33 110.888 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.477 ' CB ' ' O ' ' A' ' 69' ' ' ARG . 1.9 t-80 81.43 -25.51 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 74.44 110.889 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 69' ' ' ARG . 5.6 p30 -179.38 36.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 74.11 110.919 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.44 106.38 0.29 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.692 -0.766 . . . . 73.11 112.464 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.6 t 177.46 -48.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.846 0.355 . . . . 74.01 111.132 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.0 134.58 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.719 -0.753 . . . . 52.1 112.494 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.43 169.27 0.46 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.76 -0.733 . . . . 74.24 112.476 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -147.1 169.14 19.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.736 0.303 . . . . 74.34 110.874 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.0 p -83.84 -170.71 3.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 72.53 110.882 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.8 pt -107.01 31.54 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 75.41 111.07 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -130.77 -67.49 0.72 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 74.42 110.903 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -137.81 -65.25 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.749 . . . . 71.04 112.503 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -145.21 -40.06 0.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.887 0.375 . . . . 72.22 110.918 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.429 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.58 179.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 75.14 110.899 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.61 177.73 8.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 71.11 110.891 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.04 169.47 17.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 74.13 110.908 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -49.94 163.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 71.54 110.852 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -120.94 -74.5 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 73.53 110.854 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -165.22 169.4 16.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 72.43 110.902 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.42 37.63 3.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 73.21 110.883 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -50.22 -29.37 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.488 . . . . 65.35 111.111 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 34.7 mt -111.97 80.52 1.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.898 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.76 153.16 43.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 75.22 110.915 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -60.44 94.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 75.15 110.848 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 p -105.75 25.12 11.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 74.33 111.134 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.66 179.48 24.62 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.761 -0.733 . . . . 75.42 112.499 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 171.09 15.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.681 2.254 . . . . 73.12 112.351 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.23 29.28 70.46 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.687 -0.768 . . . . 61.32 112.499 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.1 mm -102.82 138.38 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.861 0.362 . . . . 73.31 111.137 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -109.32 144.2 37.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 74.14 110.926 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.84 -168.75 2.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 65.44 110.828 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.8 mtp -105.81 99.97 9.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.497 . . . . 75.42 110.854 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.64 50.11 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 71.11 111.082 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -86.59 -78.28 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 75.1 110.886 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -146.53 34.01 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 73.11 111.108 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.36 -111.7 4.39 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.788 -0.72 . . . . 74.42 112.466 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 111.43 2.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.701 2.267 . . . . 73.34 112.339 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 72.09 163.72 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 75.01 110.867 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 p 67.27 29.57 7.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 74.34 111.125 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.37 78.29 8.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 73.41 110.849 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -72.35 -71.97 1.0 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 62.01 112.526 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.7 p 177.29 49.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.783 0.325 . . . . 74.04 110.86 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 1.8 mm-40 -64.02 -31.1 72.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 71.14 110.922 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.468 ' HB3' ' O ' ' A' ' 111' ' ' GLN . 8.2 t80 67.71 139.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 74.22 110.877 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.554 ' CD1' ' C ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -161.08 123.14 3.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 74.22 110.894 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.9 mt -86.4 126.59 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 74.13 111.094 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.05 101.07 13.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 71.34 110.897 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.9 p -86.99 20.98 2.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 73.1 111.151 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 175.59 146.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 72.21 111.092 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 98.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 75.33 110.851 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 32.8 p -106.51 46.69 0.91 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 74.34 111.163 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -26.51 64.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 74.3 110.88 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.3 p90 -49.5 -25.42 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 75.11 110.951 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 18.1 mt -45.72 -32.19 2.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 74.04 110.936 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.5 m-20 59.47 77.21 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 75.23 110.848 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.15 42.23 0.78 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.793 -0.718 . . . . 74.52 112.46 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -26.39 37.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.831 0.348 . . . . 74.01 110.906 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -136.21 169.03 18.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.41 110.853 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 50.0 t -102.43 118.53 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 54.44 111.155 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.02 133.72 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 74.2 111.129 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -156.25 33.91 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 65.44 110.918 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.89 176.11 44.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.712 -0.756 . . . . 73.05 112.471 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -175.71 135.06 0.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.833 0.349 . . . . 73.53 110.913 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 70.2 t -39.7 107.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 74.11 111.15 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.62 -59.13 3.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 74.04 110.908 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -152.78 157.79 41.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 60.13 110.879 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.64 42.95 9.52 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.731 -0.747 . . . . 73.41 112.472 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -29.04 70.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.328 . . . . 74.12 110.882 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.86 -31.95 42.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 65.54 110.867 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.9 mm -65.21 -40.0 87.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 72.14 111.099 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.49 -27.75 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 73.45 111.129 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -80.13 -28.46 38.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 75.54 110.868 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.02 -38.72 63.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 74.42 111.122 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 28.2 mtm -60.7 -52.63 64.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 72.24 110.894 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.51 -26.32 30.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 54.45 110.95 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.412 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.37 -23.98 63.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 73.03 110.857 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.412 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 64.8 m-85 -107.66 16.11 24.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 75.13 110.839 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -110.67 168.55 13.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 61.31 112.497 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.8 m -113.71 146.71 39.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 65.2 110.847 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -75.72 66.43 2.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.091 -0.504 . . . . 74.14 110.883 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -171.11 -37.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 73.22 110.863 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 159.13 -63.15 0.3 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 63.23 112.472 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.49 175.52 0.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.377 . . . . 75.14 110.879 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.7 p -145.12 176.69 9.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 70.53 111.127 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.24 -60.66 1.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.33 110.853 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.21 -175.77 5.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 75.22 110.918 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.96 108.73 15.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 71.24 110.901 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 4.1 mp -83.74 117.96 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 74.42 111.103 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.12 165.87 18.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 74.53 111.186 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.0 mt -103.87 106.08 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 75.35 111.142 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.49 -44.96 85.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 73.44 111.144 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -161.45 158.04 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 74.3 110.845 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.2 148.27 16.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 73.04 110.876 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.09 171.77 41.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.713 -0.756 . . . . 73.51 112.466 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -65.19 142.45 58.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.871 0.367 . . . . 74.41 110.888 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.565 HD22 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -94.54 -58.75 2.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 73.33 110.918 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.932 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.5 mtp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.803 0.335 . . . . 71.22 110.868 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.3 t -137.2 134.69 47.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 74.2 111.136 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -108.62 146.31 33.42 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.621 0.724 . . . . 72.42 110.885 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 146.45 60.42 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.673 2.249 . . . . 74.45 112.373 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 m -133.19 140.22 47.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 74.02 111.139 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.469 ' HA ' HD21 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -134.21 144.67 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 70.45 111.108 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 17.8 p90 -103.13 168.43 9.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 72.22 110.897 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -148.22 87.71 1.61 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 72.52 110.891 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -51.34 103.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 74.44 110.888 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.7 mm -81.96 135.81 24.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 73.41 111.099 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -128.19 155.05 45.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.01 111.084 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -135.54 96.17 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 75.34 111.092 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 66.86 30.76 7.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 73.51 110.908 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.57 -23.74 33.09 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 73.11 112.517 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -91.99 117.3 67.65 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.639 0.733 . . . . 75.42 110.922 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.4 Cg_endo -69.79 124.45 11.08 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.661 2.241 . . . . 72.44 112.324 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.431 ' HB3' HD11 ' A' ' 138' ' ' ILE . 12.0 mt -68.98 -38.82 79.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 65.44 110.878 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.96 -129.38 2.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 75.24 112.447 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.41 137.05 54.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 74.34 110.891 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -146.26 100.21 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 74.14 111.128 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.4 t -108.67 175.26 5.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 73.22 110.811 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.442 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -146.34 130.47 17.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 74.44 110.874 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -83.5 100.78 10.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 73.01 110.892 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 mt -82.84 123.57 29.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 74.41 110.907 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -82.26 63.55 6.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 75.15 110.911 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.86 -23.44 12.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 54.02 111.079 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -64.48 -37.95 89.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 70.3 110.854 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.59 -29.06 13.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 75.41 110.875 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.7 64.92 73.14 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.6 0.714 . . . . 70.25 111.181 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -38.18 8.14 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.664 2.243 . . . . 74.22 112.344 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.36 -37.98 79.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 72.25 110.903 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.5 m -88.61 -45.07 10.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 70.32 111.137 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.03 -47.01 86.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 75.03 111.147 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -50.56 -31.08 14.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 74.45 110.891 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.81 -62.85 1.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 74.35 110.907 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.19 -22.61 61.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.33 110.865 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -83.08 -56.94 3.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 73.04 110.875 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.35 -29.69 10.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 73.44 111.156 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.9 mt -80.13 -60.89 2.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 73.43 110.908 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.0 m -55.3 -36.01 65.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 73.14 110.831 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.1 p -69.23 -31.97 70.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 74.3 111.135 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.15 -18.11 58.03 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.775 -0.726 . . . . 71.23 112.492 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.54 -32.33 40.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 63.53 110.871 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -60.78 -28.22 68.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 74.5 110.923 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.19 -15.17 56.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.749 . . . . 62.42 112.478 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -158.31 -165.4 1.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.877 0.37 . . . . 75.1 110.927 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.62 -166.74 33.42 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.723 -0.751 . . . . 70.31 112.468 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -103.73 15.06 29.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.974 0.416 . . . . 74.32 110.955 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.53 140.05 2.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 65.25 110.913 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.64 28.85 60.5 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.699 -0.762 . . . . 52.41 112.483 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 m -79.45 -177.16 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.383 . . . . 71.41 110.814 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.0 p -139.73 127.76 22.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 70.13 110.846 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -75.66 128.77 35.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 74.11 110.856 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -128.8 37.3 4.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 73.43 110.872 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.04 81.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 73.02 110.918 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.6 mt -117.9 117.97 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 75.12 111.127 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 28.8 mt -112.27 103.88 55.65 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.613 0.72 . . . . 75.12 111.104 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 53.2 Cg_endo -69.79 92.0 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.678 2.252 . . . . 72.43 112.304 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.74 -17.4 2.81 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 71.51 112.505 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.9 -53.96 1.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 74.04 110.874 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.65 174.21 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.911 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 9.3 m -113.04 -162.4 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 73.42 110.881 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 174.51 143.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 72.23 110.941 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.51 169.42 41.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 71.22 112.485 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.94 89.87 1.79 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.788 -0.72 . . . . 71.31 112.487 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -155.09 100.3 2.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.863 0.363 . . . . 73.33 110.824 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -129.06 36.78 4.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 74.04 110.901 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -92.05 66.26 4.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 73.32 111.133 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.24 -35.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 75.41 110.888 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -48.48 -35.53 13.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 73.42 110.826 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -137.14 24.52 3.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 74.34 110.893 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.35 114.22 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.722 -0.752 . . . . 73.0 112.456 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.4 p 63.71 30.64 14.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.34 . . . . 75.02 111.155 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -51.83 -87.89 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.732 -0.747 . . . . 73.1 112.505 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -49.52 130.92 26.25 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 60.45 112.498 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -173.51 151.99 2.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 75.24 110.898 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.0 p -51.62 150.0 4.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 72.32 110.857 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -61.55 -33.45 57.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 73.55 111.143 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -76.2 -34.64 59.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 64.22 110.969 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.16 -113.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 72.43 112.487 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -78.95 -44.18 23.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.91 0.386 . . . . 72.01 110.907 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.4 170.29 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 73.14 110.925 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.73 166.25 13.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 75.45 110.913 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.75 166.34 18.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 74.22 110.875 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -54.23 145.73 16.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 74.2 110.833 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -104.91 -69.98 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 72.24 110.922 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -176.38 177.35 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 71.24 110.918 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.28 37.11 3.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 71.13 110.892 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.22 -34.61 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 74.24 111.132 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.7 mt -112.02 78.03 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 72.1 110.904 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -70.1 144.16 52.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 73.42 110.936 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -51.03 99.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 62.42 110.816 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.7 p -111.8 28.96 8.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 74.2 111.138 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.45 179.64 26.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.701 -0.762 . . . . 65.2 112.507 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 163.99 36.22 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.653 2.235 . . . . 73.22 112.384 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.29 37.85 54.13 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 74.33 112.466 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.2 mm -110.19 139.9 31.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.914 0.388 . . . . 75.43 111.071 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.66 146.09 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 73.31 110.87 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.81 -158.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 75.32 110.865 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -130.4 136.83 49.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 75.41 110.89 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -120.52 100.4 7.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 62.51 111.069 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -151.16 -41.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 71.5 110.928 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -178.86 34.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 72.15 111.078 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.13 -109.99 1.77 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 72.11 112.492 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 115.19 3.98 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.708 2.272 . . . . 63.01 112.313 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 73.24 169.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 71.12 110.921 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 65.86 27.16 11.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 61.22 111.187 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -75.78 144.37 41.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.871 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.32 -100.33 0.63 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.731 -0.747 . . . . 74.42 112.471 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.9 p -158.09 37.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.839 0.352 . . . . 75.42 110.873 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.22 58.71 0.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 73.42 110.854 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -58.19 -171.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 74.3 110.88 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.549 ' O ' ' C ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -160.88 78.36 0.6 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 74.35 110.874 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.549 ' C ' ' O ' ' A' ' 113' ' ' PHE . 4.9 mt -25.1 105.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 73.04 111.119 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 37.3 t -70.29 101.57 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 75.22 110.89 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 47.9 p -90.53 21.98 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 72.13 111.185 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' A' ' 118' ' ' LYS . . . 173.25 127.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 74.5 111.16 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 117' ' ' ALA . 2.1 tttt -36.77 108.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 74.53 110.956 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 61.4 p -95.06 71.33 3.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 72.35 111.155 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -68.62 -26.61 65.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 72.25 110.873 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 17.9 p90 -56.28 -19.99 16.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 75.32 110.907 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 82.9 mt -80.81 -54.66 5.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 74.12 110.897 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 52.47 95.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 65.23 110.88 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 42.29 41.91 4.12 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.768 -0.73 . . . . 74.33 112.478 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -91.21 -9.95 43.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.828 0.347 . . . . 70.1 110.898 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -146.73 -169.99 3.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 65.23 110.827 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.6 t -115.56 109.83 29.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 72.43 111.085 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 t -88.64 136.05 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 74.53 111.112 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -157.93 40.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 72.41 110.878 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -176.32 175.47 47.48 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.701 -0.761 . . . . 62.01 112.465 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -176.1 136.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 75.31 110.929 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.3 t -38.62 108.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 72.54 111.155 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.69 -58.88 3.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 73.12 110.867 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -153.51 158.76 41.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 73.03 110.919 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.63 31.94 28.75 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.737 -0.744 . . . . 72.52 112.522 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -33.51 39.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.775 0.322 . . . . 73.24 110.901 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -34.29 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 73.25 110.876 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 17' ' ' LEU . 40.2 mm -63.81 -41.63 93.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 72.13 111.135 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.8 t -64.48 -24.87 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 74.34 111.175 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -81.62 -28.85 33.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 71.04 110.855 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.68 -38.9 64.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 74.2 111.094 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.0 mtm -59.04 -52.9 63.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 72.32 110.892 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -55.42 -25.51 36.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 74.44 110.92 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.416 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -70.02 -23.76 63.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 73.12 110.833 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.416 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 62.1 m-85 -108.24 20.8 18.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 74.13 110.879 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.01 164.96 12.35 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.789 -0.719 . . . . 62.4 112.499 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.1 m -107.41 146.93 31.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.86 0.362 . . . . 74.34 110.855 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.7 mmm-85 -74.28 69.93 1.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 75.21 110.861 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -174.44 -36.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 74.41 110.914 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 150.58 -52.22 0.51 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 65.35 112.433 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.45 -176.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.912 0.387 . . . . 72.01 110.89 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -164.93 155.97 14.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.445 . . . . 73.32 111.127 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 80.7 p -82.49 -54.75 4.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 75.31 110.905 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -79.12 177.34 8.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 75.3 110.908 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -121.41 108.55 13.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 74.31 110.882 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 4.2 mp -86.01 116.65 29.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 75.03 111.139 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.67 162.72 25.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 74.24 111.092 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.7 mt -101.86 116.02 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 63.14 111.109 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.88 -47.91 27.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 72.34 111.105 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -159.69 157.08 28.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 75.24 110.837 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.0 146.83 17.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 65.31 110.873 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.4 172.98 44.17 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.801 -0.714 . . . . 72.21 112.533 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -64.97 142.51 58.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 74.12 110.938 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.558 HD23 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -93.22 -59.93 1.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 75.51 110.883 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 74.54 110.909 179.951 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.3 mtp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.867 0.365 . . . . 72.52 110.839 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.0 t -140.86 134.84 33.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 63.24 111.119 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -110.63 154.0 43.34 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.615 0.721 . . . . 75.11 110.885 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 146.35 60.02 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.719 2.279 . . . . 73.54 112.316 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.6 m -128.6 127.8 42.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 62.14 111.179 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.63 177.84 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 74.33 111.164 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.532 ' HB3' HD22 ' A' ' 164' ' ' LEU . 2.2 p90 -160.61 178.27 9.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 75.12 110.867 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -155.96 95.25 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 73.1 110.901 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -45.37 108.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 71.11 110.839 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.9 mm -79.38 129.34 37.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 74.42 111.097 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -121.96 137.46 54.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 73.5 111.133 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -120.73 93.25 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 64.34 111.1 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.46 36.3 6.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 73.55 110.908 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.91 -16.4 61.24 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.71 -0.757 . . . . 64.21 112.474 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -102.33 109.56 60.68 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.646 0.736 . . . . 64.44 110.904 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.7 Cg_endo -69.78 127.03 13.99 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.653 2.235 . . . . 75.32 112.324 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.403 ' HB3' HD11 ' A' ' 138' ' ' ILE . 9.9 mt -67.34 -39.03 85.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 74.23 110.913 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.45 -120.82 0.97 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 64.41 112.44 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -134.91 140.86 46.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 75.01 110.907 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.43 93.12 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 74.3 111.124 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.4 t -95.35 174.19 7.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 73.13 110.833 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.434 ' N ' ' OG ' ' A' ' 21' ' ' SER . 56.5 m-85 -147.33 143.21 27.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 73.1 110.856 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -96.5 95.74 8.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 74.55 110.863 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.0 mt -78.85 124.93 28.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 75.5 110.906 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.91 63.11 7.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 75.24 110.872 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.39 -23.65 10.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 71.21 111.098 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -62.68 -39.89 95.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 62.13 110.846 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -98.27 -28.7 13.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 71.13 110.887 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.05 63.89 71.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.64 0.733 . . . . 75.32 111.1 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -36.55 10.73 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.707 2.272 . . . . 75.32 112.385 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -38.73 92.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 74.31 110.918 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.5 m -85.22 -42.3 14.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 75.11 111.13 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.67 -42.84 95.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 74.15 111.097 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -49.36 -30.59 7.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 72.11 110.922 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -68.58 -70.4 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 74.33 110.905 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.09 -32.12 21.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 75.32 110.862 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.36 -54.51 6.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 73.44 110.856 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.93 -37.3 43.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 74.53 111.115 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 mt -79.19 -58.54 3.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 75.41 110.919 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.8 m -50.13 -35.22 24.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 72.01 110.857 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.4 p -79.07 -54.39 6.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 75.51 111.145 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.28 -16.14 7.18 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.748 . . . . 74.42 112.453 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -53.86 -27.43 29.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 65.12 110.907 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.28 -17.38 41.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 73.3 110.939 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.07 -11.93 70.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 74.13 112.53 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -163.34 -168.33 1.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 75.11 110.907 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.51 -137.51 5.38 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 33.15 112.476 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -168.07 88.59 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.909 0.385 . . . . 75.53 110.949 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -79.98 82.87 5.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.079 -0.51 . . . . 71.31 110.884 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.58 -62.02 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 53.34 112.488 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 m 51.11 -169.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.816 0.341 . . . . 73.32 110.889 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.6 p -176.09 122.75 0.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 71.42 110.882 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -91.4 108.19 19.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 72.54 110.936 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -113.68 28.25 8.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.14 110.822 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.413 ' NH2' ' HZ2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -166.04 95.39 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 72.32 110.875 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mt -126.29 116.38 45.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 63.25 111.127 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.6 mt -108.57 104.84 55.57 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.616 0.722 . . . . 71.31 111.129 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 53.8 Cg_endo -69.82 88.31 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.24 . . . . 71.04 112.356 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.98 -18.67 1.96 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 70.14 112.491 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.0 -55.18 1.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 74.2 110.846 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 173.4 172.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 74.15 110.907 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 11.4 m -108.57 -160.46 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 75.11 110.918 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 176.49 140.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 73.22 110.913 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.75 137.02 2.16 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.813 -0.708 . . . . 74.41 112.54 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.58 39.41 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.692 -0.766 . . . . 72.11 112.432 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -96.94 124.53 40.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.842 0.353 . . . . 74.24 110.882 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -150.7 72.61 1.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 71.25 110.868 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.55 -42.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 74.31 111.113 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -179.48 173.51 1.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 73.33 110.893 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -108.06 36.22 2.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 73.45 110.87 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -113.01 -70.05 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 73.53 110.879 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.18 46.12 0.22 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.793 -0.717 . . . . 54.32 112.532 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.8 p -100.92 -55.05 2.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.788 0.327 . . . . 74.1 111.156 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.08 30.62 38.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.757 -0.735 . . . . 74.04 112.487 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.75 -148.33 31.87 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 61.15 112.5 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.06 155.03 11.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.816 0.341 . . . . 75.23 110.879 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.94 58.42 1.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 75.31 110.859 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 40.4 pt 40.54 34.41 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 74.54 111.166 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -165.72 51.27 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 71.22 110.892 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.54 -173.24 55.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.751 -0.738 . . . . 72.51 112.481 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -53.41 -24.67 13.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.398 . . . . 75.45 110.921 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.528 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -174.7 176.97 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 74.33 110.861 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -151.83 179.95 7.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 74.23 110.904 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.79 171.02 11.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.895 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -87.55 171.85 10.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 74.5 110.854 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -119.7 -59.45 1.81 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.468 . . . . 73.31 110.839 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.4 p30 -177.45 177.01 1.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 64.5 110.852 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.3 35.27 3.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 75.2 110.892 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mt -50.48 -32.64 10.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 73.43 111.133 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.3 mt -111.03 74.95 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 75.41 110.922 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp -70.32 147.02 50.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 63.45 110.874 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -50.88 99.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.449 . . . . 75.44 110.819 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 77.0 p -112.66 27.62 9.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 64.31 111.125 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 147.85 -179.26 24.86 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.714 -0.755 . . . . 44.42 112.467 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 170.48 16.53 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.657 2.238 . . . . 71.32 112.337 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.4 34.28 79.35 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.74 . . . . 75.14 112.494 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.5 mm -106.49 139.43 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.915 0.388 . . . . 74.41 111.083 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.415 ' CD2' ' HB2' ' A' ' 112' ' ' PHE . 0.4 OUTLIER -106.85 146.57 30.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 75.53 110.915 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.06 -156.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 72.12 110.852 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.4 mmt -131.73 127.61 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.077 -0.51 . . . . 72.44 110.898 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 111' ' ' GLN . . . -86.88 129.35 34.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 72.23 111.145 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 172.23 -168.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 73.34 110.888 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.435 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -47.47 -50.58 22.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 64.44 111.113 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 123.53 -66.89 0.5 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 55.24 112.447 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.435 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.8 Cg_endo -69.75 112.84 3.18 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.62 2.214 . . . . 74.33 112.39 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.8 OUTLIER 36.88 47.3 0.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 72.4 110.857 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.3 p -144.54 39.31 1.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 74.33 111.132 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -76.64 140.38 40.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 74.21 110.88 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.32 -131.06 3.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 54.1 112.485 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 p -138.07 29.92 2.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.805 0.336 . . . . 74.22 110.839 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.402 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 9.3 mm-40 -116.83 72.69 0.83 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 72.3 110.939 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.415 ' HB2' ' CD2' ' A' ' 98' ' ' LEU . 34.7 p90 -57.24 -174.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 75.51 110.897 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.552 ' O ' ' C ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -159.54 78.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 72.44 110.858 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.552 ' C ' ' O ' ' A' ' 113' ' ' PHE . 3.0 mt -23.38 107.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.492 . . . . 74.53 111.171 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 34.9 t -73.01 99.4 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 64.34 110.875 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 48.9 p -88.55 20.66 3.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 73.05 111.171 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 118' ' ' LYS . . . 174.17 127.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 74.14 111.13 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 117' ' ' ALA . 3.4 tttt -36.35 107.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 61.03 110.912 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.42 ' HA ' ' CZ2' ' A' ' 121' ' ' TRP . 49.5 p -94.36 72.86 3.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 75.23 111.135 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -71.45 -26.92 62.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 74.33 110.876 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.42 ' CZ2' ' HA ' ' A' ' 119' ' ' THR . 15.7 p90 -54.35 -22.02 11.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.168 -0.469 . . . . 73.44 110.913 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.1 mt -78.66 -53.12 7.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 75.33 110.881 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 54.43 95.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 72.32 110.862 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 40.43 39.88 1.81 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.76 -0.733 . . . . 64.11 112.493 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -87.07 -12.15 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 74.55 110.903 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -145.17 -164.88 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 62.15 110.82 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.8 t -121.6 111.67 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 73.0 111.104 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.1 136.85 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 73.22 111.13 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -159.48 42.43 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.12 110.856 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -175.03 178.17 46.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.81 -0.71 . . . . 71.53 112.547 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -179.39 135.35 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.82 0.343 . . . . 72.14 110.906 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.7 t -40.63 111.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 61.03 111.166 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.14 -59.93 2.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 75.34 110.878 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -151.05 165.9 32.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 74.24 110.9 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.76 34.53 48.4 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 63.2 112.485 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.43 -23.3 15.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 71.14 110.869 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.96 -31.2 62.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.433 . . . . 74.32 110.865 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.403 HD11 ' HB3' ' A' ' 17' ' ' LEU . 37.4 mm -65.89 -38.3 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 75.55 111.1 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.3 t -66.58 -27.83 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 74.12 111.089 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -80.88 -30.64 35.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 73.12 110.88 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.15 -38.52 69.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 74.24 111.088 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 38.9 mtm -62.66 -54.0 46.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 72.24 110.894 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -55.52 -24.57 32.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 75.51 110.87 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.408 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.77 -25.04 61.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 71.32 110.867 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.408 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 72.0 m-85 -108.34 19.96 19.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 75.45 110.919 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.48 163.4 12.17 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.758 -0.734 . . . . 74.33 112.449 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.3 t -112.01 146.59 37.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 73.45 110.845 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -75.06 67.96 1.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 74.21 110.856 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -172.68 -36.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 75.53 110.88 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 156.11 -93.74 0.14 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.715 -0.755 . . . . 52.44 112.461 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.413 ' HZ2' ' NH2' ' A' ' 55' ' ' ARG . 6.1 mttp -51.85 165.51 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.808 0.337 . . . . 72.32 110.919 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.5 p -143.53 -171.7 3.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 71.14 111.115 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.5 p -88.44 -62.64 1.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 75.14 110.838 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -66.06 178.06 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 74.41 110.885 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.76 107.58 10.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 74.24 110.834 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 4.9 mp -91.36 108.46 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 74.05 111.118 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.24 162.87 23.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 74.11 111.115 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 19.9 mt -97.58 128.38 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 74.51 111.092 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -93.85 -56.13 2.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 75.32 111.076 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -135.11 155.15 51.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 73.41 110.854 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.83 146.11 11.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 63.33 110.944 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.39 165.83 31.49 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.72 -0.752 . . . . 64.51 112.444 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -61.33 107.87 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 73.1 110.934 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 7' ' ' PHE . 2.7 mm? -49.75 -49.7 47.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 73.43 110.922 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 72.22 110.877 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 mtm . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.869 0.366 . . . . 75.41 110.844 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.6 p -177.31 32.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 72.25 111.13 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 62.42 157.64 0.12 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.619 0.723 . . . . 75.13 110.921 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 146.4 59.99 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.679 2.253 . . . . 71.52 112.373 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -132.7 141.78 48.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 73.55 111.155 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.439 ' HA ' HD21 ' A' ' 164' ' ' LEU . 1.1 m -133.21 143.52 38.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.33 111.133 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.561 ' HB3' HD23 ' A' ' 164' ' ' LEU . 15.4 p90 -103.13 159.79 15.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 73.14 110.872 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -143.52 87.94 1.97 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 74.45 110.847 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -50.95 106.09 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 74.25 110.857 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.5 mm -81.18 130.57 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 71.3 111.133 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -121.28 146.89 46.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 73.21 111.102 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.0 t -130.59 94.4 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 75.53 111.128 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 67.44 32.95 5.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 75.11 110.865 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.76 -19.02 56.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.707 -0.759 . . . . 71.22 112.475 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -99.28 113.68 64.97 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.63 0.729 . . . . 70.21 110.884 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.6 Cg_endo -69.81 127.01 13.93 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.67 2.247 . . . . 54.2 112.328 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.3 mt -68.4 -38.28 81.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 73.52 110.949 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.78 -125.32 1.49 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.755 -0.736 . . . . 73.3 112.497 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.92 136.42 53.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 73.33 110.908 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.1 t -144.81 99.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 63.22 111.145 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -109.95 172.58 6.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 64.51 110.84 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -144.48 142.56 30.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 73.13 110.901 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.444 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 47.6 tt0 -98.22 99.58 10.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 71.24 110.9 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.487 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 2.2 mt -80.25 122.46 26.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 72.11 110.936 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -75.59 65.53 1.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 63.44 110.911 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.55 -22.6 13.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 72.21 111.102 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -63.61 -46.21 86.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 60.33 110.883 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -91.06 -30.38 16.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.43 110.88 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.03 67.11 80.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.653 0.74 . . . . 64.01 111.14 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -39.61 6.28 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.652 2.234 . . . . 75.44 112.346 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -37.05 85.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 75.41 110.878 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 m -85.15 -40.81 16.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 72.41 111.168 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.9 -48.59 68.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 63.01 111.088 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -49.52 -32.91 13.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 75.44 110.854 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.04 -50.62 69.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 73.11 110.902 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -69.55 -44.29 71.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 71.45 110.829 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -63.96 -35.47 80.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 74.34 110.898 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.97 92.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 53.14 111.107 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mt -74.39 -45.94 43.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 63.22 110.903 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 m -57.49 -45.31 85.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 75.41 110.855 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 74.8 p -72.15 -48.64 41.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.104 -0.498 . . . . 64.35 111.11 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.74 -13.67 10.72 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.707 -0.759 . . . . 63.3 112.52 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -50.46 -34.57 25.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.856 0.36 . . . . 72.32 110.88 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -53.36 -27.97 26.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.882 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.87 -11.29 60.76 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 71.02 112.488 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -162.36 -165.79 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 72.12 110.88 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.95 -133.57 3.65 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.696 -0.764 . . . . 43.12 112.435 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -175.33 91.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.955 0.407 . . . . 75.51 110.906 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -80.68 78.02 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 75.42 110.864 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 158' ' ' ILE . . . 179.39 -66.66 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 74.13 112.502 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m 49.19 -167.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 75.12 110.818 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.46 129.36 1.03 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 70.22 110.857 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -94.52 106.84 18.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.447 . . . . 73.35 110.864 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.0 27.29 9.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 73.12 110.856 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.97 91.71 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 75.43 110.909 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.0 mt -125.86 113.04 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 75.02 111.123 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.1 mt -105.12 102.36 35.83 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.596 0.712 . . . . 75.43 111.094 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 79.32 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.665 2.244 . . . . 63.2 112.35 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.45 -25.56 0.52 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 53.04 112.477 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.33 -57.67 2.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.809 0.338 . . . . 74.43 110.867 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.44 156.77 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 73.54 110.851 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.9 m -93.11 -167.81 1.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 74.11 110.915 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 177.61 146.93 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 72.32 110.887 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.41 163.43 36.12 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.721 -0.752 . . . . 72.32 112.451 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.28 126.58 0.83 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.721 -0.752 . . . . 64.15 112.492 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -157.41 70.32 0.6 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.889 0.375 . . . . 74.01 110.883 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -74.72 -75.59 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 64.11 110.865 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 t -147.82 69.08 1.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 70.43 111.144 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -125.57 -36.8 2.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 72.3 110.875 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.4 m170 63.72 56.24 1.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 74.25 110.86 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -167.01 -42.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 74.33 110.899 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 126.48 33.57 0.66 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.71 -0.757 . . . . 63.32 112.431 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.5 p -145.41 37.62 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.81 0.338 . . . . 61.41 111.147 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.77 -167.09 43.31 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.725 -0.75 . . . . 74.33 112.519 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.81 113.35 3.8 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 72.44 112.547 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.28 178.92 6.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 74.45 110.9 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.38 150.41 20.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 53.52 110.886 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pp -53.01 -32.27 18.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 73.5 111.16 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -72.37 -34.28 67.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 75.21 110.879 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.25 -140.72 6.44 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.763 -0.732 . . . . 75.34 112.49 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -64.26 -35.27 80.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.935 0.398 . . . . 73.44 110.882 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.472 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.5 168.0 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.909 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -141.12 179.81 6.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 73.14 110.859 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.07 160.09 33.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 75.44 110.902 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.9 152.64 45.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 72.13 110.894 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -100.24 -75.81 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 70.12 110.913 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.4 p30 -166.91 173.94 8.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 65.02 110.919 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.86 34.75 3.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 72.4 110.908 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -51.03 -29.41 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 74.1 111.14 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 24.6 mt -99.99 91.7 4.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 74.41 110.878 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.9 mppp? -80.96 140.16 35.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 64.53 110.878 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -50.33 101.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 70.14 110.883 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.7 p -111.01 25.39 11.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.45 111.146 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 151.38 178.74 26.45 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 72.54 112.453 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 175.91 7.46 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.662 2.241 . . . . 75.41 112.332 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.86 37.11 93.81 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.69 -0.767 . . . . 70.44 112.474 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.1 mm -109.51 134.91 50.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.849 0.357 . . . . 73.52 111.118 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.452 HD21 ' CD1' ' A' ' 112' ' ' PHE . 2.8 mt -99.69 165.17 11.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 63.24 110.959 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.492 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 9.8 t -163.73 -128.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 63.21 110.83 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 28.8 mtm -150.24 143.15 24.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 74.24 110.844 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.58 104.13 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 63.13 111.06 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 179.8 174.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 75.2 110.896 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -50.57 -26.27 5.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 71.11 111.098 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.59 -82.93 0.33 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.709 -0.758 . . . . 75.23 112.499 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 95.06 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.687 2.258 . . . . 71.32 112.386 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 72.73 171.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 72.21 110.923 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.2 p 66.46 28.9 9.41 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 64.01 111.106 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -96.57 160.64 14.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 75.45 110.902 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.88 -132.42 3.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 72.15 112.488 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.9 t -104.48 -47.13 4.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.833 0.349 . . . . 75.53 110.86 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -47.36 109.28 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 74.2 110.906 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.492 ' HB3' ' O ' ' A' ' 99' ' ' SER . 0.1 OUTLIER -111.04 -164.1 0.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 75.24 110.898 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.412 ' H ' ' HB2' ' A' ' 112' ' ' PHE . 3.5 p90 -143.81 153.0 41.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 72.54 110.859 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.0 mt -98.09 120.36 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 74.24 111.148 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 17.4 m -89.51 95.77 10.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 70.54 110.88 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 p -68.14 -8.46 38.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 75.14 111.135 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -147.33 154.03 40.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 73.12 111.05 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -56.66 93.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 74.33 110.894 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.2 p -95.74 45.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 64.2 111.114 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -25.75 67.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 72.54 110.888 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.4 p90 -48.18 -29.75 3.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.119 -0.491 . . . . 75.02 110.864 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.8 mt -45.51 -36.41 4.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 74.01 110.891 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.32 80.47 0.21 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 63.41 110.866 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 37.95 42.11 1.07 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.701 -0.762 . . . . 75.35 112.507 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.69 -14.66 47.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.824 0.345 . . . . 73.01 110.905 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -146.43 -176.47 5.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.871 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.4 t -113.91 115.86 50.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 75.45 111.107 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 22.4 t -92.27 132.26 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 74.32 111.133 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -157.1 44.78 0.38 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 75.53 110.94 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -179.34 174.76 46.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.724 -0.751 . . . . 75.13 112.474 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.02 143.43 0.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 73.31 110.886 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.5 t -44.3 113.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 74.4 111.12 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.444 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -77.43 -59.82 2.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 75.24 110.906 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -152.53 155.23 37.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 74.3 110.902 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.99 36.91 10.56 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.739 . . . . 72.4 112.472 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -27.52 62.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.785 0.326 . . . . 75.54 110.87 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.85 -32.22 60.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 74.45 110.866 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.2 mm -66.17 -39.19 83.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 74.14 111.153 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.1 t -64.71 -26.62 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 74.22 111.165 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -81.04 -29.36 35.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 64.51 110.875 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.2 -39.5 65.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 61.24 111.092 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 35.0 mtm -61.22 -53.5 56.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 73.22 110.876 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.45 -25.41 36.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 75.31 110.934 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.413 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -70.23 -23.81 62.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 72.31 110.882 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.413 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 66.7 m-85 -108.89 20.73 18.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.4 110.863 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -111.3 171.74 14.57 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 61.32 112.482 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 t -127.9 143.29 51.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 75.32 110.868 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -71.48 79.22 0.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 65.44 110.933 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -178.91 -34.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 74.42 110.89 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.92 -83.1 0.18 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.741 . . . . 74.33 112.504 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.44 169.22 3.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 71.31 110.941 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.9 p -144.61 -171.58 3.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 73.23 111.146 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.8 p -88.64 -63.79 1.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 74.41 110.83 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -64.6 -179.68 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 74.43 110.916 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -127.71 108.81 11.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 75.35 110.899 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.14 116.54 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 74.11 111.16 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.69 164.93 24.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 65.1 111.112 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.402 ' O ' ' HA2' ' A' ' 50' ' ' GLY . 3.7 mt -102.75 126.48 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.434 . . . . 73.23 111.123 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.76 -57.67 2.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 65.34 111.085 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -135.79 152.86 51.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.442 . . . . 60.21 110.849 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.32 144.38 10.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.198 -0.456 . . . . 75.43 110.924 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.18 171.28 40.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.71 -0.757 . . . . 52.05 112.518 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -63.56 141.96 58.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 75.05 110.872 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.561 HD23 ' HB3' ' A' ' 7' ' ' PHE . 1.1 mm? -94.82 -59.61 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 72.44 110.906 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 73.13 110.872 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.1 mtm . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.855 0.36 . . . . 72.23 110.864 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.6 t -145.05 134.91 18.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 74.23 111.177 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -122.45 156.06 61.48 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.627 0.727 . . . . 74.43 110.891 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 146.14 59.21 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.674 2.249 . . . . 74.43 112.322 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -134.12 104.37 6.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 74.21 111.133 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -100.38 172.28 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.192 -0.458 . . . . 72.31 111.134 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.501 ' HB3' HD21 ' A' ' 164' ' ' LEU . 0.5 OUTLIER -160.16 172.98 16.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 75.41 110.9 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.4 ' HA ' ' HB3' ' A' ' 161' ' ' CYS . 32.1 m-85 -153.39 95.29 1.91 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 75.33 110.926 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.2 104.59 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 70.22 110.884 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.7 mm -76.17 138.21 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 74.2 111.188 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.11 168.81 16.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 75.3 111.148 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 91.5 t -144.82 99.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 63.01 111.154 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.42 25.01 7.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 65.43 110.846 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.42 -28.3 12.0 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.725 -0.75 . . . . 70.31 112.479 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.64 125.79 70.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.73 . . . . 75.33 110.894 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 120.4 7.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.641 2.228 . . . . 74.41 112.358 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.5 mt -66.2 -42.02 89.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 72.33 110.922 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.423 ' HA3' HD12 ' A' ' 138' ' ' ILE . . . 160.88 -130.99 2.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 65.44 112.478 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.26 136.55 52.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 71.53 110.893 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -143.01 100.53 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 74.25 111.179 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -109.51 172.84 6.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 71.23 110.872 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.407 ' N ' ' OG ' ' A' ' 21' ' ' SER . 43.6 m-85 -145.64 144.56 30.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 75.11 110.902 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -100.28 97.89 8.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 75.32 110.865 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.438 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 2.3 mt -82.37 128.65 34.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 75.4 110.924 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -87.16 67.3 9.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 75.42 110.932 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.57 -22.48 33.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 74.04 111.117 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -65.08 -34.16 77.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 74.31 110.882 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.2 mmtp -101.46 -31.27 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 75.42 110.927 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.78 65.64 74.72 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.588 0.708 . . . . 74.42 111.105 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -37.49 9.03 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.669 2.246 . . . . 74.43 112.321 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.15 -36.5 77.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 75.44 110.891 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.9 m -90.59 -41.32 11.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 65.04 111.143 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.69 -48.9 75.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 74.12 111.131 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -49.86 -34.29 19.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 74.15 110.922 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -65.25 -65.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 64.21 110.915 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -55.38 -36.51 66.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 75.54 110.875 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -68.61 -49.61 57.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 73.54 110.906 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.29 -25.15 32.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 75.3 111.084 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.24 -58.3 3.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 74.23 110.96 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.41 -38.4 83.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 72.04 110.872 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 42.8 p -62.59 -39.36 93.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 75.12 111.146 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.32 -19.52 31.74 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 74.15 112.493 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.71 -30.58 22.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.929 0.395 . . . . 75.13 110.905 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -31.35 69.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 74.15 110.909 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.64 -8.97 68.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 74.12 112.458 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -169.81 -165.68 0.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.963 0.411 . . . . 73.2 110.834 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.37 -142.37 12.0 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.75 -0.738 . . . . 73.2 112.46 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -115.12 21.61 14.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.896 0.379 . . . . 74.11 110.875 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.4 125.26 12.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 75.42 110.86 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.05 36.96 93.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 75.32 112.53 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -117.3 141.11 48.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.36 . . . . 73.44 110.823 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.5 p -51.99 170.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 73.0 110.88 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.24 -173.77 4.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 75.44 110.885 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -106.56 -69.75 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 73.13 110.826 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.0 ttm-85 -137.26 160.72 38.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 74.44 110.884 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.5 mt -148.49 107.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 75.02 111.16 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.1 mt -106.08 104.78 51.16 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.624 0.726 . . . . 63.43 111.077 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 79.29 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.67 2.247 . . . . 72.13 112.351 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.45 -26.53 0.27 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.749 . . . . 75.4 112.477 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.428 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.1 OUTLIER -120.61 -59.1 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 74.1 110.879 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.428 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER 170.91 156.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 74.34 110.9 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 6.6 m -85.78 -166.72 1.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 72.43 110.879 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -162.97 118.34 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 75.11 110.866 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.67 165.96 54.47 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.739 . . . . 72.05 112.495 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.34 169.1 27.4 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.737 . . . . 61.13 112.507 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.55 -175.86 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 73.42 110.857 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -132.37 -42.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 75.24 110.89 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.5 m -79.4 -69.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 74.45 111.092 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.24 159.18 39.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 74.12 110.915 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -123.29 -83.0 0.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 74.12 110.803 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 48.69 30.78 2.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 74.03 110.879 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 53.24 22.24 13.97 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 63.42 112.481 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.3 t 179.22 53.53 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 73.13 111.128 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.0 -148.09 6.89 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.758 -0.734 . . . . 71.5 112.485 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.07 141.24 2.54 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.752 . . . . 75.52 112.479 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.84 161.48 35.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.784 0.326 . . . . 72.43 110.909 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.428 ' O ' ' CG1' ' A' ' 78' ' ' ILE . 59.6 p -97.89 59.41 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 74.04 110.89 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.428 ' CG1' ' O ' ' A' ' 77' ' ' SER . 14.8 pt 43.9 30.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 75.41 111.108 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.36 26.73 9.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.931 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.18 -70.07 2.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 63.42 112.476 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -125.42 -56.2 1.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.403 . . . . 74.55 110.909 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.36 -178.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 72.13 110.907 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -146.25 179.78 7.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 72.2 110.877 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.7 166.74 11.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 73.45 110.908 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -45.51 148.32 0.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 73.2 110.881 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -107.96 -74.66 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 75.45 110.856 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -162.11 170.47 19.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 70.41 110.89 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.22 37.95 3.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 75.42 110.925 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.37 -30.13 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 75.3 111.152 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 13.6 mt -110.02 84.59 1.95 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 73.15 110.92 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -71.77 146.83 47.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 64.03 110.926 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -51.69 103.23 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 73.25 110.862 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 44.2 p -124.87 38.92 4.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 64.33 111.156 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.85 166.65 12.44 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.752 . . . . 71.25 112.49 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 160.11 50.91 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.698 2.265 . . . . 72.54 112.324 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.95 -14.53 58.53 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.69 -0.767 . . . . 65.32 112.465 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.6 mm -55.36 134.73 18.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.838 0.351 . . . . 73.31 111.131 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mt -102.07 167.46 10.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 74.54 110.945 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.24 -147.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 71.24 110.878 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.3 mmt -145.17 124.88 13.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 71.51 110.902 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -115.31 76.36 1.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 63.52 111.109 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -114.12 -40.75 3.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 72.3 110.894 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.25 25.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 75.15 111.121 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.71 -140.82 16.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.728 -0.748 . . . . 61.31 112.505 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 106' ' ' ASN . 54.0 Cg_endo -69.73 59.32 1.6 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.668 2.245 . . . . 72.2 112.355 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER 166.02 160.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 73.21 110.885 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.2 p 56.71 34.19 24.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 74.22 111.185 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.17 64.83 1.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 70.52 110.889 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -62.82 -77.85 0.2 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.748 -0.739 . . . . 75.11 112.434 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 44.0 t -164.43 43.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.342 . . . . 71.55 110.868 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -101.39 39.46 1.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 74.12 110.903 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -55.29 -178.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 75.13 110.84 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -157.58 -175.88 5.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.118 -0.492 . . . . 75.01 110.834 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mt -121.73 93.5 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 72.44 111.151 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 61' ' ' MET . 43.9 m -69.94 87.64 0.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 62.1 110.866 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.0 p -60.91 -14.88 25.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 74.22 111.118 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -143.26 153.16 42.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 73.1 111.103 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -54.51 93.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 73.54 110.862 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.9 p -93.82 52.74 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 72.22 111.149 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -24.24 65.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 73.32 110.862 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -48.95 -29.91 5.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 75.52 110.883 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 17.9 mt -47.2 -33.52 5.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 71.35 110.924 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.5 m-20 57.85 80.36 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 74.23 110.903 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.23 43.44 0.7 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 73.11 112.502 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.72 -16.29 51.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.849 0.357 . . . . 72.42 110.956 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -143.02 -167.75 2.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 73.2 110.884 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.2 t -120.34 115.14 46.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 63.21 111.142 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.4 t -86.91 133.76 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 74.23 111.078 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -154.82 41.42 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.51 110.906 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . 179.38 175.99 46.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.803 -0.713 . . . . 61.03 112.507 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -175.2 142.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 75.21 110.946 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.5 t -45.61 112.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 73.34 111.128 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.13 -61.02 2.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 73.52 110.893 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -155.68 147.14 22.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 63.23 110.883 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.82 38.57 4.88 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.728 -0.749 . . . . 65.42 112.495 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -30.36 70.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.805 0.336 . . . . 74.31 110.878 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.47 -37.57 49.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 63.4 110.881 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.423 HD12 ' HA3' ' A' ' 18' ' ' GLY . 33.0 mm -61.89 -38.54 80.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 65.43 111.091 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 74.6 t -67.11 -24.21 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 73.04 111.109 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.72 -28.77 28.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 72.53 110.869 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.13 -39.01 63.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 71.51 111.108 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 28.1 mtm -58.95 -52.42 65.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 70.53 110.866 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.26 -26.69 30.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 73.25 110.886 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.428 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.81 -24.46 63.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 74.1 110.873 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.428 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 63.1 m-85 -107.78 14.07 25.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 73.22 110.853 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -113.61 167.52 12.34 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.763 -0.732 . . . . 63.23 112.505 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.55 133.95 51.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 75.11 110.867 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -54.38 -22.69 13.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.496 . . . . 75.13 110.873 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -31.27 64.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.452 . . . . 74.01 110.895 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 141.49 -40.69 1.3 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.749 -0.739 . . . . 75.45 112.53 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.57 -177.43 0.43 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 74.31 110.909 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.3 p -146.27 159.63 43.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 72.54 111.117 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.69 -58.47 2.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 65.44 110.844 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -89.48 -177.17 5.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 73.25 110.846 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -112.21 108.17 17.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 71.21 110.87 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.0 mp -84.65 117.73 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 64.43 111.165 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.12 164.18 22.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 74.43 111.2 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.2 mt -101.32 130.74 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 75.22 111.08 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.17 -53.45 4.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 74.12 111.098 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -148.33 145.69 28.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 74.01 110.847 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.4 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -149.93 146.57 27.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 71.42 110.886 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.52 161.81 21.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.714 -0.755 . . . . 73.43 112.472 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -58.13 107.1 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 71.22 110.908 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.501 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.2 mm? -49.04 -54.88 13.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 74.03 110.921 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 75.02 110.864 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.827 0.346 . . . . 73.4 110.877 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.7 p -177.95 144.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 75.33 111.101 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -100.73 146.07 31.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.69 0.757 . . . . 65.22 110.854 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 152.48 69.17 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.702 2.268 . . . . 75.41 112.328 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -135.92 135.15 39.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 70.43 111.15 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.449 ' HA ' HD21 ' A' ' 164' ' ' LEU . 1.4 m -129.43 143.2 41.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 74.22 111.133 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 7.0 p90 -104.66 165.21 11.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 72.24 110.889 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -147.29 86.4 1.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 72.12 110.896 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -46.76 107.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 74.44 110.855 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.3 mm -85.38 119.78 34.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 71.21 111.115 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -113.43 149.85 33.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 72.44 111.095 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.2 t -133.28 98.42 2.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.451 . . . . 73.22 111.147 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.69 32.93 10.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 75.52 110.875 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.46 -18.59 57.11 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.717 -0.754 . . . . 73.14 112.486 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -98.5 114.84 65.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.651 0.739 . . . . 74.2 110.862 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.75 125.36 12.06 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.68 2.253 . . . . 73.51 112.337 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.6 mt -67.91 -39.05 83.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 73.13 110.873 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.19 -129.31 2.28 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.761 -0.733 . . . . 63.12 112.476 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -121.36 134.74 55.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 75.25 110.92 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.7 t -145.11 103.19 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 75.2 111.086 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.589 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -114.73 173.75 6.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 75.12 110.864 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.425 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.8 OUTLIER -143.57 136.8 27.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 75.11 110.922 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -91.52 98.28 11.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 75.04 110.855 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mt -80.15 125.87 30.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 64.14 110.906 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -83.58 63.17 7.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 72.24 110.933 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.64 -23.73 7.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 74.4 111.105 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.6 -35.1 76.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 73.2 110.855 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.51 -30.87 13.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 72.42 110.868 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.04 66.58 68.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.656 0.741 . . . . 73.44 111.126 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -32.71 18.04 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.664 2.243 . . . . 70.34 112.351 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -40.62 95.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 72.43 110.893 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.4 m -86.83 -44.91 11.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 73.04 111.157 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.26 82.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 72.25 111.074 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -47.62 -40.66 20.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 73.53 110.87 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -64.01 -63.33 1.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 74.31 110.882 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.43 -23.32 24.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 71.04 110.865 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.481 ' NH2' ' HG2' ' A' ' 163' ' ' GLN . 0.0 OUTLIER -74.54 -59.31 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 73.53 110.894 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.43 -30.3 62.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 73.1 111.126 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.3 mt -75.75 -58.29 3.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 74.53 110.869 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.6 m -49.64 -46.69 49.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 75.31 110.863 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.6 p -74.69 -28.81 60.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 62.0 111.172 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.58 -8.44 76.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.775 -0.726 . . . . 74.34 112.457 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -63.23 -15.82 58.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.874 0.368 . . . . 75.31 110.866 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HE3' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -49.48 -28.84 5.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 72.05 110.859 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.29 -25.83 5.64 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.696 -0.764 . . . . 73.13 112.431 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -160.25 -46.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 75.34 110.861 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.52 -146.22 21.48 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.766 -0.731 . . . . 53.13 112.466 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -175.44 92.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.99 0.424 . . . . 74.44 110.884 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.47 141.02 29.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 74.35 110.922 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.91 39.66 74.92 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.754 -0.736 . . . . 71.31 112.479 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.09 28.83 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 72.13 110.848 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 3.9 m 51.16 -170.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 70.14 110.885 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -105.06 -174.27 2.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 71.11 110.875 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -120.3 -72.78 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 74.02 110.808 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 45.2 ttm-85 -138.91 156.41 47.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 75.32 110.815 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.0 mt -147.87 113.27 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 74.14 111.143 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.5 mt -113.12 104.13 55.71 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.601 0.715 . . . . 71.54 111.178 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.4 Cg_endo -69.77 77.35 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.729 2.286 . . . . 72.01 112.327 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.01 -27.1 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.741 . . . . 72.13 112.46 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.01 -54.67 2.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 74.32 110.869 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 168.87 165.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 74.31 110.834 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.6 m -92.45 -161.25 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 63.32 110.861 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -179.57 129.58 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 72.01 110.919 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.62 75.77 0.29 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.677 -0.773 . . . . 72.43 112.43 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.45 85.81 0.41 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.717 -0.754 . . . . 51.21 112.466 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.43 111.1 16.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 75.45 110.848 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -126.76 -74.63 0.59 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 64.23 110.864 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.6 p -143.5 -41.9 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 74.21 111.165 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.78 -81.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 75.33 110.86 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.7 m170 50.0 30.33 4.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 74.3 110.853 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 t30 177.99 -74.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 73.43 110.874 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 163.9 53.72 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 74.15 112.534 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.7 t -177.79 54.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 75.21 111.17 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.57 176.0 8.98 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 74.43 112.501 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.39 110.92 1.67 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 72.15 112.47 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.52 156.18 40.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.749 0.309 . . . . 74.31 110.932 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.9 p -93.88 56.48 2.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 74.14 110.841 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.418 ' HB ' ' HE3' ' A' ' 44' ' ' LYS . 31.1 pt 40.23 37.11 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 74.44 111.103 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -157.38 47.79 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 75.32 110.927 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.95 -128.29 8.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.711 -0.757 . . . . 64.5 112.508 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -118.52 -27.0 6.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 72.51 110.855 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.472 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 177.32 167.58 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 74.4 110.893 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -139.6 177.51 7.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 73.4 110.894 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.16 157.17 37.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 75.31 110.878 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -52.73 136.24 33.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 72.14 110.899 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -91.18 -76.27 0.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 72.23 110.888 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -165.49 167.89 17.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 73.1 110.91 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.55 37.76 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 72.11 110.913 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.38 -29.91 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 74.14 111.169 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 13.8 mt -108.95 79.17 1.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 74.43 110.914 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 150.33 47.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 71.44 110.896 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -59.31 96.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 62.53 110.829 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.9 p -104.53 25.53 10.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 65.23 111.167 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 144.93 -179.08 22.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 44.15 112.487 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 171.82 13.75 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.715 2.277 . . . . 73.2 112.339 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.78 23.0 78.6 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 54.12 112.464 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.1 mm -99.04 142.7 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.891 0.377 . . . . 75.13 111.14 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.36 140.91 47.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 74.03 110.943 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.14 -167.15 2.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 72.54 110.858 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -100.24 104.95 16.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 74.41 110.863 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.419 ' CB ' ' HB3' ' A' ' 113' ' ' PHE . . . -78.42 52.37 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 74.33 111.117 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.34 -169.14 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 72.44 110.854 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -46.45 -47.59 19.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 71.34 111.074 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.67 -74.79 0.31 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.761 -0.733 . . . . 61.32 112.495 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 111.32 2.79 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.659 2.239 . . . . 71.31 112.311 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 41.35 56.64 3.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 73.35 110.924 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.0 p -153.68 44.8 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 70.4 111.178 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.33 125.15 28.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 74.51 110.893 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.24 -91.84 0.52 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.74 . . . . 74.14 112.492 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.7 t -178.73 49.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.816 0.341 . . . . 73.54 110.814 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -74.69 -40.26 61.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 74.2 110.936 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 66.25 141.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 73.44 110.873 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.551 ' CD1' ' C ' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -161.99 135.85 6.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 74.2 110.912 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.8 mt -85.9 119.32 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 72.25 111.134 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.08 98.97 10.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 73.4 110.899 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 76.7 p -86.1 18.48 3.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 64.1 111.145 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 177.31 142.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 71.31 111.071 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -51.65 99.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 75.02 110.919 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.419 ' CG2' ' CZ2' ' A' ' 121' ' ' TRP . 41.4 p -104.12 53.62 0.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 62.55 111.111 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.67 -27.32 68.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 73.35 110.894 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.419 ' CZ2' ' CG2' ' A' ' 119' ' ' THR . 6.6 p90 -48.29 -26.74 2.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.947 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 23.8 mt -44.48 -37.41 3.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 75.2 110.923 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 124' ' ' GLY . 5.5 m-20 59.16 80.98 0.17 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 62.02 110.857 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.63 41.67 0.88 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.742 -0.742 . . . . 70.11 112.473 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.12 -21.4 36.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.85 0.357 . . . . 73.44 110.909 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -144.75 -169.44 3.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 74.01 110.832 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.8 t -124.58 123.46 66.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 64.3 111.099 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 t -88.84 132.58 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 71.02 111.096 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -154.93 36.64 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 73.54 110.889 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -174.12 177.77 46.22 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.753 -0.736 . . . . 62.43 112.509 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -177.9 138.81 0.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.861 0.362 . . . . 75.41 110.905 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 77.2 t -41.94 106.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 74.44 111.123 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -59.91 2.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 73.35 110.878 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -153.46 150.0 28.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 72.43 110.91 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.8 48.25 4.23 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.729 . . . . 73.33 112.496 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -32.01 73.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.719 0.295 . . . . 75.1 110.849 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.99 -33.22 37.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 71.22 110.916 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.2 mm -64.92 -36.47 77.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 71.41 111.077 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 63.5 t -65.8 -27.59 41.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 75.44 111.144 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -81.03 -27.51 35.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 73.35 110.827 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.04 -39.89 60.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 74.51 111.116 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 33.9 mtm -60.69 -52.92 63.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 75.31 110.886 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -53.55 -27.6 27.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 74.53 110.889 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.425 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.28 -24.48 63.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 74.23 110.896 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.425 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 59.7 m-85 -109.08 21.47 17.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 73.1 110.892 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -114.54 168.14 12.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 70.04 112.466 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 m -104.73 129.84 52.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 72.52 110.891 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -54.97 -26.12 34.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 74.01 110.89 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -77.71 -28.81 51.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 74.43 110.882 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.27 -39.43 1.24 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.765 -0.731 . . . . 63.4 112.47 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -178.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 75.02 110.876 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 10.6 p -144.64 133.58 22.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 62.54 111.161 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.7 m -69.09 -41.17 77.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 73.12 110.889 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.5 -177.15 3.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 74.53 110.899 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -115.92 108.54 16.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 73.23 110.885 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 4.9 mp -92.0 119.2 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 74.1 111.12 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.0 163.7 24.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 74.22 111.145 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.5 mt -96.23 105.56 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 73.55 111.106 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.7 76.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 71.51 111.083 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -162.98 160.95 25.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 71.43 110.87 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -167.98 148.16 4.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 71.42 110.882 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.5 -173.02 44.27 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.739 -0.743 . . . . 75.24 112.492 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.481 ' HG2' ' NH2' ' A' ' 37' ' ' ARG . 3.8 mt-30 -80.93 129.59 34.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 75.1 110.91 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.549 HD23 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -83.87 -57.78 3.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 75.44 110.972 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 74.4 110.871 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.802 0.334 . . . . 65.45 110.868 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.3 t -141.02 136.4 33.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 75.04 111.121 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -72.09 149.8 92.19 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.646 0.736 . . . . 73.01 110.876 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 146.32 59.61 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.689 2.259 . . . . 64.22 112.351 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -136.29 140.53 43.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 72.45 111.127 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.455 ' HA ' HD22 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -132.84 147.62 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 71.33 111.136 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 16.5 p90 -106.64 166.48 10.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 74.12 110.849 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -144.47 90.38 2.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.4 110.914 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -51.04 117.69 2.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 64.21 110.892 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.2 mm -90.43 116.65 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 71.35 111.134 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -113.47 124.26 51.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 70.34 111.093 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 t -109.22 101.34 12.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 72.23 111.158 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.31 44.26 25.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 73.31 110.833 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.08 -2.0 87.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.734 . . . . 73.3 112.491 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -109.56 99.49 37.71 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.677 0.751 . . . . 64.24 110.883 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.71 101.29 0.89 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.703 2.269 . . . . 72.13 112.378 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.11 -35.73 82.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 71.12 110.89 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.59 -145.1 9.04 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.745 -0.741 . . . . 73.15 112.497 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.56 153.2 51.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 73.04 110.89 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.8 t -144.89 101.46 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 75.41 111.116 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 2.4 t -92.33 176.44 6.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 71.31 110.83 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.455 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -146.26 116.2 7.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 74.12 110.882 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -67.64 96.99 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 70.02 110.88 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.43 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 1.8 mt -80.16 134.32 36.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 75.41 110.885 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -94.4 66.93 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 71.44 110.849 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.95 -23.65 33.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 75.42 111.089 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.39 -29.16 67.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 63.51 110.888 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -103.11 -30.13 10.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 73.44 110.885 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.86 63.89 60.18 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.609 0.719 . . . . 75.44 111.131 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -5.85 17.19 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.689 2.259 . . . . 74.51 112.388 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.72 -45.25 11.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 74.55 110.907 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 44.2 m -92.76 -48.8 6.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 64.12 111.126 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.99 -41.89 68.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 73.33 111.109 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -58.88 -44.52 91.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 75.53 110.933 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -54.2 -50.03 68.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 74.52 110.922 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -61.53 -43.61 98.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 64.0 110.856 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -63.06 -44.01 97.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 73.52 110.907 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.85 -37.75 66.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 54.02 111.089 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 28.8 mt -71.97 -54.7 9.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 65.11 110.903 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -44.7 81.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 64.5 110.857 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.1 p -65.32 -47.0 78.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 73.21 111.118 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.09 -18.28 16.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 75.35 112.484 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -52.89 -29.06 26.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.914 0.388 . . . . 72.2 110.881 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -19.0 37.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 74.3 110.894 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.2 -13.07 40.52 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.683 -0.77 . . . . 62.31 112.476 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -176.78 -170.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.869 0.366 . . . . 73.41 110.855 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -177.83 173.15 45.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 71.25 112.466 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -117.93 60.29 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.961 0.41 . . . . 73.54 110.931 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -78.01 57.56 1.8 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.491 . . . . 75.14 110.863 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 169.76 59.06 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 63.34 112.447 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.57 151.62 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 75.12 110.852 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.9 p -96.07 129.23 43.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 63.51 110.856 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -84.39 133.95 34.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 75.24 110.885 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -132.62 40.59 3.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 73.2 110.897 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 tpp85 -162.58 71.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 75.23 110.882 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.4 mt -123.66 113.76 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.42 111.153 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.7 mt -112.91 109.59 52.44 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.618 0.723 . . . . 75.03 111.12 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 76.92 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.67 2.247 . . . . 65.03 112.319 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.79 -27.15 0.21 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 74.35 112.457 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.412 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.0 OUTLIER -115.26 -60.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 75.43 110.858 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.412 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER 172.68 173.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 65.12 110.866 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.2 m -108.83 -177.71 3.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 75.21 110.866 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -150.92 154.63 37.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 72.2 110.894 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.22 -28.69 61.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.746 -0.74 . . . . 64.14 112.499 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.61 -87.11 0.54 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.752 -0.737 . . . . 64.24 112.48 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -155.43 149.9 26.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.861 0.362 . . . . 75.55 110.828 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -71.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 64.45 110.869 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.6 t -154.95 -42.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 74.32 111.176 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.2 -170.35 2.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 75.04 110.854 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -118.84 -77.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 74.33 110.882 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 50.28 29.65 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 71.41 110.876 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 57.73 54.7 35.23 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.701 -0.761 . . . . 34.32 112.48 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 t 177.65 -49.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.828 0.347 . . . . 64.22 111.173 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.21 -146.23 16.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.707 -0.759 . . . . 71.11 112.487 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.29 -123.44 2.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.756 -0.735 . . . . 74.21 112.499 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? 179.73 145.08 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.338 . . . . 73.23 110.884 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.1 m -76.41 65.73 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 72.44 110.876 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.4 pt 41.7 34.17 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 74.13 111.144 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -164.74 -64.6 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 72.25 110.91 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -136.61 161.85 25.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 70.25 112.509 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -47.84 -32.1 5.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.904 0.383 . . . . 70.42 110.863 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.445 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.31 170.22 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 74.1 110.864 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.46 -179.9 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.886 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.85 160.0 26.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 75.44 110.888 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -52.1 151.67 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 63.13 110.823 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -100.62 -78.34 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 71.42 110.861 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -158.01 172.49 18.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 64.25 110.888 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.8 37.48 4.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 74.12 110.898 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mt -50.61 -29.35 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 64.35 111.089 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 15.1 mt -108.87 88.33 2.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 72.54 110.874 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -71.6 151.97 43.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 73.32 110.921 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -64.85 87.39 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 75.23 110.842 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.21 -51.38 11.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 75.03 111.154 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . -147.86 -164.46 11.31 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.772 -0.728 . . . . 64.41 112.477 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 173.8 10.44 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.659 2.24 . . . . 65.33 112.331 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.52 28.09 73.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.777 -0.725 . . . . 63.43 112.472 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.8 mm -100.85 140.69 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.893 0.377 . . . . 75.14 111.145 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.45 138.97 47.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 74.1 110.93 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.62 -168.1 3.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 71.52 110.863 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -94.23 103.91 15.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 75.01 110.902 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.424 ' CB ' ' HB3' ' A' ' 113' ' ' PHE . . . -75.64 69.77 2.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 64.32 111.115 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -131.71 -175.17 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 74.13 110.896 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.93 -27.15 2.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 75.15 111.112 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.4 -89.23 0.49 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.715 -0.755 . . . . 64.54 112.506 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 90.86 0.52 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.737 2.292 . . . . 74.42 112.316 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 76.07 168.53 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 64.4 110.897 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 p 69.86 28.96 4.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 73.53 111.174 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -109.28 106.65 16.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 64.4 110.879 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -90.23 -65.58 1.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 62.32 112.457 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.5 p 179.64 49.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.806 0.336 . . . . 74.45 110.836 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -62.39 -34.95 77.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 75.33 110.963 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 68.58 137.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 73.31 110.89 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -154.06 127.55 8.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 74.23 110.849 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.7 mt -83.95 125.32 40.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 74.23 111.164 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -91.15 103.48 16.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 75.2 110.894 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 69.4 p -88.42 20.75 3.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.32 111.117 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 174.87 146.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 70.01 111.13 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.411 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 1.2 tttt -54.43 99.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 74.22 110.906 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 42.2 p -105.87 46.66 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 72.21 111.125 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -25.73 65.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 75.14 110.879 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 5.6 p90 -50.12 -25.46 3.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.474 . . . . 75.24 110.905 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.9 mt -45.04 -35.72 3.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 74.21 110.888 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.0 m-20 60.74 80.45 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 65.33 110.853 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.3 42.66 0.9 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 63.2 112.52 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? -82.23 -25.49 34.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.834 0.35 . . . . 73.32 110.897 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -141.46 179.23 6.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 63.31 110.876 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.4 t -114.8 124.31 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 65.31 111.096 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.45 131.92 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 74.3 111.119 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -149.23 31.58 0.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 64.33 110.911 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -175.8 175.69 47.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.804 -0.713 . . . . 73.03 112.494 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' A' ' 132' ' ' VAL . 1.5 pttp -173.12 127.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.81 0.338 . . . . 75.45 110.885 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.471 ' C ' ' O ' ' A' ' 131' ' ' LYS . 53.8 t -32.12 106.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 74.43 111.107 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -57.16 4.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 71.13 110.895 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -157.06 157.51 34.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 75.41 110.905 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.33 32.05 10.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 65.3 112.507 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -24.23 66.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 71.43 110.848 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -39.4 79.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 71.44 110.893 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 25.9 mm -66.56 -37.7 80.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 72.13 111.134 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.17 -30.54 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 73.23 111.129 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -73.09 -30.86 63.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 74.43 110.898 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.79 -37.19 70.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 72.34 111.111 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 16.0 mtm -57.97 -53.79 54.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 62.24 110.869 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.87 -28.12 34.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 71.22 110.866 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.418 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -67.81 -24.44 65.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 64.54 110.854 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.418 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 58.5 m-85 -108.71 20.68 18.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 70.11 110.915 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.41 166.25 12.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 52.34 112.514 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.5 t -123.34 148.79 45.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.864 0.364 . . . . 62.2 110.866 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.9 mmm-85 -75.34 70.51 2.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 63.12 110.92 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -174.79 -35.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.3 110.889 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.42 -42.72 0.88 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 70.04 112.483 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.38 165.63 20.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.864 0.364 . . . . 74.32 110.854 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.8 p -145.67 154.5 42.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 75.01 111.133 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 m -71.32 -48.16 52.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 75.33 110.849 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -96.87 -178.53 4.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 74.2 110.921 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -124.05 108.86 12.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 74.33 110.887 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.76 123.12 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 70.43 111.126 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.83 158.57 40.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 71.03 111.136 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.7 mt -91.1 108.44 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 75.51 111.15 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.85 -48.4 31.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 73.34 111.099 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -151.93 162.74 40.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 62.44 110.872 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.11 148.19 4.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.901 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 176.81 172.51 41.52 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 74.33 112.498 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -63.84 140.4 58.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.836 0.351 . . . . 74.14 110.91 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.56 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -92.49 -56.19 3.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 73.33 110.894 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 73.43 110.864 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mtp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.853 0.358 . . . . 75.32 110.875 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.6 t -140.35 130.31 28.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 62.14 111.159 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -102.44 153.51 38.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.617 0.722 . . . . 72.11 110.877 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 146.72 61.0 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.672 2.248 . . . . 75.32 112.316 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -133.28 140.05 47.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 74.12 111.18 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.417 ' HA ' HD21 ' A' ' 164' ' ' LEU . 1.6 m -133.3 143.02 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 64.21 111.14 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.558 ' HB3' HD23 ' A' ' 164' ' ' LEU . 15.7 p90 -103.4 161.07 14.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 75.54 110.92 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -142.55 88.08 2.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 72.54 110.868 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -52.13 107.49 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 72.54 110.888 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 32.3 mm -78.9 131.39 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 61.34 111.117 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -126.87 123.58 37.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 62.32 111.102 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 t -108.28 94.55 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 74.13 111.156 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.1 t0 58.96 46.76 13.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 74.24 110.899 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.34 -4.37 84.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.738 -0.744 . . . . 72.51 112.477 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -111.28 102.63 53.5 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.681 0.753 . . . . 73.51 110.87 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.82 124.34 10.96 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.628 2.218 . . . . 74.01 112.33 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.1 mt -70.14 -38.76 75.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 73.24 110.926 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.39 -127.17 1.7 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.76 -0.733 . . . . 72.02 112.534 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.49 138.37 54.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.856 0.36 . . . . 75.3 110.851 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.4 t -145.04 100.05 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.12 111.083 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -108.78 175.24 5.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 70.54 110.885 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.454 ' N ' ' OG ' ' A' ' 21' ' ' SER . 1.8 m-85 -146.23 137.2 24.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 74.41 110.827 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -92.12 101.55 14.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 71.3 110.892 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -83.15 119.06 24.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 75.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -76.55 65.68 2.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 74.12 110.88 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.7 -22.77 25.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 44.13 111.099 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -65.87 -33.94 76.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 71.05 110.881 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -101.56 -29.19 12.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 62.41 110.887 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.22 65.73 64.65 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.594 0.712 . . . . 72.43 111.107 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -34.92 13.54 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.65 2.234 . . . . 73.31 112.37 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -39.55 91.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 75.54 110.909 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.5 m -87.96 -40.4 13.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 72.44 111.139 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.4 95.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 73.5 111.061 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -51.75 -35.78 44.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 73.54 110.87 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -61.37 -54.53 42.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.874 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -65.76 -45.65 81.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 73.45 110.879 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.97 -38.7 86.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 72.53 110.828 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.36 -44.28 97.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 70.21 111.093 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.5 mt -74.03 -47.21 38.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 65.43 110.933 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.1 m -51.92 -44.94 64.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 60.11 110.838 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.6 p -71.75 -34.4 69.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 75.52 111.144 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.59 -6.41 41.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.738 -0.744 . . . . 71.54 112.462 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.75 -25.09 17.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 71.2 110.856 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -32.97 74.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 75.55 110.897 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.54 -28.88 4.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 73.31 112.487 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -141.51 -39.97 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.885 0.374 . . . . 74.11 110.91 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.13 -163.91 52.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 61.54 112.467 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.54 45.83 1.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.914 0.388 . . . . 75.52 110.937 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 74.33 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 75.33 110.865 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.67 -59.38 0.33 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 73.14 112.49 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 45.8 -163.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.774 0.321 . . . . 63.44 110.909 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.2 p 179.11 116.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 60.13 110.89 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -97.37 75.35 2.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 74.3 110.867 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -73.15 -21.27 60.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 65.24 110.826 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.18 122.51 46.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 75.11 110.887 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.0 mt -150.29 111.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 75.34 111.125 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 42.8 mt -105.78 103.0 41.82 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.615 0.722 . . . . 75.43 111.179 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 83.11 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.706 2.271 . . . . 72.15 112.341 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 153.19 -20.63 0.75 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 74.34 112.525 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.21 -59.33 1.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.866 0.365 . . . . 64.33 110.859 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -178.14 175.59 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 73.14 110.866 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.4 m -120.47 -170.13 1.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 75.13 110.893 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -177.67 144.13 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 71.44 110.938 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.95 124.27 1.03 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.705 -0.76 . . . . 71.01 112.512 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.72 106.64 0.19 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.728 -0.749 . . . . 73.04 112.503 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.42 145.82 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.339 . . . . 75.2 110.88 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -163.09 44.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 73.23 110.879 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.3 p -119.19 -37.34 3.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 74.42 111.137 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.89 -172.38 3.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 75.43 110.852 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -77.82 -35.86 50.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 70.4 110.851 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -153.18 65.0 0.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 70.03 110.916 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.09 -146.22 8.3 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 64.45 112.466 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.9 p -145.84 38.93 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.794 0.33 . . . . 71.24 111.122 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.61 -113.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.728 -0.748 . . . . 75.41 112.489 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 51.55 88.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 72.04 112.474 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.88 152.25 25.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 72.35 110.88 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.9 p -61.63 157.38 17.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 75.22 110.852 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 pp -56.84 -29.47 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 65.44 111.152 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -82.89 -50.49 8.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.454 . . . . 71.3 110.884 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.76 -125.79 0.87 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.786 -0.721 . . . . 74.23 112.517 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -72.46 -33.2 66.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.885 0.374 . . . . 73.15 110.861 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.403 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.52 174.94 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 72.35 110.887 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.74 -168.52 1.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 75.25 110.85 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.28 162.67 14.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 72.23 110.902 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -54.33 115.83 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 73.3 110.881 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -93.85 -74.72 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 75.44 110.878 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -174.88 174.76 2.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 74.14 110.847 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.82 37.94 3.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 74.43 110.887 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -49.6 -30.13 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 73.31 111.131 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.1 mt -112.56 78.18 1.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.168 -0.469 . . . . 71.31 110.886 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -70.55 151.55 44.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 73.41 110.864 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -49.81 102.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 72.4 110.898 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.2 p -113.81 26.94 9.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 64.42 111.098 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.69 -177.78 24.78 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 71.12 112.54 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 174.14 9.94 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.655 2.237 . . . . 72.21 112.372 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.13 44.4 97.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 73.44 112.485 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.0 mm -110.86 140.4 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.844 0.354 . . . . 73.41 111.122 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.456 HD22 ' CD1' ' A' ' 112' ' ' PHE . 2.8 mt -108.29 155.68 20.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 64.5 110.943 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 6.8 t -167.29 -134.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 71.41 110.884 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 9.7 mmt -153.78 143.38 21.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 71.44 110.902 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -128.37 139.8 52.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 73.14 111.095 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 168.5 -31.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 74.3 110.858 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -175.95 -41.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 74.11 111.097 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.84 -77.47 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 70.33 112.484 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 112.0 2.96 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.636 2.224 . . . . 64.44 112.331 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 39.71 61.15 1.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 64.41 110.909 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.3 p -156.17 52.92 0.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 73.22 111.142 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.82 124.94 42.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 71.31 110.876 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.19 -103.48 1.97 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 73.54 112.5 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.19 30.49 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 72.23 110.858 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -112.5 40.48 2.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 73.54 110.933 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.456 ' CD1' HD22 ' A' ' 98' ' ' LEU . 5.7 p90 -58.21 -170.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 73.51 110.89 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -148.58 146.54 28.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 74.45 110.895 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -15.3 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 74.22 111.119 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 49.17 93.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 54.44 110.913 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.3 p -91.17 26.75 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 75.34 111.118 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 178.26 151.76 0.28 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 62.01 111.129 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.74 97.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 75.53 110.881 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.5 p -104.11 46.5 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 63.34 111.148 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -25.38 68.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 72.03 110.842 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -47.32 -28.61 2.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.155 -0.475 . . . . 75.23 110.938 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.6 mt -46.74 -32.82 3.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 75.22 110.865 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 62.52 77.44 0.33 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 73.34 110.869 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 36.54 43.43 0.77 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 72.45 112.45 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -80.85 -13.6 58.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 74.34 110.916 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -144.05 -169.15 3.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 74.43 110.859 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.1 t -120.69 117.39 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 73.44 111.173 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.83 134.14 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 72.15 111.119 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -156.09 37.6 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.839 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -175.4 173.55 46.3 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.772 -0.728 . . . . 70.2 112.486 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.0 pttt -175.59 139.3 0.42 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.797 0.332 . . . . 75.34 110.926 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.1 t -41.17 110.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 73.13 111.132 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.0 -59.29 2.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 71.11 110.868 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -152.12 157.14 41.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 73.3 110.897 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.09 35.54 17.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.742 . . . . 64.2 112.508 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -31.38 63.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.751 0.31 . . . . 71.24 110.909 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.59 -30.23 20.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 71.04 110.887 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 41.4 mm -66.27 -41.29 88.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 75.43 111.092 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.02 -28.29 44.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 74.53 111.152 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -79.34 -28.64 42.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 64.04 110.857 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.32 -38.46 63.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 71.15 111.112 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 28.6 mtm -59.78 -51.8 68.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 72.42 110.894 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.02 -24.69 25.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 73.12 110.903 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.408 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -72.71 -24.11 60.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 75.0 110.925 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.408 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 62.1 m-85 -108.27 16.86 22.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 75.41 110.879 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.98 178.66 17.62 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 61.23 112.491 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -141.3 132.59 26.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 63.52 110.865 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -64.58 84.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 74.51 110.855 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 179.74 -33.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 71.3 110.865 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.21 -92.49 0.15 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.8 -0.714 . . . . 73.01 112.488 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -51.17 156.53 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 73.31 110.895 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.1 p -131.66 156.02 46.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 74.11 111.145 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.63 -35.21 78.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 75.11 110.863 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -101.23 -179.59 4.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 75.52 110.859 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.8 104.55 7.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 71.44 110.846 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.8 mp -90.63 105.56 16.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 71.42 111.081 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.95 166.02 13.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 75.24 111.132 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.5 mm -98.4 119.51 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 74.24 111.118 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.96 -50.56 8.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 71.13 111.117 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -142.81 155.58 44.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 73.04 110.862 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -163.44 148.87 11.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 73.32 110.89 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 172.96 167.64 33.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.783 -0.722 . . . . 73.43 112.511 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -61.83 134.8 57.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.789 0.328 . . . . 65.1 110.927 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.558 HD23 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -85.7 -59.3 2.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 74.23 110.938 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 75.13 110.855 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.783 0.325 . . . . 74.5 110.882 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.7 t -149.87 136.32 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 74.5 111.162 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.46 142.96 29.58 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 74.41 110.889 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 146.84 61.47 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.687 2.258 . . . . 72.31 112.356 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -129.52 135.66 48.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 74.42 111.167 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -133.13 160.56 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 74.45 111.122 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.547 ' HB3' HD23 ' A' ' 164' ' ' LEU . 1.7 p90 -143.36 -179.29 6.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 74.04 110.879 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -155.89 92.99 1.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 74.23 110.896 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -44.05 104.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 74.54 110.925 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.1 mm -77.18 134.79 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.14 111.083 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -127.66 154.12 45.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 73.23 111.068 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.2 t -134.02 95.91 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 64.34 111.106 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.37 31.52 10.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 74.21 110.861 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.63 -23.39 34.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.788 -0.72 . . . . 74.53 112.471 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -92.25 115.09 64.1 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.607 0.718 . . . . 60.04 110.891 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.9 Cg_endo -69.73 123.0 9.69 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.69 2.26 . . . . 75.43 112.374 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.66 -38.66 87.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 73.23 110.909 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.65 -122.95 1.19 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.756 -0.735 . . . . 54.23 112.458 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.05 141.13 46.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 73.33 110.91 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.53 103.99 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 64.24 111.136 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.8 t -110.28 172.95 6.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 71.1 110.834 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.418 ' N ' ' OG ' ' A' ' 21' ' ' SER . 10.1 m-85 -146.29 131.61 18.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 74.32 110.906 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -85.98 98.07 10.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 71.33 110.884 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 mt -83.12 136.39 34.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 74.33 110.888 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -96.27 63.75 2.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 65.21 110.85 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.19 -24.02 16.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 71.52 111.072 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.36 -31.19 70.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 74.21 110.887 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.5 -27.07 13.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.831 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.61 63.52 47.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.577 0.703 . . . . 74.54 111.088 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -41.82 3.89 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.679 2.253 . . . . 73.03 112.354 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -55.32 -37.46 67.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 73.41 110.922 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.0 m -89.19 -53.36 4.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 62.53 111.141 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.26 -36.37 41.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 64.12 111.123 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -49.74 -32.35 13.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 72.22 110.876 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -63.84 0.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 75.04 110.926 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.37 -34.29 68.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 74.52 110.893 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -49.48 69.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.487 . . . . 71.14 110.871 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.87 -31.46 72.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 73.2 111.113 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.9 mt -75.43 -55.95 5.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 74.34 110.96 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.0 m -49.37 -48.92 46.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 73.44 110.873 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.2 p -69.05 -28.08 66.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 71.34 111.132 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.3 -14.51 65.16 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.728 . . . . 75.54 112.459 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -52.29 -25.29 9.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 73.24 110.938 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HE3' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -50.3 -28.26 7.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 75.14 110.868 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.69 -26.08 4.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.766 -0.731 . . . . 71.11 112.501 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -165.45 -47.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 74.5 110.849 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.61 177.72 0.38 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.774 -0.727 . . . . 61.41 112.488 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -94.7 26.71 3.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.004 0.43 . . . . 75.1 110.919 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.19 126.92 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 73.41 110.902 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.18 39.6 92.47 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.763 -0.732 . . . . 73.11 112.484 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -92.02 -178.66 5.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.888 0.375 . . . . 73.22 110.853 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 22.6 m -117.73 153.39 33.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 73.0 110.891 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -101.61 143.54 31.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 74.53 110.888 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -145.25 45.01 1.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 74.11 110.827 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -171.38 70.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 72.14 110.885 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.2 mt -117.39 109.46 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 73.05 111.091 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.417 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 34.6 mt -106.82 102.67 43.51 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.65 0.738 . . . . 75.1 111.148 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.5 Cg_endo -69.82 79.67 0.95 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.683 2.255 . . . . 73.01 112.309 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.19 -25.62 0.54 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 73.12 112.491 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.3 OUTLIER -117.95 -59.17 1.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.332 . . . . 74.51 110.865 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.431 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.2 OUTLIER 176.91 162.63 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 75.34 110.815 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.9 m -104.59 -169.05 1.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 75.1 110.909 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -178.72 146.91 0.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 75.42 110.939 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.38 176.67 18.02 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.728 . . . . 73.24 112.472 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.13 120.31 4.33 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.756 -0.735 . . . . 65.41 112.493 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -179.83 38.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.772 0.32 . . . . 74.41 110.836 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -128.86 35.0 4.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 72.44 110.907 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.52 -35.33 40.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 74.51 111.157 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? 63.55 160.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 72.25 110.815 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -52.14 -35.91 49.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 74.41 110.863 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.01 -39.41 59.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 63.53 110.85 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.36 48.57 5.01 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.74 . . . . 70.13 112.489 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.8 t -165.94 48.25 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.846 0.355 . . . . 72.35 111.161 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.96 -81.01 1.5 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 64.13 112.443 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.88 94.88 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.762 -0.732 . . . . 73.34 112.471 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -174.74 167.02 3.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.75 0.31 . . . . 75.23 110.916 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.25 -165.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 74.32 110.86 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.436 ' HB ' ' HE3' ' A' ' 44' ' ' LYS . 3.9 pt -94.95 28.43 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 75.04 111.144 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -135.42 -67.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 63.34 110.933 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.16 -142.65 3.49 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 74.12 112.517 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -50.23 -32.94 17.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.856 0.36 . . . . 74.3 110.889 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.444 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.69 -175.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 73.2 110.883 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -147.32 161.01 41.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 72.2 110.871 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -60.73 166.0 3.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 71.44 110.899 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -82.12 174.94 10.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 75.52 110.852 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -120.09 -76.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 73.22 110.871 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.5 p30 -158.89 176.04 12.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 74.01 110.89 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.03 37.66 3.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 75.43 110.844 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.54 -30.08 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 71.4 111.141 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 20.9 mt -109.99 82.56 1.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 73.34 110.92 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.93 150.48 46.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 71.24 110.875 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -58.03 97.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.5 110.841 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.0 p -104.06 24.09 11.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 74.44 111.122 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 147.19 -178.89 24.52 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.739 -0.743 . . . . 72.0 112.5 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 172.62 12.33 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.651 2.234 . . . . 75.25 112.327 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.92 29.56 72.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 75.45 112.473 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.5 mm -103.07 139.97 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.877 0.37 . . . . 62.51 111.119 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.409 HD23 ' CD2' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -108.86 145.97 34.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 65.23 110.935 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.95 -167.99 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 74.23 110.891 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.443 ' CE ' ' HA ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -98.38 113.71 25.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 74.4 110.859 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.03 130.45 40.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 65.44 111.077 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.544 ' CG ' ' HA3' ' A' ' 109' ' ' GLY . 0.6 OUTLIER 175.5 -70.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 65.22 110.915 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -146.85 -50.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 72.21 111.07 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.35 -70.27 0.51 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.759 -0.734 . . . . 71.44 112.522 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 110.23 2.5 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.672 2.248 . . . . 74.51 112.358 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 39.52 45.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 71.11 110.865 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.513 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 22.1 p -153.77 53.33 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 73.21 111.164 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -50.43 -37.16 36.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 73.21 110.909 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.544 ' HA3' ' CG ' ' A' ' 102' ' ' ASN . . . 77.34 -56.39 3.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 72.1 112.484 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 1.0 OUTLIER 85.73 41.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 74.34 110.839 -179.731 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.433 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 25.5 mm-40 -104.45 -14.91 15.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 75.24 110.925 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.566 ' CD1' ' C ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER 72.91 150.94 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.54 110.876 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.551 ' CD1' ' C ' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -159.23 131.11 6.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.849 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 mt -87.85 126.93 41.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 73.53 111.139 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.94 101.02 13.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.35 110.823 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.4 p -86.24 20.45 2.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 74.35 111.101 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 176.25 146.21 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 74.5 111.071 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -56.01 94.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 72.23 110.926 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.453 ' CG2' ' CZ2' ' A' ' 121' ' ' TRP . 33.8 p -100.7 56.64 0.89 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 54.45 111.126 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.04 -26.17 67.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 75.11 110.904 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.453 ' CZ2' ' CG2' ' A' ' 119' ' ' THR . 6.8 p90 -49.17 -26.4 2.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 72.31 110.908 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.7 mt -45.83 -34.16 3.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.26 -0.427 . . . . 75.22 110.926 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.6 m-20 61.93 72.5 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 73.42 110.916 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.65 42.74 0.71 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.691 -0.766 . . . . 75.11 112.519 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.78 -28.47 36.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 72.3 110.885 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -124.83 -173.22 2.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 75.11 110.845 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.11 116.86 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 63.32 111.143 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.34 135.03 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 75.44 111.137 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -160.79 34.82 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 71.34 110.872 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -172.49 176.39 45.43 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.764 -0.731 . . . . 53.12 112.497 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -174.14 136.98 0.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.803 0.335 . . . . 71.42 110.905 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.6 t -40.95 108.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 73.44 111.159 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -57.96 4.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 72.12 110.921 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -157.18 156.83 33.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.54 110.893 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.07 32.61 16.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.789 -0.719 . . . . 72.11 112.505 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -26.22 46.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 74.54 110.888 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -32.39 59.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 55.14 110.867 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.1 mm -65.29 -37.06 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 72.22 111.126 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.1 t -66.31 -28.19 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 72.42 111.104 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.21 -28.64 38.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 73.1 110.901 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.99 -40.0 60.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 64.13 111.112 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 34.6 mtm -61.27 -53.1 61.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 74.14 110.908 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.87 -24.73 24.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 75.11 110.896 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.407 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.66 -24.31 61.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.41 110.857 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.407 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 64.0 m-85 -107.7 13.94 26.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 73.02 110.878 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.1 169.08 13.64 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.732 -0.746 . . . . 72.55 112.482 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.5 p -114.08 146.71 39.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 72.31 110.859 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -73.73 72.92 1.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 73.43 110.888 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -179.53 -34.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 73.33 110.886 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 154.5 -61.3 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.775 -0.726 . . . . 74.14 112.516 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -58.31 174.37 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.35 . . . . 74.0 110.918 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.6 p -146.49 179.84 7.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 75.32 111.133 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.51 -65.19 1.03 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 54.11 110.872 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.96 -175.7 4.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 75.22 110.881 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -115.07 107.06 14.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 71.35 110.874 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.0 mp -84.85 111.36 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 73.33 111.162 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.49 165.48 17.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 72.14 111.161 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.3 mt -104.44 127.78 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 74.34 111.111 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.77 -50.38 6.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 50.33 111.085 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -148.73 150.86 33.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 63.15 110.907 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -156.87 149.54 23.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 75.4 110.835 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 164.49 170.5 29.51 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.809 -0.71 . . . . 72.51 112.535 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.28 127.53 27.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.808 0.337 . . . . 73.1 110.921 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.547 HD23 ' HB3' ' A' ' 7' ' ' PHE . 2.0 mm? -78.31 -47.7 17.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 72.22 110.974 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 63.52 110.929 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.777 0.322 . . . . 65.31 110.883 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.6 t -140.08 136.84 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 44.3 111.172 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -111.81 146.8 35.49 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.613 0.721 . . . . 74.32 110.899 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 146.1 58.67 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.64 2.227 . . . . 72.4 112.37 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -133.94 140.76 46.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 70.03 111.135 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.468 ' HA ' HD21 ' A' ' 164' ' ' LEU . 1.7 m -134.97 142.24 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 74.53 111.142 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.556 ' HB3' HD23 ' A' ' 164' ' ' LEU . 11.7 p90 -102.7 170.88 7.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 74.51 110.917 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -151.18 88.51 1.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 74.22 110.888 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -50.08 105.6 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 72.32 110.869 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.9 mm -84.97 122.12 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 63.54 111.123 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -113.76 150.99 32.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 72.12 111.097 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.1 t -132.39 95.9 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 74.24 111.119 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.66 33.97 8.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 75.51 110.896 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.47 -19.13 55.91 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.719 -0.753 . . . . 71.35 112.516 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -97.01 113.23 62.66 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.629 0.728 . . . . 74.11 110.896 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.72 126.5 13.41 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.72 2.28 . . . . 71.34 112.322 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.6 mt -69.18 -40.02 78.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.439 . . . . 65.42 110.899 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.7 -125.51 1.61 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.785 -0.721 . . . . 72.35 112.542 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -123.36 135.91 54.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 73.14 110.874 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.64 103.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 72.21 111.093 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.5 t -113.47 174.59 5.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 71.1 110.881 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.439 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -145.3 126.14 14.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 75.54 110.906 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -80.59 100.0 8.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 73.55 110.862 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.446 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 1.4 mt -83.14 120.4 25.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 73.51 110.916 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -75.94 68.29 2.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 73.33 110.899 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.2 -22.73 42.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 71.42 111.088 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -67.24 -36.72 82.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 75.12 110.885 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -97.19 -27.28 14.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.86 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.92 67.24 41.43 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.6 0.714 . . . . 73.31 111.146 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -36.05 11.39 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.673 2.249 . . . . 64.31 112.314 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.57 -37.75 82.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 75.24 110.86 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.0 m -88.85 -44.05 10.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 71.44 111.169 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.77 -46.69 89.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 73.12 111.108 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -51.03 -29.47 12.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 74.24 110.896 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.14 -64.64 0.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 75.5 110.891 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -59.05 -30.97 68.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 63.45 110.923 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.54 -51.63 19.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 71.43 110.897 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.63 -33.31 68.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 73.14 111.112 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.0 mt -76.38 -51.86 11.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 75.45 110.921 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.1 m -61.66 -37.05 82.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 72.52 110.863 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.9 p -65.81 -34.64 78.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 72.31 111.125 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.28 -15.8 53.84 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.693 -0.765 . . . . 71.43 112.489 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.89 -27.36 29.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.905 0.383 . . . . 74.01 110.899 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -72.91 -29.29 63.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 74.03 110.862 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.31 -15.37 60.28 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.706 -0.759 . . . . 64.02 112.451 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -157.63 -165.41 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 71.02 110.857 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.05 -136.05 5.4 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 74.4 112.507 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.49 30.61 6.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.932 0.396 . . . . 74.32 110.924 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -87.37 96.44 10.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 74.34 110.945 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 134.47 -38.89 1.77 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.762 -0.733 . . . . 75.52 112.44 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.13 -169.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 63.24 110.848 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.9 p -141.73 175.5 9.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.87 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -107.55 142.72 37.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.897 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -143.46 45.89 1.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 74.14 110.827 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -161.98 60.83 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 75.31 110.889 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.0 mt -104.21 108.86 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 73.03 111.127 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.6 mt -102.0 101.7 20.08 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.635 0.731 . . . . 72.13 111.126 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 89.85 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.245 . . . . 75.31 112.377 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.83 -17.6 1.99 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 61.02 112.497 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.58 -53.11 1.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 74.1 110.834 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.89 166.04 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.32 110.843 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.8 m -101.33 -173.35 2.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 70.14 110.897 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 174.1 150.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 73.05 110.941 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.09 -51.3 0.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.713 -0.756 . . . . 72.02 112.506 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.99 -158.27 20.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.784 -0.722 . . . . 73.35 112.462 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -107.35 164.82 11.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.378 . . . . 73.35 110.832 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -138.58 36.02 2.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 74.51 110.871 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.07 -73.92 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 73.34 111.144 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.25 161.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 74.44 110.941 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -134.71 37.87 3.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 70.32 110.843 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -115.17 -36.05 4.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 71.41 110.916 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 164.02 76.33 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.708 -0.758 . . . . 53.44 112.474 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.6 t 177.52 -48.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 71.43 111.136 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.02 169.6 0.42 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.676 -0.773 . . . . 71.33 112.536 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.54 135.61 6.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 75.21 112.485 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -172.65 -178.84 2.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 75.24 110.878 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.517 ' O ' ' CG1' ' A' ' 78' ' ' ILE . 3.1 p -91.35 39.58 1.0 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 74.04 110.84 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.517 ' CG1' ' O ' ' A' ' 77' ' ' SER . 0.7 OUTLIER 59.55 6.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 75.42 111.121 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.486 ' CD2' HG13 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -164.59 37.82 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 74.23 110.922 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.15 149.79 6.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.712 -0.756 . . . . 63.22 112.481 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -44.47 -33.53 1.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 72.4 110.876 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.479 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.73 166.08 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 75.22 110.874 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -132.13 177.17 7.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 75.45 110.873 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.08 157.15 28.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 73.42 110.876 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -49.94 153.75 1.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 74.22 110.852 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -104.41 -76.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.457 . . . . 73.32 110.903 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -159.32 177.45 10.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 61.44 110.917 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.29 35.59 3.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 72.2 110.895 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.65 -31.86 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 75.4 111.097 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 mt -102.79 101.79 11.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 72.03 110.884 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -90.93 138.79 31.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 75.14 110.899 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -47.35 105.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 73.51 110.876 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 43.8 p -114.95 30.04 7.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 73.12 111.134 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 144.68 176.45 18.7 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 71.34 112.507 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 178.01 5.0 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.663 2.242 . . . . 64.31 112.347 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.82 21.81 63.65 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 71.53 112.514 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.0 mm -91.75 140.37 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 74.02 111.125 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.496 HD23 ' HB2' ' A' ' 112' ' ' PHE . 0.5 OUTLIER -109.64 149.1 30.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 74.21 110.926 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.68 -164.55 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 73.24 110.892 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.0 mtm -98.71 96.6 8.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 74.4 110.892 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.45 62.09 0.51 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 74.43 111.105 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -125.15 -158.3 0.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 73.34 110.875 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.39 53.25 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 74.22 111.079 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.19 -106.07 0.14 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.713 -0.756 . . . . 75.24 112.509 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 116.65 4.66 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.707 2.271 . . . . 73.25 112.361 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 66.52 174.13 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 73.4 110.901 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 p 67.69 32.98 5.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 73.42 111.15 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.96 146.22 31.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 73.43 110.93 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -148.35 53.79 0.52 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 54.52 112.46 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.0 t 68.83 33.79 3.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 74.23 110.869 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -59.89 -168.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 74.3 110.933 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.496 ' HB2' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -175.72 155.42 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 74.04 110.912 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -168.53 68.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 72.15 110.879 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 113' ' ' PHE . 6.9 mt -33.73 107.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 72.33 111.164 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.6 m -84.6 139.23 32.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 72.4 110.899 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.1 p -105.01 27.12 8.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.172 -0.467 . . . . 72.22 111.17 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 178.65 142.94 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 75.13 111.094 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -52.36 98.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.888 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.9 p -96.13 44.78 1.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 72.42 111.197 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -26.54 65.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 70.33 110.925 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 7.3 p90 -49.68 -27.42 4.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.129 -0.487 . . . . 64.52 110.943 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 23.6 mt -47.02 -34.71 5.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 65.21 110.9 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 61.4 77.95 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 74.45 110.846 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 39.11 44.42 2.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.724 . . . . 60.13 112.436 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -81.69 -25.56 35.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 72.12 110.903 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -136.34 -169.35 2.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 75.22 110.848 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 79.4 t -123.79 112.25 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 74.32 111.158 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.5 t -79.95 131.04 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 71.41 111.138 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -150.26 37.39 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 75.25 110.909 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -175.13 173.57 46.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.707 -0.759 . . . . 70.34 112.46 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 132' ' ' VAL . 6.6 pttp -175.9 134.3 0.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 73.34 110.915 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 131' ' ' LYS . 54.0 t -37.02 105.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 71.14 111.127 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -59.31 3.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 72.51 110.921 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -154.84 158.65 39.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.893 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.29 36.3 15.06 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.731 -0.747 . . . . 73.23 112.5 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.33 -25.23 33.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 74.03 110.87 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.16 -34.19 65.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 75.41 110.866 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.9 mm -66.31 -40.02 85.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 74.51 111.139 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.2 t -63.67 -27.59 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 74.45 111.145 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.57 -30.1 52.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 64.21 110.926 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.01 -45.94 59.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 73.11 111.135 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.3 mtm -57.75 -42.02 83.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 63.02 110.875 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -53.77 -27.53 29.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 73.23 110.918 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -28.9 52.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 73.31 110.917 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -100.2 29.38 4.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 72.23 110.921 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.18 155.66 16.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.752 -0.737 . . . . 62.02 112.477 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.7 t -110.65 149.81 29.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 45.14 110.872 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -76.05 59.83 1.35 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 73.53 110.873 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -176.72 -34.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 74.31 110.889 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.83 -43.23 0.76 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 50.41 112.485 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.75 165.04 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 73.12 110.89 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 27.7 p -147.82 149.21 31.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 75.22 111.129 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.9 m -69.82 -46.08 66.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 72.15 110.828 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.12 -176.22 3.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.082 -0.508 . . . . 74.03 110.904 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -115.09 107.95 16.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 75.05 110.928 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.98 122.12 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 73.23 111.114 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.89 168.43 18.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 62.51 111.159 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 41.0 mm -105.43 114.22 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 73.03 111.084 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.58 -47.8 37.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 71.14 111.122 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -157.44 160.23 38.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.849 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.05 146.09 9.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 62.21 110.875 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.95 173.18 44.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 73.31 112.493 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -63.7 139.55 58.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 65.12 110.902 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -92.18 -56.84 2.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.901 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 72.35 110.901 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.828 0.347 . . . . 54.33 110.881 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 p -178.15 156.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 75.33 111.156 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -51.65 152.66 4.7 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 74.3 110.905 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 146.03 58.89 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.732 2.288 . . . . 71.24 112.327 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -135.22 141.69 45.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 73.03 111.159 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.448 ' HA ' HD22 ' A' ' 164' ' ' LEU . 1.5 m -134.48 143.8 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 74.53 111.101 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 19.0 p90 -102.03 160.77 14.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 72.22 110.856 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -140.42 95.51 2.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 71.44 110.936 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -58.77 113.84 2.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 65.25 110.847 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.424 HG12 HG22 ' A' ' 20' ' ' VAL . 14.8 mm -86.05 124.45 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 73.54 111.112 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -117.25 123.28 46.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 72.22 111.085 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 t -106.6 94.51 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 71.2 111.162 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 62.18 44.56 7.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.857 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.6 -1.58 88.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 73.12 112.523 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -110.05 98.68 35.9 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.627 0.727 . . . . 71.3 110.896 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.4 Cg_endo -69.81 103.98 1.26 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.737 2.292 . . . . 64.32 112.31 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.7 mp -65.74 -34.95 79.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 73.12 110.856 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.76 -143.09 7.94 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 63.13 112.484 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.08 154.06 47.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 74.33 110.838 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.424 HG22 HG12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -144.91 97.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 73.51 111.094 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -91.2 172.46 8.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 74.34 110.832 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.404 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -145.6 123.48 11.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 74.15 110.89 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.402 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 23.4 tt0 -73.7 97.48 2.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 62.21 110.857 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.419 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 1.7 mt -85.09 118.17 24.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 74.23 110.882 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -79.38 68.98 5.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 73.21 110.887 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.62 -22.22 21.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 72.01 111.122 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -69.59 -28.35 65.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 71.33 110.871 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.91 -29.57 11.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 72.24 110.927 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.18 66.42 38.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.62 0.724 . . . . 73.35 111.122 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -35.21 13.17 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.698 2.265 . . . . 73.01 112.332 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.86 -36.41 72.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 72.33 110.895 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.5 m -94.22 -43.02 8.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 75.21 111.139 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.33 91.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.415 . . . . 73.25 111.085 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -50.42 -35.53 28.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 74.14 110.873 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -64.54 -64.19 0.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 72.41 110.926 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -56.35 -34.15 66.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 75.44 110.913 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -53.26 18.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 73.13 110.904 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.74 -35.42 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 70.21 111.125 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.7 mt -72.09 -58.68 3.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 73.15 110.941 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.9 m -51.4 -41.01 60.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 75.15 110.877 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.9 p -72.23 -28.31 63.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 74.51 111.138 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.64 12.75 71.56 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 72.23 112.465 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.39 -18.42 49.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 73.41 110.861 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 29.78 1.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 75.33 110.867 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.04 -22.92 16.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.759 -0.734 . . . . 75.32 112.491 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -179.02 -169.53 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 65.22 110.914 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.4 -135.84 2.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.801 -0.714 . . . . 72.44 112.547 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.83 57.49 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.937 0.399 . . . . 74.41 110.951 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -87.17 48.8 1.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 73.14 110.876 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 174.48 54.7 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 70.13 112.492 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.83 131.14 46.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.869 0.366 . . . . 74.41 110.82 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.8 p -96.69 121.26 38.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 73.31 110.912 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -80.99 117.21 21.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 74.53 110.87 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -114.03 29.75 7.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 75.22 110.874 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.54 91.6 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 73.43 110.849 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 62' ' ' CYS . 3.1 mt -128.68 116.29 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 64.21 111.166 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.2 mt -107.89 104.47 53.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.567 0.699 . . . . 75.43 111.169 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 79.47 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.7 2.267 . . . . 73.4 112.332 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.7 -24.42 0.56 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.707 -0.759 . . . . 54.45 112.515 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.406 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.1 OUTLIER -117.64 -58.98 1.97 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.86 0.362 . . . . 75.34 110.848 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.406 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER 176.33 157.28 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 64.11 110.906 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.414 ' HB3' HG12 ' A' ' 56' ' ' ILE . 34.7 m -90.7 -167.31 1.79 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 75.42 110.865 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 174.69 142.09 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 72.34 110.937 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -178.71 148.1 8.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 74.22 112.469 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.82 112.84 1.23 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.772 -0.727 . . . . 75.22 112.505 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -179.32 116.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 70.14 110.864 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -151.73 159.3 44.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.261 -0.427 . . . . 74.23 110.931 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.51 105.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 73.01 111.099 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.89 -169.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 73.24 110.843 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -102.8 34.43 2.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 74.03 110.857 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.36 -37.29 3.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 73.5 110.869 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.99 37.36 2.73 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.78 -0.724 . . . . 52.53 112.49 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.7 p -145.43 37.94 1.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.34 . . . . 75.03 111.129 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -129.59 -178.74 15.56 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.698 -0.763 . . . . 73.24 112.483 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 56.34 39.14 82.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.713 -0.756 . . . . 74.13 112.469 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.29 159.21 43.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.789 0.328 . . . . 73.11 110.903 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.2 p -59.15 -175.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 72.12 110.852 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 pp -90.75 16.88 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 65.54 111.119 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.85 -65.44 1.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 72.21 110.952 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.82 -33.17 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 54.55 112.486 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -141.11 -54.92 0.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.93 0.395 . . . . 72.23 110.908 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.408 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.19 -177.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 72.1 110.895 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.89 -167.67 1.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.44 110.872 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -133.37 162.76 30.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 74.55 110.871 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -47.76 104.34 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 74.24 110.854 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -80.79 -67.38 0.78 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 75.34 110.882 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -177.68 173.45 1.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.92 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.19 35.54 4.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 74.11 110.885 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -49.94 -28.91 4.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 74.44 111.153 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 16.0 mt -117.38 68.69 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 74.24 110.854 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -62.28 166.53 4.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 74.24 110.863 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -68.72 83.67 0.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 64.51 110.832 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.4 p -99.86 24.54 8.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 75.53 111.12 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 155.65 177.47 28.91 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.782 -0.723 . . . . 72.3 112.496 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 170.13 17.29 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.704 2.269 . . . . 70.32 112.354 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.12 40.04 96.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 71.43 112.474 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.3 mm -108.9 136.06 45.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.832 0.348 . . . . 74.51 111.144 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.506 HD23 ' CD1' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -103.62 157.39 17.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.446 . . . . 73.41 110.899 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 3.6 t -162.19 -139.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 73.32 110.883 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 13.7 mmt -152.91 147.42 25.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 72.43 110.853 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -123.19 151.34 42.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 75.31 111.074 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 167.71 -50.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 74.45 110.915 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -174.63 29.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 73.41 111.136 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.55 -116.66 4.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 64.01 112.472 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 125.09 11.76 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.661 2.241 . . . . 75.21 112.355 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 70.54 165.76 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 73.03 110.888 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 p 67.13 29.22 7.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 73.04 111.175 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -65.24 90.38 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 74.24 110.898 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -66.52 -131.78 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.743 -0.742 . . . . 72.42 112.477 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.0 p -133.23 24.2 4.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.833 0.349 . . . . 54.24 110.861 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -106.56 55.76 0.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 75.13 110.939 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.506 ' CD1' HD23 ' A' ' 98' ' ' LEU . 4.6 p90 -58.65 -168.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 74.2 110.843 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -152.73 160.63 43.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 73.12 110.827 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 mp -105.1 91.17 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 73.44 111.13 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.5 m -64.28 90.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 75.43 110.896 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.6 p -63.93 -12.89 41.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 65.12 111.141 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -143.22 156.7 44.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 62.22 111.096 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -56.41 95.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 70.35 110.892 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.1 p -97.83 50.11 1.03 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 74.51 111.136 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -24.37 66.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 74.25 110.89 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -48.29 -30.49 4.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 74.1 110.933 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.5 mt -47.44 -34.65 7.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 72.21 110.922 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 124' ' ' GLY . 3.6 m-20 59.03 81.18 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 74.54 110.848 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.61 43.63 0.8 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.709 -0.758 . . . . 74.41 112.47 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -81.66 -16.64 50.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 74.55 110.871 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -144.75 -168.55 2.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 73.55 110.802 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.7 t -120.75 120.97 64.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 64.11 111.125 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.4 t -93.26 136.15 25.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 74.35 111.112 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -156.2 37.54 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 75.23 110.854 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -177.51 174.49 46.97 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 51.41 112.528 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 132' ' ' VAL . 5.1 pttp -172.94 132.96 0.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.347 . . . . 74.43 110.9 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' LYS . 38.2 t -36.44 107.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 72.23 111.149 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.402 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -72.27 -58.92 3.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 74.54 110.903 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -155.86 154.89 31.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 72.14 110.876 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.07 28.79 11.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 45.33 112.512 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -24.04 52.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 64.32 110.881 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.06 -36.94 73.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 75.01 110.932 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 27.4 mm -67.6 -39.57 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 73.23 111.093 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.01 -29.49 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 72.24 111.083 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -74.71 -30.55 61.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 71.3 110.897 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.74 -37.98 70.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 73.22 111.09 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 17.5 mtm -58.71 -53.44 58.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 71.51 110.85 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.85 -26.06 32.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 73.52 110.868 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.423 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.81 -23.74 63.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 65.01 110.9 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.423 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 59.8 m-85 -109.16 17.32 21.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 72.33 110.87 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -107.7 170.33 15.31 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.796 -0.716 . . . . 72.32 112.489 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 t -134.55 142.69 47.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.899 0.381 . . . . 71.53 110.837 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -69.03 82.73 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 75.51 110.846 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -179.33 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 74.43 110.885 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.75 -84.67 0.16 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 61.45 112.506 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.68 175.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 75.43 110.877 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.6 p -143.49 168.99 18.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 73.23 111.184 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.65 -48.08 35.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 70.33 110.842 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -92.29 -179.66 5.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 73.24 110.886 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -124.51 108.32 11.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 74.23 110.841 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.53 109.41 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 72.42 111.123 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.14 161.89 22.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 70.04 111.159 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.0 mm -92.85 120.07 41.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 72.53 111.134 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.15 -56.99 3.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 71.13 111.088 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -137.71 157.37 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 74.1 110.894 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -165.91 146.98 6.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 75.0 110.9 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.11 172.42 44.54 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 64.1 112.472 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -66.2 137.37 56.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.899 0.38 . . . . 62.51 110.871 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.3 mm? -88.76 -58.68 2.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 73.22 110.908 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 71.52 110.906 179.918 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 mtm . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.859 0.361 . . . . 75.13 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.2 t -145.72 127.41 8.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 74.34 111.125 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -87.14 144.84 36.85 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.669 0.747 . . . . 62.3 110.879 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 145.01 55.52 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.662 2.241 . . . . 70.34 112.347 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.4 m -130.95 129.75 42.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 55.12 111.14 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.07 170.56 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 73.32 111.141 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.569 ' HB3' HD21 ' A' ' 164' ' ' LEU . 1.5 p90 -153.92 179.5 8.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.949 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.414 ' HA ' ' HB3' ' A' ' 161' ' ' CYS . 97.9 m-85 -155.79 97.37 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 70.41 110.888 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -47.73 106.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 74.12 110.875 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.3 mm -79.03 124.27 37.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 74.12 111.138 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -116.65 134.87 54.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.34 111.085 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.0 t -116.49 96.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 73.53 111.11 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.57 35.52 22.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 61.24 110.85 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.36 -15.78 60.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 71.0 112.517 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -103.32 108.09 57.9 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.663 0.744 . . . . 62.32 110.865 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.75 126.49 13.38 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.698 2.265 . . . . 74.03 112.39 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.409 ' HB3' HD12 ' A' ' 138' ' ' ILE . 9.4 mt -68.1 -38.25 82.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 73.14 110.902 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.96 -138.64 5.89 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.77 -0.729 . . . . 73.44 112.53 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.94 140.36 48.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.811 0.339 . . . . 74.35 110.894 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.87 97.8 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 72.42 111.117 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 2.4 t -103.69 174.33 5.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 72.32 110.848 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.427 ' N ' ' OG ' ' A' ' 21' ' ' SER . 26.6 m-85 -148.12 132.1 17.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 75.21 110.891 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -88.08 98.79 11.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 71.34 110.889 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 mt -80.8 133.43 35.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 75.43 110.896 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -91.25 65.42 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 71.41 110.888 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.26 -23.58 23.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 74.22 111.119 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.77 -40.89 96.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 75.01 110.851 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -95.07 -26.8 15.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 72.25 110.906 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.78 67.44 50.28 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.615 0.721 . . . . 75.14 111.16 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -38.51 7.63 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.655 2.237 . . . . 61.44 112.326 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -38.99 90.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 71.45 110.925 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.7 m -84.76 -42.23 15.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 74.34 111.131 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.99 -48.46 78.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 62.3 111.076 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -53.88 -33.13 55.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 64.03 110.898 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -60.92 -61.71 2.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 75.13 110.888 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -63.96 -41.3 97.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 70.23 110.898 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -63.48 -31.14 72.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 75.43 110.858 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.91 67.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 71.11 111.127 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 mp -67.6 -36.76 81.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 74.21 110.937 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.2 m -69.02 -51.19 41.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 62.14 110.881 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.5 p -64.88 -32.95 74.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 75.23 111.173 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.02 -13.48 55.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 71.05 112.462 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.77 -33.45 23.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.951 0.405 . . . . 72.43 110.913 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -53.45 -27.87 27.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 72.43 110.929 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.46 -5.71 80.48 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.737 -0.744 . . . . 72.44 112.484 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -168.65 -167.58 0.79 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 75.0 110.935 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.26 -137.86 6.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.705 -0.759 . . . . 70.44 112.449 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -151.54 47.15 0.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.001 0.429 . . . . 74.3 110.925 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 139.47 58.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 74.05 110.882 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.03 -22.01 39.69 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.763 -0.732 . . . . 61.14 112.482 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.45 173.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 71.54 110.854 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 17.6 p -122.1 179.68 4.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 74.41 110.862 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -104.47 136.09 44.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 73.41 110.841 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.21 37.16 3.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 70.1 110.856 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -166.95 77.21 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 75.33 110.881 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.9 mt -120.52 111.29 31.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 74.03 111.139 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.4 mt -108.21 103.5 50.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.646 0.736 . . . . 74.22 111.135 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 76.25 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 73.22 112.361 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.99 -26.77 0.25 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.722 -0.751 . . . . 73.03 112.495 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.1 OUTLIER -117.69 -55.33 2.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.86 0.362 . . . . 74.24 110.88 -179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.401 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER 171.98 175.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 71.12 110.871 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.3 m -111.83 -168.11 1.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 72.32 110.887 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -173.15 141.98 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.22 110.941 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -58.23 -46.45 92.82 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.791 -0.719 . . . . 74.53 112.45 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.95 125.88 5.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.737 . . . . 61.13 112.444 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.08 136.48 50.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.369 . . . . 75.23 110.835 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -121.96 -48.49 2.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 65.24 110.876 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.8 p 47.02 90.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 74.13 111.143 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -48.14 -68.27 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 75.23 110.825 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -114.76 -75.64 0.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 71.35 110.856 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -125.42 35.99 4.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 74.34 110.883 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.57 122.26 0.1 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.778 -0.725 . . . . 72.24 112.516 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 t 177.66 -48.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.841 0.353 . . . . 74.24 111.099 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -51.97 -54.77 24.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.77 -0.728 . . . . 72.04 112.501 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.38 -125.06 5.51 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.719 -0.753 . . . . 73.34 112.483 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 44.7 -164.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.721 0.296 . . . . 74.35 110.912 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.15 125.88 28.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 74.04 110.896 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -50.74 -28.14 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 71.33 111.156 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -79.89 -37.48 34.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 75.15 110.912 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.95 -151.08 13.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.8 -0.714 . . . . 71.55 112.499 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -51.03 -40.14 57.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.948 0.404 . . . . 74.04 110.882 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.45 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.5 167.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 74.4 110.885 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.35 167.17 19.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.898 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.17 150.8 48.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 74.33 110.865 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -52.47 161.03 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 75.01 110.881 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -110.99 -70.77 0.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 74.32 110.858 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -170.55 173.54 5.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 63.42 110.908 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.46 37.34 3.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 74.54 110.831 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.99 -30.28 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.21 111.187 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.1 mt -108.79 80.01 1.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 74.5 110.888 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.65 154.06 34.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 75.24 110.901 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -64.13 88.42 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 75.41 110.831 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.1 p -78.57 -54.29 6.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 74.23 111.134 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.05 -165.94 11.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 72.43 112.468 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 177.91 5.08 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.633 2.222 . . . . 75.01 112.351 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.24 31.13 78.03 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.742 -0.742 . . . . 74.32 112.482 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.2 mm -107.01 140.98 23.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 72.13 111.094 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.26 144.9 35.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 73.42 110.895 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.25 146.61 22.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 75.23 110.903 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -69.74 82.83 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 63.45 110.838 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.44 142.86 42.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 73.34 111.069 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 170.59 -167.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 71.3 110.866 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.456 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -50.46 -51.46 46.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 74.01 111.102 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.14 -69.91 0.37 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 65.23 112.52 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.456 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 54.0 Cg_endo -69.76 99.26 0.73 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.725 2.283 . . . . 75.44 112.327 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 37.87 55.35 1.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 74.23 110.874 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.2 p -159.97 53.33 0.35 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 71.4 111.168 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.28 152.47 31.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 74.2 110.891 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.59 5.37 2.87 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 75.21 112.498 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 74.2 51.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.793 0.33 . . . . 72.24 110.881 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.685 ' O ' ' CB ' ' A' ' 112' ' ' PHE . 0.6 OUTLIER -70.21 -31.64 69.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 71.24 110.935 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.685 ' CB ' ' O ' ' A' ' 111' ' ' GLN . 30.6 t80 99.66 145.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 71.21 110.878 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.507 ' O ' ' CG ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -169.86 114.62 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 75.4 110.91 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.3 mt -80.94 129.07 38.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 63.21 111.119 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -91.34 92.77 8.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.447 . . . . 74.24 110.856 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.2 p -79.23 14.16 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 74.53 111.18 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 178.65 143.77 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.466 . . . . 75.32 111.052 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -50.56 98.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 75.34 110.937 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.437 ' CG2' ' CZ2' ' A' ' 121' ' ' TRP . 35.0 p -104.16 48.93 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 71.55 111.092 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -24.86 67.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 71.41 110.868 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.437 ' CZ2' ' CG2' ' A' ' 119' ' ' THR . 6.2 p90 -50.03 -26.96 4.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 74.52 110.901 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.6 mt -45.63 -35.52 4.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 75.12 110.94 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.7 m-20 61.6 80.2 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 73.43 110.819 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 35.98 43.17 0.62 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.741 -0.742 . . . . 54.44 112.497 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.46 -19.28 33.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.753 0.311 . . . . 74.54 110.908 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -142.86 -165.15 1.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.865 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.7 t -131.29 125.64 57.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 75.24 111.123 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.51 133.2 33.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 73.11 111.162 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -155.3 36.53 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 75.3 110.925 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.72 173.9 45.08 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.705 -0.76 . . . . 64.25 112.446 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -175.88 133.54 0.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 74.12 110.913 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.8 t -39.73 107.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 55.31 111.144 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -58.08 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 75.22 110.922 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -154.75 163.05 40.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 75.54 110.873 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.5 32.67 46.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.69 -0.766 . . . . 54.54 112.471 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.89 -34.05 26.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.744 0.307 . . . . 75.34 110.827 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.6 -32.24 12.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 74.43 110.847 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.409 HD12 ' HB3' ' A' ' 17' ' ' LEU . 41.8 mm -66.31 -43.35 91.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 72.34 111.135 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.75 -26.33 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 74.44 111.113 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.32 -29.73 38.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 73.25 110.864 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.31 -37.61 66.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 60.2 111.08 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 24.4 mtm -57.3 -54.25 48.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 63.5 110.912 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -25.5 34.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 71.33 110.873 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.403 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.91 -23.74 63.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 75.35 110.846 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.403 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 57.1 m-85 -108.79 17.13 22.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 75.55 110.88 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.34 168.37 12.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 62.41 112.5 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.6 m -113.76 148.22 36.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 75.24 110.892 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 -75.24 67.46 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.41 110.898 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -175.11 -35.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 71.45 110.872 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.78 -45.34 0.62 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.728 -0.749 . . . . 60.12 112.442 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.71 171.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 74.35 110.933 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.4 p -145.04 139.58 27.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 74.32 111.134 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.39 -39.89 77.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 73.15 110.826 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.39 -174.93 2.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 74.44 110.885 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.57 107.59 13.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 74.3 110.941 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.68 102.34 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 75.44 111.131 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.93 163.86 13.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 65.44 111.165 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.2 mt -102.94 116.47 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 74.22 111.131 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.72 -52.34 7.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 63.54 111.159 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -148.17 153.75 39.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 62.01 110.865 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -160.84 149.74 16.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 73.21 110.889 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.84 166.38 27.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.798 -0.715 . . . . 74.12 112.505 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -59.4 109.24 0.84 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 74.22 110.876 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.569 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.6 mm? -53.2 -48.19 68.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 75.12 110.934 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 75.32 110.913 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.9 mtm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.824 0.345 . . . . 73.01 110.879 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.4 t -149.32 127.5 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 73.45 111.143 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -118.04 146.92 40.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.595 0.712 . . . . 75.24 110.889 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 149.34 66.58 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.676 2.25 . . . . 72.42 112.355 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -136.02 137.7 41.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 73.52 111.181 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.41 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.9 m -131.61 145.64 34.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 74.21 111.113 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.641 ' HB3' HD22 ' A' ' 164' ' ' LEU . 8.2 p90 -101.93 168.04 9.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.923 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -147.81 88.9 1.71 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.893 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.86 105.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 73.13 110.882 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.2 mm -83.97 126.95 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 75.12 111.105 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -121.04 149.54 42.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 51.54 111.077 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 t -130.04 94.94 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 62.41 111.123 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.02 32.66 10.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 74.43 110.893 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.18 -21.59 42.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 70.43 112.489 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -94.18 113.07 59.82 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.644 0.735 . . . . 75.33 110.882 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.7 Cg_endo -69.81 123.32 9.97 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.649 2.233 . . . . 74.3 112.357 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.71 -37.83 79.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 63.03 110.916 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.13 -125.98 1.67 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.75 -0.738 . . . . 73.13 112.497 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.51 138.48 52.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 73.15 110.895 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.71 101.16 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 74.31 111.15 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -108.23 172.77 6.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 75.53 110.829 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.403 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -143.54 133.03 23.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 74.41 110.871 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -85.4 97.38 9.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 74.22 110.926 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 mt -81.78 117.61 22.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 72.43 110.889 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -78.7 64.96 3.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 74.33 110.827 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.79 -24.05 14.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 75.33 111.111 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -67.96 -35.14 77.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 75.2 110.849 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -95.78 -29.2 14.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 70.33 110.908 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.58 65.82 55.77 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.641 0.734 . . . . 73.4 111.129 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -29.32 23.96 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.618 2.212 . . . . 74.11 112.355 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -41.23 96.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 74.4 110.932 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.8 m -88.55 -45.31 10.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 75.31 111.143 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.98 -46.07 82.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 73.2 111.101 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -47.01 -33.66 4.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 72.44 110.911 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -64.57 -65.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 63.25 110.854 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -59.04 -28.58 66.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 73.31 110.887 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -50.6 65.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 72.34 110.847 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.54 -31.71 72.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 62.41 111.069 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 75.1 mt -73.67 -54.54 7.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 75.4 110.927 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.9 m -48.28 -43.94 33.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 65.33 110.844 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.3 p -63.34 -38.42 91.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 72.3 111.186 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.06 -10.84 44.34 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.702 -0.761 . . . . 72.4 112.496 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -28.89 27.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.399 . . . . 74.03 110.893 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -63.83 -29.05 70.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 65.24 110.915 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.35 1.38 90.04 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 74.51 112.508 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -174.89 -165.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.915 0.388 . . . . 75.34 110.865 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.67 -96.22 0.63 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 74.41 112.506 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.67 ' O ' ' C ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -119.19 -70.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.958 0.409 . . . . 73.24 110.894 -179.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.67 ' C ' ' O ' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -6.44 96.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 74.23 110.922 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 120.45 -30.61 5.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.695 -0.764 . . . . 64.22 112.498 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.37 -168.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.808 0.337 . . . . 72.03 110.875 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.1 p -142.84 171.94 13.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 72.43 110.94 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -92.82 139.97 29.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 74.14 110.909 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -123.45 32.57 5.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 74.51 110.821 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.99 114.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.423 . . . . 73.13 110.905 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.2 mt -144.96 112.47 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 72.24 111.125 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.5 mt -105.42 105.07 50.99 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.622 0.725 . . . . 71.35 111.165 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.8 Cg_endo -69.79 56.9 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.644 2.229 . . . . 74.02 112.336 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.16 33.33 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.71 -0.757 . . . . 75.05 112.476 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.43 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.0 OUTLIER -177.12 -59.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.838 0.352 . . . . 75.12 110.882 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.43 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER 174.65 157.92 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 65.21 110.885 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.5 m -97.04 -161.88 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 73.24 110.927 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 177.01 137.96 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 74.21 110.892 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.2 166.83 40.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 62.15 112.449 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.48 -151.49 2.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.694 -0.765 . . . . 71.24 112.452 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.19 168.38 19.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.812 0.339 . . . . 64.12 110.884 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -154.1 38.3 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 75.25 110.852 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 93.4 m -158.66 98.73 1.53 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 74.42 111.159 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? 63.09 162.08 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 73.11 110.845 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -112.66 36.4 3.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 65.55 110.838 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -98.89 -74.66 0.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 75.4 110.899 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.59 32.74 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.775 -0.726 . . . . 72.43 112.509 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.0 p -101.8 -55.45 2.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.795 0.331 . . . . 74.4 111.121 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.24 107.37 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.693 -0.765 . . . . 65.24 112.472 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 51.84 -170.37 0.43 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.685 -0.769 . . . . 64.45 112.516 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.79 -171.51 3.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 73.22 110.862 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.9 p -104.44 52.64 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 63.12 110.879 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.8 pt 42.24 33.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 74.23 111.098 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -155.12 -66.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 73.2 110.939 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -132.32 -88.3 0.39 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.709 -0.758 . . . . 73.52 112.486 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -130.91 -37.39 1.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 75.51 110.884 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.437 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.27 170.04 0.31 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 73.12 110.898 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -130.99 179.7 5.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 75.25 110.852 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.1 169.01 19.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 63.31 110.879 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -63.34 156.75 24.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.884 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -108.26 -68.91 0.88 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 64.01 110.853 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -175.94 178.09 1.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 73.22 110.893 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.94 36.5 2.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 74.14 110.901 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -50.61 -29.78 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 74.44 111.101 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 18.8 mt -111.61 74.79 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 71.44 110.896 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.73 153.51 41.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.12 110.859 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -52.87 101.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 73.34 110.866 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.5 p -116.03 29.15 8.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 75.32 111.126 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 151.8 174.15 22.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 62.15 112.438 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 171.33 14.73 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.638 2.225 . . . . 74.23 112.308 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.63 39.7 98.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 62.42 112.479 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.7 mm -106.13 135.28 45.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.88 0.371 . . . . 74.42 111.085 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.475 HD23 ' CD1' ' A' ' 112' ' ' PHE . 1.1 mt -101.05 149.07 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.924 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.424 ' HB2' ' HA ' ' A' ' 128' ' ' VAL . 0.2 OUTLIER 178.81 131.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 75.33 110.833 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.74 162.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 74.55 110.891 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -156.22 36.8 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 62.34 111.128 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -68.18 -35.71 78.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 71.42 110.928 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -174.61 32.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 75.21 111.06 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.04 -114.34 6.31 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.686 -0.769 . . . . 75.51 112.484 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 114.75 3.81 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.658 2.239 . . . . 70.51 112.34 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 71.19 171.86 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 74.43 110.867 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 66.66 25.68 9.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 75.31 111.143 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -80.3 130.53 35.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 71.1 110.909 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.01 -74.85 0.11 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.774 -0.727 . . . . 61.42 112.489 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.8 p -166.43 43.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 73.44 110.857 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -118.36 54.97 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 74.52 110.945 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.475 ' CD1' HD23 ' A' ' 98' ' ' LEU . 1.5 p90 -77.9 -165.91 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 73.14 110.887 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -154.44 174.58 14.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 74.43 110.837 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.0 mt -111.26 90.93 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.496 . . . . 73.34 111.15 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 55.8 m -65.55 93.13 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 74.45 110.899 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.2 p -65.8 -11.26 44.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.46 . . . . 74.45 111.191 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -145.5 154.95 42.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 65.31 111.096 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -55.64 94.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 70.14 110.915 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.7 p -96.74 49.56 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 74.51 111.097 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -26.01 68.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 71.45 110.863 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -48.11 -29.6 3.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 75.41 110.886 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 19.0 mt -46.92 -33.51 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 73.23 110.925 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.4 OUTLIER 60.54 78.17 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.847 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.94 43.81 0.9 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 62.33 112.467 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -16.27 49.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 72.25 110.87 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -141.41 -168.19 2.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 75.33 110.877 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 51.0 t -122.01 124.22 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 75.23 111.12 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.424 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 2.3 t -93.21 135.67 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.21 111.127 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -160.69 35.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 74.31 110.887 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -174.08 174.9 46.54 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.73 -0.748 . . . . 64.54 112.499 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -176.1 137.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 74.33 110.877 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.1 t -40.73 107.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 75.02 111.092 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -59.82 2.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.04 110.928 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -153.78 157.13 38.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 72.53 110.935 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.11 32.9 19.34 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.737 -0.744 . . . . 65.2 112.487 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.01 -29.19 56.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 74.5 110.93 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.26 -31.19 42.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 74.1 110.896 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.8 mm -65.58 -40.71 88.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 74.2 111.147 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.4 t -63.03 -27.36 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 75.41 111.096 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.91 -27.76 36.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 74.32 110.893 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.91 -38.68 61.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 73.41 111.097 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.8 mtm -61.42 -52.18 65.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 73.44 110.859 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -54.05 -29.61 44.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 74.04 110.904 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.429 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -65.8 -23.37 66.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 73.41 110.906 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.429 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 62.2 m-85 -108.95 18.63 20.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 72.52 110.849 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -114.03 168.46 12.58 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.693 -0.765 . . . . 73.31 112.484 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 m -113.07 146.76 38.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 74.24 110.865 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -76.01 64.45 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 75.34 110.873 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -165.48 -38.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 64.41 110.918 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 157.75 -71.39 0.25 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 74.22 112.501 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 170.4 4.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.817 0.341 . . . . 75.15 110.921 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.8 p -145.39 -173.9 4.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 72.5 111.113 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.74 -67.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 75.25 110.841 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -59.93 -179.22 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 75.02 110.903 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.62 107.07 9.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 72.14 110.913 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.1 mp -86.99 116.41 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 75.54 111.156 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.44 169.58 13.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 72.32 111.126 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 11.6 mm -104.83 109.25 27.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 74.24 111.112 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.68 -45.15 72.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 75.31 111.108 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -161.76 160.03 27.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 73.35 110.856 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.9 146.66 9.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 71.54 110.862 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.97 178.81 48.14 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.684 -0.77 . . . . 64.42 112.452 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -63.98 146.24 54.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.854 0.359 . . . . 72.42 110.922 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.641 HD22 ' HB3' ' A' ' 7' ' ' PHE . 3.5 mm? -102.4 -55.66 2.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 75.5 110.904 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 71.23 110.944 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 mtt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.837 0.351 . . . . 71.04 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.5 t -140.55 131.99 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 74.23 111.133 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -123.48 156.26 64.43 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.661 0.744 . . . . 74.21 110.855 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 145.83 58.52 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.694 2.263 . . . . 62.35 112.399 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.1 m -129.71 126.88 39.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 73.44 111.106 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.9 m -121.27 170.51 11.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.139 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.513 ' HB3' HD23 ' A' ' 164' ' ' LEU . 0.6 OUTLIER -158.52 176.37 12.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 74.53 110.882 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -153.13 96.21 2.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.864 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -43.22 106.63 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 74.35 110.867 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.1 mm -78.74 137.63 21.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 74.31 111.114 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.25 160.42 34.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 64.3 111.112 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -143.33 103.6 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 74.33 111.119 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.96 24.98 9.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 73.45 110.902 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.11 -25.29 25.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 72.34 112.512 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -90.28 125.17 60.96 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.672 0.748 . . . . 74.3 110.886 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 124.49 11.14 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.653 2.235 . . . . 74.3 112.328 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.7 mt -68.25 -38.15 81.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 75.04 110.941 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.93 -131.17 2.86 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.669 -0.777 . . . . 65.32 112.434 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.67 136.66 53.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 75.24 110.9 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.3 t -142.4 99.46 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 65.15 111.137 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 22' ' ' PHE . 1.5 t -106.36 174.01 6.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 65.32 110.839 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.434 ' N ' ' OG ' ' A' ' 21' ' ' SER . 48.2 m-85 -144.81 132.97 21.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 73.32 110.863 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -89.43 95.95 10.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 75.44 110.893 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.41 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 1.4 mt -81.06 134.61 35.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 62.33 110.896 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -92.18 66.87 4.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 72.34 110.852 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.91 -22.81 27.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 75.23 111.129 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -65.22 -39.44 92.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 71.35 110.813 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -96.58 -27.84 14.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 74.14 110.882 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.54 66.2 63.75 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.612 0.72 . . . . 71.52 111.112 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -45.91 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.703 2.268 . . . . 64.32 112.348 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -54.41 -34.71 61.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.434 . . . . 75.32 110.912 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.5 m -89.64 -54.11 4.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 73.11 111.109 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.92 -42.27 62.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 54.53 111.116 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -56.04 -27.18 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 71.51 110.925 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -66.68 -65.68 0.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 74.4 110.901 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.94 -34.66 70.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 73.45 110.888 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -70.22 -48.27 57.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 74.34 110.894 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.92 -37.18 66.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 73.33 111.118 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mt -76.92 -56.06 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.934 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.0 m -53.6 -32.75 52.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 73.31 110.886 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.6 p -73.42 -53.41 10.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 74.15 111.142 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.54 -13.92 6.49 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 74.11 112.455 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -53.63 -31.01 45.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.373 . . . . 73.41 110.877 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -27.9 60.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 72.45 110.925 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.04 -17.12 53.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 54.41 112.515 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -154.85 -165.18 1.98 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.907 0.385 . . . . 72.31 110.865 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.05 -123.41 1.47 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 73.3 112.473 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -121.7 31.72 6.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.934 0.397 . . . . 74.35 110.905 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.67 114.34 20.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 74.04 110.882 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.48 41.26 94.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 63.12 112.484 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 m -121.45 138.24 54.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.827 0.346 . . . . 74.45 110.845 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 55.9 m -56.34 150.57 14.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 72.33 110.859 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -69.37 -179.86 1.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 73.51 110.89 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -110.9 -72.62 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.15 110.854 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -143.34 157.81 44.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 73.33 110.818 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.9 mt -147.03 111.89 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 73.44 111.105 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.3 mt -109.76 102.28 49.67 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.682 0.753 . . . . 73.23 111.108 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 53.9 Cg_endo -69.77 88.53 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.714 2.276 . . . . 74.32 112.339 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.89 -20.33 1.61 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 50.0 112.46 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.54 -54.38 1.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 71.11 110.865 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 171.03 166.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.914 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.6 m -91.7 -162.08 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 72.11 110.87 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -165.4 112.84 0.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 73.54 110.961 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.09 58.83 0.43 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 72.13 112.506 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.61 78.85 0.31 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.761 -0.733 . . . . 53.21 112.468 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -177.04 87.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 65.54 110.889 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -139.72 31.99 2.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 74.12 110.916 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.78 34.04 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 71.25 111.163 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.59 55.94 3.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 74.33 110.865 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -124.59 -36.71 2.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 74.15 110.869 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -99.97 -35.98 9.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 62.52 110.897 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 135.35 149.01 5.74 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 73.22 112.5 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.6 t 41.22 36.72 0.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.842 0.353 . . . . 70.52 111.143 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -51.48 170.66 0.33 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.726 -0.749 . . . . 70.12 112.431 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.68 129.06 0.19 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.72 -0.752 . . . . 72.42 112.48 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -162.35 151.19 15.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 75.25 110.91 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.8 m -67.49 -176.73 0.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 52.12 110.86 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 pp -98.93 23.11 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 70.04 111.123 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -135.9 34.63 2.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 73.52 110.946 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.26 -109.73 2.48 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.752 -0.737 . . . . 62.41 112.516 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -111.12 -30.76 7.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.38 . . . . 74.14 110.873 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.421 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.3 179.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 71.12 110.913 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -148.15 164.98 32.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 74.11 110.838 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.61 171.31 15.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 72.24 110.865 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.76 153.88 40.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 75.32 110.877 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -106.63 -78.46 0.58 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 63.25 110.873 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.5 p30 -155.1 172.89 17.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 72.43 110.895 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.9 39.27 3.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 75.23 110.877 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -49.92 -30.26 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 75.14 111.104 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.6 mt -108.05 91.63 3.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 75.41 110.959 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.11 150.87 43.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 71.24 110.867 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -63.42 89.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 63.0 110.858 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.39 -55.3 5.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 63.22 111.102 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . -145.66 -166.73 12.05 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.719 -0.753 . . . . 41.33 112.512 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 172.17 13.17 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.686 2.257 . . . . 74.13 112.3 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.5 12.67 77.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.732 -0.747 . . . . 71.24 112.471 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.7 mm -89.05 143.39 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 75.52 111.129 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.441 HD23 ' HB2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -114.14 143.14 45.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.898 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.5 -165.25 2.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 74.54 110.872 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -95.53 104.94 16.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 73.15 110.856 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.04 77.37 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 43.23 111.141 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 22.1 p-10 -129.14 -172.28 2.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 74.44 110.897 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.22 -18.9 64.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 71.03 111.098 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.5 -82.68 0.33 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.74 -0.743 . . . . 74.42 112.512 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 96.14 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.728 2.285 . . . . 73.43 112.329 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 71.92 166.13 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 74.01 110.874 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 p 66.1 45.48 2.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 61.14 111.159 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 1.9 m-20 -43.81 -31.76 0.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 74.43 110.843 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . 70.58 -64.24 0.83 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 73.0 112.52 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 1.2 t 84.72 58.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.85 0.357 . . . . 74.0 110.849 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -109.93 -15.99 13.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 75.23 110.967 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.613 ' CD1' ' C ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER 73.47 154.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 75.14 110.883 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.563 ' O ' ' C ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -165.08 67.77 0.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 75.31 110.873 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.563 ' C ' ' O ' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -23.67 123.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 74.25 111.093 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 37.2 m -96.28 114.14 25.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 74.32 110.863 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.1 p -93.16 27.39 2.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 63.11 111.163 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 176.38 142.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 63.25 111.131 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.404 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 3.6 tttt -53.42 99.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 74.04 110.893 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 28.8 p -98.89 48.63 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 73.12 111.134 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.39 -25.52 68.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 75.15 110.904 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.8 p90 -48.99 -28.29 3.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 75.1 110.915 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 26.1 mt -48.37 -32.12 7.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 72.25 110.913 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.0 m-20 59.77 76.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.31 110.934 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.98 41.5 0.98 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.74 -0.743 . . . . 75.03 112.509 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.93 -26.4 36.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.822 0.344 . . . . 74.13 110.894 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -129.3 -167.76 1.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 73.5 110.89 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 76.0 t -127.89 118.27 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 74.13 111.139 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.53 129.94 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 70.22 111.134 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -151.2 33.49 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 72.52 110.894 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -172.68 175.28 45.77 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 43.21 112.477 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -175.75 137.28 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.813 0.34 . . . . 72.13 110.938 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.8 t -41.63 105.73 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 73.43 111.142 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -59.95 3.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 70.45 110.898 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -154.28 161.91 41.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 74.42 110.921 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.05 33.66 28.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.721 -0.752 . . . . 55.22 112.498 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -29.45 57.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 74.25 110.862 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.53 -33.02 53.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 73.42 110.885 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.3 mm -65.56 -35.72 75.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 64.12 111.122 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.3 t -67.09 -26.92 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 72.34 111.139 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -82.27 -27.81 32.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 74.24 110.869 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.74 -41.28 60.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.488 . . . . 70.14 111.083 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.3 mtm -62.27 -51.73 66.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 73.31 110.91 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -54.06 -26.01 24.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.452 . . . . 72.34 110.899 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.426 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.34 -24.59 62.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 75.51 110.84 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.426 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 67.6 m-85 -107.58 12.12 27.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 72.14 110.902 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.39 171.64 17.7 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 73.11 112.487 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.68 131.09 55.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.849 0.357 . . . . 73.24 110.876 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -54.56 -28.07 43.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 70.11 110.813 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -72.53 -29.68 63.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 71.53 110.854 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.83 -42.45 1.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 35.34 112.49 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.27 -177.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.873 0.368 . . . . 64.13 110.881 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.5 p -144.78 138.41 27.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.207 -0.451 . . . . 73.31 111.148 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.69 -44.84 63.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 73.52 110.842 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.42 -177.68 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 73.24 110.925 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.78 109.13 18.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 74.23 110.911 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.1 mp -93.46 118.24 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 75.34 111.142 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.26 162.58 26.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 74.22 111.157 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 20.0 mm -101.29 117.16 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 75.03 111.098 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.65 -47.07 20.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 65.02 111.112 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -153.74 157.49 39.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 72.25 110.848 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -160.32 147.48 16.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 75.11 110.904 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.19 161.73 21.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.7 -0.762 . . . . 63.15 112.437 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.62 108.58 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.37 . . . . 72.44 110.933 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.513 HD23 ' HB3' ' A' ' 7' ' ' PHE . 2.1 mm? -50.78 -49.86 57.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.41 110.892 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 72.45 110.915 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.837 0.351 . . . . 74.23 110.893 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 p -178.01 146.3 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 73.54 111.116 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -106.52 155.83 38.13 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.721 . . . . 74.33 110.884 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 146.95 61.54 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.629 2.22 . . . . 73.32 112.375 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -135.39 142.35 45.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 61.44 111.164 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.44 ' HA ' HD22 ' A' ' 164' ' ' LEU . 1.3 m -133.12 143.4 39.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 73.32 111.094 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 16.1 p90 -104.13 164.12 11.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 72.24 110.861 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -147.4 85.07 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 65.32 110.836 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.66 106.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 74.34 110.846 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.7 mm -85.01 134.58 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 75.24 111.095 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 156' ' ' ILE . . . -124.07 158.65 31.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 55.0 111.11 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.5 t -137.84 94.45 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 74.33 111.17 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.21 32.19 8.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 73.12 110.851 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.23 -24.0 32.55 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.759 -0.734 . . . . 75.12 112.51 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -91.74 115.01 63.74 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.633 0.73 . . . . 65.43 110.902 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.6 Cg_endo -69.76 122.59 9.27 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.682 2.254 . . . . 73.1 112.335 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.6 mt -66.64 -37.86 85.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 64.54 110.964 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.41 -122.29 1.2 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.72 -0.752 . . . . 73.34 112.48 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -130.12 138.22 50.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.853 0.359 . . . . 73.5 110.873 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.6 t -145.14 99.56 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 74.43 111.114 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.1 t -108.16 174.91 5.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 63.51 110.823 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.445 ' N ' ' OG ' ' A' ' 21' ' ' SER . 2.1 m-85 -144.92 131.81 20.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.493 . . . . 75.13 110.909 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.432 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 60.0 tt0 -86.4 97.04 10.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 71.44 110.933 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -77.39 124.43 27.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 74.13 110.925 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -80.64 64.31 5.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 75.11 110.89 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.41 -22.38 12.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 55.45 111.12 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.32 -48.96 77.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 73.05 110.847 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -90.1 -29.64 18.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 73.14 110.892 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.89 67.84 81.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.618 0.723 . . . . 74.31 111.064 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -41.01 4.59 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.713 2.275 . . . . 71.31 112.316 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -35.27 79.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 72.43 110.936 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 48.5 m -84.63 -44.23 13.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 74.34 111.112 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.18 -47.05 78.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 65.21 111.089 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -50.96 -27.03 6.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 72.01 110.889 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -65.81 -63.39 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 75.53 110.892 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -61.11 -34.78 75.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 72.41 110.867 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.78 -47.06 64.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 73.01 110.87 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.87 -39.84 72.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 74.54 111.132 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mt -79.34 -49.46 12.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 74.05 110.957 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.7 m -55.69 -37.84 68.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 74.31 110.846 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.9 p -74.91 -47.14 31.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 73.22 111.126 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.55 -11.95 13.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.738 -0.744 . . . . 73.12 112.505 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -52.07 -37.78 54.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 71.32 110.843 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -58.85 -27.48 65.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 73.53 110.905 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.76 -14.79 56.11 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.718 -0.754 . . . . 75.23 112.46 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -158.68 -166.07 1.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.885 0.374 . . . . 70.15 110.879 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.23 -133.2 2.98 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.681 -0.771 . . . . 64.02 112.446 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -149.72 48.35 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.933 0.397 . . . . 75.12 110.923 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -58.7 125.73 24.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 70.25 110.924 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.11 43.15 17.53 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.776 -0.726 . . . . 74.24 112.478 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.47 -169.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.831 0.348 . . . . 74.14 110.903 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.0 p -125.17 132.29 53.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 72.33 110.886 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -110.7 108.91 18.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 75.15 110.869 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -133.45 37.75 3.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 74.12 110.848 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.46 77.96 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 75.31 110.851 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.6 mt -117.87 109.56 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 75.41 111.15 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.2 mt -97.77 104.51 21.8 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.606 0.717 . . . . 73.24 111.155 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 53.4 Cg_endo -69.76 85.94 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.687 2.258 . . . . 64.23 112.351 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.71 -19.88 1.82 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 65.2 112.489 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.9 -56.6 1.93 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.857 0.36 . . . . 73.54 110.846 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 171.1 165.21 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 74.12 110.862 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 15.6 m -99.79 -161.85 0.9 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.445 . . . . 75.51 110.934 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.4 145.87 22.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 74.04 110.916 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.85 -64.14 1.7 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 51.14 112.454 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.59 72.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 63.53 112.536 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -51.65 159.54 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.835 0.35 . . . . 74.23 110.875 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -157.67 161.58 38.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 74.55 110.864 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.9 33.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 75.44 111.155 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? 51.94 32.58 10.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 75.13 110.903 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.3 m170 50.3 38.78 18.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 73.14 110.862 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -177.3 -75.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 70.1 110.906 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 163.75 54.52 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 72.41 112.483 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.6 t -158.79 44.31 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 62.24 111.197 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -153.82 -48.43 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.741 -0.742 . . . . 52.31 112.48 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.17 132.37 10.96 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.737 . . . . 74.43 112.494 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.73 171.08 5.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 75.12 110.923 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.406 ' O ' ' CG1' ' A' ' 78' ' ' ILE . 41.2 t -84.44 53.8 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 75.33 110.856 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.406 ' CG1' ' O ' ' A' ' 77' ' ' SER . 11.3 pt 43.17 30.93 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 74.33 111.162 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -161.34 -64.29 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 75.24 110.952 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -132.15 166.68 23.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.706 -0.759 . . . . 54.32 112.492 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.14 -26.0 2.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.917 0.389 . . . . 74.0 110.899 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.427 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 176.13 173.47 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 75.12 110.928 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -149.76 167.82 25.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 71.35 110.891 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.75 167.63 20.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 74.52 110.912 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.13 135.02 57.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 73.23 110.852 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -83.33 -77.31 0.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 75.41 110.885 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.1 p30 -156.25 174.42 15.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 75.32 110.939 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.52 36.93 3.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 73.14 110.821 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.09 -32.13 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.2 111.117 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 21.8 mt -109.99 86.96 2.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 72.54 110.932 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -75.1 145.83 41.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 73.25 110.946 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.9 m80 -49.85 103.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 70.51 110.857 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.2 p -114.4 28.4 8.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 74.11 111.117 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.17 175.76 21.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.685 -0.769 . . . . 61.51 112.469 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 175.96 7.35 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.7 2.267 . . . . 74.11 112.34 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.13 26.63 69.43 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 74.33 112.45 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.2 mm -95.9 140.34 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.828 0.347 . . . . 74.32 111.166 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.34 139.25 44.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 73.45 110.861 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.13 156.71 39.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 72.22 110.842 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -59.95 96.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 74.44 110.837 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.4 ' HB3' ' HG2' ' A' ' 111' ' ' GLN . . . -63.99 89.65 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 73.21 111.133 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.71 173.55 11.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 74.01 110.882 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.93 -23.06 6.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 72.51 111.074 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 122.44 -82.16 0.35 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 62.14 112.52 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 91.91 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.696 2.264 . . . . 65.15 112.359 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 73.66 171.8 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 74.15 110.889 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 p 66.0 39.07 4.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 75.23 111.098 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -45.36 -30.48 1.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.838 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.436 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . 51.92 -118.47 7.3 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.777 -0.725 . . . . 62.42 112.491 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 1.5 p 165.4 67.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 72.14 110.882 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.4 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 2.4 tt0 -102.79 -27.51 12.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 73.52 110.923 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.569 ' CD1' ' C ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER 68.09 151.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 75.55 110.861 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -164.39 85.81 0.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 65.42 110.927 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.2 mt -42.06 114.44 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 75.53 111.135 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.8 m -85.87 122.44 29.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 75.12 110.9 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.2 p -91.73 24.04 3.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 73.35 111.139 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 179.34 154.61 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 51.11 111.053 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.2 86.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 74.05 110.91 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 32.6 p -84.16 53.4 2.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 74.35 111.093 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -66.8 -23.14 66.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 74.12 110.909 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -53.75 -25.69 20.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 74.31 110.963 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 38.2 mt -45.6 -33.48 2.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 74.41 110.933 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 124' ' ' GLY . 1.6 m-20 61.95 76.18 0.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 62.2 110.838 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.6 41.54 0.85 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 70.23 112.478 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.67 -21.89 37.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.835 0.35 . . . . 74.14 110.938 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -137.43 -167.23 2.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 74.05 110.861 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.9 t -127.06 122.07 59.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 73.13 111.161 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 t -88.1 133.3 30.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 75.54 111.106 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -156.97 32.55 0.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 74.13 110.852 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -169.44 172.1 43.4 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.727 -0.749 . . . . 54.12 112.47 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 131' ' ' LYS . 1.6 pttt -176.11 132.41 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 73.41 110.916 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 131' ' ' LYS . 97.4 t -37.97 105.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.51 111.163 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.432 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -67.31 -58.69 4.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 75.14 110.94 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -150.99 170.29 19.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 72.22 110.87 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.13 31.0 64.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.735 . . . . 72.43 112.502 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.21 -26.38 11.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.771 0.32 . . . . 75.13 110.893 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.18 -31.89 54.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 74.54 110.886 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.4 mm -64.96 -40.26 88.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 71.24 111.107 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.43 -28.67 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 72.43 111.162 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -78.01 -29.02 49.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 73.42 110.885 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.96 57.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 71.32 111.132 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 35.9 mtm -61.38 -41.9 97.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 74.53 110.844 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.402 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 13.1 tm-20 -53.47 -30.57 41.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 72.42 110.89 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.408 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -73.55 -27.23 61.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 72.32 110.875 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.408 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 61.4 m-85 -105.44 30.01 6.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 75.52 110.81 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.0 151.69 17.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.766 -0.73 . . . . 75.23 112.51 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.5 m -114.37 140.52 48.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 63.22 110.854 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -74.11 70.18 1.55 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.34 110.886 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -179.93 -33.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 63.13 110.88 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 153.96 -100.61 0.2 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.773 -0.727 . . . . 72.4 112.468 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.32 169.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 72.32 110.912 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.6 p -143.65 -171.04 3.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 65.1 111.093 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.1 p -78.39 -55.31 5.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 63.14 110.847 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -81.54 166.66 20.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 74.42 110.877 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -111.95 110.08 20.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 74.01 110.888 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 4.8 mp -89.46 118.18 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 72.34 111.132 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.67 164.36 24.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 75.55 111.127 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.8 mt -98.44 123.04 50.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 73.4 111.073 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.53 -49.05 11.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 63.42 111.118 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -153.4 155.96 37.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 73.25 110.875 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.56 148.97 18.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 73.23 110.902 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 172.42 172.28 38.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.703 -0.76 . . . . 61.13 112.495 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -64.67 142.36 58.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.363 . . . . 63.33 110.867 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -94.86 -59.58 1.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 74.21 110.903 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 74.2 110.913 179.955 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.2 tpt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.844 0.354 . . . . 74.44 110.894 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.8 t -135.35 109.26 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.447 . . . . 75.3 111.083 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -70.63 117.51 56.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.615 0.721 . . . . 64.41 110.861 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 152.6 69.31 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.653 2.235 . . . . 72.14 112.337 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -137.78 139.64 40.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 65.54 111.145 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.44 ' HA ' HD22 ' A' ' 164' ' ' LEU . 1.4 m -127.38 142.5 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 75.31 111.142 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.59 ' HB3' HD21 ' A' ' 164' ' ' LEU . 7.3 p90 -106.1 155.45 19.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 73.21 110.872 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -143.8 86.72 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 73.13 110.847 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -47.75 125.91 9.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 73.24 110.846 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.5 mm -97.61 111.36 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 74.11 111.168 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -104.62 126.04 51.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 75.03 111.082 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 t -111.13 101.28 12.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 72.23 111.103 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 t0 59.87 43.55 14.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 73.15 110.87 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.58 0.83 88.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.747 -0.739 . . . . 73.11 112.511 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -113.22 102.4 54.74 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.628 0.728 . . . . 75.21 110.91 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.6 Cg_endo -69.81 110.88 2.67 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.626 2.217 . . . . 74.13 112.361 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.3 mp -65.45 -35.27 80.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 75.34 110.915 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.36 -133.72 3.04 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.731 . . . . 74.21 112.499 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -128.36 146.75 50.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 74.25 110.861 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.7 101.44 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 75.25 111.17 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -107.52 170.94 7.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.833 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -143.35 138.05 29.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 74.52 110.858 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.448 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 19.7 tt0 -91.17 99.94 12.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 74.42 110.865 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.406 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 5.5 mt -82.56 123.13 28.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 72.54 110.923 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -79.04 63.5 3.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 75.42 110.86 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.13 -22.32 16.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 74.41 111.062 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.17 -36.27 74.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 75.14 110.868 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.37 -25.31 15.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 72.11 110.919 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.44 65.51 34.04 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.625 0.726 . . . . 75.43 111.107 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -35.77 11.95 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.698 2.265 . . . . 74.21 112.339 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -39.82 89.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 75.32 110.859 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 98.6 m -87.28 -45.3 10.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 71.23 111.165 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.73 91.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 73.02 111.1 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -47.42 -35.15 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 74.32 110.874 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -62.64 -68.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 54.1 110.906 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -56.21 -23.44 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 72.34 110.903 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' NH2' ' HG2' ' A' ' 163' ' ' GLN . 0.0 OUTLIER -68.17 -54.21 19.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 75.34 110.854 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.57 -26.46 66.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.51 111.103 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.5 mt -79.0 -56.45 4.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 73.42 110.925 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.9 m -49.38 -46.13 46.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 65.44 110.834 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.3 p -72.44 -27.27 62.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 75.23 111.166 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.5 -8.81 74.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.726 -0.75 . . . . 73.11 112.475 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -18.55 50.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 72.21 110.883 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.36 -30.59 12.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 74.42 110.928 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.64 -23.97 6.57 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.763 -0.732 . . . . 74.12 112.509 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -160.59 -50.84 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 73.35 110.867 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.97 163.18 0.17 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.718 -0.753 . . . . 72.34 112.499 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -96.48 26.67 4.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.0 0.429 . . . . 74.35 110.934 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.17 142.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 72.21 110.904 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.83 27.05 74.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.706 -0.759 . . . . 53.32 112.487 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.37 -176.46 0.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.827 0.346 . . . . 72.32 110.844 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.9 p -126.06 122.47 35.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 74.14 110.856 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -86.98 130.61 34.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 75.23 110.877 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -147.33 46.82 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.14 110.889 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -158.94 61.59 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 75.24 110.905 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 13.7 mt -107.92 109.25 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 75.32 111.127 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.6 mt -100.2 103.78 25.23 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.604 0.716 . . . . 73.42 111.093 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.413 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 53.8 Cg_endo -69.75 85.01 0.63 Allowed 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.722 2.281 . . . . 73.53 112.34 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.37 -20.46 1.19 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.731 . . . . 71.43 112.479 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.89 -57.93 1.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.915 0.388 . . . . 72.13 110.911 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 174.19 164.48 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 62.01 110.827 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 10.1 m -100.81 -168.45 1.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 73.53 110.931 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 177.24 146.21 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 73.32 110.887 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.99 -33.22 7.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.756 . . . . 72.33 112.497 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.42 173.24 49.57 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.729 . . . . 71.33 112.496 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.13 -172.49 1.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.833 0.349 . . . . 73.41 110.839 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -150.99 52.79 0.86 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 74.24 110.916 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 p -82.6 63.22 6.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 73.34 111.155 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.44 -179.57 5.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 75.02 110.818 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -108.92 36.05 3.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 74.52 110.822 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -111.09 -73.33 0.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 72.41 110.904 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.51 32.59 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.771 -0.728 . . . . 72.21 112.5 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.2 p -101.38 -54.88 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 74.42 111.134 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.26 110.98 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 73.42 112.479 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.77 108.14 2.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 73.53 112.468 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -173.6 156.32 2.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 75.21 110.942 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.1 p -61.22 -169.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 75.14 110.884 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.2 pt -102.29 28.08 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 74.01 111.145 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -155.88 46.4 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 75.14 110.918 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.34 -133.98 11.51 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 72.12 112.479 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -79.23 -38.94 34.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.939 0.399 . . . . 62.54 110.88 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.429 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.2 176.63 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 75.12 110.893 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.75 -178.18 3.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 72.3 110.858 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -95.34 167.88 11.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.109 -0.496 . . . . 74.21 110.872 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -60.63 154.93 20.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 61.24 110.836 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -112.23 -67.44 1.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.02 110.881 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -176.45 178.11 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 75.43 110.871 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.46 35.99 3.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 74.42 110.918 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.51 -30.16 7.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 72.44 111.123 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.9 mt -111.41 79.52 1.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 73.14 110.916 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -69.89 152.05 44.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 75.5 110.897 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -56.73 97.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 74.3 110.898 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.1 p -108.93 26.31 10.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 74.01 111.145 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.58 178.64 25.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.719 -0.753 . . . . 62.53 112.496 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 171.57 14.16 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.736 2.291 . . . . 74.11 112.335 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.9 37.64 94.54 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 64.24 112.468 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 21.5 mm -108.62 136.99 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.884 0.373 . . . . 74.53 111.163 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.503 HD22 ' CD1' ' A' ' 112' ' ' PHE . 4.2 mt -103.1 162.18 13.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 73.12 110.92 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.16 -160.15 0.31 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 75.43 110.786 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.3 mmt -121.93 138.15 54.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 73.54 110.903 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.452 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -119.05 148.22 43.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 70.42 111.1 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 2.4 m-20 163.73 -50.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 75.02 110.88 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -178.11 30.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 75.13 111.101 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.33 -120.89 5.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 61.15 112.509 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 126.35 13.17 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.629 2.219 . . . . 74.11 112.337 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 69.11 173.02 0.3 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 65.52 110.898 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 p 67.07 26.38 8.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 73.41 111.142 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -72.25 146.63 47.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 74.13 110.853 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.89 -106.88 0.9 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 72.45 112.518 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.6 p -151.43 33.74 0.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.81 0.338 . . . . 70.12 110.9 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -114.42 51.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 72.33 110.902 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.503 ' CD1' HD22 ' A' ' 98' ' ' LEU . 5.4 p90 -56.85 -169.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 62.34 110.892 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.87 164.27 37.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 74.05 110.894 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.4 mt -108.66 90.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 71.42 111.145 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 57.3 m -63.41 91.29 0.05 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 72.04 110.89 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.2 p -61.68 -15.16 37.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 72.34 111.111 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -143.89 156.4 44.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 74.33 111.08 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -56.06 94.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 75.42 110.864 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.7 p -95.49 46.11 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 71.42 111.151 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -23.88 67.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 74.45 110.853 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -49.54 -28.16 5.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 75.1 110.896 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.9 mt -46.77 -34.06 4.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.227 -0.442 . . . . 75.15 110.912 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.4 OUTLIER 63.01 75.18 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 74.11 110.889 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.11 43.71 0.7 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.732 -0.747 . . . . 73.31 112.495 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -80.34 -27.42 38.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 74.34 110.91 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -127.18 -168.65 1.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 72.02 110.856 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.7 t -121.43 110.22 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 65.02 111.114 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.4 t -83.84 134.57 26.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 73.41 111.166 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -158.24 44.85 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 74.14 110.902 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . 179.02 175.25 45.89 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.772 -0.728 . . . . 75.43 112.525 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.2 pttp -174.9 145.19 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 72.13 110.927 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 32.7 t -44.73 113.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 74.23 111.155 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.448 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -78.14 -61.24 2.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 64.05 110.929 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -152.35 151.42 30.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 73.04 110.881 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.77 30.44 9.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.733 . . . . 52.21 112.529 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -26.41 26.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.782 0.325 . . . . 73.23 110.886 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.19 -34.1 68.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 74.11 110.841 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.5 mm -69.39 -38.27 76.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 64.35 111.101 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.21 -28.66 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 75.13 111.152 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -75.75 -31.31 59.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.887 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.07 -41.41 70.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 75.43 111.093 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 21.4 mtm -58.04 -45.36 87.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 72.23 110.902 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 11.3 tm-20 -54.59 -25.3 25.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 72.43 110.909 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.99 -28.87 43.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 72.23 110.9 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -105.26 34.27 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.31 110.865 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.414 ' HA3' HG23 ' A' ' 56' ' ' ILE . . . -113.58 161.01 12.84 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 73.23 112.466 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 t -117.75 143.64 46.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.89 0.376 . . . . 75.14 110.852 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -74.76 63.85 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 75.54 110.906 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -175.45 -34.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 75.44 110.893 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.59 -44.81 0.74 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.746 -0.74 . . . . 71.32 112.478 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -62.65 -169.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 75.54 110.902 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.82 147.97 4.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 74.14 111.167 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.97 -39.61 90.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 73.0 110.864 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.32 171.56 7.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 73.11 110.894 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -114.85 108.72 17.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 75.43 110.924 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.8 mp -93.39 119.52 41.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 75.33 111.121 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.71 163.09 25.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 70.52 111.122 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.5 mt -91.28 109.37 21.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 72.33 111.123 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.03 -43.47 62.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 72.04 111.07 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -162.61 155.0 19.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 75.44 110.864 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.56 148.44 16.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.211 -0.449 . . . . 71.55 110.956 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.26 -174.65 44.72 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.739 -0.743 . . . . 75.2 112.489 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.463 ' HG2' ' NH2' ' A' ' 37' ' ' ARG . 3.1 mt-30 -82.03 131.22 35.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.351 . . . . 71.42 110.897 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.59 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.2 mm? -86.92 -60.79 1.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.945 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 75.33 110.911 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.2 mtp . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.84 0.353 . . . . 75.34 110.853 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.8 t -141.45 130.43 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 71.43 111.138 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -94.29 154.81 40.35 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.596 0.712 . . . . 60.44 110.883 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 146.09 59.05 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 74.12 112.374 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -133.98 142.97 47.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 73.32 111.15 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.46 ' HA ' HD21 ' A' ' 164' ' ' LEU . 1.8 m -134.23 141.73 42.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 74.24 111.136 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.575 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 13.6 p90 -101.49 168.54 9.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 74.42 110.876 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -148.44 88.9 1.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 73.11 110.87 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -51.25 102.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 60.1 110.873 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.5 mm -80.3 135.95 24.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 74.34 111.164 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -127.71 155.41 44.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 75.0 111.142 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.9 t -136.0 94.09 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 65.21 111.139 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.61 32.01 7.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 75.54 110.873 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.55 -23.63 33.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.753 -0.737 . . . . 52.05 112.481 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -92.3 115.62 65.04 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.615 0.721 . . . . 75.44 110.922 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.4 Cg_endo -69.76 121.26 7.95 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.703 2.269 . . . . 73.23 112.319 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.1 mt -65.64 -37.58 86.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 73.41 110.927 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.43 -125.6 1.69 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 70.3 112.509 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -128.44 136.95 51.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 74.25 110.853 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.24 103.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 75.52 111.146 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -109.42 173.25 6.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 71.31 110.885 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.413 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -143.8 127.9 17.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 74.32 110.87 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -82.89 99.59 9.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 75.24 110.913 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.417 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 1.4 mt -83.18 122.79 28.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 74.23 110.889 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -77.48 67.25 3.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 75.14 110.903 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.45 -20.89 33.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 75.43 111.105 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -68.57 -38.48 80.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 74.53 110.859 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.48 -28.07 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 72.13 110.925 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.68 67.9 58.79 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.627 0.727 . . . . 64.24 111.105 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -36.91 9.89 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.705 2.27 . . . . 75.44 112.338 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.68 -37.68 82.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 73.44 110.907 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.4 m -88.53 -43.21 11.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 65.55 111.173 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.42 -49.38 77.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 75.24 111.136 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -51.29 -27.67 10.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.22 110.903 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.0 -63.83 0.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.33 110.897 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -59.94 -32.75 71.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 74.21 110.883 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -71.72 -47.8 51.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 75.23 110.903 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.3 -36.94 69.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 70.13 111.097 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.5 mt -77.65 -50.69 11.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 75.15 110.9 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.5 m -58.68 -38.13 77.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 73.14 110.873 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.5 p -71.37 -38.6 71.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 72.24 111.144 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.81 -10.8 45.27 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.732 -0.746 . . . . 73.1 112.467 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -30.72 39.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 73.02 110.854 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -65.69 -28.71 69.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 72.23 110.927 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.28 -15.98 58.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.734 . . . . 61.21 112.516 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -155.11 -167.39 2.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.895 0.379 . . . . 75.41 110.866 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.56 -158.43 28.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.749 . . . . 61.43 112.492 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -112.42 21.09 16.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.929 0.395 . . . . 73.54 110.864 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.51 121.43 5.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 74.13 110.919 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.37 44.73 9.3 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.761 -0.733 . . . . 31.45 112.458 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.7 t -92.59 -169.38 2.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.824 0.345 . . . . 63.35 110.873 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 8.1 p -121.14 143.43 49.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 74.32 110.889 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -99.98 141.28 33.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 74.31 110.871 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -151.87 48.26 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 73.02 110.807 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.1 tpp85 -172.95 68.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 75.5 110.894 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.7 mt -116.11 113.3 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 73.3 111.127 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.5 mt -110.26 103.16 53.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.629 0.728 . . . . 73.34 111.156 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 86.24 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.671 2.247 . . . . 74.41 112.353 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.57 -20.77 1.5 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.737 -0.744 . . . . 72.55 112.485 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.87 -52.47 1.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 73.41 110.869 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.51 166.46 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 73.41 110.876 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.7 m -107.34 -169.4 1.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 73.12 110.918 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 173.85 149.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 74.44 110.891 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.94 172.09 22.29 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.67 -0.776 . . . . 71.03 112.497 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.33 165.18 46.41 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.73 . . . . 72.31 112.488 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.15 -170.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.86 0.362 . . . . 74.43 110.862 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -171.97 35.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 63.31 110.88 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.92 51.72 2.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 74.15 111.151 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.11 34.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 73.33 110.878 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.92 -57.46 3.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 74.51 110.863 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -107.4 37.91 2.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 73.42 110.868 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.41 -32.59 5.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.753 -0.737 . . . . 71.33 112.486 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.5 t -160.04 45.63 0.23 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.83 0.348 . . . . 75.04 111.118 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.9 -141.74 0.34 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.757 -0.735 . . . . 70.33 112.468 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.53 174.92 21.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.73 -0.748 . . . . 73.43 112.462 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.469 ' HE2' ' N ' ' A' ' 77' ' ' SER . 0.0 OUTLIER 56.54 174.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.789 0.328 . . . . 73.31 110.889 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.469 ' N ' ' HE2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -59.61 -153.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 74.2 110.841 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.71 47.3 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 74.15 111.125 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -127.79 -77.8 0.57 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 74.44 110.951 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -151.24 -76.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.67 -0.776 . . . . 50.12 112.464 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 4.7 mm-40 -117.55 -52.58 2.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.919 0.39 . . . . 75.1 110.909 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER 179.04 152.24 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 74.42 110.908 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -117.32 167.62 11.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 74.32 110.885 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.49 161.53 16.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.494 . . . . 73.33 110.881 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -48.28 151.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 73.44 110.848 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -102.78 -76.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 61.21 110.899 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -158.25 172.8 17.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 72.13 110.934 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.13 38.02 3.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 73.55 110.901 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.31 -31.53 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 65.11 111.156 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.8 mt -107.42 91.94 3.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 75.12 110.908 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -73.36 148.2 43.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 74.32 110.903 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -57.5 96.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 75.31 110.855 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -85.19 -57.93 2.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 75.03 111.129 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -143.26 -164.88 10.46 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.774 -0.727 . . . . 75.32 112.484 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 175.31 8.3 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.667 2.244 . . . . 73.12 112.359 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.07 21.19 69.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.785 -0.721 . . . . 72.03 112.512 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.1 mm -96.19 142.54 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.381 . . . . 65.3 111.144 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -114.49 143.71 44.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 65.11 110.929 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.98 -165.24 2.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 73.44 110.882 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 35.5 mtm -92.22 99.02 11.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 74.23 110.878 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.07 60.33 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.427 . . . . 65.34 111.096 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -118.7 -179.17 3.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.04 110.922 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.07 -24.49 3.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 65.0 111.121 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.96 -80.84 0.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.759 -0.734 . . . . 64.51 112.502 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 89.56 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.664 2.243 . . . . 75.13 112.322 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 66.26 -170.37 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 75.14 110.883 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.2 p 67.32 34.42 4.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 64.32 111.154 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.83 148.47 23.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 63.42 110.913 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.65 59.2 0.44 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.73 -0.747 . . . . 63.44 112.462 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 65.2 36.2 7.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.836 0.35 . . . . 73.02 110.89 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -59.66 -169.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 74.21 110.909 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.464 ' HB2' HD22 ' A' ' 98' ' ' LEU . 0.0 OUTLIER 177.43 149.05 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.92 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -165.49 73.2 0.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 74.22 110.884 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.506 ' C ' ' O ' ' A' ' 113' ' ' PHE . 19.1 mt -28.4 106.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 75.4 111.126 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 35.7 m -80.5 117.84 21.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 73.51 110.888 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.5 p -94.84 26.36 3.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 72.12 111.154 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 176.7 145.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 55.25 111.123 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -54.83 100.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 72.11 110.9 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.9 p -101.19 47.61 0.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 75.21 111.147 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -26.25 68.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 70.44 110.852 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -48.41 -28.62 3.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 74.31 110.942 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 26.0 mt -47.4 -35.82 8.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 74.11 110.914 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 124' ' ' GLY . 1.8 m-20 61.24 81.43 0.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 72.13 110.884 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.05 43.27 0.87 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 74.33 112.497 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.98 -17.86 39.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.785 0.326 . . . . 74.41 110.885 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -143.59 -168.1 2.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 74.22 110.851 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.4 t -126.26 119.32 53.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 73.24 111.115 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.8 t -83.23 129.89 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 75.11 111.107 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -153.86 33.83 0.44 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.862 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -171.96 172.85 44.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.722 . . . . 70.41 112.486 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -175.81 135.18 0.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 73.44 110.914 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.7 t -39.69 104.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 64.03 111.13 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.75 -60.0 2.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 73.51 110.899 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -154.56 160.22 41.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 75.15 110.882 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.59 32.03 28.61 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 74.35 112.528 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -29.59 26.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.747 0.308 . . . . 73.31 110.871 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.44 -32.4 49.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 72.25 110.907 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.0 mm -65.74 -38.85 83.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 74.13 111.091 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.9 t -64.39 -27.22 42.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 74.44 111.163 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.24 -28.49 38.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 61.55 110.876 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.82 -43.2 59.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 64.53 111.096 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 40.7 mtm -60.73 -51.29 69.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 75.32 110.851 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.94 -23.2 30.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 75.2 110.881 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -23.97 61.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 75.44 110.883 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -109.73 19.85 18.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 71.54 110.885 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.5 167.37 12.35 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.773 -0.727 . . . . 72.22 112.47 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.5 m -109.8 148.15 31.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 75.54 110.851 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.4 mmm-85 -76.53 64.21 2.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 72.34 110.875 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -174.13 -36.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 73.43 110.902 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 156.76 -47.65 0.48 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 72.42 112.525 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 168.11 9.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.84 0.352 . . . . 75.43 110.935 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.3 p -144.91 -174.24 4.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 72.23 111.157 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.84 -68.3 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 62.24 110.852 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.28 -176.06 4.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 74.33 110.924 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.85 109.73 18.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 72.32 110.921 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mp -85.04 118.34 31.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 74.22 111.18 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.72 162.34 28.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 74.32 111.15 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.6 mt -101.34 120.89 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 71.41 111.12 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.98 -48.83 12.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 72.01 111.119 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -156.95 158.31 36.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 71.03 110.828 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.89 146.91 13.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 73.23 110.887 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.68 174.04 45.29 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.747 -0.74 . . . . 74.33 112.471 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -65.0 140.57 58.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.853 0.359 . . . . 74.42 110.924 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.568 HD23 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -93.41 -59.39 2.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 73.11 110.923 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 64.33 110.871 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.5 mtm . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.824 0.345 . . . . 75.32 110.893 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.7 t -144.3 136.55 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 74.04 111.147 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -123.51 154.19 66.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.605 0.717 . . . . 75.01 110.902 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 145.49 57.11 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.709 2.273 . . . . 72.21 112.341 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.9 m -128.84 128.96 44.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 65.13 111.165 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.52 172.71 11.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 74.11 111.18 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.506 ' HB3' HD21 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -162.0 174.26 13.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.905 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -153.05 97.85 2.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 64.45 110.958 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.34 108.96 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 62.11 110.861 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.2 mm -80.11 133.64 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 73.41 111.136 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -125.82 156.37 39.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 74.15 111.086 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.5 t -134.81 96.39 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 65.02 111.171 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.56 30.56 10.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 72.11 110.883 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.31 -23.8 32.11 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 45.4 112.495 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -91.79 116.03 65.68 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.658 0.742 . . . . 74.12 110.872 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.2 Cg_endo -69.77 126.09 12.9 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.687 2.258 . . . . 62.52 112.324 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.1 mt -70.32 -40.93 73.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 73.31 110.938 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.26 -122.13 1.09 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.729 -0.748 . . . . 65.11 112.493 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -134.32 143.12 47.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 74.05 110.908 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.26 100.31 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 74.33 111.156 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 22' ' ' PHE . 2.1 t -104.52 173.78 6.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 75.53 110.854 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.426 ' N ' ' OG ' ' A' ' 21' ' ' SER . 63.9 m-85 -145.18 130.74 18.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 75.41 110.88 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -86.28 95.2 9.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 74.4 110.878 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.1 134.07 36.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 73.04 110.872 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -93.1 66.58 4.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 72.2 110.849 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.67 -22.71 36.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 60.42 111.086 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -65.68 -35.65 81.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 55.31 110.865 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -99.61 -29.24 12.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 73.34 110.922 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.86 66.06 67.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 74.02 111.106 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -35.32 12.7 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.688 2.259 . . . . 73.34 112.321 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.06 -39.39 81.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 72.44 110.895 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.7 m -89.84 -49.25 6.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 74.04 111.135 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.26 -42.16 63.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 65.13 111.094 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.75 -25.18 62.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 75.25 110.919 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.7 -65.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 73.13 110.85 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -31.14 66.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 73.44 110.891 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -73.15 -52.91 12.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 75.14 110.856 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.05 -33.52 57.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 54.02 111.095 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.6 mt -80.59 -56.07 4.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 74.22 110.914 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.1 m -54.38 -36.05 63.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 63.43 110.83 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.9 p -73.9 -45.29 51.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 75.43 111.147 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.7 -14.93 19.76 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.728 -0.749 . . . . 75.42 112.477 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -32.77 46.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 75.32 110.901 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -63.23 -28.77 70.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 75.12 110.892 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.86 -16.52 50.8 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.785 -0.721 . . . . 64.01 112.518 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -156.35 -165.91 2.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.923 0.392 . . . . 74.55 110.871 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.44 -164.75 33.14 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.721 -0.752 . . . . 74.54 112.452 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -105.74 26.78 9.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.911 0.386 . . . . 64.31 110.929 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.38 129.84 16.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 74.42 110.893 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.95 37.71 88.15 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.786 -0.721 . . . . 71.11 112.483 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.4 p -71.92 -172.56 0.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 74.32 110.819 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 8.1 p -131.45 127.33 37.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 61.42 110.858 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -86.0 115.56 23.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 73.14 110.863 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -124.08 32.55 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 61.31 110.878 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.71 83.04 0.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 73.01 110.865 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.0 mt -123.24 110.67 26.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 73.34 111.153 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.4 mt -104.17 104.24 42.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.676 0.75 . . . . 75.52 111.097 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 81.95 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.684 2.256 . . . . 75.53 112.367 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.77 -21.89 0.8 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 74.4 112.508 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.42 -54.95 2.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 75.33 110.892 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 171.58 168.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 72.44 110.867 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 113' ' ' PHE . 34.7 m -106.4 -165.65 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 74.41 110.864 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.62 130.55 9.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 72.14 110.925 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -51.37 -32.48 30.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.721 -0.752 . . . . 73.51 112.457 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.0 139.91 10.71 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.748 . . . . 70.33 112.53 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -69.55 139.31 53.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.831 0.348 . . . . 72.32 110.873 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -131.59 47.76 2.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 73.32 110.878 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.27 -34.49 42.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 74.11 111.155 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -143.18 166.6 24.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 73.4 110.844 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 67.78 71.23 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.51 110.855 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 67.74 39.69 2.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 64.31 110.873 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -124.83 -32.3 0.82 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.789 -0.72 . . . . 72.12 112.518 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.4 p 63.43 31.02 15.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.757 0.313 . . . . 74.13 111.092 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.37 151.03 26.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.739 . . . . 62.44 112.493 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.51 114.82 2.66 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.786 -0.721 . . . . 75.33 112.498 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -174.63 151.14 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.817 0.342 . . . . 72.41 110.899 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.0 m -60.04 -173.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 74.0 110.877 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pp -95.14 22.56 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 74.41 111.142 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -140.83 35.54 1.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 64.42 110.911 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.97 -140.51 15.04 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.75 -0.738 . . . . 75.34 112.496 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -78.17 -31.28 49.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.892 0.377 . . . . 72.22 110.891 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.434 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.47 -179.56 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 74.33 110.894 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.66 162.7 35.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 73.55 110.892 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -78.78 167.96 20.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 74.14 110.877 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -59.35 146.02 41.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 74.41 110.85 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -102.59 -77.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 64.32 110.889 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -152.24 171.44 17.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 72.22 110.905 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.55 38.36 3.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 70.44 110.901 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mt -50.42 -30.48 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 73.11 111.131 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.6 mt -108.42 93.33 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.952 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -73.03 148.94 43.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 73.5 110.876 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -59.76 94.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.887 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.04 -59.28 2.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 71.31 111.149 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . -142.83 -166.02 10.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 73.12 112.523 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 172.24 12.98 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.676 2.251 . . . . 75.14 112.331 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.15 20.12 76.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.695 -0.764 . . . . 73.24 112.499 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.2 mm -96.21 142.52 13.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.853 0.359 . . . . 73.53 111.11 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.406 HD22 ' HB2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -112.52 141.04 46.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 75.43 110.891 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.22 165.86 32.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 74.13 110.862 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 11.8 mtm -71.92 87.19 1.01 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 72.02 110.922 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -48.35 124.6 8.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 71.14 111.127 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 24.1 p-10 -170.6 -174.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 74.31 110.912 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.03 -12.53 60.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 74.42 111.171 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.12 -83.3 0.34 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 61.3 112.51 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 96.28 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.666 2.244 . . . . 54.45 112.341 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 71.27 178.38 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 62.23 110.875 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.2 p 58.53 40.13 24.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 75.41 111.139 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.451 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 4.2 m120 -43.19 -35.3 1.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 72.54 110.894 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . 69.83 -62.83 0.69 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.8 -0.714 . . . . 71.33 112.46 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 0.6 OUTLIER 81.96 44.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.844 0.354 . . . . 72.41 110.858 -179.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -92.95 -7.63 45.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 73.31 110.88 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.553 ' CD1' ' C ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER 69.16 149.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 75.43 110.931 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.587 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -163.29 70.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 73.3 110.842 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.527 ' C ' ' O ' ' A' ' 113' ' ' PHE . 0.8 OUTLIER -27.48 124.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 71.33 111.154 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.6 m -96.0 114.08 25.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 72.05 110.909 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.9 p -92.56 28.47 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 74.31 111.114 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 175.95 141.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 74.34 111.062 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.406 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 2.1 tttt -50.63 99.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.905 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 49.6 p -98.99 55.67 1.02 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.218 -0.446 . . . . 71.33 111.125 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -23.87 61.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 73.12 110.882 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 8.1 p90 -49.88 -29.6 8.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.95 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 32.0 mt -49.45 -32.52 12.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 73.24 110.931 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.3 m-20 60.13 76.6 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 73.54 110.814 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.46 42.15 0.89 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.717 -0.754 . . . . 70.22 112.444 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.67 -21.93 32.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.831 0.348 . . . . 73.52 110.914 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -129.18 -166.72 1.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 74.33 110.844 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 79.1 t -128.99 118.76 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.21 111.152 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.82 132.57 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 62.32 111.103 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -155.13 30.1 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 72.24 110.878 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.39 173.99 43.14 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.717 -0.754 . . . . 63.1 112.476 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -175.49 135.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 63.33 110.892 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.2 t -40.58 105.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 75.14 111.114 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -59.36 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 71.33 110.903 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -154.19 -178.72 7.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.887 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.91 31.13 60.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 73.31 112.514 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.09 -24.63 55.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 74.14 110.867 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.41 -30.63 19.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 74.12 110.859 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.0 mm -65.15 -38.85 83.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 65.14 111.113 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 74.6 t -63.44 -30.4 49.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 73.01 111.179 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -76.49 -28.83 56.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 74.1 110.841 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.48 -41.3 60.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 54.45 111.102 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 33.8 mtm -61.35 -51.28 69.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 73.43 110.831 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.66 -25.52 27.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 72.24 110.951 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.84 -25.07 61.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 73.31 110.868 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -105.98 10.47 32.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 72.44 110.895 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.8 165.18 13.32 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.792 -0.718 . . . . 62.44 112.452 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.0 m -108.67 148.02 31.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 74.3 110.841 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 -75.95 60.73 1.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 73.12 110.843 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -163.38 -38.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 74.54 110.875 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 158.38 -50.99 0.41 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.789 -0.72 . . . . 74.12 112.492 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.03 174.14 7.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 71.13 110.886 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.8 p -144.36 -170.39 3.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 65.42 111.181 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 63.4 m -98.23 -67.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 62.22 110.843 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -76.89 -175.88 3.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 74.21 110.896 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.52 109.8 18.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.433 . . . . 75.44 110.879 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 4.2 mp -86.37 114.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 75.1 111.098 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.41 164.4 20.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 70.1 111.173 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.4 mt -103.89 125.65 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 73.3 111.099 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.93 -54.51 4.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 73.45 111.144 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -142.2 150.73 41.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 75.31 110.851 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -156.88 146.75 20.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 74.35 110.878 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.66 164.18 24.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.767 -0.73 . . . . 73.23 112.518 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -57.68 111.43 1.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 71.43 110.882 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.1 mm? -54.36 -51.22 65.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 74.53 110.93 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 71.01 110.872 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.871 0.367 . . . . 73.35 110.831 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t -137.32 133.7 46.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 73.11 111.151 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -106.08 141.53 22.93 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.608 0.718 . . . . 65.4 110.906 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 147.19 62.49 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.686 2.257 . . . . 74.32 112.322 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -130.96 140.85 50.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 73.24 111.174 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.474 ' HA ' HD22 ' A' ' 164' ' ' LEU . 1.5 m -135.14 142.47 39.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 74.34 111.114 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.556 ' HB3' HD21 ' A' ' 164' ' ' LEU . 11.7 p90 -103.37 161.71 13.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 74.11 110.923 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -144.45 89.18 1.98 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 75.34 110.889 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.17 103.24 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 70.33 110.838 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.8 mm -75.85 136.75 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 72.22 111.126 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -128.16 152.98 47.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.04 111.131 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 t -135.97 94.98 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.438 . . . . 74.11 111.116 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.74 31.27 4.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.44 110.859 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.02 -22.18 40.48 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.714 -0.755 . . . . 75.54 112.492 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -94.23 117.41 67.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.676 0.751 . . . . 74.42 110.859 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.75 124.56 11.2 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.683 2.255 . . . . 64.22 112.364 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.408 ' HB3' HD12 ' A' ' 138' ' ' ILE . 8.9 mt -68.87 -39.13 80.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 73.34 110.953 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.52 -135.93 4.62 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 71.12 112.433 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.32 134.33 55.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 74.12 110.917 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -145.79 102.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 73.21 111.137 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -111.44 172.36 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 75.03 110.852 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.41 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -143.97 130.95 20.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 70.03 110.894 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -84.42 100.38 11.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.52 110.896 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.444 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 1.7 mt -84.99 127.77 34.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 71.1 110.911 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -86.79 68.55 10.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 75.02 110.865 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.76 -23.9 32.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 70.41 111.077 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.5 -34.86 78.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 72.34 110.833 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 -27.45 14.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 75.5 110.901 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.42 66.78 37.18 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.636 0.732 . . . . 71.11 111.096 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -36.66 10.39 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.687 2.258 . . . . 73.33 112.3 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -37.56 80.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 74.45 110.834 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.7 m -88.53 -45.65 9.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 73.11 111.116 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.76 -38.66 82.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 72.31 111.11 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -51.22 -35.26 35.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 75.34 110.917 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -64.21 -63.18 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 75.43 110.888 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -56.93 -39.82 75.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 73.34 110.892 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.51 -47.29 76.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 74.1 110.856 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.68 74.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 75.11 111.129 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.2 mt -77.26 -54.8 6.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 74.15 110.904 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.0 m -51.67 -41.97 61.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 61.02 110.861 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -76.24 -34.44 59.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 75.22 111.103 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.26 -11.45 56.97 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.699 -0.762 . . . . 73.15 112.46 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -59.82 -18.77 46.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 72.1 110.905 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.23 -28.35 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.22 110.859 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.52 -26.03 5.26 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.798 -0.715 . . . . 53.22 112.518 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -158.67 -46.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 74.13 110.862 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.92 -149.8 43.99 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.775 -0.726 . . . . 75.04 112.498 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -179.45 92.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.954 0.407 . . . . 73.22 110.94 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.86 82.64 6.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 72.42 110.946 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 179.06 -68.34 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.71 -0.757 . . . . 64.52 112.511 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 48.36 -166.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 75.52 110.839 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.1 p -176.86 122.56 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 60.44 110.875 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -84.13 128.81 34.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 74.14 110.846 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -129.57 35.55 4.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 74.54 110.84 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.19 100.74 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 74.41 110.87 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.7 mt -140.65 113.98 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.478 . . . . 73.31 111.141 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.8 mt -113.9 113.02 47.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.592 0.711 . . . . 74.24 111.091 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 81.28 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.67 2.247 . . . . 71.21 112.388 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.38 -25.73 0.29 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 73.21 112.461 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.43 -57.37 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.884 0.373 . . . . 70.04 110.914 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 170.0 169.32 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 53.24 110.877 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.0 m -92.51 -165.78 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 74.13 110.893 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 176.49 142.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 62.32 110.968 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 150.51 112.84 0.59 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.739 . . . . 74.54 112.488 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.62 109.09 0.27 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.772 -0.728 . . . . 73.41 112.494 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -174.35 151.85 1.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.901 0.381 . . . . 71.22 110.832 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -125.16 -38.4 2.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 75.33 110.881 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 87.2 m -52.3 -36.18 52.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 71.13 111.137 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -144.86 146.78 32.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 75.02 110.907 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -116.45 39.3 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 72.12 110.834 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -127.28 -42.76 1.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 72.33 110.885 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 137.99 40.47 0.11 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.734 -0.746 . . . . 62.51 112.497 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.2 t -161.71 46.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.36 . . . . 75.22 111.127 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.15 168.76 41.88 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.706 -0.759 . . . . 73.1 112.444 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.54 103.74 1.94 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 42.53 112.468 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.89 155.96 19.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.807 0.337 . . . . 65.33 110.885 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 p -92.22 57.15 2.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 72.44 110.838 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.9 pt 42.78 30.58 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 74.34 111.114 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -170.92 55.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 74.14 110.912 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.03 177.83 51.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.744 . . . . 43.51 112.476 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -52.23 -28.3 18.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.954 0.407 . . . . 73.44 110.86 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.558 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 179.84 -175.58 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 74.13 110.905 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.431 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -142.38 -179.06 6.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 75.35 110.935 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.2 168.07 20.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 64.41 110.86 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -70.87 132.45 45.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 75.42 110.899 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -89.39 -70.11 0.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 75.41 110.886 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -172.01 172.79 4.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 73.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.9 36.78 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 73.33 110.829 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -49.64 -30.73 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 73.5 111.146 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 20.6 mt -110.42 68.13 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 74.44 110.893 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.67 156.19 14.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.913 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -61.76 92.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 73.45 110.8 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.4 p -105.35 24.82 11.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 73.23 111.121 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.39 177.93 27.41 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.704 -0.76 . . . . 73.0 112.478 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 172.9 11.74 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.674 2.249 . . . . 73.35 112.357 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.17 38.1 95.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.723 -0.751 . . . . 63.13 112.473 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.1 mm -110.69 134.37 53.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.868 0.366 . . . . 73.22 111.155 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.461 HD21 ' CD1' ' A' ' 112' ' ' PHE . 1.6 mt -100.81 156.6 17.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 72.14 110.921 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 t 175.85 126.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 65.45 110.883 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.7 mmt -50.55 162.06 0.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 73.03 110.888 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -158.0 95.12 1.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 75.21 111.108 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -118.07 -21.94 8.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 71.32 110.884 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -179.0 -32.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 64.24 111.112 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.09 -82.36 0.33 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.705 -0.759 . . . . 71.24 112.478 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 117.32 5.01 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.638 2.225 . . . . 74.3 112.368 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 40.22 41.79 1.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 75.25 110.936 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.2 p -155.73 56.0 0.61 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.165 -0.471 . . . . 74.24 111.075 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -66.1 -42.56 89.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 75.32 110.948 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.78 -152.91 52.82 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.737 -0.744 . . . . 74.31 112.459 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.17 21.42 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.859 0.362 . . . . 63.33 110.877 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.439 ' O ' ' CG ' ' A' ' 111' ' ' GLN . 5.2 tt0 -116.26 87.94 2.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 73.42 110.908 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.461 ' CD1' HD21 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -84.88 -165.15 1.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.43 . . . . 74.5 110.834 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.36 165.69 34.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 75.42 110.896 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.06 90.88 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 73.13 111.124 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 53.2 m -66.08 89.96 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 54.34 110.889 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.3 p -67.68 -8.11 32.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 74.35 111.099 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -145.9 153.3 40.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 75.41 111.138 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -56.57 94.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 63.53 110.918 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.2 p -96.73 45.99 1.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 71.21 111.148 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -24.66 67.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 64.34 110.842 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -48.51 -27.62 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 75.04 110.929 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.6 mt -45.83 -34.42 3.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 74.21 110.919 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 124' ' ' GLY . 1.7 m-20 62.17 78.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 62.01 110.834 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.07 43.07 0.63 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 64.23 112.494 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 -17.28 43.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.773 0.321 . . . . 74.11 110.875 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -143.24 -165.48 2.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 73.41 110.897 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.0 t -126.21 130.22 72.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.432 . . . . 73.33 111.114 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.9 135.86 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 75.42 111.15 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -159.33 38.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 74.21 110.865 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -178.12 173.77 46.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.73 -0.748 . . . . 51.14 112.459 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -174.99 140.0 0.51 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.854 0.359 . . . . 74.22 110.887 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.0 t -40.65 107.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 65.11 111.151 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -59.96 2.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 74.4 110.849 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -154.43 152.33 30.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 65.21 110.911 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.37 41.86 6.39 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.742 -0.742 . . . . 73.02 112.493 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -33.7 72.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.838 0.351 . . . . 63.2 110.902 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -36.31 31.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.439 . . . . 75.15 110.91 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 17' ' ' LEU . 38.3 mm -63.86 -38.97 83.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 74.21 111.088 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.2 t -66.63 -24.34 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 75.41 111.139 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.08 -27.33 30.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 73.32 110.902 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.17 59.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 64.51 111.112 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 31.7 mtm -60.0 -54.11 49.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 73.04 110.888 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.474 ' HA ' ' OE1' ' A' ' 143' ' ' GLU . 10.4 mm-40 -54.84 -28.89 53.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 63.42 110.899 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.43 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -64.22 -24.3 67.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 74.15 110.83 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.43 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 69.0 m-85 -106.85 32.5 4.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.863 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.65 170.63 15.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 73.43 112.471 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.5 t -127.37 146.97 50.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.887 0.375 . . . . 74.31 110.861 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.1 mmm-85 -72.83 77.29 1.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.897 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -174.45 -35.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 72.44 110.891 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.89 -77.5 0.24 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.705 -0.759 . . . . 73.23 112.5 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.17 168.94 9.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 72.13 110.882 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.9 p -144.16 -173.76 4.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 72.42 111.182 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.0 p -86.85 -63.03 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 72.55 110.834 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -66.2 173.54 3.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 75.33 110.86 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -122.79 109.65 14.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 75.35 110.886 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mp -85.86 119.59 34.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 73.24 111.124 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.83 163.61 28.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 74.13 111.156 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.1 mt -102.45 128.35 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 75.1 111.14 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.65 -59.55 2.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 64.31 111.109 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -134.59 155.77 49.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 63.44 110.894 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.66 143.93 4.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 71.41 110.859 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.89 173.23 43.15 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 55.12 112.483 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -64.59 140.63 58.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 73.05 110.888 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.556 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -93.28 -57.68 2.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 75.11 110.938 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 65.22 110.886 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.876 0.369 . . . . 55.420000000000002 111.126 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -103.75 152.15 38.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.659 0.742 . . . . 74.519999999999996 110.839 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 146.7 60.82 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.661 2.24 . . . . 74.019999999999996 112.359 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -131.89 141.28 49.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 70.230000000000004 111.178 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.498 ' HA ' HD23 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -135.69 144.26 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 74.540000000000006 111.14 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 18.7 p90 -101.94 165.22 11.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 75.129999999999995 110.873 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.674 ' CD2' HD13 ' A' ' 158' ' ' ILE . 7.2 m-85 -146.95 91.99 2.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 70.549999999999997 110.873 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.6 OUTLIER -54.99 101.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 72.530000000000001 110.888 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.462 ' CG1' HG21 ' A' ' 20' ' ' VAL . 49.7 mm -82.07 119.17 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 53.25 111.078 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -107.71 157.79 17.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 55.240000000000002 111.144 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.413 HG13 ' HB3' ' A' ' 154' ' ' LYS . 42.2 t -137.26 95.98 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 70.510000000000005 111.08 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.49 31.48 10.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 73.0 110.872 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.57 -22.6 38.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.711 -0.757 . . . . 33.409999999999997 112.469 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -94.7 115.41 65.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.638 0.732 . . . . 72.140000000000001 110.902 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.72 123.62 10.3 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.656 2.238 . . . . 71.329999999999998 112.381 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.467 ' HB3' HG23 ' A' ' 138' ' ' ILE . 13.8 mt -67.07 -39.54 86.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 64.420000000000002 110.953 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.4 -131.15 2.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.825 -0.702 . . . . 73.340000000000003 112.522 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.54 137.04 54.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.818 0.342 . . . . 63.340000000000003 110.867 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.537 ' CG2' HG21 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -146.1 99.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 73.219999999999999 111.132 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -107.87 173.28 6.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 64.450000000000003 110.844 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.42 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -145.94 134.47 22.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 75.209999999999994 110.892 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 49.2 tt0 -83.78 98.47 9.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 71.510000000000005 110.879 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.618 HD23 ' O ' ' A' ' 129' ' ' PHE . 4.3 mt -79.63 115.88 19.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 72.200000000000003 110.942 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -76.0 64.97 1.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 74.129999999999995 110.855 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.63 -22.54 23.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 50.240000000000002 111.103 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -66.5 -35.68 80.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 70.099999999999994 110.886 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.62 -28.87 12.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 74.329999999999998 110.926 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.14 66.52 60.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.616 0.722 . . . . 65.430000000000007 111.111 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -37.2 9.56 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.737 2.291 . . . . 70.040000000000006 112.335 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -63.48 -38.17 90.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 65.019999999999996 110.882 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 m -85.9 -41.29 15.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 75.340000000000003 111.153 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.22 -44.78 82.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 75.140000000000001 111.139 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -49.55 -30.23 8.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.010000000000005 110.881 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -67.68 -68.92 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 73.420000000000002 110.88 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -55.27 -25.62 34.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 75.430000000000007 110.94 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.476 ' O ' HG23 ' A' ' 41' ' ' THR . 0.8 OUTLIER -78.52 -55.57 5.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 74.329999999999998 110.885 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.76 -34.66 28.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 63.100000000000001 111.12 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 mt -75.8 -61.98 1.74 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 55.020000000000003 110.91 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.0 m -51.92 -33.92 39.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 53.32 110.858 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 37' ' ' ARG . 73.3 p -76.51 -31.99 58.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 65.049999999999997 111.113 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.01 -15.55 60.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 72.340000000000003 112.528 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -19.16 45.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.869 0.366 . . . . 60.509999999999998 110.888 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.776 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -51.41 -28.94 14.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 71.430000000000007 110.941 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.05 -25.25 6.13 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.739 -0.743 . . . . 54.229999999999997 112.453 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -158.08 -47.68 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.894 0.378 . . . . 72.340000000000003 110.907 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.61 -145.88 47.13 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.72 -0.752 . . . . 75.209999999999994 112.467 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -179.75 92.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.925 0.393 . . . . 73.019999999999996 110.956 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.22 85.45 6.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 74.129999999999995 110.911 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.2 -66.14 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.736 -0.745 . . . . 62.310000000000002 112.523 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.427 ' O ' HG22 ' A' ' 157' ' ' THR . 1.3 m 49.05 -166.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 75.400000000000006 110.9 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.8 147.64 16.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 64.019999999999996 110.892 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -128.73 120.58 26.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 61.25 110.876 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -144.61 42.98 1.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 73.310000000000002 110.864 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.413 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.69 72.88 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 75.540000000000006 110.88 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.697 ' CD1' HD13 ' A' ' 156' ' ' ILE . 4.8 mt -112.59 113.35 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 54.32 111.134 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.405 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 28.9 mt -104.58 103.05 37.81 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.712 . . . . 60.240000000000002 111.121 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 53.4 Cg_endo -69.85 89.56 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.691 2.261 . . . . 71.129999999999995 112.329 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.92 -19.45 1.97 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.71 -0.757 . . . . 53.350000000000001 112.445 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.78 -54.08 1.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 73.519999999999996 110.841 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.446 ' HE1' ' O ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER 173.27 171.35 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 73.540000000000006 110.883 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.446 ' O ' ' HE1' ' A' ' 61' ' ' MET . 7.1 m -111.28 -154.16 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 72.239999999999995 110.846 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 55' ' ' ARG . 10.6 tp-100 -134.68 163.38 29.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 70.540000000000006 110.893 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.757 -0.735 . . . . 70.120000000000005 112.488 -179.983 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.776 HG22 ' HD2' ' A' ' 44' ' ' LYS . 4.1 pt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.779 0.323 . . . . 62.409999999999997 111.085 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -174.31 58.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 74.319999999999993 110.892 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.54 -160.41 53.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.784 -0.722 . . . . 61.329999999999998 112.51 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.26 -40.88 59.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 73.450000000000003 110.902 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.532 ' HG2' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER 173.45 -177.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 74.120000000000005 110.878 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.35 -165.94 1.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 72.109999999999999 110.869 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.83 165.51 12.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 65.5 110.884 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -51.44 119.38 4.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.927 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -91.59 -69.16 0.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 72.010000000000005 110.857 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -177.25 177.14 1.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 74.519999999999996 110.909 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.42 36.89 3.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 110.892 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 mt -48.15 -33.63 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 60.240000000000002 111.128 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 22.1 mt -106.83 89.28 2.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 72.510000000000005 110.901 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.698 ' O ' HG23 ' A' ' 93' ' ' THR . 0.1 OUTLIER -79.25 139.23 37.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 73.409999999999997 110.911 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -49.71 101.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 74.349999999999994 110.851 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 91' ' ' LYS . 74.2 p -115.88 28.38 8.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 72.530000000000001 111.121 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.32 178.01 24.81 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 74.329999999999998 112.5 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 173.5 10.81 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.677 2.251 . . . . 75.239999999999995 112.338 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.12 32.8 85.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 75.340000000000003 112.496 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.5 mm -105.91 137.55 35.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.84 0.352 . . . . 54.439999999999998 111.159 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.519 HD21 ' CD1' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -105.16 144.86 31.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 73.329999999999998 110.958 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.58 -163.05 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 74.230000000000004 110.846 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.491 ' HE2' ' HB ' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -123.12 140.92 52.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.497 . . . . 72.200000000000003 110.859 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.794 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -139.55 34.85 2.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 45.439999999999998 111.083 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 2.5 t30 -70.43 -19.08 63.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 62.549999999999997 110.923 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.74 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . 176.64 -31.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 43.100000000000001 111.101 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.63 -89.28 0.49 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 60.210000000000001 112.495 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 117.24 4.97 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.638 2.226 . . . . 75.099999999999994 112.353 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.493 ' O ' HG23 ' A' ' 107' ' ' THR . 82.9 m-20 45.11 54.61 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 63.130000000000003 110.867 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.74 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 11.1 p -157.96 60.46 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.209999999999994 111.123 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.48 ' O ' ' C ' ' A' ' 109' ' ' GLY . 2.1 m-20 -66.05 -30.71 71.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 70.439999999999998 110.887 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 30.52 -116.14 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.749 . . . . 74.340000000000003 112.519 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.0 p -167.17 40.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.837 0.351 . . . . 62.43 110.85 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.794 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 5.5 mm100 -108.86 50.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 72.109999999999999 110.916 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.519 ' CD1' HD21 ' A' ' 98' ' ' LEU . 34.6 p90 -54.49 -176.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 75.510000000000005 110.857 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.726 ' CE2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -160.87 91.7 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 63.240000000000002 110.951 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 113' ' ' PHE . 3.0 mt -33.28 105.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 74.209999999999994 111.116 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.452 ' SG ' HG23 ' A' ' 119' ' ' THR . 41.8 t -69.59 100.51 1.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 52.219999999999999 110.914 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 13.1 p -83.94 11.31 7.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 74.439999999999998 111.146 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.49 ' O ' ' C ' ' A' ' 118' ' ' LYS . . . 177.37 124.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 73.230000000000004 111.072 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 117' ' ' ALA . 1.0 OUTLIER -30.22 105.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 71.400000000000006 110.879 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.836 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 71.0 p -87.75 73.51 9.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.5 111.144 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -69.8 -27.09 64.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 63.240000000000002 110.889 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.836 ' CZ2' HG22 ' A' ' 119' ' ' THR . 17.6 p90 -55.86 -22.47 25.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 70.5 110.906 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.682 HD12 ' OG1' ' A' ' 119' ' ' THR . 83.2 mt -77.95 -55.91 4.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 74.439999999999998 110.878 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 53.48 95.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 71.420000000000002 110.827 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 43.17 37.78 3.34 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 32.210000000000001 112.517 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.62 -11.48 48.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 63.310000000000002 110.863 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -148.46 -163.79 1.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 73.540000000000006 110.838 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.491 ' HB ' ' HE2' ' A' ' 100' ' ' MET . 25.0 t -122.09 116.03 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 73.439999999999998 111.139 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.19 134.48 27.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 71.510000000000005 111.149 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.618 ' O ' HD23 ' A' ' 24' ' ' LEU . 15.7 p90 -157.2 54.79 0.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 63.009999999999998 110.891 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.458 ' C ' ' HB2' ' A' ' 98' ' ' LEU . . . 169.92 176.29 39.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.764 -0.731 . . . . 72.340000000000003 112.486 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 132' ' ' VAL . 10.1 pttt -178.89 131.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.792 0.329 . . . . 53.539999999999999 110.905 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.724 HG11 ' HG2' ' A' ' 136' ' ' MET . 48.0 t -36.08 108.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 75.230000000000004 111.13 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.405 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -72.46 -59.33 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 64.530000000000001 110.897 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -152.93 158.35 41.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 65.120000000000005 110.896 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.16 30.94 24.11 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 73.010000000000005 112.475 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.724 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -50.93 -29.42 12.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 62.219999999999999 110.853 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.67 -33.8 35.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 62.329999999999998 110.876 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.537 HG21 ' CG2' ' A' ' 20' ' ' VAL . 44.5 mm -66.06 -44.34 92.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 62.030000000000001 111.131 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.9 t -63.96 -26.34 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 63.229999999999997 111.129 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.5 -30.72 47.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 73.420000000000002 110.857 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.92 -43.39 68.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 60.140000000000001 111.103 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 27.9 mtm -58.58 -43.98 89.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 73.140000000000001 110.859 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 8.7 tm-20 -54.25 -26.65 30.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 64.420000000000002 110.897 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -28.45 52.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 62.340000000000003 110.893 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -103.16 31.61 4.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 73.340000000000003 110.862 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -120.05 152.86 16.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 70.430000000000007 112.499 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.3 t -103.03 144.29 31.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.886 0.374 . . . . 73.0 110.865 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -73.57 65.28 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 62.240000000000002 110.832 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -175.35 -34.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 61.229999999999997 110.883 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.21 -70.9 0.34 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 61.149999999999999 112.482 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.21 170.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 75.109999999999999 110.882 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.4 t -159.48 158.85 32.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 62.509999999999998 111.113 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 86.0 p -75.38 -53.92 7.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.010000000000005 110.859 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.413 ' HB3' HG13 ' A' ' 12' ' ' VAL . 5.9 mttp -73.01 155.52 39.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 75.010000000000005 110.924 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -109.2 109.36 20.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 61.409999999999997 110.921 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.697 HD13 ' CD1' ' A' ' 56' ' ' ILE . 3.6 mp -90.81 123.06 42.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.447 . . . . 74.340000000000003 111.155 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -135.77 162.53 32.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 61.299999999999997 111.123 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.674 HD13 ' CD2' ' A' ' 8' ' ' PHE . 8.4 mt -95.69 120.76 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 70.140000000000001 111.142 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -85.32 -49.39 8.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 62.409999999999997 111.087 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -146.23 156.31 43.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 62.049999999999997 110.88 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.408 ' HA ' ' CE1' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -165.55 144.95 6.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 54.439999999999998 110.901 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.46 171.68 42.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 60.130000000000003 112.493 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -65.35 141.74 58.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 71.120000000000005 110.864 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.554 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.1 mm? -93.48 -56.47 2.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 63.109999999999999 110.892 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 75.430000000000007 110.874 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 2' ' ' VAL . 3.9 t . . . . . 0 N--CA 1.458 -0.052 0 CA-C-O 120.838 0.351 . . . . 75.310000000000002 111.125 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 -103.13 152.67 38.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.629 0.728 . . . . 63.310000000000002 110.911 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 146.54 60.22 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.641 2.227 . . . . 73.340000000000003 112.356 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -133.05 141.58 48.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 62.439999999999998 111.165 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.504 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.0 OUTLIER -134.24 143.21 38.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 74.230000000000004 111.16 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 16.6 p90 -100.94 166.37 10.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 75.400000000000006 110.871 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.588 ' CE2' HD13 ' A' ' 158' ' ' ILE . 5.9 m-85 -146.67 87.29 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 73.010000000000005 110.895 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.743 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.7 t0 -50.59 102.45 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 75.409999999999997 110.834 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.663 HG22 HD12 ' A' ' 17' ' ' LEU . 45.9 mm -80.59 128.89 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 55.399999999999999 111.121 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -122.39 154.24 37.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 111.129 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.476 HG13 ' HB3' ' A' ' 154' ' ' LYS . 41.5 t -132.44 94.24 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 63.310000000000002 111.109 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.15 31.37 13.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 65.5 110.905 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.88 -24.77 27.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.754 . . . . 51.140000000000001 112.513 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -91.44 114.57 62.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.62 0.724 . . . . 54.240000000000002 110.916 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.71 122.91 9.59 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.729 2.286 . . . . 62.509999999999998 112.34 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.663 HD12 HG22 ' A' ' 10' ' ' ILE . 12.4 mt -68.26 -38.7 82.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 73.329999999999998 110.949 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.97 -128.21 2.11 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.727 -0.749 . . . . 71.450000000000003 112.49 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.47 136.86 53.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 74.010000000000005 110.861 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.465 HG21 HG13 ' A' ' 10' ' ' ILE . 0.9 OUTLIER -146.35 102.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 64.109999999999999 111.18 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.0 OUTLIER -109.06 174.77 5.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 64.519999999999996 110.841 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.438 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.9 OUTLIER -144.85 132.66 21.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 71.349999999999994 110.924 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.4 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 60.1 tt0 -86.63 97.35 10.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 74.209999999999994 110.878 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.404 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.6 mt -80.69 119.74 23.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 74.120000000000005 110.91 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -78.35 65.19 3.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 74.099999999999994 110.868 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.45 -23.49 10.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 111.1 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -66.85 -31.92 72.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 72.25 110.827 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -101.82 -31.63 10.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 71.439999999999998 110.871 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.48 66.27 69.69 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.588 0.709 . . . . 61.039999999999999 111.169 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -39.85 6.1 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.669 2.246 . . . . 72.519999999999996 112.348 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -36.45 70.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 75.340000000000003 110.942 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.2 m -91.33 -47.91 7.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 71.040000000000006 111.151 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.4 -46.66 80.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 52.530000000000001 111.085 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -54.66 -26.05 30.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 61.130000000000003 110.864 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.569 ' HA ' HD13 ' A' ' 78' ' ' ILE . 0.8 OUTLIER -69.48 -65.31 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 64.129999999999995 110.931 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.95 -24.38 64.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 71.219999999999999 110.918 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.503 ' O ' HG23 ' A' ' 41' ' ' THR . 2.3 ttp180 -80.34 -53.15 6.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 75.219999999999999 110.858 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.04 -34.79 22.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 71.530000000000001 111.075 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 35' ' ' ASN . 3.0 mt -79.52 -59.5 2.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 65.450000000000003 110.944 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.6 m -52.65 -32.16 40.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 43.140000000000001 110.907 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 37' ' ' ARG . 71.3 p -77.51 -52.65 8.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 74.439999999999998 111.19 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.23 -17.86 7.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.741 . . . . 70.340000000000003 112.497 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -33.83 37.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.923 0.392 . . . . 72.150000000000006 110.869 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -58.52 -29.42 66.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 71.340000000000003 110.908 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.16 -13.18 60.36 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.781 -0.723 . . . . 64.040000000000006 112.486 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -160.05 -166.03 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.887 0.375 . . . . 64.150000000000006 110.903 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.54 -140.97 7.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 74.420000000000002 112.468 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -157.73 50.77 0.43 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.971 0.415 . . . . 72.219999999999999 110.912 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 142.16 21.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 72.409999999999997 110.899 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.86 21.22 73.12 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.71 -0.757 . . . . 71.450000000000003 112.464 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.11 -26.68 28.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.829 0.347 . . . . 71.329999999999998 110.85 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 0.1 OUTLIER 68.38 155.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 75.230000000000004 110.915 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -95.18 138.65 32.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 72.129999999999995 110.916 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -119.38 30.46 7.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 63.030000000000001 110.842 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -176.34 117.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 44.420000000000002 110.897 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.3 mt -146.11 114.1 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 51.049999999999997 111.135 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.6 mt -106.59 103.05 44.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.69 0.757 . . . . 74.400000000000006 111.149 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.8 Cg_endo -69.74 76.71 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.672 2.248 . . . . 55.310000000000002 112.374 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.04 -26.47 0.32 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.755 -0.736 . . . . 53.030000000000001 112.483 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.408 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -117.56 -57.47 2.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 73.510000000000005 110.853 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.449 ' C ' ' HE3' ' A' ' 61' ' ' MET . 0.0 OUTLIER 176.24 170.55 0.43 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 63.119999999999997 110.851 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 13.2 m -112.98 -177.51 3.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 64.219999999999999 110.869 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -170.6 140.39 1.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 52.509999999999998 110.922 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.752 -0.737 . . . . 71.109999999999999 112.482 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 35' ' ' ASN . 41.8 pt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.779 0.323 . . . . 75.409999999999997 111.07 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -130.77 -67.49 0.72 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 110.903 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -137.81 -65.25 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.749 . . . . 43.130000000000003 112.503 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -145.21 -40.06 0.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.887 0.375 . . . . 61.43 110.918 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.408 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.58 179.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 75.140000000000001 110.899 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.61 177.73 8.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 61.32 110.891 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.04 169.47 17.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 72.230000000000004 110.908 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -49.94 163.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 71.540000000000006 110.852 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -120.94 -74.5 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 54.140000000000001 110.854 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -165.22 169.4 16.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 63.219999999999999 110.902 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.42 37.63 3.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 73.209999999999994 110.883 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -50.22 -29.37 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.488 . . . . 65.349999999999994 111.111 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 34.7 mt -111.97 80.52 1.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 75.140000000000001 110.898 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.76 153.16 43.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 74.109999999999999 110.915 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -60.44 94.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 70.310000000000002 110.848 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 p -105.75 25.12 11.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 74.329999999999998 111.134 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.66 179.48 24.62 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.761 -0.733 . . . . 61.530000000000001 112.499 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 171.09 15.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.681 2.254 . . . . 62.0 112.351 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.23 29.28 70.46 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.687 -0.768 . . . . 61.32 112.499 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.1 mm -102.82 138.38 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.861 0.362 . . . . 71.319999999999993 111.137 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -109.32 144.2 37.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 73.349999999999994 110.926 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.84 -168.75 2.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 65.439999999999998 110.828 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.41 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 1.8 mtp -105.81 99.97 9.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.497 . . . . 75.420000000000002 110.854 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.721 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -87.64 50.11 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 61.229999999999997 111.082 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -86.59 -78.28 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 75.099999999999994 110.886 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.693 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -146.53 34.01 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 73.109999999999999 111.108 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.36 -111.7 4.39 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.788 -0.72 . . . . 74.420000000000002 112.466 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 111.43 2.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.701 2.267 . . . . 70.109999999999999 112.339 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.536 ' C ' HG23 ' A' ' 107' ' ' THR . 1.7 m-20 72.09 163.72 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 71.450000000000003 110.867 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.693 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.1 p 67.27 29.57 7.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 74.340000000000003 111.125 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.37 78.29 8.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 73.409999999999997 110.849 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -72.35 -71.97 1.0 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 62.009999999999998 112.526 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.41 ' HA ' ' HE2' ' A' ' 100' ' ' MET . 2.7 p 177.29 49.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.783 0.325 . . . . 74.040000000000006 110.86 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.482 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 1.8 mm-40 -64.02 -31.1 72.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 71.140000000000001 110.922 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.482 ' HB3' ' O ' ' A' ' 111' ' ' GLN . 8.2 t80 67.71 139.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 74.219999999999999 110.877 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.721 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -161.08 123.14 3.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 73.299999999999997 110.894 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.9 mt -86.4 126.59 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 74.129999999999995 111.094 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.05 101.07 13.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 62.240000000000002 110.897 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 73.9 p -86.99 20.98 2.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 64.019999999999996 111.151 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.762 ' O ' HG23 ' A' ' 119' ' ' THR . . . 175.59 146.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 72.209999999999994 111.092 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 98.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 63.439999999999998 110.851 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.762 HG23 ' O ' ' A' ' 117' ' ' ALA . 32.8 p -106.51 46.69 0.91 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 74.340000000000003 111.163 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -26.51 64.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 65.549999999999997 110.88 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.738 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.3 p90 -49.5 -25.42 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 70.150000000000006 110.951 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 18.1 mt -45.72 -32.19 2.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 70.530000000000001 110.936 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.5 m-20 59.47 77.21 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 75.230000000000004 110.848 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.15 42.23 0.78 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.793 -0.718 . . . . 63.210000000000001 112.46 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -80.59 -26.39 37.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.831 0.348 . . . . 74.010000000000005 110.906 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -136.21 169.03 18.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.409999999999997 110.853 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 50.0 t -102.43 118.53 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 44.240000000000002 111.155 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.02 133.72 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 72.310000000000002 111.129 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.404 ' O ' HD23 ' A' ' 24' ' ' LEU . 21.2 p90 -156.25 33.91 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 62.119999999999997 110.918 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.89 176.11 44.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.712 -0.756 . . . . 73.049999999999997 112.471 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -175.71 135.06 0.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.833 0.349 . . . . 63.109999999999999 110.913 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.682 HG11 ' HG2' ' A' ' 136' ' ' MET . 70.2 t -39.7 107.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 72.239999999999995 111.15 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.4 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -69.62 -59.13 3.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 74.040000000000006 110.908 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -152.78 157.79 41.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 51.0 110.879 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.64 42.95 9.52 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.731 -0.747 . . . . 73.409999999999997 112.472 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.682 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -62.41 -29.04 70.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.328 . . . . 61.109999999999999 110.882 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.86 -31.95 42.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 53.25 110.867 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.545 HD12 ' HB3' ' A' ' 17' ' ' LEU . 45.9 mm -65.21 -40.0 87.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 53.340000000000003 111.099 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.49 -27.75 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 73.450000000000003 111.129 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -80.13 -28.46 38.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 110.868 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.02 -38.72 63.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 74.420000000000002 111.122 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 28.2 mtm -60.7 -52.63 64.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 72.239999999999995 110.894 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -54.51 -26.32 30.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 44.329999999999998 110.95 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.433 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.37 -23.98 63.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 62.32 110.857 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.433 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 64.8 m-85 -107.66 16.11 24.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 75.129999999999995 110.839 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -110.67 168.55 13.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 61.310000000000002 112.497 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.8 m -113.71 146.71 39.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 43.210000000000001 110.847 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -75.72 66.43 2.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.091 -0.504 . . . . 72.319999999999993 110.883 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -171.11 -37.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 70.420000000000002 110.863 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 159.13 -63.15 0.3 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 63.229999999999997 112.472 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.49 175.52 0.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.377 . . . . 72.150000000000006 110.879 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.7 p -145.12 176.69 9.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 65.340000000000003 111.127 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.24 -60.66 1.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.329999999999998 110.853 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.476 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.7 OUTLIER -86.21 -175.77 5.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 75.219999999999999 110.918 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.96 108.73 15.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 53.439999999999998 110.901 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 4.1 mp -83.74 117.96 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 74.129999999999995 111.103 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER -126.12 165.87 18.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 43.350000000000001 111.186 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.588 HD13 ' CE2' ' A' ' 8' ' ' PHE . 4.0 mt -103.87 106.08 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 73.530000000000001 111.142 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.743 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -65.49 -44.96 85.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 73.439999999999998 111.144 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -161.45 158.04 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 74.299999999999997 110.845 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.2 148.27 16.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 72.099999999999994 110.876 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.09 171.77 41.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.713 -0.756 . . . . 73.510000000000005 112.466 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -65.19 142.45 58.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.871 0.367 . . . . 74.409999999999997 110.888 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.576 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -94.54 -58.75 2.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 72.430000000000007 110.918 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 70.409999999999997 110.932 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.3 t . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.795 0.331 . . . . 74.200000000000003 111.136 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -108.62 146.31 33.42 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.621 0.724 . . . . 65.239999999999995 110.885 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 146.45 60.42 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.673 2.249 . . . . 74.450000000000003 112.373 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 m -133.19 140.22 47.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 62.409999999999997 111.139 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.493 ' HA ' HD23 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -134.21 144.67 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 70.150000000000006 111.108 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.598 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 17.8 p90 -103.13 168.43 9.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 71.510000000000005 110.897 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.595 ' CE2' HD13 ' A' ' 158' ' ' ILE . 4.6 m-85 -148.22 87.71 1.61 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 72.519999999999996 110.891 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.713 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.4 t70 -51.34 103.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 74.439999999999998 110.888 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.598 HG22 HD12 ' A' ' 17' ' ' LEU . 40.7 mm -81.96 135.81 24.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 51.149999999999999 111.099 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -128.19 155.05 45.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.010000000000005 111.084 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' A' ' 154' ' ' LYS . 22.2 t -135.54 96.17 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 65.329999999999998 111.092 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 66.86 30.76 7.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 72.129999999999995 110.908 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.57 -23.74 33.09 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 73.109999999999999 112.517 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -91.99 117.3 67.65 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.639 0.733 . . . . 54.219999999999999 110.922 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.4 Cg_endo -69.79 124.45 11.08 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.661 2.241 . . . . 72.439999999999998 112.324 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.615 ' HB3' HD12 ' A' ' 138' ' ' ILE . 12.0 mt -68.98 -38.82 79.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 52.25 110.878 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.96 -129.38 2.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 75.239999999999995 112.447 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.41 137.05 54.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 74.340000000000003 110.891 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.506 HG21 HG13 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -146.26 100.21 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 74.140000000000001 111.128 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.4 t -108.67 175.26 5.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 73.219999999999999 110.811 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.442 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -146.34 130.47 17.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 71.439999999999998 110.874 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -83.5 100.78 10.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 73.010000000000005 110.892 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.9 mt -82.84 123.57 29.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 74.299999999999997 110.907 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -82.26 63.55 6.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 75.150000000000006 110.911 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.86 -23.44 12.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 54.020000000000003 111.079 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -64.48 -37.95 89.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 70.299999999999997 110.854 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.59 -29.06 13.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 72.200000000000003 110.875 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.429 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -132.7 64.92 73.14 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.6 0.714 . . . . 61.439999999999998 111.181 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -38.18 8.14 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.664 2.243 . . . . 74.219999999999999 112.344 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.36 -37.98 79.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 72.25 110.903 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.5 m -88.61 -45.07 10.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 70.319999999999993 111.137 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.03 -47.01 86.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 75.030000000000001 111.147 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -50.56 -31.08 14.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 74.109999999999999 110.891 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.81 -62.85 1.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 74.349999999999994 110.907 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.19 -22.61 61.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 71.319999999999993 110.865 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 41' ' ' THR . 1.8 ttp180 -83.08 -56.94 3.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 73.040000000000006 110.875 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.35 -29.69 10.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 73.439999999999998 111.156 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.452 HD21 HG22 ' A' ' 78' ' ' ILE . 37.9 mt -80.13 -60.89 2.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 72.329999999999998 110.908 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.0 m -55.3 -36.01 65.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 73.140000000000001 110.831 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 37' ' ' ARG . 69.1 p -69.23 -31.97 70.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 72.230000000000004 111.135 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.15 -18.11 58.03 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.775 -0.726 . . . . 51.450000000000003 112.492 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.54 -32.33 40.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 63.420000000000002 110.871 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -60.78 -28.22 68.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 73.319999999999993 110.923 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.19 -15.17 56.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.749 . . . . 62.420000000000002 112.478 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -158.31 -165.4 1.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.877 0.37 . . . . 74.310000000000002 110.927 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.424 ' HA2' HD22 ' A' ' 39' ' ' LEU . . . 156.62 -166.74 33.42 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.723 -0.751 . . . . 70.310000000000002 112.468 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -103.73 15.06 29.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.974 0.416 . . . . 74.319999999999993 110.955 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.53 140.05 2.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 63.350000000000001 110.913 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.64 28.85 60.5 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.699 -0.762 . . . . 40.43 112.483 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.68 ' O ' HG22 ' A' ' 157' ' ' THR . 2.8 m -79.45 -177.16 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.383 . . . . 55.420000000000002 110.814 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.0 p -139.73 127.76 22.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 70.129999999999995 110.846 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -75.66 128.77 35.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 74.109999999999999 110.856 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -128.8 37.3 4.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 73.430000000000007 110.872 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.04 81.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 73.019999999999996 110.918 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.469 HD12 HD13 ' A' ' 156' ' ' ILE . 2.6 mt -117.9 117.97 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 75.120000000000005 111.127 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.406 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 28.8 mt -112.27 103.88 55.65 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.613 0.72 . . . . 72.030000000000001 111.104 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.2 Cg_endo -69.79 92.0 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.678 2.252 . . . . 53.210000000000001 112.304 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.74 -17.4 2.81 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 71.510000000000005 112.505 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.9 -53.96 1.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 74.040000000000006 110.874 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.65 174.21 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 73.420000000000002 110.911 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 9.3 m -113.04 -162.4 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 73.420000000000002 110.881 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 174.51 143.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 72.230000000000004 110.941 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 61.219999999999999 112.485 -179.953 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.452 HG22 HD21 ' A' ' 39' ' ' LEU . 2.1 pp . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.837 0.351 . . . . 71.409999999999997 111.143 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -76.2 -34.64 59.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 64.219999999999999 110.969 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.16 -113.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 72.430000000000007 112.487 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -78.95 -44.18 23.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.91 0.386 . . . . 72.010000000000005 110.907 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.432 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.4 170.29 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 73.140000000000001 110.925 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.73 166.25 13.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 75.120000000000005 110.913 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.75 166.34 18.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 71.140000000000001 110.875 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -54.23 145.73 16.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 74.200000000000003 110.833 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -104.91 -69.98 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 72.239999999999995 110.922 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -176.38 177.35 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 71.239999999999995 110.918 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.28 37.11 3.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 71.129999999999995 110.892 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.22 -34.61 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 74.239999999999995 111.132 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.7 mt -112.02 78.03 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 72.099999999999994 110.904 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.455 ' O ' HG23 ' A' ' 93' ' ' THR . 2.0 mtpm? -70.1 144.16 52.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 72.120000000000005 110.936 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -51.03 99.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 50.509999999999998 110.816 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 91' ' ' LYS . 25.7 p -111.8 28.96 8.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 74.200000000000003 111.138 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.45 179.64 26.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.701 -0.762 . . . . 65.200000000000003 112.507 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 163.99 36.22 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.653 2.235 . . . . 64.5 112.384 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.29 37.85 54.13 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 54.200000000000003 112.466 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.2 mm -110.19 139.9 31.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.914 0.388 . . . . 75.430000000000007 111.071 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -107.66 146.09 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 73.310000000000002 110.87 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.81 -158.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 75.319999999999993 110.865 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.413 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 0.9 OUTLIER -130.4 136.83 49.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 74.519999999999996 110.89 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -120.52 100.4 7.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 54.32 111.069 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -151.16 -41.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 71.5 110.928 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.722 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -178.86 34.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 63.200000000000003 111.078 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.13 -109.99 1.77 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 72.109999999999999 112.492 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 115.19 3.98 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.708 2.272 . . . . 63.009999999999998 112.313 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.557 ' C ' HG23 ' A' ' 107' ' ' THR . 1.7 m-20 73.24 169.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 71.120000000000005 110.921 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.722 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 0.7 OUTLIER 65.86 27.16 11.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 61.219999999999999 111.187 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -75.78 144.37 41.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 74.040000000000006 110.871 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.32 -100.33 0.63 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.731 -0.747 . . . . 74.420000000000002 112.471 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.413 ' HA ' ' HE2' ' A' ' 100' ' ' MET . 21.9 p -158.09 37.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.839 0.352 . . . . 73.450000000000003 110.873 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.677 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 7.0 mm-40 -110.22 58.71 0.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 73.420000000000002 110.854 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.431 ' CD2' HD21 ' A' ' 98' ' ' LEU . 45.5 p90 -58.19 -171.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 74.299999999999997 110.88 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.549 ' O ' ' C ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -160.88 78.36 0.6 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 74.349999999999994 110.874 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.549 ' C ' ' O ' ' A' ' 113' ' ' PHE . 4.9 mt -25.1 105.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 54.329999999999998 111.119 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 37.3 t -70.29 101.57 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 71.430000000000007 110.89 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 47.9 p -90.53 21.98 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 72.129999999999995 111.185 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 116' ' ' THR . . . 173.25 127.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 73.140000000000001 111.16 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 117' ' ' ALA . 2.1 tttt -36.77 108.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 72.219999999999999 110.956 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.812 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 61.4 p -95.06 71.33 3.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 72.349999999999994 111.155 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -68.62 -26.61 65.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 72.25 110.873 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.812 ' CZ2' HG22 ' A' ' 119' ' ' THR . 17.9 p90 -56.28 -19.99 16.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 74.409999999999997 110.907 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.649 HD12 ' OG1' ' A' ' 119' ' ' THR . 82.9 mt -80.81 -54.66 5.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 52.549999999999997 110.897 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 52.47 95.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 65.230000000000004 110.88 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 42.29 41.91 4.12 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.768 -0.73 . . . . 54.240000000000002 112.478 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -91.21 -9.95 43.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.828 0.347 . . . . 70.099999999999994 110.898 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -146.73 -169.99 3.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 65.230000000000004 110.827 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.6 t -115.56 109.83 29.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 60.140000000000001 111.085 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 t -88.64 136.05 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 74.530000000000001 111.112 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.464 ' O ' HD23 ' A' ' 24' ' ' LEU . 13.5 p90 -157.93 40.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 72.409999999999997 110.878 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -176.32 175.47 47.48 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.701 -0.761 . . . . 62.009999999999998 112.465 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 6.4 pttt -176.1 136.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 74.310000000000002 110.929 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.698 HG11 ' HG2' ' A' ' 136' ' ' MET . 53.3 t -38.62 108.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 62.420000000000002 111.155 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.69 -58.88 3.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.867 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -153.51 158.76 41.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 73.030000000000001 110.919 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.63 31.94 28.75 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.737 -0.744 . . . . 72.510000000000005 112.522 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.698 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -52.07 -33.51 39.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.775 0.322 . . . . 60.329999999999998 110.901 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -34.29 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 62.119999999999997 110.876 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.615 HD12 ' HB3' ' A' ' 17' ' ' LEU . 40.2 mm -63.81 -41.63 93.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 72.129999999999995 111.135 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.8 t -64.48 -24.87 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 54.119999999999997 111.175 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -81.62 -28.85 33.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 63.039999999999999 110.855 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.68 -38.9 64.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 74.200000000000003 111.094 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.0 mtm -59.04 -52.9 63.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 72.230000000000004 110.892 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -55.42 -25.51 36.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 63.420000000000002 110.92 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.438 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -70.02 -23.76 63.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 72.299999999999997 110.833 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.438 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 62.1 m-85 -108.24 20.8 18.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 70.049999999999997 110.879 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.01 164.96 12.35 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.789 -0.719 . . . . 62.399999999999999 112.499 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.1 m -107.41 146.93 31.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.86 0.362 . . . . 60.119999999999997 110.855 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.7 mmm-85 -74.28 69.93 1.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 72.120000000000005 110.861 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -174.44 -36.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 74.409999999999997 110.914 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 150.58 -52.22 0.51 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 65.349999999999994 112.433 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.45 -176.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.912 0.387 . . . . 72.010000000000005 110.89 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -164.93 155.97 14.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.445 . . . . 73.319999999999993 111.127 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 80.7 p -82.49 -54.75 4.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 75.310000000000002 110.905 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.486 ' HB3' HG13 ' A' ' 12' ' ' VAL . 1.4 mttp -79.12 177.34 8.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 74.510000000000005 110.908 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -121.41 108.55 13.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 72.019999999999996 110.882 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.469 HD13 HD12 ' A' ' 56' ' ' ILE . 4.2 mp -86.01 116.65 29.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 73.120000000000005 111.139 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -126.67 162.72 25.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 74.239999999999995 111.092 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.595 HD13 ' CE2' ' A' ' 8' ' ' PHE . 5.7 mt -101.86 116.02 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 61.130000000000003 111.109 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -74.88 -47.91 27.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 31.329999999999998 111.105 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -159.69 157.08 28.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 71.450000000000003 110.837 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.0 146.83 17.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 62.310000000000002 110.873 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.4 172.98 44.17 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.801 -0.714 . . . . 52.43 112.533 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -64.97 142.51 58.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 63.439999999999998 110.938 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -93.22 -59.93 1.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 72.230000000000004 110.883 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 74.540000000000006 110.909 179.951 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 N--CA 1.458 -0.051 0 CA-C-O 120.847 0.356 . . . . 54.409999999999997 111.119 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -110.63 154.0 43.34 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.615 0.721 . . . . 63.409999999999997 110.885 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 146.35 60.02 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.719 2.279 . . . . 72.420000000000002 112.316 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.6 m -128.6 127.8 42.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 45.0 111.179 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.415 HG13 ' CD1' ' A' ' 24' ' ' LEU . 3.3 m -123.63 177.84 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 74.329999999999998 111.164 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.673 ' HB3' HD21 ' A' ' 164' ' ' LEU . 2.2 p90 -160.61 178.27 9.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 75.120000000000005 110.867 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -155.96 95.25 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 73.099999999999994 110.901 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 3.5 t70 -45.37 108.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 71.109999999999999 110.839 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.644 HG23 HG23 ' A' ' 156' ' ' ILE . 22.9 mm -79.38 129.34 37.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 72.109999999999999 111.097 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -121.96 137.46 54.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 73.5 111.133 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -120.73 93.25 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 41.399999999999999 111.1 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.46 36.3 6.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 73.549999999999997 110.908 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.91 -16.4 61.24 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.71 -0.757 . . . . 64.209999999999994 112.474 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -102.33 109.56 60.68 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.646 0.736 . . . . 61.020000000000003 110.904 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.7 Cg_endo -69.78 127.03 13.99 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.653 2.235 . . . . 74.299999999999997 112.324 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.461 ' HB3' HD12 ' A' ' 138' ' ' ILE . 9.9 mt -67.34 -39.03 85.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 73.129999999999995 110.913 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.45 -120.82 0.97 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 21.440000000000001 112.44 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -134.91 140.86 46.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 75.010000000000005 110.907 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.523 HG21 HG13 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -142.43 93.12 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 72.329999999999998 111.124 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.4 t -95.35 174.19 7.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 71.019999999999996 110.833 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.434 ' N ' ' OG ' ' A' ' 21' ' ' SER . 56.5 m-85 -147.33 143.21 27.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 73.099999999999994 110.856 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -96.5 95.74 8.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 72.430000000000007 110.863 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 129' ' ' PHE . 2.0 mt -78.85 124.93 28.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 75.5 110.906 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.91 63.11 7.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 71.420000000000002 110.872 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.39 -23.65 10.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 71.040000000000006 111.098 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -62.68 -39.89 95.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 55.240000000000002 110.846 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -98.27 -28.7 13.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 71.129999999999995 110.887 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.467 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -131.05 63.89 71.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.64 0.733 . . . . 44.420000000000002 111.1 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -36.55 10.73 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.707 2.272 . . . . 54.229999999999997 112.385 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -38.73 92.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 74.310000000000002 110.918 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.5 m -85.22 -42.3 14.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 72.430000000000007 111.13 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.67 -42.84 95.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 74.150000000000006 111.097 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -49.36 -30.59 7.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 61.149999999999999 110.922 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.529 ' HA ' HD13 ' A' ' 78' ' ' ILE . 4.1 t30 -68.58 -70.4 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 74.219999999999999 110.905 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.09 -32.12 21.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 62.340000000000003 110.862 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.521 ' O ' HG23 ' A' ' 41' ' ' THR . 0.1 OUTLIER -75.36 -54.51 6.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 73.439999999999998 110.856 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.93 -37.3 43.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 74.530000000000001 111.115 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 mt -79.19 -58.54 3.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 55.420000000000002 110.919 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.8 m -50.13 -35.22 24.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 60.149999999999999 110.857 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 37' ' ' ARG . 80.4 p -79.07 -54.39 6.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 75.510000000000005 111.145 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.28 -16.14 7.18 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.748 . . . . 74.420000000000002 112.453 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -53.86 -27.43 29.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 62.509999999999998 110.907 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HE2' HG21 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -60.28 -17.38 41.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 64.019999999999996 110.939 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.07 -11.93 70.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 62.420000000000002 112.53 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -163.34 -168.33 1.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 63.340000000000003 110.907 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.51 -137.51 5.38 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 32.140000000000001 112.476 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -168.07 88.59 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.909 0.385 . . . . 75.530000000000001 110.949 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -79.98 82.87 5.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.079 -0.51 . . . . 71.120000000000005 110.884 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.58 -62.02 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 23.52 112.488 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.459 ' O ' HG22 ' A' ' 157' ' ' THR . 20.3 m 51.11 -169.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.816 0.341 . . . . 73.319999999999993 110.889 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.6 p -176.09 122.75 0.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 71.420000000000002 110.882 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -91.4 108.19 19.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 72.540000000000006 110.936 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -113.68 28.25 8.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.140000000000001 110.822 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.04 95.39 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 72.319999999999993 110.875 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 56' ' ' ILE . 3.7 mt -126.29 116.38 45.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 45.200000000000003 111.127 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.408 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 26.6 mt -108.57 104.84 55.57 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.616 0.722 . . . . 62.229999999999997 111.129 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.8 Cg_endo -69.82 88.31 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.24 . . . . 71.040000000000006 112.356 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.98 -18.67 1.96 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 70.140000000000001 112.491 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.0 -55.18 1.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 74.200000000000003 110.846 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 173.4 172.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 64.239999999999995 110.907 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 11.4 m -108.57 -160.46 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 75.109999999999999 110.918 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 176.49 140.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 51.240000000000002 110.913 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.813 -0.708 . . . . 71.549999999999997 112.54 -179.951 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 35' ' ' ASN . 40.4 pt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.827 0.346 . . . . 74.120000000000005 111.166 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -165.72 51.27 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 71.219999999999999 110.892 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.54 -173.24 55.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.751 -0.738 . . . . 72.510000000000005 112.481 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -53.41 -24.67 13.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.398 . . . . 62.299999999999997 110.921 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.521 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -174.7 176.97 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 74.010000000000005 110.861 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -151.83 179.95 7.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 62.439999999999998 110.904 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.79 171.02 11.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 74.420000000000002 110.895 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -87.55 171.85 10.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 74.5 110.854 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -119.7 -59.45 1.81 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.468 . . . . 73.310000000000002 110.839 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.4 p30 -177.45 177.01 1.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 64.5 110.852 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.3 35.27 3.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 75.200000000000003 110.892 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mt -50.48 -32.64 10.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 73.430000000000007 111.133 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.3 mt -111.03 74.95 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 75.409999999999997 110.922 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.665 ' O ' HG23 ' A' ' 93' ' ' THR . 10.9 mtpp -70.32 147.02 50.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 63.450000000000003 110.874 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -50.88 99.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.449 . . . . 75.439999999999998 110.819 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.665 HG23 ' O ' ' A' ' 91' ' ' LYS . 77.0 p -112.66 27.62 9.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 62.140000000000001 111.125 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 147.85 -179.26 24.86 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.714 -0.755 . . . . 40.310000000000002 112.467 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 170.48 16.53 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.657 2.238 . . . . 71.319999999999993 112.337 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.4 34.28 79.35 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.74 . . . . 75.140000000000001 112.494 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.5 mm -106.49 139.43 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.915 0.388 . . . . 74.409999999999997 111.083 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -106.85 146.57 30.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 61.530000000000001 110.915 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.402 ' HG ' ' C ' ' A' ' 127' ' ' VAL . 0.1 OUTLIER -164.06 -156.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 72.120000000000005 110.852 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.4 mmt -131.73 127.61 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.077 -0.51 . . . . 72.349999999999994 110.898 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -86.88 129.35 34.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 54.229999999999997 111.145 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 172.23 -168.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 71.239999999999995 110.888 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.756 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -47.47 -50.58 22.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 64.439999999999998 111.113 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 123.53 -66.89 0.5 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 55.240000000000002 112.447 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.529 ' O ' HG23 ' A' ' 107' ' ' THR . 53.8 Cg_endo -69.75 112.84 3.18 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.62 2.214 . . . . 64.450000000000003 112.39 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.8 OUTLIER 36.88 47.3 0.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 72.400000000000006 110.857 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.756 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 21.3 p -144.54 39.31 1.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 70.129999999999995 111.132 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -76.64 140.38 40.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 74.209999999999994 110.88 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.32 -131.06 3.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 42.240000000000002 112.485 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 p -138.07 29.92 2.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.805 0.336 . . . . 74.219999999999999 110.839 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.533 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 9.3 mm-40 -116.83 72.69 0.83 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 72.299999999999997 110.939 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.416 ' HB2' ' CD2' ' A' ' 98' ' ' LEU . 34.7 p90 -57.24 -174.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 75.510000000000005 110.897 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.552 ' O ' ' C ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -159.54 78.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 72.439999999999998 110.858 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.552 ' C ' ' O ' ' A' ' 113' ' ' PHE . 3.0 mt -23.38 107.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.492 . . . . 63.200000000000003 111.171 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 34.9 t -73.01 99.4 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 64.340000000000003 110.875 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 48.9 p -88.55 20.66 3.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 63.25 111.171 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 116' ' ' THR . . . 174.17 127.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 74.140000000000001 111.13 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 117' ' ' ALA . 3.4 tttt -36.35 107.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 61.030000000000001 110.912 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.812 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 49.5 p -94.36 72.86 3.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 75.230000000000004 111.135 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -71.45 -26.92 62.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 74.329999999999998 110.876 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.812 ' CZ2' HG22 ' A' ' 119' ' ' THR . 15.7 p90 -54.35 -22.02 11.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.168 -0.469 . . . . 63.329999999999998 110.913 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.605 HD12 ' OG1' ' A' ' 119' ' ' THR . 64.1 mt -78.66 -53.12 7.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 54.450000000000003 110.881 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 54.43 95.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 61.219999999999999 110.862 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 40.43 39.88 1.81 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.76 -0.733 . . . . 41.420000000000002 112.493 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -87.07 -12.15 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 74.329999999999998 110.903 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -145.17 -164.88 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 62.149999999999999 110.82 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.402 ' C ' ' HG ' ' A' ' 99' ' ' SER . 85.8 t -121.6 111.67 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 64.400000000000006 111.104 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.1 136.85 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 70.209999999999994 111.13 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.529 ' O ' HD23 ' A' ' 24' ' ' LEU . 12.6 p90 -159.48 42.43 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 61.350000000000001 110.856 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.405 ' C ' ' HB2' ' A' ' 98' ' ' LEU . . . -175.03 178.17 46.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.81 -0.71 . . . . 71.530000000000001 112.547 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -179.39 135.35 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.82 0.343 . . . . 72.140000000000001 110.906 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.702 HG11 ' HG2' ' A' ' 136' ' ' MET . 42.7 t -40.63 111.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 61.030000000000001 111.166 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.14 -59.93 2.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 64.150000000000006 110.878 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -151.05 165.9 32.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 74.239999999999995 110.9 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.76 34.53 48.4 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 60.43 112.485 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.702 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -54.43 -23.3 15.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 71.140000000000001 110.869 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.96 -31.2 62.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.433 . . . . 73.329999999999998 110.865 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' A' ' 17' ' ' LEU . 37.4 mm -65.89 -38.3 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 75.549999999999997 111.1 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.3 t -66.58 -27.83 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 70.310000000000002 111.089 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -80.88 -30.64 35.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 73.120000000000005 110.88 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.15 -38.52 69.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 74.129999999999995 111.088 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.527 ' SD ' HG21 ' A' ' 156' ' ' ILE . 38.9 mtm -62.66 -54.0 46.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 71.319999999999993 110.894 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -55.52 -24.57 32.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 71.120000000000005 110.87 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.431 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.77 -25.04 61.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 71.120000000000005 110.867 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.431 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 72.0 m-85 -108.34 19.96 19.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 53.420000000000002 110.919 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.48 163.4 12.17 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.758 -0.734 . . . . 34.43 112.449 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.3 t -112.01 146.59 37.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 73.450000000000003 110.845 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -75.06 67.96 1.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 72.430000000000007 110.856 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -172.68 -36.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 75.530000000000001 110.88 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 156.11 -93.74 0.14 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.715 -0.755 . . . . 44.32 112.461 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -51.85 165.51 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.808 0.337 . . . . 52.450000000000003 110.919 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.5 p -143.53 -171.7 3.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 71.140000000000001 111.115 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.5 p -88.44 -62.64 1.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 75.140000000000001 110.838 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -66.06 178.06 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 74.409999999999997 110.885 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.76 107.58 10.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 110.834 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.644 HG23 HG23 ' A' ' 10' ' ' ILE . 4.9 mp -91.36 108.46 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 74.049999999999997 111.118 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -125.24 162.87 23.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 74.109999999999999 111.115 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 19.9 mt -97.58 128.38 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 72.030000000000001 111.092 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -93.85 -56.13 2.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 75.319999999999993 111.076 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -135.11 155.15 51.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 70.25 110.854 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.83 146.11 11.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 63.100000000000001 110.944 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.39 165.83 31.49 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.72 -0.752 . . . . 64.510000000000005 112.444 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.469 ' HB2' HG22 ' A' ' 41' ' ' THR . 1.4 mt-30 -61.33 107.87 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 72.340000000000003 110.934 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.673 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.7 mm? -49.75 -49.7 47.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 64.510000000000005 110.922 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 51.229999999999997 110.877 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.568 ' O ' HG22 ' A' ' 2' ' ' VAL . 9.6 p . . . . . 0 N--CA 1.458 -0.033 0 CA-C-O 120.824 0.345 . . . . 72.25 111.13 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 62.42 157.64 0.12 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.619 0.723 . . . . 75.129999999999995 110.921 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 146.4 59.99 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.679 2.253 . . . . 71.519999999999996 112.373 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -132.7 141.78 48.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 72.049999999999997 111.155 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.476 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.1 m -133.21 143.52 38.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 71.510000000000005 111.133 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.575 ' HB3' HD21 ' A' ' 164' ' ' LEU . 15.4 p90 -103.13 159.79 15.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 62.130000000000003 110.872 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.737 ' CD2' HD13 ' A' ' 158' ' ' ILE . 4.5 m-85 -143.52 87.94 1.97 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 70.430000000000007 110.847 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.7 t0 -50.95 106.09 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 74.25 110.857 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.569 HG13 HG21 ' A' ' 20' ' ' VAL . 37.5 mm -81.18 130.57 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 71.299999999999997 111.133 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -121.28 146.89 46.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 72.209999999999994 111.102 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.0 t -130.59 94.4 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 75.530000000000001 111.128 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 67.44 32.95 5.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 75.109999999999999 110.865 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.76 -19.02 56.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.707 -0.759 . . . . 71.219999999999999 112.475 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -99.28 113.68 64.97 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.63 0.729 . . . . 70.209999999999994 110.884 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.6 Cg_endo -69.81 127.01 13.93 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.67 2.247 . . . . 51.009999999999998 112.328 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.53 ' HB3' HD12 ' A' ' 138' ' ' ILE . 11.3 mt -68.4 -38.28 81.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 63.119999999999997 110.949 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.78 -125.32 1.49 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.755 -0.736 . . . . 73.299999999999997 112.497 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.92 136.42 53.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 73.319999999999993 110.908 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.569 HG21 HG13 ' A' ' 10' ' ' ILE . 1.1 t -144.81 99.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 63.219999999999999 111.145 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -109.95 172.58 6.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 64.510000000000005 110.84 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -144.48 142.56 30.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 64.109999999999999 110.901 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.463 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 47.6 tt0 -98.22 99.58 10.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 71.239999999999995 110.9 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.5 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 2.2 mt -80.25 122.46 26.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 71.230000000000004 110.936 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.41 ' O ' HG23 ' A' ' 29' ' ' VAL . 55.2 m-85 -75.59 65.53 1.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 63.130000000000003 110.911 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.55 -22.6 13.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 72.209999999999994 111.102 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -63.61 -46.21 86.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 60.329999999999998 110.883 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -91.06 -30.38 16.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.430000000000007 110.88 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.468 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -131.03 67.11 80.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.653 0.74 . . . . 64.010000000000005 111.14 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -39.61 6.28 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.652 2.234 . . . . 74.450000000000003 112.346 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -37.05 85.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.878 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 m -85.15 -40.81 16.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 41.539999999999999 111.168 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.9 -48.59 68.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 63.009999999999998 111.088 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -49.52 -32.91 13.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 75.439999999999998 110.854 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.04 -50.62 69.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 72.140000000000001 110.902 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.417 ' HD2' HD11 ' A' ' 24' ' ' LEU . 4.0 t80 -69.55 -44.29 71.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 71.450000000000003 110.829 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.412 ' O ' HG23 ' A' ' 41' ' ' THR . 1.7 ttp180 -63.96 -35.47 80.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.898 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.97 92.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 44.020000000000003 111.107 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.424 HD11 HG23 ' A' ' 78' ' ' ILE . 3.2 mt -74.39 -45.94 43.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 63.219999999999999 110.903 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 m -57.49 -45.31 85.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 75.409999999999997 110.855 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.479 HG22 ' HB2' ' A' ' 163' ' ' GLN . 74.8 p -72.15 -48.64 41.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.104 -0.498 . . . . 64.349999999999994 111.11 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.74 -13.67 10.72 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.707 -0.759 . . . . 63.299999999999997 112.52 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -50.46 -34.57 25.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.856 0.36 . . . . 72.319999999999993 110.88 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -53.36 -27.97 26.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 74.400000000000006 110.882 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.87 -11.29 60.76 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 52.340000000000003 112.488 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -162.36 -165.79 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 71.439999999999998 110.88 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.95 -133.57 3.65 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.696 -0.764 . . . . 43.119999999999997 112.435 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -175.33 91.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.955 0.407 . . . . 74.129999999999995 110.906 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -80.68 78.02 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 75.420000000000002 110.864 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 158' ' ' ILE . . . 179.39 -66.66 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 51.240000000000002 112.502 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.483 ' O ' HG22 ' A' ' 157' ' ' THR . 1.3 m 49.19 -167.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 73.430000000000007 110.818 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.46 129.36 1.03 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 53.009999999999998 110.857 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -94.52 106.84 18.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.447 . . . . 53.049999999999997 110.864 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.0 27.29 9.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 73.120000000000005 110.856 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.97 91.71 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 75.430000000000007 110.909 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.0 mt -125.86 113.04 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 52.310000000000002 111.123 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.1 mt -105.12 102.36 35.83 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.596 0.712 . . . . 74.5 111.094 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 79.32 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.665 2.244 . . . . 63.200000000000003 112.35 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.45 -25.56 0.52 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 32.229999999999997 112.477 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.33 -57.67 2.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.809 0.338 . . . . 74.329999999999998 110.867 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.44 156.77 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 73.540000000000006 110.851 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.9 m -93.11 -167.81 1.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 74.109999999999999 110.915 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 177.61 146.93 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 63.399999999999999 110.887 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.721 -0.752 . . . . 72.319999999999993 112.451 -179.983 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.424 HG23 HD11 ' A' ' 39' ' ' LEU . 1.2 pp . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.827 0.346 . . . . 73.5 111.16 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -72.37 -34.28 67.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 74.329999999999998 110.879 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.25 -140.72 6.44 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.763 -0.732 . . . . 63.549999999999997 112.49 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -64.26 -35.27 80.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.935 0.398 . . . . 73.439999999999998 110.882 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.457 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.5 168.0 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 75.430000000000007 110.909 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -141.12 179.81 6.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 73.140000000000001 110.859 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.07 160.09 33.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 72.409999999999997 110.902 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.9 152.64 45.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 72.129999999999995 110.894 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -100.24 -75.81 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 70.120000000000005 110.913 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.4 p30 -166.91 173.94 8.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 52.200000000000003 110.919 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.86 34.75 3.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 72.400000000000006 110.908 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -51.03 -29.41 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 70.510000000000005 111.14 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 24.6 mt -99.99 91.7 4.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 74.409999999999997 110.878 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.9 mppp? -80.96 140.16 35.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 64.530000000000001 110.878 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -50.33 101.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 70.140000000000001 110.883 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.7 p -111.01 25.39 11.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 72.120000000000005 111.146 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 151.38 178.74 26.45 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 72.540000000000006 112.453 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 175.91 7.46 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.662 2.241 . . . . 74.230000000000004 112.332 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.86 37.11 93.81 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.69 -0.767 . . . . 70.439999999999998 112.474 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.1 mm -109.51 134.91 50.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.849 0.357 . . . . 65.010000000000005 111.118 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.537 HD22 ' CG ' ' A' ' 112' ' ' PHE . 2.8 mt -99.69 165.17 11.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 43.420000000000002 110.959 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 9.8 t -163.73 -128.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 63.210000000000001 110.83 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.599 ' HE2' ' HB ' ' A' ' 127' ' ' VAL . 28.8 mtm -150.24 143.15 24.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 52.5 110.844 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -93.58 104.13 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 63.130000000000003 111.06 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 179.8 174.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 75.200000000000003 110.896 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -50.57 -26.27 5.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 71.109999999999999 111.098 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.59 -82.93 0.33 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.709 -0.758 . . . . 64.349999999999994 112.499 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 95.06 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.687 2.258 . . . . 71.319999999999993 112.386 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.502 ' C ' HG23 ' A' ' 107' ' ' THR . 2.7 m-20 72.73 171.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 63.240000000000002 110.923 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.502 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.2 p 66.46 28.9 9.41 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 64.010000000000005 111.106 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -96.57 160.64 14.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 75.450000000000003 110.902 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.88 -132.42 3.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 45.119999999999997 112.488 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.9 t -104.48 -47.13 4.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.833 0.349 . . . . 64.5 110.86 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 2.3 pt20 -47.36 109.28 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 73.299999999999997 110.906 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.537 ' CG ' HD22 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -111.04 -164.1 0.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 74.540000000000006 110.898 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -143.81 153.0 41.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 72.540000000000006 110.859 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.0 mt -98.09 120.36 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 73.420000000000002 111.148 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 17.4 m -89.51 95.77 10.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 64.409999999999997 110.88 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 p -68.14 -8.46 38.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 71.209999999999994 111.135 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.687 ' O ' HG23 ' A' ' 119' ' ' THR . . . -147.33 154.03 40.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 40.140000000000001 111.05 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -56.66 93.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 72.219999999999999 110.894 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.69 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 26.2 p -95.74 45.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 64.200000000000003 111.114 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -25.75 67.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 64.129999999999995 110.888 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.69 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.4 p90 -48.18 -29.75 3.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.119 -0.491 . . . . 75.019999999999996 110.864 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.8 mt -45.51 -36.41 4.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 60.340000000000003 110.891 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.32 80.47 0.21 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 63.409999999999997 110.866 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 37.95 42.11 1.07 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.701 -0.762 . . . . 51.43 112.507 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.69 -14.66 47.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.824 0.345 . . . . 62.530000000000001 110.905 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -146.43 -176.47 5.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 70.329999999999998 110.871 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.599 ' HB ' ' HE2' ' A' ' 100' ' ' MET . 55.4 t -113.91 115.86 50.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 75.450000000000003 111.107 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 98' ' ' LEU . 22.4 t -92.27 132.26 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 74.319999999999993 111.133 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.468 ' CB ' HG21 ' A' ' 29' ' ' VAL . 20.2 p90 -157.1 44.78 0.38 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 110.94 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -179.34 174.76 46.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.724 -0.751 . . . . 75.129999999999995 112.474 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.02 143.43 0.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 72.329999999999998 110.886 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.741 HG11 ' HG2' ' A' ' 136' ' ' MET . 45.5 t -44.3 113.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 52.439999999999998 111.12 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.463 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -77.43 -59.82 2.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 63.530000000000001 110.906 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -152.53 155.23 37.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 64.420000000000002 110.902 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.99 36.91 10.56 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.739 . . . . 72.400000000000006 112.472 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.741 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -57.27 -27.52 62.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.785 0.326 . . . . 75.540000000000006 110.87 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.85 -32.22 60.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 60.130000000000003 110.866 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 17' ' ' LEU . 43.2 mm -66.17 -39.19 83.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 74.140000000000001 111.153 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.1 t -64.71 -26.62 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 72.409999999999997 111.165 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -81.04 -29.36 35.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 64.510000000000005 110.875 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.2 -39.5 65.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 61.140000000000001 111.092 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 35.0 mtm -61.22 -53.5 56.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 73.219999999999999 110.876 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.45 -25.41 36.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 72.420000000000002 110.934 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.435 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -70.23 -23.81 62.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 62.020000000000003 110.882 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.435 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 66.7 m-85 -108.89 20.73 18.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.400000000000006 110.863 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -111.3 171.74 14.57 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 52.32 112.482 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 t -127.9 143.29 51.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 75.319999999999993 110.868 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -71.48 79.22 0.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 64.109999999999999 110.933 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -178.91 -34.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 74.420000000000002 110.89 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.92 -83.1 0.18 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.741 . . . . 74.329999999999998 112.504 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.44 169.22 3.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 71.310000000000002 110.941 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.9 p -144.61 -171.58 3.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 72.019999999999996 111.146 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.8 p -88.64 -63.79 1.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 110.83 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -64.6 -179.68 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 74.430000000000007 110.916 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -127.71 108.81 11.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 73.099999999999994 110.899 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.14 116.54 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 74.109999999999999 111.16 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -131.69 164.93 24.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 65.099999999999994 111.112 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.737 HD13 ' CD2' ' A' ' 8' ' ' PHE . 3.7 mt -102.75 126.48 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.434 . . . . 45.049999999999997 111.123 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -90.76 -57.67 2.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 64.340000000000003 111.085 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -135.79 152.86 51.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.442 . . . . 50.210000000000001 110.849 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.32 144.38 10.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.198 -0.456 . . . . 75.430000000000007 110.924 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.18 171.28 40.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.71 -0.757 . . . . 52.049999999999997 112.518 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.479 ' HB2' HG22 ' A' ' 41' ' ' THR . 2.1 mt-30 -63.56 141.96 58.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 74.299999999999997 110.872 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.575 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.1 mm? -94.82 -59.61 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 65.219999999999999 110.906 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 73.129999999999995 110.872 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.781 0.324 . . . . 74.230000000000004 111.177 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -122.45 156.06 61.48 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.627 0.727 . . . . 74.120000000000005 110.891 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 146.14 59.21 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.674 2.249 . . . . 72.209999999999994 112.322 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -134.12 104.37 6.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 74.209999999999994 111.133 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -100.38 172.28 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.192 -0.458 . . . . 72.310000000000002 111.134 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.657 ' HB3' HD21 ' A' ' 164' ' ' LEU . 0.5 OUTLIER -160.16 172.98 16.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 71.209999999999994 110.9 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.41 ' HA ' ' HB3' ' A' ' 161' ' ' CYS . 32.1 m-85 -153.39 95.29 1.91 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 75.329999999999998 110.926 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.676 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.9 OUTLIER -45.2 104.59 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 70.219999999999999 110.884 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.735 HG22 HD12 ' A' ' 17' ' ' LEU . 29.7 mm -76.17 138.21 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 65.140000000000001 111.188 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.11 168.81 16.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 71.310000000000002 111.148 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.471 HG23 ' HG ' ' A' ' 17' ' ' LEU . 91.5 t -144.82 99.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 63.009999999999998 111.154 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.42 25.01 7.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 54.229999999999997 110.846 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.42 -28.3 12.0 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.725 -0.75 . . . . 60.32 112.479 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.64 125.79 70.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.73 . . . . 75.329999999999998 110.894 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 120.4 7.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.641 2.228 . . . . 74.409999999999997 112.358 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.735 HD12 HG22 ' A' ' 10' ' ' ILE . 6.5 mt -66.2 -42.02 89.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 65.25 110.922 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.88 -130.99 2.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 61.409999999999997 112.478 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.26 136.55 52.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 71.530000000000001 110.893 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.52 HG21 HG13 ' A' ' 10' ' ' ILE . 0.6 OUTLIER -143.01 100.53 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 64.340000000000003 111.179 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.435 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -109.51 172.84 6.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 71.230000000000004 110.872 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.407 ' N ' ' OG ' ' A' ' 21' ' ' SER . 43.6 m-85 -145.64 144.56 30.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 110.902 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -100.28 97.89 8.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 75.319999999999993 110.865 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.515 HD23 ' O ' ' A' ' 129' ' ' PHE . 2.3 mt -82.37 128.65 34.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 70.430000000000007 110.924 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.406 ' CD1' HD13 ' A' ' 90' ' ' LEU . 38.2 m-85 -87.16 67.3 9.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 75.420000000000002 110.932 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.57 -22.48 33.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 74.040000000000006 111.117 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -65.08 -34.16 77.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 74.310000000000002 110.882 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.2 mmtp -101.46 -31.27 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 75.420000000000002 110.927 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.406 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -132.78 65.64 74.72 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.588 0.708 . . . . 65.400000000000006 111.105 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -37.49 9.03 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.669 2.246 . . . . 74.430000000000007 112.321 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.15 -36.5 77.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 72.219999999999999 110.891 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.9 m -90.59 -41.32 11.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 65.040000000000006 111.143 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.69 -48.9 75.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 74.120000000000005 111.131 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -49.86 -34.29 19.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 74.150000000000006 110.922 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -65.25 -65.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 64.209999999999994 110.915 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -55.38 -36.51 66.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 75.540000000000006 110.875 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 41' ' ' THR . 2.2 ttp180 -68.61 -49.61 57.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 73.540000000000006 110.906 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.29 -25.15 32.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 40.329999999999998 111.084 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.24 -58.3 3.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 73.120000000000005 110.96 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.41 -38.4 83.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 72.040000000000006 110.872 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.487 HG22 ' HB2' ' A' ' 163' ' ' GLN . 42.8 p -62.59 -39.36 93.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 74.519999999999996 111.146 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.32 -19.52 31.74 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 74.150000000000006 112.493 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.71 -30.58 22.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.929 0.395 . . . . 75.129999999999995 110.905 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.567 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -59.53 -31.35 69.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 74.150000000000006 110.909 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.64 -8.97 68.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 44.25 112.458 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -169.81 -165.68 0.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.963 0.411 . . . . 73.200000000000003 110.834 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.37 -142.37 12.0 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.75 -0.738 . . . . 55.100000000000001 112.46 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -115.12 21.61 14.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.896 0.379 . . . . 74.109999999999999 110.875 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.4 125.26 12.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 75.420000000000002 110.86 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.05 36.96 93.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 75.319999999999993 112.53 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -117.3 141.11 48.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.36 . . . . 73.439999999999998 110.823 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.5 p -51.99 170.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 73.0 110.88 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.24 -173.77 4.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 75.439999999999998 110.885 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -106.56 -69.75 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 64.530000000000001 110.826 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.0 ttm-85 -137.26 160.72 38.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 71.230000000000004 110.884 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.563 HD12 HD13 ' A' ' 156' ' ' ILE . 40.5 mt -148.49 107.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 75.019999999999996 111.16 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.1 mt -106.08 104.78 51.16 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.624 0.726 . . . . 63.43 111.077 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.42 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 54.1 Cg_endo -69.77 79.29 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.67 2.247 . . . . 60.43 112.351 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.45 -26.53 0.27 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.749 . . . . 75.400000000000006 112.477 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.1 OUTLIER -120.61 -59.1 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 74.099999999999994 110.879 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.435 ' HB3' ' HA ' ' A' ' 115' ' ' CYS . 0.0 OUTLIER 170.91 156.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 73.209999999999994 110.9 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 6.6 m -85.78 -166.72 1.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 72.430000000000007 110.879 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -162.97 118.34 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 75.109999999999999 110.866 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.739 . . . . 52.310000000000002 112.495 180.0 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.567 HG22 ' HD2' ' A' ' 44' ' ' LYS . 14.8 pt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.815 0.34 . . . . 74.299999999999997 111.108 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.36 26.73 9.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 73.430000000000007 110.931 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.18 -70.07 2.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 32.100000000000001 112.476 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -125.42 -56.2 1.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.403 . . . . 74.549999999999997 110.909 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.437 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.36 -178.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 72.129999999999995 110.907 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -146.25 179.78 7.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 72.200000000000003 110.877 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.7 166.74 11.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 73.219999999999999 110.908 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -45.51 148.32 0.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 73.200000000000003 110.881 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -107.96 -74.66 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 75.450000000000003 110.856 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -162.11 170.47 19.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 70.409999999999997 110.89 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.22 37.95 3.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 75.420000000000002 110.925 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.37 -30.13 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 73.140000000000001 111.152 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.406 HD13 ' CD1' ' A' ' 25' ' ' PHE . 13.6 mt -110.02 84.59 1.95 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 73.150000000000006 110.92 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.467 ' O ' HG23 ' A' ' 93' ' ' THR . 23.6 mttp -71.77 146.83 47.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 64.030000000000001 110.926 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -51.69 103.23 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 73.25 110.862 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 91' ' ' LYS . 44.2 p -124.87 38.92 4.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 64.329999999999998 111.156 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.85 166.65 12.44 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.752 . . . . 71.25 112.49 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 160.11 50.91 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.698 2.265 . . . . 64.010000000000005 112.324 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.419 ' HA2' HG23 ' A' ' 132' ' ' VAL . . . 87.95 -14.53 58.53 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.69 -0.767 . . . . 65.319999999999993 112.465 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.6 mm -55.36 134.73 18.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.838 0.351 . . . . 72.340000000000003 111.131 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.664 HD22 ' HB2' ' A' ' 112' ' ' PHE . 3.8 mt -102.07 167.46 10.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 65.019999999999996 110.945 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.24 -147.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 62.299999999999997 110.878 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.407 ' HG3' ' HB3' ' A' ' 108' ' ' ASN . 6.3 mmt -145.17 124.88 13.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 71.510000000000005 110.902 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -115.31 76.36 1.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 63.520000000000003 111.109 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -114.12 -40.75 3.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 72.299999999999997 110.894 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.25 25.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 70.439999999999998 111.121 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.71 -140.82 16.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.728 -0.748 . . . . 61.310000000000002 112.505 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 106' ' ' ASN . 54.0 Cg_endo -69.73 59.32 1.6 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.668 2.245 . . . . 72.200000000000003 112.355 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER 166.02 160.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 62.109999999999999 110.885 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.2 p 56.71 34.19 24.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 70.439999999999998 111.185 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.407 ' HB3' ' HG3' ' A' ' 100' ' ' MET . 1.0 OUTLIER -75.17 64.83 1.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 70.519999999999996 110.889 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -62.82 -77.85 0.2 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.748 -0.739 . . . . 75.109999999999999 112.434 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 44.0 t -164.43 43.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.342 . . . . 71.549999999999997 110.868 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -101.39 39.46 1.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 74.120000000000005 110.903 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.664 ' HB2' HD22 ' A' ' 98' ' ' LEU . 32.3 p90 -55.29 -178.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 74.420000000000002 110.84 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.519 ' O ' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -157.58 -175.88 5.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.118 -0.492 . . . . 71.099999999999994 110.834 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 114' ' ' ILE . 2.8 mt -121.73 93.5 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 72.439999999999998 111.151 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 61' ' ' MET . 43.9 m -69.94 87.64 0.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 61.509999999999998 110.866 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.0 p -60.91 -14.88 25.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 71.310000000000002 111.118 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 119' ' ' THR . . . -143.26 153.16 42.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 70.420000000000002 111.103 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -54.51 93.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 42.229999999999997 110.862 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.71 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 24.9 p -93.82 52.74 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 72.219999999999999 111.149 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -24.24 65.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 110.862 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.71 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.6 p90 -48.95 -29.91 5.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 72.420000000000002 110.883 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 17.9 mt -47.2 -33.52 5.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 60.329999999999998 110.924 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.5 m-20 57.85 80.36 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 74.230000000000004 110.903 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.23 43.44 0.7 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 73.109999999999999 112.502 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.72 -16.29 51.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.849 0.357 . . . . 71.329999999999998 110.956 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -143.02 -167.75 2.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 73.200000000000003 110.884 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.2 t -120.34 115.14 46.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 63.200000000000003 111.142 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 98' ' ' LEU . 27.4 t -86.91 133.76 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 74.230000000000004 111.078 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.515 ' O ' HD23 ' A' ' 24' ' ' LEU . 16.7 p90 -154.82 41.42 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.510000000000005 110.906 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . 179.38 175.99 46.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.803 -0.713 . . . . 35.340000000000003 112.507 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -175.2 142.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 73.109999999999999 110.946 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.639 HG11 ' HG2' ' A' ' 136' ' ' MET . 34.5 t -45.61 112.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 73.230000000000004 111.128 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.13 -61.02 2.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 73.439999999999998 110.893 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -155.68 147.14 22.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 63.229999999999997 110.883 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.82 38.57 4.88 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.728 -0.749 . . . . 65.420000000000002 112.495 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.639 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -61.17 -30.36 70.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.805 0.336 . . . . 64.430000000000007 110.878 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.47 -37.57 49.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 63.399999999999999 110.881 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 17' ' ' LEU . 33.0 mm -61.89 -38.54 80.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 65.430000000000007 111.091 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.437 ' CG1' HG21 ' A' ' 114' ' ' ILE . 74.6 t -67.11 -24.21 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 73.040000000000006 111.109 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.72 -28.77 28.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 72.530000000000001 110.869 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.13 -39.01 63.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 71.510000000000005 111.108 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 28.1 mtm -58.95 -52.42 65.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 70.120000000000005 110.866 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -54.26 -26.69 30.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 54.409999999999997 110.886 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.45 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.81 -24.46 63.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 72.319999999999993 110.873 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.45 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 63.1 m-85 -107.78 14.07 25.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 73.219999999999999 110.853 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -113.61 167.52 12.34 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.763 -0.732 . . . . 52.219999999999999 112.505 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.55 133.95 51.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 75.109999999999999 110.867 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -54.38 -22.69 13.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.496 . . . . 65.140000000000001 110.873 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.79 -31.27 64.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.452 . . . . 65.129999999999995 110.895 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 141.49 -40.69 1.3 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.749 -0.739 . . . . 75.450000000000003 112.53 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.57 -177.43 0.43 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 74.310000000000002 110.909 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.3 p -146.27 159.63 43.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 72.540000000000006 111.117 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.69 -58.47 2.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 65.439999999999998 110.844 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -89.48 -177.17 5.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 72.409999999999997 110.846 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -112.21 108.17 17.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 54.310000000000002 110.87 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.563 HD13 HD12 ' A' ' 56' ' ' ILE . 5.0 mp -84.65 117.73 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 64.430000000000007 111.165 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.12 164.18 22.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 74.430000000000007 111.2 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.2 mt -101.32 130.74 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 64.430000000000007 111.08 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -89.17 -53.45 4.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 74.120000000000005 111.098 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -148.33 145.69 28.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 74.010000000000005 110.847 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -149.93 146.57 27.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 71.420000000000002 110.886 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.52 161.81 21.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.714 -0.755 . . . . 73.319999999999993 112.472 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.487 ' HB2' HG22 ' A' ' 41' ' ' THR . 1.1 mt-30 -58.13 107.1 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 71.219999999999999 110.908 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.657 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.2 mm? -49.04 -54.88 13.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 71.019999999999996 110.921 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 55.240000000000002 110.864 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.859 0.361 . . . . 70.030000000000001 111.101 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -100.73 146.07 31.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.69 0.757 . . . . 65.219999999999999 110.854 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 152.48 69.17 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.702 2.268 . . . . 75.409999999999997 112.328 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -135.92 135.15 39.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 70.430000000000007 111.15 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.503 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.4 m -129.43 143.2 41.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 72.200000000000003 111.133 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 7.0 p90 -104.66 165.21 11.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 71.319999999999993 110.889 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.566 ' HE2' HD13 ' A' ' 158' ' ' ILE . 5.5 m-85 -147.29 86.4 1.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 72.120000000000005 110.896 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.776 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 2.1 t70 -46.76 107.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 74.439999999999998 110.855 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.557 HG13 HG21 ' A' ' 20' ' ' VAL . 46.3 mm -85.38 119.78 34.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 54.329999999999998 111.115 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -113.43 149.85 33.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 72.439999999999998 111.095 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 154' ' ' LYS . 18.2 t -133.28 98.42 2.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.451 . . . . 73.219999999999999 111.147 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.69 32.93 10.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 75.519999999999996 110.875 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.46 -18.59 57.11 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.717 -0.754 . . . . 73.140000000000001 112.486 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -98.5 114.84 65.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.651 0.739 . . . . 71.409999999999997 110.862 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.53 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.75 125.36 12.06 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.68 2.253 . . . . 73.510000000000005 112.337 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.513 HD12 HG22 ' A' ' 10' ' ' ILE . 12.6 mt -67.91 -39.05 83.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 70.519999999999996 110.873 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.19 -129.31 2.28 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.761 -0.733 . . . . 62.409999999999997 112.476 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -121.36 134.74 55.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 74.129999999999995 110.92 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.557 HG21 HG13 ' A' ' 10' ' ' ILE . 1.7 t -145.11 103.19 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 75.200000000000003 111.086 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -114.73 173.75 6.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 75.120000000000005 110.864 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.425 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.8 OUTLIER -143.57 136.8 27.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 75.109999999999999 110.922 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -91.52 98.28 11.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 75.040000000000006 110.855 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 129' ' ' PHE . 2.9 mt -80.15 125.87 30.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 64.140000000000001 110.906 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CD1' HD13 ' A' ' 90' ' ' LEU . 46.3 m-85 -83.58 63.17 7.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 62.240000000000002 110.933 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.64 -23.73 7.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 74.400000000000006 111.105 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.6 -35.1 76.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 63.409999999999997 110.855 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.51 -30.87 13.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 71.239999999999995 110.868 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.414 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -135.04 66.58 68.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.656 0.741 . . . . 73.230000000000004 111.126 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -32.71 18.04 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.664 2.243 . . . . 63.200000000000003 112.351 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -40.62 95.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 64.420000000000002 110.893 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.438 HG21 ' CD1' ' A' ' 129' ' ' PHE . 86.4 m -86.83 -44.91 11.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 73.040000000000006 111.157 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.26 82.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 63.030000000000001 111.074 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -47.62 -40.66 20.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 73.530000000000001 110.87 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.448 ' OD1' HG23 ' A' ' 78' ' ' ILE . 2.8 t30 -64.01 -63.33 1.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 74.310000000000002 110.882 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.43 -23.32 24.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 71.040000000000006 110.865 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.505 ' NH2' ' HG2' ' A' ' 163' ' ' GLN . 0.0 OUTLIER -74.54 -59.31 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 71.230000000000004 110.894 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.43 -30.3 62.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 73.099999999999994 111.126 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.3 mt -75.75 -58.29 3.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 74.030000000000001 110.869 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.6 m -49.64 -46.69 49.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 75.310000000000002 110.863 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.6 p -74.69 -28.81 60.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 54.240000000000002 111.172 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.58 -8.44 76.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.775 -0.726 . . . . 74.340000000000003 112.457 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -63.23 -15.82 58.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.874 0.368 . . . . 75.310000000000002 110.866 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HE3' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -49.48 -28.84 5.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 64.409999999999997 110.859 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.29 -25.83 5.64 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.696 -0.764 . . . . 73.129999999999995 112.431 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -160.25 -46.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 75.340000000000003 110.861 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.52 -146.22 21.48 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.766 -0.731 . . . . 53.130000000000003 112.466 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -175.44 92.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.99 0.424 . . . . 74.340000000000003 110.884 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.47 141.02 29.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 72.420000000000002 110.922 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.91 39.66 74.92 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.754 -0.736 . . . . 71.310000000000002 112.479 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.09 28.83 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 64.329999999999998 110.848 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 3.9 m 51.16 -170.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 61.140000000000001 110.885 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -105.06 -174.27 2.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 62.25 110.875 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -120.3 -72.78 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 74.019999999999996 110.808 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 45.2 ttm-85 -138.91 156.41 47.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 75.319999999999993 110.815 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.558 HD12 HD13 ' A' ' 156' ' ' ILE . 38.0 mt -147.87 113.27 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 74.140000000000001 111.143 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.5 mt -113.12 104.13 55.71 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.601 0.715 . . . . 63.119999999999997 111.178 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.4 Cg_endo -69.77 77.35 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.729 2.286 . . . . 70.209999999999994 112.327 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.01 -27.1 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.741 . . . . 64.209999999999994 112.46 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.01 -54.67 2.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 74.319999999999993 110.869 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 168.87 165.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 110.834 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.6 m -92.45 -161.25 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 52.32 110.861 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -179.57 129.58 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 72.010000000000005 110.919 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.677 -0.773 . . . . 72.430000000000007 112.43 -179.947 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.448 HG23 ' OD1' ' A' ' 35' ' ' ASN . 31.1 pt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.866 0.365 . . . . 63.5 111.103 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -157.38 47.79 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 63.310000000000002 110.927 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.95 -128.29 8.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.711 -0.757 . . . . 64.5 112.508 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -118.52 -27.0 6.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 72.510000000000005 110.855 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.456 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 177.32 167.58 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 74.400000000000006 110.893 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -139.6 177.51 7.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 73.400000000000006 110.894 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.16 157.17 37.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.878 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -52.73 136.24 33.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 61.020000000000003 110.899 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -91.18 -76.27 0.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 54.539999999999999 110.888 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -165.49 167.89 17.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 70.310000000000002 110.91 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.55 37.76 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 70.099999999999994 110.913 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.38 -29.91 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 71.340000000000003 111.169 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.419 HD13 ' CD1' ' A' ' 25' ' ' PHE . 13.8 mt -108.95 79.17 1.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 74.430000000000007 110.914 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 150.33 47.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 71.439999999999998 110.896 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -59.31 96.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 62.530000000000001 110.829 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.9 p -104.53 25.53 10.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 41.030000000000001 111.167 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 144.93 -179.08 22.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 43.240000000000002 112.487 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 171.82 13.75 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.715 2.277 . . . . 73.200000000000003 112.339 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.78 23.0 78.6 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 43.030000000000001 112.464 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.1 mm -99.04 142.7 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.891 0.377 . . . . 75.129999999999995 111.14 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.409 ' HB2' ' C ' ' A' ' 130' ' ' GLY . 0.2 OUTLIER -113.36 140.91 47.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 110.943 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.14 -167.15 2.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 110.858 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -100.24 104.95 16.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 74.409999999999997 110.863 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.976 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -78.42 52.37 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 74.329999999999998 111.117 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.34 -169.14 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 72.439999999999998 110.854 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.793 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -46.45 -47.59 19.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 45.009999999999998 111.074 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.67 -74.79 0.31 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.761 -0.733 . . . . 61.32 112.495 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.411 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.4 Cg_endo -69.81 111.32 2.79 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.659 2.239 . . . . 71.310000000000002 112.311 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 41.35 56.64 3.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 73.349999999999994 110.924 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.793 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 11.0 p -153.68 44.8 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 62.009999999999998 111.178 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.33 125.15 28.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 65.209999999999994 110.893 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.24 -91.84 0.52 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.74 . . . . 72.140000000000001 112.492 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.7 t -178.73 49.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.816 0.341 . . . . 73.540000000000006 110.814 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.671 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 3.8 mm-40 -74.69 -40.26 61.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 74.200000000000003 110.936 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 66.25 141.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 73.439999999999998 110.873 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.976 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.2 OUTLIER -161.99 135.85 6.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 74.200000000000003 110.912 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.417 HG21 ' CG1' ' A' ' 139' ' ' VAL . 2.8 mt -85.9 119.32 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 63.43 111.134 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.08 98.97 10.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 73.400000000000006 110.899 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 76.7 p -86.1 18.48 3.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 64.099999999999994 111.145 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.768 ' O ' HG23 ' A' ' 119' ' ' THR . . . 177.31 142.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 71.310000000000002 111.071 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -51.65 99.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 72.109999999999999 110.919 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.777 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 41.4 p -104.12 53.62 0.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 62.549999999999997 111.111 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.67 -27.32 68.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 73.329999999999998 110.894 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.777 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.6 p90 -48.29 -26.74 2.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 74.230000000000004 110.947 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 23.8 mt -44.48 -37.41 3.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 75.200000000000003 110.923 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 124' ' ' GLY . 5.5 m-20 59.16 80.98 0.17 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 62.020000000000003 110.857 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.63 41.67 0.88 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.742 -0.742 . . . . 70.109999999999999 112.473 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.12 -21.4 36.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.85 0.357 . . . . 73.439999999999998 110.909 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -144.75 -169.44 3.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 74.010000000000005 110.832 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.8 t -124.58 123.46 66.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 64.299999999999997 111.099 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 t -88.84 132.58 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 71.019999999999996 111.096 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.438 ' CD1' HG21 ' A' ' 32' ' ' THR . 23.9 p90 -154.93 36.64 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 72.430000000000007 110.889 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -174.12 177.77 46.22 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.753 -0.736 . . . . 62.43 112.509 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -177.9 138.81 0.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.861 0.362 . . . . 75.409999999999997 110.905 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.54 HG11 ' HG2' ' A' ' 136' ' ' MET . 77.2 t -41.94 106.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 73.340000000000003 111.123 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -59.91 2.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 71.319999999999993 110.878 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -153.46 150.0 28.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 65.129999999999995 110.91 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.8 48.25 4.23 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.729 . . . . 63.140000000000001 112.496 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.54 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -66.45 -32.01 73.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.719 0.295 . . . . 75.099999999999994 110.849 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.99 -33.22 37.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 71.219999999999999 110.916 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 17' ' ' LEU . 45.2 mm -64.92 -36.47 77.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 71.200000000000003 111.077 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.417 ' CG1' HG21 ' A' ' 114' ' ' ILE . 63.5 t -65.8 -27.59 41.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 50.509999999999998 111.144 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -81.03 -27.51 35.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 73.349999999999994 110.827 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.04 -39.89 60.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 74.510000000000005 111.116 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 33.9 mtm -60.69 -52.92 63.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 110.886 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.443 ' OE1' HG23 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -53.55 -27.6 27.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 74.530000000000001 110.889 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.447 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.28 -24.48 63.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 74.230000000000004 110.896 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.447 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 59.7 m-85 -109.08 21.47 17.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 73.099999999999994 110.892 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -114.54 168.14 12.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 60.039999999999999 112.466 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 m -104.73 129.84 52.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 72.519999999999996 110.891 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -54.97 -26.12 34.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 72.129999999999995 110.89 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -77.71 -28.81 51.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.882 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.27 -39.43 1.24 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.765 -0.731 . . . . 54.409999999999997 112.47 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -178.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 75.019999999999996 110.876 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 10.6 p -144.64 133.58 22.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 54.420000000000002 111.161 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.7 m -69.09 -41.17 77.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 65.310000000000002 110.889 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.514 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -105.5 -177.15 3.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 74.530000000000001 110.899 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.55 ' HD2' HG22 ' A' ' 157' ' ' THR . 2.0 tppp? -115.92 108.54 16.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 73.230000000000004 110.885 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.558 HD13 HD12 ' A' ' 56' ' ' ILE . 4.9 mp -92.0 119.2 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 64.209999999999994 111.12 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.55 HG22 ' HD2' ' A' ' 155' ' ' LYS . 0.6 OUTLIER -129.0 163.7 24.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 55.350000000000001 111.145 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.566 HD13 ' HE2' ' A' ' 8' ' ' PHE . 7.5 mt -96.23 105.56 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 111.106 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.776 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -69.31 -41.7 76.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 71.510000000000005 111.083 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -162.98 160.95 25.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 71.430000000000007 110.87 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -167.98 148.16 4.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 71.420000000000002 110.882 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.5 -173.02 44.27 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.739 -0.743 . . . . 75.239999999999995 112.492 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.505 ' HG2' ' NH2' ' A' ' 37' ' ' ARG . 3.8 mt-30 -80.93 129.59 34.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 75.099999999999994 110.91 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.555 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -83.87 -57.78 3.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 75.439999999999998 110.972 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 71.219999999999999 110.871 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.863 0.363 . . . . 64.299999999999997 111.121 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -72.09 149.8 92.19 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.646 0.736 . . . . 73.010000000000005 110.876 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 146.32 59.61 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.689 2.259 . . . . 64.219999999999999 112.351 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -136.29 140.53 43.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 72.450000000000003 111.127 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.5 ' HA ' HD23 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -132.84 147.62 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 71.329999999999998 111.136 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.588 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 16.5 p90 -106.64 166.48 10.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 74.120000000000005 110.849 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.618 ' CE2' HD13 ' A' ' 158' ' ' ILE . 6.3 m-85 -144.47 90.38 2.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.400000000000006 110.914 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.551 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 2.1 t0 -51.04 117.69 2.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 64.209999999999994 110.892 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.421 HG23 HG23 ' A' ' 156' ' ' ILE . 22.2 mm -90.43 116.65 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 65.439999999999998 111.134 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -113.47 124.26 51.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 70.340000000000003 111.093 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.619 HG23 HD13 ' A' ' 17' ' ' LEU . 12.9 t -109.22 101.34 12.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 72.230000000000004 111.158 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.31 44.26 25.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 73.310000000000002 110.833 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.08 -2.0 87.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.734 . . . . 73.299999999999997 112.491 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.413 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 10.3 mm-40 -109.56 99.49 37.71 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.677 0.751 . . . . 63.420000000000002 110.883 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.71 101.29 0.89 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.703 2.269 . . . . 65.519999999999996 112.378 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.619 HD13 HG23 ' A' ' 12' ' ' VAL . 8.4 mp -65.11 -35.73 82.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 62.109999999999999 110.89 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.59 -145.1 9.04 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.745 -0.741 . . . . 73.150000000000006 112.497 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.56 153.2 51.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 73.040000000000006 110.89 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.468 HG11 ' CG2' ' A' ' 139' ' ' VAL . 5.8 t -144.89 101.46 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 72.230000000000004 111.116 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 2.4 t -92.33 176.44 6.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 62.310000000000002 110.83 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.455 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -146.26 116.2 7.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 74.120000000000005 110.882 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -67.64 96.99 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 63.32 110.88 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.8 mt -80.16 134.32 36.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 75.030000000000001 110.885 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -94.4 66.93 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 71.140000000000001 110.849 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.95 -23.65 33.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 75.420000000000002 111.089 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.39 -29.16 67.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 63.140000000000001 110.888 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -103.11 -30.13 10.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 73.140000000000001 110.885 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.86 63.89 60.18 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.609 0.719 . . . . 62.310000000000002 111.131 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -5.85 17.19 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.689 2.259 . . . . 61.409999999999997 112.388 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.72 -45.25 11.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 74.549999999999997 110.907 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.432 HG23 ' HE1' ' A' ' 100' ' ' MET . 44.2 m -92.76 -48.8 6.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 53.240000000000002 111.126 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.99 -41.89 68.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 73.329999999999998 111.109 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -58.88 -44.52 91.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 71.439999999999998 110.933 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.468 ' OD1' HG23 ' A' ' 78' ' ' ILE . 3.0 t30 -54.2 -50.03 68.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 72.400000000000006 110.922 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -61.53 -43.61 98.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 64.0 110.856 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -63.06 -44.01 97.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 73.519999999999996 110.907 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.85 -37.75 66.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 52.530000000000001 111.089 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.422 HD23 ' HG2' ' A' ' 44' ' ' LYS . 28.8 mt -71.97 -54.7 9.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 54.399999999999999 110.903 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -44.7 81.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 64.5 110.857 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.404 HG22 ' HB2' ' A' ' 163' ' ' GLN . 40.1 p -65.32 -47.0 78.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 65.430000000000007 111.118 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.09 -18.28 16.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 72.239999999999995 112.484 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -52.89 -29.06 26.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.914 0.388 . . . . 72.200000000000003 110.881 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.804 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -58.83 -19.0 37.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 72.010000000000005 110.894 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.2 -13.07 40.52 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.683 -0.77 . . . . 62.310000000000002 112.476 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -176.78 -170.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.869 0.366 . . . . 73.409999999999997 110.855 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -177.83 173.15 45.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 62.520000000000003 112.466 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -117.93 60.29 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.961 0.41 . . . . 73.239999999999995 110.931 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -78.01 57.56 1.8 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.491 . . . . 71.209999999999994 110.863 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 169.76 59.06 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 54.109999999999999 112.447 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.537 ' O ' HG22 ' A' ' 157' ' ' THR . 0.3 OUTLIER -114.57 151.62 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 75.120000000000005 110.852 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.9 p -96.07 129.23 43.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 53.350000000000001 110.856 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -84.39 133.95 34.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 75.239999999999995 110.885 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -132.62 40.59 3.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 65.400000000000006 110.897 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.43 ' HG2' ' NE2' ' A' ' 63' ' ' GLN . 14.1 tpp85 -162.58 71.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 75.230000000000004 110.882 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.453 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.4 mt -123.66 113.76 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.420000000000002 111.153 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.7 mt -112.91 109.59 52.44 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.618 0.723 . . . . 64.319999999999993 111.12 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.0 Cg_endo -69.76 76.92 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.67 2.247 . . . . 63.100000000000001 112.319 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.79 -27.15 0.21 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 74.349999999999994 112.457 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.403 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.0 OUTLIER -115.26 -60.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 74.030000000000001 110.858 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.403 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER 172.68 173.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 55.100000000000001 110.866 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.2 m -108.83 -177.71 3.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 75.209999999999994 110.866 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.545 ' CG ' ' HB1' ' A' ' 101' ' ' ALA . 0.9 OUTLIER -150.92 154.63 37.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 53.310000000000002 110.894 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.746 -0.74 . . . . 64.140000000000001 112.499 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.804 HG22 ' HD2' ' A' ' 44' ' ' LYS . 16.4 pt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.848 0.356 . . . . 60.219999999999999 111.144 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -164.74 -64.6 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 72.25 110.91 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -136.61 161.85 25.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 70.25 112.509 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -47.84 -32.1 5.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.904 0.383 . . . . 64.530000000000001 110.863 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.427 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.31 170.22 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 74.099999999999994 110.864 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.46 -179.9 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 63.450000000000003 110.886 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.85 160.0 26.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 74.200000000000003 110.888 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -52.1 151.67 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 63.130000000000003 110.823 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -100.62 -78.34 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 71.420000000000002 110.861 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -158.01 172.49 18.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 52.109999999999999 110.888 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.8 37.48 4.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 65.109999999999999 110.898 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mt -50.61 -29.35 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 64.349999999999994 111.089 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 15.1 mt -108.87 88.33 2.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 72.540000000000006 110.874 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -71.6 151.97 43.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 64.439999999999998 110.921 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -64.85 87.39 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 75.230000000000004 110.842 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.21 -51.38 11.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 75.030000000000001 111.154 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . -147.86 -164.46 11.31 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.772 -0.728 . . . . 63.43 112.477 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 173.8 10.44 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.659 2.24 . . . . 62.229999999999997 112.331 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.52 28.09 73.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.777 -0.725 . . . . 63.43 112.472 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.8 mm -100.85 140.69 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.893 0.377 . . . . 75.140000000000001 111.145 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -111.45 138.97 47.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 110.93 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.62 -168.1 3.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 71.519999999999996 110.863 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.432 ' HE1' HG23 ' A' ' 32' ' ' THR . 0.5 OUTLIER -94.23 103.91 15.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 64.549999999999997 110.902 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.937 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -75.64 69.77 2.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 64.319999999999993 111.115 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -131.71 -175.17 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 74.129999999999995 110.896 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.93 -27.15 2.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 64.329999999999998 111.112 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.4 -89.23 0.49 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.715 -0.755 . . . . 64.540000000000006 112.506 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 90.86 0.52 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.737 2.292 . . . . 73.530000000000001 112.316 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.561 ' C ' HG23 ' A' ' 107' ' ' THR . 2.9 m-20 76.07 168.53 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 64.400000000000006 110.897 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.561 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.1 p 69.86 28.96 4.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 73.530000000000001 111.174 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -109.28 106.65 16.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 64.400000000000006 110.879 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -90.23 -65.58 1.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 50.439999999999998 112.457 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.5 p 179.64 49.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.806 0.336 . . . . 73.239999999999995 110.836 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.686 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 3.4 mm-40 -62.39 -34.95 77.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 71.329999999999998 110.963 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 68.58 137.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 62.009999999999998 110.89 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.937 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -154.06 127.55 8.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 74.230000000000004 110.849 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.7 mt -83.95 125.32 40.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 73.329999999999998 111.164 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -91.15 103.48 16.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 73.319999999999993 110.894 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 69.4 p -88.42 20.75 3.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 111.117 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.732 ' O ' HG23 ' A' ' 119' ' ' THR . . . 174.87 146.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 52.310000000000002 111.13 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.425 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 1.2 tttt -54.43 99.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 65.219999999999999 110.906 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.732 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 42.2 p -105.87 46.66 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 72.209999999999994 111.125 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -25.73 65.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 75.140000000000001 110.879 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.732 ' CZ2' HG22 ' A' ' 119' ' ' THR . 5.6 p90 -50.12 -25.46 3.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.474 . . . . 72.329999999999998 110.905 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.9 mt -45.04 -35.72 3.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 73.409999999999997 110.888 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.0 m-20 60.74 80.45 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 65.329999999999998 110.853 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.3 42.66 0.9 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 63.200000000000003 112.52 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? -82.23 -25.49 34.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.834 0.35 . . . . 73.319999999999993 110.897 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -141.46 179.23 6.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 63.310000000000002 110.876 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.4 t -114.8 124.31 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 62.240000000000002 111.096 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.45 131.92 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 74.299999999999997 111.119 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.459 ' O ' HD23 ' A' ' 24' ' ' LEU . 43.3 p90 -149.23 31.58 0.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 62.25 110.911 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -175.8 175.69 47.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.804 -0.713 . . . . 73.030000000000001 112.494 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' A' ' 132' ' ' VAL . 1.5 pttp -173.12 127.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.81 0.338 . . . . 75.450000000000003 110.885 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.761 HG11 ' HG2' ' A' ' 136' ' ' MET . 53.8 t -32.12 106.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 64.430000000000007 111.107 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -57.16 4.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 70.510000000000005 110.895 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -157.06 157.51 34.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 75.409999999999997 110.905 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.33 32.05 10.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 65.299999999999997 112.507 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.761 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -61.16 -24.23 66.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 64.0 110.848 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -39.4 79.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 71.439999999999998 110.893 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.477 HD12 ' HB3' ' A' ' 17' ' ' LEU . 25.9 mm -66.56 -37.7 80.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 54.439999999999998 111.134 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.468 ' CG2' HG11 ' A' ' 20' ' ' VAL . 69.0 t -64.17 -30.54 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 73.230000000000004 111.129 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -73.09 -30.86 63.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 74.430000000000007 110.898 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.79 -37.19 70.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 61.119999999999997 111.111 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 16.0 mtm -57.97 -53.79 54.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 51.25 110.869 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.453 ' OE1' HG23 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -53.87 -28.12 34.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 61.140000000000001 110.866 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.44 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -67.81 -24.44 65.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 64.299999999999997 110.854 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.44 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 58.5 m-85 -108.71 20.68 18.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 70.109999999999999 110.915 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.41 166.25 12.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 52.119999999999997 112.514 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.5 t -123.34 148.79 45.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.864 0.364 . . . . 62.200000000000003 110.866 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.9 mmm-85 -75.34 70.51 2.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 61.009999999999998 110.92 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -174.79 -35.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.299999999999997 110.889 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.42 -42.72 0.88 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 70.040000000000006 112.483 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.38 165.63 20.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.864 0.364 . . . . 73.349999999999994 110.854 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.8 p -145.67 154.5 42.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 75.010000000000005 111.133 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 m -71.32 -48.16 52.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 75.329999999999998 110.849 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.413 ' HB3' HG13 ' A' ' 12' ' ' VAL . 6.0 mttt -96.87 -178.53 4.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 70.420000000000002 110.921 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -124.05 108.86 12.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 63.119999999999997 110.887 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.421 HG23 HG23 ' A' ' 10' ' ' ILE . 4.7 mp -92.76 123.12 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 70.430000000000007 111.126 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -131.83 158.57 40.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 64.129999999999995 111.136 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.618 HD13 ' CE2' ' A' ' 8' ' ' PHE . 9.7 mt -91.1 108.44 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 63.0 111.15 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -73.85 -48.4 31.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 63.039999999999999 111.099 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -151.93 162.74 40.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 54.409999999999997 110.872 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.11 148.19 4.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 74.310000000000002 110.901 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 176.81 172.51 41.52 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 74.329999999999998 112.498 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.404 ' HB2' HG22 ' A' ' 41' ' ' THR . 2.4 mt-30 -63.84 140.4 58.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.836 0.351 . . . . 74.140000000000001 110.91 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -92.49 -56.19 3.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 55.539999999999999 110.894 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 63.329999999999998 110.864 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.6 t . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.82 0.343 . . . . 51.539999999999999 111.159 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -102.44 153.51 38.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.617 0.722 . . . . 70.299999999999997 110.877 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 146.72 61.0 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.672 2.248 . . . . 75.319999999999993 112.316 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -133.28 140.05 47.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 74.120000000000005 111.18 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.458 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.6 m -133.3 143.02 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 64.209999999999994 111.14 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.577 ' HB3' HD21 ' A' ' 164' ' ' LEU . 15.7 p90 -103.4 161.07 14.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 71.099999999999994 110.92 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -142.55 88.08 2.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 72.540000000000006 110.868 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.493 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 2.3 t70 -52.13 107.49 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 60.130000000000003 110.888 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.841 HG23 HG23 ' A' ' 156' ' ' ILE . 32.3 mm -78.9 131.39 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 50.399999999999999 111.117 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -126.87 123.58 37.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 62.32 111.102 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.467 HG12 ' HG2' ' A' ' 154' ' ' LYS . 1.9 t -108.28 94.55 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 73.530000000000001 111.156 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.1 t0 58.96 46.76 13.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 73.040000000000006 110.899 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.34 -4.37 84.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.738 -0.744 . . . . 65.129999999999995 112.477 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.441 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -111.28 102.63 53.5 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.681 0.753 . . . . 72.439999999999998 110.87 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.82 124.34 10.96 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.628 2.218 . . . . 74.010000000000005 112.33 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.429 ' HB3' HD12 ' A' ' 138' ' ' ILE . 11.1 mt -70.14 -38.76 75.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 70.340000000000003 110.926 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.39 -127.17 1.7 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.76 -0.733 . . . . 72.019999999999996 112.534 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.49 138.37 54.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.856 0.36 . . . . 75.219999999999999 110.851 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.561 HG21 HG13 ' A' ' 10' ' ' ILE . 1.4 t -145.04 100.05 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 64.129999999999995 111.083 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -108.78 175.24 5.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 53.310000000000002 110.885 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.454 ' N ' ' OG ' ' A' ' 21' ' ' SER . 1.8 m-85 -146.23 137.2 24.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 74.409999999999997 110.827 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.406 ' HB2' ' CE ' ' A' ' 133' ' ' LYS . 16.2 tt0 -92.12 101.55 14.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 71.299999999999997 110.892 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.7 mt -83.15 119.06 24.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 63.240000000000002 110.939 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.432 ' CD1' HD13 ' A' ' 90' ' ' LEU . 58.3 m-85 -76.55 65.68 2.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 74.120000000000005 110.88 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.7 -22.77 25.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 44.130000000000003 111.099 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -65.87 -33.94 76.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 71.049999999999997 110.881 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -101.56 -29.19 12.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 51.439999999999998 110.887 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.416 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -135.22 65.73 64.65 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.594 0.712 . . . . 72.430000000000007 111.107 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -34.92 13.54 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.65 2.234 . . . . 73.310000000000002 112.37 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -39.55 91.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 75.540000000000006 110.909 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.5 m -87.96 -40.4 13.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 72.439999999999998 111.139 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.4 95.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 73.129999999999995 111.061 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -51.75 -35.78 44.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 65.140000000000001 110.87 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -61.37 -54.53 42.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 45.240000000000002 110.874 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -65.76 -45.65 81.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 73.450000000000003 110.879 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.97 -38.7 86.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 72.430000000000007 110.828 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.36 -44.28 97.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 61.240000000000002 111.093 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.5 mt -74.03 -47.21 38.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 62.100000000000001 110.933 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.1 m -51.92 -44.94 64.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 60.109999999999999 110.838 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.6 p -71.75 -34.4 69.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 61.100000000000001 111.144 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.59 -6.41 41.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.738 -0.744 . . . . 71.040000000000006 112.462 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.75 -25.09 17.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 54.43 110.856 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.582 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -65.63 -32.97 74.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 60.210000000000001 110.897 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.54 -28.88 4.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 73.310000000000002 112.487 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -141.51 -39.97 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.885 0.374 . . . . 74.109999999999999 110.91 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.13 -163.91 52.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 61.539999999999999 112.467 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.54 45.83 1.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.914 0.388 . . . . 71.140000000000001 110.937 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 74.33 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 74.150000000000006 110.865 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.67 -59.38 0.33 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 73.140000000000001 112.49 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 45.8 -163.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.774 0.321 . . . . 60.520000000000003 110.909 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.2 p 179.11 116.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 60.130000000000003 110.89 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.628 ' HE1' HD11 ' A' ' 158' ' ' ILE . 72.3 m-85 -97.37 75.35 2.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 71.420000000000002 110.867 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -73.15 -21.27 60.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 62.520000000000003 110.826 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.18 122.51 46.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 65.409999999999997 110.887 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.434 ' HB ' HG21 ' A' ' 152' ' ' THR . 29.0 mt -150.29 111.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 64.420000000000002 111.125 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.4 ' O ' HG22 ' A' ' 57' ' ' ILE . 42.8 mt -105.78 103.0 41.82 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.615 0.722 . . . . 75.430000000000007 111.179 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 83.11 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.706 2.271 . . . . 72.150000000000006 112.341 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 153.19 -20.63 0.75 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 74.340000000000003 112.525 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.21 -59.33 1.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.866 0.365 . . . . 64.329999999999998 110.859 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -178.14 175.59 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 73.140000000000001 110.866 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.4 m -120.47 -170.13 1.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 73.120000000000005 110.893 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -177.67 144.13 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 71.439999999999998 110.938 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.705 -0.76 . . . . 63.32 112.512 -179.956 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.582 HG22 ' HD2' ' A' ' 44' ' ' LYS . 1.5 pp . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.836 0.35 . . . . 65.439999999999998 111.152 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -82.89 -50.49 8.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.454 . . . . 71.299999999999997 110.884 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.76 -125.79 0.87 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.786 -0.721 . . . . 43.25 112.517 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -72.46 -33.2 66.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.885 0.374 . . . . 73.150000000000006 110.861 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.52 174.94 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 72.319999999999993 110.887 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.74 -168.52 1.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 72.109999999999999 110.85 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.28 162.67 14.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 72.230000000000004 110.902 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -54.33 115.83 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 73.299999999999997 110.881 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -93.85 -74.72 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 75.439999999999998 110.878 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -174.88 174.76 2.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 74.140000000000001 110.847 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.82 37.94 3.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 63.210000000000001 110.887 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -49.6 -30.13 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 73.310000000000002 111.131 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.432 HD13 ' CD1' ' A' ' 25' ' ' PHE . 10.1 mt -112.56 78.18 1.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.168 -0.469 . . . . 62.210000000000001 110.886 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 93' ' ' THR . 4.1 mtpt -70.55 151.55 44.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 72.140000000000001 110.864 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -49.81 102.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 72.400000000000006 110.898 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 91' ' ' LYS . 25.2 p -113.81 26.94 9.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 64.420000000000002 111.098 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.69 -177.78 24.78 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 44.420000000000002 112.54 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 174.14 9.94 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.655 2.237 . . . . 63.439999999999998 112.372 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.13 44.4 97.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 73.439999999999998 112.485 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 115' ' ' CYS . 14.0 mm -110.86 140.4 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.844 0.354 . . . . 55.329999999999998 111.122 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 98' ' ' LEU . 2.8 mt -108.29 155.68 20.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 44.039999999999999 110.943 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 6.8 t -167.29 -134.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 61.109999999999999 110.884 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 9.7 mmt -153.78 143.38 21.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 71.439999999999998 110.902 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -128.37 139.8 52.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 65.209999999999994 111.095 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 168.5 -31.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 74.299999999999997 110.858 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.732 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -175.95 -41.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 74.109999999999999 111.097 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.84 -77.47 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 70.329999999999998 112.484 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 112.0 2.96 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.636 2.224 . . . . 63.340000000000003 112.331 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.436 ' O ' HG23 ' A' ' 107' ' ' THR . 1.3 p-10 39.71 61.15 1.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 64.409999999999997 110.909 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.732 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 10.3 p -156.17 52.92 0.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 70.409999999999997 111.142 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.82 124.94 42.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 71.310000000000002 110.876 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.19 -103.48 1.97 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 73.540000000000006 112.5 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.19 30.49 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 64.319999999999993 110.858 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.633 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 6.3 mm-40 -112.5 40.48 2.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 72.549999999999997 110.933 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' A' ' 99' ' ' SER . 5.7 p90 -58.21 -170.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 73.010000000000005 110.89 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -148.58 146.54 28.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 74.450000000000003 110.895 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.45 HG21 HG13 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -74.79 -15.3 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 74.219999999999999 111.119 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER 49.17 93.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 52.0 110.913 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.549 HG22 ' CG1' ' A' ' 139' ' ' VAL . 82.3 p -91.17 26.75 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 62.329999999999998 111.118 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.621 ' O ' HG23 ' A' ' 119' ' ' THR . . . 178.26 151.76 0.28 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 62.009999999999998 111.129 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.74 97.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 44.299999999999997 110.881 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.699 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 26.5 p -104.11 46.5 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 52.310000000000002 111.148 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -25.38 68.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 71.030000000000001 110.842 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.699 ' CZ2' HG22 ' A' ' 119' ' ' THR . 5.4 p90 -47.32 -28.61 2.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.155 -0.475 . . . . 75.230000000000004 110.938 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.6 mt -46.74 -32.82 3.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 64.209999999999994 110.865 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 62.52 77.44 0.33 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 72.040000000000006 110.869 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 36.54 43.43 0.77 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 60.240000000000002 112.45 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -80.85 -13.6 58.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 74.140000000000001 110.916 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -144.05 -169.15 3.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 110.859 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.1 t -120.69 117.39 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 72.340000000000003 111.173 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 98' ' ' LEU . 2.6 t -88.83 134.14 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 72.150000000000006 111.119 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.445 ' O ' HD23 ' A' ' 24' ' ' LEU . 19.9 p90 -156.09 37.6 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 74.430000000000007 110.839 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -175.4 173.55 46.3 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.772 -0.728 . . . . 70.200000000000003 112.486 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 8.0 pttt -175.59 139.3 0.42 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.797 0.332 . . . . 75.340000000000003 110.926 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.654 HG11 ' HG2' ' A' ' 136' ' ' MET . 55.1 t -41.17 110.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 73.129999999999995 111.132 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.406 ' CE ' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -73.0 -59.29 2.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 71.109999999999999 110.868 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -152.12 157.14 41.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 42.130000000000003 110.897 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.09 35.54 17.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.742 . . . . 32.439999999999998 112.508 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.654 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -56.13 -31.38 63.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.751 0.31 . . . . 71.239999999999995 110.909 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.59 -30.23 20.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 71.040000000000006 110.887 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.443 HG21 ' CG2' ' A' ' 20' ' ' VAL . 41.4 mm -66.27 -41.29 88.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 75.430000000000007 111.092 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.549 ' CG1' HG22 ' A' ' 116' ' ' THR . 59.1 t -62.02 -28.29 44.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 53.240000000000002 111.152 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -79.34 -28.64 42.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 64.040000000000006 110.857 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.32 -38.46 63.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 35.5 111.112 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.569 ' SD ' HG21 ' A' ' 156' ' ' ILE . 28.6 mtm -59.78 -51.8 68.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 72.109999999999999 110.894 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.02 -24.69 25.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 73.120000000000005 110.903 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.43 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -72.71 -24.11 60.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 73.230000000000004 110.925 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.43 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 62.1 m-85 -108.27 16.86 22.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 65.510000000000005 110.879 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.98 178.66 17.62 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 61.229999999999997 112.491 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -141.3 132.59 26.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 45.25 110.865 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -64.58 84.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 62.509999999999998 110.855 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 179.74 -33.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 71.299999999999997 110.865 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.21 -92.49 0.15 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.8 -0.714 . . . . 73.010000000000005 112.488 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -51.17 156.53 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 73.310000000000002 110.895 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.434 HG21 ' HB ' ' A' ' 56' ' ' ILE . 39.1 p -131.66 156.02 46.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 111.145 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.63 -35.21 78.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 73.129999999999995 110.863 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.467 ' HG2' HG12 ' A' ' 12' ' ' VAL . 2.1 mttp -101.23 -179.59 4.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 75.519999999999996 110.859 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.8 104.55 7.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 62.409999999999997 110.846 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.841 HG23 HG23 ' A' ' 10' ' ' ILE . 4.8 mp -90.63 105.56 16.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 71.109999999999999 111.081 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.95 166.02 13.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 70.299999999999997 111.132 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.628 HD11 ' HE1' ' A' ' 53' ' ' PHE . 6.5 mm -98.4 119.51 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 72.319999999999993 111.118 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -82.96 -50.56 8.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 65.129999999999995 111.117 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -142.81 155.58 44.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 73.040000000000006 110.862 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -163.44 148.87 11.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 73.319999999999993 110.89 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 172.96 167.64 33.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.783 -0.722 . . . . 55.219999999999999 112.511 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -61.83 134.8 57.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.789 0.328 . . . . 61.420000000000002 110.927 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.577 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -85.7 -59.3 2.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 74.129999999999995 110.938 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 75.129999999999995 110.855 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.822 0.344 . . . . 74.5 111.162 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.46 142.96 29.58 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 74.409999999999997 110.889 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 146.84 61.47 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.687 2.258 . . . . 65.109999999999999 112.356 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -129.52 135.66 48.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 74.420000000000002 111.167 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -133.13 160.56 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 61.350000000000001 111.122 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 1.7 p90 -143.36 -179.29 6.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 73.409999999999997 110.879 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -155.89 92.99 1.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 74.230000000000004 110.896 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.58 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.8 OUTLIER -44.05 104.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 74.540000000000006 110.925 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.672 HG22 HD12 ' A' ' 17' ' ' LEU . 26.1 mm -77.18 134.79 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 73.329999999999998 111.083 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -127.66 154.12 45.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 43.329999999999998 111.068 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.53 HG13 ' HB3' ' A' ' 154' ' ' LYS . 33.2 t -134.02 95.91 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 64.340000000000003 111.106 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.37 31.52 10.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 71.329999999999998 110.861 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.63 -23.39 34.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.788 -0.72 . . . . 74.530000000000001 112.471 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -92.25 115.09 64.1 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.607 0.718 . . . . 60.039999999999999 110.891 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.9 Cg_endo -69.73 123.0 9.69 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.69 2.26 . . . . 75.400000000000006 112.374 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.672 HD12 HG22 ' A' ' 10' ' ' ILE . 13.1 mt -66.66 -38.66 87.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 73.230000000000004 110.909 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.65 -122.95 1.19 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.756 -0.735 . . . . 42.109999999999999 112.458 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.05 141.13 46.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 73.329999999999998 110.91 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.539 HG21 HG13 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -143.53 103.99 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 55.450000000000003 111.136 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.8 t -110.28 172.95 6.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 71.099999999999994 110.834 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.418 ' N ' ' OG ' ' A' ' 21' ' ' SER . 10.1 m-85 -146.29 131.61 18.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 73.140000000000001 110.906 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -85.98 98.07 10.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 61.310000000000002 110.884 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 129' ' ' PHE . 3.6 mt -83.12 136.39 34.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 73.299999999999997 110.888 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -96.27 63.75 2.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 65.209999999999994 110.85 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.19 -24.02 16.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 71.519999999999996 111.072 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.36 -31.19 70.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 74.209999999999994 110.887 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.5 -27.07 13.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 73.319999999999993 110.831 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.451 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -136.61 63.52 47.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.577 0.703 . . . . 71.239999999999995 111.088 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -41.82 3.89 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.679 2.253 . . . . 73.030000000000001 112.354 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -55.32 -37.46 67.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 73.409999999999997 110.922 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.424 HG21 ' CD1' ' A' ' 129' ' ' PHE . 16.0 m -89.19 -53.36 4.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 62.530000000000001 111.141 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.26 -36.37 41.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 44.399999999999999 111.123 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -49.74 -32.35 13.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 72.219999999999999 110.876 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.46 ' ND2' HG12 ' A' ' 78' ' ' ILE . 3.5 t-20 -66.48 -63.84 0.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 75.040000000000006 110.926 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.37 -34.29 68.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 74.519999999999996 110.893 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.5 ' HE ' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -65.05 -49.48 69.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.487 . . . . 70.310000000000002 110.871 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.87 -31.46 72.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 70.120000000000005 111.113 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.9 mt -75.43 -55.95 5.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 62.350000000000001 110.96 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.0 m -49.37 -48.92 46.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 71.120000000000005 110.873 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.5 HG23 ' HE ' ' A' ' 37' ' ' ARG . 17.2 p -69.05 -28.08 66.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 71.340000000000003 111.132 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.3 -14.51 65.16 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.728 . . . . 75.540000000000006 112.459 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -52.29 -25.29 9.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 73.239999999999995 110.938 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.785 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -50.3 -28.26 7.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 75.140000000000001 110.868 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.69 -26.08 4.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.766 -0.731 . . . . 43.420000000000002 112.501 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -165.45 -47.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 74.420000000000002 110.849 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.61 177.72 0.38 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.774 -0.727 . . . . 61.409999999999997 112.488 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -94.7 26.71 3.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.004 0.43 . . . . 75.099999999999994 110.919 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.19 126.92 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 73.120000000000005 110.902 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.18 39.6 92.47 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.763 -0.732 . . . . 73.109999999999999 112.484 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -92.02 -178.66 5.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.888 0.375 . . . . 73.219999999999999 110.853 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 22.6 m -117.73 153.39 33.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 73.0 110.891 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -101.61 143.54 31.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 71.140000000000001 110.888 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -145.25 45.01 1.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 73.540000000000006 110.827 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -171.38 70.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 72.140000000000001 110.885 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 56' ' ' ILE . 11.2 mt -117.39 109.46 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 71.519999999999996 111.091 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.6 mt -106.82 102.67 43.51 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.65 0.738 . . . . 71.430000000000007 111.148 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.5 Cg_endo -69.82 79.67 0.95 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.683 2.255 . . . . 73.010000000000005 112.309 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.19 -25.62 0.54 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 73.120000000000005 112.491 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.43 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.3 OUTLIER -117.95 -59.17 1.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.332 . . . . 74.510000000000005 110.865 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.43 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.2 OUTLIER 176.91 162.63 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 75.340000000000003 110.815 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.9 m -104.59 -169.05 1.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 110.909 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -178.72 146.91 0.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 75.420000000000002 110.939 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.728 . . . . 71.239999999999995 112.472 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.785 HG22 ' HD2' ' A' ' 44' ' ' LYS . 3.9 pt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.857 0.361 . . . . 45.210000000000001 111.144 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -135.42 -67.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 63.340000000000003 110.933 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.16 -142.65 3.49 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 60.399999999999999 112.517 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -50.23 -32.94 17.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.856 0.36 . . . . 74.299999999999997 110.889 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.427 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.69 -175.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 60.32 110.883 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -147.32 161.01 41.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 72.200000000000003 110.871 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -60.73 166.0 3.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 65.510000000000005 110.899 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -82.12 174.94 10.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 75.519999999999996 110.852 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -120.09 -76.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 73.019999999999996 110.871 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.5 p30 -158.89 176.04 12.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 74.010000000000005 110.89 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.03 37.66 3.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 75.430000000000007 110.844 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.54 -30.08 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 71.030000000000001 111.141 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 20.9 mt -109.99 82.56 1.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 65.310000000000002 110.92 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.93 150.48 46.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 63.219999999999999 110.875 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -58.03 97.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.5 110.841 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.0 p -104.06 24.09 11.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 53.25 111.122 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 147.19 -178.89 24.52 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.739 -0.743 . . . . 70.25 112.5 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 172.62 12.33 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.651 2.234 . . . . 75.25 112.327 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.92 29.56 72.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 75.450000000000003 112.473 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.5 mm -103.07 139.97 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.877 0.37 . . . . 54.32 111.119 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.48 HD21 ' CD2' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -108.86 145.97 34.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 65.230000000000004 110.935 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.95 -167.99 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 53.409999999999997 110.891 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.579 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -98.38 113.71 25.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 74.400000000000006 110.859 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.886 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -94.03 130.45 40.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 62.109999999999999 111.077 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.562 ' CG ' ' HA3' ' A' ' 109' ' ' GLY . 0.6 OUTLIER 175.5 -70.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 65.219999999999999 110.915 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.833 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -146.85 -50.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 70.140000000000001 111.07 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.35 -70.27 0.51 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.759 -0.734 . . . . 71.439999999999998 112.522 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 110.23 2.5 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.672 2.248 . . . . 71.030000000000001 112.358 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 39.52 45.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 71.109999999999999 110.865 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.833 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 22.1 p -153.77 53.33 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 65.340000000000003 111.164 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -50.43 -37.16 36.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 73.209999999999994 110.909 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.562 ' HA3' ' CG ' ' A' ' 102' ' ' ASN . . . 77.34 -56.39 3.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 72.099999999999994 112.484 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.579 ' HA ' ' HE2' ' A' ' 100' ' ' MET . 1.0 OUTLIER 85.73 41.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 54.32 110.839 -179.731 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 25.5 mm-40 -104.45 -14.91 15.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 75.239999999999995 110.925 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.566 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER 72.91 150.94 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.540000000000006 110.876 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.886 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -159.23 131.11 6.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 73.340000000000003 110.849 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 mt -87.85 126.93 41.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 73.530000000000001 111.139 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.94 101.02 13.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.349999999999994 110.823 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 68.4 p -86.24 20.45 2.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 74.349999999999994 111.101 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.718 ' O ' HG23 ' A' ' 119' ' ' THR . . . 176.25 146.21 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 74.5 111.071 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -56.01 94.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 62.520000000000003 110.926 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.811 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 33.8 p -100.7 56.64 0.89 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 54.450000000000003 111.126 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.04 -26.17 67.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 75.109999999999999 110.904 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.811 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.8 p90 -49.17 -26.4 2.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 71.530000000000001 110.908 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.7 mt -45.83 -34.16 3.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.26 -0.427 . . . . 75.219999999999999 110.926 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.6 m-20 61.93 72.5 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 71.200000000000003 110.916 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.65 42.74 0.71 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.691 -0.766 . . . . 75.109999999999999 112.519 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.78 -28.47 36.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 63.200000000000003 110.885 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -124.83 -173.22 2.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 75.109999999999999 110.845 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.11 116.86 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 60.219999999999999 111.143 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.34 135.03 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 35.149999999999999 111.137 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.485 ' O ' HD23 ' A' ' 24' ' ' LEU . 16.4 p90 -160.79 34.82 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 65.230000000000004 110.872 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -172.49 176.39 45.43 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.764 -0.731 . . . . 53.119999999999997 112.497 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -174.14 136.98 0.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.803 0.335 . . . . 65.019999999999996 110.905 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.664 HG11 ' HG2' ' A' ' 136' ' ' MET . 79.6 t -40.95 108.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 73.439999999999998 111.159 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -57.96 4.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 72.120000000000005 110.921 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -157.18 156.83 33.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.540000000000006 110.893 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.07 32.61 16.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.789 -0.719 . . . . 61.130000000000003 112.505 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.664 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -55.89 -26.22 46.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 74.540000000000006 110.888 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -32.39 59.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 55.140000000000001 110.867 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.603 HD12 ' HB3' ' A' ' 17' ' ' LEU . 40.1 mm -65.29 -37.06 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 72.219999999999999 111.126 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.1 t -66.31 -28.19 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 72.319999999999993 111.104 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.21 -28.64 38.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 72.519999999999996 110.901 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.99 -40.0 60.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 54.210000000000001 111.112 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 34.6 mtm -61.27 -53.1 61.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 74.140000000000001 110.908 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.448 ' OE1' HG23 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -54.87 -24.73 24.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 75.109999999999999 110.896 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.43 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.66 -24.31 61.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 73.430000000000007 110.857 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.43 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 64.0 m-85 -107.7 13.94 26.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 73.019999999999996 110.878 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.1 169.08 13.64 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.732 -0.746 . . . . 72.549999999999997 112.482 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.5 p -114.08 146.71 39.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 72.310000000000002 110.859 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -73.73 72.92 1.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 73.430000000000007 110.888 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -179.53 -34.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 73.329999999999998 110.886 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 154.5 -61.3 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.775 -0.726 . . . . 74.140000000000001 112.516 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -58.31 174.37 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.35 . . . . 52.219999999999999 110.918 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.6 p -146.49 179.84 7.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 75.319999999999993 111.133 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.51 -65.19 1.03 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 40.030000000000001 110.872 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.53 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -78.96 -175.7 4.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 75.109999999999999 110.881 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -115.07 107.06 14.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 71.349999999999994 110.874 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.41 HG23 HG23 ' A' ' 10' ' ' ILE . 4.0 mp -84.85 111.36 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 71.400000000000006 111.162 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.49 165.48 17.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 72.140000000000001 111.161 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.3 mt -104.44 127.78 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 74.340000000000003 111.111 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.58 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -88.77 -50.38 6.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 41.43 111.085 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -148.73 150.86 33.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 63.149999999999999 110.907 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -156.87 149.54 23.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 73.530000000000001 110.835 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 164.49 170.5 29.51 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.809 -0.71 . . . . 53.119999999999997 112.535 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.28 127.53 27.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.808 0.337 . . . . 73.099999999999994 110.921 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.55 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.0 mm? -78.31 -47.7 17.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 72.219999999999999 110.974 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 53.109999999999999 110.929 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.6 t . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.809 0.338 . . . . 44.299999999999997 111.172 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -111.81 146.8 35.49 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.613 0.721 . . . . 74.319999999999993 110.899 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 146.1 58.67 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.64 2.227 . . . . 64.230000000000004 112.37 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -133.94 140.76 46.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 65.310000000000002 111.135 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.495 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.7 m -134.97 142.24 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 74.530000000000001 111.142 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 11.7 p90 -102.7 170.88 7.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 74.510000000000005 110.917 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.409 ' HA ' ' HB3' ' A' ' 161' ' ' CYS . 6.9 m-85 -151.18 88.51 1.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 74.140000000000001 110.888 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.644 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 3.0 t70 -50.08 105.6 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 72.319999999999993 110.869 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.683 HG22 HD12 ' A' ' 17' ' ' LEU . 35.9 mm -84.97 122.12 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 62.100000000000001 111.123 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -113.76 150.99 32.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 72.120000000000005 111.097 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.433 HG13 ' HB3' ' A' ' 154' ' ' LYS . 21.1 t -132.39 95.9 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 74.129999999999995 111.119 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.66 33.97 8.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 63.049999999999997 110.896 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.47 -19.13 55.91 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.719 -0.753 . . . . 71.349999999999994 112.516 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -97.01 113.23 62.66 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.629 0.728 . . . . 72.120000000000005 110.896 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.72 126.5 13.41 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.72 2.28 . . . . 71.340000000000003 112.322 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.683 HD12 HG22 ' A' ' 10' ' ' ILE . 13.6 mt -69.18 -40.02 78.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.439 . . . . 44.219999999999999 110.899 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.7 -125.51 1.61 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.785 -0.721 . . . . 55.100000000000001 112.542 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -123.36 135.91 54.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 72.420000000000002 110.874 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.509 HG21 HG13 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -146.64 103.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 72.209999999999994 111.093 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.5 t -113.47 174.59 5.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 53.200000000000003 110.881 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.439 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -145.3 126.14 14.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 75.540000000000006 110.906 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -80.59 100.0 8.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 73.549999999999997 110.862 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.463 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 1.4 mt -83.14 120.4 25.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 73.510000000000005 110.916 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -75.94 68.29 2.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 72.310000000000002 110.899 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.2 -22.73 42.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 50.340000000000003 111.088 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -67.24 -36.72 82.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 75.120000000000005 110.885 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -97.19 -27.28 14.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 72.239999999999995 110.86 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.426 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -138.92 67.24 41.43 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.6 0.714 . . . . 73.310000000000002 111.146 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -36.05 11.39 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.673 2.249 . . . . 64.310000000000002 112.314 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.57 -37.75 82.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 75.239999999999995 110.86 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.41 HG21 ' CD1' ' A' ' 129' ' ' PHE . 58.0 m -88.85 -44.05 10.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 34.409999999999997 111.169 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.77 -46.69 89.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 70.239999999999995 111.108 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -51.03 -29.47 12.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 72.420000000000002 110.896 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -66.14 -64.64 0.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 75.5 110.891 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -59.05 -30.97 68.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 63.450000000000003 110.923 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.482 ' O ' HG23 ' A' ' 41' ' ' THR . 0.8 OUTLIER -72.54 -51.63 19.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 71.430000000000007 110.897 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.63 -33.31 68.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 73.140000000000001 111.112 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.522 HD23 ' HG2' ' A' ' 44' ' ' LYS . 31.0 mt -76.38 -51.86 11.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 75.450000000000003 110.921 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.1 m -61.66 -37.05 82.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 72.519999999999996 110.863 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 37' ' ' ARG . 26.9 p -65.81 -34.64 78.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 72.310000000000002 111.125 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.28 -15.8 53.84 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.693 -0.765 . . . . 43.240000000000002 112.489 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.89 -27.36 29.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.905 0.383 . . . . 72.010000000000005 110.899 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.522 ' HG2' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -72.91 -29.29 63.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 64.239999999999995 110.862 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.31 -15.37 60.28 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.706 -0.759 . . . . 51.299999999999997 112.451 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -157.63 -165.41 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 64.219999999999999 110.857 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.05 -136.05 5.4 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 71.299999999999997 112.507 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.49 30.61 6.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.932 0.396 . . . . 73.140000000000001 110.924 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -87.37 96.44 10.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 70.239999999999995 110.945 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 134.47 -38.89 1.77 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.762 -0.733 . . . . 71.519999999999996 112.44 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.13 -169.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 63.240000000000002 110.848 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.9 p -141.73 175.5 9.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 63.229999999999997 110.87 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.444 ' CZ ' HD11 ' A' ' 158' ' ' ILE . 9.4 m-85 -107.55 142.72 37.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 75.319999999999993 110.897 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -143.46 45.89 1.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 74.140000000000001 110.827 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -161.98 60.83 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 75.310000000000002 110.889 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 19.0 mt -104.21 108.86 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 73.030000000000001 111.127 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.6 mt -102.0 101.7 20.08 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.635 0.731 . . . . 72.129999999999995 111.126 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 89.85 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.245 . . . . 75.310000000000002 112.377 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.83 -17.6 1.99 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 42.329999999999998 112.497 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.58 -53.11 1.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 74.099999999999994 110.834 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.413 ' HB3' ' HA ' ' A' ' 115' ' ' CYS . 0.0 OUTLIER 172.89 166.04 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.120000000000005 110.843 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 4.8 m -101.33 -173.35 2.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 70.140000000000001 110.897 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 174.1 150.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 72.349999999999994 110.941 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.713 -0.756 . . . . 72.019999999999996 112.506 179.993 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.501 HG13 ' CD2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.804 0.335 . . . . 64.109999999999999 111.121 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.501 ' CD2' HG13 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -164.59 37.82 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 74.230000000000004 110.922 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.15 149.79 6.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.712 -0.756 . . . . 63.219999999999999 112.481 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -44.47 -33.53 1.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 63.109999999999999 110.876 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.465 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.73 166.08 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 63.439999999999998 110.874 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -132.13 177.17 7.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 75.450000000000003 110.873 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.08 157.15 28.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 73.420000000000002 110.876 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -49.94 153.75 1.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 74.219999999999999 110.852 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -104.41 -76.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.457 . . . . 73.319999999999993 110.903 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.467 ' O ' HG22 ' A' ' 127' ' ' VAL . 47.4 p30 -159.32 177.45 10.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 61.439999999999998 110.917 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.29 35.59 3.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 63.299999999999997 110.895 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.65 -31.86 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 75.400000000000006 111.097 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 mt -102.79 101.79 11.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 72.030000000000001 110.884 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.671 ' O ' HG23 ' A' ' 93' ' ' THR . 1.6 mtpt -90.93 138.79 31.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 74.5 110.899 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -47.35 105.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 73.510000000000005 110.876 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.671 HG23 ' O ' ' A' ' 91' ' ' LYS . 43.8 p -114.95 30.04 7.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 65.439999999999998 111.134 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 144.68 176.45 18.7 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 53.32 112.507 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 178.01 5.0 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.663 2.242 . . . . 55.109999999999999 112.347 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.82 21.81 63.65 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 71.530000000000001 112.514 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.0 mm -91.75 140.37 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 74.019999999999996 111.125 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -109.64 149.1 30.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 72.120000000000005 110.926 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.68 -164.55 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 72.239999999999995 110.892 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.596 ' HE2' ' HB ' ' A' ' 127' ' ' VAL . 2.0 mtm -98.71 96.6 8.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 74.400000000000006 110.892 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -72.45 62.09 0.51 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 51.530000000000001 111.105 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.405 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 8.7 p-10 -125.15 -158.3 0.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 73.340000000000003 110.875 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.662 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -76.39 53.25 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 62.109999999999999 111.079 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.19 -106.07 0.14 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.713 -0.756 . . . . 62.229999999999997 112.509 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 116.65 4.66 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.707 2.271 . . . . 73.25 112.361 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.489 ' C ' HG23 ' A' ' 107' ' ' THR . 1.1 m-20 66.52 174.13 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 70.120000000000005 110.901 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.662 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.3 p 67.69 32.98 5.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 73.420000000000002 111.15 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.96 146.22 31.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 62.43 110.93 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -148.35 53.79 0.52 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 54.520000000000003 112.46 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.0 t 68.83 33.79 3.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 74.230000000000004 110.869 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -59.89 -168.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 74.299999999999997 110.933 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.436 ' HE2' HD12 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -175.72 155.42 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 73.329999999999998 110.912 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -168.53 68.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 71.340000000000003 110.879 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 113' ' ' PHE . 6.9 mt -33.73 107.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 65.219999999999999 111.164 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.413 ' HA ' ' HB3' ' A' ' 61' ' ' MET . 33.6 m -84.6 139.23 32.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 63.5 110.899 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.1 p -105.01 27.12 8.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.172 -0.467 . . . . 72.219999999999999 111.17 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.665 ' O ' HG23 ' A' ' 119' ' ' THR . . . 178.65 142.94 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 71.049999999999997 111.094 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -52.36 98.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 55.229999999999997 110.888 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.709 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 33.9 p -96.13 44.78 1.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 72.420000000000002 111.197 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -26.54 65.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 70.329999999999998 110.925 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.709 ' CZ2' HG22 ' A' ' 119' ' ' THR . 7.3 p90 -49.68 -27.42 4.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.129 -0.487 . . . . 64.519999999999996 110.943 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 23.6 mt -47.02 -34.71 5.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 61.119999999999997 110.9 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 61.4 77.95 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 71.409999999999997 110.846 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 39.11 44.42 2.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.724 . . . . 52.399999999999999 112.436 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -81.69 -25.56 35.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 72.120000000000005 110.903 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -136.34 -169.35 2.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.848 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.596 ' HB ' ' HE2' ' A' ' 100' ' ' MET . 79.4 t -123.79 112.25 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 111.158 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.5 t -79.95 131.04 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 71.209999999999994 111.138 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.459 ' O ' HD23 ' A' ' 24' ' ' LEU . 30.5 p90 -150.26 37.39 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 75.25 110.909 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -175.13 173.57 46.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.707 -0.759 . . . . 70.340000000000003 112.46 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 132' ' ' VAL . 6.6 pttp -175.9 134.3 0.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 73.099999999999994 110.915 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.761 HG11 ' HG2' ' A' ' 136' ' ' MET . 54.0 t -37.02 105.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 111.127 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -59.31 3.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 63.299999999999997 110.921 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -154.84 158.65 39.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 110.893 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.29 36.3 15.06 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.731 -0.747 . . . . 73.230000000000004 112.5 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.761 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -55.33 -25.23 33.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 74.030000000000001 110.87 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.16 -34.19 65.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 75.409999999999997 110.866 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.547 HD12 ' HB3' ' A' ' 17' ' ' LEU . 37.9 mm -66.31 -40.02 85.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 64.409999999999997 111.139 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.2 t -63.67 -27.59 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 74.450000000000003 111.145 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.57 -30.1 52.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 51.140000000000001 110.926 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.01 -45.94 59.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 73.109999999999999 111.135 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.3 mtm -57.75 -42.02 83.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 62.530000000000001 110.875 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -53.77 -27.53 29.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 73.230000000000004 110.918 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -28.9 52.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 73.310000000000002 110.917 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -100.2 29.38 4.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 72.230000000000004 110.921 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.18 155.66 16.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.752 -0.737 . . . . 61.130000000000003 112.477 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.7 t -110.65 149.81 29.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 35.43 110.872 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -76.05 59.83 1.35 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 72.230000000000004 110.873 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -176.72 -34.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 74.310000000000002 110.889 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.83 -43.23 0.76 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 50.409999999999997 112.485 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.75 165.04 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 72.209999999999994 110.89 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 27.7 p -147.82 149.21 31.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 75.109999999999999 111.129 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.9 m -69.82 -46.08 66.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 63.439999999999998 110.828 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.433 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -104.12 -176.22 3.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.082 -0.508 . . . . 74.030000000000001 110.904 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -115.09 107.95 16.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 73.409999999999997 110.928 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.98 122.12 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 70.230000000000004 111.114 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.89 168.43 18.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 30.52 111.159 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.444 HD11 ' CZ ' ' A' ' 53' ' ' PHE . 41.0 mm -105.43 114.22 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 42.210000000000001 111.084 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -73.58 -47.8 37.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 35.329999999999998 111.122 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -157.44 160.23 38.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.230000000000004 110.849 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -164.05 146.09 9.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 62.210000000000001 110.875 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.95 173.18 44.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 73.310000000000002 112.493 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -63.7 139.55 58.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 65.120000000000005 110.902 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.553 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -92.18 -56.84 2.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 74.209999999999994 110.901 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 72.349999999999994 110.901 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.826 0.346 . . . . 75.329999999999998 111.156 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -51.65 152.66 4.7 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 73.019999999999996 110.905 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 146.03 58.89 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.732 2.288 . . . . 51.210000000000001 112.327 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -135.22 141.69 45.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 73.030000000000001 111.159 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.481 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.5 m -134.48 143.8 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 73.329999999999998 111.101 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 19.0 p90 -102.03 160.77 14.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 65.209999999999994 110.856 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -140.42 95.51 2.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 71.439999999999998 110.936 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.6 t70 -58.77 113.84 2.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 65.25 110.847 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.874 HG23 HG23 ' A' ' 156' ' ' ILE . 14.8 mm -86.05 124.45 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 73.540000000000006 111.112 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -117.25 123.28 46.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 72.219999999999999 111.085 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.661 HG23 HD13 ' A' ' 17' ' ' LEU . 11.5 t -106.6 94.51 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 62.32 111.162 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 62.18 44.56 7.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 72.519999999999996 110.857 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.6 -1.58 88.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 73.120000000000005 112.523 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 8.5 mm-40 -110.05 98.68 35.9 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.627 0.727 . . . . 71.299999999999997 110.896 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.4 Cg_endo -69.81 103.98 1.26 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.737 2.292 . . . . 43.340000000000003 112.31 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.661 HD13 HG23 ' A' ' 12' ' ' VAL . 7.7 mp -65.74 -34.95 79.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 64.140000000000001 110.856 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.76 -143.09 7.94 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 63.130000000000003 112.484 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.08 154.06 47.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 71.209999999999994 110.838 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.441 HG21 HG13 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -144.91 97.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 62.25 111.094 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -91.2 172.46 8.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 74.340000000000003 110.832 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.404 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -145.6 123.48 11.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 74.150000000000006 110.89 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.418 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 23.4 tt0 -73.7 97.48 2.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 62.210000000000001 110.857 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.7 mt -85.09 118.17 24.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 60.439999999999998 110.882 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.423 ' CD1' HD13 ' A' ' 90' ' ' LEU . 52.5 m-85 -79.38 68.98 5.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 73.209999999999994 110.887 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.62 -22.22 21.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 72.010000000000005 111.122 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -69.59 -28.35 65.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 32.240000000000002 110.871 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.91 -29.57 11.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 110.927 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.416 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -139.18 66.42 38.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.62 0.724 . . . . 73.349999999999994 111.122 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -35.21 13.17 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.698 2.265 . . . . 73.010000000000005 112.332 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.86 -36.41 72.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 71.200000000000003 110.895 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.402 HG22 ' CE2' ' A' ' 129' ' ' PHE . 63.5 m -94.22 -43.02 8.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 75.209999999999994 111.139 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.33 91.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.415 . . . . 73.25 111.085 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -50.42 -35.53 28.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 74.140000000000001 110.873 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -64.54 -64.19 0.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 110.926 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -56.35 -34.15 66.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 75.439999999999998 110.913 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.517 ' O ' HG23 ' A' ' 41' ' ' THR . 0.3 OUTLIER -69.87 -53.26 18.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 72.439999999999998 110.904 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 44' ' ' LYS . . . -56.74 -35.42 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 55.219999999999999 111.125 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.7 mt -72.09 -58.68 3.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 73.150000000000006 110.941 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.9 m -51.4 -41.01 60.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 72.400000000000006 110.877 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 37' ' ' ARG . 63.9 p -72.23 -28.31 63.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 74.120000000000005 111.138 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.64 12.75 71.56 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 72.230000000000004 112.465 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.39 -18.42 49.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 73.409999999999997 110.861 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.572 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -90.98 29.78 1.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 75.329999999999998 110.867 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.04 -22.92 16.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.759 -0.734 . . . . 75.319999999999993 112.491 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -179.02 -169.53 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 35.420000000000002 110.914 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.4 -135.84 2.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.801 -0.714 . . . . 72.439999999999998 112.547 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.83 57.49 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.937 0.399 . . . . 74.409999999999997 110.951 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -87.17 48.8 1.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 64.400000000000006 110.876 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 174.48 54.7 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 63.340000000000003 112.492 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.83 131.14 46.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.869 0.366 . . . . 74.409999999999997 110.82 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.8 p -96.69 121.26 38.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 61.340000000000003 110.912 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -80.99 117.21 21.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 73.340000000000003 110.87 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -114.03 29.75 7.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 74.109999999999999 110.874 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.54 91.6 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 54.240000000000002 110.849 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.471 ' O ' HG22 ' A' ' 56' ' ' ILE . 3.1 mt -128.68 116.29 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 63.439999999999998 111.166 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.2 mt -107.89 104.47 53.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.567 0.699 . . . . 74.450000000000003 111.169 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 79.47 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.7 2.267 . . . . 70.209999999999994 112.332 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.7 -24.42 0.56 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.707 -0.759 . . . . 54.450000000000003 112.515 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.64 -58.98 1.97 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.86 0.362 . . . . 55.25 110.848 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.33 157.28 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 61.299999999999997 110.906 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.418 ' HB3' HG12 ' A' ' 56' ' ' ILE . 34.7 m -90.7 -167.31 1.79 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 63.420000000000002 110.865 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 174.69 142.09 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 62.350000000000001 110.937 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 74.209999999999994 112.469 -179.928 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.559 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.7 pp . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.866 0.365 . . . . 53.130000000000003 111.119 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.85 -65.44 1.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 72.209999999999994 110.952 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.82 -33.17 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 43.030000000000001 112.486 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -141.11 -54.92 0.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.93 0.395 . . . . 71.239999999999995 110.908 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.19 -177.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 71.340000000000003 110.895 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.89 -167.67 1.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.439999999999998 110.872 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -133.37 162.76 30.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 71.319999999999993 110.871 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -47.76 104.34 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 74.239999999999995 110.854 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -80.79 -67.38 0.78 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 75.340000000000003 110.882 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -177.68 173.45 1.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 110.92 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.19 35.54 4.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 74.109999999999999 110.885 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -49.94 -28.91 4.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 74.439999999999998 111.153 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.423 HD13 ' CD1' ' A' ' 25' ' ' PHE . 16.0 mt -117.38 68.69 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 74.239999999999995 110.854 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -62.28 166.53 4.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 73.450000000000003 110.863 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -68.72 83.67 0.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 64.510000000000005 110.832 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.4 p -99.86 24.54 8.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 72.510000000000005 111.12 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 155.65 177.47 28.91 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.782 -0.723 . . . . 70.120000000000005 112.496 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 170.13 17.29 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.704 2.269 . . . . 45.210000000000001 112.354 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.12 40.04 96.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 61.530000000000001 112.474 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.3 mm -108.9 136.06 45.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.832 0.348 . . . . 74.510000000000005 111.144 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.505 HD21 ' CD1' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -103.62 157.39 17.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.446 . . . . 72.25 110.899 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 3.6 t -162.19 -139.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 41.049999999999997 110.883 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 13.7 mmt -152.91 147.42 25.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 72.430000000000007 110.853 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -123.19 151.34 42.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 75.310000000000002 111.074 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 167.71 -50.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 74.450000000000003 110.915 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -174.63 29.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 73.019999999999996 111.136 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.55 -116.66 4.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 31.440000000000001 112.472 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 125.09 11.76 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.661 2.241 . . . . 65.400000000000006 112.355 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.488 ' C ' HG23 ' A' ' 107' ' ' THR . 1.3 m-20 70.54 165.76 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 73.030000000000001 110.888 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.488 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.3 p 67.13 29.22 7.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 73.040000000000006 111.175 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -65.24 90.38 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 74.239999999999995 110.898 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -66.52 -131.78 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.743 -0.742 . . . . 72.420000000000002 112.477 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.0 p -133.23 24.2 4.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.833 0.349 . . . . 51.310000000000002 110.861 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.532 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 2.1 pt20 -106.56 55.76 0.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 75.129999999999995 110.939 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.505 ' CD1' HD21 ' A' ' 98' ' ' LEU . 4.6 p90 -58.65 -168.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 60.450000000000003 110.843 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -152.73 160.63 43.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.827 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 114' ' ' ILE . 2.4 mp -105.1 91.17 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 73.439999999999998 111.13 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.5 m -64.28 90.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 75.430000000000007 110.896 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.6 p -63.93 -12.89 41.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 65.120000000000005 111.141 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.688 ' O ' HG23 ' A' ' 119' ' ' THR . . . -143.22 156.7 44.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 62.219999999999999 111.096 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -56.41 95.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 61.509999999999998 110.892 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 117' ' ' ALA . 23.1 p -97.83 50.11 1.03 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 45.420000000000002 111.136 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -24.37 66.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 74.25 110.89 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.687 ' CZ2' HG22 ' A' ' 119' ' ' THR . 5.9 p90 -48.29 -30.49 4.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 74.099999999999994 110.933 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.5 mt -47.44 -34.65 7.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 65.120000000000005 110.922 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 124' ' ' GLY . 3.6 m-20 59.03 81.18 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 74.540000000000006 110.848 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.61 43.63 0.8 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.709 -0.758 . . . . 74.140000000000001 112.47 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -81.66 -16.64 50.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 74.549999999999997 110.871 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -144.75 -168.55 2.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 55.509999999999998 110.802 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.7 t -120.75 120.97 64.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 64.109999999999999 111.125 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 98' ' ' LEU . 20.4 t -93.26 136.15 25.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 74.349999999999994 111.112 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.481 ' O ' HD23 ' A' ' 24' ' ' LEU . 13.3 p90 -156.2 37.54 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 72.099999999999994 110.854 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -177.51 174.49 46.97 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 50.240000000000002 112.528 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 132' ' ' VAL . 5.1 pttp -172.94 132.96 0.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.347 . . . . 73.010000000000005 110.9 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.749 HG11 ' HG2' ' A' ' 136' ' ' MET . 38.2 t -36.44 107.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 45.520000000000003 111.149 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.418 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -72.27 -58.92 3.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 70.150000000000006 110.903 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -155.86 154.89 31.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 72.140000000000001 110.876 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.07 28.79 11.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 45.329999999999998 112.512 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.749 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -57.33 -24.04 52.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 63.420000000000002 110.881 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.06 -36.94 73.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 75.010000000000005 110.932 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.466 HD12 ' HB3' ' A' ' 17' ' ' LEU . 27.4 mm -67.6 -39.57 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 63.530000000000001 111.093 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.407 HG11 HG21 ' A' ' 114' ' ' ILE . 75.9 t -63.01 -29.49 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 65.129999999999995 111.083 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -74.71 -30.55 61.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 71.299999999999997 110.897 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.74 -37.98 70.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 73.219999999999999 111.09 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.576 ' SD ' HG21 ' A' ' 156' ' ' ILE . 17.5 mtm -58.71 -53.44 58.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 71.510000000000005 110.85 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.85 -26.06 32.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 73.519999999999996 110.868 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.445 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.81 -23.74 63.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 63.109999999999999 110.9 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.445 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 59.8 m-85 -109.16 17.32 21.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 72.329999999999998 110.87 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -107.7 170.33 15.31 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.796 -0.716 . . . . 72.319999999999993 112.489 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 t -134.55 142.69 47.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.899 0.381 . . . . 55.420000000000002 110.837 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -69.03 82.73 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 74.409999999999997 110.846 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -179.33 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 110.885 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.75 -84.67 0.16 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 61.450000000000003 112.506 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.68 175.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 75.409999999999997 110.877 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.6 p -143.49 168.99 18.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 72.450000000000003 111.184 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.65 -48.08 35.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 70.329999999999998 110.842 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.405 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -92.29 -179.66 5.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 71.219999999999999 110.886 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -124.51 108.32 11.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.841 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.874 HG23 HG23 ' A' ' 10' ' ' ILE . 4.8 mp -94.53 109.41 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 71.340000000000003 111.123 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.14 161.89 22.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 63.229999999999997 111.159 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.0 mm -92.85 120.07 41.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 63.539999999999999 111.134 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -86.15 -56.99 3.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 61.439999999999998 111.088 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -137.71 157.37 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 74.099999999999994 110.894 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -165.91 146.98 6.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 75.0 110.9 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.11 172.42 44.54 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 64.099999999999994 112.472 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -66.2 137.37 56.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.899 0.38 . . . . 62.509999999999998 110.871 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.564 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.3 mm? -88.76 -58.68 2.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 73.219999999999999 110.908 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 62.200000000000003 110.906 179.918 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.89 0.376 . . . . 54.329999999999998 111.125 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -87.14 144.84 36.85 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.669 0.747 . . . . 62.299999999999997 110.879 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 145.01 55.52 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.662 2.241 . . . . 70.340000000000003 112.347 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.4 m -130.95 129.75 42.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 55.119999999999997 111.14 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.07 170.56 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 73.319999999999993 111.141 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.599 ' HB3' HD21 ' A' ' 164' ' ' LEU . 1.5 p90 -153.92 179.5 8.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 75.219999999999999 110.949 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.423 ' HA ' ' HB3' ' A' ' 161' ' ' CYS . 97.9 m-85 -155.79 97.37 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 70.409999999999997 110.888 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.64 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 5.9 t0 -47.73 106.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 65.25 110.875 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.87 HG23 HG23 ' A' ' 156' ' ' ILE . 43.3 mm -79.03 124.27 37.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 62.420000000000002 111.138 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -116.65 134.87 54.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.340000000000003 111.085 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.504 HG13 ' HB3' ' A' ' 154' ' ' LYS . 5.0 t -116.49 96.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 63.009999999999998 111.11 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.57 35.52 22.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 61.240000000000002 110.85 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.36 -15.78 60.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 71.0 112.517 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.6 tt0 -103.32 108.09 57.9 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.663 0.744 . . . . 54.210000000000001 110.865 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.75 126.49 13.38 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.698 2.265 . . . . 72.209999999999994 112.39 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.1 -38.25 82.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 72.450000000000003 110.902 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.96 -138.64 5.89 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.77 -0.729 . . . . 73.439999999999998 112.53 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.94 140.36 48.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.811 0.339 . . . . 64.239999999999995 110.894 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.474 ' CG2' HG21 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -143.87 97.8 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 72.420000000000002 111.117 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 2.4 t -103.69 174.33 5.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 72.319999999999993 110.848 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.427 ' N ' ' OG ' ' A' ' 21' ' ' SER . 26.6 m-85 -148.12 132.1 17.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 74.019999999999996 110.891 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -88.08 98.79 11.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 71.340000000000003 110.889 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.5 mt -80.8 133.43 35.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 74.109999999999999 110.896 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -91.25 65.42 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 71.409999999999997 110.888 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.26 -23.58 23.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 32.439999999999998 111.119 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.77 -40.89 96.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 75.010000000000005 110.851 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -95.07 -26.8 15.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 70.519999999999996 110.906 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.442 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -137.78 67.44 50.28 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.615 0.721 . . . . 63.439999999999998 111.16 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -38.51 7.63 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.655 2.237 . . . . 44.399999999999999 112.326 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -38.99 90.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 61.210000000000001 110.925 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.7 m -84.76 -42.23 15.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 63.030000000000001 111.131 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.99 -48.46 78.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 62.299999999999997 111.076 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -53.88 -33.13 55.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 64.030000000000001 110.898 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.681 ' O ' HD12 ' A' ' 39' ' ' LEU . 1.3 t30 -60.92 -61.71 2.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 73.140000000000001 110.888 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -63.96 -41.3 97.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 70.230000000000004 110.898 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.481 ' O ' HG23 ' A' ' 41' ' ' THR . 1.1 ttp180 -63.48 -31.14 72.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 75.430000000000007 110.858 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.91 67.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 71.109999999999999 111.127 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.681 HD12 ' O ' ' A' ' 35' ' ' ASN . 1.2 mp -67.6 -36.76 81.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 62.25 110.937 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.2 m -69.02 -51.19 41.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 61.420000000000002 110.881 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 37' ' ' ARG . 73.5 p -64.88 -32.95 74.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 71.299999999999997 111.173 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.02 -13.48 55.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 71.049999999999997 112.462 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.77 -33.45 23.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.951 0.405 . . . . 72.430000000000007 110.913 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -53.45 -27.87 27.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 72.230000000000004 110.929 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.46 -5.71 80.48 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.737 -0.744 . . . . 72.439999999999998 112.484 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -168.65 -167.58 0.79 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 73.519999999999996 110.935 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.26 -137.86 6.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.705 -0.759 . . . . 24.34 112.449 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -151.54 47.15 0.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.001 0.429 . . . . 74.299999999999997 110.925 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 139.47 58.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 74.049999999999997 110.882 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.03 -22.01 39.69 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.763 -0.732 . . . . 61.140000000000001 112.482 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.45 173.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 71.540000000000006 110.854 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.509 ' HB3' HG23 ' A' ' 157' ' ' THR . 17.6 p -122.1 179.68 4.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 74.409999999999997 110.862 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -104.47 136.09 44.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 71.530000000000001 110.841 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.21 37.16 3.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 70.099999999999994 110.856 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -166.95 77.21 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 75.329999999999998 110.881 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.446 HG23 ' OE1' ' A' ' 143' ' ' GLU . 11.9 mt -120.52 111.29 31.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 44.450000000000003 111.139 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.4 mt -108.21 103.5 50.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.646 0.736 . . . . 62.030000000000001 111.135 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 54.2 Cg_endo -69.75 76.25 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 54.219999999999999 112.361 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.99 -26.77 0.25 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.722 -0.751 . . . . 73.030000000000001 112.495 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.69 -55.33 2.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.86 0.362 . . . . 74.239999999999995 110.88 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.442 ' HE3' ' O ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER 171.98 175.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 71.120000000000005 110.871 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.442 ' O ' ' HE3' ' A' ' 61' ' ' MET . 5.3 m -111.83 -168.11 1.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 72.230000000000004 110.887 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -173.15 141.98 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 110.941 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.791 -0.719 . . . . 74.530000000000001 112.45 -179.955 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.42 HG22 ' HD2' ' A' ' 44' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.878 0.371 . . . . 71.329999999999998 111.156 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -79.89 -37.48 34.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 75.150000000000006 110.912 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.95 -151.08 13.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.8 -0.714 . . . . 71.549999999999997 112.499 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -51.03 -40.14 57.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.948 0.404 . . . . 73.510000000000005 110.882 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.436 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.5 167.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 72.140000000000001 110.885 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.35 167.17 19.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 73.230000000000004 110.898 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.17 150.8 48.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 74.329999999999998 110.865 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -52.47 161.03 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 75.010000000000005 110.881 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -110.99 -70.77 0.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.858 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -170.55 173.54 5.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 63.420000000000002 110.908 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.46 37.34 3.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 74.540000000000006 110.831 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.99 -30.28 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 73.109999999999999 111.187 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.1 mt -108.79 80.01 1.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 54.140000000000001 110.888 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.65 154.06 34.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 75.239999999999995 110.901 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -64.13 88.42 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 75.409999999999997 110.831 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.1 p -78.57 -54.29 6.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 74.230000000000004 111.134 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.05 -165.94 11.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 72.430000000000007 112.468 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 177.91 5.08 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.633 2.222 . . . . 75.010000000000005 112.351 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.24 31.13 78.03 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.742 -0.742 . . . . 73.329999999999998 112.482 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.2 mm -107.01 140.98 23.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 60.229999999999997 111.094 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.815 HD11 ' CE2' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -108.26 144.9 35.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 73.420000000000002 110.895 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.25 146.61 22.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 75.230000000000004 110.903 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -69.74 82.83 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 55.229999999999997 110.838 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.858 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -57.44 142.86 42.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 72.120000000000005 111.069 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 170.59 -167.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 71.299999999999997 110.866 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.682 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -50.46 -51.46 46.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 53.240000000000002 111.102 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.14 -69.91 0.37 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 42.119999999999997 112.52 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.477 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 54.0 Cg_endo -69.76 99.26 0.73 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.725 2.283 . . . . 45.340000000000003 112.327 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.529 ' O ' HG23 ' A' ' 107' ' ' THR . 0.4 OUTLIER 37.87 55.35 1.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 74.230000000000004 110.874 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.682 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.2 p -159.97 53.33 0.35 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 64.510000000000005 111.168 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.28 152.47 31.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 32.229999999999997 110.891 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.59 5.37 2.87 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 75.209999999999994 112.498 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 74.2 51.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.793 0.33 . . . . 72.239999999999995 110.881 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.697 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 0.6 OUTLIER -70.21 -31.64 69.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 71.239999999999995 110.935 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.815 ' CE2' HD11 ' A' ' 98' ' ' LEU . 30.6 t80 99.66 145.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 62.340000000000003 110.878 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.858 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -169.86 114.62 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 72.019999999999996 110.91 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.3 mt -80.94 129.07 38.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 63.210000000000001 111.119 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -91.34 92.77 8.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.447 . . . . 64.129999999999995 110.856 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 45.2 p -79.23 14.16 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 74.219999999999999 111.18 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.809 ' O ' HG23 ' A' ' 119' ' ' THR . . . 178.65 143.77 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.466 . . . . 74.120000000000005 111.052 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -50.56 98.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 61.539999999999999 110.937 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 117' ' ' ALA . 35.0 p -104.16 48.93 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 43.439999999999998 111.092 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -24.86 67.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 71.0 110.868 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.8 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.2 p90 -50.03 -26.96 4.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 74.519999999999996 110.901 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.6 mt -45.63 -35.52 4.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 73.299999999999997 110.94 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.7 m-20 61.6 80.2 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 110.819 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 35.98 43.17 0.62 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.741 -0.742 . . . . 51.210000000000001 112.497 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.46 -19.28 33.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.753 0.311 . . . . 74.540000000000006 110.908 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -142.86 -165.15 1.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 73.430000000000007 110.865 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.7 t -131.29 125.64 57.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 74.150000000000006 111.123 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.51 133.2 33.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 73.109999999999999 111.162 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.48 ' O ' HD23 ' A' ' 24' ' ' LEU . 23.0 p90 -155.3 36.53 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 74.049999999999997 110.925 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -171.72 173.9 45.08 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.705 -0.76 . . . . 64.25 112.446 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -175.88 133.54 0.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 74.120000000000005 110.913 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.698 HG11 ' HG2' ' A' ' 136' ' ' MET . 76.8 t -39.73 107.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 54.409999999999997 111.144 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -58.08 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 72.310000000000002 110.922 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -154.75 163.05 40.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 71.540000000000006 110.873 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.5 32.67 46.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.69 -0.766 . . . . 54.539999999999999 112.471 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.698 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -50.89 -34.05 26.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.744 0.307 . . . . 75.209999999999994 110.827 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.6 -32.24 12.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 74.409999999999997 110.847 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.474 HG21 ' CG2' ' A' ' 20' ' ' VAL . 41.8 mm -66.31 -43.35 91.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 72.340000000000003 111.135 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.75 -26.33 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 41.119999999999997 111.113 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.32 -29.73 38.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 73.25 110.864 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.31 -37.61 66.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 60.200000000000003 111.08 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 24.4 mtm -57.3 -54.25 48.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 61.399999999999999 110.912 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.446 ' OE1' HG23 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -55.32 -25.5 34.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 60.43 110.873 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.424 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.91 -23.74 63.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 75.349999999999994 110.846 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.424 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 57.1 m-85 -108.79 17.13 22.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 75.549999999999997 110.88 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.34 168.37 12.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 62.409999999999997 112.5 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.6 m -113.76 148.22 36.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 75.239999999999995 110.892 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 -75.24 67.46 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.898 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -175.11 -35.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 71.450000000000003 110.872 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.78 -45.34 0.62 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.728 -0.749 . . . . 60.119999999999997 112.442 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.71 171.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 74.200000000000003 110.933 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.4 p -145.04 139.58 27.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 74.319999999999993 111.134 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.39 -39.89 77.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 73.150000000000006 110.826 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.504 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -107.39 -174.93 2.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 74.439999999999998 110.885 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.57 107.59 13.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 110.941 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.87 HG23 HG23 ' A' ' 10' ' ' ILE . 3.9 mp -89.68 102.34 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 75.439999999999998 111.131 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.509 HG23 ' HB3' ' A' ' 52' ' ' CYS . 0.0 OUTLIER -109.93 163.86 13.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 65.439999999999998 111.165 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.2 mt -102.94 116.47 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 72.109999999999999 111.131 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -81.72 -52.34 7.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 63.539999999999999 111.159 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -148.17 153.75 39.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 62.009999999999998 110.865 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -160.84 149.74 16.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 110.889 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.84 166.38 27.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.798 -0.715 . . . . 31.539999999999999 112.505 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -59.4 109.24 0.84 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 74.219999999999999 110.876 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.599 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.6 mm? -53.2 -48.19 68.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 73.239999999999995 110.934 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 75.319999999999993 110.913 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.83 0.348 . . . . 71.239999999999995 111.143 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -118.04 146.92 40.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.595 0.712 . . . . 75.239999999999995 110.889 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 149.34 66.58 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.676 2.25 . . . . 72.420000000000002 112.355 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -136.02 137.7 41.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 55.119999999999997 111.181 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.568 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.9 m -131.61 145.64 34.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 55.439999999999998 111.113 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.837 ' HB3' HD21 ' A' ' 164' ' ' LEU . 8.2 p90 -101.93 168.04 9.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 110.923 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -147.81 88.9 1.71 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 73.129999999999995 110.893 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.709 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -51.86 105.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 72.150000000000006 110.882 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.575 HG13 HG21 ' A' ' 20' ' ' VAL . 38.2 mm -83.97 126.95 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 75.120000000000005 111.105 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -121.04 149.54 42.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 35.229999999999997 111.077 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 t -130.04 94.94 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 62.350000000000001 111.123 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.02 32.66 10.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 71.109999999999999 110.893 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.18 -21.59 42.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 62.020000000000003 112.489 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -94.18 113.07 59.82 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.644 0.735 . . . . 74.319999999999993 110.882 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.7 Cg_endo -69.81 123.32 9.97 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.649 2.233 . . . . 53.109999999999999 112.357 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.56 ' HB3' HD12 ' A' ' 138' ' ' ILE . 12.0 mt -68.71 -37.83 79.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 63.030000000000001 110.916 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.13 -125.98 1.67 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.75 -0.738 . . . . 43.0 112.497 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.51 138.48 52.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 61.310000000000002 110.895 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.575 HG21 HG13 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -145.71 101.16 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 74.310000000000002 111.15 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -108.23 172.77 6.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 45.229999999999997 110.829 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.403 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -143.54 133.03 23.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 74.409999999999997 110.871 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -85.4 97.38 9.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 74.219999999999999 110.926 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 129' ' ' PHE . 3.2 mt -81.78 117.61 22.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 52.450000000000003 110.889 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -78.7 64.96 3.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 73.439999999999998 110.827 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.79 -24.05 14.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 20.030000000000001 111.111 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -67.96 -35.14 77.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 64.310000000000002 110.849 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -95.78 -29.2 14.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 70.099999999999994 110.908 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.404 HG21 ' HA ' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -136.58 65.82 55.77 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.641 0.734 . . . . 73.400000000000006 111.129 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -29.32 23.96 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.618 2.212 . . . . 44.25 112.355 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -41.23 96.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 74.400000000000006 110.932 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.8 m -88.55 -45.31 10.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 72.340000000000003 111.143 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.98 -46.07 82.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 73.140000000000001 111.101 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -47.01 -33.66 4.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 72.439999999999998 110.911 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.487 ' HA ' HD13 ' A' ' 78' ' ' ILE . 2.6 t30 -64.57 -65.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 54.109999999999999 110.854 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -59.04 -28.58 66.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 73.310000000000002 110.887 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -50.6 65.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 72.340000000000003 110.847 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.54 -31.71 72.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 62.409999999999997 111.069 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.876 HD21 HG22 ' A' ' 78' ' ' ILE . 75.1 mt -73.67 -54.54 7.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 75.400000000000006 110.927 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.9 m -48.28 -43.94 33.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 61.140000000000001 110.844 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.777 HG22 ' HG3' ' A' ' 163' ' ' GLN . 40.3 p -63.34 -38.42 91.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 72.299999999999997 111.186 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.06 -10.84 44.34 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.702 -0.761 . . . . 52.350000000000001 112.496 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -28.89 27.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.399 . . . . 51.210000000000001 110.893 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.695 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -63.83 -29.05 70.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 63.340000000000003 110.915 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.35 1.38 90.04 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 74.510000000000005 112.508 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -174.89 -165.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.915 0.388 . . . . 75.340000000000003 110.865 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.67 -96.22 0.63 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 61.229999999999997 112.506 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.67 ' O ' ' C ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -119.19 -70.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.958 0.409 . . . . 73.239999999999995 110.894 -179.82 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.67 ' C ' ' O ' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -6.44 96.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 60.340000000000003 110.922 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 120.45 -30.61 5.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.695 -0.764 . . . . 53.100000000000001 112.498 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.37 -168.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.808 0.337 . . . . 62.539999999999999 110.875 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.1 p -142.84 171.94 13.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 45.340000000000003 110.94 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.655 ' HE1' HD11 ' A' ' 158' ' ' ILE . 8.8 m-85 -92.82 139.97 29.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 74.140000000000001 110.909 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -123.45 32.57 5.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 73.319999999999993 110.821 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.99 114.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.423 . . . . 73.129999999999995 110.905 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.46 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.2 mt -144.96 112.47 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 70.329999999999998 111.125 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.478 HD12 ' HE2' ' A' ' 61' ' ' MET . 38.5 mt -105.42 105.07 50.99 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.622 0.725 . . . . 62.530000000000001 111.165 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.8 Cg_endo -69.79 56.9 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.644 2.229 . . . . 72.099999999999994 112.336 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.16 33.33 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.71 -0.757 . . . . 50.299999999999997 112.476 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.419 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.0 OUTLIER -177.12 -59.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.838 0.352 . . . . 75.120000000000005 110.882 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.478 ' HE2' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER 174.65 157.92 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 64.409999999999997 110.885 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.5 m -97.04 -161.88 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 33.530000000000001 110.927 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 177.01 137.96 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 74.109999999999999 110.892 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 62.149999999999999 112.449 -179.946 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.876 HG22 HD21 ' A' ' 39' ' ' LEU . 18.8 pt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.844 0.354 . . . . 74.230000000000004 111.098 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -155.12 -66.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 64.120000000000005 110.939 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -132.32 -88.3 0.39 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.709 -0.758 . . . . 73.519999999999996 112.486 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -130.91 -37.39 1.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 75.510000000000005 110.884 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.422 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.27 170.04 0.31 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 71.340000000000003 110.898 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -130.99 179.7 5.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 62.009999999999998 110.852 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.1 169.01 19.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 63.310000000000002 110.879 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -63.34 156.75 24.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 72.030000000000001 110.884 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -108.26 -68.91 0.88 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 64.010000000000005 110.853 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -175.94 178.09 1.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 73.219999999999999 110.893 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.94 36.5 2.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 74.140000000000001 110.901 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -50.61 -29.78 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 72.040000000000006 111.101 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 18.8 mt -111.61 74.79 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 71.439999999999998 110.896 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.73 153.51 41.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.120000000000005 110.859 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -52.87 101.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.129999999999995 110.866 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.5 p -116.03 29.15 8.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 75.319999999999993 111.126 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 151.8 174.15 22.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 62.149999999999999 112.438 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 171.33 14.73 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.638 2.225 . . . . 74.230000000000004 112.308 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.63 39.7 98.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 45.409999999999997 112.479 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.436 ' HA ' HD13 ' A' ' 97' ' ' ILE . 14.7 mm -106.13 135.28 45.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.88 0.371 . . . . 74.420000000000002 111.085 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 98' ' ' LEU . 1.1 mt -101.05 149.07 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 74.230000000000004 110.924 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.455 ' HB2' ' HA ' ' A' ' 128' ' ' VAL . 0.2 OUTLIER 178.81 131.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 63.439999999999998 110.833 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.74 162.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 73.319999999999993 110.891 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.471 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . . . -156.22 36.8 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 52.219999999999999 111.128 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -68.18 -35.71 78.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 71.420000000000002 110.928 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.706 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -174.61 32.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 71.310000000000002 111.06 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.04 -114.34 6.31 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.686 -0.769 . . . . 75.510000000000005 112.484 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 114.75 3.81 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.658 2.239 . . . . 64.430000000000007 112.34 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.529 ' C ' HG23 ' A' ' 107' ' ' THR . 3.4 m-20 71.19 171.86 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 74.430000000000007 110.867 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.706 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.0 OUTLIER 66.66 25.68 9.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 75.310000000000002 111.143 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -80.3 130.53 35.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 65.019999999999996 110.909 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.01 -74.85 0.11 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.774 -0.727 . . . . 61.420000000000002 112.489 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.8 p -166.43 43.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 73.439999999999998 110.857 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.436 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 42.8 mm-40 -118.36 54.97 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 74.519999999999996 110.945 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -77.9 -165.91 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 73.140000000000001 110.887 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -154.44 174.58 14.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 72.219999999999999 110.837 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 114' ' ' ILE . 3.0 mt -111.26 90.93 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.496 . . . . 73.340000000000003 111.15 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 55.8 m -65.55 93.13 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 53.350000000000001 110.899 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.2 p -65.8 -11.26 44.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.46 . . . . 74.450000000000003 111.191 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 119' ' ' THR . . . -145.5 154.95 42.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 65.310000000000002 111.096 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -55.64 94.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 70.140000000000001 110.915 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 117' ' ' ALA . 25.7 p -96.74 49.56 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 74.510000000000005 111.097 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -26.01 68.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 65.239999999999995 110.863 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.695 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.6 p90 -48.11 -29.6 3.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 73.109999999999999 110.886 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 19.0 mt -46.92 -33.51 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 65.319999999999993 110.925 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.4 OUTLIER 60.54 78.17 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.847 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.94 43.81 0.9 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 62.329999999999998 112.467 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -16.27 49.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 72.25 110.87 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -141.41 -168.19 2.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 75.329999999999998 110.877 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 51.0 t -122.01 124.22 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 75.230000000000004 111.12 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.455 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 2.3 t -93.21 135.67 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.209999999999994 111.127 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.446 ' O ' HD23 ' A' ' 24' ' ' LEU . 14.1 p90 -160.69 35.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 74.310000000000002 110.887 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -174.08 174.9 46.54 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.73 -0.748 . . . . 64.540000000000006 112.499 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -176.1 137.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 64.25 110.877 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.725 HG11 ' HG2' ' A' ' 136' ' ' MET . 54.1 t -40.73 107.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 70.400000000000006 111.092 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -59.82 2.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.040000000000006 110.928 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -153.78 157.13 38.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 72.530000000000001 110.935 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.11 32.9 19.34 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.737 -0.744 . . . . 44.140000000000001 112.487 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.725 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -55.01 -29.19 56.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 71.219999999999999 110.93 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.26 -31.19 42.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 74.099999999999994 110.896 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 17' ' ' LEU . 43.8 mm -65.58 -40.71 88.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 62.420000000000002 111.147 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.4 t -63.03 -27.36 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 62.340000000000003 111.096 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.91 -27.76 36.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 74.140000000000001 110.893 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.91 -38.68 61.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 62.310000000000002 111.097 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.8 mtm -61.42 -52.18 65.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 73.439999999999998 110.859 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -54.05 -29.61 44.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 74.040000000000006 110.904 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.452 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -65.8 -23.37 66.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 64.040000000000006 110.906 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.452 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 62.2 m-85 -108.95 18.63 20.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 72.519999999999996 110.849 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -114.03 168.46 12.58 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.693 -0.765 . . . . 73.310000000000002 112.484 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 m -113.07 146.76 38.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 53.43 110.865 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -76.01 64.45 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 75.340000000000003 110.873 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -165.48 -38.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 64.409999999999997 110.918 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 157.75 -71.39 0.25 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 74.219999999999999 112.501 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 170.4 4.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.817 0.341 . . . . 74.340000000000003 110.921 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.8 p -145.39 -173.9 4.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 72.5 111.113 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.74 -67.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 72.319999999999993 110.841 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -59.93 -179.22 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 70.409999999999997 110.903 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.62 107.07 9.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 71.129999999999995 110.913 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 4.1 mp -86.99 116.41 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 75.540000000000006 111.156 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.44 169.58 13.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 111.126 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.655 HD11 ' HE1' ' A' ' 53' ' ' PHE . 11.6 mm -104.83 109.25 27.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 73.209999999999994 111.112 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.709 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -68.68 -45.15 72.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 73.129999999999995 111.108 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -161.76 160.03 27.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 73.349999999999994 110.856 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.9 146.66 9.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 71.129999999999995 110.862 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.97 178.81 48.14 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.684 -0.77 . . . . 51.229999999999997 112.452 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.777 ' HG3' HG22 ' A' ' 41' ' ' THR . 3.6 mt-30 -63.98 146.24 54.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.854 0.359 . . . . 72.0 110.922 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.837 HD21 ' HB3' ' A' ' 7' ' ' PHE . 3.5 mm? -102.4 -55.66 2.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 75.5 110.904 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 64.25 110.944 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.838 0.352 . . . . 63.130000000000003 111.133 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -123.48 156.26 64.43 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.661 0.744 . . . . 74.209999999999994 110.855 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 145.83 58.52 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.694 2.263 . . . . 62.340000000000003 112.399 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.1 m -129.71 126.88 39.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 73.439999999999998 111.106 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.9 m -121.27 170.51 11.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 65.5 111.139 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.669 ' HB3' HD21 ' A' ' 164' ' ' LEU . 0.6 OUTLIER -158.52 176.37 12.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 63.43 110.882 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -153.13 96.21 2.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 63.149999999999999 110.864 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.6 t70 -43.22 106.63 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 74.349999999999994 110.867 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.708 HG22 HD12 ' A' ' 17' ' ' LEU . 34.1 mm -78.74 137.63 21.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 63.240000000000002 111.114 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -131.25 160.42 34.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 64.299999999999997 111.112 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -143.33 103.6 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 62.439999999999998 111.119 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.96 24.98 9.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 73.450000000000003 110.902 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.11 -25.29 25.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 33.509999999999998 112.512 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -90.28 125.17 60.96 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.672 0.748 . . . . 72.219999999999999 110.886 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.5 Cg_endo -69.76 124.49 11.14 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.653 2.235 . . . . 43.240000000000002 112.328 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.708 HD12 HG22 ' A' ' 10' ' ' ILE . 9.7 mt -68.25 -38.15 81.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 75.040000000000006 110.941 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.93 -131.17 2.86 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.669 -0.777 . . . . 65.319999999999993 112.434 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.67 136.66 53.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 52.439999999999998 110.9 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.584 HG21 HG13 ' A' ' 10' ' ' ILE . 1.3 t -142.4 99.46 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 65.150000000000006 111.137 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 22' ' ' PHE . 1.5 t -106.36 174.01 6.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 61.520000000000003 110.839 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.474 ' CZ ' HD11 ' A' ' 114' ' ' ILE . 48.2 m-85 -144.81 132.97 21.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 71.450000000000003 110.863 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -89.43 95.95 10.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 71.230000000000004 110.893 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.4 mt -81.06 134.61 35.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 54.310000000000002 110.896 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -92.18 66.87 4.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 110.852 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.91 -22.81 27.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 74.200000000000003 111.129 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -65.22 -39.44 92.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 61.32 110.813 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -96.58 -27.84 14.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 74.140000000000001 110.882 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.458 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -135.54 66.2 63.75 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.612 0.72 . . . . 71.519999999999996 111.112 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -45.91 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.703 2.268 . . . . 64.319999999999993 112.348 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -54.41 -34.71 61.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.434 . . . . 63.520000000000003 110.912 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.428 HG21 ' CD1' ' A' ' 129' ' ' PHE . 32.5 m -89.64 -54.11 4.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 65.049999999999997 111.109 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.92 -42.27 62.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 54.530000000000001 111.116 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -56.04 -27.18 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 71.510000000000005 110.925 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -66.68 -65.68 0.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 74.400000000000006 110.901 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.94 -34.66 70.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 73.439999999999998 110.888 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.485 ' O ' HG23 ' A' ' 41' ' ' THR . 3.5 ttp180 -70.22 -48.27 57.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 74.340000000000003 110.894 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.92 -37.18 66.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 73.329999999999998 111.118 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.5 HD22 ' HA2' ' A' ' 47' ' ' GLY . 3.1 mt -76.92 -56.06 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 72.230000000000004 110.934 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.0 m -53.6 -32.75 52.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 73.310000000000002 110.886 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 37' ' ' ARG . 30.6 p -73.42 -53.41 10.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 74.150000000000006 111.142 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.54 -13.92 6.49 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 74.109999999999999 112.455 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -53.63 -31.01 45.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.373 . . . . 73.409999999999997 110.877 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -27.9 60.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 72.450000000000003 110.925 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.04 -17.12 53.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 54.119999999999997 112.515 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -154.85 -165.18 1.98 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.907 0.385 . . . . 71.319999999999993 110.865 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA2' HD22 ' A' ' 39' ' ' LEU . . . 152.05 -123.41 1.47 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 73.299999999999997 112.473 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -121.7 31.72 6.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.934 0.397 . . . . 74.349999999999994 110.905 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.67 114.34 20.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 71.5 110.882 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.48 41.26 94.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 63.119999999999997 112.484 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 m -121.45 138.24 54.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.827 0.346 . . . . 72.040000000000006 110.845 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 55.9 m -56.34 150.57 14.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 72.329999999999998 110.859 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -69.37 -179.86 1.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 73.510000000000005 110.89 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -110.9 -72.62 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.150000000000006 110.854 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -143.34 157.81 44.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 73.329999999999998 110.818 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.515 HD12 HD13 ' A' ' 156' ' ' ILE . 44.9 mt -147.03 111.89 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 64.400000000000006 111.105 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.3 mt -109.76 102.28 49.67 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.682 0.753 . . . . 73.230000000000004 111.108 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 53.9 Cg_endo -69.77 88.53 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.714 2.276 . . . . 62.200000000000003 112.339 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.89 -20.33 1.61 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 50.0 112.46 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.54 -54.38 1.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 70.209999999999994 110.865 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.416 ' HB3' ' HA ' ' A' ' 115' ' ' CYS . 0.0 OUTLIER 171.03 166.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 110.914 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.6 m -91.7 -162.08 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 72.109999999999999 110.87 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -165.4 112.84 0.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 73.540000000000006 110.961 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 72.129999999999995 112.506 -179.958 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 78' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.875 0.369 . . . . 70.040000000000006 111.123 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -135.9 34.63 2.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 73.400000000000006 110.946 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.26 -109.73 2.48 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.752 -0.737 . . . . 55.119999999999997 112.516 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -111.12 -30.76 7.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.38 . . . . 70.019999999999996 110.873 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.401 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.3 179.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 71.120000000000005 110.913 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -148.15 164.98 32.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 73.329999999999998 110.838 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.61 171.31 15.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 64.010000000000005 110.865 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.76 153.88 40.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 75.319999999999993 110.877 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -106.63 -78.46 0.58 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 63.0 110.873 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.5 p30 -155.1 172.89 17.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 71.340000000000003 110.895 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.9 39.27 3.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 61.329999999999998 110.877 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -49.92 -30.26 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 75.140000000000001 111.104 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.6 mt -108.05 91.63 3.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 75.409999999999997 110.959 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.11 150.87 43.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 53.439999999999998 110.867 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -63.42 89.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 53.229999999999997 110.858 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.39 -55.3 5.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 62.109999999999999 111.102 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . -145.66 -166.73 12.05 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.719 -0.753 . . . . 41.329999999999998 112.512 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 172.17 13.17 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.686 2.257 . . . . 74.129999999999995 112.3 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.5 12.67 77.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.732 -0.747 . . . . 50.310000000000002 112.471 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.7 mm -89.05 143.39 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 75.519999999999996 111.129 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -114.14 143.14 45.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 62.350000000000001 110.898 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.5 -165.25 2.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 74.219999999999999 110.872 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.426 ' HG3' ' HB ' ' A' ' 127' ' ' VAL . 0.1 OUTLIER -95.53 104.94 16.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 110.856 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.584 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -70.04 77.37 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 43.229999999999997 111.141 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 22.1 p-10 -129.14 -172.28 2.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 65.209999999999994 110.897 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.22 -18.9 64.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 71.030000000000001 111.098 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.5 -82.68 0.33 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.74 -0.743 . . . . 74.420000000000002 112.512 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 96.14 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.728 2.285 . . . . 53.409999999999997 112.329 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.41 ' C ' HG23 ' A' ' 107' ' ' THR . 1.6 m-20 71.92 166.13 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 74.010000000000005 110.874 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.41 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.7 p 66.1 45.48 2.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 61.140000000000001 111.159 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 1.9 m-20 -43.81 -31.76 0.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 74.430000000000007 110.843 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . 70.58 -64.24 0.83 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 73.0 112.52 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 1.2 t 84.72 58.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.85 0.357 . . . . 74.0 110.849 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -109.93 -15.99 13.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 74.319999999999993 110.967 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.613 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER 73.47 154.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 75.140000000000001 110.883 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.584 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -165.08 67.77 0.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 72.200000000000003 110.873 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.563 ' C ' ' O ' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -23.67 123.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 73.129999999999995 111.093 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 61' ' ' MET . 37.2 m -96.28 114.14 25.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 74.319999999999993 110.863 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 68.1 p -93.16 27.39 2.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 53.140000000000001 111.163 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 119' ' ' THR . . . 176.38 142.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 42.509999999999998 111.131 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.415 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 3.6 tttt -53.42 99.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 72.310000000000002 110.893 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.718 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 28.8 p -98.89 48.63 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 73.120000000000005 111.134 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.39 -25.52 68.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 75.150000000000006 110.904 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.718 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.8 p90 -48.99 -28.29 3.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 75.099999999999994 110.915 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.443 HD13 ' HD2' ' A' ' 126' ' ' HIS . 26.1 mt -48.37 -32.12 7.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 72.25 110.913 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.0 m-20 59.77 76.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.310000000000002 110.934 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.98 41.5 0.98 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.74 -0.743 . . . . 61.130000000000003 112.509 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.93 -26.4 36.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.822 0.344 . . . . 74.129999999999995 110.894 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.443 ' HD2' HD13 ' A' ' 122' ' ' LEU . 19.9 m-70 -129.3 -167.76 1.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 73.5 110.89 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.426 ' HB ' ' HG3' ' A' ' 100' ' ' MET . 76.0 t -127.89 118.27 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 51.219999999999999 111.139 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.53 129.94 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 70.219999999999999 111.134 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.469 ' O ' HD23 ' A' ' 24' ' ' LEU . 35.4 p90 -151.2 33.49 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 72.519999999999996 110.894 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -172.68 175.28 45.77 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 43.210000000000001 112.477 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 2.1 pttt -175.75 137.28 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.813 0.34 . . . . 54.520000000000003 110.938 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.686 HG11 ' HG2' ' A' ' 136' ' ' MET . 53.8 t -41.63 105.73 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 73.430000000000007 111.142 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -59.95 3.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 70.450000000000003 110.898 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -154.28 161.91 41.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 73.430000000000007 110.921 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.05 33.66 28.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.721 -0.752 . . . . 11.44 112.498 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.686 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -55.06 -29.45 57.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 74.25 110.862 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.53 -33.02 53.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 65.120000000000005 110.885 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 17' ' ' LEU . 37.3 mm -65.56 -35.72 75.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 53.350000000000001 111.122 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.3 t -67.09 -26.92 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 72.340000000000003 111.139 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -82.27 -27.81 32.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 54.420000000000002 110.869 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.74 -41.28 60.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.488 . . . . 45.229999999999997 111.083 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.3 mtm -62.27 -51.73 66.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 63.310000000000002 110.91 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -54.06 -26.01 24.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.452 . . . . 72.340000000000003 110.899 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.447 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.34 -24.59 62.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 72.150000000000006 110.84 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.447 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 67.6 m-85 -107.58 12.12 27.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 72.140000000000001 110.902 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.39 171.64 17.7 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 63.530000000000001 112.487 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.68 131.09 55.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.849 0.357 . . . . 73.239999999999995 110.876 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -54.56 -28.07 43.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 63.350000000000001 110.813 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -72.53 -29.68 63.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 71.530000000000001 110.854 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.83 -42.45 1.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 30.109999999999999 112.49 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.27 -177.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.873 0.368 . . . . 54.409999999999997 110.881 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.5 p -144.78 138.41 27.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.207 -0.451 . . . . 72.010000000000005 111.148 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.69 -44.84 63.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 73.519999999999996 110.842 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.42 -177.68 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 73.239999999999995 110.925 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.78 109.13 18.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 74.230000000000004 110.911 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.515 HD13 HD12 ' A' ' 56' ' ' ILE . 5.1 mp -93.46 118.24 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 74.019999999999996 111.142 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.26 162.58 26.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 111.157 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 20.0 mm -101.29 117.16 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 75.030000000000001 111.098 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -77.65 -47.07 20.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 65.019999999999996 111.112 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -153.74 157.49 39.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 72.25 110.848 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -160.32 147.48 16.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 75.109999999999999 110.904 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.19 161.73 21.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.7 -0.762 . . . . 63.149999999999999 112.437 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.62 108.58 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.37 . . . . 54.310000000000002 110.933 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.669 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.1 mm? -50.78 -49.86 57.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.409999999999997 110.892 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 62.039999999999999 110.915 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 C--O 1.23 0.035 0 CA-C-O 120.849 0.357 . . . . 71.439999999999998 111.116 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -106.52 155.83 38.13 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.721 . . . . 74.329999999999998 110.884 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 146.95 61.54 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.629 2.22 . . . . 73.319999999999993 112.375 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -135.39 142.35 45.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 61.439999999999998 111.164 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.465 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.3 m -133.12 143.4 39.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 73.319999999999993 111.094 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 16.1 p90 -104.13 164.12 11.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 71.349999999999994 110.861 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.693 ' CD2' HD13 ' A' ' 158' ' ' ILE . 5.2 m-85 -147.4 85.07 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 65.319999999999993 110.836 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.673 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.8 OUTLIER -49.66 106.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 60.009999999999998 110.846 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.661 HG22 HD12 ' A' ' 17' ' ' LEU . 34.7 mm -85.01 134.58 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 71.540000000000006 111.095 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -124.07 158.65 31.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 53.329999999999998 111.11 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 154' ' ' LYS . 40.5 t -137.84 94.45 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 74.329999999999998 111.17 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.21 32.19 8.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 72.400000000000006 110.851 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.23 -24.0 32.55 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.759 -0.734 . . . . 71.439999999999998 112.51 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -91.74 115.01 63.74 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.633 0.73 . . . . 52.420000000000002 110.902 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.6 Cg_endo -69.76 122.59 9.27 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.682 2.254 . . . . 70.230000000000004 112.335 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.661 HD12 HG22 ' A' ' 10' ' ' ILE . 14.6 mt -66.64 -37.86 85.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 64.540000000000006 110.964 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.41 -122.29 1.2 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.72 -0.752 . . . . 61.340000000000003 112.48 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -130.12 138.22 50.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.853 0.359 . . . . 73.5 110.873 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.562 HG21 HG13 ' A' ' 10' ' ' ILE . 1.6 t -145.14 99.56 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 73.230000000000004 111.114 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.1 t -108.16 174.91 5.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 62.229999999999997 110.823 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.445 ' N ' ' OG ' ' A' ' 21' ' ' SER . 2.1 m-85 -144.92 131.81 20.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.493 . . . . 75.129999999999995 110.909 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.45 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 60.0 tt0 -86.4 97.04 10.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 71.439999999999998 110.933 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.7 mt -77.39 124.43 27.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 52.340000000000003 110.925 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -80.64 64.31 5.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 65.409999999999997 110.89 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.41 -22.38 12.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 55.450000000000003 111.12 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.32 -48.96 77.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 71.219999999999999 110.847 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -90.1 -29.64 18.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 70.510000000000005 110.892 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.446 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -130.89 67.84 81.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.618 0.723 . . . . 73.25 111.064 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -41.01 4.59 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.713 2.275 . . . . 34.240000000000002 112.316 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -35.27 79.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 72.430000000000007 110.936 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 48.5 m -84.63 -44.23 13.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 74.340000000000003 111.112 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.18 -47.05 78.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 65.209999999999994 111.089 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -50.96 -27.03 6.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 72.010000000000005 110.889 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.469 ' HA ' HD13 ' A' ' 78' ' ' ILE . 1.9 t30 -65.81 -63.39 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 75.530000000000001 110.892 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -61.11 -34.78 75.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 72.409999999999997 110.867 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.516 ' O ' HG23 ' A' ' 41' ' ' THR . 0.7 OUTLIER -69.78 -47.06 64.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 54.420000000000002 110.87 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.87 -39.84 72.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 52.420000000000002 111.132 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.506 HD22 ' HA2' ' A' ' 47' ' ' GLY . 4.1 mt -79.34 -49.46 12.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 74.049999999999997 110.957 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.7 m -55.69 -37.84 68.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 71.150000000000006 110.846 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 37' ' ' ARG . 73.9 p -74.91 -47.14 31.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 73.219999999999999 111.126 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.55 -11.95 13.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.738 -0.744 . . . . 62.0 112.505 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -52.07 -37.78 54.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 65.019999999999996 110.843 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -58.85 -27.48 65.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 73.530000000000001 110.905 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.76 -14.79 56.11 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.718 -0.754 . . . . 75.230000000000004 112.46 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -158.68 -166.07 1.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.885 0.374 . . . . 70.150000000000006 110.879 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.506 ' HA2' HD22 ' A' ' 39' ' ' LEU . . . 163.23 -133.2 2.98 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.681 -0.771 . . . . 34.530000000000001 112.446 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -149.72 48.35 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.933 0.397 . . . . 75.120000000000005 110.923 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -58.7 125.73 24.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 70.25 110.924 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.11 43.15 17.53 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.776 -0.726 . . . . 65.200000000000003 112.478 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.466 ' O ' HG22 ' A' ' 157' ' ' THR . 0.7 OUTLIER -60.47 -169.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.831 0.348 . . . . 74.140000000000001 110.903 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.0 p -125.17 132.29 53.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 62.439999999999998 110.886 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -110.7 108.91 18.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 74.109999999999999 110.869 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -133.45 37.75 3.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 110.848 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.46 77.96 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 65.239999999999995 110.851 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.548 HD12 HD13 ' A' ' 156' ' ' ILE . 13.6 mt -117.87 109.56 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 62.439999999999998 111.15 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 30.2 mt -97.77 104.51 21.8 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.606 0.717 . . . . 73.239999999999995 111.155 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.4 Cg_endo -69.76 85.94 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.687 2.258 . . . . 51.240000000000002 112.351 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.71 -19.88 1.82 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 65.200000000000003 112.489 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.9 -56.6 1.93 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.857 0.36 . . . . 70.239999999999995 110.846 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.624 ' HE3' ' O ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER 171.1 165.21 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 62.439999999999998 110.862 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.624 ' O ' ' HE3' ' A' ' 61' ' ' MET . 15.6 m -99.79 -161.85 0.9 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.445 . . . . 75.510000000000005 110.934 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.4 145.87 22.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 74.040000000000006 110.916 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 51.140000000000001 112.454 -179.965 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.469 HD13 ' HA ' ' A' ' 35' ' ' ASN . 11.3 pt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.884 0.373 . . . . 62.210000000000001 111.162 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -161.34 -64.29 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 110.952 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -132.15 166.68 23.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.706 -0.759 . . . . 53.100000000000001 112.492 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.14 -26.0 2.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.917 0.389 . . . . 74.0 110.899 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.41 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 176.13 173.47 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 75.120000000000005 110.928 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -149.76 167.82 25.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 71.349999999999994 110.891 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.75 167.63 20.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 74.519999999999996 110.912 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.13 135.02 57.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 73.230000000000004 110.852 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -83.33 -77.31 0.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 110.885 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.1 p30 -156.25 174.42 15.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 75.319999999999993 110.939 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.52 36.93 3.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 65.120000000000005 110.821 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.09 -32.13 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 73.150000000000006 111.117 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 21.8 mt -109.99 86.96 2.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 72.540000000000006 110.932 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.726 ' O ' HG23 ' A' ' 93' ' ' THR . 5.7 mtpt -75.1 145.83 41.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 73.129999999999995 110.946 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.52 ' CE1' HD12 ' A' ' 122' ' ' LEU . 16.9 m80 -49.85 103.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 70.510000000000005 110.857 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 91' ' ' LYS . 79.2 p -114.4 28.4 8.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 72.439999999999998 111.117 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.17 175.76 21.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.685 -0.769 . . . . 61.509999999999998 112.469 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 175.96 7.35 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.7 2.267 . . . . 74.109999999999999 112.34 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.13 26.63 69.43 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 74.329999999999998 112.45 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.2 mm -95.9 140.34 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.828 0.347 . . . . 61.43 111.166 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.445 HD21 ' HD2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -109.34 139.25 44.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 73.450000000000003 110.861 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.13 156.71 39.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 72.219999999999999 110.842 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.474 ' HE1' ' HB3' ' A' ' 110' ' ' SER . 1.0 OUTLIER -59.95 96.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 74.439999999999998 110.837 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.4 ' HB3' ' HG2' ' A' ' 111' ' ' GLN . . . -63.99 89.65 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 71.219999999999999 111.133 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 107' ' ' THR . 0.8 OUTLIER -134.71 173.55 11.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 74.010000000000005 110.882 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.93 -23.06 6.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 72.510000000000005 111.074 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 122.44 -82.16 0.35 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 62.140000000000001 112.52 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 91.91 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.696 2.264 . . . . 65.150000000000006 112.359 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.446 ' C ' HG23 ' A' ' 107' ' ' THR . 2.3 m-20 73.66 171.8 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 72.040000000000006 110.889 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.446 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.3 p 66.0 39.07 4.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 111.098 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -45.36 -30.48 1.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.838 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.436 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . 51.92 -118.47 7.3 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.777 -0.725 . . . . 62.420000000000002 112.491 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.474 ' HB3' ' HE1' ' A' ' 100' ' ' MET . 1.5 p 165.4 67.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 72.140000000000001 110.882 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.4 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 2.4 tt0 -102.79 -27.51 12.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 63.210000000000001 110.923 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.602 ' HZ ' HD12 ' A' ' 114' ' ' ILE . 0.0 OUTLIER 68.09 151.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.230000000000004 110.861 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -164.39 85.81 0.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 65.420000000000002 110.927 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.602 HD12 ' HZ ' ' A' ' 112' ' ' PHE . 2.2 mt -42.06 114.44 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 71.120000000000005 111.135 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.8 m -85.87 122.44 29.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 62.119999999999997 110.9 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.2 p -91.73 24.04 3.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 73.349999999999994 111.139 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 119' ' ' THR . . . 179.34 154.61 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 51.109999999999999 111.053 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.2 86.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 74.049999999999997 110.91 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.736 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 32.6 p -84.16 53.4 2.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 61.340000000000003 111.093 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -66.8 -23.14 66.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 74.120000000000005 110.909 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.736 ' CZ2' HG22 ' A' ' 119' ' ' THR . 11.6 p90 -53.75 -25.69 20.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 70.450000000000003 110.963 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.545 HD22 ' HE2' ' A' ' 126' ' ' HIS . 38.2 mt -45.6 -33.48 2.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 74.409999999999997 110.933 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 124' ' ' GLY . 1.6 m-20 61.95 76.18 0.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 62.200000000000003 110.838 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.6 41.54 0.85 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 70.230000000000004 112.478 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.67 -21.89 37.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.835 0.35 . . . . 74.140000000000001 110.938 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.545 ' HE2' HD22 ' A' ' 122' ' ' LEU . 9.7 m-70 -137.43 -167.23 2.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 74.049999999999997 110.861 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.9 t -127.06 122.07 59.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 73.129999999999995 111.161 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 t -88.1 133.3 30.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 61.420000000000002 111.106 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.451 ' O ' HD23 ' A' ' 24' ' ' LEU . 19.0 p90 -156.97 32.55 0.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 74.129999999999995 110.852 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -169.44 172.1 43.4 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.727 -0.749 . . . . 54.119999999999997 112.47 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 131' ' ' LYS . 1.6 pttt -176.11 132.41 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 63.43 110.916 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.654 HG11 ' HG2' ' A' ' 136' ' ' MET . 97.4 t -37.97 105.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.510000000000005 111.163 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.45 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -67.31 -58.69 4.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 75.140000000000001 110.94 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -150.99 170.29 19.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 72.219999999999999 110.87 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.13 31.0 64.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.735 . . . . 72.430000000000007 112.502 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.654 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -52.21 -26.38 11.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.771 0.32 . . . . 72.25 110.893 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.18 -31.89 54.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 74.540000000000006 110.886 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.632 HD12 ' HB3' ' A' ' 17' ' ' LEU . 43.4 mm -64.96 -40.26 88.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 71.239999999999995 111.107 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.43 -28.67 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 72.430000000000007 111.162 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -78.01 -29.02 49.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 73.420000000000002 110.885 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.96 57.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 71.319999999999993 111.132 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.487 ' SD ' HG21 ' A' ' 156' ' ' ILE . 35.9 mtm -61.38 -41.9 97.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 74.530000000000001 110.844 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -53.47 -30.57 41.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 72.420000000000002 110.89 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.43 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -73.55 -27.23 61.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 72.319999999999993 110.875 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.43 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 61.4 m-85 -105.44 30.01 6.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 75.519999999999996 110.81 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.0 151.69 17.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.766 -0.73 . . . . 75.230000000000004 112.51 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.5 m -114.37 140.52 48.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 63.219999999999999 110.854 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -74.11 70.18 1.55 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.340000000000003 110.886 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -179.93 -33.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 63.130000000000003 110.88 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 153.96 -100.61 0.2 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.773 -0.727 . . . . 70.140000000000001 112.468 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.32 169.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 55.420000000000002 110.912 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.6 p -143.65 -171.04 3.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 65.099999999999994 111.093 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.1 p -78.39 -55.31 5.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 63.109999999999999 110.847 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.456 ' HB3' HG13 ' A' ' 12' ' ' VAL . 3.7 mttp -81.54 166.66 20.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 74.420000000000002 110.877 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -111.95 110.08 20.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.310000000000002 110.888 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.548 HD13 HD12 ' A' ' 56' ' ' ILE . 4.8 mp -89.46 118.18 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 71.030000000000001 111.132 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -129.67 164.36 24.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 111.127 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.693 HD13 ' CD2' ' A' ' 8' ' ' PHE . 6.8 mt -98.44 123.04 50.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 73.400000000000006 111.073 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.673 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -81.53 -49.05 11.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 63.420000000000002 111.118 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -153.4 155.96 37.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 73.25 110.875 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.56 148.97 18.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 73.230000000000004 110.902 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 172.42 172.28 38.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.703 -0.76 . . . . 61.130000000000003 112.495 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.406 ' OE1' HG21 ' A' ' 41' ' ' THR . 2.7 mt-30 -64.67 142.36 58.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.363 . . . . 60.210000000000001 110.867 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -94.86 -59.58 1.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 72.299999999999997 110.903 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 110.913 179.955 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.458 -0.049 0 CA-C-O 120.839 0.352 . . . . 53.399999999999999 111.083 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -70.63 117.51 56.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.615 0.721 . . . . 64.409999999999997 110.861 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 152.6 69.31 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.653 2.235 . . . . 72.140000000000001 112.337 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -137.78 139.64 40.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 61.210000000000001 111.145 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.492 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.4 m -127.38 142.5 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 75.310000000000002 111.142 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.6 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 7.3 p90 -106.1 155.45 19.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 73.209999999999994 110.872 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.593 ' CE2' HD13 ' A' ' 158' ' ' ILE . 3.9 m-85 -143.8 86.72 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 73.129999999999995 110.847 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.736 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 4.0 t70 -47.75 125.91 9.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 72.129999999999995 110.846 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.67 HG23 HG23 ' A' ' 156' ' ' ILE . 17.5 mm -97.61 111.36 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 111.168 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -104.62 126.04 51.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 70.430000000000007 111.082 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.634 HG23 HD13 ' A' ' 17' ' ' LEU . 11.9 t -111.13 101.28 12.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 54.149999999999999 111.103 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 t0 59.87 43.55 14.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 73.150000000000006 110.87 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.58 0.83 88.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.747 -0.739 . . . . 73.109999999999999 112.511 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 10.2 mm-40 -113.22 102.4 54.74 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.628 0.728 . . . . 72.430000000000007 110.91 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.6 Cg_endo -69.81 110.88 2.67 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.626 2.217 . . . . 70.140000000000001 112.361 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.634 HD13 HG23 ' A' ' 12' ' ' VAL . 6.3 mp -65.45 -35.27 80.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 75.340000000000003 110.915 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.36 -133.72 3.04 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.731 . . . . 60.530000000000001 112.499 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -128.36 146.75 50.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 44.100000000000001 110.861 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.52 HG21 HG13 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -143.7 101.44 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 75.25 111.17 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -107.52 170.94 7.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 40.25 110.833 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -143.35 138.05 29.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 74.519999999999996 110.858 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.465 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 19.7 tt0 -91.17 99.94 12.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 74.420000000000002 110.865 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 129' ' ' PHE . 5.5 mt -82.56 123.13 28.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 72.540000000000006 110.923 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.464 ' CD1' HD13 ' A' ' 90' ' ' LEU . 40.6 m-85 -79.04 63.5 3.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 73.140000000000001 110.86 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.13 -22.32 16.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 74.409999999999997 111.062 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.17 -36.27 74.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 75.140000000000001 110.868 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.37 -25.31 15.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 53.409999999999997 110.919 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.444 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -139.44 65.51 34.04 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.625 0.726 . . . . 75.430000000000007 111.107 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -35.77 11.95 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.698 2.265 . . . . 71.420000000000002 112.339 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -39.82 89.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 75.319999999999993 110.859 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 98.6 m -87.28 -45.3 10.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 71.230000000000004 111.165 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.73 91.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 73.019999999999996 111.1 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -47.42 -35.15 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 74.319999999999993 110.874 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -62.64 -68.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 52.130000000000003 110.906 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -56.21 -23.44 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 71.540000000000006 110.903 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.485 ' NH2' ' HG2' ' A' ' 163' ' ' GLN . 0.0 OUTLIER -68.17 -54.21 19.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 75.340000000000003 110.854 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.57 -26.46 66.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 52.509999999999998 111.103 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.502 HD13 ' HE2' ' A' ' 48' ' ' TYR . 97.5 mt -79.0 -56.45 4.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 73.420000000000002 110.925 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.9 m -49.38 -46.13 46.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 65.439999999999998 110.834 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.3 p -72.44 -27.27 62.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 75.230000000000004 111.166 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.5 -8.81 74.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.726 -0.75 . . . . 73.109999999999999 112.475 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -18.55 50.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 72.209999999999994 110.883 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.737 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -50.36 -30.59 12.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 74.409999999999997 110.928 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.64 -23.97 6.57 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.763 -0.732 . . . . 70.219999999999999 112.509 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -160.59 -50.84 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 72.129999999999995 110.867 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.97 163.18 0.17 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.718 -0.753 . . . . 72.340000000000003 112.499 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.502 ' HE2' HD13 ' A' ' 39' ' ' LEU . 44.8 p90 -96.48 26.67 4.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.0 0.429 . . . . 74.349999999999994 110.934 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.17 142.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 72.209999999999994 110.904 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.83 27.05 74.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.706 -0.759 . . . . 53.32 112.487 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.712 ' O ' HG22 ' A' ' 157' ' ' THR . 0.4 OUTLIER -66.37 -176.46 0.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.827 0.346 . . . . 64.319999999999993 110.844 -179.741 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.9 p -126.06 122.47 35.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 72.140000000000001 110.856 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -86.98 130.61 34.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 75.230000000000004 110.877 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -147.33 46.82 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 110.889 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -158.94 61.59 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 75.239999999999995 110.905 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 13.7 mt -107.92 109.25 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 71.219999999999999 111.127 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.401 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 26.6 mt -100.2 103.78 25.23 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.604 0.716 . . . . 73.420000000000002 111.093 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.8 Cg_endo -69.75 85.01 0.63 Allowed 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.722 2.281 . . . . 73.530000000000001 112.34 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.37 -20.46 1.19 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.731 . . . . 71.430000000000007 112.479 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.89 -57.93 1.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.915 0.388 . . . . 64.340000000000003 110.911 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 174.19 164.48 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 62.009999999999998 110.827 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 10.1 m -100.81 -168.45 1.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 73.530000000000001 110.931 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 177.24 146.21 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 70.230000000000004 110.887 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.756 . . . . 72.329999999999998 112.497 179.991 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.737 HG22 ' HD2' ' A' ' 44' ' ' LYS . 5.2 pt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.829 0.347 . . . . 74.010000000000005 111.145 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -155.88 46.4 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 72.319999999999993 110.918 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.34 -133.98 11.51 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 65.150000000000006 112.479 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -79.23 -38.94 34.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.939 0.399 . . . . 60.119999999999997 110.88 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.41 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.2 176.63 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 73.239999999999995 110.893 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.75 -178.18 3.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 71.239999999999995 110.858 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -95.34 167.88 11.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.109 -0.496 . . . . 74.209999999999994 110.872 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -60.63 154.93 20.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 61.240000000000002 110.836 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -112.23 -67.44 1.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.019999999999996 110.881 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -176.45 178.11 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 75.430000000000007 110.871 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.46 35.99 3.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 63.140000000000001 110.918 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.51 -30.16 7.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 64.230000000000004 111.123 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 25' ' ' PHE . 12.9 mt -111.41 79.52 1.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 61.149999999999999 110.916 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -69.89 152.05 44.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 72.540000000000006 110.897 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -56.73 97.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 74.299999999999997 110.898 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.1 p -108.93 26.31 10.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 72.340000000000003 111.145 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.58 178.64 25.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.719 -0.753 . . . . 44.32 112.496 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 171.57 14.16 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.736 2.291 . . . . 74.109999999999999 112.335 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.9 37.64 94.54 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 64.239999999999995 112.468 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 97' ' ' ILE . 21.5 mm -108.62 136.99 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.884 0.373 . . . . 43.119999999999997 111.163 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' A' ' 112' ' ' PHE . 4.2 mt -103.1 162.18 13.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 72.230000000000004 110.92 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.16 -160.15 0.31 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 75.430000000000007 110.786 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.3 mmt -121.93 138.15 54.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 73.540000000000006 110.903 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -119.05 148.22 43.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 44.420000000000002 111.1 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 0.3 OUTLIER 163.73 -50.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 75.019999999999996 110.88 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -178.11 30.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 75.129999999999995 111.101 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.33 -120.89 5.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 35.43 112.509 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 126.35 13.17 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.629 2.219 . . . . 74.109999999999999 112.337 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.494 ' C ' HG23 ' A' ' 107' ' ' THR . 4.0 m-20 69.11 173.02 0.3 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 65.519999999999996 110.898 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.494 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.3 p 67.07 26.38 8.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 73.409999999999997 111.142 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -72.25 146.63 47.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 71.219999999999999 110.853 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.89 -106.88 0.9 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 72.450000000000003 112.518 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.6 p -151.43 33.74 0.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.81 0.338 . . . . 70.120000000000005 110.9 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.668 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 3.7 pt20 -114.42 51.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 72.219999999999999 110.902 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.539 ' HB2' HD22 ' A' ' 98' ' ' LEU . 5.4 p90 -56.85 -169.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 62.340000000000003 110.892 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.452 ' O ' HD23 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -151.87 164.27 37.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 74.049999999999997 110.894 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 114' ' ' ILE . 3.4 mt -108.66 90.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 71.420000000000002 111.145 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 57.3 m -63.41 91.29 0.05 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 72.040000000000006 110.89 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.2 p -61.68 -15.16 37.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 42.509999999999998 111.111 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 119' ' ' THR . . . -143.89 156.4 44.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 71.219999999999999 111.08 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -56.06 94.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 75.420000000000002 110.864 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 117' ' ' ALA . 23.7 p -95.49 46.11 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 54.219999999999999 111.151 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -23.88 67.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 74.450000000000003 110.853 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.687 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.0 p90 -49.54 -28.16 5.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 72.200000000000003 110.896 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.9 mt -46.77 -34.06 4.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.227 -0.442 . . . . 54.520000000000003 110.912 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.4 OUTLIER 63.01 75.18 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 64.040000000000006 110.889 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.11 43.71 0.7 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.732 -0.747 . . . . 51.329999999999998 112.495 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -80.34 -27.42 38.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 64.430000000000007 110.91 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -127.18 -168.65 1.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 52.219999999999999 110.856 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.7 t -121.43 110.22 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 62.310000000000002 111.114 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 98' ' ' LEU . 16.4 t -83.84 134.57 26.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 72.439999999999998 111.166 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.444 ' CB ' HG21 ' A' ' 29' ' ' VAL . 12.5 p90 -158.24 44.85 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 74.140000000000001 110.902 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . 179.02 175.25 45.89 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.772 -0.728 . . . . 75.430000000000007 112.525 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.2 pttp -174.9 145.19 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 71.120000000000005 110.927 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.761 HG11 ' HG2' ' A' ' 136' ' ' MET . 32.7 t -44.73 113.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 61.149999999999999 111.155 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.465 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -78.14 -61.24 2.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 61.219999999999999 110.929 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -152.35 151.42 30.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 54.439999999999998 110.881 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.77 30.44 9.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.733 . . . . 42.240000000000002 112.529 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.761 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -54.02 -26.41 26.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.782 0.325 . . . . 73.230000000000004 110.886 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.19 -34.1 68.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 71.150000000000006 110.841 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.503 HD12 ' HB3' ' A' ' 17' ' ' LEU . 23.5 mm -69.39 -38.27 76.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 62.399999999999999 111.101 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.21 -28.66 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.530000000000001 111.152 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -75.75 -31.31 59.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.887 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.07 -41.41 70.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 45.350000000000001 111.093 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 21.4 mtm -58.04 -45.36 87.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 72.209999999999994 110.902 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 11.3 tm-20 -54.59 -25.3 25.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 62.420000000000002 110.909 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.405 ' HG3' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -78.99 -28.87 43.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 71.310000000000002 110.9 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.405 ' CG ' ' HG3' ' A' ' 144' ' ' ARG . 46.9 m-85 -105.26 34.27 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.310000000000002 110.865 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -113.58 161.01 12.84 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 73.230000000000004 112.466 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 t -117.75 143.64 46.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.89 0.376 . . . . 64.519999999999996 110.852 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -74.76 63.85 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 73.219999999999999 110.906 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -175.45 -34.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 70.109999999999999 110.893 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.59 -44.81 0.74 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.746 -0.74 . . . . 10.41 112.478 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -62.65 -169.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 75.540000000000006 110.902 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.82 147.97 4.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 64.239999999999995 111.167 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.97 -39.61 90.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 51.210000000000001 110.864 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.408 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -101.32 171.56 7.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 73.109999999999999 110.894 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -114.85 108.72 17.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 72.310000000000002 110.924 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.67 HG23 HG23 ' A' ' 10' ' ' ILE . 4.8 mp -93.39 119.52 41.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 75.329999999999998 111.121 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.712 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -127.71 163.09 25.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 70.519999999999996 111.122 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.593 HD13 ' CE2' ' A' ' 8' ' ' PHE . 8.5 mt -91.28 109.37 21.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 72.329999999999998 111.123 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.736 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -73.03 -43.47 62.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 71.409999999999997 111.07 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -162.61 155.0 19.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 75.439999999999998 110.864 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.56 148.44 16.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.211 -0.449 . . . . 71.549999999999997 110.956 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.26 -174.65 44.72 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.739 -0.743 . . . . 75.200000000000003 112.489 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.485 ' HG2' ' NH2' ' A' ' 37' ' ' ARG . 3.1 mt-30 -82.03 131.22 35.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.351 . . . . 65.420000000000002 110.897 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.581 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.2 mm? -86.92 -60.79 1.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 73.040000000000006 110.945 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 75.329999999999998 110.911 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.888 0.375 . . . . 45.140000000000001 111.138 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -94.29 154.81 40.35 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.596 0.712 . . . . 60.439999999999998 110.883 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 146.09 59.05 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 62.130000000000003 112.374 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -133.98 142.97 47.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 43.130000000000003 111.15 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.487 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.8 m -134.23 141.73 42.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 74.239999999999995 111.136 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 13.6 p90 -101.49 168.54 9.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 74.420000000000002 110.876 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.635 ' CD2' HD13 ' A' ' 158' ' ' ILE . 5.4 m-85 -148.44 88.9 1.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 70.439999999999998 110.87 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.697 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.7 t70 -51.25 102.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 60.100000000000001 110.873 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.665 HG22 HD12 ' A' ' 17' ' ' LEU . 34.5 mm -80.3 135.95 24.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 74.340000000000003 111.164 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -127.71 155.41 44.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 111.142 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.426 HG13 ' HB3' ' A' ' 154' ' ' LYS . 48.9 t -136.0 94.09 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 65.209999999999994 111.139 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.61 32.01 7.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 75.540000000000006 110.873 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.55 -23.63 33.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.753 -0.737 . . . . 42.219999999999999 112.481 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -92.3 115.62 65.04 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.615 0.721 . . . . 61.299999999999997 110.922 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.4 Cg_endo -69.76 121.26 7.95 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.703 2.269 . . . . 71.430000000000007 112.319 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.665 HD12 HG22 ' A' ' 10' ' ' ILE . 14.1 mt -65.64 -37.58 86.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 73.409999999999997 110.927 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.43 -125.6 1.69 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 70.299999999999997 112.509 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -128.44 136.95 51.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 74.25 110.853 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.572 HG21 HG13 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -145.24 103.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 70.329999999999998 111.146 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -109.42 173.25 6.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 71.310000000000002 110.885 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.413 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -143.8 127.9 17.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 74.319999999999993 110.87 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -82.89 99.59 9.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 75.030000000000001 110.913 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.4 mt -83.18 122.79 28.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 63.350000000000001 110.889 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -77.48 67.25 3.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 75.140000000000001 110.903 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.45 -20.89 33.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 75.430000000000007 111.105 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -68.57 -38.48 80.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 72.209999999999994 110.859 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.48 -28.07 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 72.129999999999995 110.925 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.427 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -136.68 67.9 58.79 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.627 0.727 . . . . 34.140000000000001 111.105 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -36.91 9.89 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.705 2.27 . . . . 74.400000000000006 112.338 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.68 -37.68 82.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 72.329999999999998 110.907 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.4 m -88.53 -43.21 11.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 65.549999999999997 111.173 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.42 -49.38 77.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 50.020000000000003 111.136 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -51.29 -27.67 10.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 110.903 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.0 -63.83 0.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.329999999999998 110.897 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -59.94 -32.75 71.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 74.209999999999994 110.883 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.47 ' O ' HG23 ' A' ' 41' ' ' THR . 1.6 ttp180 -71.72 -47.8 51.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 75.230000000000004 110.903 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.3 -36.94 69.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 64.430000000000007 111.097 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.5 mt -77.65 -50.69 11.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 75.030000000000001 110.9 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.5 m -58.68 -38.13 77.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 73.140000000000001 110.873 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 37' ' ' ARG . 46.5 p -71.37 -38.6 71.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 72.239999999999995 111.144 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.81 -10.8 45.27 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.732 -0.746 . . . . 73.099999999999994 112.467 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -30.72 39.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 64.040000000000006 110.854 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -65.69 -28.71 69.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 63.240000000000002 110.927 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.28 -15.98 58.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.734 . . . . 61.210000000000001 112.516 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -155.11 -167.39 2.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.895 0.379 . . . . 75.409999999999997 110.866 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.56 -158.43 28.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.749 . . . . 44.219999999999999 112.492 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -112.42 21.09 16.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.929 0.395 . . . . 73.540000000000006 110.864 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.51 121.43 5.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 74.129999999999995 110.919 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.37 44.73 9.3 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.761 -0.733 . . . . 24.420000000000002 112.458 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.613 ' O ' HG22 ' A' ' 157' ' ' THR . 9.7 t -92.59 -169.38 2.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.824 0.345 . . . . 54.43 110.873 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 8.1 p -121.14 143.43 49.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 74.319999999999993 110.889 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -99.98 141.28 33.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 74.310000000000002 110.871 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -151.87 48.26 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 73.019999999999996 110.807 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.1 tpp85 -172.95 68.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 75.5 110.894 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 56' ' ' ILE . 4.7 mt -116.11 113.3 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 73.299999999999997 111.127 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.5 mt -110.26 103.16 53.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.629 0.728 . . . . 73.340000000000003 111.156 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 86.24 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.671 2.247 . . . . 74.409999999999997 112.353 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.57 -20.77 1.5 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.737 -0.744 . . . . 64.099999999999994 112.485 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.87 -52.47 1.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 73.409999999999997 110.869 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.51 166.46 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 73.409999999999997 110.876 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.7 m -107.34 -169.4 1.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 73.120000000000005 110.918 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 173.85 149.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 71.230000000000004 110.891 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.67 -0.776 . . . . 71.030000000000001 112.497 -179.945 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.873 0.368 . . . . 74.150000000000006 111.125 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -127.79 -77.8 0.57 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 110.951 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -151.24 -76.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.67 -0.776 . . . . 45.049999999999997 112.464 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 4.7 mm-40 -117.55 -52.58 2.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.919 0.39 . . . . 75.099999999999994 110.909 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER 179.04 152.24 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 110.908 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -117.32 167.62 11.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 72.219999999999999 110.885 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.49 161.53 16.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.494 . . . . 73.329999999999998 110.881 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -48.28 151.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 73.439999999999998 110.848 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -102.78 -76.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 61.210000000000001 110.899 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -158.25 172.8 17.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 71.349999999999994 110.934 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.13 38.02 3.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 73.549999999999997 110.901 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.31 -31.53 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 62.409999999999997 111.156 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.8 mt -107.42 91.94 3.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 71.519999999999996 110.908 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -73.36 148.2 43.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 72.219999999999999 110.903 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -57.5 96.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 75.310000000000002 110.855 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -85.19 -57.93 2.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 75.030000000000001 111.129 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -143.26 -164.88 10.46 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.774 -0.727 . . . . 75.319999999999993 112.484 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 175.31 8.3 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.667 2.244 . . . . 73.120000000000005 112.359 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.07 21.19 69.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.785 -0.721 . . . . 62.450000000000003 112.512 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.1 mm -96.19 142.54 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.381 . . . . 64.140000000000001 111.144 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -114.49 143.71 44.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 64.540000000000006 110.929 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.98 -165.24 2.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 73.439999999999998 110.882 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 35.5 mtm -92.22 99.02 11.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 71.439999999999998 110.878 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -73.07 60.33 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.427 . . . . 65.109999999999999 111.096 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -118.7 -179.17 3.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.040000000000006 110.922 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.07 -24.49 3.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 65.0 111.121 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.96 -80.84 0.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.759 -0.734 . . . . 64.510000000000005 112.502 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 89.56 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.664 2.243 . . . . 71.329999999999998 112.322 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.505 ' C ' HG23 ' A' ' 107' ' ' THR . 40.6 m-20 66.26 -170.37 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 75.140000000000001 110.883 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.505 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.2 p 67.32 34.42 4.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 61.520000000000003 111.154 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.83 148.47 23.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 55.119999999999997 110.913 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.65 59.2 0.44 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.73 -0.747 . . . . 63.439999999999998 112.462 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 65.2 36.2 7.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.836 0.35 . . . . 73.019999999999996 110.89 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -59.66 -169.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 70.200000000000003 110.909 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 177.43 149.05 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 73.129999999999995 110.92 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -165.49 73.2 0.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 71.030000000000001 110.884 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.506 ' C ' ' O ' ' A' ' 113' ' ' PHE . 19.1 mt -28.4 106.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 72.439999999999998 111.126 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 35.7 m -80.5 117.84 21.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 73.510000000000005 110.888 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 60.5 p -94.84 26.36 3.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 61.25 111.154 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.683 ' O ' HG23 ' A' ' 119' ' ' THR . . . 176.7 145.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 55.25 111.123 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -54.83 100.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 64.340000000000003 110.9 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.695 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 27.9 p -101.19 47.61 0.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 75.209999999999994 111.147 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -26.25 68.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 63.549999999999997 110.852 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.695 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.6 p90 -48.41 -28.62 3.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 73.030000000000001 110.942 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 26.0 mt -47.4 -35.82 8.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 74.109999999999999 110.914 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 124' ' ' GLY . 1.8 m-20 61.24 81.43 0.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 62.119999999999997 110.884 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.05 43.27 0.87 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 74.329999999999998 112.497 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.98 -17.86 39.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.785 0.326 . . . . 74.409999999999997 110.885 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -143.59 -168.1 2.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 74.219999999999999 110.851 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.4 t -126.26 119.32 53.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 51.539999999999999 111.115 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.8 t -83.23 129.89 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 53.43 111.107 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.492 ' O ' HD23 ' A' ' 24' ' ' LEU . 31.9 p90 -153.86 33.83 0.44 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.340000000000003 110.862 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -171.96 172.85 44.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.722 . . . . 70.409999999999997 112.486 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -175.81 135.18 0.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 73.439999999999998 110.914 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.741 HG11 ' HG2' ' A' ' 136' ' ' MET . 58.7 t -39.69 104.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 64.030000000000001 111.13 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.75 -60.0 2.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 73.510000000000005 110.899 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -154.56 160.22 41.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 74.040000000000006 110.882 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.59 32.03 28.61 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 74.349999999999994 112.528 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.741 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -52.62 -29.59 26.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.747 0.308 . . . . 73.310000000000002 110.871 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.44 -32.4 49.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 71.400000000000006 110.907 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.54 HD12 ' HB3' ' A' ' 17' ' ' LEU . 44.0 mm -65.74 -38.85 83.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 71.349999999999994 111.091 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.9 t -64.39 -27.22 42.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 73.299999999999997 111.163 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.24 -28.49 38.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 55.43 110.876 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.82 -43.2 59.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 51.409999999999997 111.096 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 40.7 mtm -60.73 -51.29 69.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 75.319999999999993 110.851 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.423 ' OE1' HG23 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -55.94 -23.2 30.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 75.200000000000003 110.881 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -23.97 61.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 75.439999999999998 110.883 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -109.73 19.85 18.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 71.120000000000005 110.885 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.5 167.37 12.35 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.773 -0.727 . . . . 72.140000000000001 112.47 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.5 m -109.8 148.15 31.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 53.210000000000001 110.851 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.4 mmm-85 -76.53 64.21 2.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 72.230000000000004 110.875 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -174.13 -36.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 73.430000000000007 110.902 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 156.76 -47.65 0.48 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 72.420000000000002 112.525 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 168.11 9.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.84 0.352 . . . . 73.349999999999994 110.935 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.3 p -144.91 -174.24 4.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 72.049999999999997 111.157 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.84 -68.3 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 31.219999999999999 110.852 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.426 ' HB3' HG13 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -79.28 -176.06 4.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 74.329999999999998 110.924 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.85 109.73 18.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 71.120000000000005 110.921 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mp -85.04 118.34 31.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 64.099999999999994 111.18 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.613 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -129.72 162.34 28.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 53.409999999999997 111.15 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.635 HD13 ' CD2' ' A' ' 8' ' ' PHE . 7.6 mt -101.34 120.89 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 64.219999999999999 111.12 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.697 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -79.98 -48.83 12.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 62.039999999999999 111.119 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -156.95 158.31 36.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 61.530000000000001 110.828 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.89 146.91 13.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 73.230000000000004 110.887 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.68 174.04 45.29 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.747 -0.74 . . . . 74.329999999999998 112.471 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -65.0 140.57 58.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.853 0.359 . . . . 61.219999999999999 110.924 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.569 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -93.41 -59.39 2.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 110.923 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 54.200000000000003 110.871 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.7 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.834 0.349 . . . . 74.040000000000006 111.147 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -123.51 154.19 66.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.605 0.717 . . . . 73.329999999999998 110.902 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 145.49 57.11 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.709 2.273 . . . . 53.32 112.341 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.9 m -128.84 128.96 44.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 61.299999999999997 111.165 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.403 HG13 ' CD1' ' A' ' 24' ' ' LEU . 2.4 m -124.52 172.71 11.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 51.340000000000003 111.18 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.666 ' HB3' HD21 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -162.0 174.26 13.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 71.549999999999997 110.905 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -153.05 97.85 2.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 63.200000000000003 110.958 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.9 OUTLIER -45.34 108.96 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 62.109999999999999 110.861 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.818 HG22 HD12 ' A' ' 17' ' ' LEU . 42.2 mm -80.11 133.64 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 73.409999999999997 111.136 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -125.82 156.37 39.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 74.150000000000006 111.086 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 154' ' ' LYS . 42.5 t -134.81 96.39 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 64.010000000000005 111.171 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.56 30.56 10.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 72.109999999999999 110.883 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.31 -23.8 32.11 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 45.399999999999999 112.495 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -91.79 116.03 65.68 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.658 0.742 . . . . 74.120000000000005 110.872 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.2 Cg_endo -69.77 126.09 12.9 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.687 2.258 . . . . 62.520000000000003 112.324 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.818 HD12 HG22 ' A' ' 10' ' ' ILE . 12.1 mt -70.32 -40.93 73.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 73.310000000000002 110.938 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.26 -122.13 1.09 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.729 -0.748 . . . . 65.109999999999999 112.493 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -134.32 143.12 47.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 74.049999999999997 110.908 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.47 HG21 HG13 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -146.26 100.31 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 70.200000000000003 111.156 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 2.1 t -104.52 173.78 6.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 73.400000000000006 110.854 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.556 ' CZ ' HD11 ' A' ' 114' ' ' ILE . 63.9 m-85 -145.18 130.74 18.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 61.439999999999998 110.88 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -86.28 95.2 9.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 71.409999999999997 110.878 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.1 mt -80.1 134.07 36.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 73.040000000000006 110.872 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -93.1 66.58 4.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 72.200000000000003 110.849 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.67 -22.71 36.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 60.420000000000002 111.086 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -65.68 -35.65 81.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 55.310000000000002 110.865 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -99.61 -29.24 12.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 71.439999999999998 110.922 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.425 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -134.86 66.06 67.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 74.019999999999996 111.106 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -35.32 12.7 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.688 2.259 . . . . 73.340000000000003 112.321 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.06 -39.39 81.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 64.200000000000003 110.895 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.401 HG21 ' CD1' ' A' ' 129' ' ' PHE . 31.7 m -89.84 -49.25 6.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 74.040000000000006 111.135 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.26 -42.16 63.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 63.420000000000002 111.094 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.75 -25.18 62.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 75.25 110.919 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.7 -65.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 73.129999999999995 110.85 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -31.14 66.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 73.439999999999998 110.891 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.557 ' O ' HG23 ' A' ' 41' ' ' THR . 1.3 ttp180 -73.15 -52.91 12.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 75.099999999999994 110.856 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.05 -33.52 57.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 54.020000000000003 111.095 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.5 HD22 ' HA2' ' A' ' 47' ' ' GLY . 12.6 mt -80.59 -56.07 4.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 74.219999999999999 110.914 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.1 m -54.38 -36.05 63.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 44.32 110.83 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 37' ' ' ARG . 69.9 p -73.9 -45.29 51.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 75.430000000000007 111.147 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.7 -14.93 19.76 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.728 -0.749 . . . . 64.420000000000002 112.477 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -32.77 46.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 75.230000000000004 110.901 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -63.23 -28.77 70.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 64.409999999999997 110.892 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.86 -16.52 50.8 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.785 -0.721 . . . . 64.010000000000005 112.518 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -156.35 -165.91 2.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.923 0.392 . . . . 74.549999999999997 110.871 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA2' HD22 ' A' ' 39' ' ' LEU . . . 157.44 -164.75 33.14 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.721 -0.752 . . . . 52.539999999999999 112.452 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -105.74 26.78 9.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.911 0.386 . . . . 64.310000000000002 110.929 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.38 129.84 16.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 71.010000000000005 110.893 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.95 37.71 88.15 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.786 -0.721 . . . . 63.530000000000001 112.483 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.4 p -71.92 -172.56 0.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 50.039999999999999 110.819 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 8.1 p -131.45 127.33 37.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 61.420000000000002 110.858 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -86.0 115.56 23.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 73.140000000000001 110.863 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -124.08 32.55 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 61.310000000000002 110.878 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.71 83.04 0.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 72.209999999999994 110.865 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 56' ' ' ILE . 10.0 mt -123.24 110.67 26.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 64.5 111.153 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.4 mt -104.17 104.24 42.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.676 0.75 . . . . 71.310000000000002 111.097 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 81.95 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.684 2.256 . . . . 75.530000000000001 112.367 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.77 -21.89 0.8 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 74.400000000000006 112.508 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.42 -54.95 2.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 75.329999999999998 110.892 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 171.58 168.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 72.439999999999998 110.867 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 113' ' ' PHE . 34.7 m -106.4 -165.65 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 70.310000000000002 110.864 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.62 130.55 9.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 72.140000000000001 110.925 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.721 -0.752 . . . . 73.439999999999998 112.457 -179.969 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.515 ' O ' HD12 ' A' ' 78' ' ' ILE . 1.2 pp . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.878 0.371 . . . . 63.420000000000002 111.142 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -140.83 35.54 1.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 63.109999999999999 110.911 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.97 -140.51 15.04 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.75 -0.738 . . . . 63.530000000000001 112.496 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -78.17 -31.28 49.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.892 0.377 . . . . 72.219999999999999 110.891 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.47 -179.56 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 74.329999999999998 110.894 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.66 162.7 35.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 61.100000000000001 110.892 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -78.78 167.96 20.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 74.140000000000001 110.877 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -59.35 146.02 41.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 74.409999999999997 110.85 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -102.59 -77.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 64.319999999999993 110.889 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -152.24 171.44 17.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 63.399999999999999 110.905 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.55 38.36 3.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 70.439999999999998 110.901 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mt -50.42 -30.48 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 73.109999999999999 111.131 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.6 mt -108.42 93.33 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.952 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -73.03 148.94 43.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 64.030000000000001 110.876 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -59.76 94.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.887 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.04 -59.28 2.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 71.310000000000002 111.149 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . -142.83 -166.02 10.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 73.120000000000005 112.523 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 172.24 12.98 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.676 2.251 . . . . 75.140000000000001 112.331 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.15 20.12 76.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.695 -0.764 . . . . 71.530000000000001 112.499 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.2 mm -96.21 142.52 13.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.853 0.359 . . . . 73.530000000000001 111.11 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.438 HD21 ' CD2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -112.52 141.04 46.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 71.310000000000002 110.891 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.22 165.86 32.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 53.520000000000003 110.862 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 11.8 mtm -71.92 87.19 1.01 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 72.019999999999996 110.922 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.792 ' HB3' ' CG ' ' A' ' 111' ' ' GLN . . . -48.35 124.6 8.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 62.450000000000003 111.127 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 24.1 p-10 -170.6 -174.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 72.140000000000001 110.912 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.03 -12.53 60.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 74.420000000000002 111.171 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.12 -83.3 0.34 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 61.299999999999997 112.51 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 96.28 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.666 2.244 . . . . 54.450000000000003 112.341 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 71.27 178.38 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 55.130000000000003 110.875 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.2 p 58.53 40.13 24.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 75.409999999999997 111.139 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 4.2 m120 -43.19 -35.3 1.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 72.540000000000006 110.894 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . 69.83 -62.83 0.69 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.8 -0.714 . . . . 71.329999999999998 112.46 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 0.6 OUTLIER 81.96 44.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.844 0.354 . . . . 34.539999999999999 110.858 -179.759 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.792 ' CG ' ' HB3' ' A' ' 101' ' ' ALA . 24.5 pt20 -92.95 -7.63 45.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 71.030000000000001 110.88 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.553 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER 69.16 149.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 72.030000000000001 110.931 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.587 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -163.29 70.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 72.200000000000003 110.842 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.556 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -27.48 124.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 53.030000000000001 111.154 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.6 m -96.0 114.08 25.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 72.049999999999997 110.909 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 45.9 p -92.56 28.47 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 72.219999999999999 111.114 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.697 ' O ' HG23 ' A' ' 119' ' ' THR . . . 175.95 141.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 63.520000000000003 111.062 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.418 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 2.1 tttt -50.63 99.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 71.299999999999997 110.905 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.798 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 49.6 p -98.99 55.67 1.02 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.218 -0.446 . . . . 61.020000000000003 111.125 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -23.87 61.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 73.120000000000005 110.882 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.798 ' CZ2' HG22 ' A' ' 119' ' ' THR . 8.1 p90 -49.88 -29.6 8.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 74.430000000000007 110.95 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.707 HD22 ' NE2' ' A' ' 126' ' ' HIS . 32.0 mt -49.45 -32.52 12.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 62.329999999999998 110.931 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.3 m-20 60.13 76.6 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 73.140000000000001 110.814 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.46 42.15 0.89 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.717 -0.754 . . . . 70.219999999999999 112.444 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.67 -21.93 32.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.831 0.348 . . . . 72.340000000000003 110.914 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.707 ' NE2' HD22 ' A' ' 122' ' ' LEU . 5.6 m-70 -129.18 -166.72 1.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 74.329999999999998 110.844 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 79.1 t -128.99 118.76 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 65.439999999999998 111.152 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.82 132.57 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 41.109999999999999 111.103 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.425 ' CB ' HG21 ' A' ' 29' ' ' VAL . 22.7 p90 -155.13 30.1 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 64.209999999999994 110.878 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -168.39 173.99 43.14 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.717 -0.754 . . . . 63.100000000000001 112.476 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 7.2 pttt -175.49 135.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 63.329999999999998 110.892 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' ' 136' ' ' MET . 71.2 t -40.58 105.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 75.140000000000001 111.114 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -59.36 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 71.329999999999998 110.903 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -154.19 -178.72 7.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 64.109999999999999 110.887 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.91 31.13 60.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 73.310000000000002 112.514 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.503 ' HB2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -57.09 -24.63 55.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 72.010000000000005 110.867 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.41 -30.63 19.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 74.120000000000005 110.859 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.642 HD12 ' HB3' ' A' ' 17' ' ' LEU . 40.0 mm -65.15 -38.85 83.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 65.140000000000001 111.113 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 74.6 t -63.44 -30.4 49.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 65.230000000000004 111.179 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -76.49 -28.83 56.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 74.099999999999994 110.841 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.48 -41.3 60.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 54.450000000000003 111.102 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.417 ' SD ' HG21 ' A' ' 10' ' ' ILE . 33.8 mtm -61.35 -51.28 69.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 53.229999999999997 110.831 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.66 -25.52 27.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 72.239999999999995 110.951 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.418 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.84 -25.07 61.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 73.310000000000002 110.868 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.418 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 70.9 m-85 -105.98 10.47 32.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 72.439999999999998 110.895 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.8 165.18 13.32 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.792 -0.718 . . . . 62.439999999999998 112.452 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.0 m -108.67 148.02 31.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 74.239999999999995 110.841 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 -75.95 60.73 1.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 72.239999999999995 110.843 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -163.38 -38.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 74.540000000000006 110.875 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 158.38 -50.99 0.41 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.789 -0.72 . . . . 30.41 112.492 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.03 174.14 7.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 55.0 110.886 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.8 p -144.36 -170.39 3.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 54.240000000000002 111.181 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 63.4 m -98.23 -67.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 52.5 110.843 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.492 ' HB3' HG13 ' A' ' 12' ' ' VAL . 1.4 mttp -76.89 -175.88 3.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 73.340000000000003 110.896 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.52 109.8 18.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.433 . . . . 75.439999999999998 110.879 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.495 HG23 HG23 ' A' ' 10' ' ' ILE . 4.2 mp -86.37 114.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 73.030000000000001 111.098 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.41 164.4 20.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 64.129999999999995 111.173 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.4 mt -103.89 125.65 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 64.409999999999997 111.099 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -87.93 -54.51 4.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 73.450000000000003 111.144 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -142.2 150.73 41.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 75.310000000000002 110.851 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -156.88 146.75 20.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 22.440000000000001 110.878 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.66 164.18 24.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.767 -0.73 . . . . 43.149999999999999 112.518 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.409 ' HB2' HG22 ' A' ' 41' ' ' THR . 1.3 tt0 -57.68 111.43 1.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 64.310000000000002 110.882 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.666 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.1 mm? -54.36 -51.22 65.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 72.25 110.93 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 71.010000000000005 110.872 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.458 -0.031 0 CA-C-O 120.861 0.362 . . . . 52.229999999999997 111.151 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -106.08 141.53 22.93 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.608 0.718 . . . . 61.310000000000002 110.906 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 147.19 62.49 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.686 2.257 . . . . 74.319999999999993 112.322 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -130.96 140.85 50.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 71.099999999999994 111.174 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.509 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.5 m -135.14 142.47 39.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 62.420000000000002 111.114 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.558 ' HB3' HD21 ' A' ' 164' ' ' LEU . 11.7 p90 -103.37 161.71 13.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 74.109999999999999 110.923 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.745 ' CD2' HD13 ' A' ' 158' ' ' ILE . 4.6 m-85 -144.45 89.18 1.98 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 110.889 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.6 OUTLIER -51.17 103.24 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 61.109999999999999 110.838 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.513 HG13 HG21 ' A' ' 20' ' ' VAL . 29.8 mm -75.85 136.75 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 62.509999999999998 111.126 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -128.16 152.98 47.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.040000000000006 111.131 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 t -135.97 94.98 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.438 . . . . 62.409999999999997 111.116 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.74 31.27 4.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.439999999999998 110.859 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.02 -22.18 40.48 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.714 -0.755 . . . . 75.209999999999994 112.492 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -94.23 117.41 67.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.676 0.751 . . . . 55.219999999999999 110.859 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.75 124.56 11.2 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.683 2.255 . . . . 64.219999999999999 112.364 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.522 ' HB3' HD12 ' A' ' 138' ' ' ILE . 8.9 mt -68.87 -39.13 80.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 63.130000000000003 110.953 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.52 -135.93 4.62 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 64.340000000000003 112.433 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.32 134.33 55.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 53.140000000000001 110.917 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.513 HG21 HG13 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -145.79 102.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 73.209999999999994 111.137 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -111.44 172.36 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 64.409999999999997 110.852 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.41 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -143.97 130.95 20.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 64.310000000000002 110.894 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.403 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 25.9 tt0 -84.42 100.38 11.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.519999999999996 110.896 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.459 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 1.7 mt -84.99 127.77 34.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 70.340000000000003 110.911 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.42 ' CD1' HD13 ' A' ' 90' ' ' LEU . 46.7 m-85 -86.79 68.55 10.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 75.019999999999996 110.865 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.76 -23.9 32.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 70.409999999999997 111.077 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.5 -34.86 78.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 72.340000000000003 110.833 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 -27.45 14.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 75.230000000000004 110.901 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.422 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -139.42 66.78 37.18 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.636 0.732 . . . . 71.109999999999999 111.096 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -36.66 10.39 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.687 2.258 . . . . 73.329999999999998 112.3 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -37.56 80.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 74.450000000000003 110.834 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.7 m -88.53 -45.65 9.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 54.539999999999999 111.116 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.76 -38.66 82.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 72.310000000000002 111.11 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -51.22 -35.26 35.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 75.340000000000003 110.917 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -64.21 -63.18 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 75.430000000000007 110.888 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -56.93 -39.82 75.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 73.340000000000003 110.892 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.51 -47.29 76.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 72.530000000000001 110.856 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.68 74.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 75.109999999999999 111.129 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.2 mt -77.26 -54.8 6.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 72.329999999999998 110.904 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.0 m -51.67 -41.97 61.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 61.020000000000003 110.861 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -76.24 -34.44 59.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 73.329999999999998 111.103 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.26 -11.45 56.97 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.699 -0.762 . . . . 73.150000000000006 112.46 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -59.82 -18.77 46.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 62.200000000000003 110.905 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.614 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -49.23 -28.35 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 70.239999999999995 110.859 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.52 -26.03 5.26 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.798 -0.715 . . . . 53.219999999999999 112.518 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -158.67 -46.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 74.129999999999995 110.862 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.92 -149.8 43.99 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.775 -0.726 . . . . 75.040000000000006 112.498 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -179.45 92.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.954 0.407 . . . . 73.219999999999999 110.94 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.86 82.64 6.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 72.420000000000002 110.946 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 179.06 -68.34 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.71 -0.757 . . . . 41.130000000000003 112.511 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.463 ' O ' HG22 ' A' ' 157' ' ' THR . 0.7 OUTLIER 48.36 -166.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 54.130000000000003 110.839 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.1 p -176.86 122.56 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 52.229999999999997 110.875 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.406 ' CD1' HG22 ' A' ' 156' ' ' ILE . 24.7 m-85 -84.13 128.81 34.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 74.140000000000001 110.846 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -129.57 35.55 4.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 74.540000000000006 110.84 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.19 100.74 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 74.409999999999997 110.87 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.7 mt -140.65 113.98 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.478 . . . . 62.229999999999997 111.141 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.412 ' O ' HG22 ' A' ' 57' ' ' ILE . 6.8 mt -113.9 113.02 47.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.592 0.711 . . . . 74.239999999999995 111.091 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 81.28 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.67 2.247 . . . . 44.409999999999997 112.388 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.38 -25.73 0.29 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 73.209999999999994 112.461 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.43 -57.37 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.884 0.373 . . . . 62.399999999999999 110.914 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 170.0 169.32 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 53.240000000000002 110.877 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.0 m -92.51 -165.78 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 63.509999999999998 110.893 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 176.49 142.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 61.409999999999997 110.968 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.739 . . . . 53.299999999999997 112.488 -179.97 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.614 HG22 ' HD2' ' A' ' 44' ' ' LYS . 5.9 pt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.807 0.337 . . . . 71.010000000000005 111.114 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -170.92 55.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 72.099999999999994 110.912 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.03 177.83 51.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.744 . . . . 43.509999999999998 112.476 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -52.23 -28.3 18.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.954 0.407 . . . . 73.439999999999998 110.86 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.555 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 179.84 -175.58 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 74.129999999999995 110.905 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.431 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -142.38 -179.06 6.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 75.349999999999994 110.935 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.2 168.07 20.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 51.030000000000001 110.86 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -70.87 132.45 45.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 74.530000000000001 110.899 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -89.39 -70.11 0.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 75.409999999999997 110.886 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -172.01 172.79 4.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 73.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.9 36.78 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 73.329999999999998 110.829 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -49.64 -30.73 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 73.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.42 HD13 ' CD1' ' A' ' 25' ' ' PHE . 20.6 mt -110.42 68.13 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 74.439999999999998 110.893 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.67 156.19 14.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 62.140000000000001 110.913 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -61.76 92.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 72.140000000000001 110.8 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.4 p -105.35 24.82 11.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 62.200000000000003 111.121 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.39 177.93 27.41 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.704 -0.76 . . . . 73.0 112.478 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 172.9 11.74 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.674 2.249 . . . . 73.349999999999994 112.357 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.17 38.1 95.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.723 -0.751 . . . . 43.43 112.473 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 97' ' ' ILE . 24.1 mm -110.69 134.37 53.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.868 0.366 . . . . 72.109999999999999 111.155 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.518 HD22 ' CG ' ' A' ' 112' ' ' PHE . 1.6 mt -100.81 156.6 17.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 72.140000000000001 110.921 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 t 175.85 126.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 65.450000000000003 110.883 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.437 ' HE3' ' HA ' ' A' ' 110' ' ' SER . 3.7 mmt -50.55 162.06 0.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 73.030000000000001 110.888 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.447 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . . . -158.0 95.12 1.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 75.209999999999994 111.108 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -118.07 -21.94 8.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 51.009999999999998 110.884 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.84 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -179.0 -32.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 64.239999999999995 111.112 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.09 -82.36 0.33 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.705 -0.759 . . . . 71.239999999999995 112.478 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 117.32 5.01 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.638 2.225 . . . . 72.319999999999993 112.368 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.424 ' O ' HG23 ' A' ' 107' ' ' THR . 5.6 m-80 40.22 41.79 1.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 75.25 110.936 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.84 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 7.2 p -155.73 56.0 0.61 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.165 -0.471 . . . . 74.239999999999995 111.075 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 100' ' ' MET . 1.5 m-20 -66.1 -42.56 89.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 75.319999999999993 110.948 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.78 -152.91 52.82 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.737 -0.744 . . . . 74.310000000000002 112.459 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.437 ' HA ' ' HE3' ' A' ' 100' ' ' MET . 0.3 OUTLIER -130.17 21.42 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.859 0.362 . . . . 53.039999999999999 110.877 -179.703 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.439 ' O ' ' CG ' ' A' ' 111' ' ' GLN . 5.2 tt0 -116.26 87.94 2.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 73.420000000000002 110.908 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.518 ' CG ' HD22 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -84.88 -165.15 1.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.43 . . . . 72.439999999999998 110.834 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -153.36 165.69 34.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 70.310000000000002 110.896 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.57 HG21 ' CG1' ' A' ' 139' ' ' VAL . 2.4 mp -100.06 90.88 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 72.310000000000002 111.124 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 53.2 m -66.08 89.96 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 52.229999999999997 110.889 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.3 p -67.68 -8.11 32.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 74.349999999999994 111.099 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.704 ' O ' HG23 ' A' ' 119' ' ' THR . . . -145.9 153.3 40.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 111.138 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -56.57 94.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 63.530000000000001 110.918 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 117' ' ' ALA . 24.2 p -96.73 45.99 1.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 71.209999999999994 111.148 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -24.66 67.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 64.340000000000003 110.842 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.686 ' CZ2' HG22 ' A' ' 119' ' ' THR . 5.9 p90 -48.51 -27.62 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 72.329999999999998 110.929 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.6 mt -45.83 -34.42 3.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 72.010000000000005 110.919 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 124' ' ' GLY . 1.7 m-20 62.17 78.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 62.009999999999998 110.834 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.07 43.07 0.63 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 60.399999999999999 112.494 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 -17.28 43.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.773 0.321 . . . . 74.109999999999999 110.875 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -143.24 -165.48 2.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 71.439999999999998 110.897 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.0 t -126.21 130.22 72.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.432 . . . . 73.329999999999998 111.114 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.9 135.86 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 65.129999999999995 111.15 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.452 ' O ' HD23 ' A' ' 24' ' ' LEU . 12.8 p90 -159.33 38.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 74.209999999999994 110.865 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -178.12 173.77 46.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.73 -0.748 . . . . 51.140000000000001 112.459 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -174.99 140.0 0.51 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.854 0.359 . . . . 74.219999999999999 110.887 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.695 HG11 ' HG2' ' A' ' 136' ' ' MET . 42.0 t -40.65 107.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 65.109999999999999 111.151 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.403 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -72.15 -59.96 2.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 64.420000000000002 110.849 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -154.43 152.33 30.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 63.25 110.911 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.37 41.86 6.39 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.742 -0.742 . . . . 73.019999999999996 112.493 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.695 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -60.08 -33.7 72.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.838 0.351 . . . . 63.140000000000001 110.902 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -36.31 31.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.439 . . . . 75.150000000000006 110.91 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.522 HD12 ' HB3' ' A' ' 17' ' ' LEU . 38.3 mm -63.86 -38.97 83.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 54.509999999999998 111.088 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.57 ' CG1' HG21 ' A' ' 114' ' ' ILE . 76.2 t -66.63 -24.34 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 61.009999999999998 111.139 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.08 -27.33 30.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 73.319999999999993 110.902 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.17 59.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 53.329999999999998 111.112 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 31.7 mtm -60.0 -54.11 49.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 73.040000000000006 110.888 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.48 ' OE1' ' HA ' ' A' ' 143' ' ' GLU . 10.4 mm-40 -54.84 -28.89 53.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 55.25 110.899 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.451 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -64.22 -24.3 67.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 64.239999999999995 110.83 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.451 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 69.0 m-85 -106.85 32.5 4.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 110.863 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.65 170.63 15.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 73.430000000000007 112.471 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.5 t -127.37 146.97 50.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.887 0.375 . . . . 71.349999999999994 110.861 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.1 mmm-85 -72.83 77.29 1.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 73.230000000000004 110.897 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -174.45 -35.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 60.130000000000003 110.891 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.89 -77.5 0.24 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.705 -0.759 . . . . 73.230000000000004 112.5 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.17 168.94 9.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 71.319999999999993 110.882 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.9 p -144.16 -173.76 4.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 60.210000000000001 111.182 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.0 p -86.85 -63.03 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 72.549999999999997 110.834 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -66.2 173.54 3.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 72.230000000000004 110.86 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -122.79 109.65 14.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 75.349999999999994 110.886 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 156' ' ' ILE . 4.2 mp -85.86 119.59 34.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 73.239999999999995 111.124 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -132.83 163.61 28.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 60.32 111.156 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.745 HD13 ' CD2' ' A' ' 8' ' ' PHE . 5.1 mt -102.45 128.35 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 75.099999999999994 111.14 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -91.65 -59.55 2.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 64.310000000000002 111.109 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -134.59 155.77 49.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 63.439999999999998 110.894 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.66 143.93 4.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 64.019999999999996 110.859 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.89 173.23 43.15 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 53.409999999999997 112.483 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -64.59 140.63 58.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 65.099999999999994 110.888 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.558 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -93.28 -57.68 2.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 75.109999999999999 110.938 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 65.219999999999999 110.886 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.816 0.341 . . . . 64.129999999999995 110.885 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.5 t -140.39 131.94 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 55.420000000000002 111.126 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -103.75 152.15 38.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.659 0.742 . . . . 74.519999999999996 110.839 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 146.7 60.82 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.661 2.24 . . . . 74.019999999999996 112.359 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -131.89 141.28 49.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 70.230000000000004 111.178 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.498 ' HA ' HD23 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -135.69 144.26 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 74.540000000000006 111.14 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 18.7 p90 -101.94 165.22 11.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 75.129999999999995 110.873 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.674 ' CD2' HD13 ' A' ' 158' ' ' ILE . 7.2 m-85 -146.95 91.99 2.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 70.549999999999997 110.873 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.6 OUTLIER -54.99 101.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 72.530000000000001 110.888 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.462 ' CG1' HG21 ' A' ' 20' ' ' VAL . 49.7 mm -82.07 119.17 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 53.25 111.078 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -107.71 157.79 17.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 55.240000000000002 111.144 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.413 HG13 ' HB3' ' A' ' 154' ' ' LYS . 42.2 t -137.26 95.98 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 70.510000000000005 111.08 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.49 31.48 10.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 73.0 110.872 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.57 -22.6 38.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.711 -0.757 . . . . 33.409999999999997 112.469 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -94.7 115.41 65.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.638 0.732 . . . . 72.140000000000001 110.902 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.72 123.62 10.3 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.656 2.238 . . . . 71.329999999999998 112.381 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.467 ' HB3' HG23 ' A' ' 138' ' ' ILE . 13.8 mt -67.07 -39.54 86.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 64.420000000000002 110.953 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.4 -131.15 2.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.825 -0.702 . . . . 73.340000000000003 112.522 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.54 137.04 54.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.818 0.342 . . . . 63.340000000000003 110.867 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.537 ' CG2' HG21 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -146.1 99.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 73.219999999999999 111.132 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -107.87 173.28 6.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 64.450000000000003 110.844 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.42 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -145.94 134.47 22.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 75.209999999999994 110.892 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 49.2 tt0 -83.78 98.47 9.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 71.510000000000005 110.879 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.618 HD23 ' O ' ' A' ' 129' ' ' PHE . 4.3 mt -79.63 115.88 19.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 72.200000000000003 110.942 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -76.0 64.97 1.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 74.129999999999995 110.855 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.63 -22.54 23.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 50.240000000000002 111.103 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -66.5 -35.68 80.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 70.099999999999994 110.886 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.62 -28.87 12.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 74.329999999999998 110.926 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.14 66.52 60.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.616 0.722 . . . . 65.430000000000007 111.111 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -37.2 9.56 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.737 2.291 . . . . 70.040000000000006 112.335 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -63.48 -38.17 90.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 65.019999999999996 110.882 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 m -85.9 -41.29 15.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 75.340000000000003 111.153 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.22 -44.78 82.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 75.140000000000001 111.139 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -49.55 -30.23 8.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.010000000000005 110.881 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -67.68 -68.92 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 73.420000000000002 110.88 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -55.27 -25.62 34.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 75.430000000000007 110.94 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.476 ' O ' HG23 ' A' ' 41' ' ' THR . 0.8 OUTLIER -78.52 -55.57 5.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 74.329999999999998 110.885 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.76 -34.66 28.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 63.100000000000001 111.12 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 mt -75.8 -61.98 1.74 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 55.020000000000003 110.91 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.0 m -51.92 -33.92 39.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 53.32 110.858 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 37' ' ' ARG . 73.3 p -76.51 -31.99 58.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 65.049999999999997 111.113 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.01 -15.55 60.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 72.340000000000003 112.528 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -19.16 45.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.869 0.366 . . . . 60.509999999999998 110.888 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.776 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -51.41 -28.94 14.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 71.430000000000007 110.941 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.05 -25.25 6.13 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.739 -0.743 . . . . 54.229999999999997 112.453 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -158.08 -47.68 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.894 0.378 . . . . 72.340000000000003 110.907 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.61 -145.88 47.13 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.72 -0.752 . . . . 75.209999999999994 112.467 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -179.75 92.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.925 0.393 . . . . 73.019999999999996 110.956 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.22 85.45 6.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 74.129999999999995 110.911 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.2 -66.14 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.736 -0.745 . . . . 62.310000000000002 112.523 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.427 ' O ' HG22 ' A' ' 157' ' ' THR . 1.3 m 49.05 -166.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 75.400000000000006 110.9 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.8 147.64 16.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 64.019999999999996 110.892 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -128.73 120.58 26.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 61.25 110.876 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -144.61 42.98 1.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 73.310000000000002 110.864 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.413 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.69 72.88 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 75.540000000000006 110.88 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.697 ' CD1' HD13 ' A' ' 156' ' ' ILE . 4.8 mt -112.59 113.35 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 54.32 111.134 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.405 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 28.9 mt -104.58 103.05 37.81 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.712 . . . . 60.240000000000002 111.121 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 53.4 Cg_endo -69.85 89.56 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.691 2.261 . . . . 71.129999999999995 112.329 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.92 -19.45 1.97 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.71 -0.757 . . . . 53.350000000000001 112.445 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.78 -54.08 1.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 73.519999999999996 110.841 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.446 ' HE1' ' O ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER 173.27 171.35 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 73.540000000000006 110.883 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.446 ' O ' ' HE1' ' A' ' 61' ' ' MET . 7.1 m -111.28 -154.16 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 72.239999999999995 110.846 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 55' ' ' ARG . 10.6 tp-100 -134.68 163.38 29.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 70.540000000000006 110.893 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.71 -103.24 2.83 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.757 -0.735 . . . . 70.120000000000005 112.488 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.05 139.21 5.76 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 75.319999999999993 112.5 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.69 146.06 52.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 64.019999999999996 110.807 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -167.77 121.58 0.95 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 55.25 110.887 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.38 -57.72 0.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 74.400000000000006 111.173 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.43 35.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 74.310000000000002 110.917 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.05 -35.77 10.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 75.25 110.802 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -116.62 -35.6 4.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 74.129999999999995 110.851 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 132.55 144.0 5.19 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.741 . . . . 51.450000000000003 112.494 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.4 p 62.92 30.21 16.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.321 . . . . 71.420000000000002 111.143 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.4 -165.54 0.33 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 72.319999999999993 112.46 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -151.23 -131.62 1.81 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.698 -0.763 . . . . 43.039999999999999 112.481 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -175.11 -167.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.349 . . . . 74.510000000000005 110.887 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.404 ' O ' ' CG1' ' A' ' 78' ' ' ILE . 7.3 p -90.16 42.61 1.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.436 . . . . 60.219999999999999 110.905 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.776 HG22 ' HD2' ' A' ' 44' ' ' LYS . 4.1 pt 44.51 28.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 62.409999999999997 111.085 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -174.31 58.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 74.319999999999993 110.892 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.54 -160.41 53.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.784 -0.722 . . . . 61.329999999999998 112.51 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.26 -40.88 59.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 73.450000000000003 110.902 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.532 ' HG2' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER 173.45 -177.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 74.120000000000005 110.878 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.35 -165.94 1.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 72.109999999999999 110.869 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.83 165.51 12.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 65.5 110.884 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -51.44 119.38 4.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.927 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -91.59 -69.16 0.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 72.010000000000005 110.857 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -177.25 177.14 1.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 74.519999999999996 110.909 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.42 36.89 3.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 110.892 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 mt -48.15 -33.63 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 60.240000000000002 111.128 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 22.1 mt -106.83 89.28 2.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 72.510000000000005 110.901 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.698 ' O ' HG23 ' A' ' 93' ' ' THR . 0.1 OUTLIER -79.25 139.23 37.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 73.409999999999997 110.911 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -49.71 101.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 74.349999999999994 110.851 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 91' ' ' LYS . 74.2 p -115.88 28.38 8.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 72.530000000000001 111.121 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.32 178.01 24.81 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 74.329999999999998 112.5 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 173.5 10.81 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.677 2.251 . . . . 75.239999999999995 112.338 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.12 32.8 85.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 75.340000000000003 112.496 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.5 mm -105.91 137.55 35.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.84 0.352 . . . . 54.439999999999998 111.159 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.519 HD21 ' CD1' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -105.16 144.86 31.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 73.329999999999998 110.958 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.58 -163.05 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 74.230000000000004 110.846 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.491 ' HE2' ' HB ' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -123.12 140.92 52.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.497 . . . . 72.200000000000003 110.859 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.794 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -139.55 34.85 2.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 45.439999999999998 111.083 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 2.5 t30 -70.43 -19.08 63.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 62.549999999999997 110.923 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.74 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . 176.64 -31.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 43.100000000000001 111.101 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.63 -89.28 0.49 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 60.210000000000001 112.495 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 117.24 4.97 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.638 2.226 . . . . 75.099999999999994 112.353 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.493 ' O ' HG23 ' A' ' 107' ' ' THR . 82.9 m-20 45.11 54.61 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 63.130000000000003 110.867 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.74 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 11.1 p -157.96 60.46 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.209999999999994 111.123 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.48 ' O ' ' C ' ' A' ' 109' ' ' GLY . 2.1 m-20 -66.05 -30.71 71.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 70.439999999999998 110.887 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 30.52 -116.14 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.749 . . . . 74.340000000000003 112.519 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.0 p -167.17 40.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.837 0.351 . . . . 62.43 110.85 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.794 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 5.5 mm100 -108.86 50.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 72.109999999999999 110.916 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.519 ' CD1' HD21 ' A' ' 98' ' ' LEU . 34.6 p90 -54.49 -176.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 75.510000000000005 110.857 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.726 ' CE2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -160.87 91.7 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 63.240000000000002 110.951 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 113' ' ' PHE . 3.0 mt -33.28 105.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 74.209999999999994 111.116 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.452 ' SG ' HG23 ' A' ' 119' ' ' THR . 41.8 t -69.59 100.51 1.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 52.219999999999999 110.914 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 13.1 p -83.94 11.31 7.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 74.439999999999998 111.146 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.49 ' O ' ' C ' ' A' ' 118' ' ' LYS . . . 177.37 124.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 73.230000000000004 111.072 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 117' ' ' ALA . 1.0 OUTLIER -30.22 105.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 71.400000000000006 110.879 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.836 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 71.0 p -87.75 73.51 9.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.5 111.144 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -69.8 -27.09 64.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 63.240000000000002 110.889 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.836 ' CZ2' HG22 ' A' ' 119' ' ' THR . 17.6 p90 -55.86 -22.47 25.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 70.5 110.906 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.682 HD12 ' OG1' ' A' ' 119' ' ' THR . 83.2 mt -77.95 -55.91 4.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 74.439999999999998 110.878 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 53.48 95.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 71.420000000000002 110.827 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 43.17 37.78 3.34 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 32.210000000000001 112.517 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.62 -11.48 48.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 63.310000000000002 110.863 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -148.46 -163.79 1.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 73.540000000000006 110.838 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.491 ' HB ' ' HE2' ' A' ' 100' ' ' MET . 25.0 t -122.09 116.03 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 73.439999999999998 111.139 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.19 134.48 27.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 71.510000000000005 111.149 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.618 ' O ' HD23 ' A' ' 24' ' ' LEU . 15.7 p90 -157.2 54.79 0.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 63.009999999999998 110.891 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.458 ' C ' ' HB2' ' A' ' 98' ' ' LEU . . . 169.92 176.29 39.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.764 -0.731 . . . . 72.340000000000003 112.486 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 132' ' ' VAL . 10.1 pttt -178.89 131.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.792 0.329 . . . . 53.539999999999999 110.905 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.724 HG11 ' HG2' ' A' ' 136' ' ' MET . 48.0 t -36.08 108.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 75.230000000000004 111.13 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.405 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -72.46 -59.33 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 64.530000000000001 110.897 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -152.93 158.35 41.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 65.120000000000005 110.896 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.16 30.94 24.11 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 73.010000000000005 112.475 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.724 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -50.93 -29.42 12.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 62.219999999999999 110.853 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.67 -33.8 35.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 62.329999999999998 110.876 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.537 HG21 ' CG2' ' A' ' 20' ' ' VAL . 44.5 mm -66.06 -44.34 92.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 62.030000000000001 111.131 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.9 t -63.96 -26.34 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 63.229999999999997 111.129 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.5 -30.72 47.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 73.420000000000002 110.857 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.92 -43.39 68.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 60.140000000000001 111.103 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 27.9 mtm -58.58 -43.98 89.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 73.140000000000001 110.859 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 8.7 tm-20 -54.25 -26.65 30.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 64.420000000000002 110.897 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -28.45 52.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 62.340000000000003 110.893 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -103.16 31.61 4.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 73.340000000000003 110.862 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -120.05 152.86 16.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 70.430000000000007 112.499 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.3 t -103.03 144.29 31.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.886 0.374 . . . . 73.0 110.865 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -73.57 65.28 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 62.240000000000002 110.832 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -175.35 -34.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 61.229999999999997 110.883 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.21 -70.9 0.34 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 61.149999999999999 112.482 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.21 170.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 75.109999999999999 110.882 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.4 t -159.48 158.85 32.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 62.509999999999998 111.113 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 86.0 p -75.38 -53.92 7.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.010000000000005 110.859 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.413 ' HB3' HG13 ' A' ' 12' ' ' VAL . 5.9 mttp -73.01 155.52 39.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 75.010000000000005 110.924 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -109.2 109.36 20.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 61.409999999999997 110.921 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.697 HD13 ' CD1' ' A' ' 56' ' ' ILE . 3.6 mp -90.81 123.06 42.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.447 . . . . 74.340000000000003 111.155 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -135.77 162.53 32.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 61.299999999999997 111.123 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.674 HD13 ' CD2' ' A' ' 8' ' ' PHE . 8.4 mt -95.69 120.76 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 70.140000000000001 111.142 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -85.32 -49.39 8.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 62.409999999999997 111.087 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -146.23 156.31 43.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 62.049999999999997 110.88 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.408 ' HA ' ' CE1' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -165.55 144.95 6.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 54.439999999999998 110.901 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.46 171.68 42.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 60.130000000000003 112.493 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -65.35 141.74 58.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 71.120000000000005 110.864 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.554 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.1 mm? -93.48 -56.47 2.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 63.109999999999999 110.892 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 75.430000000000007 110.874 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.865 0.364 . . . . 71.109999999999999 110.875 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 2' ' ' VAL . 3.9 t 61.7 106.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 75.310000000000002 111.125 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 -103.13 152.67 38.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.629 0.728 . . . . 63.310000000000002 110.911 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 146.54 60.22 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.641 2.227 . . . . 73.340000000000003 112.356 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -133.05 141.58 48.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 62.439999999999998 111.165 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.504 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.0 OUTLIER -134.24 143.21 38.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 74.230000000000004 111.16 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 16.6 p90 -100.94 166.37 10.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 75.400000000000006 110.871 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.588 ' CE2' HD13 ' A' ' 158' ' ' ILE . 5.9 m-85 -146.67 87.29 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 73.010000000000005 110.895 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.743 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.7 t0 -50.59 102.45 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 75.409999999999997 110.834 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.663 HG22 HD12 ' A' ' 17' ' ' LEU . 45.9 mm -80.59 128.89 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 55.399999999999999 111.121 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -122.39 154.24 37.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 111.129 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.476 HG13 ' HB3' ' A' ' 154' ' ' LYS . 41.5 t -132.44 94.24 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 63.310000000000002 111.109 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.15 31.37 13.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 65.5 110.905 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.88 -24.77 27.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.754 . . . . 51.140000000000001 112.513 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -91.44 114.57 62.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.62 0.724 . . . . 54.240000000000002 110.916 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.71 122.91 9.59 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.729 2.286 . . . . 62.509999999999998 112.34 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.663 HD12 HG22 ' A' ' 10' ' ' ILE . 12.4 mt -68.26 -38.7 82.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 73.329999999999998 110.949 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.97 -128.21 2.11 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.727 -0.749 . . . . 71.450000000000003 112.49 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.47 136.86 53.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 74.010000000000005 110.861 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.465 HG21 HG13 ' A' ' 10' ' ' ILE . 0.9 OUTLIER -146.35 102.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 64.109999999999999 111.18 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.0 OUTLIER -109.06 174.77 5.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 64.519999999999996 110.841 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.438 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.9 OUTLIER -144.85 132.66 21.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 71.349999999999994 110.924 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.4 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 60.1 tt0 -86.63 97.35 10.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 74.209999999999994 110.878 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.404 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.6 mt -80.69 119.74 23.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 74.120000000000005 110.91 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -78.35 65.19 3.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 74.099999999999994 110.868 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.45 -23.49 10.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 111.1 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -66.85 -31.92 72.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 72.25 110.827 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -101.82 -31.63 10.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 71.439999999999998 110.871 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.48 66.27 69.69 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.588 0.709 . . . . 61.039999999999999 111.169 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -39.85 6.1 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.669 2.246 . . . . 72.519999999999996 112.348 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -36.45 70.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 75.340000000000003 110.942 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.2 m -91.33 -47.91 7.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 71.040000000000006 111.151 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.4 -46.66 80.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 52.530000000000001 111.085 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -54.66 -26.05 30.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 61.130000000000003 110.864 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.569 ' HA ' HD13 ' A' ' 78' ' ' ILE . 0.8 OUTLIER -69.48 -65.31 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 64.129999999999995 110.931 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.95 -24.38 64.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 71.219999999999999 110.918 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.503 ' O ' HG23 ' A' ' 41' ' ' THR . 2.3 ttp180 -80.34 -53.15 6.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 75.219999999999999 110.858 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.04 -34.79 22.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 71.530000000000001 111.075 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 35' ' ' ASN . 3.0 mt -79.52 -59.5 2.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 65.450000000000003 110.944 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.6 m -52.65 -32.16 40.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 43.140000000000001 110.907 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 37' ' ' ARG . 71.3 p -77.51 -52.65 8.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 74.439999999999998 111.19 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.23 -17.86 7.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.741 . . . . 70.340000000000003 112.497 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -33.83 37.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.923 0.392 . . . . 72.150000000000006 110.869 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -58.52 -29.42 66.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 71.340000000000003 110.908 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.16 -13.18 60.36 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.781 -0.723 . . . . 64.040000000000006 112.486 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -160.05 -166.03 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.887 0.375 . . . . 64.150000000000006 110.903 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.54 -140.97 7.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 74.420000000000002 112.468 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -157.73 50.77 0.43 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.971 0.415 . . . . 72.219999999999999 110.912 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 142.16 21.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 72.409999999999997 110.899 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.86 21.22 73.12 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.71 -0.757 . . . . 71.450000000000003 112.464 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.11 -26.68 28.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.829 0.347 . . . . 71.329999999999998 110.85 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 0.1 OUTLIER 68.38 155.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 75.230000000000004 110.915 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -95.18 138.65 32.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 72.129999999999995 110.916 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -119.38 30.46 7.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 63.030000000000001 110.842 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -176.34 117.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 44.420000000000002 110.897 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.3 mt -146.11 114.1 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 51.049999999999997 111.135 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.6 mt -106.59 103.05 44.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.69 0.757 . . . . 74.400000000000006 111.149 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.8 Cg_endo -69.74 76.71 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.672 2.248 . . . . 55.310000000000002 112.374 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.04 -26.47 0.32 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.755 -0.736 . . . . 53.030000000000001 112.483 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.408 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -117.56 -57.47 2.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 73.510000000000005 110.853 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.449 ' C ' ' HE3' ' A' ' 61' ' ' MET . 0.0 OUTLIER 176.24 170.55 0.43 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 63.119999999999997 110.851 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 13.2 m -112.98 -177.51 3.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 64.219999999999999 110.869 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -170.6 140.39 1.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 52.509999999999998 110.922 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.52 -144.93 4.13 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.752 -0.737 . . . . 71.109999999999999 112.482 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 52.46 32.63 38.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.727 -0.749 . . . . 71.239999999999995 112.479 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -92.28 113.17 25.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.827 0.346 . . . . 64.319999999999993 110.866 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.497 ' O ' HG23 ' A' ' 68' ' ' THR . 13.8 p90 -167.52 28.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 73.510000000000005 110.885 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER 179.62 107.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 64.340000000000003 111.201 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 70' ' ' HIS . 3.6 mmm180 -116.8 -76.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 74.430000000000007 110.888 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.477 ' CB ' ' O ' ' A' ' 69' ' ' ARG . 1.9 t-80 81.43 -25.51 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 65.349999999999994 110.889 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -179.38 36.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 74.109999999999999 110.919 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.44 106.38 0.29 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.692 -0.766 . . . . 73.109999999999999 112.464 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.6 t 177.46 -48.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.846 0.355 . . . . 74.010000000000005 111.132 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.0 134.58 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.719 -0.753 . . . . 45.43 112.494 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.43 169.27 0.46 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.76 -0.733 . . . . 74.209999999999994 112.476 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -147.1 169.14 19.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.736 0.303 . . . . 72.439999999999998 110.874 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.0 p -83.84 -170.71 3.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 51.140000000000001 110.882 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 35' ' ' ASN . 41.8 pt -107.01 31.54 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 75.409999999999997 111.07 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -130.77 -67.49 0.72 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 110.903 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -137.81 -65.25 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.749 . . . . 43.130000000000003 112.503 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -145.21 -40.06 0.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.887 0.375 . . . . 61.43 110.918 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.408 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.58 179.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 75.140000000000001 110.899 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.61 177.73 8.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 61.32 110.891 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.04 169.47 17.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 72.230000000000004 110.908 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -49.94 163.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 71.540000000000006 110.852 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -120.94 -74.5 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 54.140000000000001 110.854 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -165.22 169.4 16.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 63.219999999999999 110.902 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.42 37.63 3.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 73.209999999999994 110.883 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -50.22 -29.37 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.488 . . . . 65.349999999999994 111.111 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 34.7 mt -111.97 80.52 1.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 75.140000000000001 110.898 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.76 153.16 43.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 74.109999999999999 110.915 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -60.44 94.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 70.310000000000002 110.848 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 p -105.75 25.12 11.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 74.329999999999998 111.134 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.66 179.48 24.62 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.761 -0.733 . . . . 61.530000000000001 112.499 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 171.09 15.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.681 2.254 . . . . 62.0 112.351 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.23 29.28 70.46 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.687 -0.768 . . . . 61.32 112.499 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.1 mm -102.82 138.38 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.861 0.362 . . . . 71.319999999999993 111.137 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -109.32 144.2 37.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 73.349999999999994 110.926 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.84 -168.75 2.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 65.439999999999998 110.828 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.41 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 1.8 mtp -105.81 99.97 9.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.497 . . . . 75.420000000000002 110.854 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.721 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -87.64 50.11 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 61.229999999999997 111.082 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -86.59 -78.28 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 75.099999999999994 110.886 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.693 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -146.53 34.01 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 73.109999999999999 111.108 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.36 -111.7 4.39 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.788 -0.72 . . . . 74.420000000000002 112.466 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 111.43 2.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.701 2.267 . . . . 70.109999999999999 112.339 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.536 ' C ' HG23 ' A' ' 107' ' ' THR . 1.7 m-20 72.09 163.72 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 71.450000000000003 110.867 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.693 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.1 p 67.27 29.57 7.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 74.340000000000003 111.125 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.37 78.29 8.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 73.409999999999997 110.849 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -72.35 -71.97 1.0 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 62.009999999999998 112.526 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.41 ' HA ' ' HE2' ' A' ' 100' ' ' MET . 2.7 p 177.29 49.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.783 0.325 . . . . 74.040000000000006 110.86 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.482 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 1.8 mm-40 -64.02 -31.1 72.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 71.140000000000001 110.922 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.482 ' HB3' ' O ' ' A' ' 111' ' ' GLN . 8.2 t80 67.71 139.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 74.219999999999999 110.877 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.721 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -161.08 123.14 3.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 73.299999999999997 110.894 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.9 mt -86.4 126.59 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 74.129999999999995 111.094 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.05 101.07 13.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 62.240000000000002 110.897 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 73.9 p -86.99 20.98 2.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 64.019999999999996 111.151 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.762 ' O ' HG23 ' A' ' 119' ' ' THR . . . 175.59 146.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 72.209999999999994 111.092 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 98.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 63.439999999999998 110.851 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.762 HG23 ' O ' ' A' ' 117' ' ' ALA . 32.8 p -106.51 46.69 0.91 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 74.340000000000003 111.163 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -26.51 64.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 65.549999999999997 110.88 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.738 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.3 p90 -49.5 -25.42 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 70.150000000000006 110.951 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 18.1 mt -45.72 -32.19 2.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 70.530000000000001 110.936 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.5 m-20 59.47 77.21 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 75.230000000000004 110.848 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.15 42.23 0.78 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.793 -0.718 . . . . 63.210000000000001 112.46 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -80.59 -26.39 37.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.831 0.348 . . . . 74.010000000000005 110.906 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -136.21 169.03 18.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.409999999999997 110.853 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 50.0 t -102.43 118.53 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 44.240000000000002 111.155 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.02 133.72 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 72.310000000000002 111.129 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.404 ' O ' HD23 ' A' ' 24' ' ' LEU . 21.2 p90 -156.25 33.91 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 62.119999999999997 110.918 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.89 176.11 44.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.712 -0.756 . . . . 73.049999999999997 112.471 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -175.71 135.06 0.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.833 0.349 . . . . 63.109999999999999 110.913 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.682 HG11 ' HG2' ' A' ' 136' ' ' MET . 70.2 t -39.7 107.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 72.239999999999995 111.15 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.4 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -69.62 -59.13 3.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 74.040000000000006 110.908 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -152.78 157.79 41.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 51.0 110.879 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.64 42.95 9.52 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.731 -0.747 . . . . 73.409999999999997 112.472 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.682 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -62.41 -29.04 70.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.328 . . . . 61.109999999999999 110.882 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.86 -31.95 42.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 53.25 110.867 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.545 HD12 ' HB3' ' A' ' 17' ' ' LEU . 45.9 mm -65.21 -40.0 87.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 53.340000000000003 111.099 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.49 -27.75 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 73.450000000000003 111.129 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -80.13 -28.46 38.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 110.868 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.02 -38.72 63.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 74.420000000000002 111.122 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 28.2 mtm -60.7 -52.63 64.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 72.239999999999995 110.894 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -54.51 -26.32 30.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 44.329999999999998 110.95 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.433 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.37 -23.98 63.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 62.32 110.857 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.433 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 64.8 m-85 -107.66 16.11 24.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 75.129999999999995 110.839 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -110.67 168.55 13.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 61.310000000000002 112.497 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.8 m -113.71 146.71 39.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 43.210000000000001 110.847 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -75.72 66.43 2.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.091 -0.504 . . . . 72.319999999999993 110.883 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -171.11 -37.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 70.420000000000002 110.863 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 159.13 -63.15 0.3 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 63.229999999999997 112.472 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.49 175.52 0.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.377 . . . . 72.150000000000006 110.879 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.7 p -145.12 176.69 9.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 65.340000000000003 111.127 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.24 -60.66 1.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.329999999999998 110.853 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.476 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.7 OUTLIER -86.21 -175.77 5.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 75.219999999999999 110.918 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.96 108.73 15.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 53.439999999999998 110.901 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 4.1 mp -83.74 117.96 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 74.129999999999995 111.103 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER -126.12 165.87 18.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 43.350000000000001 111.186 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.588 HD13 ' CE2' ' A' ' 8' ' ' PHE . 4.0 mt -103.87 106.08 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 73.530000000000001 111.142 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.743 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -65.49 -44.96 85.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 73.439999999999998 111.144 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -161.45 158.04 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 74.299999999999997 110.845 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.2 148.27 16.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 72.099999999999994 110.876 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.09 171.77 41.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.713 -0.756 . . . . 73.510000000000005 112.466 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -65.19 142.45 58.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.871 0.367 . . . . 74.409999999999997 110.888 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.576 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -94.54 -58.75 2.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 72.430000000000007 110.918 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 70.409999999999997 110.932 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.5 mtp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.803 0.335 . . . . 71.219999999999999 110.868 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.3 t -137.2 134.69 47.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 111.136 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -108.62 146.31 33.42 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.621 0.724 . . . . 65.239999999999995 110.885 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 146.45 60.42 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.673 2.249 . . . . 74.450000000000003 112.373 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 m -133.19 140.22 47.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 62.409999999999997 111.139 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.493 ' HA ' HD23 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -134.21 144.67 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 70.150000000000006 111.108 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.598 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 17.8 p90 -103.13 168.43 9.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 71.510000000000005 110.897 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.595 ' CE2' HD13 ' A' ' 158' ' ' ILE . 4.6 m-85 -148.22 87.71 1.61 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 72.519999999999996 110.891 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.713 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.4 t70 -51.34 103.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 74.439999999999998 110.888 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.598 HG22 HD12 ' A' ' 17' ' ' LEU . 40.7 mm -81.96 135.81 24.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 51.149999999999999 111.099 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -128.19 155.05 45.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.010000000000005 111.084 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' A' ' 154' ' ' LYS . 22.2 t -135.54 96.17 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 65.329999999999998 111.092 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 66.86 30.76 7.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 72.129999999999995 110.908 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.57 -23.74 33.09 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 73.109999999999999 112.517 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -91.99 117.3 67.65 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.639 0.733 . . . . 54.219999999999999 110.922 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.4 Cg_endo -69.79 124.45 11.08 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.661 2.241 . . . . 72.439999999999998 112.324 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.615 ' HB3' HD12 ' A' ' 138' ' ' ILE . 12.0 mt -68.98 -38.82 79.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 52.25 110.878 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.96 -129.38 2.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 75.239999999999995 112.447 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.41 137.05 54.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 74.340000000000003 110.891 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.506 HG21 HG13 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -146.26 100.21 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 74.140000000000001 111.128 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.4 t -108.67 175.26 5.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 73.219999999999999 110.811 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.442 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -146.34 130.47 17.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 71.439999999999998 110.874 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -83.5 100.78 10.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 73.010000000000005 110.892 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.9 mt -82.84 123.57 29.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 74.299999999999997 110.907 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -82.26 63.55 6.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 75.150000000000006 110.911 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.86 -23.44 12.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 54.020000000000003 111.079 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -64.48 -37.95 89.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 70.299999999999997 110.854 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.59 -29.06 13.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 72.200000000000003 110.875 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.429 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -132.7 64.92 73.14 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.6 0.714 . . . . 61.439999999999998 111.181 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -38.18 8.14 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.664 2.243 . . . . 74.219999999999999 112.344 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.36 -37.98 79.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 72.25 110.903 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.5 m -88.61 -45.07 10.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 70.319999999999993 111.137 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.03 -47.01 86.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 75.030000000000001 111.147 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -50.56 -31.08 14.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 74.109999999999999 110.891 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.81 -62.85 1.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 74.349999999999994 110.907 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.19 -22.61 61.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 71.319999999999993 110.865 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 41' ' ' THR . 1.8 ttp180 -83.08 -56.94 3.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 73.040000000000006 110.875 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.35 -29.69 10.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 73.439999999999998 111.156 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.452 HD21 HG22 ' A' ' 78' ' ' ILE . 37.9 mt -80.13 -60.89 2.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 72.329999999999998 110.908 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.0 m -55.3 -36.01 65.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 73.140000000000001 110.831 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 37' ' ' ARG . 69.1 p -69.23 -31.97 70.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 72.230000000000004 111.135 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.15 -18.11 58.03 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.775 -0.726 . . . . 51.450000000000003 112.492 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.54 -32.33 40.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 63.420000000000002 110.871 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -60.78 -28.22 68.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 73.319999999999993 110.923 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.19 -15.17 56.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.749 . . . . 62.420000000000002 112.478 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -158.31 -165.4 1.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.877 0.37 . . . . 74.310000000000002 110.927 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.424 ' HA2' HD22 ' A' ' 39' ' ' LEU . . . 156.62 -166.74 33.42 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.723 -0.751 . . . . 70.310000000000002 112.468 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -103.73 15.06 29.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.974 0.416 . . . . 74.319999999999993 110.955 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.53 140.05 2.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 63.350000000000001 110.913 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.64 28.85 60.5 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.699 -0.762 . . . . 40.43 112.483 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.68 ' O ' HG22 ' A' ' 157' ' ' THR . 2.8 m -79.45 -177.16 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.383 . . . . 55.420000000000002 110.814 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.0 p -139.73 127.76 22.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 70.129999999999995 110.846 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -75.66 128.77 35.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 74.109999999999999 110.856 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -128.8 37.3 4.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 73.430000000000007 110.872 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.04 81.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 73.019999999999996 110.918 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.469 HD12 HD13 ' A' ' 156' ' ' ILE . 2.6 mt -117.9 117.97 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 75.120000000000005 111.127 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.406 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 28.8 mt -112.27 103.88 55.65 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.613 0.72 . . . . 72.030000000000001 111.104 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.2 Cg_endo -69.79 92.0 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.678 2.252 . . . . 53.210000000000001 112.304 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.74 -17.4 2.81 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 71.510000000000005 112.505 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.9 -53.96 1.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 74.040000000000006 110.874 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.65 174.21 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 73.420000000000002 110.911 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 9.3 m -113.04 -162.4 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 73.420000000000002 110.881 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 174.51 143.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 72.230000000000004 110.941 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.51 169.42 41.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 61.219999999999999 112.485 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.94 89.87 1.79 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.788 -0.72 . . . . 51.340000000000003 112.487 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -155.09 100.3 2.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.863 0.363 . . . . 73.329999999999998 110.824 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -129.06 36.78 4.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 70.030000000000001 110.901 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -92.05 66.26 4.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 54.420000000000002 111.133 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.24 -35.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 75.040000000000006 110.888 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -48.48 -35.53 13.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 50.009999999999998 110.826 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -137.14 24.52 3.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 71.219999999999999 110.893 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.416 ' C ' HG23 ' A' ' 73' ' ' THR . . . 65.35 114.22 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.722 -0.752 . . . . 73.0 112.456 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.416 HG23 ' C ' ' A' ' 72' ' ' GLY . 1.4 p 63.71 30.64 14.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.34 . . . . 75.019999999999996 111.155 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -51.83 -87.89 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.732 -0.747 . . . . 73.099999999999994 112.505 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -49.52 130.92 26.25 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 51.340000000000003 112.498 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -173.51 151.99 2.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 73.299999999999997 110.898 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.404 ' HG ' ' C ' ' A' ' 80' ' ' GLY . 59.0 p -51.62 150.0 4.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 63.240000000000002 110.857 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.452 HG22 HD21 ' A' ' 39' ' ' LEU . 2.1 pp -61.55 -33.45 57.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 71.409999999999997 111.143 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -76.2 -34.64 59.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 64.219999999999999 110.969 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.404 ' C ' ' HG ' ' A' ' 77' ' ' SER . . . 170.16 -113.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 72.430000000000007 112.487 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -78.95 -44.18 23.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.91 0.386 . . . . 72.010000000000005 110.907 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.432 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.4 170.29 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 73.140000000000001 110.925 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.73 166.25 13.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 75.120000000000005 110.913 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.75 166.34 18.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 71.140000000000001 110.875 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -54.23 145.73 16.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 74.200000000000003 110.833 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -104.91 -69.98 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 72.239999999999995 110.922 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -176.38 177.35 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 71.239999999999995 110.918 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.28 37.11 3.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 71.129999999999995 110.892 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.22 -34.61 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 74.239999999999995 111.132 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.7 mt -112.02 78.03 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 72.099999999999994 110.904 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.455 ' O ' HG23 ' A' ' 93' ' ' THR . 2.0 mtpm? -70.1 144.16 52.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 72.120000000000005 110.936 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -51.03 99.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 50.509999999999998 110.816 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 91' ' ' LYS . 25.7 p -111.8 28.96 8.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 74.200000000000003 111.138 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.45 179.64 26.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.701 -0.762 . . . . 65.200000000000003 112.507 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 163.99 36.22 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.653 2.235 . . . . 64.5 112.384 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.29 37.85 54.13 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 54.200000000000003 112.466 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.2 mm -110.19 139.9 31.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.914 0.388 . . . . 75.430000000000007 111.071 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -107.66 146.09 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 73.310000000000002 110.87 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.81 -158.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 75.319999999999993 110.865 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.413 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 0.9 OUTLIER -130.4 136.83 49.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 74.519999999999996 110.89 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -120.52 100.4 7.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 54.32 111.069 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -151.16 -41.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 71.5 110.928 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.722 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -178.86 34.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 63.200000000000003 111.078 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.13 -109.99 1.77 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 72.109999999999999 112.492 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 115.19 3.98 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.708 2.272 . . . . 63.009999999999998 112.313 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.557 ' C ' HG23 ' A' ' 107' ' ' THR . 1.7 m-20 73.24 169.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 71.120000000000005 110.921 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.722 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 0.7 OUTLIER 65.86 27.16 11.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 61.219999999999999 111.187 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -75.78 144.37 41.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 74.040000000000006 110.871 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.32 -100.33 0.63 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.731 -0.747 . . . . 74.420000000000002 112.471 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.413 ' HA ' ' HE2' ' A' ' 100' ' ' MET . 21.9 p -158.09 37.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.839 0.352 . . . . 73.450000000000003 110.873 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.677 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 7.0 mm-40 -110.22 58.71 0.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 73.420000000000002 110.854 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.431 ' CD2' HD21 ' A' ' 98' ' ' LEU . 45.5 p90 -58.19 -171.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 74.299999999999997 110.88 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.549 ' O ' ' C ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -160.88 78.36 0.6 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 74.349999999999994 110.874 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.549 ' C ' ' O ' ' A' ' 113' ' ' PHE . 4.9 mt -25.1 105.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 54.329999999999998 111.119 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 37.3 t -70.29 101.57 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 71.430000000000007 110.89 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 47.9 p -90.53 21.98 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 72.129999999999995 111.185 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 116' ' ' THR . . . 173.25 127.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 73.140000000000001 111.16 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 117' ' ' ALA . 2.1 tttt -36.77 108.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 72.219999999999999 110.956 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.812 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 61.4 p -95.06 71.33 3.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 72.349999999999994 111.155 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -68.62 -26.61 65.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 72.25 110.873 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.812 ' CZ2' HG22 ' A' ' 119' ' ' THR . 17.9 p90 -56.28 -19.99 16.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 74.409999999999997 110.907 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.649 HD12 ' OG1' ' A' ' 119' ' ' THR . 82.9 mt -80.81 -54.66 5.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 52.549999999999997 110.897 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 52.47 95.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 65.230000000000004 110.88 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 42.29 41.91 4.12 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.768 -0.73 . . . . 54.240000000000002 112.478 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -91.21 -9.95 43.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.828 0.347 . . . . 70.099999999999994 110.898 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -146.73 -169.99 3.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 65.230000000000004 110.827 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.6 t -115.56 109.83 29.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 60.140000000000001 111.085 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 t -88.64 136.05 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 74.530000000000001 111.112 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.464 ' O ' HD23 ' A' ' 24' ' ' LEU . 13.5 p90 -157.93 40.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 72.409999999999997 110.878 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -176.32 175.47 47.48 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.701 -0.761 . . . . 62.009999999999998 112.465 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 6.4 pttt -176.1 136.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 74.310000000000002 110.929 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.698 HG11 ' HG2' ' A' ' 136' ' ' MET . 53.3 t -38.62 108.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 62.420000000000002 111.155 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.69 -58.88 3.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.867 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -153.51 158.76 41.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 73.030000000000001 110.919 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.63 31.94 28.75 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.737 -0.744 . . . . 72.510000000000005 112.522 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.698 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -52.07 -33.51 39.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.775 0.322 . . . . 60.329999999999998 110.901 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -34.29 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 62.119999999999997 110.876 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.615 HD12 ' HB3' ' A' ' 17' ' ' LEU . 40.2 mm -63.81 -41.63 93.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 72.129999999999995 111.135 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.8 t -64.48 -24.87 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 54.119999999999997 111.175 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -81.62 -28.85 33.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 63.039999999999999 110.855 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.68 -38.9 64.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 74.200000000000003 111.094 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.0 mtm -59.04 -52.9 63.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 72.230000000000004 110.892 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -55.42 -25.51 36.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 63.420000000000002 110.92 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.438 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -70.02 -23.76 63.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 72.299999999999997 110.833 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.438 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 62.1 m-85 -108.24 20.8 18.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 70.049999999999997 110.879 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.01 164.96 12.35 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.789 -0.719 . . . . 62.399999999999999 112.499 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.1 m -107.41 146.93 31.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.86 0.362 . . . . 60.119999999999997 110.855 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.7 mmm-85 -74.28 69.93 1.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 72.120000000000005 110.861 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -174.44 -36.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 74.409999999999997 110.914 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 150.58 -52.22 0.51 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 65.349999999999994 112.433 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.45 -176.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.912 0.387 . . . . 72.010000000000005 110.89 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -164.93 155.97 14.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.445 . . . . 73.319999999999993 111.127 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 80.7 p -82.49 -54.75 4.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 75.310000000000002 110.905 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.486 ' HB3' HG13 ' A' ' 12' ' ' VAL . 1.4 mttp -79.12 177.34 8.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 74.510000000000005 110.908 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -121.41 108.55 13.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 72.019999999999996 110.882 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.469 HD13 HD12 ' A' ' 56' ' ' ILE . 4.2 mp -86.01 116.65 29.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 73.120000000000005 111.139 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -126.67 162.72 25.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 74.239999999999995 111.092 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.595 HD13 ' CE2' ' A' ' 8' ' ' PHE . 5.7 mt -101.86 116.02 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 61.130000000000003 111.109 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -74.88 -47.91 27.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 31.329999999999998 111.105 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -159.69 157.08 28.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 71.450000000000003 110.837 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.0 146.83 17.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 62.310000000000002 110.873 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.4 172.98 44.17 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.801 -0.714 . . . . 52.43 112.533 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -64.97 142.51 58.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 63.439999999999998 110.938 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -93.22 -59.93 1.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 72.230000000000004 110.883 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 74.540000000000006 110.909 179.951 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.3 mtp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.867 0.365 . . . . 50.329999999999998 110.839 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.0 t -140.86 134.84 33.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 54.409999999999997 111.119 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -110.63 154.0 43.34 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.615 0.721 . . . . 63.409999999999997 110.885 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 146.35 60.02 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.719 2.279 . . . . 72.420000000000002 112.316 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.6 m -128.6 127.8 42.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 45.0 111.179 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.415 HG13 ' CD1' ' A' ' 24' ' ' LEU . 3.3 m -123.63 177.84 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 74.329999999999998 111.164 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.673 ' HB3' HD21 ' A' ' 164' ' ' LEU . 2.2 p90 -160.61 178.27 9.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 75.120000000000005 110.867 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -155.96 95.25 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 73.099999999999994 110.901 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 3.5 t70 -45.37 108.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 71.109999999999999 110.839 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.644 HG23 HG23 ' A' ' 156' ' ' ILE . 22.9 mm -79.38 129.34 37.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 72.109999999999999 111.097 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -121.96 137.46 54.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 73.5 111.133 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -120.73 93.25 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 41.399999999999999 111.1 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.46 36.3 6.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 73.549999999999997 110.908 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.91 -16.4 61.24 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.71 -0.757 . . . . 64.209999999999994 112.474 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -102.33 109.56 60.68 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.646 0.736 . . . . 61.020000000000003 110.904 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.7 Cg_endo -69.78 127.03 13.99 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.653 2.235 . . . . 74.299999999999997 112.324 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.461 ' HB3' HD12 ' A' ' 138' ' ' ILE . 9.9 mt -67.34 -39.03 85.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 73.129999999999995 110.913 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.45 -120.82 0.97 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 21.440000000000001 112.44 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -134.91 140.86 46.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 75.010000000000005 110.907 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.523 HG21 HG13 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -142.43 93.12 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 72.329999999999998 111.124 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.4 t -95.35 174.19 7.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 71.019999999999996 110.833 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.434 ' N ' ' OG ' ' A' ' 21' ' ' SER . 56.5 m-85 -147.33 143.21 27.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 73.099999999999994 110.856 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -96.5 95.74 8.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 72.430000000000007 110.863 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 129' ' ' PHE . 2.0 mt -78.85 124.93 28.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 75.5 110.906 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.91 63.11 7.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 71.420000000000002 110.872 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.39 -23.65 10.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 71.040000000000006 111.098 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -62.68 -39.89 95.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 55.240000000000002 110.846 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -98.27 -28.7 13.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 71.129999999999995 110.887 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.467 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -131.05 63.89 71.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.64 0.733 . . . . 44.420000000000002 111.1 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -36.55 10.73 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.707 2.272 . . . . 54.229999999999997 112.385 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -38.73 92.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 74.310000000000002 110.918 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.5 m -85.22 -42.3 14.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 72.430000000000007 111.13 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.67 -42.84 95.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 74.150000000000006 111.097 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -49.36 -30.59 7.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 61.149999999999999 110.922 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.529 ' HA ' HD13 ' A' ' 78' ' ' ILE . 4.1 t30 -68.58 -70.4 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 74.219999999999999 110.905 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.09 -32.12 21.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 62.340000000000003 110.862 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.521 ' O ' HG23 ' A' ' 41' ' ' THR . 0.1 OUTLIER -75.36 -54.51 6.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 73.439999999999998 110.856 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.93 -37.3 43.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 74.530000000000001 111.115 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 mt -79.19 -58.54 3.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 55.420000000000002 110.919 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.8 m -50.13 -35.22 24.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 60.149999999999999 110.857 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 37' ' ' ARG . 80.4 p -79.07 -54.39 6.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 75.510000000000005 111.145 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.28 -16.14 7.18 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.748 . . . . 74.420000000000002 112.453 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -53.86 -27.43 29.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 62.509999999999998 110.907 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HE2' HG21 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -60.28 -17.38 41.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 64.019999999999996 110.939 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.07 -11.93 70.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 62.420000000000002 112.53 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -163.34 -168.33 1.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 63.340000000000003 110.907 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.51 -137.51 5.38 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 32.140000000000001 112.476 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -168.07 88.59 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.909 0.385 . . . . 75.530000000000001 110.949 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -79.98 82.87 5.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.079 -0.51 . . . . 71.120000000000005 110.884 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.58 -62.02 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 23.52 112.488 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.459 ' O ' HG22 ' A' ' 157' ' ' THR . 20.3 m 51.11 -169.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.816 0.341 . . . . 73.319999999999993 110.889 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.6 p -176.09 122.75 0.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 71.420000000000002 110.882 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -91.4 108.19 19.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 72.540000000000006 110.936 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -113.68 28.25 8.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.140000000000001 110.822 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.04 95.39 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 72.319999999999993 110.875 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 56' ' ' ILE . 3.7 mt -126.29 116.38 45.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 45.200000000000003 111.127 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.408 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 26.6 mt -108.57 104.84 55.57 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.616 0.722 . . . . 62.229999999999997 111.129 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.8 Cg_endo -69.82 88.31 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.24 . . . . 71.040000000000006 112.356 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.98 -18.67 1.96 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 70.140000000000001 112.491 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.0 -55.18 1.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 74.200000000000003 110.846 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 173.4 172.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 64.239999999999995 110.907 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 11.4 m -108.57 -160.46 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 75.109999999999999 110.918 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 176.49 140.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 51.240000000000002 110.913 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.75 137.02 2.16 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.813 -0.708 . . . . 71.549999999999997 112.54 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.58 39.41 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.692 -0.766 . . . . 64.230000000000004 112.432 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -96.94 124.53 40.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.842 0.353 . . . . 73.209999999999994 110.882 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -150.7 72.61 1.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 65.099999999999994 110.868 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.55 -42.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 64.549999999999997 111.113 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -179.48 173.51 1.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 73.329999999999998 110.893 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -108.06 36.22 2.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 73.450000000000003 110.87 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -113.01 -70.05 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 73.530000000000001 110.879 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.18 46.12 0.22 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.793 -0.717 . . . . 54.32 112.532 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.8 p -100.92 -55.05 2.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.788 0.327 . . . . 55.229999999999997 111.156 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.08 30.62 38.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.757 -0.735 . . . . 35.439999999999998 112.487 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.75 -148.33 31.87 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 45.310000000000002 112.5 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.06 155.03 11.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.816 0.341 . . . . 73.120000000000005 110.879 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.441 ' HG ' ' HE1' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -95.94 58.42 1.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 75.310000000000002 110.859 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 35' ' ' ASN . 40.4 pt 40.54 34.41 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 74.120000000000005 111.166 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -165.72 51.27 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 71.219999999999999 110.892 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.54 -173.24 55.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.751 -0.738 . . . . 72.510000000000005 112.481 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -53.41 -24.67 13.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.398 . . . . 62.299999999999997 110.921 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.521 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -174.7 176.97 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 74.010000000000005 110.861 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.441 ' HE1' ' HG ' ' A' ' 77' ' ' SER . 4.4 p90 -151.83 179.95 7.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 62.439999999999998 110.904 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.79 171.02 11.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 74.420000000000002 110.895 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -87.55 171.85 10.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 74.5 110.854 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -119.7 -59.45 1.81 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.468 . . . . 73.310000000000002 110.839 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.4 p30 -177.45 177.01 1.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 64.5 110.852 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.3 35.27 3.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 75.200000000000003 110.892 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mt -50.48 -32.64 10.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 73.430000000000007 111.133 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.3 mt -111.03 74.95 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 75.409999999999997 110.922 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.665 ' O ' HG23 ' A' ' 93' ' ' THR . 10.9 mtpp -70.32 147.02 50.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 63.450000000000003 110.874 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -50.88 99.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.449 . . . . 75.439999999999998 110.819 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.665 HG23 ' O ' ' A' ' 91' ' ' LYS . 77.0 p -112.66 27.62 9.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 62.140000000000001 111.125 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 147.85 -179.26 24.86 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.714 -0.755 . . . . 40.310000000000002 112.467 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 170.48 16.53 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.657 2.238 . . . . 71.319999999999993 112.337 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.4 34.28 79.35 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.74 . . . . 75.140000000000001 112.494 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.5 mm -106.49 139.43 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.915 0.388 . . . . 74.409999999999997 111.083 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -106.85 146.57 30.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 61.530000000000001 110.915 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.402 ' HG ' ' C ' ' A' ' 127' ' ' VAL . 0.1 OUTLIER -164.06 -156.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 72.120000000000005 110.852 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.4 mmt -131.73 127.61 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.077 -0.51 . . . . 72.349999999999994 110.898 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -86.88 129.35 34.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 54.229999999999997 111.145 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 172.23 -168.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 71.239999999999995 110.888 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.756 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -47.47 -50.58 22.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 64.439999999999998 111.113 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 123.53 -66.89 0.5 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 55.240000000000002 112.447 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.529 ' O ' HG23 ' A' ' 107' ' ' THR . 53.8 Cg_endo -69.75 112.84 3.18 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.62 2.214 . . . . 64.450000000000003 112.39 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.8 OUTLIER 36.88 47.3 0.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 72.400000000000006 110.857 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.756 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 21.3 p -144.54 39.31 1.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 70.129999999999995 111.132 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -76.64 140.38 40.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 74.209999999999994 110.88 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.32 -131.06 3.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 42.240000000000002 112.485 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 p -138.07 29.92 2.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.805 0.336 . . . . 74.219999999999999 110.839 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.533 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 9.3 mm-40 -116.83 72.69 0.83 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 72.299999999999997 110.939 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.416 ' HB2' ' CD2' ' A' ' 98' ' ' LEU . 34.7 p90 -57.24 -174.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 75.510000000000005 110.897 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.552 ' O ' ' C ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -159.54 78.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 72.439999999999998 110.858 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.552 ' C ' ' O ' ' A' ' 113' ' ' PHE . 3.0 mt -23.38 107.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.492 . . . . 63.200000000000003 111.171 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 34.9 t -73.01 99.4 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 64.340000000000003 110.875 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 48.9 p -88.55 20.66 3.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 63.25 111.171 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 116' ' ' THR . . . 174.17 127.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 74.140000000000001 111.13 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 117' ' ' ALA . 3.4 tttt -36.35 107.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 61.030000000000001 110.912 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.812 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 49.5 p -94.36 72.86 3.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 75.230000000000004 111.135 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -71.45 -26.92 62.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 74.329999999999998 110.876 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.812 ' CZ2' HG22 ' A' ' 119' ' ' THR . 15.7 p90 -54.35 -22.02 11.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.168 -0.469 . . . . 63.329999999999998 110.913 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.605 HD12 ' OG1' ' A' ' 119' ' ' THR . 64.1 mt -78.66 -53.12 7.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 54.450000000000003 110.881 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 54.43 95.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 61.219999999999999 110.862 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 40.43 39.88 1.81 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.76 -0.733 . . . . 41.420000000000002 112.493 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -87.07 -12.15 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 74.329999999999998 110.903 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -145.17 -164.88 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 62.149999999999999 110.82 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.402 ' C ' ' HG ' ' A' ' 99' ' ' SER . 85.8 t -121.6 111.67 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 64.400000000000006 111.104 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.1 136.85 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 70.209999999999994 111.13 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.529 ' O ' HD23 ' A' ' 24' ' ' LEU . 12.6 p90 -159.48 42.43 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 61.350000000000001 110.856 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.405 ' C ' ' HB2' ' A' ' 98' ' ' LEU . . . -175.03 178.17 46.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.81 -0.71 . . . . 71.530000000000001 112.547 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -179.39 135.35 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.82 0.343 . . . . 72.140000000000001 110.906 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.702 HG11 ' HG2' ' A' ' 136' ' ' MET . 42.7 t -40.63 111.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 61.030000000000001 111.166 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.14 -59.93 2.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 64.150000000000006 110.878 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -151.05 165.9 32.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 74.239999999999995 110.9 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.76 34.53 48.4 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 60.43 112.485 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.702 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -54.43 -23.3 15.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 71.140000000000001 110.869 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.96 -31.2 62.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.433 . . . . 73.329999999999998 110.865 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' A' ' 17' ' ' LEU . 37.4 mm -65.89 -38.3 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 75.549999999999997 111.1 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.3 t -66.58 -27.83 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 70.310000000000002 111.089 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -80.88 -30.64 35.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 73.120000000000005 110.88 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.15 -38.52 69.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 74.129999999999995 111.088 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.527 ' SD ' HG21 ' A' ' 156' ' ' ILE . 38.9 mtm -62.66 -54.0 46.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 71.319999999999993 110.894 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -55.52 -24.57 32.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 71.120000000000005 110.87 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.431 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.77 -25.04 61.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 71.120000000000005 110.867 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.431 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 72.0 m-85 -108.34 19.96 19.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 53.420000000000002 110.919 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.48 163.4 12.17 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.758 -0.734 . . . . 34.43 112.449 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.3 t -112.01 146.59 37.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 73.450000000000003 110.845 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -75.06 67.96 1.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 72.430000000000007 110.856 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -172.68 -36.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 75.530000000000001 110.88 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 156.11 -93.74 0.14 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.715 -0.755 . . . . 44.32 112.461 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -51.85 165.51 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.808 0.337 . . . . 52.450000000000003 110.919 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.5 p -143.53 -171.7 3.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 71.140000000000001 111.115 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.5 p -88.44 -62.64 1.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 75.140000000000001 110.838 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -66.06 178.06 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 74.409999999999997 110.885 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.76 107.58 10.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 110.834 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.644 HG23 HG23 ' A' ' 10' ' ' ILE . 4.9 mp -91.36 108.46 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 74.049999999999997 111.118 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -125.24 162.87 23.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 74.109999999999999 111.115 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 19.9 mt -97.58 128.38 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 72.030000000000001 111.092 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -93.85 -56.13 2.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 75.319999999999993 111.076 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -135.11 155.15 51.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 70.25 110.854 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.83 146.11 11.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 63.100000000000001 110.944 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.39 165.83 31.49 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.72 -0.752 . . . . 64.510000000000005 112.444 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.469 ' HB2' HG22 ' A' ' 41' ' ' THR . 1.4 mt-30 -61.33 107.87 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 72.340000000000003 110.934 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.673 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.7 mm? -49.75 -49.7 47.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 64.510000000000005 110.922 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 51.229999999999997 110.877 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 mtm . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.869 0.366 . . . . 71.140000000000001 110.844 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.568 ' O ' HG22 ' A' ' 2' ' ' VAL . 9.6 p -177.31 32.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 72.25 111.13 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 62.42 157.64 0.12 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.619 0.723 . . . . 75.129999999999995 110.921 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 146.4 59.99 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.679 2.253 . . . . 71.519999999999996 112.373 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -132.7 141.78 48.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 72.049999999999997 111.155 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.476 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.1 m -133.21 143.52 38.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 71.510000000000005 111.133 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.575 ' HB3' HD21 ' A' ' 164' ' ' LEU . 15.4 p90 -103.13 159.79 15.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 62.130000000000003 110.872 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.737 ' CD2' HD13 ' A' ' 158' ' ' ILE . 4.5 m-85 -143.52 87.94 1.97 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 70.430000000000007 110.847 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.7 t0 -50.95 106.09 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 74.25 110.857 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.569 HG13 HG21 ' A' ' 20' ' ' VAL . 37.5 mm -81.18 130.57 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 71.299999999999997 111.133 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -121.28 146.89 46.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 72.209999999999994 111.102 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.0 t -130.59 94.4 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 75.530000000000001 111.128 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 67.44 32.95 5.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 75.109999999999999 110.865 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.76 -19.02 56.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.707 -0.759 . . . . 71.219999999999999 112.475 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -99.28 113.68 64.97 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.63 0.729 . . . . 70.209999999999994 110.884 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.6 Cg_endo -69.81 127.01 13.93 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.67 2.247 . . . . 51.009999999999998 112.328 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.53 ' HB3' HD12 ' A' ' 138' ' ' ILE . 11.3 mt -68.4 -38.28 81.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 63.119999999999997 110.949 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.78 -125.32 1.49 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.755 -0.736 . . . . 73.299999999999997 112.497 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.92 136.42 53.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 73.319999999999993 110.908 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.569 HG21 HG13 ' A' ' 10' ' ' ILE . 1.1 t -144.81 99.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 63.219999999999999 111.145 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -109.95 172.58 6.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 64.510000000000005 110.84 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -144.48 142.56 30.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 64.109999999999999 110.901 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.463 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 47.6 tt0 -98.22 99.58 10.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 71.239999999999995 110.9 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.5 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 2.2 mt -80.25 122.46 26.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 71.230000000000004 110.936 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.41 ' O ' HG23 ' A' ' 29' ' ' VAL . 55.2 m-85 -75.59 65.53 1.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 63.130000000000003 110.911 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.55 -22.6 13.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 72.209999999999994 111.102 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -63.61 -46.21 86.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 60.329999999999998 110.883 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -91.06 -30.38 16.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.430000000000007 110.88 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.468 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -131.03 67.11 80.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.653 0.74 . . . . 64.010000000000005 111.14 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -39.61 6.28 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.652 2.234 . . . . 74.450000000000003 112.346 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -37.05 85.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.878 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 m -85.15 -40.81 16.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 41.539999999999999 111.168 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.9 -48.59 68.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 63.009999999999998 111.088 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -49.52 -32.91 13.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 75.439999999999998 110.854 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.04 -50.62 69.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 72.140000000000001 110.902 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.417 ' HD2' HD11 ' A' ' 24' ' ' LEU . 4.0 t80 -69.55 -44.29 71.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 71.450000000000003 110.829 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.412 ' O ' HG23 ' A' ' 41' ' ' THR . 1.7 ttp180 -63.96 -35.47 80.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.898 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.97 92.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 44.020000000000003 111.107 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.424 HD11 HG23 ' A' ' 78' ' ' ILE . 3.2 mt -74.39 -45.94 43.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 63.219999999999999 110.903 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 m -57.49 -45.31 85.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 75.409999999999997 110.855 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.479 HG22 ' HB2' ' A' ' 163' ' ' GLN . 74.8 p -72.15 -48.64 41.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.104 -0.498 . . . . 64.349999999999994 111.11 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.74 -13.67 10.72 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.707 -0.759 . . . . 63.299999999999997 112.52 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -50.46 -34.57 25.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.856 0.36 . . . . 72.319999999999993 110.88 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -53.36 -27.97 26.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 74.400000000000006 110.882 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.87 -11.29 60.76 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 52.340000000000003 112.488 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -162.36 -165.79 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 71.439999999999998 110.88 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.95 -133.57 3.65 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.696 -0.764 . . . . 43.119999999999997 112.435 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -175.33 91.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.955 0.407 . . . . 74.129999999999995 110.906 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -80.68 78.02 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 75.420000000000002 110.864 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 158' ' ' ILE . . . 179.39 -66.66 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 51.240000000000002 112.502 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.483 ' O ' HG22 ' A' ' 157' ' ' THR . 1.3 m 49.19 -167.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 73.430000000000007 110.818 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.46 129.36 1.03 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 53.009999999999998 110.857 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -94.52 106.84 18.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.447 . . . . 53.049999999999997 110.864 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.0 27.29 9.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 73.120000000000005 110.856 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.97 91.71 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 75.430000000000007 110.909 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.0 mt -125.86 113.04 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 52.310000000000002 111.123 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.1 mt -105.12 102.36 35.83 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.596 0.712 . . . . 74.5 111.094 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 79.32 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.665 2.244 . . . . 63.200000000000003 112.35 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.45 -25.56 0.52 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 32.229999999999997 112.477 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.33 -57.67 2.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.809 0.338 . . . . 74.329999999999998 110.867 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.44 156.77 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 73.540000000000006 110.851 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.9 m -93.11 -167.81 1.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 74.109999999999999 110.915 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 177.61 146.93 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 63.399999999999999 110.887 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.41 163.43 36.12 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.721 -0.752 . . . . 72.319999999999993 112.451 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.28 126.58 0.83 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.721 -0.752 . . . . 54.210000000000001 112.492 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -157.41 70.32 0.6 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.889 0.375 . . . . 74.010000000000005 110.883 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -74.72 -75.59 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 63.530000000000001 110.865 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 t -147.82 69.08 1.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 70.430000000000007 111.144 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -125.57 -36.8 2.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 62.329999999999998 110.875 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.4 m170 63.72 56.24 1.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 74.25 110.86 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -167.01 -42.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 74.319999999999993 110.899 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 126.48 33.57 0.66 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.71 -0.757 . . . . 62.409999999999997 112.431 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.5 p -145.41 37.62 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.81 0.338 . . . . 61.409999999999997 111.147 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.77 -167.09 43.31 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.725 -0.75 . . . . 62.140000000000001 112.519 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.81 113.35 3.8 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 72.439999999999998 112.547 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.28 178.92 6.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 63.210000000000001 110.9 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.38 150.41 20.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 53.520000000000003 110.886 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.424 HG23 HD11 ' A' ' 39' ' ' LEU . 1.2 pp -53.01 -32.27 18.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 73.5 111.16 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -72.37 -34.28 67.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 74.329999999999998 110.879 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.25 -140.72 6.44 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.763 -0.732 . . . . 63.549999999999997 112.49 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -64.26 -35.27 80.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.935 0.398 . . . . 73.439999999999998 110.882 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.457 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.5 168.0 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 75.430000000000007 110.909 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -141.12 179.81 6.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 73.140000000000001 110.859 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.07 160.09 33.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 72.409999999999997 110.902 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.9 152.64 45.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 72.129999999999995 110.894 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -100.24 -75.81 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 70.120000000000005 110.913 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.4 p30 -166.91 173.94 8.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 52.200000000000003 110.919 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.86 34.75 3.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 72.400000000000006 110.908 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -51.03 -29.41 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 70.510000000000005 111.14 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 24.6 mt -99.99 91.7 4.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 74.409999999999997 110.878 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.9 mppp? -80.96 140.16 35.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 64.530000000000001 110.878 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -50.33 101.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 70.140000000000001 110.883 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.7 p -111.01 25.39 11.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 72.120000000000005 111.146 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 151.38 178.74 26.45 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 72.540000000000006 112.453 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 175.91 7.46 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.662 2.241 . . . . 74.230000000000004 112.332 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.86 37.11 93.81 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.69 -0.767 . . . . 70.439999999999998 112.474 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.1 mm -109.51 134.91 50.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.849 0.357 . . . . 65.010000000000005 111.118 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.537 HD22 ' CG ' ' A' ' 112' ' ' PHE . 2.8 mt -99.69 165.17 11.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 43.420000000000002 110.959 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 9.8 t -163.73 -128.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 63.210000000000001 110.83 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.599 ' HE2' ' HB ' ' A' ' 127' ' ' VAL . 28.8 mtm -150.24 143.15 24.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 52.5 110.844 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -93.58 104.13 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 63.130000000000003 111.06 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 179.8 174.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 75.200000000000003 110.896 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -50.57 -26.27 5.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 71.109999999999999 111.098 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.59 -82.93 0.33 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.709 -0.758 . . . . 64.349999999999994 112.499 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 95.06 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.687 2.258 . . . . 71.319999999999993 112.386 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.502 ' C ' HG23 ' A' ' 107' ' ' THR . 2.7 m-20 72.73 171.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 63.240000000000002 110.923 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.502 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.2 p 66.46 28.9 9.41 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 64.010000000000005 111.106 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -96.57 160.64 14.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 75.450000000000003 110.902 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.88 -132.42 3.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 45.119999999999997 112.488 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.9 t -104.48 -47.13 4.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.833 0.349 . . . . 64.5 110.86 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 2.3 pt20 -47.36 109.28 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 73.299999999999997 110.906 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.537 ' CG ' HD22 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -111.04 -164.1 0.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 74.540000000000006 110.898 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -143.81 153.0 41.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 72.540000000000006 110.859 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.0 mt -98.09 120.36 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 73.420000000000002 111.148 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 17.4 m -89.51 95.77 10.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 64.409999999999997 110.88 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 p -68.14 -8.46 38.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 71.209999999999994 111.135 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.687 ' O ' HG23 ' A' ' 119' ' ' THR . . . -147.33 154.03 40.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 40.140000000000001 111.05 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -56.66 93.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 72.219999999999999 110.894 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.69 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 26.2 p -95.74 45.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 64.200000000000003 111.114 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -25.75 67.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 64.129999999999995 110.888 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.69 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.4 p90 -48.18 -29.75 3.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.119 -0.491 . . . . 75.019999999999996 110.864 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.8 mt -45.51 -36.41 4.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 60.340000000000003 110.891 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.32 80.47 0.21 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 63.409999999999997 110.866 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 37.95 42.11 1.07 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.701 -0.762 . . . . 51.43 112.507 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.69 -14.66 47.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.824 0.345 . . . . 62.530000000000001 110.905 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -146.43 -176.47 5.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 70.329999999999998 110.871 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.599 ' HB ' ' HE2' ' A' ' 100' ' ' MET . 55.4 t -113.91 115.86 50.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 75.450000000000003 111.107 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 98' ' ' LEU . 22.4 t -92.27 132.26 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 74.319999999999993 111.133 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.468 ' CB ' HG21 ' A' ' 29' ' ' VAL . 20.2 p90 -157.1 44.78 0.38 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 110.94 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -179.34 174.76 46.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.724 -0.751 . . . . 75.129999999999995 112.474 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.02 143.43 0.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 72.329999999999998 110.886 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.741 HG11 ' HG2' ' A' ' 136' ' ' MET . 45.5 t -44.3 113.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 52.439999999999998 111.12 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.463 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -77.43 -59.82 2.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 63.530000000000001 110.906 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -152.53 155.23 37.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 64.420000000000002 110.902 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.99 36.91 10.56 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.739 . . . . 72.400000000000006 112.472 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.741 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -57.27 -27.52 62.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.785 0.326 . . . . 75.540000000000006 110.87 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.85 -32.22 60.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 60.130000000000003 110.866 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 17' ' ' LEU . 43.2 mm -66.17 -39.19 83.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 74.140000000000001 111.153 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.1 t -64.71 -26.62 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 72.409999999999997 111.165 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -81.04 -29.36 35.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 64.510000000000005 110.875 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.2 -39.5 65.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 61.140000000000001 111.092 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 35.0 mtm -61.22 -53.5 56.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 73.219999999999999 110.876 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.45 -25.41 36.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 72.420000000000002 110.934 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.435 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -70.23 -23.81 62.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 62.020000000000003 110.882 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.435 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 66.7 m-85 -108.89 20.73 18.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.400000000000006 110.863 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -111.3 171.74 14.57 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 52.32 112.482 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 t -127.9 143.29 51.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 75.319999999999993 110.868 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -71.48 79.22 0.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 64.109999999999999 110.933 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -178.91 -34.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 74.420000000000002 110.89 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.92 -83.1 0.18 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.741 . . . . 74.329999999999998 112.504 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.44 169.22 3.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 71.310000000000002 110.941 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.9 p -144.61 -171.58 3.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 72.019999999999996 111.146 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.8 p -88.64 -63.79 1.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 110.83 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -64.6 -179.68 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 74.430000000000007 110.916 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -127.71 108.81 11.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 73.099999999999994 110.899 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.14 116.54 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 74.109999999999999 111.16 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -131.69 164.93 24.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 65.099999999999994 111.112 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.737 HD13 ' CD2' ' A' ' 8' ' ' PHE . 3.7 mt -102.75 126.48 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.434 . . . . 45.049999999999997 111.123 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -90.76 -57.67 2.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 64.340000000000003 111.085 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -135.79 152.86 51.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.442 . . . . 50.210000000000001 110.849 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.32 144.38 10.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.198 -0.456 . . . . 75.430000000000007 110.924 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.18 171.28 40.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.71 -0.757 . . . . 52.049999999999997 112.518 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.479 ' HB2' HG22 ' A' ' 41' ' ' THR . 2.1 mt-30 -63.56 141.96 58.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 74.299999999999997 110.872 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.575 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.1 mm? -94.82 -59.61 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 65.219999999999999 110.906 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 73.129999999999995 110.872 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.1 mtm . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.855 0.36 . . . . 51.210000000000001 110.864 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.6 t -145.05 134.91 18.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 74.230000000000004 111.177 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -122.45 156.06 61.48 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.627 0.727 . . . . 74.120000000000005 110.891 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 146.14 59.21 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.674 2.249 . . . . 72.209999999999994 112.322 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -134.12 104.37 6.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 74.209999999999994 111.133 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -100.38 172.28 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.192 -0.458 . . . . 72.310000000000002 111.134 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.657 ' HB3' HD21 ' A' ' 164' ' ' LEU . 0.5 OUTLIER -160.16 172.98 16.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 71.209999999999994 110.9 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.41 ' HA ' ' HB3' ' A' ' 161' ' ' CYS . 32.1 m-85 -153.39 95.29 1.91 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 75.329999999999998 110.926 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.676 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.9 OUTLIER -45.2 104.59 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 70.219999999999999 110.884 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.735 HG22 HD12 ' A' ' 17' ' ' LEU . 29.7 mm -76.17 138.21 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 65.140000000000001 111.188 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.11 168.81 16.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 71.310000000000002 111.148 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.471 HG23 ' HG ' ' A' ' 17' ' ' LEU . 91.5 t -144.82 99.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 63.009999999999998 111.154 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.42 25.01 7.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 54.229999999999997 110.846 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.42 -28.3 12.0 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.725 -0.75 . . . . 60.32 112.479 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.64 125.79 70.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.73 . . . . 75.329999999999998 110.894 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 120.4 7.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.641 2.228 . . . . 74.409999999999997 112.358 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.735 HD12 HG22 ' A' ' 10' ' ' ILE . 6.5 mt -66.2 -42.02 89.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 65.25 110.922 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.88 -130.99 2.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 61.409999999999997 112.478 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.26 136.55 52.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 71.530000000000001 110.893 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.52 HG21 HG13 ' A' ' 10' ' ' ILE . 0.6 OUTLIER -143.01 100.53 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 64.340000000000003 111.179 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.435 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -109.51 172.84 6.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 71.230000000000004 110.872 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.407 ' N ' ' OG ' ' A' ' 21' ' ' SER . 43.6 m-85 -145.64 144.56 30.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 110.902 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -100.28 97.89 8.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 75.319999999999993 110.865 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.515 HD23 ' O ' ' A' ' 129' ' ' PHE . 2.3 mt -82.37 128.65 34.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 70.430000000000007 110.924 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.406 ' CD1' HD13 ' A' ' 90' ' ' LEU . 38.2 m-85 -87.16 67.3 9.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 75.420000000000002 110.932 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.57 -22.48 33.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 74.040000000000006 111.117 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -65.08 -34.16 77.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 74.310000000000002 110.882 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.2 mmtp -101.46 -31.27 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 75.420000000000002 110.927 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.406 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -132.78 65.64 74.72 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.588 0.708 . . . . 65.400000000000006 111.105 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -37.49 9.03 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.669 2.246 . . . . 74.430000000000007 112.321 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.15 -36.5 77.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 72.219999999999999 110.891 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.9 m -90.59 -41.32 11.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 65.040000000000006 111.143 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.69 -48.9 75.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 74.120000000000005 111.131 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -49.86 -34.29 19.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 74.150000000000006 110.922 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -65.25 -65.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 64.209999999999994 110.915 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -55.38 -36.51 66.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 75.540000000000006 110.875 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 41' ' ' THR . 2.2 ttp180 -68.61 -49.61 57.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 73.540000000000006 110.906 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.29 -25.15 32.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 40.329999999999998 111.084 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.24 -58.3 3.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 73.120000000000005 110.96 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.41 -38.4 83.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 72.040000000000006 110.872 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.487 HG22 ' HB2' ' A' ' 163' ' ' GLN . 42.8 p -62.59 -39.36 93.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 74.519999999999996 111.146 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.32 -19.52 31.74 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 74.150000000000006 112.493 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.71 -30.58 22.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.929 0.395 . . . . 75.129999999999995 110.905 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.567 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -59.53 -31.35 69.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 74.150000000000006 110.909 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.64 -8.97 68.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 44.25 112.458 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -169.81 -165.68 0.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.963 0.411 . . . . 73.200000000000003 110.834 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.37 -142.37 12.0 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.75 -0.738 . . . . 55.100000000000001 112.46 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -115.12 21.61 14.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.896 0.379 . . . . 74.109999999999999 110.875 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.4 125.26 12.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 75.420000000000002 110.86 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.05 36.96 93.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 75.319999999999993 112.53 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -117.3 141.11 48.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.36 . . . . 73.439999999999998 110.823 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.5 p -51.99 170.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 73.0 110.88 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.24 -173.77 4.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 75.439999999999998 110.885 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -106.56 -69.75 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 64.530000000000001 110.826 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.0 ttm-85 -137.26 160.72 38.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 71.230000000000004 110.884 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.563 HD12 HD13 ' A' ' 156' ' ' ILE . 40.5 mt -148.49 107.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 75.019999999999996 111.16 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.1 mt -106.08 104.78 51.16 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.624 0.726 . . . . 63.43 111.077 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.42 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 54.1 Cg_endo -69.77 79.29 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.67 2.247 . . . . 60.43 112.351 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.45 -26.53 0.27 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.749 . . . . 75.400000000000006 112.477 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.1 OUTLIER -120.61 -59.1 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 74.099999999999994 110.879 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.435 ' HB3' ' HA ' ' A' ' 115' ' ' CYS . 0.0 OUTLIER 170.91 156.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 73.209999999999994 110.9 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 6.6 m -85.78 -166.72 1.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 72.430000000000007 110.879 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -162.97 118.34 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 75.109999999999999 110.866 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.67 165.96 54.47 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.739 . . . . 52.310000000000002 112.495 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.34 169.1 27.4 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.737 . . . . 61.130000000000003 112.507 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.55 -175.86 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 73.420000000000002 110.857 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -132.37 -42.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.129999999999995 110.89 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.5 m -79.4 -69.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 70.439999999999998 111.092 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.24 159.18 39.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 53.439999999999998 110.915 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -123.29 -83.0 0.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 74.120000000000005 110.803 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.66 ' O ' HG22 ' A' ' 73' ' ' THR . 8.6 t-20 48.69 30.78 2.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 74.030000000000001 110.879 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 53.24 22.24 13.97 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 63.420000000000002 112.481 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 71' ' ' ASN . 6.3 t 179.22 53.53 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 72.010000000000005 111.128 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.0 -148.09 6.89 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.758 -0.734 . . . . 71.5 112.485 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.07 141.24 2.54 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.752 . . . . 70.299999999999997 112.479 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.84 161.48 35.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.784 0.326 . . . . 42.229999999999997 110.909 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.428 ' O ' ' CG1' ' A' ' 78' ' ' ILE . 59.6 p -97.89 59.41 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 52.350000000000001 110.89 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.567 HG22 ' HD2' ' A' ' 44' ' ' LYS . 14.8 pt 43.9 30.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 74.299999999999997 111.108 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.36 26.73 9.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 73.430000000000007 110.931 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.18 -70.07 2.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 32.100000000000001 112.476 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -125.42 -56.2 1.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.403 . . . . 74.549999999999997 110.909 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.437 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.36 -178.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 72.129999999999995 110.907 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -146.25 179.78 7.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 72.200000000000003 110.877 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.7 166.74 11.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 73.219999999999999 110.908 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -45.51 148.32 0.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 73.200000000000003 110.881 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -107.96 -74.66 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 75.450000000000003 110.856 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -162.11 170.47 19.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 70.409999999999997 110.89 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.22 37.95 3.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 75.420000000000002 110.925 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.37 -30.13 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 73.140000000000001 111.152 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.406 HD13 ' CD1' ' A' ' 25' ' ' PHE . 13.6 mt -110.02 84.59 1.95 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 73.150000000000006 110.92 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.467 ' O ' HG23 ' A' ' 93' ' ' THR . 23.6 mttp -71.77 146.83 47.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 64.030000000000001 110.926 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -51.69 103.23 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 73.25 110.862 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 91' ' ' LYS . 44.2 p -124.87 38.92 4.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 64.329999999999998 111.156 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.85 166.65 12.44 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.752 . . . . 71.25 112.49 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 160.11 50.91 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.698 2.265 . . . . 64.010000000000005 112.324 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.419 ' HA2' HG23 ' A' ' 132' ' ' VAL . . . 87.95 -14.53 58.53 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.69 -0.767 . . . . 65.319999999999993 112.465 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.6 mm -55.36 134.73 18.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.838 0.351 . . . . 72.340000000000003 111.131 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.664 HD22 ' HB2' ' A' ' 112' ' ' PHE . 3.8 mt -102.07 167.46 10.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 65.019999999999996 110.945 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.24 -147.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 62.299999999999997 110.878 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.407 ' HG3' ' HB3' ' A' ' 108' ' ' ASN . 6.3 mmt -145.17 124.88 13.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 71.510000000000005 110.902 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -115.31 76.36 1.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 63.520000000000003 111.109 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.447 ' ND2' ' HG3' ' A' ' 111' ' ' GLN . 0.7 OUTLIER -114.12 -40.75 3.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 72.299999999999997 110.894 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.25 25.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 70.439999999999998 111.121 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.71 -140.82 16.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.728 -0.748 . . . . 61.310000000000002 112.505 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 106' ' ' ASN . 54.0 Cg_endo -69.73 59.32 1.6 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.668 2.245 . . . . 72.200000000000003 112.355 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER 166.02 160.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 62.109999999999999 110.885 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.2 p 56.71 34.19 24.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 70.439999999999998 111.185 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.407 ' HB3' ' HG3' ' A' ' 100' ' ' MET . 1.0 OUTLIER -75.17 64.83 1.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 70.519999999999996 110.889 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -62.82 -77.85 0.2 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.748 -0.739 . . . . 75.109999999999999 112.434 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 44.0 t -164.43 43.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.342 . . . . 71.549999999999997 110.868 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.447 ' HG3' ' ND2' ' A' ' 102' ' ' ASN . 38.3 mm-40 -101.39 39.46 1.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 74.120000000000005 110.903 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.664 ' HB2' HD22 ' A' ' 98' ' ' LEU . 32.3 p90 -55.29 -178.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 74.420000000000002 110.84 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.519 ' O ' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -157.58 -175.88 5.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.118 -0.492 . . . . 71.099999999999994 110.834 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 114' ' ' ILE . 2.8 mt -121.73 93.5 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 72.439999999999998 111.151 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 61' ' ' MET . 43.9 m -69.94 87.64 0.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 61.509999999999998 110.866 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.0 p -60.91 -14.88 25.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 71.310000000000002 111.118 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 119' ' ' THR . . . -143.26 153.16 42.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 70.420000000000002 111.103 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -54.51 93.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 42.229999999999997 110.862 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.71 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 24.9 p -93.82 52.74 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 72.219999999999999 111.149 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -24.24 65.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 110.862 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.71 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.6 p90 -48.95 -29.91 5.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 72.420000000000002 110.883 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 17.9 mt -47.2 -33.52 5.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 60.329999999999998 110.924 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.5 m-20 57.85 80.36 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 74.230000000000004 110.903 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.23 43.44 0.7 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 73.109999999999999 112.502 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.72 -16.29 51.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.849 0.357 . . . . 71.329999999999998 110.956 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -143.02 -167.75 2.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 73.200000000000003 110.884 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.2 t -120.34 115.14 46.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 63.200000000000003 111.142 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 98' ' ' LEU . 27.4 t -86.91 133.76 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 74.230000000000004 111.078 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.515 ' O ' HD23 ' A' ' 24' ' ' LEU . 16.7 p90 -154.82 41.42 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.510000000000005 110.906 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . 179.38 175.99 46.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.803 -0.713 . . . . 35.340000000000003 112.507 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -175.2 142.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 73.109999999999999 110.946 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.639 HG11 ' HG2' ' A' ' 136' ' ' MET . 34.5 t -45.61 112.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 73.230000000000004 111.128 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.13 -61.02 2.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 73.439999999999998 110.893 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -155.68 147.14 22.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 63.229999999999997 110.883 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.82 38.57 4.88 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.728 -0.749 . . . . 65.420000000000002 112.495 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.639 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -61.17 -30.36 70.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.805 0.336 . . . . 64.430000000000007 110.878 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.47 -37.57 49.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 63.399999999999999 110.881 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 17' ' ' LEU . 33.0 mm -61.89 -38.54 80.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 65.430000000000007 111.091 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.437 ' CG1' HG21 ' A' ' 114' ' ' ILE . 74.6 t -67.11 -24.21 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 73.040000000000006 111.109 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.72 -28.77 28.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 72.530000000000001 110.869 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.13 -39.01 63.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 71.510000000000005 111.108 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 28.1 mtm -58.95 -52.42 65.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 70.120000000000005 110.866 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -54.26 -26.69 30.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 54.409999999999997 110.886 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.45 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.81 -24.46 63.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 72.319999999999993 110.873 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.45 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 63.1 m-85 -107.78 14.07 25.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 73.219999999999999 110.853 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -113.61 167.52 12.34 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.763 -0.732 . . . . 52.219999999999999 112.505 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.55 133.95 51.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 75.109999999999999 110.867 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -54.38 -22.69 13.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.496 . . . . 65.140000000000001 110.873 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.79 -31.27 64.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.452 . . . . 65.129999999999995 110.895 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 141.49 -40.69 1.3 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.749 -0.739 . . . . 75.450000000000003 112.53 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.57 -177.43 0.43 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 74.310000000000002 110.909 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.3 p -146.27 159.63 43.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 72.540000000000006 111.117 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.69 -58.47 2.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 65.439999999999998 110.844 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -89.48 -177.17 5.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 72.409999999999997 110.846 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -112.21 108.17 17.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 54.310000000000002 110.87 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.563 HD13 HD12 ' A' ' 56' ' ' ILE . 5.0 mp -84.65 117.73 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 64.430000000000007 111.165 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.12 164.18 22.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 74.430000000000007 111.2 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.2 mt -101.32 130.74 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 64.430000000000007 111.08 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -89.17 -53.45 4.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 74.120000000000005 111.098 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -148.33 145.69 28.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 74.010000000000005 110.847 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -149.93 146.57 27.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 71.420000000000002 110.886 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.52 161.81 21.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.714 -0.755 . . . . 73.319999999999993 112.472 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.487 ' HB2' HG22 ' A' ' 41' ' ' THR . 1.1 mt-30 -58.13 107.1 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 71.219999999999999 110.908 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.657 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.2 mm? -49.04 -54.88 13.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 71.019999999999996 110.921 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 55.240000000000002 110.864 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.827 0.346 . . . . 73.219999999999999 110.877 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.7 p -177.95 144.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 70.030000000000001 111.101 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -100.73 146.07 31.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.69 0.757 . . . . 65.219999999999999 110.854 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 152.48 69.17 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.702 2.268 . . . . 75.409999999999997 112.328 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -135.92 135.15 39.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 70.430000000000007 111.15 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.503 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.4 m -129.43 143.2 41.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 72.200000000000003 111.133 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 7.0 p90 -104.66 165.21 11.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 71.319999999999993 110.889 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.566 ' HE2' HD13 ' A' ' 158' ' ' ILE . 5.5 m-85 -147.29 86.4 1.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 72.120000000000005 110.896 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.776 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 2.1 t70 -46.76 107.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 74.439999999999998 110.855 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.557 HG13 HG21 ' A' ' 20' ' ' VAL . 46.3 mm -85.38 119.78 34.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 54.329999999999998 111.115 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -113.43 149.85 33.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 72.439999999999998 111.095 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 154' ' ' LYS . 18.2 t -133.28 98.42 2.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.451 . . . . 73.219999999999999 111.147 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.69 32.93 10.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 75.519999999999996 110.875 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.46 -18.59 57.11 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.717 -0.754 . . . . 73.140000000000001 112.486 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -98.5 114.84 65.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.651 0.739 . . . . 71.409999999999997 110.862 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.53 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.75 125.36 12.06 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.68 2.253 . . . . 73.510000000000005 112.337 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.513 HD12 HG22 ' A' ' 10' ' ' ILE . 12.6 mt -67.91 -39.05 83.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 70.519999999999996 110.873 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.19 -129.31 2.28 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.761 -0.733 . . . . 62.409999999999997 112.476 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -121.36 134.74 55.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 74.129999999999995 110.92 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.557 HG21 HG13 ' A' ' 10' ' ' ILE . 1.7 t -145.11 103.19 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 75.200000000000003 111.086 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -114.73 173.75 6.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 75.120000000000005 110.864 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.425 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.8 OUTLIER -143.57 136.8 27.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 75.109999999999999 110.922 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -91.52 98.28 11.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 75.040000000000006 110.855 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 129' ' ' PHE . 2.9 mt -80.15 125.87 30.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 64.140000000000001 110.906 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CD1' HD13 ' A' ' 90' ' ' LEU . 46.3 m-85 -83.58 63.17 7.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 62.240000000000002 110.933 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.64 -23.73 7.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 74.400000000000006 111.105 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.6 -35.1 76.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 63.409999999999997 110.855 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.51 -30.87 13.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 71.239999999999995 110.868 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.414 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -135.04 66.58 68.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.656 0.741 . . . . 73.230000000000004 111.126 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -32.71 18.04 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.664 2.243 . . . . 63.200000000000003 112.351 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -40.62 95.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 64.420000000000002 110.893 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.438 HG21 ' CD1' ' A' ' 129' ' ' PHE . 86.4 m -86.83 -44.91 11.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 73.040000000000006 111.157 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.26 82.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 63.030000000000001 111.074 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -47.62 -40.66 20.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 73.530000000000001 110.87 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.448 ' OD1' HG23 ' A' ' 78' ' ' ILE . 2.8 t30 -64.01 -63.33 1.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 74.310000000000002 110.882 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.43 -23.32 24.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 71.040000000000006 110.865 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.505 ' NH2' ' HG2' ' A' ' 163' ' ' GLN . 0.0 OUTLIER -74.54 -59.31 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 71.230000000000004 110.894 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.43 -30.3 62.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 73.099999999999994 111.126 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.3 mt -75.75 -58.29 3.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 74.030000000000001 110.869 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.6 m -49.64 -46.69 49.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 75.310000000000002 110.863 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.6 p -74.69 -28.81 60.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 54.240000000000002 111.172 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.58 -8.44 76.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.775 -0.726 . . . . 74.340000000000003 112.457 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -63.23 -15.82 58.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.874 0.368 . . . . 75.310000000000002 110.866 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HE3' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -49.48 -28.84 5.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 64.409999999999997 110.859 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.29 -25.83 5.64 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.696 -0.764 . . . . 73.129999999999995 112.431 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -160.25 -46.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 75.340000000000003 110.861 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.52 -146.22 21.48 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.766 -0.731 . . . . 53.130000000000003 112.466 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -175.44 92.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.99 0.424 . . . . 74.340000000000003 110.884 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.47 141.02 29.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 72.420000000000002 110.922 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.91 39.66 74.92 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.754 -0.736 . . . . 71.310000000000002 112.479 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.09 28.83 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 64.329999999999998 110.848 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 3.9 m 51.16 -170.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 61.140000000000001 110.885 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -105.06 -174.27 2.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 62.25 110.875 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -120.3 -72.78 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 74.019999999999996 110.808 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 45.2 ttm-85 -138.91 156.41 47.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 75.319999999999993 110.815 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.558 HD12 HD13 ' A' ' 156' ' ' ILE . 38.0 mt -147.87 113.27 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 74.140000000000001 111.143 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.5 mt -113.12 104.13 55.71 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.601 0.715 . . . . 63.119999999999997 111.178 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.4 Cg_endo -69.77 77.35 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.729 2.286 . . . . 70.209999999999994 112.327 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.01 -27.1 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.741 . . . . 64.209999999999994 112.46 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.01 -54.67 2.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 74.319999999999993 110.869 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 168.87 165.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 110.834 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.6 m -92.45 -161.25 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 52.32 110.861 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -179.57 129.58 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 72.010000000000005 110.919 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.62 75.77 0.29 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.677 -0.773 . . . . 72.430000000000007 112.43 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.45 85.81 0.41 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.717 -0.754 . . . . 51.210000000000001 112.466 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.43 111.1 16.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 75.450000000000003 110.848 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -126.76 -74.63 0.59 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 63.049999999999997 110.864 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.6 p -143.5 -41.9 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 74.010000000000005 111.165 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.78 -81.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 71.329999999999998 110.86 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.7 m170 50.0 30.33 4.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 74.299999999999997 110.853 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 t30 177.99 -74.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 73.430000000000007 110.874 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 163.9 53.72 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 74.150000000000006 112.534 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.7 t -177.79 54.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 72.409999999999997 111.17 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.57 176.0 8.98 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 73.230000000000004 112.501 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.39 110.92 1.67 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 41.119999999999997 112.47 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.52 156.18 40.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.749 0.309 . . . . 72.400000000000006 110.932 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.9 p -93.88 56.48 2.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 74.140000000000001 110.841 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.448 HG23 ' OD1' ' A' ' 35' ' ' ASN . 31.1 pt 40.23 37.11 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 63.5 111.103 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -157.38 47.79 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 63.310000000000002 110.927 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.95 -128.29 8.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.711 -0.757 . . . . 64.5 112.508 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -118.52 -27.0 6.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 72.510000000000005 110.855 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.456 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 177.32 167.58 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 74.400000000000006 110.893 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -139.6 177.51 7.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 73.400000000000006 110.894 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.16 157.17 37.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.878 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -52.73 136.24 33.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 61.020000000000003 110.899 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -91.18 -76.27 0.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 54.539999999999999 110.888 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -165.49 167.89 17.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 70.310000000000002 110.91 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.55 37.76 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 70.099999999999994 110.913 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.38 -29.91 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 71.340000000000003 111.169 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.419 HD13 ' CD1' ' A' ' 25' ' ' PHE . 13.8 mt -108.95 79.17 1.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 74.430000000000007 110.914 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 150.33 47.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 71.439999999999998 110.896 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -59.31 96.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 62.530000000000001 110.829 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.9 p -104.53 25.53 10.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 41.030000000000001 111.167 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 144.93 -179.08 22.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 43.240000000000002 112.487 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 171.82 13.75 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.715 2.277 . . . . 73.200000000000003 112.339 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.78 23.0 78.6 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 43.030000000000001 112.464 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.1 mm -99.04 142.7 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.891 0.377 . . . . 75.129999999999995 111.14 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.409 ' HB2' ' C ' ' A' ' 130' ' ' GLY . 0.2 OUTLIER -113.36 140.91 47.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 110.943 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.14 -167.15 2.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 110.858 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -100.24 104.95 16.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 74.409999999999997 110.863 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.976 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -78.42 52.37 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 74.329999999999998 111.117 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.34 -169.14 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 72.439999999999998 110.854 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.793 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -46.45 -47.59 19.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 45.009999999999998 111.074 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.67 -74.79 0.31 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.761 -0.733 . . . . 61.32 112.495 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.411 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.4 Cg_endo -69.81 111.32 2.79 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.659 2.239 . . . . 71.310000000000002 112.311 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 41.35 56.64 3.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 73.349999999999994 110.924 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.793 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 11.0 p -153.68 44.8 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 62.009999999999998 111.178 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.33 125.15 28.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 65.209999999999994 110.893 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.24 -91.84 0.52 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.74 . . . . 72.140000000000001 112.492 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.7 t -178.73 49.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.816 0.341 . . . . 73.540000000000006 110.814 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.671 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 3.8 mm-40 -74.69 -40.26 61.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 74.200000000000003 110.936 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 66.25 141.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 73.439999999999998 110.873 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.976 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.2 OUTLIER -161.99 135.85 6.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 74.200000000000003 110.912 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.417 HG21 ' CG1' ' A' ' 139' ' ' VAL . 2.8 mt -85.9 119.32 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 63.43 111.134 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.08 98.97 10.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 73.400000000000006 110.899 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 76.7 p -86.1 18.48 3.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 64.099999999999994 111.145 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.768 ' O ' HG23 ' A' ' 119' ' ' THR . . . 177.31 142.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 71.310000000000002 111.071 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -51.65 99.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 72.109999999999999 110.919 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.777 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 41.4 p -104.12 53.62 0.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 62.549999999999997 111.111 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.67 -27.32 68.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 73.329999999999998 110.894 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.777 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.6 p90 -48.29 -26.74 2.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 74.230000000000004 110.947 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 23.8 mt -44.48 -37.41 3.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 75.200000000000003 110.923 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 124' ' ' GLY . 5.5 m-20 59.16 80.98 0.17 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 62.020000000000003 110.857 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.63 41.67 0.88 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.742 -0.742 . . . . 70.109999999999999 112.473 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.12 -21.4 36.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.85 0.357 . . . . 73.439999999999998 110.909 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -144.75 -169.44 3.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 74.010000000000005 110.832 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.8 t -124.58 123.46 66.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 64.299999999999997 111.099 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 t -88.84 132.58 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 71.019999999999996 111.096 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.438 ' CD1' HG21 ' A' ' 32' ' ' THR . 23.9 p90 -154.93 36.64 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 72.430000000000007 110.889 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -174.12 177.77 46.22 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.753 -0.736 . . . . 62.43 112.509 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -177.9 138.81 0.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.861 0.362 . . . . 75.409999999999997 110.905 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.54 HG11 ' HG2' ' A' ' 136' ' ' MET . 77.2 t -41.94 106.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 73.340000000000003 111.123 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -59.91 2.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 71.319999999999993 110.878 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -153.46 150.0 28.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 65.129999999999995 110.91 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.8 48.25 4.23 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.729 . . . . 63.140000000000001 112.496 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.54 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -66.45 -32.01 73.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.719 0.295 . . . . 75.099999999999994 110.849 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.99 -33.22 37.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 71.219999999999999 110.916 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 17' ' ' LEU . 45.2 mm -64.92 -36.47 77.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 71.200000000000003 111.077 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.417 ' CG1' HG21 ' A' ' 114' ' ' ILE . 63.5 t -65.8 -27.59 41.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 50.509999999999998 111.144 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -81.03 -27.51 35.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 73.349999999999994 110.827 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.04 -39.89 60.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 74.510000000000005 111.116 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 33.9 mtm -60.69 -52.92 63.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 110.886 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.443 ' OE1' HG23 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -53.55 -27.6 27.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 74.530000000000001 110.889 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.447 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.28 -24.48 63.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 74.230000000000004 110.896 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.447 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 59.7 m-85 -109.08 21.47 17.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 73.099999999999994 110.892 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -114.54 168.14 12.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 60.039999999999999 112.466 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 m -104.73 129.84 52.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 72.519999999999996 110.891 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -54.97 -26.12 34.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 72.129999999999995 110.89 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -77.71 -28.81 51.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.882 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.27 -39.43 1.24 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.765 -0.731 . . . . 54.409999999999997 112.47 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -178.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 75.019999999999996 110.876 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 10.6 p -144.64 133.58 22.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 54.420000000000002 111.161 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.7 m -69.09 -41.17 77.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 65.310000000000002 110.889 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.514 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -105.5 -177.15 3.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 74.530000000000001 110.899 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.55 ' HD2' HG22 ' A' ' 157' ' ' THR . 2.0 tppp? -115.92 108.54 16.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 73.230000000000004 110.885 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.558 HD13 HD12 ' A' ' 56' ' ' ILE . 4.9 mp -92.0 119.2 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 64.209999999999994 111.12 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.55 HG22 ' HD2' ' A' ' 155' ' ' LYS . 0.6 OUTLIER -129.0 163.7 24.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 55.350000000000001 111.145 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.566 HD13 ' HE2' ' A' ' 8' ' ' PHE . 7.5 mt -96.23 105.56 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 111.106 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.776 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -69.31 -41.7 76.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 71.510000000000005 111.083 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -162.98 160.95 25.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 71.430000000000007 110.87 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -167.98 148.16 4.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 71.420000000000002 110.882 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.5 -173.02 44.27 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.739 -0.743 . . . . 75.239999999999995 112.492 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.505 ' HG2' ' NH2' ' A' ' 37' ' ' ARG . 3.8 mt-30 -80.93 129.59 34.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 75.099999999999994 110.91 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.555 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -83.87 -57.78 3.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 75.439999999999998 110.972 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 71.219999999999999 110.871 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.802 0.334 . . . . 65.450000000000003 110.868 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.3 t -141.02 136.4 33.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 64.299999999999997 111.121 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -72.09 149.8 92.19 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.646 0.736 . . . . 73.010000000000005 110.876 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 146.32 59.61 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.689 2.259 . . . . 64.219999999999999 112.351 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -136.29 140.53 43.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 72.450000000000003 111.127 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.5 ' HA ' HD23 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -132.84 147.62 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 71.329999999999998 111.136 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.588 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 16.5 p90 -106.64 166.48 10.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 74.120000000000005 110.849 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.618 ' CE2' HD13 ' A' ' 158' ' ' ILE . 6.3 m-85 -144.47 90.38 2.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.400000000000006 110.914 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.551 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 2.1 t0 -51.04 117.69 2.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 64.209999999999994 110.892 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.421 HG23 HG23 ' A' ' 156' ' ' ILE . 22.2 mm -90.43 116.65 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 65.439999999999998 111.134 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -113.47 124.26 51.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 70.340000000000003 111.093 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.619 HG23 HD13 ' A' ' 17' ' ' LEU . 12.9 t -109.22 101.34 12.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 72.230000000000004 111.158 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.31 44.26 25.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 73.310000000000002 110.833 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.08 -2.0 87.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.734 . . . . 73.299999999999997 112.491 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.413 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 10.3 mm-40 -109.56 99.49 37.71 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.677 0.751 . . . . 63.420000000000002 110.883 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.71 101.29 0.89 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.703 2.269 . . . . 65.519999999999996 112.378 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.619 HD13 HG23 ' A' ' 12' ' ' VAL . 8.4 mp -65.11 -35.73 82.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 62.109999999999999 110.89 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.59 -145.1 9.04 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.745 -0.741 . . . . 73.150000000000006 112.497 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.56 153.2 51.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 73.040000000000006 110.89 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.468 HG11 ' CG2' ' A' ' 139' ' ' VAL . 5.8 t -144.89 101.46 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 72.230000000000004 111.116 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 2.4 t -92.33 176.44 6.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 62.310000000000002 110.83 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.455 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -146.26 116.2 7.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 74.120000000000005 110.882 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -67.64 96.99 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 63.32 110.88 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.8 mt -80.16 134.32 36.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 75.030000000000001 110.885 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -94.4 66.93 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 71.140000000000001 110.849 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.95 -23.65 33.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 75.420000000000002 111.089 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.39 -29.16 67.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 63.140000000000001 110.888 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -103.11 -30.13 10.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 73.140000000000001 110.885 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.86 63.89 60.18 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.609 0.719 . . . . 62.310000000000002 111.131 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -5.85 17.19 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.689 2.259 . . . . 61.409999999999997 112.388 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.72 -45.25 11.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 74.549999999999997 110.907 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.432 HG23 ' HE1' ' A' ' 100' ' ' MET . 44.2 m -92.76 -48.8 6.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 53.240000000000002 111.126 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.99 -41.89 68.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 73.329999999999998 111.109 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -58.88 -44.52 91.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 71.439999999999998 110.933 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.468 ' OD1' HG23 ' A' ' 78' ' ' ILE . 3.0 t30 -54.2 -50.03 68.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 72.400000000000006 110.922 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -61.53 -43.61 98.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 64.0 110.856 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -63.06 -44.01 97.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 73.519999999999996 110.907 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.85 -37.75 66.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 52.530000000000001 111.089 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.422 HD23 ' HG2' ' A' ' 44' ' ' LYS . 28.8 mt -71.97 -54.7 9.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 54.399999999999999 110.903 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -44.7 81.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 64.5 110.857 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.404 HG22 ' HB2' ' A' ' 163' ' ' GLN . 40.1 p -65.32 -47.0 78.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 65.430000000000007 111.118 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.09 -18.28 16.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 72.239999999999995 112.484 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -52.89 -29.06 26.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.914 0.388 . . . . 72.200000000000003 110.881 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.804 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -58.83 -19.0 37.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 72.010000000000005 110.894 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.2 -13.07 40.52 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.683 -0.77 . . . . 62.310000000000002 112.476 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -176.78 -170.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.869 0.366 . . . . 73.409999999999997 110.855 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -177.83 173.15 45.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 62.520000000000003 112.466 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -117.93 60.29 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.961 0.41 . . . . 73.239999999999995 110.931 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -78.01 57.56 1.8 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.491 . . . . 71.209999999999994 110.863 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 169.76 59.06 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 54.109999999999999 112.447 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.537 ' O ' HG22 ' A' ' 157' ' ' THR . 0.3 OUTLIER -114.57 151.62 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 75.120000000000005 110.852 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.9 p -96.07 129.23 43.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 53.350000000000001 110.856 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -84.39 133.95 34.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 75.239999999999995 110.885 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -132.62 40.59 3.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 65.400000000000006 110.897 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.43 ' HG2' ' NE2' ' A' ' 63' ' ' GLN . 14.1 tpp85 -162.58 71.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 75.230000000000004 110.882 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.453 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.4 mt -123.66 113.76 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.420000000000002 111.153 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.7 mt -112.91 109.59 52.44 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.618 0.723 . . . . 64.319999999999993 111.12 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.0 Cg_endo -69.76 76.92 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.67 2.247 . . . . 63.100000000000001 112.319 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.79 -27.15 0.21 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 74.349999999999994 112.457 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.403 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.0 OUTLIER -115.26 -60.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 74.030000000000001 110.858 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.403 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER 172.68 173.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 55.100000000000001 110.866 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.2 m -108.83 -177.71 3.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 75.209999999999994 110.866 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.545 ' CG ' ' HB1' ' A' ' 101' ' ' ALA . 0.9 OUTLIER -150.92 154.63 37.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 53.310000000000002 110.894 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.22 -28.69 61.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.746 -0.74 . . . . 64.140000000000001 112.499 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.61 -87.11 0.54 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.752 -0.737 . . . . 64.239999999999995 112.48 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -155.43 149.9 26.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.861 0.362 . . . . 75.549999999999997 110.828 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -71.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 64.450000000000003 110.869 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.6 t -154.95 -42.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 72.510000000000005 111.176 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.2 -170.35 2.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 75.040000000000006 110.854 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -118.84 -77.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 74.329999999999998 110.882 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 50.28 29.65 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 65.239999999999995 110.876 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 57.73 54.7 35.23 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.701 -0.761 . . . . 33.340000000000003 112.48 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.409 HG23 ' N ' ' A' ' 74' ' ' GLY . 1.8 t 177.65 -49.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.828 0.347 . . . . 54.149999999999999 111.173 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.409 ' N ' HG23 ' A' ' 73' ' ' THR . . . 107.21 -146.23 16.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.707 -0.759 . . . . 71.109999999999999 112.487 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.29 -123.44 2.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.756 -0.735 . . . . 74.209999999999994 112.499 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? 179.73 145.08 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.338 . . . . 73.230000000000004 110.884 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.1 m -76.41 65.73 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 52.100000000000001 110.876 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.804 HG22 ' HD2' ' A' ' 44' ' ' LYS . 16.4 pt 41.7 34.17 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 60.219999999999999 111.144 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -164.74 -64.6 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 72.25 110.91 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -136.61 161.85 25.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 70.25 112.509 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -47.84 -32.1 5.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.904 0.383 . . . . 64.530000000000001 110.863 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.427 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.31 170.22 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 74.099999999999994 110.864 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.46 -179.9 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 63.450000000000003 110.886 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.85 160.0 26.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 74.200000000000003 110.888 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -52.1 151.67 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 63.130000000000003 110.823 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -100.62 -78.34 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 71.420000000000002 110.861 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -158.01 172.49 18.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 52.109999999999999 110.888 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.8 37.48 4.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 65.109999999999999 110.898 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mt -50.61 -29.35 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 64.349999999999994 111.089 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 15.1 mt -108.87 88.33 2.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 72.540000000000006 110.874 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -71.6 151.97 43.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 64.439999999999998 110.921 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -64.85 87.39 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 75.230000000000004 110.842 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.21 -51.38 11.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 75.030000000000001 111.154 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . -147.86 -164.46 11.31 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.772 -0.728 . . . . 63.43 112.477 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 173.8 10.44 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.659 2.24 . . . . 62.229999999999997 112.331 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.52 28.09 73.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.777 -0.725 . . . . 63.43 112.472 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.8 mm -100.85 140.69 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.893 0.377 . . . . 75.140000000000001 111.145 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -111.45 138.97 47.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 110.93 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.62 -168.1 3.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 71.519999999999996 110.863 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.432 ' HE1' HG23 ' A' ' 32' ' ' THR . 0.5 OUTLIER -94.23 103.91 15.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 64.549999999999997 110.902 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.937 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -75.64 69.77 2.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 64.319999999999993 111.115 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -131.71 -175.17 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 74.129999999999995 110.896 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.93 -27.15 2.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 64.329999999999998 111.112 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.4 -89.23 0.49 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.715 -0.755 . . . . 64.540000000000006 112.506 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 90.86 0.52 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.737 2.292 . . . . 73.530000000000001 112.316 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.561 ' C ' HG23 ' A' ' 107' ' ' THR . 2.9 m-20 76.07 168.53 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 64.400000000000006 110.897 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.561 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.1 p 69.86 28.96 4.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 73.530000000000001 111.174 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -109.28 106.65 16.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 64.400000000000006 110.879 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -90.23 -65.58 1.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 50.439999999999998 112.457 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.5 p 179.64 49.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.806 0.336 . . . . 73.239999999999995 110.836 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.686 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 3.4 mm-40 -62.39 -34.95 77.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 71.329999999999998 110.963 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 68.58 137.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 62.009999999999998 110.89 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.937 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -154.06 127.55 8.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 74.230000000000004 110.849 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.7 mt -83.95 125.32 40.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 73.329999999999998 111.164 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -91.15 103.48 16.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 73.319999999999993 110.894 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 69.4 p -88.42 20.75 3.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 111.117 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.732 ' O ' HG23 ' A' ' 119' ' ' THR . . . 174.87 146.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 52.310000000000002 111.13 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.425 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 1.2 tttt -54.43 99.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 65.219999999999999 110.906 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.732 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 42.2 p -105.87 46.66 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 72.209999999999994 111.125 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -25.73 65.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 75.140000000000001 110.879 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.732 ' CZ2' HG22 ' A' ' 119' ' ' THR . 5.6 p90 -50.12 -25.46 3.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.474 . . . . 72.329999999999998 110.905 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.9 mt -45.04 -35.72 3.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 73.409999999999997 110.888 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.0 m-20 60.74 80.45 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 65.329999999999998 110.853 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.3 42.66 0.9 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 63.200000000000003 112.52 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? -82.23 -25.49 34.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.834 0.35 . . . . 73.319999999999993 110.897 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -141.46 179.23 6.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 63.310000000000002 110.876 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.4 t -114.8 124.31 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 62.240000000000002 111.096 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.45 131.92 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 74.299999999999997 111.119 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.459 ' O ' HD23 ' A' ' 24' ' ' LEU . 43.3 p90 -149.23 31.58 0.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 62.25 110.911 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -175.8 175.69 47.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.804 -0.713 . . . . 73.030000000000001 112.494 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' A' ' 132' ' ' VAL . 1.5 pttp -173.12 127.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.81 0.338 . . . . 75.450000000000003 110.885 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.761 HG11 ' HG2' ' A' ' 136' ' ' MET . 53.8 t -32.12 106.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 64.430000000000007 111.107 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -57.16 4.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 70.510000000000005 110.895 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -157.06 157.51 34.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 75.409999999999997 110.905 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.33 32.05 10.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 65.299999999999997 112.507 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.761 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -61.16 -24.23 66.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 64.0 110.848 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -39.4 79.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 71.439999999999998 110.893 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.477 HD12 ' HB3' ' A' ' 17' ' ' LEU . 25.9 mm -66.56 -37.7 80.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 54.439999999999998 111.134 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.468 ' CG2' HG11 ' A' ' 20' ' ' VAL . 69.0 t -64.17 -30.54 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 73.230000000000004 111.129 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -73.09 -30.86 63.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 74.430000000000007 110.898 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.79 -37.19 70.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 61.119999999999997 111.111 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 16.0 mtm -57.97 -53.79 54.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 51.25 110.869 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.453 ' OE1' HG23 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -53.87 -28.12 34.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 61.140000000000001 110.866 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.44 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -67.81 -24.44 65.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 64.299999999999997 110.854 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.44 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 58.5 m-85 -108.71 20.68 18.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 70.109999999999999 110.915 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.41 166.25 12.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 52.119999999999997 112.514 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.5 t -123.34 148.79 45.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.864 0.364 . . . . 62.200000000000003 110.866 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.9 mmm-85 -75.34 70.51 2.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 61.009999999999998 110.92 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -174.79 -35.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.299999999999997 110.889 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.42 -42.72 0.88 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 70.040000000000006 112.483 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.38 165.63 20.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.864 0.364 . . . . 73.349999999999994 110.854 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.8 p -145.67 154.5 42.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 75.010000000000005 111.133 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 m -71.32 -48.16 52.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 75.329999999999998 110.849 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.413 ' HB3' HG13 ' A' ' 12' ' ' VAL . 6.0 mttt -96.87 -178.53 4.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 70.420000000000002 110.921 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -124.05 108.86 12.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 63.119999999999997 110.887 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.421 HG23 HG23 ' A' ' 10' ' ' ILE . 4.7 mp -92.76 123.12 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 70.430000000000007 111.126 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -131.83 158.57 40.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 64.129999999999995 111.136 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.618 HD13 ' CE2' ' A' ' 8' ' ' PHE . 9.7 mt -91.1 108.44 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 63.0 111.15 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -73.85 -48.4 31.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 63.039999999999999 111.099 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -151.93 162.74 40.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 54.409999999999997 110.872 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.11 148.19 4.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 74.310000000000002 110.901 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 176.81 172.51 41.52 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 74.329999999999998 112.498 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.404 ' HB2' HG22 ' A' ' 41' ' ' THR . 2.4 mt-30 -63.84 140.4 58.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.836 0.351 . . . . 74.140000000000001 110.91 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -92.49 -56.19 3.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 55.539999999999999 110.894 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 63.329999999999998 110.864 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mtp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.853 0.358 . . . . 75.319999999999993 110.875 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.6 t -140.35 130.31 28.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 51.539999999999999 111.159 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -102.44 153.51 38.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.617 0.722 . . . . 70.299999999999997 110.877 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 146.72 61.0 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.672 2.248 . . . . 75.319999999999993 112.316 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -133.28 140.05 47.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 74.120000000000005 111.18 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.458 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.6 m -133.3 143.02 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 64.209999999999994 111.14 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.577 ' HB3' HD21 ' A' ' 164' ' ' LEU . 15.7 p90 -103.4 161.07 14.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 71.099999999999994 110.92 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -142.55 88.08 2.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 72.540000000000006 110.868 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.493 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 2.3 t70 -52.13 107.49 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 60.130000000000003 110.888 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.841 HG23 HG23 ' A' ' 156' ' ' ILE . 32.3 mm -78.9 131.39 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 50.399999999999999 111.117 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -126.87 123.58 37.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 62.32 111.102 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.467 HG12 ' HG2' ' A' ' 154' ' ' LYS . 1.9 t -108.28 94.55 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 73.530000000000001 111.156 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.1 t0 58.96 46.76 13.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 73.040000000000006 110.899 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.34 -4.37 84.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.738 -0.744 . . . . 65.129999999999995 112.477 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.441 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -111.28 102.63 53.5 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.681 0.753 . . . . 72.439999999999998 110.87 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.82 124.34 10.96 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.628 2.218 . . . . 74.010000000000005 112.33 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.429 ' HB3' HD12 ' A' ' 138' ' ' ILE . 11.1 mt -70.14 -38.76 75.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 70.340000000000003 110.926 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.39 -127.17 1.7 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.76 -0.733 . . . . 72.019999999999996 112.534 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.49 138.37 54.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.856 0.36 . . . . 75.219999999999999 110.851 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.561 HG21 HG13 ' A' ' 10' ' ' ILE . 1.4 t -145.04 100.05 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 64.129999999999995 111.083 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -108.78 175.24 5.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 53.310000000000002 110.885 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.454 ' N ' ' OG ' ' A' ' 21' ' ' SER . 1.8 m-85 -146.23 137.2 24.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 74.409999999999997 110.827 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.406 ' HB2' ' CE ' ' A' ' 133' ' ' LYS . 16.2 tt0 -92.12 101.55 14.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 71.299999999999997 110.892 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.7 mt -83.15 119.06 24.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 63.240000000000002 110.939 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.432 ' CD1' HD13 ' A' ' 90' ' ' LEU . 58.3 m-85 -76.55 65.68 2.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 74.120000000000005 110.88 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.7 -22.77 25.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 44.130000000000003 111.099 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -65.87 -33.94 76.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 71.049999999999997 110.881 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -101.56 -29.19 12.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 51.439999999999998 110.887 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.416 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -135.22 65.73 64.65 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.594 0.712 . . . . 72.430000000000007 111.107 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -34.92 13.54 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.65 2.234 . . . . 73.310000000000002 112.37 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -39.55 91.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 75.540000000000006 110.909 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.5 m -87.96 -40.4 13.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 72.439999999999998 111.139 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.4 95.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 73.129999999999995 111.061 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -51.75 -35.78 44.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 65.140000000000001 110.87 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -61.37 -54.53 42.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 45.240000000000002 110.874 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -65.76 -45.65 81.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 73.450000000000003 110.879 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.97 -38.7 86.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 72.430000000000007 110.828 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.36 -44.28 97.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 61.240000000000002 111.093 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.5 mt -74.03 -47.21 38.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 62.100000000000001 110.933 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.1 m -51.92 -44.94 64.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 60.109999999999999 110.838 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.6 p -71.75 -34.4 69.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 61.100000000000001 111.144 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.59 -6.41 41.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.738 -0.744 . . . . 71.040000000000006 112.462 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.75 -25.09 17.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 54.43 110.856 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.582 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -65.63 -32.97 74.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 60.210000000000001 110.897 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.54 -28.88 4.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 73.310000000000002 112.487 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -141.51 -39.97 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.885 0.374 . . . . 74.109999999999999 110.91 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.13 -163.91 52.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 61.539999999999999 112.467 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.54 45.83 1.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.914 0.388 . . . . 71.140000000000001 110.937 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 74.33 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 74.150000000000006 110.865 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.67 -59.38 0.33 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 73.140000000000001 112.49 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 45.8 -163.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.774 0.321 . . . . 60.520000000000003 110.909 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.2 p 179.11 116.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 60.130000000000003 110.89 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.628 ' HE1' HD11 ' A' ' 158' ' ' ILE . 72.3 m-85 -97.37 75.35 2.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 71.420000000000002 110.867 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -73.15 -21.27 60.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 62.520000000000003 110.826 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.18 122.51 46.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 65.409999999999997 110.887 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.434 ' HB ' HG21 ' A' ' 152' ' ' THR . 29.0 mt -150.29 111.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 64.420000000000002 111.125 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.4 ' O ' HG22 ' A' ' 57' ' ' ILE . 42.8 mt -105.78 103.0 41.82 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.615 0.722 . . . . 75.430000000000007 111.179 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 83.11 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.706 2.271 . . . . 72.150000000000006 112.341 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 153.19 -20.63 0.75 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 74.340000000000003 112.525 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.21 -59.33 1.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.866 0.365 . . . . 64.329999999999998 110.859 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -178.14 175.59 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 73.140000000000001 110.866 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.4 m -120.47 -170.13 1.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 73.120000000000005 110.893 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -177.67 144.13 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 71.439999999999998 110.938 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.95 124.27 1.03 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.705 -0.76 . . . . 63.32 112.512 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.72 106.64 0.19 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.728 -0.749 . . . . 73.040000000000006 112.503 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.42 145.82 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.339 . . . . 75.200000000000003 110.88 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -163.09 44.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 73.230000000000004 110.879 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.3 p -119.19 -37.34 3.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 74.420000000000002 111.137 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.89 -172.38 3.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 75.430000000000007 110.852 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -77.82 -35.86 50.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 65.319999999999993 110.851 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -153.18 65.0 0.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 70.030000000000001 110.916 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.09 -146.22 8.3 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 64.450000000000003 112.466 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.9 p -145.84 38.93 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.794 0.33 . . . . 71.239999999999995 111.122 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.61 -113.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.728 -0.748 . . . . 75.409999999999997 112.489 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 51.55 88.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 43.039999999999999 112.474 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.88 152.25 25.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 55.240000000000002 110.88 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.9 p -61.63 157.38 17.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 63.009999999999998 110.852 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.582 HG22 ' HD2' ' A' ' 44' ' ' LYS . 1.5 pp -56.84 -29.47 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 65.439999999999998 111.152 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -82.89 -50.49 8.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.454 . . . . 71.299999999999997 110.884 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.76 -125.79 0.87 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.786 -0.721 . . . . 43.25 112.517 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -72.46 -33.2 66.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.885 0.374 . . . . 73.150000000000006 110.861 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.52 174.94 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 72.319999999999993 110.887 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.74 -168.52 1.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 72.109999999999999 110.85 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.28 162.67 14.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 72.230000000000004 110.902 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -54.33 115.83 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 73.299999999999997 110.881 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -93.85 -74.72 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 75.439999999999998 110.878 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -174.88 174.76 2.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 74.140000000000001 110.847 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.82 37.94 3.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 63.210000000000001 110.887 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -49.6 -30.13 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 73.310000000000002 111.131 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.432 HD13 ' CD1' ' A' ' 25' ' ' PHE . 10.1 mt -112.56 78.18 1.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.168 -0.469 . . . . 62.210000000000001 110.886 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 93' ' ' THR . 4.1 mtpt -70.55 151.55 44.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 72.140000000000001 110.864 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -49.81 102.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 72.400000000000006 110.898 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 91' ' ' LYS . 25.2 p -113.81 26.94 9.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 64.420000000000002 111.098 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.69 -177.78 24.78 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 44.420000000000002 112.54 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 174.14 9.94 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.655 2.237 . . . . 63.439999999999998 112.372 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.13 44.4 97.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 73.439999999999998 112.485 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 115' ' ' CYS . 14.0 mm -110.86 140.4 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.844 0.354 . . . . 55.329999999999998 111.122 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 98' ' ' LEU . 2.8 mt -108.29 155.68 20.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 44.039999999999999 110.943 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 6.8 t -167.29 -134.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 61.109999999999999 110.884 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 9.7 mmt -153.78 143.38 21.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 71.439999999999998 110.902 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -128.37 139.8 52.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 65.209999999999994 111.095 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 168.5 -31.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 74.299999999999997 110.858 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.732 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -175.95 -41.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 74.109999999999999 111.097 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.84 -77.47 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 70.329999999999998 112.484 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 112.0 2.96 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.636 2.224 . . . . 63.340000000000003 112.331 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.436 ' O ' HG23 ' A' ' 107' ' ' THR . 1.3 p-10 39.71 61.15 1.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 64.409999999999997 110.909 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.732 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 10.3 p -156.17 52.92 0.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 70.409999999999997 111.142 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.82 124.94 42.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 71.310000000000002 110.876 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.19 -103.48 1.97 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 73.540000000000006 112.5 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.19 30.49 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 64.319999999999993 110.858 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.633 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 6.3 mm-40 -112.5 40.48 2.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 72.549999999999997 110.933 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' A' ' 99' ' ' SER . 5.7 p90 -58.21 -170.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 73.010000000000005 110.89 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -148.58 146.54 28.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 74.450000000000003 110.895 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.45 HG21 HG13 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -74.79 -15.3 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 74.219999999999999 111.119 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER 49.17 93.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 52.0 110.913 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.549 HG22 ' CG1' ' A' ' 139' ' ' VAL . 82.3 p -91.17 26.75 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 62.329999999999998 111.118 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.621 ' O ' HG23 ' A' ' 119' ' ' THR . . . 178.26 151.76 0.28 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 62.009999999999998 111.129 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.74 97.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 44.299999999999997 110.881 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.699 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 26.5 p -104.11 46.5 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 52.310000000000002 111.148 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -25.38 68.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 71.030000000000001 110.842 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.699 ' CZ2' HG22 ' A' ' 119' ' ' THR . 5.4 p90 -47.32 -28.61 2.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.155 -0.475 . . . . 75.230000000000004 110.938 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.6 mt -46.74 -32.82 3.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 64.209999999999994 110.865 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 62.52 77.44 0.33 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 72.040000000000006 110.869 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 36.54 43.43 0.77 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 60.240000000000002 112.45 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -80.85 -13.6 58.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 74.140000000000001 110.916 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -144.05 -169.15 3.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 110.859 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.1 t -120.69 117.39 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 72.340000000000003 111.173 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 98' ' ' LEU . 2.6 t -88.83 134.14 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 72.150000000000006 111.119 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.445 ' O ' HD23 ' A' ' 24' ' ' LEU . 19.9 p90 -156.09 37.6 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 74.430000000000007 110.839 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -175.4 173.55 46.3 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.772 -0.728 . . . . 70.200000000000003 112.486 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 8.0 pttt -175.59 139.3 0.42 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.797 0.332 . . . . 75.340000000000003 110.926 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.654 HG11 ' HG2' ' A' ' 136' ' ' MET . 55.1 t -41.17 110.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 73.129999999999995 111.132 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.406 ' CE ' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -73.0 -59.29 2.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 71.109999999999999 110.868 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -152.12 157.14 41.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 42.130000000000003 110.897 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.09 35.54 17.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.742 . . . . 32.439999999999998 112.508 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.654 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -56.13 -31.38 63.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.751 0.31 . . . . 71.239999999999995 110.909 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.59 -30.23 20.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 71.040000000000006 110.887 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.443 HG21 ' CG2' ' A' ' 20' ' ' VAL . 41.4 mm -66.27 -41.29 88.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 75.430000000000007 111.092 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.549 ' CG1' HG22 ' A' ' 116' ' ' THR . 59.1 t -62.02 -28.29 44.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 53.240000000000002 111.152 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -79.34 -28.64 42.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 64.040000000000006 110.857 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.32 -38.46 63.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 35.5 111.112 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.569 ' SD ' HG21 ' A' ' 156' ' ' ILE . 28.6 mtm -59.78 -51.8 68.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 72.109999999999999 110.894 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.02 -24.69 25.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 73.120000000000005 110.903 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.43 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -72.71 -24.11 60.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 73.230000000000004 110.925 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.43 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 62.1 m-85 -108.27 16.86 22.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 65.510000000000005 110.879 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.98 178.66 17.62 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 61.229999999999997 112.491 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -141.3 132.59 26.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 45.25 110.865 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -64.58 84.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 62.509999999999998 110.855 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 179.74 -33.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 71.299999999999997 110.865 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.21 -92.49 0.15 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.8 -0.714 . . . . 73.010000000000005 112.488 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -51.17 156.53 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 73.310000000000002 110.895 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.434 HG21 ' HB ' ' A' ' 56' ' ' ILE . 39.1 p -131.66 156.02 46.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 111.145 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.63 -35.21 78.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 73.129999999999995 110.863 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.467 ' HG2' HG12 ' A' ' 12' ' ' VAL . 2.1 mttp -101.23 -179.59 4.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 75.519999999999996 110.859 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.8 104.55 7.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 62.409999999999997 110.846 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.841 HG23 HG23 ' A' ' 10' ' ' ILE . 4.8 mp -90.63 105.56 16.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 71.109999999999999 111.081 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.95 166.02 13.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 70.299999999999997 111.132 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.628 HD11 ' HE1' ' A' ' 53' ' ' PHE . 6.5 mm -98.4 119.51 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 72.319999999999993 111.118 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -82.96 -50.56 8.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 65.129999999999995 111.117 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -142.81 155.58 44.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 73.040000000000006 110.862 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -163.44 148.87 11.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 73.319999999999993 110.89 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 172.96 167.64 33.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.783 -0.722 . . . . 55.219999999999999 112.511 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -61.83 134.8 57.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.789 0.328 . . . . 61.420000000000002 110.927 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.577 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -85.7 -59.3 2.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 74.129999999999995 110.938 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 75.129999999999995 110.855 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.783 0.325 . . . . 74.5 110.882 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.7 t -149.87 136.32 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 74.5 111.162 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.46 142.96 29.58 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 74.409999999999997 110.889 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 146.84 61.47 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.687 2.258 . . . . 65.109999999999999 112.356 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -129.52 135.66 48.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 74.420000000000002 111.167 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -133.13 160.56 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 61.350000000000001 111.122 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 1.7 p90 -143.36 -179.29 6.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 73.409999999999997 110.879 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -155.89 92.99 1.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 74.230000000000004 110.896 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.58 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.8 OUTLIER -44.05 104.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 74.540000000000006 110.925 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.672 HG22 HD12 ' A' ' 17' ' ' LEU . 26.1 mm -77.18 134.79 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 73.329999999999998 111.083 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -127.66 154.12 45.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 43.329999999999998 111.068 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.53 HG13 ' HB3' ' A' ' 154' ' ' LYS . 33.2 t -134.02 95.91 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 64.340000000000003 111.106 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.37 31.52 10.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 71.329999999999998 110.861 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.63 -23.39 34.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.788 -0.72 . . . . 74.530000000000001 112.471 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -92.25 115.09 64.1 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.607 0.718 . . . . 60.039999999999999 110.891 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.9 Cg_endo -69.73 123.0 9.69 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.69 2.26 . . . . 75.400000000000006 112.374 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.672 HD12 HG22 ' A' ' 10' ' ' ILE . 13.1 mt -66.66 -38.66 87.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 73.230000000000004 110.909 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.65 -122.95 1.19 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.756 -0.735 . . . . 42.109999999999999 112.458 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.05 141.13 46.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 73.329999999999998 110.91 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.539 HG21 HG13 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -143.53 103.99 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 55.450000000000003 111.136 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.8 t -110.28 172.95 6.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 71.099999999999994 110.834 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.418 ' N ' ' OG ' ' A' ' 21' ' ' SER . 10.1 m-85 -146.29 131.61 18.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 73.140000000000001 110.906 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -85.98 98.07 10.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 61.310000000000002 110.884 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 129' ' ' PHE . 3.6 mt -83.12 136.39 34.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 73.299999999999997 110.888 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -96.27 63.75 2.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 65.209999999999994 110.85 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.19 -24.02 16.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 71.519999999999996 111.072 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.36 -31.19 70.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 74.209999999999994 110.887 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.5 -27.07 13.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 73.319999999999993 110.831 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.451 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -136.61 63.52 47.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.577 0.703 . . . . 71.239999999999995 111.088 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -41.82 3.89 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.679 2.253 . . . . 73.030000000000001 112.354 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -55.32 -37.46 67.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 73.409999999999997 110.922 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.424 HG21 ' CD1' ' A' ' 129' ' ' PHE . 16.0 m -89.19 -53.36 4.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 62.530000000000001 111.141 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.26 -36.37 41.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 44.399999999999999 111.123 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -49.74 -32.35 13.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 72.219999999999999 110.876 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.475 ' ND2' HG23 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -66.48 -63.84 0.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 75.040000000000006 110.926 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.37 -34.29 68.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 74.519999999999996 110.893 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.5 ' HE ' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -65.05 -49.48 69.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.487 . . . . 70.310000000000002 110.871 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.87 -31.46 72.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 70.120000000000005 111.113 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.9 mt -75.43 -55.95 5.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 62.350000000000001 110.96 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.0 m -49.37 -48.92 46.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 71.120000000000005 110.873 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.5 HG23 ' HE ' ' A' ' 37' ' ' ARG . 17.2 p -69.05 -28.08 66.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 71.340000000000003 111.132 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.3 -14.51 65.16 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.728 . . . . 75.540000000000006 112.459 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -52.29 -25.29 9.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 73.239999999999995 110.938 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.785 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -50.3 -28.26 7.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 75.140000000000001 110.868 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.69 -26.08 4.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.766 -0.731 . . . . 43.420000000000002 112.501 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -165.45 -47.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 74.420000000000002 110.849 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.61 177.72 0.38 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.774 -0.727 . . . . 61.409999999999997 112.488 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -94.7 26.71 3.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.004 0.43 . . . . 75.099999999999994 110.919 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.19 126.92 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 73.120000000000005 110.902 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.18 39.6 92.47 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.763 -0.732 . . . . 73.109999999999999 112.484 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -92.02 -178.66 5.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.888 0.375 . . . . 73.219999999999999 110.853 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 22.6 m -117.73 153.39 33.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 73.0 110.891 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -101.61 143.54 31.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 71.140000000000001 110.888 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -145.25 45.01 1.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 73.540000000000006 110.827 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -171.38 70.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 72.140000000000001 110.885 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 56' ' ' ILE . 11.2 mt -117.39 109.46 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 71.519999999999996 111.091 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.6 mt -106.82 102.67 43.51 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.65 0.738 . . . . 71.430000000000007 111.148 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.5 Cg_endo -69.82 79.67 0.95 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.683 2.255 . . . . 73.010000000000005 112.309 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.19 -25.62 0.54 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 73.120000000000005 112.491 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.43 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.3 OUTLIER -117.95 -59.17 1.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.332 . . . . 74.510000000000005 110.865 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.43 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.2 OUTLIER 176.91 162.63 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 75.340000000000003 110.815 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.9 m -104.59 -169.05 1.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 110.909 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -178.72 146.91 0.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 75.420000000000002 110.939 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.38 176.67 18.02 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.728 . . . . 71.239999999999995 112.472 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.13 120.31 4.33 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.756 -0.735 . . . . 55.329999999999998 112.493 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -179.83 38.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.772 0.32 . . . . 74.409999999999997 110.836 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -128.86 35.0 4.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 72.439999999999998 110.907 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.52 -35.33 40.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 74.510000000000005 111.157 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? 63.55 160.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 71.319999999999993 110.815 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -52.14 -35.91 49.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 74.409999999999997 110.863 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.01 -39.41 59.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 63.530000000000001 110.85 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.36 48.57 5.01 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.74 . . . . 52.32 112.489 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.8 t -165.94 48.25 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.846 0.355 . . . . 72.349999999999994 111.161 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.96 -81.01 1.5 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 64.129999999999995 112.443 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.88 94.88 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.762 -0.732 . . . . 71.230000000000004 112.471 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -174.74 167.02 3.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.75 0.31 . . . . 71.010000000000005 110.916 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.25 -165.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 74.319999999999993 110.86 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.785 HG22 ' HD2' ' A' ' 44' ' ' LYS . 3.9 pt -94.95 28.43 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 45.210000000000001 111.144 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -135.42 -67.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 63.340000000000003 110.933 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.16 -142.65 3.49 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 60.399999999999999 112.517 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -50.23 -32.94 17.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.856 0.36 . . . . 74.299999999999997 110.889 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.427 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.69 -175.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 60.32 110.883 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -147.32 161.01 41.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 72.200000000000003 110.871 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -60.73 166.0 3.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 65.510000000000005 110.899 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -82.12 174.94 10.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 75.519999999999996 110.852 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -120.09 -76.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 73.019999999999996 110.871 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.5 p30 -158.89 176.04 12.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 74.010000000000005 110.89 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.03 37.66 3.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 75.430000000000007 110.844 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.54 -30.08 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 71.030000000000001 111.141 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 20.9 mt -109.99 82.56 1.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 65.310000000000002 110.92 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.93 150.48 46.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 63.219999999999999 110.875 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -58.03 97.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.5 110.841 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.0 p -104.06 24.09 11.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 53.25 111.122 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 147.19 -178.89 24.52 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.739 -0.743 . . . . 70.25 112.5 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 172.62 12.33 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.651 2.234 . . . . 75.25 112.327 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.92 29.56 72.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 75.450000000000003 112.473 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.5 mm -103.07 139.97 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.877 0.37 . . . . 54.32 111.119 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.48 HD21 ' CD2' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -108.86 145.97 34.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 65.230000000000004 110.935 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.95 -167.99 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 53.409999999999997 110.891 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.579 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -98.38 113.71 25.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 74.400000000000006 110.859 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.886 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -94.03 130.45 40.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 62.109999999999999 111.077 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.562 ' CG ' ' HA3' ' A' ' 109' ' ' GLY . 0.6 OUTLIER 175.5 -70.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 65.219999999999999 110.915 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.833 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -146.85 -50.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 70.140000000000001 111.07 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.35 -70.27 0.51 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.759 -0.734 . . . . 71.439999999999998 112.522 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 110.23 2.5 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.672 2.248 . . . . 71.030000000000001 112.358 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 39.52 45.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 71.109999999999999 110.865 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.833 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 22.1 p -153.77 53.33 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 65.340000000000003 111.164 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -50.43 -37.16 36.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 73.209999999999994 110.909 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.562 ' HA3' ' CG ' ' A' ' 102' ' ' ASN . . . 77.34 -56.39 3.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 72.099999999999994 112.484 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.579 ' HA ' ' HE2' ' A' ' 100' ' ' MET . 1.0 OUTLIER 85.73 41.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 54.32 110.839 -179.731 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 25.5 mm-40 -104.45 -14.91 15.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 75.239999999999995 110.925 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.566 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER 72.91 150.94 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.540000000000006 110.876 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.886 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -159.23 131.11 6.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 73.340000000000003 110.849 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 mt -87.85 126.93 41.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 73.530000000000001 111.139 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.94 101.02 13.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.349999999999994 110.823 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 68.4 p -86.24 20.45 2.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 74.349999999999994 111.101 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.718 ' O ' HG23 ' A' ' 119' ' ' THR . . . 176.25 146.21 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 74.5 111.071 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -56.01 94.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 62.520000000000003 110.926 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.811 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 33.8 p -100.7 56.64 0.89 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 54.450000000000003 111.126 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.04 -26.17 67.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 75.109999999999999 110.904 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.811 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.8 p90 -49.17 -26.4 2.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 71.530000000000001 110.908 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.7 mt -45.83 -34.16 3.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.26 -0.427 . . . . 75.219999999999999 110.926 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.6 m-20 61.93 72.5 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 71.200000000000003 110.916 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.65 42.74 0.71 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.691 -0.766 . . . . 75.109999999999999 112.519 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.78 -28.47 36.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 63.200000000000003 110.885 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -124.83 -173.22 2.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 75.109999999999999 110.845 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.11 116.86 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 60.219999999999999 111.143 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.34 135.03 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 35.149999999999999 111.137 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.485 ' O ' HD23 ' A' ' 24' ' ' LEU . 16.4 p90 -160.79 34.82 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 65.230000000000004 110.872 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -172.49 176.39 45.43 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.764 -0.731 . . . . 53.119999999999997 112.497 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -174.14 136.98 0.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.803 0.335 . . . . 65.019999999999996 110.905 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.664 HG11 ' HG2' ' A' ' 136' ' ' MET . 79.6 t -40.95 108.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 73.439999999999998 111.159 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -57.96 4.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 72.120000000000005 110.921 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -157.18 156.83 33.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.540000000000006 110.893 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.07 32.61 16.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.789 -0.719 . . . . 61.130000000000003 112.505 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.664 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -55.89 -26.22 46.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 74.540000000000006 110.888 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -32.39 59.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 55.140000000000001 110.867 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.603 HD12 ' HB3' ' A' ' 17' ' ' LEU . 40.1 mm -65.29 -37.06 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 72.219999999999999 111.126 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.1 t -66.31 -28.19 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 72.319999999999993 111.104 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.21 -28.64 38.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 72.519999999999996 110.901 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.99 -40.0 60.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 54.210000000000001 111.112 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 34.6 mtm -61.27 -53.1 61.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 74.140000000000001 110.908 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.448 ' OE1' HG23 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -54.87 -24.73 24.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 75.109999999999999 110.896 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.43 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.66 -24.31 61.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 73.430000000000007 110.857 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.43 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 64.0 m-85 -107.7 13.94 26.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 73.019999999999996 110.878 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.1 169.08 13.64 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.732 -0.746 . . . . 72.549999999999997 112.482 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.5 p -114.08 146.71 39.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 72.310000000000002 110.859 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -73.73 72.92 1.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 73.430000000000007 110.888 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -179.53 -34.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 73.329999999999998 110.886 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 154.5 -61.3 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.775 -0.726 . . . . 74.140000000000001 112.516 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -58.31 174.37 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.35 . . . . 52.219999999999999 110.918 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.6 p -146.49 179.84 7.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 75.319999999999993 111.133 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.51 -65.19 1.03 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 40.030000000000001 110.872 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.53 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -78.96 -175.7 4.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 75.109999999999999 110.881 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -115.07 107.06 14.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 71.349999999999994 110.874 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.41 HG23 HG23 ' A' ' 10' ' ' ILE . 4.0 mp -84.85 111.36 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 71.400000000000006 111.162 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.49 165.48 17.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 72.140000000000001 111.161 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.3 mt -104.44 127.78 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 74.340000000000003 111.111 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.58 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -88.77 -50.38 6.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 41.43 111.085 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -148.73 150.86 33.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 63.149999999999999 110.907 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -156.87 149.54 23.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 73.530000000000001 110.835 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 164.49 170.5 29.51 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.809 -0.71 . . . . 53.119999999999997 112.535 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.28 127.53 27.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.808 0.337 . . . . 73.099999999999994 110.921 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.55 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.0 mm? -78.31 -47.7 17.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 72.219999999999999 110.974 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 53.109999999999999 110.929 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.777 0.322 . . . . 64.319999999999993 110.883 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.6 t -140.08 136.84 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 44.299999999999997 111.172 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -111.81 146.8 35.49 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.613 0.721 . . . . 74.319999999999993 110.899 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 146.1 58.67 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.64 2.227 . . . . 64.230000000000004 112.37 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -133.94 140.76 46.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 65.310000000000002 111.135 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.495 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.7 m -134.97 142.24 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 74.530000000000001 111.142 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 11.7 p90 -102.7 170.88 7.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 74.510000000000005 110.917 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.409 ' HA ' ' HB3' ' A' ' 161' ' ' CYS . 6.9 m-85 -151.18 88.51 1.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 74.140000000000001 110.888 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.644 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 3.0 t70 -50.08 105.6 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 72.319999999999993 110.869 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.683 HG22 HD12 ' A' ' 17' ' ' LEU . 35.9 mm -84.97 122.12 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 62.100000000000001 111.123 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -113.76 150.99 32.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 72.120000000000005 111.097 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.433 HG13 ' HB3' ' A' ' 154' ' ' LYS . 21.1 t -132.39 95.9 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 74.129999999999995 111.119 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.66 33.97 8.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 63.049999999999997 110.896 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.47 -19.13 55.91 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.719 -0.753 . . . . 71.349999999999994 112.516 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -97.01 113.23 62.66 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.629 0.728 . . . . 72.120000000000005 110.896 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.72 126.5 13.41 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.72 2.28 . . . . 71.340000000000003 112.322 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.683 HD12 HG22 ' A' ' 10' ' ' ILE . 13.6 mt -69.18 -40.02 78.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.439 . . . . 44.219999999999999 110.899 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.7 -125.51 1.61 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.785 -0.721 . . . . 55.100000000000001 112.542 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -123.36 135.91 54.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 72.420000000000002 110.874 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.509 HG21 HG13 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -146.64 103.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 72.209999999999994 111.093 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.5 t -113.47 174.59 5.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 53.200000000000003 110.881 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.439 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -145.3 126.14 14.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 75.540000000000006 110.906 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -80.59 100.0 8.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 73.549999999999997 110.862 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.463 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 1.4 mt -83.14 120.4 25.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 73.510000000000005 110.916 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -75.94 68.29 2.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 72.310000000000002 110.899 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.2 -22.73 42.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 50.340000000000003 111.088 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -67.24 -36.72 82.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 75.120000000000005 110.885 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -97.19 -27.28 14.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 72.239999999999995 110.86 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.426 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -138.92 67.24 41.43 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.6 0.714 . . . . 73.310000000000002 111.146 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -36.05 11.39 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.673 2.249 . . . . 64.310000000000002 112.314 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.57 -37.75 82.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 75.239999999999995 110.86 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.41 HG21 ' CD1' ' A' ' 129' ' ' PHE . 58.0 m -88.85 -44.05 10.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 34.409999999999997 111.169 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.77 -46.69 89.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 70.239999999999995 111.108 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -51.03 -29.47 12.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 72.420000000000002 110.896 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.14 -64.64 0.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 75.5 110.891 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -59.05 -30.97 68.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 63.450000000000003 110.923 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.482 ' O ' HG23 ' A' ' 41' ' ' THR . 0.8 OUTLIER -72.54 -51.63 19.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 71.430000000000007 110.897 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.63 -33.31 68.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 73.140000000000001 111.112 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.522 HD23 ' HG2' ' A' ' 44' ' ' LYS . 31.0 mt -76.38 -51.86 11.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 75.450000000000003 110.921 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.1 m -61.66 -37.05 82.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 72.519999999999996 110.863 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 37' ' ' ARG . 26.9 p -65.81 -34.64 78.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 72.310000000000002 111.125 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.28 -15.8 53.84 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.693 -0.765 . . . . 43.240000000000002 112.489 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.89 -27.36 29.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.905 0.383 . . . . 72.010000000000005 110.899 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.522 ' HG2' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -72.91 -29.29 63.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 64.239999999999995 110.862 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.31 -15.37 60.28 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.706 -0.759 . . . . 51.299999999999997 112.451 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -157.63 -165.41 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 64.219999999999999 110.857 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.05 -136.05 5.4 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 71.299999999999997 112.507 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.49 30.61 6.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.932 0.396 . . . . 73.140000000000001 110.924 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -87.37 96.44 10.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 70.239999999999995 110.945 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 134.47 -38.89 1.77 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.762 -0.733 . . . . 71.519999999999996 112.44 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.13 -169.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 63.240000000000002 110.848 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.9 p -141.73 175.5 9.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 63.229999999999997 110.87 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.444 ' CZ ' HD11 ' A' ' 158' ' ' ILE . 9.4 m-85 -107.55 142.72 37.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 75.319999999999993 110.897 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -143.46 45.89 1.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 74.140000000000001 110.827 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -161.98 60.83 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 75.310000000000002 110.889 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 19.0 mt -104.21 108.86 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 73.030000000000001 111.127 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.6 mt -102.0 101.7 20.08 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.635 0.731 . . . . 72.129999999999995 111.126 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 89.85 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.245 . . . . 75.310000000000002 112.377 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.83 -17.6 1.99 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 42.329999999999998 112.497 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.58 -53.11 1.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 74.099999999999994 110.834 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.413 ' HB3' ' HA ' ' A' ' 115' ' ' CYS . 0.0 OUTLIER 172.89 166.04 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.120000000000005 110.843 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 4.8 m -101.33 -173.35 2.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 70.140000000000001 110.897 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 174.1 150.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 72.349999999999994 110.941 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.09 -51.3 0.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.713 -0.756 . . . . 72.019999999999996 112.506 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.99 -158.27 20.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.784 -0.722 . . . . 42.200000000000003 112.462 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -107.35 164.82 11.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.378 . . . . 73.349999999999994 110.832 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -138.58 36.02 2.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 63.109999999999999 110.871 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.07 -73.92 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 73.340000000000003 111.144 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.25 161.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 74.439999999999998 110.941 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -134.71 37.87 3.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 64.019999999999996 110.843 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -115.17 -36.05 4.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 71.409999999999997 110.916 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 164.02 76.33 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.708 -0.758 . . . . 53.439999999999998 112.474 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.6 t 177.52 -48.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 70.540000000000006 111.136 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.02 169.6 0.42 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.676 -0.773 . . . . 71.329999999999998 112.536 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.54 135.61 6.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 41.109999999999999 112.485 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -172.65 -178.84 2.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 52.049999999999997 110.878 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.517 ' O ' ' CG1' ' A' ' 78' ' ' ILE . 3.1 p -91.35 39.58 1.0 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 74.040000000000006 110.84 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.517 ' CG1' ' O ' ' A' ' 77' ' ' SER . 0.7 OUTLIER 59.55 6.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 64.109999999999999 111.121 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.501 ' CD2' HG13 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -164.59 37.82 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 74.230000000000004 110.922 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.15 149.79 6.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.712 -0.756 . . . . 63.219999999999999 112.481 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -44.47 -33.53 1.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 63.109999999999999 110.876 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.465 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.73 166.08 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 63.439999999999998 110.874 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -132.13 177.17 7.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 75.450000000000003 110.873 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.08 157.15 28.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 73.420000000000002 110.876 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -49.94 153.75 1.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 74.219999999999999 110.852 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -104.41 -76.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.457 . . . . 73.319999999999993 110.903 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.467 ' O ' HG22 ' A' ' 127' ' ' VAL . 47.4 p30 -159.32 177.45 10.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 61.439999999999998 110.917 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.29 35.59 3.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 63.299999999999997 110.895 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.65 -31.86 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 75.400000000000006 111.097 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 mt -102.79 101.79 11.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 72.030000000000001 110.884 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.671 ' O ' HG23 ' A' ' 93' ' ' THR . 1.6 mtpt -90.93 138.79 31.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 74.5 110.899 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -47.35 105.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 73.510000000000005 110.876 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.671 HG23 ' O ' ' A' ' 91' ' ' LYS . 43.8 p -114.95 30.04 7.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 65.439999999999998 111.134 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 144.68 176.45 18.7 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 53.32 112.507 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 178.01 5.0 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.663 2.242 . . . . 55.109999999999999 112.347 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.82 21.81 63.65 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 71.530000000000001 112.514 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.0 mm -91.75 140.37 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 74.019999999999996 111.125 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -109.64 149.1 30.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 72.120000000000005 110.926 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.68 -164.55 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 72.239999999999995 110.892 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.596 ' HE2' ' HB ' ' A' ' 127' ' ' VAL . 2.0 mtm -98.71 96.6 8.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 74.400000000000006 110.892 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -72.45 62.09 0.51 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 51.530000000000001 111.105 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.405 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 8.7 p-10 -125.15 -158.3 0.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 73.340000000000003 110.875 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.662 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -76.39 53.25 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 62.109999999999999 111.079 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.19 -106.07 0.14 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.713 -0.756 . . . . 62.229999999999997 112.509 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 116.65 4.66 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.707 2.271 . . . . 73.25 112.361 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.489 ' C ' HG23 ' A' ' 107' ' ' THR . 1.1 m-20 66.52 174.13 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 70.120000000000005 110.901 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.662 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.3 p 67.69 32.98 5.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 73.420000000000002 111.15 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.96 146.22 31.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 62.43 110.93 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -148.35 53.79 0.52 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 54.520000000000003 112.46 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.0 t 68.83 33.79 3.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 74.230000000000004 110.869 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -59.89 -168.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 74.299999999999997 110.933 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.436 ' HE2' HD12 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -175.72 155.42 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 73.329999999999998 110.912 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -168.53 68.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 71.340000000000003 110.879 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 113' ' ' PHE . 6.9 mt -33.73 107.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 65.219999999999999 111.164 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.413 ' HA ' ' HB3' ' A' ' 61' ' ' MET . 33.6 m -84.6 139.23 32.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 63.5 110.899 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.1 p -105.01 27.12 8.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.172 -0.467 . . . . 72.219999999999999 111.17 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.665 ' O ' HG23 ' A' ' 119' ' ' THR . . . 178.65 142.94 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 71.049999999999997 111.094 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -52.36 98.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 55.229999999999997 110.888 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.709 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 33.9 p -96.13 44.78 1.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 72.420000000000002 111.197 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -26.54 65.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 70.329999999999998 110.925 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.709 ' CZ2' HG22 ' A' ' 119' ' ' THR . 7.3 p90 -49.68 -27.42 4.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.129 -0.487 . . . . 64.519999999999996 110.943 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 23.6 mt -47.02 -34.71 5.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 61.119999999999997 110.9 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 61.4 77.95 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 71.409999999999997 110.846 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 39.11 44.42 2.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.724 . . . . 52.399999999999999 112.436 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -81.69 -25.56 35.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 72.120000000000005 110.903 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -136.34 -169.35 2.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.848 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.596 ' HB ' ' HE2' ' A' ' 100' ' ' MET . 79.4 t -123.79 112.25 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 111.158 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.5 t -79.95 131.04 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 71.209999999999994 111.138 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.459 ' O ' HD23 ' A' ' 24' ' ' LEU . 30.5 p90 -150.26 37.39 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 75.25 110.909 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -175.13 173.57 46.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.707 -0.759 . . . . 70.340000000000003 112.46 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 132' ' ' VAL . 6.6 pttp -175.9 134.3 0.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 73.099999999999994 110.915 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.761 HG11 ' HG2' ' A' ' 136' ' ' MET . 54.0 t -37.02 105.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 111.127 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -59.31 3.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 63.299999999999997 110.921 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -154.84 158.65 39.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 110.893 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.29 36.3 15.06 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.731 -0.747 . . . . 73.230000000000004 112.5 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.761 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -55.33 -25.23 33.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 74.030000000000001 110.87 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.16 -34.19 65.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 75.409999999999997 110.866 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.547 HD12 ' HB3' ' A' ' 17' ' ' LEU . 37.9 mm -66.31 -40.02 85.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 64.409999999999997 111.139 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.2 t -63.67 -27.59 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 74.450000000000003 111.145 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.57 -30.1 52.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 51.140000000000001 110.926 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.01 -45.94 59.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 73.109999999999999 111.135 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.3 mtm -57.75 -42.02 83.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 62.530000000000001 110.875 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -53.77 -27.53 29.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 73.230000000000004 110.918 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -28.9 52.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 73.310000000000002 110.917 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -100.2 29.38 4.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 72.230000000000004 110.921 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.18 155.66 16.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.752 -0.737 . . . . 61.130000000000003 112.477 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.7 t -110.65 149.81 29.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 35.43 110.872 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -76.05 59.83 1.35 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 72.230000000000004 110.873 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -176.72 -34.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 74.310000000000002 110.889 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.83 -43.23 0.76 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 50.409999999999997 112.485 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.75 165.04 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 72.209999999999994 110.89 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 27.7 p -147.82 149.21 31.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 75.109999999999999 111.129 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.9 m -69.82 -46.08 66.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 63.439999999999998 110.828 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.433 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -104.12 -176.22 3.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.082 -0.508 . . . . 74.030000000000001 110.904 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -115.09 107.95 16.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 73.409999999999997 110.928 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.98 122.12 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 70.230000000000004 111.114 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.89 168.43 18.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 30.52 111.159 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.444 HD11 ' CZ ' ' A' ' 53' ' ' PHE . 41.0 mm -105.43 114.22 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 42.210000000000001 111.084 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -73.58 -47.8 37.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 35.329999999999998 111.122 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -157.44 160.23 38.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.230000000000004 110.849 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -164.05 146.09 9.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 62.210000000000001 110.875 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.95 173.18 44.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 73.310000000000002 112.493 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -63.7 139.55 58.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 65.120000000000005 110.902 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.553 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -92.18 -56.84 2.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 74.209999999999994 110.901 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 72.349999999999994 110.901 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.828 0.347 . . . . 44.210000000000001 110.881 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 p -178.15 156.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 75.329999999999998 111.156 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -51.65 152.66 4.7 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 73.019999999999996 110.905 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 146.03 58.89 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.732 2.288 . . . . 51.210000000000001 112.327 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -135.22 141.69 45.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 73.030000000000001 111.159 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.481 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.5 m -134.48 143.8 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 73.329999999999998 111.101 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 19.0 p90 -102.03 160.77 14.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 65.209999999999994 110.856 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -140.42 95.51 2.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 71.439999999999998 110.936 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.6 t70 -58.77 113.84 2.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 65.25 110.847 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.874 HG23 HG23 ' A' ' 156' ' ' ILE . 14.8 mm -86.05 124.45 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 73.540000000000006 111.112 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -117.25 123.28 46.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 72.219999999999999 111.085 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.661 HG23 HD13 ' A' ' 17' ' ' LEU . 11.5 t -106.6 94.51 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 62.32 111.162 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 62.18 44.56 7.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 72.519999999999996 110.857 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.6 -1.58 88.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 73.120000000000005 112.523 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 8.5 mm-40 -110.05 98.68 35.9 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.627 0.727 . . . . 71.299999999999997 110.896 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.4 Cg_endo -69.81 103.98 1.26 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.737 2.292 . . . . 43.340000000000003 112.31 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.661 HD13 HG23 ' A' ' 12' ' ' VAL . 7.7 mp -65.74 -34.95 79.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 64.140000000000001 110.856 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.76 -143.09 7.94 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 63.130000000000003 112.484 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.08 154.06 47.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 71.209999999999994 110.838 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.441 HG21 HG13 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -144.91 97.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 62.25 111.094 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -91.2 172.46 8.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 74.340000000000003 110.832 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.404 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -145.6 123.48 11.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 74.150000000000006 110.89 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.418 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 23.4 tt0 -73.7 97.48 2.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 62.210000000000001 110.857 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.7 mt -85.09 118.17 24.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 60.439999999999998 110.882 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.423 ' CD1' HD13 ' A' ' 90' ' ' LEU . 52.5 m-85 -79.38 68.98 5.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 73.209999999999994 110.887 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.62 -22.22 21.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 72.010000000000005 111.122 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -69.59 -28.35 65.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 32.240000000000002 110.871 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.91 -29.57 11.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 110.927 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.416 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -139.18 66.42 38.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.62 0.724 . . . . 73.349999999999994 111.122 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -35.21 13.17 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.698 2.265 . . . . 73.010000000000005 112.332 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.86 -36.41 72.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 71.200000000000003 110.895 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.402 HG22 ' CE2' ' A' ' 129' ' ' PHE . 63.5 m -94.22 -43.02 8.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 75.209999999999994 111.139 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.33 91.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.415 . . . . 73.25 111.085 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -50.42 -35.53 28.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 74.140000000000001 110.873 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -64.54 -64.19 0.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 110.926 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -56.35 -34.15 66.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 75.439999999999998 110.913 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.517 ' O ' HG23 ' A' ' 41' ' ' THR . 0.3 OUTLIER -69.87 -53.26 18.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 72.439999999999998 110.904 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 44' ' ' LYS . . . -56.74 -35.42 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 55.219999999999999 111.125 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.7 mt -72.09 -58.68 3.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 73.150000000000006 110.941 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.9 m -51.4 -41.01 60.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 72.400000000000006 110.877 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 37' ' ' ARG . 63.9 p -72.23 -28.31 63.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 74.120000000000005 111.138 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.64 12.75 71.56 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 72.230000000000004 112.465 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.39 -18.42 49.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 73.409999999999997 110.861 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.572 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -90.98 29.78 1.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 75.329999999999998 110.867 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.04 -22.92 16.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.759 -0.734 . . . . 75.319999999999993 112.491 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -179.02 -169.53 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 35.420000000000002 110.914 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.4 -135.84 2.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.801 -0.714 . . . . 72.439999999999998 112.547 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.614 ' HH ' ' HD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -148.83 57.49 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.937 0.399 . . . . 74.409999999999997 110.951 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -87.17 48.8 1.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 64.400000000000006 110.876 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 174.48 54.7 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 63.340000000000003 112.492 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.83 131.14 46.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.869 0.366 . . . . 74.409999999999997 110.82 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.8 p -96.69 121.26 38.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 61.340000000000003 110.912 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -80.99 117.21 21.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 73.340000000000003 110.87 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -114.03 29.75 7.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 74.109999999999999 110.874 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.54 91.6 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 54.240000000000002 110.849 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.471 ' O ' HG22 ' A' ' 56' ' ' ILE . 3.1 mt -128.68 116.29 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 63.439999999999998 111.166 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.2 mt -107.89 104.47 53.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.567 0.699 . . . . 74.450000000000003 111.169 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 79.47 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.7 2.267 . . . . 70.209999999999994 112.332 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.7 -24.42 0.56 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.707 -0.759 . . . . 54.450000000000003 112.515 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.64 -58.98 1.97 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.86 0.362 . . . . 55.25 110.848 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.33 157.28 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 61.299999999999997 110.906 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.418 ' HB3' HG12 ' A' ' 56' ' ' ILE . 34.7 m -90.7 -167.31 1.79 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 63.420000000000002 110.865 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 174.69 142.09 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 62.350000000000001 110.937 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -178.71 148.1 8.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 74.209999999999994 112.469 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.82 112.84 1.23 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.772 -0.727 . . . . 75.219999999999999 112.505 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -179.32 116.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 70.140000000000001 110.864 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.614 ' HD1' ' HH ' ' A' ' 48' ' ' TYR . 2.3 p90 -151.73 159.3 44.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.261 -0.427 . . . . 74.230000000000004 110.931 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.51 105.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 63.140000000000001 111.099 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.89 -169.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 73.239999999999995 110.843 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -102.8 34.43 2.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 74.030000000000001 110.857 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.36 -37.29 3.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 53.240000000000002 110.869 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.99 37.36 2.73 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.78 -0.724 . . . . 50.450000000000003 112.49 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.7 p -145.43 37.94 1.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.34 . . . . 74.230000000000004 111.129 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -129.59 -178.74 15.56 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.698 -0.763 . . . . 64.540000000000006 112.483 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 56.34 39.14 82.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.713 -0.756 . . . . 52.520000000000003 112.469 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.29 159.21 43.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.789 0.328 . . . . 73.109999999999999 110.903 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.2 p -59.15 -175.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 72.120000000000005 110.852 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.559 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.7 pp -90.75 16.88 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 53.130000000000003 111.119 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.85 -65.44 1.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 72.209999999999994 110.952 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.82 -33.17 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 43.030000000000001 112.486 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -141.11 -54.92 0.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.93 0.395 . . . . 71.239999999999995 110.908 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.19 -177.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 71.340000000000003 110.895 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.89 -167.67 1.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.439999999999998 110.872 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -133.37 162.76 30.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 71.319999999999993 110.871 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -47.76 104.34 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 74.239999999999995 110.854 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -80.79 -67.38 0.78 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 75.340000000000003 110.882 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -177.68 173.45 1.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 110.92 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.19 35.54 4.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 74.109999999999999 110.885 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -49.94 -28.91 4.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 74.439999999999998 111.153 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.423 HD13 ' CD1' ' A' ' 25' ' ' PHE . 16.0 mt -117.38 68.69 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 74.239999999999995 110.854 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -62.28 166.53 4.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 73.450000000000003 110.863 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -68.72 83.67 0.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 64.510000000000005 110.832 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.4 p -99.86 24.54 8.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 72.510000000000005 111.12 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 155.65 177.47 28.91 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.782 -0.723 . . . . 70.120000000000005 112.496 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 170.13 17.29 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.704 2.269 . . . . 45.210000000000001 112.354 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.12 40.04 96.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 61.530000000000001 112.474 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.3 mm -108.9 136.06 45.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.832 0.348 . . . . 74.510000000000005 111.144 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.505 HD21 ' CD1' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -103.62 157.39 17.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.446 . . . . 72.25 110.899 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 3.6 t -162.19 -139.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 41.049999999999997 110.883 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 13.7 mmt -152.91 147.42 25.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 72.430000000000007 110.853 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -123.19 151.34 42.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 75.310000000000002 111.074 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 167.71 -50.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 74.450000000000003 110.915 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -174.63 29.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 73.019999999999996 111.136 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.55 -116.66 4.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 31.440000000000001 112.472 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 125.09 11.76 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.661 2.241 . . . . 65.400000000000006 112.355 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.488 ' C ' HG23 ' A' ' 107' ' ' THR . 1.3 m-20 70.54 165.76 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 73.030000000000001 110.888 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.488 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.3 p 67.13 29.22 7.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 73.040000000000006 111.175 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -65.24 90.38 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 74.239999999999995 110.898 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -66.52 -131.78 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.743 -0.742 . . . . 72.420000000000002 112.477 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.0 p -133.23 24.2 4.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.833 0.349 . . . . 51.310000000000002 110.861 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.532 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 2.1 pt20 -106.56 55.76 0.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 75.129999999999995 110.939 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.505 ' CD1' HD21 ' A' ' 98' ' ' LEU . 4.6 p90 -58.65 -168.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 60.450000000000003 110.843 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -152.73 160.63 43.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.827 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 114' ' ' ILE . 2.4 mp -105.1 91.17 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 73.439999999999998 111.13 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.5 m -64.28 90.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 75.430000000000007 110.896 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.6 p -63.93 -12.89 41.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 65.120000000000005 111.141 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.688 ' O ' HG23 ' A' ' 119' ' ' THR . . . -143.22 156.7 44.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 62.219999999999999 111.096 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -56.41 95.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 61.509999999999998 110.892 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 117' ' ' ALA . 23.1 p -97.83 50.11 1.03 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 45.420000000000002 111.136 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -24.37 66.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 74.25 110.89 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.687 ' CZ2' HG22 ' A' ' 119' ' ' THR . 5.9 p90 -48.29 -30.49 4.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 74.099999999999994 110.933 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.5 mt -47.44 -34.65 7.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 65.120000000000005 110.922 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 124' ' ' GLY . 3.6 m-20 59.03 81.18 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 74.540000000000006 110.848 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.61 43.63 0.8 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.709 -0.758 . . . . 74.140000000000001 112.47 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -81.66 -16.64 50.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 74.549999999999997 110.871 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -144.75 -168.55 2.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 55.509999999999998 110.802 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.7 t -120.75 120.97 64.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 64.109999999999999 111.125 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 98' ' ' LEU . 20.4 t -93.26 136.15 25.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 74.349999999999994 111.112 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.481 ' O ' HD23 ' A' ' 24' ' ' LEU . 13.3 p90 -156.2 37.54 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 72.099999999999994 110.854 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -177.51 174.49 46.97 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 50.240000000000002 112.528 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 132' ' ' VAL . 5.1 pttp -172.94 132.96 0.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.347 . . . . 73.010000000000005 110.9 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.749 HG11 ' HG2' ' A' ' 136' ' ' MET . 38.2 t -36.44 107.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 45.520000000000003 111.149 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.418 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -72.27 -58.92 3.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 70.150000000000006 110.903 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -155.86 154.89 31.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 72.140000000000001 110.876 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.07 28.79 11.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 45.329999999999998 112.512 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.749 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -57.33 -24.04 52.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 63.420000000000002 110.881 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.06 -36.94 73.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 75.010000000000005 110.932 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.466 HD12 ' HB3' ' A' ' 17' ' ' LEU . 27.4 mm -67.6 -39.57 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 63.530000000000001 111.093 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.407 HG11 HG21 ' A' ' 114' ' ' ILE . 75.9 t -63.01 -29.49 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 65.129999999999995 111.083 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -74.71 -30.55 61.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 71.299999999999997 110.897 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.74 -37.98 70.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 73.219999999999999 111.09 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.576 ' SD ' HG21 ' A' ' 156' ' ' ILE . 17.5 mtm -58.71 -53.44 58.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 71.510000000000005 110.85 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.85 -26.06 32.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 73.519999999999996 110.868 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.445 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.81 -23.74 63.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 63.109999999999999 110.9 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.445 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 59.8 m-85 -109.16 17.32 21.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 72.329999999999998 110.87 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -107.7 170.33 15.31 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.796 -0.716 . . . . 72.319999999999993 112.489 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 t -134.55 142.69 47.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.899 0.381 . . . . 55.420000000000002 110.837 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -69.03 82.73 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 74.409999999999997 110.846 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -179.33 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 110.885 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.75 -84.67 0.16 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 61.450000000000003 112.506 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.68 175.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 75.409999999999997 110.877 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.6 p -143.49 168.99 18.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 72.450000000000003 111.184 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.65 -48.08 35.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 70.329999999999998 110.842 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.405 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -92.29 -179.66 5.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 71.219999999999999 110.886 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -124.51 108.32 11.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.841 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.874 HG23 HG23 ' A' ' 10' ' ' ILE . 4.8 mp -94.53 109.41 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 71.340000000000003 111.123 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.14 161.89 22.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 63.229999999999997 111.159 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.0 mm -92.85 120.07 41.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 63.539999999999999 111.134 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -86.15 -56.99 3.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 61.439999999999998 111.088 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -137.71 157.37 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 74.099999999999994 110.894 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -165.91 146.98 6.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 75.0 110.9 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.11 172.42 44.54 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 64.099999999999994 112.472 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -66.2 137.37 56.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.899 0.38 . . . . 62.509999999999998 110.871 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.564 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.3 mm? -88.76 -58.68 2.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 73.219999999999999 110.908 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 62.200000000000003 110.906 179.918 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 mtm . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.859 0.361 . . . . 75.129999999999995 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.2 t -145.72 127.41 8.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 54.329999999999998 111.125 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -87.14 144.84 36.85 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.669 0.747 . . . . 62.299999999999997 110.879 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 145.01 55.52 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.662 2.241 . . . . 70.340000000000003 112.347 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.4 m -130.95 129.75 42.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 55.119999999999997 111.14 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.07 170.56 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 73.319999999999993 111.141 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.599 ' HB3' HD21 ' A' ' 164' ' ' LEU . 1.5 p90 -153.92 179.5 8.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 75.219999999999999 110.949 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.423 ' HA ' ' HB3' ' A' ' 161' ' ' CYS . 97.9 m-85 -155.79 97.37 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 70.409999999999997 110.888 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.64 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 5.9 t0 -47.73 106.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 65.25 110.875 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.87 HG23 HG23 ' A' ' 156' ' ' ILE . 43.3 mm -79.03 124.27 37.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 62.420000000000002 111.138 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -116.65 134.87 54.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.340000000000003 111.085 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.504 HG13 ' HB3' ' A' ' 154' ' ' LYS . 5.0 t -116.49 96.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 63.009999999999998 111.11 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.57 35.52 22.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 61.240000000000002 110.85 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.36 -15.78 60.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 71.0 112.517 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.6 tt0 -103.32 108.09 57.9 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.663 0.744 . . . . 54.210000000000001 110.865 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.75 126.49 13.38 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.698 2.265 . . . . 72.209999999999994 112.39 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.1 -38.25 82.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 72.450000000000003 110.902 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.96 -138.64 5.89 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.77 -0.729 . . . . 73.439999999999998 112.53 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.94 140.36 48.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.811 0.339 . . . . 64.239999999999995 110.894 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.474 ' CG2' HG21 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -143.87 97.8 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 72.420000000000002 111.117 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 2.4 t -103.69 174.33 5.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 72.319999999999993 110.848 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.427 ' N ' ' OG ' ' A' ' 21' ' ' SER . 26.6 m-85 -148.12 132.1 17.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 74.019999999999996 110.891 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -88.08 98.79 11.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 71.340000000000003 110.889 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.5 mt -80.8 133.43 35.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 74.109999999999999 110.896 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -91.25 65.42 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 71.409999999999997 110.888 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.26 -23.58 23.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 32.439999999999998 111.119 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.77 -40.89 96.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 75.010000000000005 110.851 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -95.07 -26.8 15.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 70.519999999999996 110.906 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.442 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -137.78 67.44 50.28 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.615 0.721 . . . . 63.439999999999998 111.16 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -38.51 7.63 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.655 2.237 . . . . 44.399999999999999 112.326 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -38.99 90.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 61.210000000000001 110.925 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.7 m -84.76 -42.23 15.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 63.030000000000001 111.131 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.99 -48.46 78.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 62.299999999999997 111.076 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -53.88 -33.13 55.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 64.030000000000001 110.898 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.681 ' O ' HD12 ' A' ' 39' ' ' LEU . 1.3 t30 -60.92 -61.71 2.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 73.140000000000001 110.888 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -63.96 -41.3 97.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 70.230000000000004 110.898 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.481 ' O ' HG23 ' A' ' 41' ' ' THR . 1.1 ttp180 -63.48 -31.14 72.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 75.430000000000007 110.858 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.91 67.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 71.109999999999999 111.127 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.681 HD12 ' O ' ' A' ' 35' ' ' ASN . 1.2 mp -67.6 -36.76 81.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 62.25 110.937 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.2 m -69.02 -51.19 41.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 61.420000000000002 110.881 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 37' ' ' ARG . 73.5 p -64.88 -32.95 74.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 71.299999999999997 111.173 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.02 -13.48 55.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 71.049999999999997 112.462 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.77 -33.45 23.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.951 0.405 . . . . 72.430000000000007 110.913 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -53.45 -27.87 27.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 72.230000000000004 110.929 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.46 -5.71 80.48 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.737 -0.744 . . . . 72.439999999999998 112.484 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -168.65 -167.58 0.79 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 73.519999999999996 110.935 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.26 -137.86 6.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.705 -0.759 . . . . 24.34 112.449 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -151.54 47.15 0.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.001 0.429 . . . . 74.299999999999997 110.925 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 139.47 58.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 74.049999999999997 110.882 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.03 -22.01 39.69 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.763 -0.732 . . . . 61.140000000000001 112.482 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.45 173.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 71.540000000000006 110.854 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.509 ' HB3' HG23 ' A' ' 157' ' ' THR . 17.6 p -122.1 179.68 4.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 74.409999999999997 110.862 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -104.47 136.09 44.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 71.530000000000001 110.841 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.21 37.16 3.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 70.099999999999994 110.856 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -166.95 77.21 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 75.329999999999998 110.881 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.446 HG23 ' OE1' ' A' ' 143' ' ' GLU . 11.9 mt -120.52 111.29 31.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 44.450000000000003 111.139 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.4 mt -108.21 103.5 50.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.646 0.736 . . . . 62.030000000000001 111.135 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 54.2 Cg_endo -69.75 76.25 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 54.219999999999999 112.361 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.99 -26.77 0.25 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.722 -0.751 . . . . 73.030000000000001 112.495 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.69 -55.33 2.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.86 0.362 . . . . 74.239999999999995 110.88 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.442 ' HE3' ' O ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER 171.98 175.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 71.120000000000005 110.871 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.442 ' O ' ' HE3' ' A' ' 61' ' ' MET . 5.3 m -111.83 -168.11 1.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 72.230000000000004 110.887 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -173.15 141.98 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 110.941 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -58.23 -46.45 92.82 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.791 -0.719 . . . . 74.530000000000001 112.45 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.95 125.88 5.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.737 . . . . 61.130000000000003 112.444 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.08 136.48 50.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.369 . . . . 73.349999999999994 110.835 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -121.96 -48.49 2.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 65.239999999999995 110.876 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.8 p 47.02 90.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 74.129999999999995 111.143 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -48.14 -68.27 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 74.349999999999994 110.825 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -114.76 -75.64 0.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 71.349999999999994 110.856 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -125.42 35.99 4.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 70.129999999999995 110.883 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.57 122.26 0.1 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.778 -0.725 . . . . 72.239999999999995 112.516 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.401 HG23 ' N ' ' A' ' 74' ' ' GLY . 1.7 t 177.66 -48.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.841 0.353 . . . . 74.239999999999995 111.099 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.401 ' N ' HG23 ' A' ' 73' ' ' THR . . . -51.97 -54.77 24.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.77 -0.728 . . . . 52.200000000000003 112.501 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.38 -125.06 5.51 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.719 -0.753 . . . . 73.340000000000003 112.483 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 44.7 -164.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.721 0.296 . . . . 74.349999999999994 110.912 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.15 125.88 28.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 45.130000000000003 110.896 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.42 HG22 ' HD2' ' A' ' 44' ' ' LYS . 1.0 OUTLIER -50.74 -28.14 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 71.329999999999998 111.156 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -79.89 -37.48 34.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 75.150000000000006 110.912 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.95 -151.08 13.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.8 -0.714 . . . . 71.549999999999997 112.499 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -51.03 -40.14 57.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.948 0.404 . . . . 73.510000000000005 110.882 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.436 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.5 167.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 72.140000000000001 110.885 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.35 167.17 19.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 73.230000000000004 110.898 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.17 150.8 48.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 74.329999999999998 110.865 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -52.47 161.03 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 75.010000000000005 110.881 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -110.99 -70.77 0.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.858 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -170.55 173.54 5.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 63.420000000000002 110.908 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.46 37.34 3.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 74.540000000000006 110.831 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.99 -30.28 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 73.109999999999999 111.187 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.1 mt -108.79 80.01 1.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 54.140000000000001 110.888 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.65 154.06 34.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 75.239999999999995 110.901 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -64.13 88.42 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 75.409999999999997 110.831 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.1 p -78.57 -54.29 6.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 74.230000000000004 111.134 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.05 -165.94 11.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 72.430000000000007 112.468 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 177.91 5.08 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.633 2.222 . . . . 75.010000000000005 112.351 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.24 31.13 78.03 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.742 -0.742 . . . . 73.329999999999998 112.482 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.2 mm -107.01 140.98 23.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 60.229999999999997 111.094 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.815 HD11 ' CE2' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -108.26 144.9 35.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 73.420000000000002 110.895 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.25 146.61 22.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 75.230000000000004 110.903 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -69.74 82.83 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 55.229999999999997 110.838 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.858 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -57.44 142.86 42.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 72.120000000000005 111.069 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 170.59 -167.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 71.299999999999997 110.866 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.682 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -50.46 -51.46 46.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 53.240000000000002 111.102 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.14 -69.91 0.37 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 42.119999999999997 112.52 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.477 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 54.0 Cg_endo -69.76 99.26 0.73 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.725 2.283 . . . . 45.340000000000003 112.327 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.529 ' O ' HG23 ' A' ' 107' ' ' THR . 0.4 OUTLIER 37.87 55.35 1.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 74.230000000000004 110.874 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.682 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.2 p -159.97 53.33 0.35 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 64.510000000000005 111.168 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.28 152.47 31.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 32.229999999999997 110.891 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.59 5.37 2.87 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 75.209999999999994 112.498 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 74.2 51.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.793 0.33 . . . . 72.239999999999995 110.881 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.697 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 0.6 OUTLIER -70.21 -31.64 69.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 71.239999999999995 110.935 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.815 ' CE2' HD11 ' A' ' 98' ' ' LEU . 30.6 t80 99.66 145.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 62.340000000000003 110.878 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.858 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -169.86 114.62 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 72.019999999999996 110.91 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.3 mt -80.94 129.07 38.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 63.210000000000001 111.119 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -91.34 92.77 8.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.447 . . . . 64.129999999999995 110.856 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 45.2 p -79.23 14.16 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 74.219999999999999 111.18 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.809 ' O ' HG23 ' A' ' 119' ' ' THR . . . 178.65 143.77 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.466 . . . . 74.120000000000005 111.052 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -50.56 98.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 61.539999999999999 110.937 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 117' ' ' ALA . 35.0 p -104.16 48.93 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 43.439999999999998 111.092 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -24.86 67.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 71.0 110.868 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.8 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.2 p90 -50.03 -26.96 4.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 74.519999999999996 110.901 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.6 mt -45.63 -35.52 4.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 73.299999999999997 110.94 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.7 m-20 61.6 80.2 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 110.819 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 35.98 43.17 0.62 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.741 -0.742 . . . . 51.210000000000001 112.497 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.46 -19.28 33.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.753 0.311 . . . . 74.540000000000006 110.908 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -142.86 -165.15 1.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 73.430000000000007 110.865 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.7 t -131.29 125.64 57.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 74.150000000000006 111.123 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.51 133.2 33.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 73.109999999999999 111.162 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.48 ' O ' HD23 ' A' ' 24' ' ' LEU . 23.0 p90 -155.3 36.53 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 74.049999999999997 110.925 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -171.72 173.9 45.08 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.705 -0.76 . . . . 64.25 112.446 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -175.88 133.54 0.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 74.120000000000005 110.913 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.698 HG11 ' HG2' ' A' ' 136' ' ' MET . 76.8 t -39.73 107.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 54.409999999999997 111.144 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -58.08 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 72.310000000000002 110.922 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -154.75 163.05 40.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 71.540000000000006 110.873 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.5 32.67 46.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.69 -0.766 . . . . 54.539999999999999 112.471 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.698 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -50.89 -34.05 26.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.744 0.307 . . . . 75.209999999999994 110.827 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.6 -32.24 12.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 74.409999999999997 110.847 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.474 HG21 ' CG2' ' A' ' 20' ' ' VAL . 41.8 mm -66.31 -43.35 91.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 72.340000000000003 111.135 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.75 -26.33 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 41.119999999999997 111.113 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.32 -29.73 38.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 73.25 110.864 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.31 -37.61 66.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 60.200000000000003 111.08 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 24.4 mtm -57.3 -54.25 48.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 61.399999999999999 110.912 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.446 ' OE1' HG23 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -55.32 -25.5 34.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 60.43 110.873 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.424 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.91 -23.74 63.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 75.349999999999994 110.846 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.424 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 57.1 m-85 -108.79 17.13 22.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 75.549999999999997 110.88 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.34 168.37 12.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 62.409999999999997 112.5 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.6 m -113.76 148.22 36.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 75.239999999999995 110.892 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 -75.24 67.46 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.898 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -175.11 -35.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 71.450000000000003 110.872 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.78 -45.34 0.62 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.728 -0.749 . . . . 60.119999999999997 112.442 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.71 171.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 74.200000000000003 110.933 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.4 p -145.04 139.58 27.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 74.319999999999993 111.134 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.39 -39.89 77.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 73.150000000000006 110.826 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.504 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -107.39 -174.93 2.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 74.439999999999998 110.885 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.57 107.59 13.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 110.941 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.87 HG23 HG23 ' A' ' 10' ' ' ILE . 3.9 mp -89.68 102.34 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 75.439999999999998 111.131 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.509 HG23 ' HB3' ' A' ' 52' ' ' CYS . 0.0 OUTLIER -109.93 163.86 13.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 65.439999999999998 111.165 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.2 mt -102.94 116.47 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 72.109999999999999 111.131 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -81.72 -52.34 7.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 63.539999999999999 111.159 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -148.17 153.75 39.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 62.009999999999998 110.865 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -160.84 149.74 16.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 110.889 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.84 166.38 27.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.798 -0.715 . . . . 31.539999999999999 112.505 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -59.4 109.24 0.84 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 74.219999999999999 110.876 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.599 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.6 mm? -53.2 -48.19 68.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 73.239999999999995 110.934 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 75.319999999999993 110.913 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.9 mtm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.824 0.345 . . . . 61.539999999999999 110.879 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.4 t -149.32 127.5 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 71.239999999999995 111.143 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -118.04 146.92 40.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.595 0.712 . . . . 75.239999999999995 110.889 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 149.34 66.58 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.676 2.25 . . . . 72.420000000000002 112.355 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -136.02 137.7 41.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 55.119999999999997 111.181 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.568 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.9 m -131.61 145.64 34.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 55.439999999999998 111.113 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.837 ' HB3' HD21 ' A' ' 164' ' ' LEU . 8.2 p90 -101.93 168.04 9.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 110.923 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -147.81 88.9 1.71 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 73.129999999999995 110.893 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.709 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -51.86 105.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 72.150000000000006 110.882 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.575 HG13 HG21 ' A' ' 20' ' ' VAL . 38.2 mm -83.97 126.95 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 75.120000000000005 111.105 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -121.04 149.54 42.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 35.229999999999997 111.077 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 t -130.04 94.94 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 62.350000000000001 111.123 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.02 32.66 10.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 71.109999999999999 110.893 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.18 -21.59 42.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 62.020000000000003 112.489 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -94.18 113.07 59.82 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.644 0.735 . . . . 74.319999999999993 110.882 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.7 Cg_endo -69.81 123.32 9.97 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.649 2.233 . . . . 53.109999999999999 112.357 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.56 ' HB3' HD12 ' A' ' 138' ' ' ILE . 12.0 mt -68.71 -37.83 79.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 63.030000000000001 110.916 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.13 -125.98 1.67 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.75 -0.738 . . . . 43.0 112.497 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.51 138.48 52.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 61.310000000000002 110.895 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.575 HG21 HG13 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -145.71 101.16 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 74.310000000000002 111.15 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -108.23 172.77 6.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 45.229999999999997 110.829 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.403 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -143.54 133.03 23.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 74.409999999999997 110.871 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -85.4 97.38 9.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 74.219999999999999 110.926 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 129' ' ' PHE . 3.2 mt -81.78 117.61 22.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 52.450000000000003 110.889 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -78.7 64.96 3.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 73.439999999999998 110.827 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.79 -24.05 14.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 20.030000000000001 111.111 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -67.96 -35.14 77.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 64.310000000000002 110.849 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -95.78 -29.2 14.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 70.099999999999994 110.908 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.404 HG21 ' HA ' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -136.58 65.82 55.77 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.641 0.734 . . . . 73.400000000000006 111.129 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -29.32 23.96 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.618 2.212 . . . . 44.25 112.355 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -41.23 96.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 74.400000000000006 110.932 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.8 m -88.55 -45.31 10.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 72.340000000000003 111.143 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.98 -46.07 82.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 73.140000000000001 111.101 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -47.01 -33.66 4.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 72.439999999999998 110.911 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.487 ' HA ' HD13 ' A' ' 78' ' ' ILE . 2.6 t30 -64.57 -65.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 54.109999999999999 110.854 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -59.04 -28.58 66.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 73.310000000000002 110.887 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -50.6 65.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 72.340000000000003 110.847 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.54 -31.71 72.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 62.409999999999997 111.069 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.876 HD21 HG22 ' A' ' 78' ' ' ILE . 75.1 mt -73.67 -54.54 7.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 75.400000000000006 110.927 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.9 m -48.28 -43.94 33.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 61.140000000000001 110.844 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.777 HG22 ' HG3' ' A' ' 163' ' ' GLN . 40.3 p -63.34 -38.42 91.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 72.299999999999997 111.186 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.06 -10.84 44.34 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.702 -0.761 . . . . 52.350000000000001 112.496 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -28.89 27.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.399 . . . . 51.210000000000001 110.893 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.695 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -63.83 -29.05 70.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 63.340000000000003 110.915 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.35 1.38 90.04 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 74.510000000000005 112.508 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -174.89 -165.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.915 0.388 . . . . 75.340000000000003 110.865 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.67 -96.22 0.63 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 61.229999999999997 112.506 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.67 ' O ' ' C ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -119.19 -70.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.958 0.409 . . . . 73.239999999999995 110.894 -179.82 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.67 ' C ' ' O ' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -6.44 96.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 60.340000000000003 110.922 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 120.45 -30.61 5.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.695 -0.764 . . . . 53.100000000000001 112.498 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.37 -168.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.808 0.337 . . . . 62.539999999999999 110.875 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.1 p -142.84 171.94 13.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 45.340000000000003 110.94 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.655 ' HE1' HD11 ' A' ' 158' ' ' ILE . 8.8 m-85 -92.82 139.97 29.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 74.140000000000001 110.909 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -123.45 32.57 5.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 73.319999999999993 110.821 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.99 114.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.423 . . . . 73.129999999999995 110.905 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.46 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.2 mt -144.96 112.47 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 70.329999999999998 111.125 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.478 HD12 ' HE2' ' A' ' 61' ' ' MET . 38.5 mt -105.42 105.07 50.99 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.622 0.725 . . . . 62.530000000000001 111.165 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.8 Cg_endo -69.79 56.9 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.644 2.229 . . . . 72.099999999999994 112.336 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.16 33.33 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.71 -0.757 . . . . 50.299999999999997 112.476 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.419 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.0 OUTLIER -177.12 -59.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.838 0.352 . . . . 75.120000000000005 110.882 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.478 ' HE2' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER 174.65 157.92 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 64.409999999999997 110.885 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.5 m -97.04 -161.88 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 33.530000000000001 110.927 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 177.01 137.96 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 74.109999999999999 110.892 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.2 166.83 40.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 62.149999999999999 112.449 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.48 -151.49 2.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.694 -0.765 . . . . 71.239999999999995 112.452 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.19 168.38 19.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.812 0.339 . . . . 64.120000000000005 110.884 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -154.1 38.3 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 62.140000000000001 110.852 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 93.4 m -158.66 98.73 1.53 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 111.159 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? 63.09 162.08 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 64.450000000000003 110.845 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -112.66 36.4 3.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 65.549999999999997 110.838 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -98.89 -74.66 0.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 75.400000000000006 110.899 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.59 32.74 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.775 -0.726 . . . . 72.430000000000007 112.509 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.0 p -101.8 -55.45 2.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.795 0.331 . . . . 51.399999999999999 111.121 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.24 107.37 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.693 -0.765 . . . . 60.310000000000002 112.472 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 51.84 -170.37 0.43 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.685 -0.769 . . . . 31.5 112.516 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.79 -171.51 3.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 63.420000000000002 110.862 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.9 p -104.44 52.64 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 45.149999999999999 110.879 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.876 HG22 HD21 ' A' ' 39' ' ' LEU . 18.8 pt 42.24 33.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 74.230000000000004 111.098 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -155.12 -66.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 64.120000000000005 110.939 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -132.32 -88.3 0.39 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.709 -0.758 . . . . 73.519999999999996 112.486 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -130.91 -37.39 1.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 75.510000000000005 110.884 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.422 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.27 170.04 0.31 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 71.340000000000003 110.898 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -130.99 179.7 5.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 62.009999999999998 110.852 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.1 169.01 19.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 63.310000000000002 110.879 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -63.34 156.75 24.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 72.030000000000001 110.884 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -108.26 -68.91 0.88 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 64.010000000000005 110.853 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -175.94 178.09 1.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 73.219999999999999 110.893 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.94 36.5 2.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 74.140000000000001 110.901 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -50.61 -29.78 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 72.040000000000006 111.101 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 18.8 mt -111.61 74.79 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 71.439999999999998 110.896 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.73 153.51 41.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.120000000000005 110.859 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -52.87 101.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.129999999999995 110.866 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.5 p -116.03 29.15 8.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 75.319999999999993 111.126 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 151.8 174.15 22.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 62.149999999999999 112.438 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 171.33 14.73 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.638 2.225 . . . . 74.230000000000004 112.308 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.63 39.7 98.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 45.409999999999997 112.479 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.436 ' HA ' HD13 ' A' ' 97' ' ' ILE . 14.7 mm -106.13 135.28 45.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.88 0.371 . . . . 74.420000000000002 111.085 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 98' ' ' LEU . 1.1 mt -101.05 149.07 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 74.230000000000004 110.924 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.455 ' HB2' ' HA ' ' A' ' 128' ' ' VAL . 0.2 OUTLIER 178.81 131.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 63.439999999999998 110.833 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.74 162.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 73.319999999999993 110.891 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.471 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . . . -156.22 36.8 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 52.219999999999999 111.128 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -68.18 -35.71 78.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 71.420000000000002 110.928 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.706 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -174.61 32.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 71.310000000000002 111.06 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.04 -114.34 6.31 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.686 -0.769 . . . . 75.510000000000005 112.484 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 114.75 3.81 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.658 2.239 . . . . 64.430000000000007 112.34 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.529 ' C ' HG23 ' A' ' 107' ' ' THR . 3.4 m-20 71.19 171.86 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 74.430000000000007 110.867 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.706 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.0 OUTLIER 66.66 25.68 9.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 75.310000000000002 111.143 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -80.3 130.53 35.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 65.019999999999996 110.909 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.01 -74.85 0.11 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.774 -0.727 . . . . 61.420000000000002 112.489 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.8 p -166.43 43.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 73.439999999999998 110.857 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.436 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 42.8 mm-40 -118.36 54.97 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 74.519999999999996 110.945 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -77.9 -165.91 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 73.140000000000001 110.887 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -154.44 174.58 14.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 72.219999999999999 110.837 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 114' ' ' ILE . 3.0 mt -111.26 90.93 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.496 . . . . 73.340000000000003 111.15 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 55.8 m -65.55 93.13 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 53.350000000000001 110.899 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.2 p -65.8 -11.26 44.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.46 . . . . 74.450000000000003 111.191 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 119' ' ' THR . . . -145.5 154.95 42.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 65.310000000000002 111.096 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -55.64 94.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 70.140000000000001 110.915 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 117' ' ' ALA . 25.7 p -96.74 49.56 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 74.510000000000005 111.097 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -26.01 68.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 65.239999999999995 110.863 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.695 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.6 p90 -48.11 -29.6 3.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 73.109999999999999 110.886 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 19.0 mt -46.92 -33.51 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 65.319999999999993 110.925 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.4 OUTLIER 60.54 78.17 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.847 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.94 43.81 0.9 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 62.329999999999998 112.467 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -16.27 49.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 72.25 110.87 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -141.41 -168.19 2.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 75.329999999999998 110.877 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 51.0 t -122.01 124.22 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 75.230000000000004 111.12 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.455 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 2.3 t -93.21 135.67 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.209999999999994 111.127 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.446 ' O ' HD23 ' A' ' 24' ' ' LEU . 14.1 p90 -160.69 35.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 74.310000000000002 110.887 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -174.08 174.9 46.54 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.73 -0.748 . . . . 64.540000000000006 112.499 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -176.1 137.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 64.25 110.877 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.725 HG11 ' HG2' ' A' ' 136' ' ' MET . 54.1 t -40.73 107.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 70.400000000000006 111.092 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -59.82 2.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.040000000000006 110.928 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -153.78 157.13 38.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 72.530000000000001 110.935 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.11 32.9 19.34 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.737 -0.744 . . . . 44.140000000000001 112.487 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.725 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -55.01 -29.19 56.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 71.219999999999999 110.93 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.26 -31.19 42.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 74.099999999999994 110.896 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 17' ' ' LEU . 43.8 mm -65.58 -40.71 88.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 62.420000000000002 111.147 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.4 t -63.03 -27.36 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 62.340000000000003 111.096 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.91 -27.76 36.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 74.140000000000001 110.893 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.91 -38.68 61.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 62.310000000000002 111.097 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.8 mtm -61.42 -52.18 65.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 73.439999999999998 110.859 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -54.05 -29.61 44.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 74.040000000000006 110.904 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.452 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -65.8 -23.37 66.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 64.040000000000006 110.906 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.452 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 62.2 m-85 -108.95 18.63 20.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 72.519999999999996 110.849 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -114.03 168.46 12.58 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.693 -0.765 . . . . 73.310000000000002 112.484 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 m -113.07 146.76 38.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 53.43 110.865 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -76.01 64.45 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 75.340000000000003 110.873 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -165.48 -38.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 64.409999999999997 110.918 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 157.75 -71.39 0.25 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 74.219999999999999 112.501 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 170.4 4.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.817 0.341 . . . . 74.340000000000003 110.921 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.8 p -145.39 -173.9 4.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 72.5 111.113 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.74 -67.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 72.319999999999993 110.841 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -59.93 -179.22 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 70.409999999999997 110.903 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.62 107.07 9.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 71.129999999999995 110.913 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 4.1 mp -86.99 116.41 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 75.540000000000006 111.156 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.44 169.58 13.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 111.126 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.655 HD11 ' HE1' ' A' ' 53' ' ' PHE . 11.6 mm -104.83 109.25 27.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 73.209999999999994 111.112 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.709 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -68.68 -45.15 72.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 73.129999999999995 111.108 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -161.76 160.03 27.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 73.349999999999994 110.856 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.9 146.66 9.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 71.129999999999995 110.862 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.97 178.81 48.14 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.684 -0.77 . . . . 51.229999999999997 112.452 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.777 ' HG3' HG22 ' A' ' 41' ' ' THR . 3.6 mt-30 -63.98 146.24 54.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.854 0.359 . . . . 72.0 110.922 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.837 HD21 ' HB3' ' A' ' 7' ' ' PHE . 3.5 mm? -102.4 -55.66 2.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 75.5 110.904 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 64.25 110.944 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 mtt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.837 0.351 . . . . 60.329999999999998 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.5 t -140.55 131.99 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 63.130000000000003 111.133 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -123.48 156.26 64.43 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.661 0.744 . . . . 74.209999999999994 110.855 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 145.83 58.52 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.694 2.263 . . . . 62.340000000000003 112.399 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.1 m -129.71 126.88 39.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 73.439999999999998 111.106 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.9 m -121.27 170.51 11.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 65.5 111.139 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.669 ' HB3' HD21 ' A' ' 164' ' ' LEU . 0.6 OUTLIER -158.52 176.37 12.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 63.43 110.882 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -153.13 96.21 2.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 63.149999999999999 110.864 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.6 t70 -43.22 106.63 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 74.349999999999994 110.867 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.708 HG22 HD12 ' A' ' 17' ' ' LEU . 34.1 mm -78.74 137.63 21.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 63.240000000000002 111.114 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -131.25 160.42 34.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 64.299999999999997 111.112 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -143.33 103.6 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 62.439999999999998 111.119 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.96 24.98 9.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 73.450000000000003 110.902 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.11 -25.29 25.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 33.509999999999998 112.512 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -90.28 125.17 60.96 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.672 0.748 . . . . 72.219999999999999 110.886 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.5 Cg_endo -69.76 124.49 11.14 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.653 2.235 . . . . 43.240000000000002 112.328 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.708 HD12 HG22 ' A' ' 10' ' ' ILE . 9.7 mt -68.25 -38.15 81.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 75.040000000000006 110.941 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.93 -131.17 2.86 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.669 -0.777 . . . . 65.319999999999993 112.434 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.67 136.66 53.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 52.439999999999998 110.9 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.584 HG21 HG13 ' A' ' 10' ' ' ILE . 1.3 t -142.4 99.46 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 65.150000000000006 111.137 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 22' ' ' PHE . 1.5 t -106.36 174.01 6.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 61.520000000000003 110.839 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.474 ' CZ ' HD11 ' A' ' 114' ' ' ILE . 48.2 m-85 -144.81 132.97 21.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 71.450000000000003 110.863 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -89.43 95.95 10.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 71.230000000000004 110.893 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.4 mt -81.06 134.61 35.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 54.310000000000002 110.896 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -92.18 66.87 4.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 110.852 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.91 -22.81 27.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 74.200000000000003 111.129 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -65.22 -39.44 92.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 61.32 110.813 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -96.58 -27.84 14.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 74.140000000000001 110.882 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.458 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -135.54 66.2 63.75 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.612 0.72 . . . . 71.519999999999996 111.112 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -45.91 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.703 2.268 . . . . 64.319999999999993 112.348 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -54.41 -34.71 61.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.434 . . . . 63.520000000000003 110.912 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.428 HG21 ' CD1' ' A' ' 129' ' ' PHE . 32.5 m -89.64 -54.11 4.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 65.049999999999997 111.109 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.92 -42.27 62.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 54.530000000000001 111.116 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -56.04 -27.18 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 71.510000000000005 110.925 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -66.68 -65.68 0.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 74.400000000000006 110.901 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.94 -34.66 70.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 73.439999999999998 110.888 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.485 ' O ' HG23 ' A' ' 41' ' ' THR . 3.5 ttp180 -70.22 -48.27 57.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 74.340000000000003 110.894 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.92 -37.18 66.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 73.329999999999998 111.118 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.5 HD22 ' HA2' ' A' ' 47' ' ' GLY . 3.1 mt -76.92 -56.06 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 72.230000000000004 110.934 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.0 m -53.6 -32.75 52.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 73.310000000000002 110.886 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 37' ' ' ARG . 30.6 p -73.42 -53.41 10.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 74.150000000000006 111.142 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.54 -13.92 6.49 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 74.109999999999999 112.455 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -53.63 -31.01 45.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.373 . . . . 73.409999999999997 110.877 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -27.9 60.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 72.450000000000003 110.925 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.04 -17.12 53.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 54.119999999999997 112.515 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -154.85 -165.18 1.98 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.907 0.385 . . . . 71.319999999999993 110.865 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA2' HD22 ' A' ' 39' ' ' LEU . . . 152.05 -123.41 1.47 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 73.299999999999997 112.473 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -121.7 31.72 6.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.934 0.397 . . . . 74.349999999999994 110.905 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.67 114.34 20.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 71.5 110.882 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.48 41.26 94.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 63.119999999999997 112.484 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 m -121.45 138.24 54.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.827 0.346 . . . . 72.040000000000006 110.845 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 55.9 m -56.34 150.57 14.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 72.329999999999998 110.859 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -69.37 -179.86 1.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 73.510000000000005 110.89 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -110.9 -72.62 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.150000000000006 110.854 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -143.34 157.81 44.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 73.329999999999998 110.818 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.515 HD12 HD13 ' A' ' 156' ' ' ILE . 44.9 mt -147.03 111.89 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 64.400000000000006 111.105 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.3 mt -109.76 102.28 49.67 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.682 0.753 . . . . 73.230000000000004 111.108 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 53.9 Cg_endo -69.77 88.53 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.714 2.276 . . . . 62.200000000000003 112.339 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.89 -20.33 1.61 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 50.0 112.46 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.54 -54.38 1.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 70.209999999999994 110.865 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.416 ' HB3' ' HA ' ' A' ' 115' ' ' CYS . 0.0 OUTLIER 171.03 166.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 110.914 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.6 m -91.7 -162.08 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 72.109999999999999 110.87 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -165.4 112.84 0.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 73.540000000000006 110.961 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.09 58.83 0.43 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 72.129999999999995 112.506 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.61 78.85 0.31 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.761 -0.733 . . . . 53.210000000000001 112.468 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -177.04 87.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 65.540000000000006 110.889 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -139.72 31.99 2.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 74.120000000000005 110.916 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.78 34.04 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 71.25 111.163 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.59 55.94 3.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 74.329999999999998 110.865 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -124.59 -36.71 2.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 74.140000000000001 110.869 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -99.97 -35.98 9.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 62.520000000000003 110.897 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 135.35 149.01 5.74 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 73.219999999999999 112.5 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.6 t 41.22 36.72 0.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.842 0.353 . . . . 70.519999999999996 111.143 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -51.48 170.66 0.33 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.726 -0.749 . . . . 64.129999999999995 112.431 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.68 129.06 0.19 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.72 -0.752 . . . . 62.229999999999997 112.48 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -162.35 151.19 15.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 74.310000000000002 110.91 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.8 m -67.49 -176.73 0.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 51.409999999999997 110.86 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 78' ' ' ILE . 1.1 pp -98.93 23.11 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 70.040000000000006 111.123 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -135.9 34.63 2.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 73.400000000000006 110.946 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.26 -109.73 2.48 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.752 -0.737 . . . . 55.119999999999997 112.516 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -111.12 -30.76 7.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.38 . . . . 70.019999999999996 110.873 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.401 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.3 179.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 71.120000000000005 110.913 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -148.15 164.98 32.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 73.329999999999998 110.838 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.61 171.31 15.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 64.010000000000005 110.865 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.76 153.88 40.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 75.319999999999993 110.877 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -106.63 -78.46 0.58 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 63.0 110.873 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.5 p30 -155.1 172.89 17.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 71.340000000000003 110.895 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.9 39.27 3.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 61.329999999999998 110.877 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -49.92 -30.26 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 75.140000000000001 111.104 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.6 mt -108.05 91.63 3.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 75.409999999999997 110.959 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.11 150.87 43.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 53.439999999999998 110.867 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -63.42 89.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 53.229999999999997 110.858 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.39 -55.3 5.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 62.109999999999999 111.102 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . -145.66 -166.73 12.05 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.719 -0.753 . . . . 41.329999999999998 112.512 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 172.17 13.17 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.686 2.257 . . . . 74.129999999999995 112.3 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.5 12.67 77.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.732 -0.747 . . . . 50.310000000000002 112.471 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.7 mm -89.05 143.39 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 75.519999999999996 111.129 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -114.14 143.14 45.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 62.350000000000001 110.898 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.5 -165.25 2.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 74.219999999999999 110.872 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.426 ' HG3' ' HB ' ' A' ' 127' ' ' VAL . 0.1 OUTLIER -95.53 104.94 16.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 110.856 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.584 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -70.04 77.37 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 43.229999999999997 111.141 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 22.1 p-10 -129.14 -172.28 2.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 65.209999999999994 110.897 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.22 -18.9 64.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 71.030000000000001 111.098 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.5 -82.68 0.33 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.74 -0.743 . . . . 74.420000000000002 112.512 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 96.14 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.728 2.285 . . . . 53.409999999999997 112.329 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.41 ' C ' HG23 ' A' ' 107' ' ' THR . 1.6 m-20 71.92 166.13 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 74.010000000000005 110.874 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.41 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.7 p 66.1 45.48 2.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 61.140000000000001 111.159 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 1.9 m-20 -43.81 -31.76 0.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 74.430000000000007 110.843 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . 70.58 -64.24 0.83 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 73.0 112.52 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 1.2 t 84.72 58.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.85 0.357 . . . . 74.0 110.849 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -109.93 -15.99 13.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 74.319999999999993 110.967 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.613 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER 73.47 154.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 75.140000000000001 110.883 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.584 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -165.08 67.77 0.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 72.200000000000003 110.873 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.563 ' C ' ' O ' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -23.67 123.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 73.129999999999995 111.093 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 61' ' ' MET . 37.2 m -96.28 114.14 25.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 74.319999999999993 110.863 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 68.1 p -93.16 27.39 2.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 53.140000000000001 111.163 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 119' ' ' THR . . . 176.38 142.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 42.509999999999998 111.131 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.415 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 3.6 tttt -53.42 99.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 72.310000000000002 110.893 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.718 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 28.8 p -98.89 48.63 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 73.120000000000005 111.134 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.39 -25.52 68.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 75.150000000000006 110.904 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.718 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.8 p90 -48.99 -28.29 3.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 75.099999999999994 110.915 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.443 HD13 ' HD2' ' A' ' 126' ' ' HIS . 26.1 mt -48.37 -32.12 7.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 72.25 110.913 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.0 m-20 59.77 76.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.310000000000002 110.934 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.98 41.5 0.98 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.74 -0.743 . . . . 61.130000000000003 112.509 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.93 -26.4 36.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.822 0.344 . . . . 74.129999999999995 110.894 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.443 ' HD2' HD13 ' A' ' 122' ' ' LEU . 19.9 m-70 -129.3 -167.76 1.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 73.5 110.89 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.426 ' HB ' ' HG3' ' A' ' 100' ' ' MET . 76.0 t -127.89 118.27 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 51.219999999999999 111.139 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.53 129.94 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 70.219999999999999 111.134 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.469 ' O ' HD23 ' A' ' 24' ' ' LEU . 35.4 p90 -151.2 33.49 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 72.519999999999996 110.894 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -172.68 175.28 45.77 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 43.210000000000001 112.477 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 2.1 pttt -175.75 137.28 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.813 0.34 . . . . 54.520000000000003 110.938 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.686 HG11 ' HG2' ' A' ' 136' ' ' MET . 53.8 t -41.63 105.73 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 73.430000000000007 111.142 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -59.95 3.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 70.450000000000003 110.898 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -154.28 161.91 41.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 73.430000000000007 110.921 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.05 33.66 28.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.721 -0.752 . . . . 11.44 112.498 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.686 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -55.06 -29.45 57.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 74.25 110.862 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.53 -33.02 53.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 65.120000000000005 110.885 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 17' ' ' LEU . 37.3 mm -65.56 -35.72 75.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 53.350000000000001 111.122 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.3 t -67.09 -26.92 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 72.340000000000003 111.139 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -82.27 -27.81 32.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 54.420000000000002 110.869 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.74 -41.28 60.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.488 . . . . 45.229999999999997 111.083 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.3 mtm -62.27 -51.73 66.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 63.310000000000002 110.91 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -54.06 -26.01 24.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.452 . . . . 72.340000000000003 110.899 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.447 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.34 -24.59 62.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 72.150000000000006 110.84 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.447 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 67.6 m-85 -107.58 12.12 27.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 72.140000000000001 110.902 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.39 171.64 17.7 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 63.530000000000001 112.487 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.68 131.09 55.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.849 0.357 . . . . 73.239999999999995 110.876 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -54.56 -28.07 43.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 63.350000000000001 110.813 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -72.53 -29.68 63.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 71.530000000000001 110.854 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.83 -42.45 1.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 30.109999999999999 112.49 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.27 -177.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.873 0.368 . . . . 54.409999999999997 110.881 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.5 p -144.78 138.41 27.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.207 -0.451 . . . . 72.010000000000005 111.148 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.69 -44.84 63.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 73.519999999999996 110.842 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.42 -177.68 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 73.239999999999995 110.925 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.78 109.13 18.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 74.230000000000004 110.911 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.515 HD13 HD12 ' A' ' 56' ' ' ILE . 5.1 mp -93.46 118.24 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 74.019999999999996 111.142 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.26 162.58 26.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 111.157 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 20.0 mm -101.29 117.16 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 75.030000000000001 111.098 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -77.65 -47.07 20.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 65.019999999999996 111.112 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -153.74 157.49 39.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 72.25 110.848 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -160.32 147.48 16.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 75.109999999999999 110.904 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.19 161.73 21.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.7 -0.762 . . . . 63.149999999999999 112.437 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.62 108.58 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.37 . . . . 54.310000000000002 110.933 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.669 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.1 mm? -50.78 -49.86 57.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.409999999999997 110.892 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 62.039999999999999 110.915 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.837 0.351 . . . . 74.230000000000004 110.893 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 p -178.01 146.3 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 71.439999999999998 111.116 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -106.52 155.83 38.13 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.721 . . . . 74.329999999999998 110.884 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 146.95 61.54 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.629 2.22 . . . . 73.319999999999993 112.375 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -135.39 142.35 45.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 61.439999999999998 111.164 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.465 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.3 m -133.12 143.4 39.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 73.319999999999993 111.094 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 16.1 p90 -104.13 164.12 11.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 71.349999999999994 110.861 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.693 ' CD2' HD13 ' A' ' 158' ' ' ILE . 5.2 m-85 -147.4 85.07 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 65.319999999999993 110.836 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.673 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.8 OUTLIER -49.66 106.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 60.009999999999998 110.846 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.661 HG22 HD12 ' A' ' 17' ' ' LEU . 34.7 mm -85.01 134.58 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 71.540000000000006 111.095 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -124.07 158.65 31.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 53.329999999999998 111.11 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 154' ' ' LYS . 40.5 t -137.84 94.45 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 74.329999999999998 111.17 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.21 32.19 8.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 72.400000000000006 110.851 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.23 -24.0 32.55 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.759 -0.734 . . . . 71.439999999999998 112.51 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -91.74 115.01 63.74 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.633 0.73 . . . . 52.420000000000002 110.902 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.6 Cg_endo -69.76 122.59 9.27 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.682 2.254 . . . . 70.230000000000004 112.335 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.661 HD12 HG22 ' A' ' 10' ' ' ILE . 14.6 mt -66.64 -37.86 85.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 64.540000000000006 110.964 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.41 -122.29 1.2 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.72 -0.752 . . . . 61.340000000000003 112.48 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -130.12 138.22 50.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.853 0.359 . . . . 73.5 110.873 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.562 HG21 HG13 ' A' ' 10' ' ' ILE . 1.6 t -145.14 99.56 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 73.230000000000004 111.114 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.1 t -108.16 174.91 5.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 62.229999999999997 110.823 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.445 ' N ' ' OG ' ' A' ' 21' ' ' SER . 2.1 m-85 -144.92 131.81 20.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.493 . . . . 75.129999999999995 110.909 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.45 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 60.0 tt0 -86.4 97.04 10.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 71.439999999999998 110.933 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.7 mt -77.39 124.43 27.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 52.340000000000003 110.925 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -80.64 64.31 5.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 65.409999999999997 110.89 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.41 -22.38 12.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 55.450000000000003 111.12 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.32 -48.96 77.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 71.219999999999999 110.847 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -90.1 -29.64 18.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 70.510000000000005 110.892 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.446 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -130.89 67.84 81.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.618 0.723 . . . . 73.25 111.064 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -41.01 4.59 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.713 2.275 . . . . 34.240000000000002 112.316 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -35.27 79.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 72.430000000000007 110.936 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 48.5 m -84.63 -44.23 13.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 74.340000000000003 111.112 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.18 -47.05 78.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 65.209999999999994 111.089 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -50.96 -27.03 6.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 72.010000000000005 110.889 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.469 ' HA ' HD13 ' A' ' 78' ' ' ILE . 1.9 t30 -65.81 -63.39 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 75.530000000000001 110.892 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -61.11 -34.78 75.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 72.409999999999997 110.867 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.516 ' O ' HG23 ' A' ' 41' ' ' THR . 0.7 OUTLIER -69.78 -47.06 64.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 54.420000000000002 110.87 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.87 -39.84 72.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 52.420000000000002 111.132 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.506 HD22 ' HA2' ' A' ' 47' ' ' GLY . 4.1 mt -79.34 -49.46 12.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 74.049999999999997 110.957 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.7 m -55.69 -37.84 68.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 71.150000000000006 110.846 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 37' ' ' ARG . 73.9 p -74.91 -47.14 31.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 73.219999999999999 111.126 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.55 -11.95 13.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.738 -0.744 . . . . 62.0 112.505 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -52.07 -37.78 54.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 65.019999999999996 110.843 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -58.85 -27.48 65.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 73.530000000000001 110.905 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.76 -14.79 56.11 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.718 -0.754 . . . . 75.230000000000004 112.46 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -158.68 -166.07 1.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.885 0.374 . . . . 70.150000000000006 110.879 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.506 ' HA2' HD22 ' A' ' 39' ' ' LEU . . . 163.23 -133.2 2.98 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.681 -0.771 . . . . 34.530000000000001 112.446 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -149.72 48.35 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.933 0.397 . . . . 75.120000000000005 110.923 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -58.7 125.73 24.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 70.25 110.924 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.11 43.15 17.53 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.776 -0.726 . . . . 65.200000000000003 112.478 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.466 ' O ' HG22 ' A' ' 157' ' ' THR . 0.7 OUTLIER -60.47 -169.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.831 0.348 . . . . 74.140000000000001 110.903 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.0 p -125.17 132.29 53.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 62.439999999999998 110.886 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -110.7 108.91 18.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 74.109999999999999 110.869 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -133.45 37.75 3.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 110.848 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.46 77.96 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 65.239999999999995 110.851 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.548 HD12 HD13 ' A' ' 156' ' ' ILE . 13.6 mt -117.87 109.56 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 62.439999999999998 111.15 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 30.2 mt -97.77 104.51 21.8 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.606 0.717 . . . . 73.239999999999995 111.155 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.4 Cg_endo -69.76 85.94 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.687 2.258 . . . . 51.240000000000002 112.351 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.71 -19.88 1.82 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 65.200000000000003 112.489 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.9 -56.6 1.93 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.857 0.36 . . . . 70.239999999999995 110.846 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.624 ' HE3' ' O ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER 171.1 165.21 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 62.439999999999998 110.862 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.624 ' O ' ' HE3' ' A' ' 61' ' ' MET . 15.6 m -99.79 -161.85 0.9 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.445 . . . . 75.510000000000005 110.934 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.4 145.87 22.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 74.040000000000006 110.916 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.85 -64.14 1.7 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 51.140000000000001 112.454 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.59 72.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 63.530000000000001 112.536 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -51.65 159.54 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.835 0.35 . . . . 74.230000000000004 110.875 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -157.67 161.58 38.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 73.129999999999995 110.864 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.57 HG22 ' HA2' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -160.9 33.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 75.439999999999998 111.155 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.474 ' HG2' HG23 ' A' ' 73' ' ' THR . 2.5 tpm_? 51.94 32.58 10.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 75.129999999999995 110.903 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.3 m170 50.3 38.78 18.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 73.140000000000001 110.862 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -177.3 -75.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 70.099999999999994 110.906 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.57 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 163.75 54.52 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 42.109999999999999 112.483 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.474 HG23 ' HG2' ' A' ' 69' ' ' ARG . 9.6 t -158.79 44.31 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 54.130000000000003 111.197 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -153.82 -48.43 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.741 -0.742 . . . . 45.420000000000002 112.48 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.17 132.37 10.96 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.737 . . . . 74.430000000000007 112.494 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.73 171.08 5.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 75.120000000000005 110.923 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.406 ' O ' ' CG1' ' A' ' 78' ' ' ILE . 41.2 t -84.44 53.8 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 75.329999999999998 110.856 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.469 HD13 ' HA ' ' A' ' 35' ' ' ASN . 11.3 pt 43.17 30.93 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 62.210000000000001 111.162 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -161.34 -64.29 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 110.952 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -132.15 166.68 23.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.706 -0.759 . . . . 53.100000000000001 112.492 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.14 -26.0 2.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.917 0.389 . . . . 74.0 110.899 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.41 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 176.13 173.47 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 75.120000000000005 110.928 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -149.76 167.82 25.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 71.349999999999994 110.891 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.75 167.63 20.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 74.519999999999996 110.912 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.13 135.02 57.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 73.230000000000004 110.852 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -83.33 -77.31 0.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 110.885 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.1 p30 -156.25 174.42 15.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 75.319999999999993 110.939 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.52 36.93 3.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 65.120000000000005 110.821 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.09 -32.13 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 73.150000000000006 111.117 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 21.8 mt -109.99 86.96 2.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 72.540000000000006 110.932 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.726 ' O ' HG23 ' A' ' 93' ' ' THR . 5.7 mtpt -75.1 145.83 41.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 73.129999999999995 110.946 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.52 ' CE1' HD12 ' A' ' 122' ' ' LEU . 16.9 m80 -49.85 103.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 70.510000000000005 110.857 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 91' ' ' LYS . 79.2 p -114.4 28.4 8.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 72.439999999999998 111.117 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.17 175.76 21.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.685 -0.769 . . . . 61.509999999999998 112.469 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 175.96 7.35 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.7 2.267 . . . . 74.109999999999999 112.34 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.13 26.63 69.43 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 74.329999999999998 112.45 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.2 mm -95.9 140.34 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.828 0.347 . . . . 61.43 111.166 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.445 HD21 ' HD2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -109.34 139.25 44.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 73.450000000000003 110.861 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.13 156.71 39.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 72.219999999999999 110.842 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.474 ' HE1' ' HB3' ' A' ' 110' ' ' SER . 1.0 OUTLIER -59.95 96.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 74.439999999999998 110.837 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.4 ' HB3' ' HG2' ' A' ' 111' ' ' GLN . . . -63.99 89.65 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 71.219999999999999 111.133 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 107' ' ' THR . 0.8 OUTLIER -134.71 173.55 11.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 74.010000000000005 110.882 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.93 -23.06 6.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 72.510000000000005 111.074 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 122.44 -82.16 0.35 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 62.140000000000001 112.52 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 91.91 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.696 2.264 . . . . 65.150000000000006 112.359 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.446 ' C ' HG23 ' A' ' 107' ' ' THR . 2.3 m-20 73.66 171.8 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 72.040000000000006 110.889 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.446 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.3 p 66.0 39.07 4.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 111.098 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -45.36 -30.48 1.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.838 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.436 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . 51.92 -118.47 7.3 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.777 -0.725 . . . . 62.420000000000002 112.491 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.474 ' HB3' ' HE1' ' A' ' 100' ' ' MET . 1.5 p 165.4 67.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 72.140000000000001 110.882 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.4 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 2.4 tt0 -102.79 -27.51 12.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 63.210000000000001 110.923 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.602 ' HZ ' HD12 ' A' ' 114' ' ' ILE . 0.0 OUTLIER 68.09 151.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.230000000000004 110.861 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -164.39 85.81 0.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 65.420000000000002 110.927 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.602 HD12 ' HZ ' ' A' ' 112' ' ' PHE . 2.2 mt -42.06 114.44 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 71.120000000000005 111.135 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.8 m -85.87 122.44 29.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 62.119999999999997 110.9 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.2 p -91.73 24.04 3.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 73.349999999999994 111.139 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 119' ' ' THR . . . 179.34 154.61 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 51.109999999999999 111.053 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.2 86.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 74.049999999999997 110.91 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.736 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 32.6 p -84.16 53.4 2.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 61.340000000000003 111.093 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -66.8 -23.14 66.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 74.120000000000005 110.909 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.736 ' CZ2' HG22 ' A' ' 119' ' ' THR . 11.6 p90 -53.75 -25.69 20.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 70.450000000000003 110.963 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.545 HD22 ' HE2' ' A' ' 126' ' ' HIS . 38.2 mt -45.6 -33.48 2.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 74.409999999999997 110.933 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 124' ' ' GLY . 1.6 m-20 61.95 76.18 0.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 62.200000000000003 110.838 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.6 41.54 0.85 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 70.230000000000004 112.478 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.67 -21.89 37.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.835 0.35 . . . . 74.140000000000001 110.938 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.545 ' HE2' HD22 ' A' ' 122' ' ' LEU . 9.7 m-70 -137.43 -167.23 2.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 74.049999999999997 110.861 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.9 t -127.06 122.07 59.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 73.129999999999995 111.161 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 t -88.1 133.3 30.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 61.420000000000002 111.106 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.451 ' O ' HD23 ' A' ' 24' ' ' LEU . 19.0 p90 -156.97 32.55 0.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 74.129999999999995 110.852 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -169.44 172.1 43.4 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.727 -0.749 . . . . 54.119999999999997 112.47 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 131' ' ' LYS . 1.6 pttt -176.11 132.41 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 63.43 110.916 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.654 HG11 ' HG2' ' A' ' 136' ' ' MET . 97.4 t -37.97 105.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.510000000000005 111.163 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.45 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -67.31 -58.69 4.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 75.140000000000001 110.94 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -150.99 170.29 19.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 72.219999999999999 110.87 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.13 31.0 64.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.735 . . . . 72.430000000000007 112.502 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.654 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -52.21 -26.38 11.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.771 0.32 . . . . 72.25 110.893 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.18 -31.89 54.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 74.540000000000006 110.886 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.632 HD12 ' HB3' ' A' ' 17' ' ' LEU . 43.4 mm -64.96 -40.26 88.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 71.239999999999995 111.107 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.43 -28.67 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 72.430000000000007 111.162 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -78.01 -29.02 49.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 73.420000000000002 110.885 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.96 57.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 71.319999999999993 111.132 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.487 ' SD ' HG21 ' A' ' 156' ' ' ILE . 35.9 mtm -61.38 -41.9 97.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 74.530000000000001 110.844 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -53.47 -30.57 41.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 72.420000000000002 110.89 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.43 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -73.55 -27.23 61.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 72.319999999999993 110.875 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.43 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 61.4 m-85 -105.44 30.01 6.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 75.519999999999996 110.81 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.0 151.69 17.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.766 -0.73 . . . . 75.230000000000004 112.51 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.5 m -114.37 140.52 48.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 63.219999999999999 110.854 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -74.11 70.18 1.55 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.340000000000003 110.886 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -179.93 -33.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 63.130000000000003 110.88 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 153.96 -100.61 0.2 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.773 -0.727 . . . . 70.140000000000001 112.468 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.32 169.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 55.420000000000002 110.912 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.6 p -143.65 -171.04 3.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 65.099999999999994 111.093 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.1 p -78.39 -55.31 5.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 63.109999999999999 110.847 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.456 ' HB3' HG13 ' A' ' 12' ' ' VAL . 3.7 mttp -81.54 166.66 20.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 74.420000000000002 110.877 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -111.95 110.08 20.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.310000000000002 110.888 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.548 HD13 HD12 ' A' ' 56' ' ' ILE . 4.8 mp -89.46 118.18 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 71.030000000000001 111.132 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -129.67 164.36 24.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 111.127 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.693 HD13 ' CD2' ' A' ' 8' ' ' PHE . 6.8 mt -98.44 123.04 50.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 73.400000000000006 111.073 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.673 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -81.53 -49.05 11.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 63.420000000000002 111.118 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -153.4 155.96 37.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 73.25 110.875 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.56 148.97 18.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 73.230000000000004 110.902 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 172.42 172.28 38.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.703 -0.76 . . . . 61.130000000000003 112.495 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.406 ' OE1' HG21 ' A' ' 41' ' ' THR . 2.7 mt-30 -64.67 142.36 58.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.363 . . . . 60.210000000000001 110.867 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -94.86 -59.58 1.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 72.299999999999997 110.903 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 110.913 179.955 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.2 tpt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.844 0.354 . . . . 73.430000000000007 110.894 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.8 t -135.35 109.26 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.447 . . . . 53.399999999999999 111.083 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -70.63 117.51 56.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.615 0.721 . . . . 64.409999999999997 110.861 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 152.6 69.31 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.653 2.235 . . . . 72.140000000000001 112.337 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -137.78 139.64 40.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 61.210000000000001 111.145 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.492 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.4 m -127.38 142.5 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 75.310000000000002 111.142 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.6 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 7.3 p90 -106.1 155.45 19.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 73.209999999999994 110.872 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.593 ' CE2' HD13 ' A' ' 158' ' ' ILE . 3.9 m-85 -143.8 86.72 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 73.129999999999995 110.847 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.736 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 4.0 t70 -47.75 125.91 9.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 72.129999999999995 110.846 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.67 HG23 HG23 ' A' ' 156' ' ' ILE . 17.5 mm -97.61 111.36 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 111.168 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -104.62 126.04 51.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 70.430000000000007 111.082 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.634 HG23 HD13 ' A' ' 17' ' ' LEU . 11.9 t -111.13 101.28 12.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 54.149999999999999 111.103 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 t0 59.87 43.55 14.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 73.150000000000006 110.87 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.58 0.83 88.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.747 -0.739 . . . . 73.109999999999999 112.511 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 10.2 mm-40 -113.22 102.4 54.74 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.628 0.728 . . . . 72.430000000000007 110.91 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.6 Cg_endo -69.81 110.88 2.67 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.626 2.217 . . . . 70.140000000000001 112.361 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.634 HD13 HG23 ' A' ' 12' ' ' VAL . 6.3 mp -65.45 -35.27 80.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 75.340000000000003 110.915 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.36 -133.72 3.04 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.731 . . . . 60.530000000000001 112.499 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -128.36 146.75 50.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 44.100000000000001 110.861 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.52 HG21 HG13 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -143.7 101.44 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 75.25 111.17 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -107.52 170.94 7.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 40.25 110.833 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -143.35 138.05 29.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 74.519999999999996 110.858 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.465 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 19.7 tt0 -91.17 99.94 12.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 74.420000000000002 110.865 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 129' ' ' PHE . 5.5 mt -82.56 123.13 28.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 72.540000000000006 110.923 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.464 ' CD1' HD13 ' A' ' 90' ' ' LEU . 40.6 m-85 -79.04 63.5 3.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 73.140000000000001 110.86 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.13 -22.32 16.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 74.409999999999997 111.062 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.17 -36.27 74.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 75.140000000000001 110.868 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.37 -25.31 15.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 53.409999999999997 110.919 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.444 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -139.44 65.51 34.04 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.625 0.726 . . . . 75.430000000000007 111.107 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -35.77 11.95 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.698 2.265 . . . . 71.420000000000002 112.339 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -39.82 89.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 75.319999999999993 110.859 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 98.6 m -87.28 -45.3 10.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 71.230000000000004 111.165 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.73 91.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 73.019999999999996 111.1 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -47.42 -35.15 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 74.319999999999993 110.874 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -62.64 -68.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 52.130000000000003 110.906 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -56.21 -23.44 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 71.540000000000006 110.903 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.485 ' NH2' ' HG2' ' A' ' 163' ' ' GLN . 0.0 OUTLIER -68.17 -54.21 19.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 75.340000000000003 110.854 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.57 -26.46 66.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 52.509999999999998 111.103 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.502 HD13 ' HE2' ' A' ' 48' ' ' TYR . 97.5 mt -79.0 -56.45 4.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 73.420000000000002 110.925 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.9 m -49.38 -46.13 46.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 65.439999999999998 110.834 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.3 p -72.44 -27.27 62.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 75.230000000000004 111.166 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.5 -8.81 74.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.726 -0.75 . . . . 73.109999999999999 112.475 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -18.55 50.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 72.209999999999994 110.883 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.737 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -50.36 -30.59 12.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 74.409999999999997 110.928 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.64 -23.97 6.57 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.763 -0.732 . . . . 70.219999999999999 112.509 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -160.59 -50.84 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 72.129999999999995 110.867 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.97 163.18 0.17 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.718 -0.753 . . . . 72.340000000000003 112.499 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.502 ' HE2' HD13 ' A' ' 39' ' ' LEU . 44.8 p90 -96.48 26.67 4.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.0 0.429 . . . . 74.349999999999994 110.934 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.17 142.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 72.209999999999994 110.904 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.83 27.05 74.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.706 -0.759 . . . . 53.32 112.487 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.712 ' O ' HG22 ' A' ' 157' ' ' THR . 0.4 OUTLIER -66.37 -176.46 0.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.827 0.346 . . . . 64.319999999999993 110.844 -179.741 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.9 p -126.06 122.47 35.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 72.140000000000001 110.856 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -86.98 130.61 34.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 75.230000000000004 110.877 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -147.33 46.82 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 110.889 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -158.94 61.59 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 75.239999999999995 110.905 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 13.7 mt -107.92 109.25 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 71.219999999999999 111.127 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.401 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 26.6 mt -100.2 103.78 25.23 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.604 0.716 . . . . 73.420000000000002 111.093 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.8 Cg_endo -69.75 85.01 0.63 Allowed 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.722 2.281 . . . . 73.530000000000001 112.34 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.37 -20.46 1.19 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.731 . . . . 71.430000000000007 112.479 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.89 -57.93 1.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.915 0.388 . . . . 64.340000000000003 110.911 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 174.19 164.48 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 62.009999999999998 110.827 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 10.1 m -100.81 -168.45 1.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 73.530000000000001 110.931 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 177.24 146.21 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 70.230000000000004 110.887 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.99 -33.22 7.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.756 . . . . 72.329999999999998 112.497 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.42 173.24 49.57 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.729 . . . . 71.329999999999998 112.496 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.13 -172.49 1.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.833 0.349 . . . . 73.409999999999997 110.839 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -150.99 52.79 0.86 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 74.239999999999995 110.916 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 p -82.6 63.22 6.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 51.409999999999997 111.155 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.44 -179.57 5.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 64.040000000000006 110.818 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -108.92 36.05 3.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 74.519999999999996 110.822 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -111.09 -73.33 0.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 72.409999999999997 110.904 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.51 32.59 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.771 -0.728 . . . . 72.209999999999994 112.5 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.2 p -101.38 -54.88 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 74.109999999999999 111.134 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.26 110.98 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 70.340000000000003 112.479 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.77 108.14 2.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 73.099999999999994 112.468 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -173.6 156.32 2.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 75.209999999999994 110.942 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.1 p -61.22 -169.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 75.140000000000001 110.884 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.737 HG22 ' HD2' ' A' ' 44' ' ' LYS . 5.2 pt -102.29 28.08 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 74.010000000000005 111.145 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -155.88 46.4 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 72.319999999999993 110.918 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.34 -133.98 11.51 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 65.150000000000006 112.479 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -79.23 -38.94 34.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.939 0.399 . . . . 60.119999999999997 110.88 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.41 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.2 176.63 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 73.239999999999995 110.893 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.75 -178.18 3.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 71.239999999999995 110.858 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -95.34 167.88 11.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.109 -0.496 . . . . 74.209999999999994 110.872 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -60.63 154.93 20.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 61.240000000000002 110.836 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -112.23 -67.44 1.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.019999999999996 110.881 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -176.45 178.11 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 75.430000000000007 110.871 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.46 35.99 3.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 63.140000000000001 110.918 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.51 -30.16 7.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 64.230000000000004 111.123 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 25' ' ' PHE . 12.9 mt -111.41 79.52 1.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 61.149999999999999 110.916 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -69.89 152.05 44.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 72.540000000000006 110.897 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -56.73 97.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 74.299999999999997 110.898 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.1 p -108.93 26.31 10.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 72.340000000000003 111.145 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.58 178.64 25.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.719 -0.753 . . . . 44.32 112.496 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 171.57 14.16 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.736 2.291 . . . . 74.109999999999999 112.335 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.9 37.64 94.54 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 64.239999999999995 112.468 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 97' ' ' ILE . 21.5 mm -108.62 136.99 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.884 0.373 . . . . 43.119999999999997 111.163 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' A' ' 112' ' ' PHE . 4.2 mt -103.1 162.18 13.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 72.230000000000004 110.92 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.16 -160.15 0.31 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 75.430000000000007 110.786 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.3 mmt -121.93 138.15 54.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 73.540000000000006 110.903 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -119.05 148.22 43.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 44.420000000000002 111.1 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 0.3 OUTLIER 163.73 -50.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 75.019999999999996 110.88 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -178.11 30.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 75.129999999999995 111.101 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.33 -120.89 5.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 35.43 112.509 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 126.35 13.17 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.629 2.219 . . . . 74.109999999999999 112.337 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.494 ' C ' HG23 ' A' ' 107' ' ' THR . 4.0 m-20 69.11 173.02 0.3 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 65.519999999999996 110.898 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.494 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.3 p 67.07 26.38 8.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 73.409999999999997 111.142 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -72.25 146.63 47.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 71.219999999999999 110.853 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.89 -106.88 0.9 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 72.450000000000003 112.518 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.6 p -151.43 33.74 0.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.81 0.338 . . . . 70.120000000000005 110.9 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.668 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 3.7 pt20 -114.42 51.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 72.219999999999999 110.902 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.539 ' HB2' HD22 ' A' ' 98' ' ' LEU . 5.4 p90 -56.85 -169.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 62.340000000000003 110.892 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.452 ' O ' HD23 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -151.87 164.27 37.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 74.049999999999997 110.894 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 114' ' ' ILE . 3.4 mt -108.66 90.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 71.420000000000002 111.145 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 57.3 m -63.41 91.29 0.05 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 72.040000000000006 110.89 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.2 p -61.68 -15.16 37.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 42.509999999999998 111.111 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 119' ' ' THR . . . -143.89 156.4 44.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 71.219999999999999 111.08 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -56.06 94.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 75.420000000000002 110.864 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 117' ' ' ALA . 23.7 p -95.49 46.11 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 54.219999999999999 111.151 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -23.88 67.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 74.450000000000003 110.853 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.687 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.0 p90 -49.54 -28.16 5.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 72.200000000000003 110.896 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.9 mt -46.77 -34.06 4.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.227 -0.442 . . . . 54.520000000000003 110.912 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.4 OUTLIER 63.01 75.18 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 64.040000000000006 110.889 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.11 43.71 0.7 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.732 -0.747 . . . . 51.329999999999998 112.495 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -80.34 -27.42 38.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 64.430000000000007 110.91 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -127.18 -168.65 1.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 52.219999999999999 110.856 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.7 t -121.43 110.22 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 62.310000000000002 111.114 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 98' ' ' LEU . 16.4 t -83.84 134.57 26.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 72.439999999999998 111.166 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.444 ' CB ' HG21 ' A' ' 29' ' ' VAL . 12.5 p90 -158.24 44.85 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 74.140000000000001 110.902 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . 179.02 175.25 45.89 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.772 -0.728 . . . . 75.430000000000007 112.525 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.2 pttp -174.9 145.19 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 71.120000000000005 110.927 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.761 HG11 ' HG2' ' A' ' 136' ' ' MET . 32.7 t -44.73 113.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 61.149999999999999 111.155 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.465 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -78.14 -61.24 2.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 61.219999999999999 110.929 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -152.35 151.42 30.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 54.439999999999998 110.881 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.77 30.44 9.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.733 . . . . 42.240000000000002 112.529 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.761 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -54.02 -26.41 26.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.782 0.325 . . . . 73.230000000000004 110.886 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.19 -34.1 68.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 71.150000000000006 110.841 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.503 HD12 ' HB3' ' A' ' 17' ' ' LEU . 23.5 mm -69.39 -38.27 76.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 62.399999999999999 111.101 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.21 -28.66 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.530000000000001 111.152 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -75.75 -31.31 59.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.887 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.07 -41.41 70.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 45.350000000000001 111.093 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 21.4 mtm -58.04 -45.36 87.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 72.209999999999994 110.902 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 11.3 tm-20 -54.59 -25.3 25.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 62.420000000000002 110.909 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.405 ' HG3' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -78.99 -28.87 43.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 71.310000000000002 110.9 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.405 ' CG ' ' HG3' ' A' ' 144' ' ' ARG . 46.9 m-85 -105.26 34.27 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.310000000000002 110.865 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -113.58 161.01 12.84 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 73.230000000000004 112.466 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 t -117.75 143.64 46.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.89 0.376 . . . . 64.519999999999996 110.852 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -74.76 63.85 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 73.219999999999999 110.906 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -175.45 -34.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 70.109999999999999 110.893 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.59 -44.81 0.74 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.746 -0.74 . . . . 10.41 112.478 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -62.65 -169.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 75.540000000000006 110.902 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.82 147.97 4.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 64.239999999999995 111.167 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.97 -39.61 90.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 51.210000000000001 110.864 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.408 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -101.32 171.56 7.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 73.109999999999999 110.894 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -114.85 108.72 17.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 72.310000000000002 110.924 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.67 HG23 HG23 ' A' ' 10' ' ' ILE . 4.8 mp -93.39 119.52 41.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 75.329999999999998 111.121 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.712 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -127.71 163.09 25.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 70.519999999999996 111.122 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.593 HD13 ' CE2' ' A' ' 8' ' ' PHE . 8.5 mt -91.28 109.37 21.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 72.329999999999998 111.123 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.736 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -73.03 -43.47 62.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 71.409999999999997 111.07 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -162.61 155.0 19.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 75.439999999999998 110.864 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.56 148.44 16.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.211 -0.449 . . . . 71.549999999999997 110.956 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.26 -174.65 44.72 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.739 -0.743 . . . . 75.200000000000003 112.489 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.485 ' HG2' ' NH2' ' A' ' 37' ' ' ARG . 3.1 mt-30 -82.03 131.22 35.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.351 . . . . 65.420000000000002 110.897 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.581 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.2 mm? -86.92 -60.79 1.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 73.040000000000006 110.945 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 75.329999999999998 110.911 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.2 mtp . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.84 0.353 . . . . 75.340000000000003 110.853 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.8 t -141.45 130.43 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 45.140000000000001 111.138 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -94.29 154.81 40.35 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.596 0.712 . . . . 60.439999999999998 110.883 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 146.09 59.05 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 62.130000000000003 112.374 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -133.98 142.97 47.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 43.130000000000003 111.15 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.487 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.8 m -134.23 141.73 42.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 74.239999999999995 111.136 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 13.6 p90 -101.49 168.54 9.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 74.420000000000002 110.876 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.635 ' CD2' HD13 ' A' ' 158' ' ' ILE . 5.4 m-85 -148.44 88.9 1.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 70.439999999999998 110.87 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.697 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.7 t70 -51.25 102.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 60.100000000000001 110.873 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.665 HG22 HD12 ' A' ' 17' ' ' LEU . 34.5 mm -80.3 135.95 24.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 74.340000000000003 111.164 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -127.71 155.41 44.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 111.142 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.426 HG13 ' HB3' ' A' ' 154' ' ' LYS . 48.9 t -136.0 94.09 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 65.209999999999994 111.139 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.61 32.01 7.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 75.540000000000006 110.873 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.55 -23.63 33.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.753 -0.737 . . . . 42.219999999999999 112.481 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -92.3 115.62 65.04 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.615 0.721 . . . . 61.299999999999997 110.922 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.4 Cg_endo -69.76 121.26 7.95 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.703 2.269 . . . . 71.430000000000007 112.319 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.665 HD12 HG22 ' A' ' 10' ' ' ILE . 14.1 mt -65.64 -37.58 86.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 73.409999999999997 110.927 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.43 -125.6 1.69 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 70.299999999999997 112.509 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -128.44 136.95 51.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 74.25 110.853 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.572 HG21 HG13 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -145.24 103.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 70.329999999999998 111.146 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -109.42 173.25 6.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 71.310000000000002 110.885 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.413 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -143.8 127.9 17.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 74.319999999999993 110.87 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -82.89 99.59 9.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 75.030000000000001 110.913 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.4 mt -83.18 122.79 28.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 63.350000000000001 110.889 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -77.48 67.25 3.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 75.140000000000001 110.903 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.45 -20.89 33.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 75.430000000000007 111.105 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -68.57 -38.48 80.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 72.209999999999994 110.859 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.48 -28.07 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 72.129999999999995 110.925 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.427 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -136.68 67.9 58.79 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.627 0.727 . . . . 34.140000000000001 111.105 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -36.91 9.89 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.705 2.27 . . . . 74.400000000000006 112.338 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.68 -37.68 82.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 72.329999999999998 110.907 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.4 m -88.53 -43.21 11.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 65.549999999999997 111.173 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.42 -49.38 77.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 50.020000000000003 111.136 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -51.29 -27.67 10.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 110.903 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.0 -63.83 0.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.329999999999998 110.897 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -59.94 -32.75 71.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 74.209999999999994 110.883 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.47 ' O ' HG23 ' A' ' 41' ' ' THR . 1.6 ttp180 -71.72 -47.8 51.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 75.230000000000004 110.903 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.3 -36.94 69.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 64.430000000000007 111.097 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.5 mt -77.65 -50.69 11.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 75.030000000000001 110.9 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.5 m -58.68 -38.13 77.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 73.140000000000001 110.873 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 37' ' ' ARG . 46.5 p -71.37 -38.6 71.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 72.239999999999995 111.144 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.81 -10.8 45.27 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.732 -0.746 . . . . 73.099999999999994 112.467 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -30.72 39.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 64.040000000000006 110.854 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -65.69 -28.71 69.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 63.240000000000002 110.927 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.28 -15.98 58.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.734 . . . . 61.210000000000001 112.516 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -155.11 -167.39 2.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.895 0.379 . . . . 75.409999999999997 110.866 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.56 -158.43 28.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.749 . . . . 44.219999999999999 112.492 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -112.42 21.09 16.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.929 0.395 . . . . 73.540000000000006 110.864 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.51 121.43 5.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 74.129999999999995 110.919 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.37 44.73 9.3 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.761 -0.733 . . . . 24.420000000000002 112.458 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.613 ' O ' HG22 ' A' ' 157' ' ' THR . 9.7 t -92.59 -169.38 2.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.824 0.345 . . . . 54.43 110.873 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 8.1 p -121.14 143.43 49.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 74.319999999999993 110.889 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -99.98 141.28 33.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 74.310000000000002 110.871 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -151.87 48.26 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 73.019999999999996 110.807 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.1 tpp85 -172.95 68.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 75.5 110.894 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 56' ' ' ILE . 4.7 mt -116.11 113.3 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 73.299999999999997 111.127 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.5 mt -110.26 103.16 53.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.629 0.728 . . . . 73.340000000000003 111.156 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 86.24 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.671 2.247 . . . . 74.409999999999997 112.353 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.57 -20.77 1.5 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.737 -0.744 . . . . 64.099999999999994 112.485 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.87 -52.47 1.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 73.409999999999997 110.869 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.51 166.46 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 73.409999999999997 110.876 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.7 m -107.34 -169.4 1.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 73.120000000000005 110.918 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 173.85 149.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 71.230000000000004 110.891 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.94 172.09 22.29 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.67 -0.776 . . . . 71.030000000000001 112.497 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.33 165.18 46.41 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.73 . . . . 72.310000000000002 112.488 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.15 -170.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.86 0.362 . . . . 74.430000000000007 110.862 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -171.97 35.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 62.549999999999997 110.88 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.92 51.72 2.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 74.150000000000006 111.151 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.11 34.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 73.329999999999998 110.878 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.92 -57.46 3.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 71.200000000000003 110.863 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -107.4 37.91 2.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 70.209999999999994 110.868 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.41 -32.59 5.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.753 -0.737 . . . . 30.129999999999999 112.486 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.5 t -160.04 45.63 0.23 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.83 0.348 . . . . 75.040000000000006 111.118 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.9 -141.74 0.34 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.757 -0.735 . . . . 54.030000000000001 112.468 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.53 174.92 21.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.73 -0.748 . . . . 73.430000000000007 112.462 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.49 ' HE2' ' N ' ' A' ' 77' ' ' SER . 0.0 OUTLIER 56.54 174.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.789 0.328 . . . . 73.310000000000002 110.889 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.49 ' N ' ' HE2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -59.61 -153.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 63.149999999999999 110.841 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.71 47.3 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 74.150000000000006 111.125 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -127.79 -77.8 0.57 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 110.951 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.452 ' H ' ' NZ ' ' A' ' 76' ' ' LYS . . . -151.24 -76.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.67 -0.776 . . . . 45.049999999999997 112.464 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 4.7 mm-40 -117.55 -52.58 2.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.919 0.39 . . . . 75.099999999999994 110.909 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER 179.04 152.24 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 110.908 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -117.32 167.62 11.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 72.219999999999999 110.885 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.49 161.53 16.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.494 . . . . 73.329999999999998 110.881 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -48.28 151.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 73.439999999999998 110.848 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -102.78 -76.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 61.210000000000001 110.899 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -158.25 172.8 17.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 71.349999999999994 110.934 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.13 38.02 3.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 73.549999999999997 110.901 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.31 -31.53 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 62.409999999999997 111.156 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.8 mt -107.42 91.94 3.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 71.519999999999996 110.908 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -73.36 148.2 43.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 72.219999999999999 110.903 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -57.5 96.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 75.310000000000002 110.855 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -85.19 -57.93 2.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 75.030000000000001 111.129 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -143.26 -164.88 10.46 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.774 -0.727 . . . . 75.319999999999993 112.484 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 175.31 8.3 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.667 2.244 . . . . 73.120000000000005 112.359 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.07 21.19 69.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.785 -0.721 . . . . 62.450000000000003 112.512 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.1 mm -96.19 142.54 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.381 . . . . 64.140000000000001 111.144 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -114.49 143.71 44.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 64.540000000000006 110.929 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.98 -165.24 2.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 73.439999999999998 110.882 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 35.5 mtm -92.22 99.02 11.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 71.439999999999998 110.878 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -73.07 60.33 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.427 . . . . 65.109999999999999 111.096 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -118.7 -179.17 3.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.040000000000006 110.922 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.07 -24.49 3.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 65.0 111.121 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.96 -80.84 0.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.759 -0.734 . . . . 64.510000000000005 112.502 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 89.56 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.664 2.243 . . . . 71.329999999999998 112.322 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.505 ' C ' HG23 ' A' ' 107' ' ' THR . 40.6 m-20 66.26 -170.37 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 75.140000000000001 110.883 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.505 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.2 p 67.32 34.42 4.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 61.520000000000003 111.154 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.83 148.47 23.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 55.119999999999997 110.913 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.65 59.2 0.44 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.73 -0.747 . . . . 63.439999999999998 112.462 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 65.2 36.2 7.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.836 0.35 . . . . 73.019999999999996 110.89 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -59.66 -169.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 70.200000000000003 110.909 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 177.43 149.05 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 73.129999999999995 110.92 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -165.49 73.2 0.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 71.030000000000001 110.884 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.506 ' C ' ' O ' ' A' ' 113' ' ' PHE . 19.1 mt -28.4 106.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 72.439999999999998 111.126 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 35.7 m -80.5 117.84 21.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 73.510000000000005 110.888 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 60.5 p -94.84 26.36 3.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 61.25 111.154 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.683 ' O ' HG23 ' A' ' 119' ' ' THR . . . 176.7 145.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 55.25 111.123 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -54.83 100.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 64.340000000000003 110.9 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.695 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 27.9 p -101.19 47.61 0.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 75.209999999999994 111.147 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -26.25 68.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 63.549999999999997 110.852 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.695 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.6 p90 -48.41 -28.62 3.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 73.030000000000001 110.942 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 26.0 mt -47.4 -35.82 8.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 74.109999999999999 110.914 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 124' ' ' GLY . 1.8 m-20 61.24 81.43 0.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 62.119999999999997 110.884 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.05 43.27 0.87 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 74.329999999999998 112.497 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.98 -17.86 39.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.785 0.326 . . . . 74.409999999999997 110.885 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -143.59 -168.1 2.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 74.219999999999999 110.851 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.4 t -126.26 119.32 53.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 51.539999999999999 111.115 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.8 t -83.23 129.89 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 53.43 111.107 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.492 ' O ' HD23 ' A' ' 24' ' ' LEU . 31.9 p90 -153.86 33.83 0.44 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.340000000000003 110.862 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -171.96 172.85 44.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.722 . . . . 70.409999999999997 112.486 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -175.81 135.18 0.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 73.439999999999998 110.914 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.741 HG11 ' HG2' ' A' ' 136' ' ' MET . 58.7 t -39.69 104.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 64.030000000000001 111.13 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.75 -60.0 2.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 73.510000000000005 110.899 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -154.56 160.22 41.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 74.040000000000006 110.882 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.59 32.03 28.61 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 74.349999999999994 112.528 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.741 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -52.62 -29.59 26.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.747 0.308 . . . . 73.310000000000002 110.871 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.44 -32.4 49.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 71.400000000000006 110.907 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.54 HD12 ' HB3' ' A' ' 17' ' ' LEU . 44.0 mm -65.74 -38.85 83.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 71.349999999999994 111.091 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.9 t -64.39 -27.22 42.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 73.299999999999997 111.163 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.24 -28.49 38.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 55.43 110.876 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.82 -43.2 59.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 51.409999999999997 111.096 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 40.7 mtm -60.73 -51.29 69.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 75.319999999999993 110.851 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.423 ' OE1' HG23 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -55.94 -23.2 30.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 75.200000000000003 110.881 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -23.97 61.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 75.439999999999998 110.883 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -109.73 19.85 18.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 71.120000000000005 110.885 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.5 167.37 12.35 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.773 -0.727 . . . . 72.140000000000001 112.47 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.5 m -109.8 148.15 31.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 53.210000000000001 110.851 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.4 mmm-85 -76.53 64.21 2.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 72.230000000000004 110.875 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -174.13 -36.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 73.430000000000007 110.902 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 156.76 -47.65 0.48 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 72.420000000000002 112.525 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 168.11 9.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.84 0.352 . . . . 73.349999999999994 110.935 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.3 p -144.91 -174.24 4.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 72.049999999999997 111.157 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.84 -68.3 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 31.219999999999999 110.852 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.426 ' HB3' HG13 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -79.28 -176.06 4.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 74.329999999999998 110.924 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.85 109.73 18.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 71.120000000000005 110.921 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mp -85.04 118.34 31.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 64.099999999999994 111.18 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.613 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -129.72 162.34 28.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 53.409999999999997 111.15 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.635 HD13 ' CD2' ' A' ' 8' ' ' PHE . 7.6 mt -101.34 120.89 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 64.219999999999999 111.12 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.697 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -79.98 -48.83 12.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 62.039999999999999 111.119 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -156.95 158.31 36.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 61.530000000000001 110.828 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.89 146.91 13.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 73.230000000000004 110.887 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.68 174.04 45.29 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.747 -0.74 . . . . 74.329999999999998 112.471 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -65.0 140.57 58.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.853 0.359 . . . . 61.219999999999999 110.924 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.569 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -93.41 -59.39 2.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 110.923 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 54.200000000000003 110.871 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.5 mtm . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.824 0.345 . . . . 75.319999999999993 110.893 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.7 t -144.3 136.55 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 74.040000000000006 111.147 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -123.51 154.19 66.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.605 0.717 . . . . 73.329999999999998 110.902 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 145.49 57.11 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.709 2.273 . . . . 53.32 112.341 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.9 m -128.84 128.96 44.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 61.299999999999997 111.165 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.403 HG13 ' CD1' ' A' ' 24' ' ' LEU . 2.4 m -124.52 172.71 11.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 51.340000000000003 111.18 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.666 ' HB3' HD21 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -162.0 174.26 13.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 71.549999999999997 110.905 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -153.05 97.85 2.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 63.200000000000003 110.958 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.9 OUTLIER -45.34 108.96 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 62.109999999999999 110.861 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.818 HG22 HD12 ' A' ' 17' ' ' LEU . 42.2 mm -80.11 133.64 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 73.409999999999997 111.136 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -125.82 156.37 39.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 74.150000000000006 111.086 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 154' ' ' LYS . 42.5 t -134.81 96.39 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 64.010000000000005 111.171 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.56 30.56 10.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 72.109999999999999 110.883 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.31 -23.8 32.11 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 45.399999999999999 112.495 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -91.79 116.03 65.68 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.658 0.742 . . . . 74.120000000000005 110.872 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.2 Cg_endo -69.77 126.09 12.9 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.687 2.258 . . . . 62.520000000000003 112.324 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.818 HD12 HG22 ' A' ' 10' ' ' ILE . 12.1 mt -70.32 -40.93 73.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 73.310000000000002 110.938 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.26 -122.13 1.09 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.729 -0.748 . . . . 65.109999999999999 112.493 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -134.32 143.12 47.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 74.049999999999997 110.908 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.47 HG21 HG13 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -146.26 100.31 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 70.200000000000003 111.156 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 2.1 t -104.52 173.78 6.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 73.400000000000006 110.854 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.556 ' CZ ' HD11 ' A' ' 114' ' ' ILE . 63.9 m-85 -145.18 130.74 18.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 61.439999999999998 110.88 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -86.28 95.2 9.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 71.409999999999997 110.878 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.1 mt -80.1 134.07 36.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 73.040000000000006 110.872 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -93.1 66.58 4.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 72.200000000000003 110.849 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.67 -22.71 36.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 60.420000000000002 111.086 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -65.68 -35.65 81.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 55.310000000000002 110.865 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -99.61 -29.24 12.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 71.439999999999998 110.922 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.425 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -134.86 66.06 67.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 74.019999999999996 111.106 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -35.32 12.7 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.688 2.259 . . . . 73.340000000000003 112.321 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.06 -39.39 81.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 64.200000000000003 110.895 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.401 HG21 ' CD1' ' A' ' 129' ' ' PHE . 31.7 m -89.84 -49.25 6.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 74.040000000000006 111.135 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.26 -42.16 63.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 63.420000000000002 111.094 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.75 -25.18 62.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 75.25 110.919 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.7 -65.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 73.129999999999995 110.85 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -31.14 66.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 73.439999999999998 110.891 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.557 ' O ' HG23 ' A' ' 41' ' ' THR . 1.3 ttp180 -73.15 -52.91 12.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 75.099999999999994 110.856 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.05 -33.52 57.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 54.020000000000003 111.095 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.5 HD22 ' HA2' ' A' ' 47' ' ' GLY . 12.6 mt -80.59 -56.07 4.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 74.219999999999999 110.914 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.1 m -54.38 -36.05 63.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 44.32 110.83 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 37' ' ' ARG . 69.9 p -73.9 -45.29 51.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 75.430000000000007 111.147 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.7 -14.93 19.76 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.728 -0.749 . . . . 64.420000000000002 112.477 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -32.77 46.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 75.230000000000004 110.901 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -63.23 -28.77 70.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 64.409999999999997 110.892 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.86 -16.52 50.8 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.785 -0.721 . . . . 64.010000000000005 112.518 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -156.35 -165.91 2.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.923 0.392 . . . . 74.549999999999997 110.871 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA2' HD22 ' A' ' 39' ' ' LEU . . . 157.44 -164.75 33.14 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.721 -0.752 . . . . 52.539999999999999 112.452 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -105.74 26.78 9.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.911 0.386 . . . . 64.310000000000002 110.929 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.38 129.84 16.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 71.010000000000005 110.893 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.95 37.71 88.15 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.786 -0.721 . . . . 63.530000000000001 112.483 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.4 p -71.92 -172.56 0.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 50.039999999999999 110.819 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 8.1 p -131.45 127.33 37.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 61.420000000000002 110.858 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -86.0 115.56 23.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 73.140000000000001 110.863 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -124.08 32.55 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 61.310000000000002 110.878 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.71 83.04 0.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 72.209999999999994 110.865 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 56' ' ' ILE . 10.0 mt -123.24 110.67 26.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 64.5 111.153 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.4 mt -104.17 104.24 42.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.676 0.75 . . . . 71.310000000000002 111.097 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 81.95 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.684 2.256 . . . . 75.530000000000001 112.367 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.77 -21.89 0.8 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 74.400000000000006 112.508 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.42 -54.95 2.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 75.329999999999998 110.892 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 171.58 168.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 72.439999999999998 110.867 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 113' ' ' PHE . 34.7 m -106.4 -165.65 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 70.310000000000002 110.864 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.62 130.55 9.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 72.140000000000001 110.925 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -51.37 -32.48 30.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.721 -0.752 . . . . 73.439999999999998 112.457 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.0 139.91 10.71 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.748 . . . . 51.130000000000003 112.53 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -69.55 139.31 53.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.831 0.348 . . . . 72.319999999999993 110.873 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -131.59 47.76 2.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 73.319999999999993 110.878 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.27 -34.49 42.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 74.109999999999999 111.155 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -143.18 166.6 24.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 64.439999999999998 110.844 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 67.78 71.23 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.510000000000005 110.855 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 67.74 39.69 2.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 63.109999999999999 110.873 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -124.83 -32.3 0.82 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.789 -0.72 . . . . 53.219999999999999 112.518 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.4 p 63.43 31.02 15.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.757 0.313 . . . . 62.149999999999999 111.092 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.37 151.03 26.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.739 . . . . 62.439999999999998 112.493 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.51 114.82 2.66 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.786 -0.721 . . . . 63.130000000000003 112.498 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -174.63 151.14 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.817 0.342 . . . . 65.150000000000006 110.899 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.0 m -60.04 -173.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 73.230000000000004 110.877 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.515 ' O ' HD12 ' A' ' 78' ' ' ILE . 1.2 pp -95.14 22.56 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 63.420000000000002 111.142 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -140.83 35.54 1.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 63.109999999999999 110.911 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.97 -140.51 15.04 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.75 -0.738 . . . . 63.530000000000001 112.496 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -78.17 -31.28 49.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.892 0.377 . . . . 72.219999999999999 110.891 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.47 -179.56 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 74.329999999999998 110.894 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.66 162.7 35.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 61.100000000000001 110.892 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -78.78 167.96 20.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 74.140000000000001 110.877 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -59.35 146.02 41.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 74.409999999999997 110.85 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -102.59 -77.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 64.319999999999993 110.889 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -152.24 171.44 17.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 63.399999999999999 110.905 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.55 38.36 3.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 70.439999999999998 110.901 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mt -50.42 -30.48 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 73.109999999999999 111.131 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.6 mt -108.42 93.33 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.952 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -73.03 148.94 43.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 64.030000000000001 110.876 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -59.76 94.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.887 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.04 -59.28 2.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 71.310000000000002 111.149 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . -142.83 -166.02 10.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 73.120000000000005 112.523 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 172.24 12.98 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.676 2.251 . . . . 75.140000000000001 112.331 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.15 20.12 76.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.695 -0.764 . . . . 71.530000000000001 112.499 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.2 mm -96.21 142.52 13.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.853 0.359 . . . . 73.530000000000001 111.11 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.438 HD21 ' CD2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -112.52 141.04 46.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 71.310000000000002 110.891 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.22 165.86 32.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 53.520000000000003 110.862 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 11.8 mtm -71.92 87.19 1.01 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 72.019999999999996 110.922 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.792 ' HB3' ' CG ' ' A' ' 111' ' ' GLN . . . -48.35 124.6 8.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 62.450000000000003 111.127 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 24.1 p-10 -170.6 -174.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 72.140000000000001 110.912 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.03 -12.53 60.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 74.420000000000002 111.171 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.12 -83.3 0.34 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 61.299999999999997 112.51 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 96.28 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.666 2.244 . . . . 54.450000000000003 112.341 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 71.27 178.38 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 55.130000000000003 110.875 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.2 p 58.53 40.13 24.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 75.409999999999997 111.139 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 4.2 m120 -43.19 -35.3 1.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 72.540000000000006 110.894 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . 69.83 -62.83 0.69 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.8 -0.714 . . . . 71.329999999999998 112.46 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 0.6 OUTLIER 81.96 44.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.844 0.354 . . . . 34.539999999999999 110.858 -179.759 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.792 ' CG ' ' HB3' ' A' ' 101' ' ' ALA . 24.5 pt20 -92.95 -7.63 45.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 71.030000000000001 110.88 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.553 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER 69.16 149.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 72.030000000000001 110.931 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.587 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -163.29 70.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 72.200000000000003 110.842 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.556 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -27.48 124.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 53.030000000000001 111.154 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.6 m -96.0 114.08 25.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 72.049999999999997 110.909 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 45.9 p -92.56 28.47 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 72.219999999999999 111.114 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.697 ' O ' HG23 ' A' ' 119' ' ' THR . . . 175.95 141.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 63.520000000000003 111.062 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.418 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 2.1 tttt -50.63 99.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 71.299999999999997 110.905 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.798 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 49.6 p -98.99 55.67 1.02 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.218 -0.446 . . . . 61.020000000000003 111.125 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -23.87 61.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 73.120000000000005 110.882 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.798 ' CZ2' HG22 ' A' ' 119' ' ' THR . 8.1 p90 -49.88 -29.6 8.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 74.430000000000007 110.95 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.707 HD22 ' NE2' ' A' ' 126' ' ' HIS . 32.0 mt -49.45 -32.52 12.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 62.329999999999998 110.931 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.3 m-20 60.13 76.6 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 73.140000000000001 110.814 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.46 42.15 0.89 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.717 -0.754 . . . . 70.219999999999999 112.444 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.67 -21.93 32.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.831 0.348 . . . . 72.340000000000003 110.914 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.707 ' NE2' HD22 ' A' ' 122' ' ' LEU . 5.6 m-70 -129.18 -166.72 1.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 74.329999999999998 110.844 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 79.1 t -128.99 118.76 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 65.439999999999998 111.152 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.82 132.57 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 41.109999999999999 111.103 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.425 ' CB ' HG21 ' A' ' 29' ' ' VAL . 22.7 p90 -155.13 30.1 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 64.209999999999994 110.878 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -168.39 173.99 43.14 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.717 -0.754 . . . . 63.100000000000001 112.476 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 7.2 pttt -175.49 135.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 63.329999999999998 110.892 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' ' 136' ' ' MET . 71.2 t -40.58 105.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 75.140000000000001 111.114 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -59.36 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 71.329999999999998 110.903 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -154.19 -178.72 7.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 64.109999999999999 110.887 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.91 31.13 60.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 73.310000000000002 112.514 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.503 ' HB2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -57.09 -24.63 55.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 72.010000000000005 110.867 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.41 -30.63 19.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 74.120000000000005 110.859 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.642 HD12 ' HB3' ' A' ' 17' ' ' LEU . 40.0 mm -65.15 -38.85 83.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 65.140000000000001 111.113 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 74.6 t -63.44 -30.4 49.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 65.230000000000004 111.179 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -76.49 -28.83 56.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 74.099999999999994 110.841 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.48 -41.3 60.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 54.450000000000003 111.102 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.417 ' SD ' HG21 ' A' ' 10' ' ' ILE . 33.8 mtm -61.35 -51.28 69.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 53.229999999999997 110.831 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.66 -25.52 27.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 72.239999999999995 110.951 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.418 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.84 -25.07 61.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 73.310000000000002 110.868 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.418 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 70.9 m-85 -105.98 10.47 32.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 72.439999999999998 110.895 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.8 165.18 13.32 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.792 -0.718 . . . . 62.439999999999998 112.452 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.0 m -108.67 148.02 31.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 74.239999999999995 110.841 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 -75.95 60.73 1.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 72.239999999999995 110.843 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -163.38 -38.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 74.540000000000006 110.875 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 158.38 -50.99 0.41 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.789 -0.72 . . . . 30.41 112.492 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.03 174.14 7.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 55.0 110.886 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.8 p -144.36 -170.39 3.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 54.240000000000002 111.181 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 63.4 m -98.23 -67.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 52.5 110.843 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.492 ' HB3' HG13 ' A' ' 12' ' ' VAL . 1.4 mttp -76.89 -175.88 3.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 73.340000000000003 110.896 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.52 109.8 18.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.433 . . . . 75.439999999999998 110.879 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.495 HG23 HG23 ' A' ' 10' ' ' ILE . 4.2 mp -86.37 114.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 73.030000000000001 111.098 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.41 164.4 20.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 64.129999999999995 111.173 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.4 mt -103.89 125.65 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 64.409999999999997 111.099 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -87.93 -54.51 4.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 73.450000000000003 111.144 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -142.2 150.73 41.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 75.310000000000002 110.851 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -156.88 146.75 20.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 22.440000000000001 110.878 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.66 164.18 24.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.767 -0.73 . . . . 43.149999999999999 112.518 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.409 ' HB2' HG22 ' A' ' 41' ' ' THR . 1.3 tt0 -57.68 111.43 1.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 64.310000000000002 110.882 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.666 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.1 mm? -54.36 -51.22 65.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 72.25 110.93 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 71.010000000000005 110.872 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.871 0.367 . . . . 72.129999999999995 110.831 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t -137.32 133.7 46.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 52.229999999999997 111.151 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -106.08 141.53 22.93 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.608 0.718 . . . . 61.310000000000002 110.906 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 147.19 62.49 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.686 2.257 . . . . 74.319999999999993 112.322 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -130.96 140.85 50.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 71.099999999999994 111.174 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.509 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.5 m -135.14 142.47 39.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 62.420000000000002 111.114 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.558 ' HB3' HD21 ' A' ' 164' ' ' LEU . 11.7 p90 -103.37 161.71 13.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 74.109999999999999 110.923 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.745 ' CD2' HD13 ' A' ' 158' ' ' ILE . 4.6 m-85 -144.45 89.18 1.98 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 110.889 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.6 OUTLIER -51.17 103.24 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 61.109999999999999 110.838 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.513 HG13 HG21 ' A' ' 20' ' ' VAL . 29.8 mm -75.85 136.75 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 62.509999999999998 111.126 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -128.16 152.98 47.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.040000000000006 111.131 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 t -135.97 94.98 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.438 . . . . 62.409999999999997 111.116 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.74 31.27 4.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.439999999999998 110.859 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.02 -22.18 40.48 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.714 -0.755 . . . . 75.209999999999994 112.492 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -94.23 117.41 67.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.676 0.751 . . . . 55.219999999999999 110.859 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.75 124.56 11.2 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.683 2.255 . . . . 64.219999999999999 112.364 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.522 ' HB3' HD12 ' A' ' 138' ' ' ILE . 8.9 mt -68.87 -39.13 80.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 63.130000000000003 110.953 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.52 -135.93 4.62 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 64.340000000000003 112.433 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.32 134.33 55.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 53.140000000000001 110.917 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.513 HG21 HG13 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -145.79 102.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 73.209999999999994 111.137 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -111.44 172.36 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 64.409999999999997 110.852 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.41 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -143.97 130.95 20.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 64.310000000000002 110.894 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.403 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 25.9 tt0 -84.42 100.38 11.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.519999999999996 110.896 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.459 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 1.7 mt -84.99 127.77 34.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 70.340000000000003 110.911 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.42 ' CD1' HD13 ' A' ' 90' ' ' LEU . 46.7 m-85 -86.79 68.55 10.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 75.019999999999996 110.865 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.76 -23.9 32.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 70.409999999999997 111.077 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.5 -34.86 78.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 72.340000000000003 110.833 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 -27.45 14.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 75.230000000000004 110.901 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.422 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -139.42 66.78 37.18 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.636 0.732 . . . . 71.109999999999999 111.096 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -36.66 10.39 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.687 2.258 . . . . 73.329999999999998 112.3 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -37.56 80.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 74.450000000000003 110.834 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.7 m -88.53 -45.65 9.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 54.539999999999999 111.116 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.76 -38.66 82.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 72.310000000000002 111.11 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -51.22 -35.26 35.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 75.340000000000003 110.917 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -64.21 -63.18 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 75.430000000000007 110.888 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -56.93 -39.82 75.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 73.340000000000003 110.892 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.51 -47.29 76.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 72.530000000000001 110.856 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.68 74.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 75.109999999999999 111.129 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.2 mt -77.26 -54.8 6.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 72.329999999999998 110.904 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.0 m -51.67 -41.97 61.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 61.020000000000003 110.861 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -76.24 -34.44 59.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 73.329999999999998 111.103 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.26 -11.45 56.97 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.699 -0.762 . . . . 73.150000000000006 112.46 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -59.82 -18.77 46.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 62.200000000000003 110.905 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.614 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -49.23 -28.35 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 70.239999999999995 110.859 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.52 -26.03 5.26 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.798 -0.715 . . . . 53.219999999999999 112.518 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -158.67 -46.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 74.129999999999995 110.862 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.92 -149.8 43.99 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.775 -0.726 . . . . 75.040000000000006 112.498 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -179.45 92.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.954 0.407 . . . . 73.219999999999999 110.94 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.86 82.64 6.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 72.420000000000002 110.946 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 179.06 -68.34 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.71 -0.757 . . . . 41.130000000000003 112.511 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.463 ' O ' HG22 ' A' ' 157' ' ' THR . 0.7 OUTLIER 48.36 -166.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 54.130000000000003 110.839 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.1 p -176.86 122.56 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 52.229999999999997 110.875 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.406 ' CD1' HG22 ' A' ' 156' ' ' ILE . 24.7 m-85 -84.13 128.81 34.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 74.140000000000001 110.846 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -129.57 35.55 4.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 74.540000000000006 110.84 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.19 100.74 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 74.409999999999997 110.87 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.7 mt -140.65 113.98 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.478 . . . . 62.229999999999997 111.141 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.412 ' O ' HG22 ' A' ' 57' ' ' ILE . 6.8 mt -113.9 113.02 47.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.592 0.711 . . . . 74.239999999999995 111.091 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 81.28 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.67 2.247 . . . . 44.409999999999997 112.388 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.38 -25.73 0.29 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 73.209999999999994 112.461 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.43 -57.37 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.884 0.373 . . . . 62.399999999999999 110.914 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 170.0 169.32 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 53.240000000000002 110.877 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.0 m -92.51 -165.78 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 63.509999999999998 110.893 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 176.49 142.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 61.409999999999997 110.968 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 150.51 112.84 0.59 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.739 . . . . 53.299999999999997 112.488 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.62 109.09 0.27 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.772 -0.728 . . . . 73.140000000000001 112.494 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -174.35 151.85 1.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.901 0.381 . . . . 71.219999999999999 110.832 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -125.16 -38.4 2.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 75.329999999999998 110.881 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 87.2 m -52.3 -36.18 52.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 71.129999999999995 111.137 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -144.86 146.78 32.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 74.439999999999998 110.907 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -116.45 39.3 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 65.219999999999999 110.834 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -127.28 -42.76 1.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 72.049999999999997 110.885 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 137.99 40.47 0.11 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.734 -0.746 . . . . 61.210000000000001 112.497 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.2 t -161.71 46.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.36 . . . . 75.219999999999999 111.127 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.15 168.76 41.88 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.706 -0.759 . . . . 73.099999999999994 112.444 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.54 103.74 1.94 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 42.530000000000001 112.468 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.89 155.96 19.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.807 0.337 . . . . 54.140000000000001 110.885 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 p -92.22 57.15 2.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 61.409999999999997 110.838 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.614 HG22 ' HD2' ' A' ' 44' ' ' LYS . 5.9 pt 42.78 30.58 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 71.010000000000005 111.114 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -170.92 55.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 72.099999999999994 110.912 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.03 177.83 51.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.744 . . . . 43.509999999999998 112.476 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -52.23 -28.3 18.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.954 0.407 . . . . 73.439999999999998 110.86 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.555 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 179.84 -175.58 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 74.129999999999995 110.905 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.431 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -142.38 -179.06 6.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 75.349999999999994 110.935 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.2 168.07 20.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 51.030000000000001 110.86 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -70.87 132.45 45.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 74.530000000000001 110.899 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -89.39 -70.11 0.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 75.409999999999997 110.886 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -172.01 172.79 4.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 73.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.9 36.78 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 73.329999999999998 110.829 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -49.64 -30.73 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 73.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.42 HD13 ' CD1' ' A' ' 25' ' ' PHE . 20.6 mt -110.42 68.13 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 74.439999999999998 110.893 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.67 156.19 14.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 62.140000000000001 110.913 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -61.76 92.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 72.140000000000001 110.8 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.4 p -105.35 24.82 11.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 62.200000000000003 111.121 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.39 177.93 27.41 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.704 -0.76 . . . . 73.0 112.478 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 172.9 11.74 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.674 2.249 . . . . 73.349999999999994 112.357 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.17 38.1 95.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.723 -0.751 . . . . 43.43 112.473 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 97' ' ' ILE . 24.1 mm -110.69 134.37 53.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.868 0.366 . . . . 72.109999999999999 111.155 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.518 HD22 ' CG ' ' A' ' 112' ' ' PHE . 1.6 mt -100.81 156.6 17.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 72.140000000000001 110.921 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 t 175.85 126.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 65.450000000000003 110.883 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.437 ' HE3' ' HA ' ' A' ' 110' ' ' SER . 3.7 mmt -50.55 162.06 0.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 73.030000000000001 110.888 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.447 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . . . -158.0 95.12 1.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 75.209999999999994 111.108 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -118.07 -21.94 8.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 51.009999999999998 110.884 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.84 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -179.0 -32.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 64.239999999999995 111.112 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.09 -82.36 0.33 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.705 -0.759 . . . . 71.239999999999995 112.478 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 117.32 5.01 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.638 2.225 . . . . 72.319999999999993 112.368 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.424 ' O ' HG23 ' A' ' 107' ' ' THR . 5.6 m-80 40.22 41.79 1.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 75.25 110.936 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.84 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 7.2 p -155.73 56.0 0.61 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.165 -0.471 . . . . 74.239999999999995 111.075 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 100' ' ' MET . 1.5 m-20 -66.1 -42.56 89.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 75.319999999999993 110.948 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.78 -152.91 52.82 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.737 -0.744 . . . . 74.310000000000002 112.459 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.437 ' HA ' ' HE3' ' A' ' 100' ' ' MET . 0.3 OUTLIER -130.17 21.42 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.859 0.362 . . . . 53.039999999999999 110.877 -179.703 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.439 ' O ' ' CG ' ' A' ' 111' ' ' GLN . 5.2 tt0 -116.26 87.94 2.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 73.420000000000002 110.908 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.518 ' CG ' HD22 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -84.88 -165.15 1.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.43 . . . . 72.439999999999998 110.834 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -153.36 165.69 34.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 70.310000000000002 110.896 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.57 HG21 ' CG1' ' A' ' 139' ' ' VAL . 2.4 mp -100.06 90.88 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 72.310000000000002 111.124 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 53.2 m -66.08 89.96 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 52.229999999999997 110.889 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.3 p -67.68 -8.11 32.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 74.349999999999994 111.099 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.704 ' O ' HG23 ' A' ' 119' ' ' THR . . . -145.9 153.3 40.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 111.138 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -56.57 94.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 63.530000000000001 110.918 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 117' ' ' ALA . 24.2 p -96.73 45.99 1.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 71.209999999999994 111.148 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -24.66 67.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 64.340000000000003 110.842 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.686 ' CZ2' HG22 ' A' ' 119' ' ' THR . 5.9 p90 -48.51 -27.62 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 72.329999999999998 110.929 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.6 mt -45.83 -34.42 3.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 72.010000000000005 110.919 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 124' ' ' GLY . 1.7 m-20 62.17 78.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 62.009999999999998 110.834 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.07 43.07 0.63 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 60.399999999999999 112.494 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 -17.28 43.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.773 0.321 . . . . 74.109999999999999 110.875 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -143.24 -165.48 2.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 71.439999999999998 110.897 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.0 t -126.21 130.22 72.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.432 . . . . 73.329999999999998 111.114 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.9 135.86 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 65.129999999999995 111.15 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.452 ' O ' HD23 ' A' ' 24' ' ' LEU . 12.8 p90 -159.33 38.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 74.209999999999994 110.865 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -178.12 173.77 46.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.73 -0.748 . . . . 51.140000000000001 112.459 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -174.99 140.0 0.51 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.854 0.359 . . . . 74.219999999999999 110.887 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.695 HG11 ' HG2' ' A' ' 136' ' ' MET . 42.0 t -40.65 107.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 65.109999999999999 111.151 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.403 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -72.15 -59.96 2.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 64.420000000000002 110.849 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -154.43 152.33 30.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 63.25 110.911 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.37 41.86 6.39 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.742 -0.742 . . . . 73.019999999999996 112.493 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.695 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -60.08 -33.7 72.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.838 0.351 . . . . 63.140000000000001 110.902 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -36.31 31.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.439 . . . . 75.150000000000006 110.91 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.522 HD12 ' HB3' ' A' ' 17' ' ' LEU . 38.3 mm -63.86 -38.97 83.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 54.509999999999998 111.088 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.57 ' CG1' HG21 ' A' ' 114' ' ' ILE . 76.2 t -66.63 -24.34 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 61.009999999999998 111.139 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.08 -27.33 30.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 73.319999999999993 110.902 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.17 59.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 53.329999999999998 111.112 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 31.7 mtm -60.0 -54.11 49.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 73.040000000000006 110.888 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.48 ' OE1' ' HA ' ' A' ' 143' ' ' GLU . 10.4 mm-40 -54.84 -28.89 53.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 55.25 110.899 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.451 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -64.22 -24.3 67.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 64.239999999999995 110.83 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.451 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 69.0 m-85 -106.85 32.5 4.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 110.863 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.65 170.63 15.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 73.430000000000007 112.471 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.5 t -127.37 146.97 50.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.887 0.375 . . . . 71.349999999999994 110.861 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.1 mmm-85 -72.83 77.29 1.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 73.230000000000004 110.897 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -174.45 -35.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 60.130000000000003 110.891 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.89 -77.5 0.24 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.705 -0.759 . . . . 73.230000000000004 112.5 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.17 168.94 9.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 71.319999999999993 110.882 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.9 p -144.16 -173.76 4.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 60.210000000000001 111.182 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.0 p -86.85 -63.03 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 72.549999999999997 110.834 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -66.2 173.54 3.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 72.230000000000004 110.86 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -122.79 109.65 14.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 75.349999999999994 110.886 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 156' ' ' ILE . 4.2 mp -85.86 119.59 34.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 73.239999999999995 111.124 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -132.83 163.61 28.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 60.32 111.156 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.745 HD13 ' CD2' ' A' ' 8' ' ' PHE . 5.1 mt -102.45 128.35 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 75.099999999999994 111.14 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -91.65 -59.55 2.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 64.310000000000002 111.109 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -134.59 155.77 49.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 63.439999999999998 110.894 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.66 143.93 4.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 64.019999999999996 110.859 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.89 173.23 43.15 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 53.409999999999997 112.483 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -64.59 140.63 58.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 65.099999999999994 110.888 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.558 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -93.28 -57.68 2.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 75.109999999999999 110.938 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 65.219999999999999 110.886 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.876 0.369 . . . . 55.420000000000002 111.126 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -103.75 152.15 38.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.659 0.742 . . . . 74.519999999999996 110.839 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 146.7 60.82 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.661 2.24 . . . . 74.019999999999996 112.359 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -131.89 141.28 49.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 70.230000000000004 111.178 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.498 ' HA ' HD23 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -135.69 144.26 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 74.540000000000006 111.14 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 18.7 p90 -101.94 165.22 11.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 75.129999999999995 110.873 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.674 ' CD2' HD13 ' A' ' 158' ' ' ILE . 7.2 m-85 -146.95 91.99 2.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 70.549999999999997 110.873 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.6 OUTLIER -54.99 101.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 72.530000000000001 110.888 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.462 ' CG1' HG21 ' A' ' 20' ' ' VAL . 49.7 mm -82.07 119.17 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 53.25 111.078 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -107.71 157.79 17.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 55.240000000000002 111.144 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.413 HG13 ' HB3' ' A' ' 154' ' ' LYS . 42.2 t -137.26 95.98 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 70.510000000000005 111.08 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.49 31.48 10.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 73.0 110.872 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.57 -22.6 38.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.711 -0.757 . . . . 33.409999999999997 112.469 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -94.7 115.41 65.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.638 0.732 . . . . 72.140000000000001 110.902 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.72 123.62 10.3 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.656 2.238 . . . . 71.329999999999998 112.381 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.467 ' HB3' HG23 ' A' ' 138' ' ' ILE . 13.8 mt -67.07 -39.54 86.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 64.420000000000002 110.953 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.4 -131.15 2.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.825 -0.702 . . . . 73.340000000000003 112.522 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.54 137.04 54.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.818 0.342 . . . . 63.340000000000003 110.867 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.537 ' CG2' HG21 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -146.1 99.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 73.219999999999999 111.132 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -107.87 173.28 6.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 64.450000000000003 110.844 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.42 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -145.94 134.47 22.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 75.209999999999994 110.892 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 49.2 tt0 -83.78 98.47 9.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 71.510000000000005 110.879 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.618 HD23 ' O ' ' A' ' 129' ' ' PHE . 4.3 mt -79.63 115.88 19.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 72.200000000000003 110.942 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -76.0 64.97 1.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 74.129999999999995 110.855 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.63 -22.54 23.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 50.240000000000002 111.103 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -66.5 -35.68 80.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 70.099999999999994 110.886 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.62 -28.87 12.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 74.329999999999998 110.926 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.14 66.52 60.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.616 0.722 . . . . 65.430000000000007 111.111 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -37.2 9.56 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.737 2.291 . . . . 70.040000000000006 112.335 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -63.48 -38.17 90.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 65.019999999999996 110.882 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 m -85.9 -41.29 15.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 75.340000000000003 111.153 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.22 -44.78 82.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 75.140000000000001 111.139 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -49.55 -30.23 8.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.010000000000005 110.881 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -67.68 -68.92 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 73.420000000000002 110.88 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -55.27 -25.62 34.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 75.430000000000007 110.94 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.476 ' O ' HG23 ' A' ' 41' ' ' THR . 0.8 OUTLIER -78.52 -55.57 5.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 74.329999999999998 110.885 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.76 -34.66 28.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 63.100000000000001 111.12 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 mt -75.8 -61.98 1.74 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 55.020000000000003 110.91 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.0 m -51.92 -33.92 39.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 53.32 110.858 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 37' ' ' ARG . 73.3 p -76.51 -31.99 58.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 65.049999999999997 111.113 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.01 -15.55 60.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 72.340000000000003 112.528 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -19.16 45.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.869 0.366 . . . . 60.509999999999998 110.888 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.776 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -51.41 -28.94 14.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 71.430000000000007 110.941 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.05 -25.25 6.13 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.739 -0.743 . . . . 54.229999999999997 112.453 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -158.08 -47.68 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.894 0.378 . . . . 72.340000000000003 110.907 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.61 -145.88 47.13 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.72 -0.752 . . . . 75.209999999999994 112.467 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -179.75 92.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.925 0.393 . . . . 73.019999999999996 110.956 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.22 85.45 6.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 74.129999999999995 110.911 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.2 -66.14 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.736 -0.745 . . . . 62.310000000000002 112.523 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.427 ' O ' HG22 ' A' ' 157' ' ' THR . 1.3 m 49.05 -166.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 75.400000000000006 110.9 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.8 147.64 16.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 64.019999999999996 110.892 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -128.73 120.58 26.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 61.25 110.876 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -144.61 42.98 1.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 73.310000000000002 110.864 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.413 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.69 72.88 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 75.540000000000006 110.88 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.697 ' CD1' HD13 ' A' ' 156' ' ' ILE . 4.8 mt -112.59 113.35 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 54.32 111.134 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.405 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 28.9 mt -104.58 103.05 37.81 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.712 . . . . 60.240000000000002 111.121 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 53.4 Cg_endo -69.85 89.56 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.691 2.261 . . . . 71.129999999999995 112.329 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.92 -19.45 1.97 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.71 -0.757 . . . . 53.350000000000001 112.445 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.78 -54.08 1.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 73.519999999999996 110.841 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.446 ' HE1' ' O ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER 173.27 171.35 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 73.540000000000006 110.883 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.446 ' O ' ' HE1' ' A' ' 61' ' ' MET . 7.1 m -111.28 -154.16 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 72.239999999999995 110.846 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 55' ' ' ARG . 54.6 tp60 -134.68 163.38 29.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 70.540000000000006 110.893 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.757 -0.735 . . . . 70.120000000000005 112.488 -179.983 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.776 HG22 ' HD2' ' A' ' 44' ' ' LYS . 4.1 pt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.779 0.323 . . . . 62.409999999999997 111.085 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -174.31 58.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 74.319999999999993 110.892 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.54 -160.41 53.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.784 -0.722 . . . . 61.329999999999998 112.51 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.26 -40.88 59.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 73.450000000000003 110.902 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.532 ' HG2' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER 173.45 -177.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 74.120000000000005 110.878 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.35 -165.94 1.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 72.109999999999999 110.869 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.83 165.51 12.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 65.5 110.884 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -51.44 119.38 4.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.927 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -91.59 -69.16 0.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 72.010000000000005 110.857 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -177.25 177.14 1.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 74.519999999999996 110.909 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.42 36.89 3.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 110.892 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 mt -48.15 -33.63 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 60.240000000000002 111.128 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 22.1 mt -106.83 89.28 2.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 72.510000000000005 110.901 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.698 ' O ' HG23 ' A' ' 93' ' ' THR . 0.1 OUTLIER -79.25 139.23 37.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 73.409999999999997 110.911 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -49.71 101.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 74.349999999999994 110.851 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 91' ' ' LYS . 74.2 p -115.88 28.38 8.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 72.530000000000001 111.121 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.32 178.01 24.81 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 74.329999999999998 112.5 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 173.5 10.81 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.677 2.251 . . . . 75.239999999999995 112.338 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.12 32.8 85.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 75.340000000000003 112.496 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.5 mm -105.91 137.55 35.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.84 0.352 . . . . 54.439999999999998 111.159 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.519 HD21 ' CD1' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -105.16 144.86 31.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 73.329999999999998 110.958 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.58 -163.05 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 74.230000000000004 110.846 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.491 ' HE2' ' HB ' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -123.12 140.92 52.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.497 . . . . 72.200000000000003 110.859 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.794 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -139.55 34.85 2.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 45.439999999999998 111.083 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 1.1 t-20 -70.43 -19.08 63.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 62.549999999999997 110.923 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.74 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . 176.64 -31.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 43.100000000000001 111.101 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.63 -89.28 0.49 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 60.210000000000001 112.495 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 117.24 4.97 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.638 2.226 . . . . 75.099999999999994 112.353 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.493 ' O ' HG23 ' A' ' 107' ' ' THR . 82.9 m-20 45.11 54.61 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 63.130000000000003 110.867 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.74 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 11.1 p -157.96 60.46 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.209999999999994 111.123 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.48 ' O ' ' C ' ' A' ' 109' ' ' GLY . 2.1 m-20 -66.05 -30.71 71.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 70.439999999999998 110.887 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 30.52 -116.14 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.749 . . . . 74.340000000000003 112.519 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.0 p -167.17 40.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.837 0.351 . . . . 62.43 110.85 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.794 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 3.5 mm-40 -108.86 50.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 72.109999999999999 110.916 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.519 ' CD1' HD21 ' A' ' 98' ' ' LEU . 34.6 p90 -54.49 -176.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 75.510000000000005 110.857 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.726 ' CE2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -160.87 91.7 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 63.240000000000002 110.951 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 113' ' ' PHE . 3.0 mt -33.28 105.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 74.209999999999994 111.116 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.452 ' SG ' HG23 ' A' ' 119' ' ' THR . 41.8 t -69.59 100.51 1.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 52.219999999999999 110.914 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 13.1 p -83.94 11.31 7.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 74.439999999999998 111.146 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.49 ' O ' ' C ' ' A' ' 118' ' ' LYS . . . 177.37 124.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 73.230000000000004 111.072 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 117' ' ' ALA . 1.0 OUTLIER -30.22 105.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 71.400000000000006 110.879 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.836 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 71.0 p -87.75 73.51 9.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.5 111.144 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -69.8 -27.09 64.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 63.240000000000002 110.889 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.836 ' CZ2' HG22 ' A' ' 119' ' ' THR . 17.6 p90 -55.86 -22.47 25.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 70.5 110.906 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.682 HD12 ' OG1' ' A' ' 119' ' ' THR . 83.2 mt -77.95 -55.91 4.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 74.439999999999998 110.878 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 53.48 95.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 71.420000000000002 110.827 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 43.17 37.78 3.34 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 32.210000000000001 112.517 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.62 -11.48 48.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 63.310000000000002 110.863 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -148.46 -163.79 1.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 73.540000000000006 110.838 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.491 ' HB ' ' HE2' ' A' ' 100' ' ' MET . 25.0 t -122.09 116.03 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 73.439999999999998 111.139 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.19 134.48 27.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 71.510000000000005 111.149 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.618 ' O ' HD23 ' A' ' 24' ' ' LEU . 15.7 p90 -157.2 54.79 0.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 63.009999999999998 110.891 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.458 ' C ' ' HB2' ' A' ' 98' ' ' LEU . . . 169.92 176.29 39.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.764 -0.731 . . . . 72.340000000000003 112.486 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 132' ' ' VAL . 10.1 pttt -178.89 131.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.792 0.329 . . . . 53.539999999999999 110.905 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.724 HG11 ' HG2' ' A' ' 136' ' ' MET . 48.0 t -36.08 108.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 75.230000000000004 111.13 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.405 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -72.46 -59.33 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 64.530000000000001 110.897 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -152.93 158.35 41.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 65.120000000000005 110.896 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.16 30.94 24.11 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 73.010000000000005 112.475 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.724 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -50.93 -29.42 12.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 62.219999999999999 110.853 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.67 -33.8 35.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 62.329999999999998 110.876 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.537 HG21 ' CG2' ' A' ' 20' ' ' VAL . 44.5 mm -66.06 -44.34 92.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 62.030000000000001 111.131 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.9 t -63.96 -26.34 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 63.229999999999997 111.129 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.5 -30.72 47.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 73.420000000000002 110.857 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.92 -43.39 68.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 60.140000000000001 111.103 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 27.9 mtm -58.58 -43.98 89.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 73.140000000000001 110.859 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 8.7 tm-20 -54.25 -26.65 30.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 64.420000000000002 110.897 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -28.45 52.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 62.340000000000003 110.893 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -103.16 31.61 4.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 73.340000000000003 110.862 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -120.05 152.86 16.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 70.430000000000007 112.499 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.3 t -103.03 144.29 31.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.886 0.374 . . . . 73.0 110.865 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -73.57 65.28 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 62.240000000000002 110.832 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -175.35 -34.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 61.229999999999997 110.883 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.21 -70.9 0.34 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 61.149999999999999 112.482 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.21 170.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 75.109999999999999 110.882 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.4 t -159.48 158.85 32.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 62.509999999999998 111.113 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 86.0 p -75.38 -53.92 7.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.010000000000005 110.859 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.413 ' HB3' HG13 ' A' ' 12' ' ' VAL . 5.9 mttp -73.01 155.52 39.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 75.010000000000005 110.924 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -109.2 109.36 20.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 61.409999999999997 110.921 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.697 HD13 ' CD1' ' A' ' 56' ' ' ILE . 3.6 mp -90.81 123.06 42.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.447 . . . . 74.340000000000003 111.155 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -135.77 162.53 32.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 61.299999999999997 111.123 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.674 HD13 ' CD2' ' A' ' 8' ' ' PHE . 8.4 mt -95.69 120.76 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 70.140000000000001 111.142 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -85.32 -49.39 8.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 62.409999999999997 111.087 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -146.23 156.31 43.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 62.049999999999997 110.88 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.408 ' HA ' ' CE1' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -165.55 144.95 6.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 54.439999999999998 110.901 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.46 171.68 42.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 60.130000000000003 112.493 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -65.35 141.74 58.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 71.120000000000005 110.864 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.554 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.1 mm? -93.48 -56.47 2.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 63.109999999999999 110.892 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 75.430000000000007 110.874 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 2' ' ' VAL . 3.9 t . . . . . 0 N--CA 1.458 -0.052 0 CA-C-O 120.838 0.351 . . . . 75.310000000000002 111.125 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 -103.13 152.67 38.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.629 0.728 . . . . 63.310000000000002 110.911 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 146.54 60.22 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.641 2.227 . . . . 73.340000000000003 112.356 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -133.05 141.58 48.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 62.439999999999998 111.165 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.504 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.0 OUTLIER -134.24 143.21 38.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 74.230000000000004 111.16 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 16.6 p90 -100.94 166.37 10.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 75.400000000000006 110.871 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.588 ' CE2' HD13 ' A' ' 158' ' ' ILE . 5.9 m-85 -146.67 87.29 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 73.010000000000005 110.895 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.743 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.7 t0 -50.59 102.45 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 75.409999999999997 110.834 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.663 HG22 HD12 ' A' ' 17' ' ' LEU . 45.9 mm -80.59 128.89 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 55.399999999999999 111.121 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -122.39 154.24 37.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 111.129 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.476 HG13 ' HB3' ' A' ' 154' ' ' LYS . 41.5 t -132.44 94.24 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 63.310000000000002 111.109 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.15 31.37 13.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 65.5 110.905 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.88 -24.77 27.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.754 . . . . 51.140000000000001 112.513 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -91.44 114.57 62.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.62 0.724 . . . . 54.240000000000002 110.916 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.71 122.91 9.59 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.729 2.286 . . . . 62.509999999999998 112.34 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.663 HD12 HG22 ' A' ' 10' ' ' ILE . 12.4 mt -68.26 -38.7 82.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 73.329999999999998 110.949 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.97 -128.21 2.11 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.727 -0.749 . . . . 71.450000000000003 112.49 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.47 136.86 53.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 74.010000000000005 110.861 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.465 HG21 HG13 ' A' ' 10' ' ' ILE . 0.9 OUTLIER -146.35 102.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 64.109999999999999 111.18 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.0 OUTLIER -109.06 174.77 5.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 64.519999999999996 110.841 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.438 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.9 OUTLIER -144.85 132.66 21.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 71.349999999999994 110.924 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.4 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 60.1 tt0 -86.63 97.35 10.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 74.209999999999994 110.878 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.404 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.6 mt -80.69 119.74 23.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 74.120000000000005 110.91 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -78.35 65.19 3.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 74.099999999999994 110.868 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.45 -23.49 10.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 111.1 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -66.85 -31.92 72.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 72.25 110.827 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -101.82 -31.63 10.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 71.439999999999998 110.871 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.48 66.27 69.69 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.588 0.709 . . . . 61.039999999999999 111.169 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -39.85 6.1 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.669 2.246 . . . . 72.519999999999996 112.348 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -36.45 70.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 75.340000000000003 110.942 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.2 m -91.33 -47.91 7.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 71.040000000000006 111.151 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.4 -46.66 80.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 52.530000000000001 111.085 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -54.66 -26.05 30.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 61.130000000000003 110.864 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.569 ' HA ' HD13 ' A' ' 78' ' ' ILE . 0.8 OUTLIER -69.48 -65.31 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 64.129999999999995 110.931 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.95 -24.38 64.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 71.219999999999999 110.918 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.503 ' O ' HG23 ' A' ' 41' ' ' THR . 2.3 ttp180 -80.34 -53.15 6.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 75.219999999999999 110.858 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.04 -34.79 22.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 71.530000000000001 111.075 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 35' ' ' ASN . 3.0 mt -79.52 -59.5 2.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 65.450000000000003 110.944 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.6 m -52.65 -32.16 40.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 43.140000000000001 110.907 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 37' ' ' ARG . 71.3 p -77.51 -52.65 8.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 74.439999999999998 111.19 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.23 -17.86 7.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.741 . . . . 70.340000000000003 112.497 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -33.83 37.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.923 0.392 . . . . 72.150000000000006 110.869 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -58.52 -29.42 66.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 71.340000000000003 110.908 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.16 -13.18 60.36 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.781 -0.723 . . . . 64.040000000000006 112.486 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -160.05 -166.03 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.887 0.375 . . . . 64.150000000000006 110.903 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.54 -140.97 7.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 74.420000000000002 112.468 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -157.73 50.77 0.43 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.971 0.415 . . . . 72.219999999999999 110.912 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 142.16 21.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 72.409999999999997 110.899 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.86 21.22 73.12 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.71 -0.757 . . . . 71.450000000000003 112.464 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.11 -26.68 28.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.829 0.347 . . . . 71.329999999999998 110.85 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 0.1 OUTLIER 68.38 155.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 75.230000000000004 110.915 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -95.18 138.65 32.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 72.129999999999995 110.916 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -119.38 30.46 7.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 63.030000000000001 110.842 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -176.34 117.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 44.420000000000002 110.897 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.3 mt -146.11 114.1 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 51.049999999999997 111.135 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.6 mt -106.59 103.05 44.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.69 0.757 . . . . 74.400000000000006 111.149 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.8 Cg_endo -69.74 76.71 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.672 2.248 . . . . 55.310000000000002 112.374 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.04 -26.47 0.32 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.755 -0.736 . . . . 53.030000000000001 112.483 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.408 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -117.56 -57.47 2.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 73.510000000000005 110.853 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.449 ' C ' ' HE3' ' A' ' 61' ' ' MET . 0.0 OUTLIER 176.24 170.55 0.43 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 63.119999999999997 110.851 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 13.2 m -112.98 -177.51 3.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 64.219999999999999 110.869 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -170.6 140.39 1.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 52.509999999999998 110.922 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.752 -0.737 . . . . 71.109999999999999 112.482 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 35' ' ' ASN . 41.8 pt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.779 0.323 . . . . 75.409999999999997 111.07 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -130.77 -67.49 0.72 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 110.903 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -137.81 -65.25 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.749 . . . . 43.130000000000003 112.503 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -145.21 -40.06 0.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.887 0.375 . . . . 61.43 110.918 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.408 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.58 179.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 75.140000000000001 110.899 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.61 177.73 8.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 61.32 110.891 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.04 169.47 17.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 72.230000000000004 110.908 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -49.94 163.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 71.540000000000006 110.852 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -120.94 -74.5 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 54.140000000000001 110.854 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -165.22 169.4 16.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 63.219999999999999 110.902 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.42 37.63 3.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 73.209999999999994 110.883 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -50.22 -29.37 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.488 . . . . 65.349999999999994 111.111 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 34.7 mt -111.97 80.52 1.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 75.140000000000001 110.898 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.76 153.16 43.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 74.109999999999999 110.915 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -60.44 94.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 70.310000000000002 110.848 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 p -105.75 25.12 11.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 74.329999999999998 111.134 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.66 179.48 24.62 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.761 -0.733 . . . . 61.530000000000001 112.499 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 171.09 15.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.681 2.254 . . . . 62.0 112.351 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.23 29.28 70.46 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.687 -0.768 . . . . 61.32 112.499 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.1 mm -102.82 138.38 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.861 0.362 . . . . 71.319999999999993 111.137 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -109.32 144.2 37.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 73.349999999999994 110.926 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.84 -168.75 2.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 65.439999999999998 110.828 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.41 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 1.8 mtp -105.81 99.97 9.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.497 . . . . 75.420000000000002 110.854 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.721 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -87.64 50.11 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 61.229999999999997 111.082 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -86.59 -78.28 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 75.099999999999994 110.886 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.693 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -146.53 34.01 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 73.109999999999999 111.108 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.36 -111.7 4.39 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.788 -0.72 . . . . 74.420000000000002 112.466 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 111.43 2.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.701 2.267 . . . . 70.109999999999999 112.339 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.536 ' C ' HG23 ' A' ' 107' ' ' THR . 1.7 m-20 72.09 163.72 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 71.450000000000003 110.867 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.693 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.1 p 67.27 29.57 7.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 74.340000000000003 111.125 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.37 78.29 8.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 73.409999999999997 110.849 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -72.35 -71.97 1.0 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 62.009999999999998 112.526 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.41 ' HA ' ' HE2' ' A' ' 100' ' ' MET . 2.7 p 177.29 49.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.783 0.325 . . . . 74.040000000000006 110.86 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.482 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 1.8 mm-40 -64.02 -31.1 72.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 71.140000000000001 110.922 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.482 ' HB3' ' O ' ' A' ' 111' ' ' GLN . 8.2 t80 67.71 139.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 74.219999999999999 110.877 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.721 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -161.08 123.14 3.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 73.299999999999997 110.894 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.9 mt -86.4 126.59 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 74.129999999999995 111.094 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.05 101.07 13.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 62.240000000000002 110.897 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 73.9 p -86.99 20.98 2.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 64.019999999999996 111.151 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.762 ' O ' HG23 ' A' ' 119' ' ' THR . . . 175.59 146.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 72.209999999999994 111.092 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 98.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 63.439999999999998 110.851 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.762 HG23 ' O ' ' A' ' 117' ' ' ALA . 32.8 p -106.51 46.69 0.91 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 74.340000000000003 111.163 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -26.51 64.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 65.549999999999997 110.88 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.738 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.3 p90 -49.5 -25.42 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 70.150000000000006 110.951 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 18.1 mt -45.72 -32.19 2.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 70.530000000000001 110.936 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.5 m-20 59.47 77.21 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 75.230000000000004 110.848 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.15 42.23 0.78 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.793 -0.718 . . . . 63.210000000000001 112.46 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -80.59 -26.39 37.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.831 0.348 . . . . 74.010000000000005 110.906 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -136.21 169.03 18.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.409999999999997 110.853 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 50.0 t -102.43 118.53 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 44.240000000000002 111.155 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.02 133.72 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 72.310000000000002 111.129 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.404 ' O ' HD23 ' A' ' 24' ' ' LEU . 21.2 p90 -156.25 33.91 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 62.119999999999997 110.918 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.89 176.11 44.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.712 -0.756 . . . . 73.049999999999997 112.471 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -175.71 135.06 0.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.833 0.349 . . . . 63.109999999999999 110.913 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.682 HG11 ' HG2' ' A' ' 136' ' ' MET . 70.2 t -39.7 107.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 72.239999999999995 111.15 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.4 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -69.62 -59.13 3.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 74.040000000000006 110.908 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -152.78 157.79 41.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 51.0 110.879 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.64 42.95 9.52 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.731 -0.747 . . . . 73.409999999999997 112.472 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.682 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -62.41 -29.04 70.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.328 . . . . 61.109999999999999 110.882 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.86 -31.95 42.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 53.25 110.867 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.545 HD12 ' HB3' ' A' ' 17' ' ' LEU . 45.9 mm -65.21 -40.0 87.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 53.340000000000003 111.099 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.49 -27.75 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 73.450000000000003 111.129 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -80.13 -28.46 38.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 110.868 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.02 -38.72 63.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 74.420000000000002 111.122 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 28.2 mtm -60.7 -52.63 64.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 72.239999999999995 110.894 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -54.51 -26.32 30.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 44.329999999999998 110.95 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.433 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.37 -23.98 63.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 62.32 110.857 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.433 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 64.8 m-85 -107.66 16.11 24.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 75.129999999999995 110.839 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -110.67 168.55 13.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 61.310000000000002 112.497 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.8 m -113.71 146.71 39.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 43.210000000000001 110.847 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -75.72 66.43 2.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.091 -0.504 . . . . 72.319999999999993 110.883 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -171.11 -37.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 70.420000000000002 110.863 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 159.13 -63.15 0.3 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 63.229999999999997 112.472 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.49 175.52 0.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.377 . . . . 72.150000000000006 110.879 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.7 p -145.12 176.69 9.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 65.340000000000003 111.127 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.24 -60.66 1.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.329999999999998 110.853 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.476 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.7 OUTLIER -86.21 -175.77 5.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 75.219999999999999 110.918 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.96 108.73 15.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 53.439999999999998 110.901 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 4.1 mp -83.74 117.96 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 74.129999999999995 111.103 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER -126.12 165.87 18.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 43.350000000000001 111.186 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.588 HD13 ' CE2' ' A' ' 8' ' ' PHE . 4.0 mt -103.87 106.08 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 73.530000000000001 111.142 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.743 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -65.49 -44.96 85.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 73.439999999999998 111.144 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -161.45 158.04 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 74.299999999999997 110.845 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.2 148.27 16.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 72.099999999999994 110.876 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.09 171.77 41.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.713 -0.756 . . . . 73.510000000000005 112.466 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -65.19 142.45 58.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.871 0.367 . . . . 74.409999999999997 110.888 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.576 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -94.54 -58.75 2.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 72.430000000000007 110.918 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 70.409999999999997 110.932 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.3 t . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.795 0.331 . . . . 74.200000000000003 111.136 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -108.62 146.31 33.42 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.621 0.724 . . . . 65.239999999999995 110.885 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 146.45 60.42 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.673 2.249 . . . . 74.450000000000003 112.373 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 m -133.19 140.22 47.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 62.409999999999997 111.139 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.493 ' HA ' HD23 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -134.21 144.67 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 70.150000000000006 111.108 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.598 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 17.8 p90 -103.13 168.43 9.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 71.510000000000005 110.897 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.595 ' CE2' HD13 ' A' ' 158' ' ' ILE . 4.6 m-85 -148.22 87.71 1.61 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 72.519999999999996 110.891 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.713 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.4 t70 -51.34 103.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 74.439999999999998 110.888 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.598 HG22 HD12 ' A' ' 17' ' ' LEU . 40.7 mm -81.96 135.81 24.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 51.149999999999999 111.099 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -128.19 155.05 45.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.010000000000005 111.084 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' A' ' 154' ' ' LYS . 22.2 t -135.54 96.17 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 65.329999999999998 111.092 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 66.86 30.76 7.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 72.129999999999995 110.908 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.57 -23.74 33.09 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 73.109999999999999 112.517 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -91.99 117.3 67.65 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.639 0.733 . . . . 54.219999999999999 110.922 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.4 Cg_endo -69.79 124.45 11.08 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.661 2.241 . . . . 72.439999999999998 112.324 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.615 ' HB3' HD12 ' A' ' 138' ' ' ILE . 12.0 mt -68.98 -38.82 79.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 52.25 110.878 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.96 -129.38 2.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 75.239999999999995 112.447 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.41 137.05 54.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 74.340000000000003 110.891 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.506 HG21 HG13 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -146.26 100.21 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 74.140000000000001 111.128 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.4 t -108.67 175.26 5.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 73.219999999999999 110.811 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.442 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -146.34 130.47 17.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 71.439999999999998 110.874 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -83.5 100.78 10.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 73.010000000000005 110.892 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.9 mt -82.84 123.57 29.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 74.299999999999997 110.907 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -82.26 63.55 6.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 75.150000000000006 110.911 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.86 -23.44 12.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 54.020000000000003 111.079 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -64.48 -37.95 89.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 70.299999999999997 110.854 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.59 -29.06 13.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 72.200000000000003 110.875 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.429 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -132.7 64.92 73.14 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.6 0.714 . . . . 61.439999999999998 111.181 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -38.18 8.14 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.664 2.243 . . . . 74.219999999999999 112.344 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.36 -37.98 79.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 72.25 110.903 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.5 m -88.61 -45.07 10.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 70.319999999999993 111.137 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.03 -47.01 86.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 75.030000000000001 111.147 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -50.56 -31.08 14.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 74.109999999999999 110.891 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.81 -62.85 1.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 74.349999999999994 110.907 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.19 -22.61 61.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 71.319999999999993 110.865 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 41' ' ' THR . 1.8 ttp180 -83.08 -56.94 3.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 73.040000000000006 110.875 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.35 -29.69 10.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 73.439999999999998 111.156 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.452 HD21 HG22 ' A' ' 78' ' ' ILE . 37.9 mt -80.13 -60.89 2.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 72.329999999999998 110.908 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.0 m -55.3 -36.01 65.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 73.140000000000001 110.831 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 37' ' ' ARG . 69.1 p -69.23 -31.97 70.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 72.230000000000004 111.135 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.15 -18.11 58.03 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.775 -0.726 . . . . 51.450000000000003 112.492 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.54 -32.33 40.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 63.420000000000002 110.871 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -60.78 -28.22 68.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 73.319999999999993 110.923 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.19 -15.17 56.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.749 . . . . 62.420000000000002 112.478 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -158.31 -165.4 1.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.877 0.37 . . . . 74.310000000000002 110.927 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.424 ' HA2' HD22 ' A' ' 39' ' ' LEU . . . 156.62 -166.74 33.42 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.723 -0.751 . . . . 70.310000000000002 112.468 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -103.73 15.06 29.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.974 0.416 . . . . 74.319999999999993 110.955 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.53 140.05 2.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 63.350000000000001 110.913 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.64 28.85 60.5 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.699 -0.762 . . . . 40.43 112.483 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.68 ' O ' HG22 ' A' ' 157' ' ' THR . 2.8 m -79.45 -177.16 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.383 . . . . 55.420000000000002 110.814 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.0 p -139.73 127.76 22.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 70.129999999999995 110.846 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -75.66 128.77 35.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 74.109999999999999 110.856 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -128.8 37.3 4.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 73.430000000000007 110.872 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.04 81.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 73.019999999999996 110.918 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.469 HD12 HD13 ' A' ' 156' ' ' ILE . 2.6 mt -117.9 117.97 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 75.120000000000005 111.127 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.406 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 28.8 mt -112.27 103.88 55.65 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.613 0.72 . . . . 72.030000000000001 111.104 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.2 Cg_endo -69.79 92.0 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.678 2.252 . . . . 53.210000000000001 112.304 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.74 -17.4 2.81 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 71.510000000000005 112.505 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.9 -53.96 1.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 74.040000000000006 110.874 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.65 174.21 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 73.420000000000002 110.911 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 9.3 m -113.04 -162.4 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 73.420000000000002 110.881 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 174.51 143.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 72.230000000000004 110.941 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 61.219999999999999 112.485 -179.953 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.452 HG22 HD21 ' A' ' 39' ' ' LEU . 2.1 pp . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.837 0.351 . . . . 71.409999999999997 111.143 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -76.2 -34.64 59.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 64.219999999999999 110.969 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.16 -113.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 72.430000000000007 112.487 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -78.95 -44.18 23.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.91 0.386 . . . . 72.010000000000005 110.907 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.432 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.4 170.29 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 73.140000000000001 110.925 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.73 166.25 13.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 75.120000000000005 110.913 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.75 166.34 18.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 71.140000000000001 110.875 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -54.23 145.73 16.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 74.200000000000003 110.833 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -104.91 -69.98 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 72.239999999999995 110.922 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -176.38 177.35 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 71.239999999999995 110.918 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.28 37.11 3.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 71.129999999999995 110.892 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.22 -34.61 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 74.239999999999995 111.132 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.7 mt -112.02 78.03 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 72.099999999999994 110.904 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.455 ' O ' HG23 ' A' ' 93' ' ' THR . 2.0 mtpm? -70.1 144.16 52.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 72.120000000000005 110.936 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -51.03 99.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 50.509999999999998 110.816 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 91' ' ' LYS . 25.7 p -111.8 28.96 8.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 74.200000000000003 111.138 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.45 179.64 26.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.701 -0.762 . . . . 65.200000000000003 112.507 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 163.99 36.22 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.653 2.235 . . . . 64.5 112.384 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.29 37.85 54.13 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 54.200000000000003 112.466 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.2 mm -110.19 139.9 31.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.914 0.388 . . . . 75.430000000000007 111.071 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -107.66 146.09 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 73.310000000000002 110.87 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.81 -158.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 75.319999999999993 110.865 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.413 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 0.9 OUTLIER -130.4 136.83 49.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 74.519999999999996 110.89 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -120.52 100.4 7.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 54.32 111.069 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -151.16 -41.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 71.5 110.928 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.722 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -178.86 34.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 63.200000000000003 111.078 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.13 -109.99 1.77 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 72.109999999999999 112.492 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 115.19 3.98 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.708 2.272 . . . . 63.009999999999998 112.313 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.557 ' C ' HG23 ' A' ' 107' ' ' THR . 1.7 m-20 73.24 169.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 71.120000000000005 110.921 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.722 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 0.7 OUTLIER 65.86 27.16 11.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 61.219999999999999 111.187 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -75.78 144.37 41.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 74.040000000000006 110.871 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.32 -100.33 0.63 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.731 -0.747 . . . . 74.420000000000002 112.471 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.413 ' HA ' ' HE2' ' A' ' 100' ' ' MET . 21.9 p -158.09 37.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.839 0.352 . . . . 73.450000000000003 110.873 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.677 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -110.22 58.71 0.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 73.420000000000002 110.854 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.431 ' CD2' HD21 ' A' ' 98' ' ' LEU . 45.5 p90 -58.19 -171.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 74.299999999999997 110.88 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.549 ' O ' ' C ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -160.88 78.36 0.6 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 74.349999999999994 110.874 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.549 ' C ' ' O ' ' A' ' 113' ' ' PHE . 4.9 mt -25.1 105.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 54.329999999999998 111.119 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 37.3 t -70.29 101.57 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 71.430000000000007 110.89 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 47.9 p -90.53 21.98 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 72.129999999999995 111.185 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 116' ' ' THR . . . 173.25 127.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 73.140000000000001 111.16 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 117' ' ' ALA . 2.1 tttt -36.77 108.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 72.219999999999999 110.956 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.812 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 61.4 p -95.06 71.33 3.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 72.349999999999994 111.155 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -68.62 -26.61 65.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 72.25 110.873 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.812 ' CZ2' HG22 ' A' ' 119' ' ' THR . 17.9 p90 -56.28 -19.99 16.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 74.409999999999997 110.907 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.649 HD12 ' OG1' ' A' ' 119' ' ' THR . 82.9 mt -80.81 -54.66 5.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 52.549999999999997 110.897 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 52.47 95.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 65.230000000000004 110.88 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 42.29 41.91 4.12 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.768 -0.73 . . . . 54.240000000000002 112.478 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -91.21 -9.95 43.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.828 0.347 . . . . 70.099999999999994 110.898 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -146.73 -169.99 3.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 65.230000000000004 110.827 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.6 t -115.56 109.83 29.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 60.140000000000001 111.085 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 t -88.64 136.05 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 74.530000000000001 111.112 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.464 ' O ' HD23 ' A' ' 24' ' ' LEU . 13.5 p90 -157.93 40.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 72.409999999999997 110.878 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -176.32 175.47 47.48 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.701 -0.761 . . . . 62.009999999999998 112.465 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 6.4 pttt -176.1 136.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 74.310000000000002 110.929 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.698 HG11 ' HG2' ' A' ' 136' ' ' MET . 53.3 t -38.62 108.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 62.420000000000002 111.155 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.69 -58.88 3.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.867 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -153.51 158.76 41.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 73.030000000000001 110.919 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.63 31.94 28.75 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.737 -0.744 . . . . 72.510000000000005 112.522 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.698 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -52.07 -33.51 39.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.775 0.322 . . . . 60.329999999999998 110.901 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -34.29 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 62.119999999999997 110.876 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.615 HD12 ' HB3' ' A' ' 17' ' ' LEU . 40.2 mm -63.81 -41.63 93.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 72.129999999999995 111.135 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.8 t -64.48 -24.87 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 54.119999999999997 111.175 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -81.62 -28.85 33.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 63.039999999999999 110.855 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.68 -38.9 64.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 74.200000000000003 111.094 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.0 mtm -59.04 -52.9 63.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 72.230000000000004 110.892 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -55.42 -25.51 36.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 63.420000000000002 110.92 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.438 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -70.02 -23.76 63.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 72.299999999999997 110.833 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.438 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 62.1 m-85 -108.24 20.8 18.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 70.049999999999997 110.879 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.01 164.96 12.35 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.789 -0.719 . . . . 62.399999999999999 112.499 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.1 m -107.41 146.93 31.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.86 0.362 . . . . 60.119999999999997 110.855 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.7 mmm-85 -74.28 69.93 1.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 72.120000000000005 110.861 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -174.44 -36.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 74.409999999999997 110.914 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 150.58 -52.22 0.51 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 65.349999999999994 112.433 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.45 -176.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.912 0.387 . . . . 72.010000000000005 110.89 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -164.93 155.97 14.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.445 . . . . 73.319999999999993 111.127 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 80.7 p -82.49 -54.75 4.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 75.310000000000002 110.905 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.486 ' HB3' HG13 ' A' ' 12' ' ' VAL . 1.4 mttp -79.12 177.34 8.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 74.510000000000005 110.908 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -121.41 108.55 13.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 72.019999999999996 110.882 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.469 HD13 HD12 ' A' ' 56' ' ' ILE . 4.2 mp -86.01 116.65 29.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 73.120000000000005 111.139 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -126.67 162.72 25.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 74.239999999999995 111.092 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.595 HD13 ' CE2' ' A' ' 8' ' ' PHE . 5.7 mt -101.86 116.02 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 61.130000000000003 111.109 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -74.88 -47.91 27.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 31.329999999999998 111.105 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -159.69 157.08 28.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 71.450000000000003 110.837 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.0 146.83 17.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 62.310000000000002 110.873 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.4 172.98 44.17 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.801 -0.714 . . . . 52.43 112.533 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -64.97 142.51 58.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 63.439999999999998 110.938 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -93.22 -59.93 1.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 72.230000000000004 110.883 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 74.540000000000006 110.909 179.951 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 N--CA 1.458 -0.051 0 CA-C-O 120.847 0.356 . . . . 54.409999999999997 111.119 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -110.63 154.0 43.34 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.615 0.721 . . . . 63.409999999999997 110.885 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 146.35 60.02 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.719 2.279 . . . . 72.420000000000002 112.316 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.6 m -128.6 127.8 42.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 45.0 111.179 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.415 HG13 ' CD1' ' A' ' 24' ' ' LEU . 3.3 m -123.63 177.84 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 74.329999999999998 111.164 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.673 ' HB3' HD21 ' A' ' 164' ' ' LEU . 2.2 p90 -160.61 178.27 9.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 75.120000000000005 110.867 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -155.96 95.25 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 73.099999999999994 110.901 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 3.5 t70 -45.37 108.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 71.109999999999999 110.839 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.644 HG23 HG23 ' A' ' 156' ' ' ILE . 22.9 mm -79.38 129.34 37.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 72.109999999999999 111.097 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -121.96 137.46 54.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 73.5 111.133 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -120.73 93.25 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 41.399999999999999 111.1 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.46 36.3 6.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 73.549999999999997 110.908 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.91 -16.4 61.24 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.71 -0.757 . . . . 64.209999999999994 112.474 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -102.33 109.56 60.68 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.646 0.736 . . . . 61.020000000000003 110.904 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.7 Cg_endo -69.78 127.03 13.99 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.653 2.235 . . . . 74.299999999999997 112.324 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.461 ' HB3' HD12 ' A' ' 138' ' ' ILE . 9.9 mt -67.34 -39.03 85.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 73.129999999999995 110.913 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.45 -120.82 0.97 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 21.440000000000001 112.44 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -134.91 140.86 46.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 75.010000000000005 110.907 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.523 HG21 HG13 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -142.43 93.12 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 72.329999999999998 111.124 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.4 t -95.35 174.19 7.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 71.019999999999996 110.833 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.434 ' N ' ' OG ' ' A' ' 21' ' ' SER . 56.5 m-85 -147.33 143.21 27.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 73.099999999999994 110.856 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -96.5 95.74 8.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 72.430000000000007 110.863 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 129' ' ' PHE . 2.0 mt -78.85 124.93 28.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 75.5 110.906 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.91 63.11 7.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 71.420000000000002 110.872 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.39 -23.65 10.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 71.040000000000006 111.098 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -62.68 -39.89 95.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 55.240000000000002 110.846 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -98.27 -28.7 13.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 71.129999999999995 110.887 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.467 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -131.05 63.89 71.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.64 0.733 . . . . 44.420000000000002 111.1 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -36.55 10.73 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.707 2.272 . . . . 54.229999999999997 112.385 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -38.73 92.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 74.310000000000002 110.918 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.5 m -85.22 -42.3 14.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 72.430000000000007 111.13 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.67 -42.84 95.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 74.150000000000006 111.097 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -49.36 -30.59 7.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 61.149999999999999 110.922 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.529 ' HA ' HD13 ' A' ' 78' ' ' ILE . 4.1 t30 -68.58 -70.4 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 74.219999999999999 110.905 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.09 -32.12 21.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 62.340000000000003 110.862 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.521 ' O ' HG23 ' A' ' 41' ' ' THR . 0.1 OUTLIER -75.36 -54.51 6.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 73.439999999999998 110.856 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.93 -37.3 43.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 74.530000000000001 111.115 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 mt -79.19 -58.54 3.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 55.420000000000002 110.919 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.8 m -50.13 -35.22 24.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 60.149999999999999 110.857 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 37' ' ' ARG . 80.4 p -79.07 -54.39 6.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 75.510000000000005 111.145 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.28 -16.14 7.18 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.748 . . . . 74.420000000000002 112.453 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -53.86 -27.43 29.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 62.509999999999998 110.907 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HE2' HG21 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -60.28 -17.38 41.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 64.019999999999996 110.939 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.07 -11.93 70.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 62.420000000000002 112.53 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -163.34 -168.33 1.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 63.340000000000003 110.907 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.51 -137.51 5.38 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 32.140000000000001 112.476 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -168.07 88.59 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.909 0.385 . . . . 75.530000000000001 110.949 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -79.98 82.87 5.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.079 -0.51 . . . . 71.120000000000005 110.884 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.58 -62.02 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 23.52 112.488 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.459 ' O ' HG22 ' A' ' 157' ' ' THR . 20.3 m 51.11 -169.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.816 0.341 . . . . 73.319999999999993 110.889 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.6 p -176.09 122.75 0.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 71.420000000000002 110.882 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -91.4 108.19 19.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 72.540000000000006 110.936 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -113.68 28.25 8.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.140000000000001 110.822 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.04 95.39 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 72.319999999999993 110.875 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 56' ' ' ILE . 3.7 mt -126.29 116.38 45.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 45.200000000000003 111.127 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.408 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 26.6 mt -108.57 104.84 55.57 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.616 0.722 . . . . 62.229999999999997 111.129 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.8 Cg_endo -69.82 88.31 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.24 . . . . 71.040000000000006 112.356 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.98 -18.67 1.96 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 70.140000000000001 112.491 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.0 -55.18 1.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 74.200000000000003 110.846 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 173.4 172.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 64.239999999999995 110.907 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 11.4 m -108.57 -160.46 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 75.109999999999999 110.918 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 176.49 140.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 51.240000000000002 110.913 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.813 -0.708 . . . . 71.549999999999997 112.54 -179.951 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 35' ' ' ASN . 40.4 pt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.827 0.346 . . . . 74.120000000000005 111.166 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -165.72 51.27 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 71.219999999999999 110.892 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.54 -173.24 55.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.751 -0.738 . . . . 72.510000000000005 112.481 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -53.41 -24.67 13.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.398 . . . . 62.299999999999997 110.921 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.521 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -174.7 176.97 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 74.010000000000005 110.861 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -151.83 179.95 7.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 62.439999999999998 110.904 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.79 171.02 11.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 74.420000000000002 110.895 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -87.55 171.85 10.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 74.5 110.854 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -119.7 -59.45 1.81 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.468 . . . . 73.310000000000002 110.839 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.4 p30 -177.45 177.01 1.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 64.5 110.852 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.3 35.27 3.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 75.200000000000003 110.892 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mt -50.48 -32.64 10.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 73.430000000000007 111.133 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.3 mt -111.03 74.95 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 75.409999999999997 110.922 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.665 ' O ' HG23 ' A' ' 93' ' ' THR . 10.9 mtpp -70.32 147.02 50.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 63.450000000000003 110.874 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -50.88 99.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.449 . . . . 75.439999999999998 110.819 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.665 HG23 ' O ' ' A' ' 91' ' ' LYS . 77.0 p -112.66 27.62 9.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 62.140000000000001 111.125 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 147.85 -179.26 24.86 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.714 -0.755 . . . . 40.310000000000002 112.467 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 170.48 16.53 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.657 2.238 . . . . 71.319999999999993 112.337 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.4 34.28 79.35 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.74 . . . . 75.140000000000001 112.494 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.5 mm -106.49 139.43 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.915 0.388 . . . . 74.409999999999997 111.083 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -106.85 146.57 30.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 61.530000000000001 110.915 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.402 ' HG ' ' C ' ' A' ' 127' ' ' VAL . 0.1 OUTLIER -164.06 -156.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 72.120000000000005 110.852 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.4 mmt -131.73 127.61 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.077 -0.51 . . . . 72.349999999999994 110.898 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -86.88 129.35 34.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 54.229999999999997 111.145 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 172.23 -168.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 71.239999999999995 110.888 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.756 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -47.47 -50.58 22.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 64.439999999999998 111.113 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 123.53 -66.89 0.5 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 55.240000000000002 112.447 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.529 ' O ' HG23 ' A' ' 107' ' ' THR . 53.8 Cg_endo -69.75 112.84 3.18 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.62 2.214 . . . . 64.450000000000003 112.39 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.8 OUTLIER 36.88 47.3 0.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 72.400000000000006 110.857 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.756 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 21.3 p -144.54 39.31 1.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 70.129999999999995 111.132 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -76.64 140.38 40.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 74.209999999999994 110.88 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.32 -131.06 3.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 42.240000000000002 112.485 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 p -138.07 29.92 2.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.805 0.336 . . . . 74.219999999999999 110.839 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.533 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 9.3 mm-40 -116.83 72.69 0.83 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 72.299999999999997 110.939 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.416 ' HB2' ' CD2' ' A' ' 98' ' ' LEU . 34.7 p90 -57.24 -174.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 75.510000000000005 110.897 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.552 ' O ' ' C ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -159.54 78.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 72.439999999999998 110.858 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.552 ' C ' ' O ' ' A' ' 113' ' ' PHE . 3.0 mt -23.38 107.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.492 . . . . 63.200000000000003 111.171 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 34.9 t -73.01 99.4 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 64.340000000000003 110.875 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 48.9 p -88.55 20.66 3.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 63.25 111.171 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 116' ' ' THR . . . 174.17 127.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 74.140000000000001 111.13 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 117' ' ' ALA . 3.4 tttt -36.35 107.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 61.030000000000001 110.912 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.812 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 49.5 p -94.36 72.86 3.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 75.230000000000004 111.135 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -71.45 -26.92 62.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 74.329999999999998 110.876 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.812 ' CZ2' HG22 ' A' ' 119' ' ' THR . 15.7 p90 -54.35 -22.02 11.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.168 -0.469 . . . . 63.329999999999998 110.913 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.605 HD12 ' OG1' ' A' ' 119' ' ' THR . 64.1 mt -78.66 -53.12 7.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 54.450000000000003 110.881 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 54.43 95.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 61.219999999999999 110.862 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 40.43 39.88 1.81 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.76 -0.733 . . . . 41.420000000000002 112.493 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -87.07 -12.15 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 74.329999999999998 110.903 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -145.17 -164.88 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 62.149999999999999 110.82 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.402 ' C ' ' HG ' ' A' ' 99' ' ' SER . 85.8 t -121.6 111.67 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 64.400000000000006 111.104 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.1 136.85 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 70.209999999999994 111.13 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.529 ' O ' HD23 ' A' ' 24' ' ' LEU . 12.6 p90 -159.48 42.43 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 61.350000000000001 110.856 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.405 ' C ' ' HB2' ' A' ' 98' ' ' LEU . . . -175.03 178.17 46.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.81 -0.71 . . . . 71.530000000000001 112.547 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -179.39 135.35 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.82 0.343 . . . . 72.140000000000001 110.906 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.702 HG11 ' HG2' ' A' ' 136' ' ' MET . 42.7 t -40.63 111.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 61.030000000000001 111.166 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.14 -59.93 2.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 64.150000000000006 110.878 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -151.05 165.9 32.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 74.239999999999995 110.9 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.76 34.53 48.4 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 60.43 112.485 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.702 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -54.43 -23.3 15.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 71.140000000000001 110.869 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.96 -31.2 62.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.433 . . . . 73.329999999999998 110.865 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' A' ' 17' ' ' LEU . 37.4 mm -65.89 -38.3 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 75.549999999999997 111.1 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.3 t -66.58 -27.83 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 70.310000000000002 111.089 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -80.88 -30.64 35.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 73.120000000000005 110.88 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.15 -38.52 69.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 74.129999999999995 111.088 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.527 ' SD ' HG21 ' A' ' 156' ' ' ILE . 38.9 mtm -62.66 -54.0 46.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 71.319999999999993 110.894 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -55.52 -24.57 32.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 71.120000000000005 110.87 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.431 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.77 -25.04 61.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 71.120000000000005 110.867 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.431 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 72.0 m-85 -108.34 19.96 19.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 53.420000000000002 110.919 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.48 163.4 12.17 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.758 -0.734 . . . . 34.43 112.449 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.3 t -112.01 146.59 37.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 73.450000000000003 110.845 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -75.06 67.96 1.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 72.430000000000007 110.856 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -172.68 -36.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 75.530000000000001 110.88 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 156.11 -93.74 0.14 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.715 -0.755 . . . . 44.32 112.461 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -51.85 165.51 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.808 0.337 . . . . 52.450000000000003 110.919 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.5 p -143.53 -171.7 3.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 71.140000000000001 111.115 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.5 p -88.44 -62.64 1.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 75.140000000000001 110.838 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -66.06 178.06 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 74.409999999999997 110.885 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.76 107.58 10.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 110.834 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.644 HG23 HG23 ' A' ' 10' ' ' ILE . 4.9 mp -91.36 108.46 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 74.049999999999997 111.118 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -125.24 162.87 23.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 74.109999999999999 111.115 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 19.9 mt -97.58 128.38 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 72.030000000000001 111.092 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -93.85 -56.13 2.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 75.319999999999993 111.076 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -135.11 155.15 51.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 70.25 110.854 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.83 146.11 11.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 63.100000000000001 110.944 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.39 165.83 31.49 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.72 -0.752 . . . . 64.510000000000005 112.444 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.469 ' HB2' HG22 ' A' ' 41' ' ' THR . 1.4 mt-30 -61.33 107.87 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 72.340000000000003 110.934 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.673 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.7 mm? -49.75 -49.7 47.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 64.510000000000005 110.922 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 51.229999999999997 110.877 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.568 ' O ' HG22 ' A' ' 2' ' ' VAL . 9.6 p . . . . . 0 N--CA 1.458 -0.033 0 CA-C-O 120.824 0.345 . . . . 72.25 111.13 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 62.42 157.64 0.12 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.619 0.723 . . . . 75.129999999999995 110.921 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 146.4 59.99 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.679 2.253 . . . . 71.519999999999996 112.373 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -132.7 141.78 48.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 72.049999999999997 111.155 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.476 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.1 m -133.21 143.52 38.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 71.510000000000005 111.133 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.575 ' HB3' HD21 ' A' ' 164' ' ' LEU . 15.4 p90 -103.13 159.79 15.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 62.130000000000003 110.872 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.737 ' CD2' HD13 ' A' ' 158' ' ' ILE . 4.5 m-85 -143.52 87.94 1.97 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 70.430000000000007 110.847 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.7 t0 -50.95 106.09 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 74.25 110.857 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.569 HG13 HG21 ' A' ' 20' ' ' VAL . 37.5 mm -81.18 130.57 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 71.299999999999997 111.133 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -121.28 146.89 46.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 72.209999999999994 111.102 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.0 t -130.59 94.4 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 75.530000000000001 111.128 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 67.44 32.95 5.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 75.109999999999999 110.865 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.76 -19.02 56.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.707 -0.759 . . . . 71.219999999999999 112.475 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -99.28 113.68 64.97 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.63 0.729 . . . . 70.209999999999994 110.884 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.6 Cg_endo -69.81 127.01 13.93 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.67 2.247 . . . . 51.009999999999998 112.328 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.53 ' HB3' HD12 ' A' ' 138' ' ' ILE . 11.3 mt -68.4 -38.28 81.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 63.119999999999997 110.949 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.78 -125.32 1.49 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.755 -0.736 . . . . 73.299999999999997 112.497 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.92 136.42 53.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 73.319999999999993 110.908 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.569 HG21 HG13 ' A' ' 10' ' ' ILE . 1.1 t -144.81 99.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 63.219999999999999 111.145 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -109.95 172.58 6.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 64.510000000000005 110.84 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -144.48 142.56 30.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 64.109999999999999 110.901 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.463 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 47.6 tt0 -98.22 99.58 10.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 71.239999999999995 110.9 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.5 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 2.2 mt -80.25 122.46 26.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 71.230000000000004 110.936 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.41 ' O ' HG23 ' A' ' 29' ' ' VAL . 55.2 m-85 -75.59 65.53 1.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 63.130000000000003 110.911 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.55 -22.6 13.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 72.209999999999994 111.102 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -63.61 -46.21 86.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 60.329999999999998 110.883 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -91.06 -30.38 16.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.430000000000007 110.88 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.468 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -131.03 67.11 80.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.653 0.74 . . . . 64.010000000000005 111.14 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -39.61 6.28 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.652 2.234 . . . . 74.450000000000003 112.346 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -37.05 85.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.878 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 m -85.15 -40.81 16.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 41.539999999999999 111.168 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.9 -48.59 68.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 63.009999999999998 111.088 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -49.52 -32.91 13.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 75.439999999999998 110.854 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.04 -50.62 69.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 72.140000000000001 110.902 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.417 ' HD2' HD11 ' A' ' 24' ' ' LEU . 4.0 t80 -69.55 -44.29 71.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 71.450000000000003 110.829 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.412 ' O ' HG23 ' A' ' 41' ' ' THR . 1.7 ttp180 -63.96 -35.47 80.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.898 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.97 92.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 44.020000000000003 111.107 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.424 HD11 HG23 ' A' ' 78' ' ' ILE . 3.2 mt -74.39 -45.94 43.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 63.219999999999999 110.903 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 m -57.49 -45.31 85.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 75.409999999999997 110.855 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.479 HG22 ' HB2' ' A' ' 163' ' ' GLN . 74.8 p -72.15 -48.64 41.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.104 -0.498 . . . . 64.349999999999994 111.11 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.74 -13.67 10.72 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.707 -0.759 . . . . 63.299999999999997 112.52 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -50.46 -34.57 25.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.856 0.36 . . . . 72.319999999999993 110.88 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -53.36 -27.97 26.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 74.400000000000006 110.882 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.87 -11.29 60.76 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 52.340000000000003 112.488 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -162.36 -165.79 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 71.439999999999998 110.88 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.95 -133.57 3.65 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.696 -0.764 . . . . 43.119999999999997 112.435 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -175.33 91.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.955 0.407 . . . . 74.129999999999995 110.906 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -80.68 78.02 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 75.420000000000002 110.864 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 158' ' ' ILE . . . 179.39 -66.66 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 51.240000000000002 112.502 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.483 ' O ' HG22 ' A' ' 157' ' ' THR . 1.3 m 49.19 -167.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 73.430000000000007 110.818 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.46 129.36 1.03 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 53.009999999999998 110.857 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -94.52 106.84 18.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.447 . . . . 53.049999999999997 110.864 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.0 27.29 9.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 73.120000000000005 110.856 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.97 91.71 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 75.430000000000007 110.909 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.0 mt -125.86 113.04 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 52.310000000000002 111.123 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.1 mt -105.12 102.36 35.83 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.596 0.712 . . . . 74.5 111.094 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 79.32 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.665 2.244 . . . . 63.200000000000003 112.35 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.45 -25.56 0.52 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 32.229999999999997 112.477 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.33 -57.67 2.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.809 0.338 . . . . 74.329999999999998 110.867 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.44 156.77 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 73.540000000000006 110.851 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.9 m -93.11 -167.81 1.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 74.109999999999999 110.915 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 177.61 146.93 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 63.399999999999999 110.887 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.721 -0.752 . . . . 72.319999999999993 112.451 -179.983 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.424 HG23 HD11 ' A' ' 39' ' ' LEU . 1.2 pp . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.827 0.346 . . . . 73.5 111.16 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -72.37 -34.28 67.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 74.329999999999998 110.879 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.25 -140.72 6.44 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.763 -0.732 . . . . 63.549999999999997 112.49 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -64.26 -35.27 80.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.935 0.398 . . . . 73.439999999999998 110.882 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.457 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.5 168.0 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 75.430000000000007 110.909 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -141.12 179.81 6.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 73.140000000000001 110.859 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.07 160.09 33.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 72.409999999999997 110.902 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.9 152.64 45.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 72.129999999999995 110.894 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -100.24 -75.81 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 70.120000000000005 110.913 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.4 p30 -166.91 173.94 8.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 52.200000000000003 110.919 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.86 34.75 3.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 72.400000000000006 110.908 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -51.03 -29.41 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 70.510000000000005 111.14 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 24.6 mt -99.99 91.7 4.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 74.409999999999997 110.878 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.9 mppp? -80.96 140.16 35.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 64.530000000000001 110.878 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -50.33 101.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 70.140000000000001 110.883 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.7 p -111.01 25.39 11.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 72.120000000000005 111.146 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 151.38 178.74 26.45 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 72.540000000000006 112.453 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 175.91 7.46 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.662 2.241 . . . . 74.230000000000004 112.332 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.86 37.11 93.81 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.69 -0.767 . . . . 70.439999999999998 112.474 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.1 mm -109.51 134.91 50.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.849 0.357 . . . . 65.010000000000005 111.118 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.537 HD22 ' CG ' ' A' ' 112' ' ' PHE . 2.8 mt -99.69 165.17 11.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 43.420000000000002 110.959 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 9.8 t -163.73 -128.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 63.210000000000001 110.83 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.599 ' HE2' ' HB ' ' A' ' 127' ' ' VAL . 28.8 mtm -150.24 143.15 24.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 52.5 110.844 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -93.58 104.13 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 63.130000000000003 111.06 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 179.8 174.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 75.200000000000003 110.896 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -50.57 -26.27 5.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 71.109999999999999 111.098 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.59 -82.93 0.33 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.709 -0.758 . . . . 64.349999999999994 112.499 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 95.06 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.687 2.258 . . . . 71.319999999999993 112.386 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.502 ' C ' HG23 ' A' ' 107' ' ' THR . 2.7 m-20 72.73 171.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 63.240000000000002 110.923 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.502 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.2 p 66.46 28.9 9.41 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 64.010000000000005 111.106 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -96.57 160.64 14.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 75.450000000000003 110.902 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.88 -132.42 3.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 45.119999999999997 112.488 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.9 t -104.48 -47.13 4.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.833 0.349 . . . . 64.5 110.86 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 2.3 pt20 -47.36 109.28 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 73.299999999999997 110.906 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.537 ' CG ' HD22 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -111.04 -164.1 0.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 74.540000000000006 110.898 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -143.81 153.0 41.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 72.540000000000006 110.859 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.0 mt -98.09 120.36 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 73.420000000000002 111.148 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 17.4 m -89.51 95.77 10.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 64.409999999999997 110.88 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 p -68.14 -8.46 38.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 71.209999999999994 111.135 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.687 ' O ' HG23 ' A' ' 119' ' ' THR . . . -147.33 154.03 40.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 40.140000000000001 111.05 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -56.66 93.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 72.219999999999999 110.894 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.69 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 26.2 p -95.74 45.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 64.200000000000003 111.114 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -25.75 67.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 64.129999999999995 110.888 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.69 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.4 p90 -48.18 -29.75 3.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.119 -0.491 . . . . 75.019999999999996 110.864 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.8 mt -45.51 -36.41 4.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 60.340000000000003 110.891 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.32 80.47 0.21 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 63.409999999999997 110.866 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 37.95 42.11 1.07 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.701 -0.762 . . . . 51.43 112.507 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.69 -14.66 47.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.824 0.345 . . . . 62.530000000000001 110.905 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -146.43 -176.47 5.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 70.329999999999998 110.871 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.599 ' HB ' ' HE2' ' A' ' 100' ' ' MET . 55.4 t -113.91 115.86 50.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 75.450000000000003 111.107 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 98' ' ' LEU . 22.4 t -92.27 132.26 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 74.319999999999993 111.133 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.468 ' CB ' HG21 ' A' ' 29' ' ' VAL . 20.2 p90 -157.1 44.78 0.38 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 110.94 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -179.34 174.76 46.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.724 -0.751 . . . . 75.129999999999995 112.474 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.02 143.43 0.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 72.329999999999998 110.886 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.741 HG11 ' HG2' ' A' ' 136' ' ' MET . 45.5 t -44.3 113.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 52.439999999999998 111.12 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.463 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -77.43 -59.82 2.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 63.530000000000001 110.906 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -152.53 155.23 37.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 64.420000000000002 110.902 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.99 36.91 10.56 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.739 . . . . 72.400000000000006 112.472 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.741 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -57.27 -27.52 62.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.785 0.326 . . . . 75.540000000000006 110.87 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.85 -32.22 60.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 60.130000000000003 110.866 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 17' ' ' LEU . 43.2 mm -66.17 -39.19 83.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 74.140000000000001 111.153 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.1 t -64.71 -26.62 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 72.409999999999997 111.165 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -81.04 -29.36 35.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 64.510000000000005 110.875 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.2 -39.5 65.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 61.140000000000001 111.092 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 35.0 mtm -61.22 -53.5 56.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 73.219999999999999 110.876 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.45 -25.41 36.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 72.420000000000002 110.934 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.435 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -70.23 -23.81 62.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 62.020000000000003 110.882 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.435 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 66.7 m-85 -108.89 20.73 18.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.400000000000006 110.863 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -111.3 171.74 14.57 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 52.32 112.482 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 t -127.9 143.29 51.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 75.319999999999993 110.868 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -71.48 79.22 0.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 64.109999999999999 110.933 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -178.91 -34.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 74.420000000000002 110.89 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.92 -83.1 0.18 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.741 . . . . 74.329999999999998 112.504 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.44 169.22 3.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 71.310000000000002 110.941 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.9 p -144.61 -171.58 3.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 72.019999999999996 111.146 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.8 p -88.64 -63.79 1.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 110.83 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -64.6 -179.68 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 74.430000000000007 110.916 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -127.71 108.81 11.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 73.099999999999994 110.899 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.14 116.54 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 74.109999999999999 111.16 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -131.69 164.93 24.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 65.099999999999994 111.112 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.737 HD13 ' CD2' ' A' ' 8' ' ' PHE . 3.7 mt -102.75 126.48 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.434 . . . . 45.049999999999997 111.123 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -90.76 -57.67 2.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 64.340000000000003 111.085 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -135.79 152.86 51.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.442 . . . . 50.210000000000001 110.849 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.32 144.38 10.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.198 -0.456 . . . . 75.430000000000007 110.924 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.18 171.28 40.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.71 -0.757 . . . . 52.049999999999997 112.518 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.479 ' HB2' HG22 ' A' ' 41' ' ' THR . 2.1 mt-30 -63.56 141.96 58.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 74.299999999999997 110.872 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.575 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.1 mm? -94.82 -59.61 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 65.219999999999999 110.906 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 73.129999999999995 110.872 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.781 0.324 . . . . 74.230000000000004 111.177 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -122.45 156.06 61.48 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.627 0.727 . . . . 74.120000000000005 110.891 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 146.14 59.21 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.674 2.249 . . . . 72.209999999999994 112.322 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -134.12 104.37 6.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 74.209999999999994 111.133 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -100.38 172.28 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.192 -0.458 . . . . 72.310000000000002 111.134 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.657 ' HB3' HD21 ' A' ' 164' ' ' LEU . 0.5 OUTLIER -160.16 172.98 16.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 71.209999999999994 110.9 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.41 ' HA ' ' HB3' ' A' ' 161' ' ' CYS . 32.1 m-85 -153.39 95.29 1.91 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 75.329999999999998 110.926 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.676 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.9 OUTLIER -45.2 104.59 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 70.219999999999999 110.884 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.735 HG22 HD12 ' A' ' 17' ' ' LEU . 29.7 mm -76.17 138.21 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 65.140000000000001 111.188 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.11 168.81 16.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 71.310000000000002 111.148 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.471 HG23 ' HG ' ' A' ' 17' ' ' LEU . 91.5 t -144.82 99.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 63.009999999999998 111.154 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.42 25.01 7.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 54.229999999999997 110.846 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.42 -28.3 12.0 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.725 -0.75 . . . . 60.32 112.479 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.64 125.79 70.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.73 . . . . 75.329999999999998 110.894 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 120.4 7.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.641 2.228 . . . . 74.409999999999997 112.358 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.735 HD12 HG22 ' A' ' 10' ' ' ILE . 6.5 mt -66.2 -42.02 89.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 65.25 110.922 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.88 -130.99 2.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 61.409999999999997 112.478 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.26 136.55 52.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 71.530000000000001 110.893 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.52 HG21 HG13 ' A' ' 10' ' ' ILE . 0.6 OUTLIER -143.01 100.53 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 64.340000000000003 111.179 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.435 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -109.51 172.84 6.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 71.230000000000004 110.872 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.407 ' N ' ' OG ' ' A' ' 21' ' ' SER . 43.6 m-85 -145.64 144.56 30.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 110.902 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -100.28 97.89 8.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 75.319999999999993 110.865 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.515 HD23 ' O ' ' A' ' 129' ' ' PHE . 2.3 mt -82.37 128.65 34.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 70.430000000000007 110.924 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.406 ' CD1' HD13 ' A' ' 90' ' ' LEU . 38.2 m-85 -87.16 67.3 9.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 75.420000000000002 110.932 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.57 -22.48 33.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 74.040000000000006 111.117 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -65.08 -34.16 77.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 74.310000000000002 110.882 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.2 mmtp -101.46 -31.27 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 75.420000000000002 110.927 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.406 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -132.78 65.64 74.72 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.588 0.708 . . . . 65.400000000000006 111.105 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -37.49 9.03 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.669 2.246 . . . . 74.430000000000007 112.321 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.15 -36.5 77.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 72.219999999999999 110.891 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.9 m -90.59 -41.32 11.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 65.040000000000006 111.143 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.69 -48.9 75.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 74.120000000000005 111.131 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -49.86 -34.29 19.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 74.150000000000006 110.922 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -65.25 -65.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 64.209999999999994 110.915 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -55.38 -36.51 66.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 75.540000000000006 110.875 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 41' ' ' THR . 2.2 ttp180 -68.61 -49.61 57.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 73.540000000000006 110.906 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.29 -25.15 32.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 40.329999999999998 111.084 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.24 -58.3 3.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 73.120000000000005 110.96 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.41 -38.4 83.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 72.040000000000006 110.872 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.487 HG22 ' HB2' ' A' ' 163' ' ' GLN . 42.8 p -62.59 -39.36 93.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 74.519999999999996 111.146 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.32 -19.52 31.74 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 74.150000000000006 112.493 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.71 -30.58 22.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.929 0.395 . . . . 75.129999999999995 110.905 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.567 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -59.53 -31.35 69.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 74.150000000000006 110.909 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.64 -8.97 68.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 44.25 112.458 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -169.81 -165.68 0.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.963 0.411 . . . . 73.200000000000003 110.834 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.37 -142.37 12.0 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.75 -0.738 . . . . 55.100000000000001 112.46 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -115.12 21.61 14.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.896 0.379 . . . . 74.109999999999999 110.875 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.4 125.26 12.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 75.420000000000002 110.86 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.05 36.96 93.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 75.319999999999993 112.53 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -117.3 141.11 48.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.36 . . . . 73.439999999999998 110.823 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.5 p -51.99 170.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 73.0 110.88 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.24 -173.77 4.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 75.439999999999998 110.885 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -106.56 -69.75 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 64.530000000000001 110.826 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.0 ttm-85 -137.26 160.72 38.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 71.230000000000004 110.884 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.563 HD12 HD13 ' A' ' 156' ' ' ILE . 40.5 mt -148.49 107.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 75.019999999999996 111.16 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.1 mt -106.08 104.78 51.16 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.624 0.726 . . . . 63.43 111.077 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.42 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 54.1 Cg_endo -69.77 79.29 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.67 2.247 . . . . 60.43 112.351 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.45 -26.53 0.27 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.749 . . . . 75.400000000000006 112.477 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.1 OUTLIER -120.61 -59.1 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 74.099999999999994 110.879 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.435 ' HB3' ' HA ' ' A' ' 115' ' ' CYS . 0.0 OUTLIER 170.91 156.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 73.209999999999994 110.9 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 6.6 m -85.78 -166.72 1.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 72.430000000000007 110.879 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -162.97 118.34 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 75.109999999999999 110.866 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.739 . . . . 52.310000000000002 112.495 180.0 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.567 HG22 ' HD2' ' A' ' 44' ' ' LYS . 14.8 pt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.815 0.34 . . . . 74.299999999999997 111.108 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.36 26.73 9.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 73.430000000000007 110.931 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.18 -70.07 2.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 32.100000000000001 112.476 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -125.42 -56.2 1.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.403 . . . . 74.549999999999997 110.909 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.437 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.36 -178.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 72.129999999999995 110.907 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -146.25 179.78 7.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 72.200000000000003 110.877 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.7 166.74 11.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 73.219999999999999 110.908 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -45.51 148.32 0.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 73.200000000000003 110.881 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -107.96 -74.66 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 75.450000000000003 110.856 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -162.11 170.47 19.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 70.409999999999997 110.89 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.22 37.95 3.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 75.420000000000002 110.925 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.37 -30.13 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 73.140000000000001 111.152 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.406 HD13 ' CD1' ' A' ' 25' ' ' PHE . 13.6 mt -110.02 84.59 1.95 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 73.150000000000006 110.92 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.467 ' O ' HG23 ' A' ' 93' ' ' THR . 23.6 mttp -71.77 146.83 47.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 64.030000000000001 110.926 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -51.69 103.23 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 73.25 110.862 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 91' ' ' LYS . 44.2 p -124.87 38.92 4.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 64.329999999999998 111.156 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.85 166.65 12.44 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.752 . . . . 71.25 112.49 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 160.11 50.91 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.698 2.265 . . . . 64.010000000000005 112.324 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.419 ' HA2' HG23 ' A' ' 132' ' ' VAL . . . 87.95 -14.53 58.53 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.69 -0.767 . . . . 65.319999999999993 112.465 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.6 mm -55.36 134.73 18.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.838 0.351 . . . . 72.340000000000003 111.131 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.664 HD22 ' HB2' ' A' ' 112' ' ' PHE . 3.8 mt -102.07 167.46 10.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 65.019999999999996 110.945 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.24 -147.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 62.299999999999997 110.878 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.407 ' HG3' ' HB3' ' A' ' 108' ' ' ASN . 6.3 mmt -145.17 124.88 13.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 71.510000000000005 110.902 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -115.31 76.36 1.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 63.520000000000003 111.109 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -114.12 -40.75 3.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 72.299999999999997 110.894 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.25 25.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 70.439999999999998 111.121 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.71 -140.82 16.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.728 -0.748 . . . . 61.310000000000002 112.505 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 106' ' ' ASN . 54.0 Cg_endo -69.73 59.32 1.6 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.668 2.245 . . . . 72.200000000000003 112.355 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER 166.02 160.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 62.109999999999999 110.885 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.2 p 56.71 34.19 24.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 70.439999999999998 111.185 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.407 ' HB3' ' HG3' ' A' ' 100' ' ' MET . 1.0 OUTLIER -75.17 64.83 1.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 70.519999999999996 110.889 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -62.82 -77.85 0.2 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.748 -0.739 . . . . 75.109999999999999 112.434 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 44.0 t -164.43 43.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.342 . . . . 71.549999999999997 110.868 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -101.39 39.46 1.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 74.120000000000005 110.903 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.664 ' HB2' HD22 ' A' ' 98' ' ' LEU . 32.3 p90 -55.29 -178.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 74.420000000000002 110.84 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.519 ' O ' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -157.58 -175.88 5.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.118 -0.492 . . . . 71.099999999999994 110.834 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 114' ' ' ILE . 2.8 mt -121.73 93.5 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 72.439999999999998 111.151 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 61' ' ' MET . 43.9 m -69.94 87.64 0.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 61.509999999999998 110.866 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.0 p -60.91 -14.88 25.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 71.310000000000002 111.118 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 119' ' ' THR . . . -143.26 153.16 42.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 70.420000000000002 111.103 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -54.51 93.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 42.229999999999997 110.862 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.71 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 24.9 p -93.82 52.74 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 72.219999999999999 111.149 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -24.24 65.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 110.862 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.71 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.6 p90 -48.95 -29.91 5.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 72.420000000000002 110.883 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 17.9 mt -47.2 -33.52 5.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 60.329999999999998 110.924 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.5 m-20 57.85 80.36 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 74.230000000000004 110.903 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.23 43.44 0.7 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 73.109999999999999 112.502 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.72 -16.29 51.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.849 0.357 . . . . 71.329999999999998 110.956 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -143.02 -167.75 2.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 73.200000000000003 110.884 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.2 t -120.34 115.14 46.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 63.200000000000003 111.142 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 98' ' ' LEU . 27.4 t -86.91 133.76 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 74.230000000000004 111.078 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.515 ' O ' HD23 ' A' ' 24' ' ' LEU . 16.7 p90 -154.82 41.42 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.510000000000005 110.906 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . 179.38 175.99 46.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.803 -0.713 . . . . 35.340000000000003 112.507 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -175.2 142.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 73.109999999999999 110.946 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.639 HG11 ' HG2' ' A' ' 136' ' ' MET . 34.5 t -45.61 112.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 73.230000000000004 111.128 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.13 -61.02 2.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 73.439999999999998 110.893 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -155.68 147.14 22.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 63.229999999999997 110.883 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.82 38.57 4.88 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.728 -0.749 . . . . 65.420000000000002 112.495 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.639 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -61.17 -30.36 70.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.805 0.336 . . . . 64.430000000000007 110.878 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.47 -37.57 49.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 63.399999999999999 110.881 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 17' ' ' LEU . 33.0 mm -61.89 -38.54 80.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 65.430000000000007 111.091 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.437 ' CG1' HG21 ' A' ' 114' ' ' ILE . 74.6 t -67.11 -24.21 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 73.040000000000006 111.109 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.72 -28.77 28.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 72.530000000000001 110.869 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.13 -39.01 63.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 71.510000000000005 111.108 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 28.1 mtm -58.95 -52.42 65.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 70.120000000000005 110.866 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -54.26 -26.69 30.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 54.409999999999997 110.886 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.45 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.81 -24.46 63.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 72.319999999999993 110.873 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.45 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 63.1 m-85 -107.78 14.07 25.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 73.219999999999999 110.853 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -113.61 167.52 12.34 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.763 -0.732 . . . . 52.219999999999999 112.505 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.55 133.95 51.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 75.109999999999999 110.867 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -54.38 -22.69 13.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.496 . . . . 65.140000000000001 110.873 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -31.27 64.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.452 . . . . 65.129999999999995 110.895 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 141.49 -40.69 1.3 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.749 -0.739 . . . . 75.450000000000003 112.53 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.57 -177.43 0.43 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 74.310000000000002 110.909 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.3 p -146.27 159.63 43.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 72.540000000000006 111.117 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.69 -58.47 2.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 65.439999999999998 110.844 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -89.48 -177.17 5.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 72.409999999999997 110.846 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -112.21 108.17 17.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 54.310000000000002 110.87 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.563 HD13 HD12 ' A' ' 56' ' ' ILE . 5.0 mp -84.65 117.73 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 64.430000000000007 111.165 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.12 164.18 22.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 74.430000000000007 111.2 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.2 mt -101.32 130.74 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 64.430000000000007 111.08 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -89.17 -53.45 4.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 74.120000000000005 111.098 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -148.33 145.69 28.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 74.010000000000005 110.847 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -149.93 146.57 27.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 71.420000000000002 110.886 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.52 161.81 21.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.714 -0.755 . . . . 73.319999999999993 112.472 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.487 ' HB2' HG22 ' A' ' 41' ' ' THR . 1.1 mt-30 -58.13 107.1 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 71.219999999999999 110.908 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.657 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.2 mm? -49.04 -54.88 13.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 71.019999999999996 110.921 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 55.240000000000002 110.864 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.859 0.361 . . . . 70.030000000000001 111.101 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -100.73 146.07 31.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.69 0.757 . . . . 65.219999999999999 110.854 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 152.48 69.17 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.702 2.268 . . . . 75.409999999999997 112.328 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -135.92 135.15 39.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 70.430000000000007 111.15 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.503 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.4 m -129.43 143.2 41.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 72.200000000000003 111.133 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 7.0 p90 -104.66 165.21 11.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 71.319999999999993 110.889 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.566 ' HE2' HD13 ' A' ' 158' ' ' ILE . 5.5 m-85 -147.29 86.4 1.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 72.120000000000005 110.896 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.776 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 2.1 t70 -46.76 107.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 74.439999999999998 110.855 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.557 HG13 HG21 ' A' ' 20' ' ' VAL . 46.3 mm -85.38 119.78 34.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 54.329999999999998 111.115 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -113.43 149.85 33.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 72.439999999999998 111.095 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 154' ' ' LYS . 18.2 t -133.28 98.42 2.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.451 . . . . 73.219999999999999 111.147 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.69 32.93 10.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 75.519999999999996 110.875 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.46 -18.59 57.11 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.717 -0.754 . . . . 73.140000000000001 112.486 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -98.5 114.84 65.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.651 0.739 . . . . 71.409999999999997 110.862 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.53 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.75 125.36 12.06 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.68 2.253 . . . . 73.510000000000005 112.337 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.513 HD12 HG22 ' A' ' 10' ' ' ILE . 12.6 mt -67.91 -39.05 83.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 70.519999999999996 110.873 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.19 -129.31 2.28 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.761 -0.733 . . . . 62.409999999999997 112.476 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -121.36 134.74 55.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 74.129999999999995 110.92 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.557 HG21 HG13 ' A' ' 10' ' ' ILE . 1.7 t -145.11 103.19 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 75.200000000000003 111.086 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -114.73 173.75 6.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 75.120000000000005 110.864 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.425 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.8 OUTLIER -143.57 136.8 27.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 75.109999999999999 110.922 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -91.52 98.28 11.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 75.040000000000006 110.855 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 129' ' ' PHE . 2.9 mt -80.15 125.87 30.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 64.140000000000001 110.906 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CD1' HD13 ' A' ' 90' ' ' LEU . 46.3 m-85 -83.58 63.17 7.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 62.240000000000002 110.933 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.64 -23.73 7.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 74.400000000000006 111.105 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.6 -35.1 76.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 63.409999999999997 110.855 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.51 -30.87 13.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 71.239999999999995 110.868 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.414 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -135.04 66.58 68.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.656 0.741 . . . . 73.230000000000004 111.126 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -32.71 18.04 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.664 2.243 . . . . 63.200000000000003 112.351 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -40.62 95.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 64.420000000000002 110.893 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.438 HG21 ' CD1' ' A' ' 129' ' ' PHE . 86.4 m -86.83 -44.91 11.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 73.040000000000006 111.157 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.26 82.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 63.030000000000001 111.074 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -47.62 -40.66 20.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 73.530000000000001 110.87 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.448 ' OD1' HG23 ' A' ' 78' ' ' ILE . 2.8 t30 -64.01 -63.33 1.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 74.310000000000002 110.882 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.43 -23.32 24.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 71.040000000000006 110.865 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.505 ' NH2' ' HG2' ' A' ' 163' ' ' GLN . 0.0 OUTLIER -74.54 -59.31 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 71.230000000000004 110.894 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.43 -30.3 62.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 73.099999999999994 111.126 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.3 mt -75.75 -58.29 3.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 74.030000000000001 110.869 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.6 m -49.64 -46.69 49.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 75.310000000000002 110.863 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.6 p -74.69 -28.81 60.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 54.240000000000002 111.172 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.58 -8.44 76.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.775 -0.726 . . . . 74.340000000000003 112.457 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -63.23 -15.82 58.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.874 0.368 . . . . 75.310000000000002 110.866 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HE3' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -49.48 -28.84 5.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 64.409999999999997 110.859 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.29 -25.83 5.64 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.696 -0.764 . . . . 73.129999999999995 112.431 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -160.25 -46.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 75.340000000000003 110.861 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.52 -146.22 21.48 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.766 -0.731 . . . . 53.130000000000003 112.466 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -175.44 92.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.99 0.424 . . . . 74.340000000000003 110.884 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.47 141.02 29.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 72.420000000000002 110.922 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.91 39.66 74.92 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.754 -0.736 . . . . 71.310000000000002 112.479 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.09 28.83 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 64.329999999999998 110.848 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 3.9 m 51.16 -170.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 61.140000000000001 110.885 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -105.06 -174.27 2.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 62.25 110.875 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -120.3 -72.78 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 74.019999999999996 110.808 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 45.2 ttm-85 -138.91 156.41 47.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 75.319999999999993 110.815 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.558 HD12 HD13 ' A' ' 156' ' ' ILE . 38.0 mt -147.87 113.27 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 74.140000000000001 111.143 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.5 mt -113.12 104.13 55.71 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.601 0.715 . . . . 63.119999999999997 111.178 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.4 Cg_endo -69.77 77.35 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.729 2.286 . . . . 70.209999999999994 112.327 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.01 -27.1 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.741 . . . . 64.209999999999994 112.46 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.01 -54.67 2.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 74.319999999999993 110.869 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 168.87 165.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 110.834 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.6 m -92.45 -161.25 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 52.32 110.861 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -179.57 129.58 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 72.010000000000005 110.919 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.677 -0.773 . . . . 72.430000000000007 112.43 -179.947 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.448 HG23 ' OD1' ' A' ' 35' ' ' ASN . 31.1 pt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.866 0.365 . . . . 63.5 111.103 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -157.38 47.79 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 63.310000000000002 110.927 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.95 -128.29 8.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.711 -0.757 . . . . 64.5 112.508 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -118.52 -27.0 6.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 72.510000000000005 110.855 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.456 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 177.32 167.58 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 74.400000000000006 110.893 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -139.6 177.51 7.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 73.400000000000006 110.894 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.16 157.17 37.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.878 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -52.73 136.24 33.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 61.020000000000003 110.899 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -91.18 -76.27 0.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 54.539999999999999 110.888 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -165.49 167.89 17.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 70.310000000000002 110.91 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.55 37.76 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 70.099999999999994 110.913 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.38 -29.91 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 71.340000000000003 111.169 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.419 HD13 ' CD1' ' A' ' 25' ' ' PHE . 13.8 mt -108.95 79.17 1.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 74.430000000000007 110.914 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 150.33 47.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 71.439999999999998 110.896 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -59.31 96.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 62.530000000000001 110.829 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.9 p -104.53 25.53 10.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 41.030000000000001 111.167 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 144.93 -179.08 22.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 43.240000000000002 112.487 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 171.82 13.75 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.715 2.277 . . . . 73.200000000000003 112.339 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.78 23.0 78.6 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 43.030000000000001 112.464 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.1 mm -99.04 142.7 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.891 0.377 . . . . 75.129999999999995 111.14 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.409 ' HB2' ' C ' ' A' ' 130' ' ' GLY . 0.2 OUTLIER -113.36 140.91 47.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 110.943 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.14 -167.15 2.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 110.858 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -100.24 104.95 16.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 74.409999999999997 110.863 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.976 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -78.42 52.37 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 74.329999999999998 111.117 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.34 -169.14 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 72.439999999999998 110.854 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.793 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -46.45 -47.59 19.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 45.009999999999998 111.074 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.67 -74.79 0.31 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.761 -0.733 . . . . 61.32 112.495 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.411 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.4 Cg_endo -69.81 111.32 2.79 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.659 2.239 . . . . 71.310000000000002 112.311 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 41.35 56.64 3.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 73.349999999999994 110.924 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.793 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 11.0 p -153.68 44.8 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 62.009999999999998 111.178 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.33 125.15 28.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 65.209999999999994 110.893 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.24 -91.84 0.52 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.74 . . . . 72.140000000000001 112.492 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.7 t -178.73 49.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.816 0.341 . . . . 73.540000000000006 110.814 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.671 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 3.8 mm-40 -74.69 -40.26 61.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 74.200000000000003 110.936 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 66.25 141.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 73.439999999999998 110.873 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.976 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.2 OUTLIER -161.99 135.85 6.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 74.200000000000003 110.912 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.417 HG21 ' CG1' ' A' ' 139' ' ' VAL . 2.8 mt -85.9 119.32 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 63.43 111.134 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.08 98.97 10.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 73.400000000000006 110.899 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 76.7 p -86.1 18.48 3.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 64.099999999999994 111.145 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.768 ' O ' HG23 ' A' ' 119' ' ' THR . . . 177.31 142.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 71.310000000000002 111.071 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -51.65 99.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 72.109999999999999 110.919 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.777 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 41.4 p -104.12 53.62 0.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 62.549999999999997 111.111 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.67 -27.32 68.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 73.329999999999998 110.894 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.777 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.6 p90 -48.29 -26.74 2.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 74.230000000000004 110.947 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 23.8 mt -44.48 -37.41 3.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 75.200000000000003 110.923 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 124' ' ' GLY . 5.5 m-20 59.16 80.98 0.17 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 62.020000000000003 110.857 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.63 41.67 0.88 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.742 -0.742 . . . . 70.109999999999999 112.473 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.12 -21.4 36.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.85 0.357 . . . . 73.439999999999998 110.909 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -144.75 -169.44 3.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 74.010000000000005 110.832 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.8 t -124.58 123.46 66.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 64.299999999999997 111.099 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 t -88.84 132.58 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 71.019999999999996 111.096 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.438 ' CD1' HG21 ' A' ' 32' ' ' THR . 23.9 p90 -154.93 36.64 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 72.430000000000007 110.889 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -174.12 177.77 46.22 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.753 -0.736 . . . . 62.43 112.509 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -177.9 138.81 0.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.861 0.362 . . . . 75.409999999999997 110.905 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.54 HG11 ' HG2' ' A' ' 136' ' ' MET . 77.2 t -41.94 106.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 73.340000000000003 111.123 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -59.91 2.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 71.319999999999993 110.878 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -153.46 150.0 28.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 65.129999999999995 110.91 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.8 48.25 4.23 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.729 . . . . 63.140000000000001 112.496 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.54 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -66.45 -32.01 73.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.719 0.295 . . . . 75.099999999999994 110.849 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.99 -33.22 37.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 71.219999999999999 110.916 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 17' ' ' LEU . 45.2 mm -64.92 -36.47 77.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 71.200000000000003 111.077 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.417 ' CG1' HG21 ' A' ' 114' ' ' ILE . 63.5 t -65.8 -27.59 41.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 50.509999999999998 111.144 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -81.03 -27.51 35.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 73.349999999999994 110.827 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.04 -39.89 60.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 74.510000000000005 111.116 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 33.9 mtm -60.69 -52.92 63.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 110.886 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.443 ' OE1' HG23 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -53.55 -27.6 27.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 74.530000000000001 110.889 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.447 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.28 -24.48 63.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 74.230000000000004 110.896 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.447 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 59.7 m-85 -109.08 21.47 17.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 73.099999999999994 110.892 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -114.54 168.14 12.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 60.039999999999999 112.466 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 m -104.73 129.84 52.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 72.519999999999996 110.891 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -54.97 -26.12 34.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 72.129999999999995 110.89 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -77.71 -28.81 51.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.882 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.27 -39.43 1.24 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.765 -0.731 . . . . 54.409999999999997 112.47 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -178.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 75.019999999999996 110.876 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 10.6 p -144.64 133.58 22.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 54.420000000000002 111.161 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.7 m -69.09 -41.17 77.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 65.310000000000002 110.889 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.514 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -105.5 -177.15 3.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 74.530000000000001 110.899 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.55 ' HD2' HG22 ' A' ' 157' ' ' THR . 2.0 tppp? -115.92 108.54 16.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 73.230000000000004 110.885 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.558 HD13 HD12 ' A' ' 56' ' ' ILE . 4.9 mp -92.0 119.2 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 64.209999999999994 111.12 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.55 HG22 ' HD2' ' A' ' 155' ' ' LYS . 0.6 OUTLIER -129.0 163.7 24.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 55.350000000000001 111.145 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.566 HD13 ' HE2' ' A' ' 8' ' ' PHE . 7.5 mt -96.23 105.56 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 111.106 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.776 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -69.31 -41.7 76.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 71.510000000000005 111.083 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -162.98 160.95 25.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 71.430000000000007 110.87 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -167.98 148.16 4.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 71.420000000000002 110.882 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.5 -173.02 44.27 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.739 -0.743 . . . . 75.239999999999995 112.492 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.505 ' HG2' ' NH2' ' A' ' 37' ' ' ARG . 3.8 mt-30 -80.93 129.59 34.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 75.099999999999994 110.91 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.555 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -83.87 -57.78 3.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 75.439999999999998 110.972 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 71.219999999999999 110.871 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.863 0.363 . . . . 64.299999999999997 111.121 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -72.09 149.8 92.19 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.646 0.736 . . . . 73.010000000000005 110.876 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 146.32 59.61 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.689 2.259 . . . . 64.219999999999999 112.351 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -136.29 140.53 43.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 72.450000000000003 111.127 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.5 ' HA ' HD23 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -132.84 147.62 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 71.329999999999998 111.136 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.588 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 16.5 p90 -106.64 166.48 10.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 74.120000000000005 110.849 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.618 ' CE2' HD13 ' A' ' 158' ' ' ILE . 6.3 m-85 -144.47 90.38 2.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.400000000000006 110.914 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.551 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 2.1 t0 -51.04 117.69 2.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 64.209999999999994 110.892 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.421 HG23 HG23 ' A' ' 156' ' ' ILE . 22.2 mm -90.43 116.65 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 65.439999999999998 111.134 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -113.47 124.26 51.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 70.340000000000003 111.093 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.619 HG23 HD13 ' A' ' 17' ' ' LEU . 12.9 t -109.22 101.34 12.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 72.230000000000004 111.158 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.31 44.26 25.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 73.310000000000002 110.833 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.08 -2.0 87.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.734 . . . . 73.299999999999997 112.491 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.413 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 10.3 mm-40 -109.56 99.49 37.71 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.677 0.751 . . . . 63.420000000000002 110.883 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.71 101.29 0.89 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.703 2.269 . . . . 65.519999999999996 112.378 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.619 HD13 HG23 ' A' ' 12' ' ' VAL . 8.4 mp -65.11 -35.73 82.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 62.109999999999999 110.89 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.59 -145.1 9.04 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.745 -0.741 . . . . 73.150000000000006 112.497 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.56 153.2 51.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 73.040000000000006 110.89 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.468 HG11 ' CG2' ' A' ' 139' ' ' VAL . 5.8 t -144.89 101.46 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 72.230000000000004 111.116 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 2.4 t -92.33 176.44 6.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 62.310000000000002 110.83 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.455 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -146.26 116.2 7.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 74.120000000000005 110.882 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -67.64 96.99 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 63.32 110.88 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.8 mt -80.16 134.32 36.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 75.030000000000001 110.885 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -94.4 66.93 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 71.140000000000001 110.849 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.95 -23.65 33.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 75.420000000000002 111.089 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.39 -29.16 67.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 63.140000000000001 110.888 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -103.11 -30.13 10.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 73.140000000000001 110.885 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.86 63.89 60.18 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.609 0.719 . . . . 62.310000000000002 111.131 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -5.85 17.19 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.689 2.259 . . . . 61.409999999999997 112.388 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.72 -45.25 11.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 74.549999999999997 110.907 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.432 HG23 ' HE1' ' A' ' 100' ' ' MET . 44.2 m -92.76 -48.8 6.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 53.240000000000002 111.126 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.99 -41.89 68.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 73.329999999999998 111.109 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -58.88 -44.52 91.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 71.439999999999998 110.933 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.468 ' OD1' HG23 ' A' ' 78' ' ' ILE . 3.0 t30 -54.2 -50.03 68.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 72.400000000000006 110.922 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -61.53 -43.61 98.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 64.0 110.856 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -63.06 -44.01 97.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 73.519999999999996 110.907 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.85 -37.75 66.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 52.530000000000001 111.089 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.422 HD23 ' HG2' ' A' ' 44' ' ' LYS . 28.8 mt -71.97 -54.7 9.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 54.399999999999999 110.903 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -44.7 81.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 64.5 110.857 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.404 HG22 ' HB2' ' A' ' 163' ' ' GLN . 40.1 p -65.32 -47.0 78.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 65.430000000000007 111.118 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.09 -18.28 16.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 72.239999999999995 112.484 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -52.89 -29.06 26.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.914 0.388 . . . . 72.200000000000003 110.881 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.804 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -58.83 -19.0 37.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 72.010000000000005 110.894 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.2 -13.07 40.52 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.683 -0.77 . . . . 62.310000000000002 112.476 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -176.78 -170.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.869 0.366 . . . . 73.409999999999997 110.855 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -177.83 173.15 45.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 62.520000000000003 112.466 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -117.93 60.29 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.961 0.41 . . . . 73.239999999999995 110.931 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -78.01 57.56 1.8 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.491 . . . . 71.209999999999994 110.863 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 169.76 59.06 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 54.109999999999999 112.447 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.537 ' O ' HG22 ' A' ' 157' ' ' THR . 0.3 OUTLIER -114.57 151.62 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 75.120000000000005 110.852 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.9 p -96.07 129.23 43.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 53.350000000000001 110.856 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -84.39 133.95 34.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 75.239999999999995 110.885 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -132.62 40.59 3.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 65.400000000000006 110.897 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 tpp85 -162.58 71.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 75.230000000000004 110.882 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.453 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.4 mt -123.66 113.76 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.420000000000002 111.153 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.7 mt -112.91 109.59 52.44 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.618 0.723 . . . . 64.319999999999993 111.12 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.0 Cg_endo -69.76 76.92 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.67 2.247 . . . . 63.100000000000001 112.319 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.79 -27.15 0.21 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 74.349999999999994 112.457 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.403 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.0 OUTLIER -115.26 -60.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 74.030000000000001 110.858 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.411 ' HE3' ' O ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER 172.68 173.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 55.100000000000001 110.866 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.411 ' O ' ' HE3' ' A' ' 61' ' ' MET . 7.2 m -108.83 -177.71 3.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 75.209999999999994 110.866 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.545 ' CG ' ' HB1' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -150.92 154.63 37.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 53.310000000000002 110.894 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.746 -0.74 . . . . 64.140000000000001 112.499 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.804 HG22 ' HD2' ' A' ' 44' ' ' LYS . 16.4 pt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.848 0.356 . . . . 60.219999999999999 111.144 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -164.74 -64.6 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 72.25 110.91 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -136.61 161.85 25.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 70.25 112.509 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -47.84 -32.1 5.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.904 0.383 . . . . 64.530000000000001 110.863 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.427 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.31 170.22 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 74.099999999999994 110.864 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.46 -179.9 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 63.450000000000003 110.886 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.85 160.0 26.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 74.200000000000003 110.888 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -52.1 151.67 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 63.130000000000003 110.823 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -100.62 -78.34 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 71.420000000000002 110.861 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -158.01 172.49 18.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 52.109999999999999 110.888 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.8 37.48 4.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 65.109999999999999 110.898 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mt -50.61 -29.35 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 64.349999999999994 111.089 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 15.1 mt -108.87 88.33 2.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 72.540000000000006 110.874 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -71.6 151.97 43.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 64.439999999999998 110.921 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -64.85 87.39 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 75.230000000000004 110.842 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.21 -51.38 11.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 75.030000000000001 111.154 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . -147.86 -164.46 11.31 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.772 -0.728 . . . . 63.43 112.477 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 173.8 10.44 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.659 2.24 . . . . 62.229999999999997 112.331 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.52 28.09 73.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.777 -0.725 . . . . 63.43 112.472 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.8 mm -100.85 140.69 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.893 0.377 . . . . 75.140000000000001 111.145 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -111.45 138.97 47.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 110.93 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.62 -168.1 3.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 71.519999999999996 110.863 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.432 ' HE1' HG23 ' A' ' 32' ' ' THR . 0.5 OUTLIER -94.23 103.91 15.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 64.549999999999997 110.902 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.937 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -75.64 69.77 2.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 64.319999999999993 111.115 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -131.71 -175.17 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 74.129999999999995 110.896 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.93 -27.15 2.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 64.329999999999998 111.112 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.4 -89.23 0.49 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.715 -0.755 . . . . 64.540000000000006 112.506 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 90.86 0.52 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.737 2.292 . . . . 73.530000000000001 112.316 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.561 ' C ' HG23 ' A' ' 107' ' ' THR . 2.9 m-20 76.07 168.53 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 64.400000000000006 110.897 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.561 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.1 p 69.86 28.96 4.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 73.530000000000001 111.174 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -109.28 106.65 16.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 64.400000000000006 110.879 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -90.23 -65.58 1.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 50.439999999999998 112.457 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.5 p 179.64 49.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.806 0.336 . . . . 73.239999999999995 110.836 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.686 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 3.4 mm-40 -62.39 -34.95 77.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 71.329999999999998 110.963 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 68.58 137.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 62.009999999999998 110.89 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.937 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -154.06 127.55 8.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 74.230000000000004 110.849 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.7 mt -83.95 125.32 40.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 73.329999999999998 111.164 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -91.15 103.48 16.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 73.319999999999993 110.894 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 69.4 p -88.42 20.75 3.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 111.117 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.732 ' O ' HG23 ' A' ' 119' ' ' THR . . . 174.87 146.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 52.310000000000002 111.13 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.425 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 1.2 tttt -54.43 99.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 65.219999999999999 110.906 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.732 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 42.2 p -105.87 46.66 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 72.209999999999994 111.125 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -25.73 65.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 75.140000000000001 110.879 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.732 ' CZ2' HG22 ' A' ' 119' ' ' THR . 5.6 p90 -50.12 -25.46 3.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.474 . . . . 72.329999999999998 110.905 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.9 mt -45.04 -35.72 3.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 73.409999999999997 110.888 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.0 m-20 60.74 80.45 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 65.329999999999998 110.853 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.3 42.66 0.9 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 63.200000000000003 112.52 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? -82.23 -25.49 34.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.834 0.35 . . . . 73.319999999999993 110.897 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -141.46 179.23 6.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 63.310000000000002 110.876 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.4 t -114.8 124.31 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 62.240000000000002 111.096 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.45 131.92 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 74.299999999999997 111.119 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.459 ' O ' HD23 ' A' ' 24' ' ' LEU . 43.3 p90 -149.23 31.58 0.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 62.25 110.911 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -175.8 175.69 47.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.804 -0.713 . . . . 73.030000000000001 112.494 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' A' ' 132' ' ' VAL . 1.5 pttp -173.12 127.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.81 0.338 . . . . 75.450000000000003 110.885 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.761 HG11 ' HG2' ' A' ' 136' ' ' MET . 53.8 t -32.12 106.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 64.430000000000007 111.107 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -57.16 4.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 70.510000000000005 110.895 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -157.06 157.51 34.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 75.409999999999997 110.905 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.33 32.05 10.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 65.299999999999997 112.507 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.761 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -61.16 -24.23 66.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 64.0 110.848 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -39.4 79.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 71.439999999999998 110.893 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.477 HD12 ' HB3' ' A' ' 17' ' ' LEU . 25.9 mm -66.56 -37.7 80.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 54.439999999999998 111.134 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.468 ' CG2' HG11 ' A' ' 20' ' ' VAL . 69.0 t -64.17 -30.54 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 73.230000000000004 111.129 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -73.09 -30.86 63.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 74.430000000000007 110.898 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.79 -37.19 70.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 61.119999999999997 111.111 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 16.0 mtm -57.97 -53.79 54.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 51.25 110.869 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.453 ' OE1' HG23 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -53.87 -28.12 34.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 61.140000000000001 110.866 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.44 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -67.81 -24.44 65.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 64.299999999999997 110.854 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.44 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 58.5 m-85 -108.71 20.68 18.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 70.109999999999999 110.915 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.41 166.25 12.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 52.119999999999997 112.514 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.5 t -123.34 148.79 45.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.864 0.364 . . . . 62.200000000000003 110.866 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.9 mmm-85 -75.34 70.51 2.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 61.009999999999998 110.92 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -174.79 -35.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.299999999999997 110.889 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.42 -42.72 0.88 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 70.040000000000006 112.483 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.38 165.63 20.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.864 0.364 . . . . 73.349999999999994 110.854 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.8 p -145.67 154.5 42.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 75.010000000000005 111.133 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 m -71.32 -48.16 52.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 75.329999999999998 110.849 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.413 ' HB3' HG13 ' A' ' 12' ' ' VAL . 6.0 mttt -96.87 -178.53 4.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 70.420000000000002 110.921 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -124.05 108.86 12.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 63.119999999999997 110.887 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.421 HG23 HG23 ' A' ' 10' ' ' ILE . 4.7 mp -92.76 123.12 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 70.430000000000007 111.126 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -131.83 158.57 40.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 64.129999999999995 111.136 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.618 HD13 ' CE2' ' A' ' 8' ' ' PHE . 9.7 mt -91.1 108.44 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 63.0 111.15 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -73.85 -48.4 31.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 63.039999999999999 111.099 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -151.93 162.74 40.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 54.409999999999997 110.872 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.11 148.19 4.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 74.310000000000002 110.901 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 176.81 172.51 41.52 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 74.329999999999998 112.498 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.404 ' HB2' HG22 ' A' ' 41' ' ' THR . 2.4 mt-30 -63.84 140.4 58.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.836 0.351 . . . . 74.140000000000001 110.91 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -92.49 -56.19 3.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 55.539999999999999 110.894 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 63.329999999999998 110.864 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.6 t . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.82 0.343 . . . . 51.539999999999999 111.159 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -102.44 153.51 38.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.617 0.722 . . . . 70.299999999999997 110.877 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 146.72 61.0 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.672 2.248 . . . . 75.319999999999993 112.316 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -133.28 140.05 47.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 74.120000000000005 111.18 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.458 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.6 m -133.3 143.02 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 64.209999999999994 111.14 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.577 ' HB3' HD21 ' A' ' 164' ' ' LEU . 15.7 p90 -103.4 161.07 14.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 71.099999999999994 110.92 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -142.55 88.08 2.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 72.540000000000006 110.868 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.493 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 2.3 t70 -52.13 107.49 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 60.130000000000003 110.888 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.841 HG23 HG23 ' A' ' 156' ' ' ILE . 32.3 mm -78.9 131.39 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 50.399999999999999 111.117 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -126.87 123.58 37.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 62.32 111.102 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.467 HG12 ' HG2' ' A' ' 154' ' ' LYS . 1.9 t -108.28 94.55 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 73.530000000000001 111.156 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.1 t0 58.96 46.76 13.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 73.040000000000006 110.899 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.34 -4.37 84.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.738 -0.744 . . . . 65.129999999999995 112.477 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.441 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -111.28 102.63 53.5 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.681 0.753 . . . . 72.439999999999998 110.87 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.82 124.34 10.96 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.628 2.218 . . . . 74.010000000000005 112.33 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.429 ' HB3' HD12 ' A' ' 138' ' ' ILE . 11.1 mt -70.14 -38.76 75.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 70.340000000000003 110.926 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.39 -127.17 1.7 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.76 -0.733 . . . . 72.019999999999996 112.534 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.49 138.37 54.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.856 0.36 . . . . 75.219999999999999 110.851 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.561 HG21 HG13 ' A' ' 10' ' ' ILE . 1.4 t -145.04 100.05 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 64.129999999999995 111.083 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -108.78 175.24 5.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 53.310000000000002 110.885 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.454 ' N ' ' OG ' ' A' ' 21' ' ' SER . 1.8 m-85 -146.23 137.2 24.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 74.409999999999997 110.827 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.406 ' HB2' ' CE ' ' A' ' 133' ' ' LYS . 16.2 tt0 -92.12 101.55 14.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 71.299999999999997 110.892 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.7 mt -83.15 119.06 24.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 63.240000000000002 110.939 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.432 ' CD1' HD13 ' A' ' 90' ' ' LEU . 58.3 m-85 -76.55 65.68 2.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 74.120000000000005 110.88 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.7 -22.77 25.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 44.130000000000003 111.099 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -65.87 -33.94 76.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 71.049999999999997 110.881 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -101.56 -29.19 12.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 51.439999999999998 110.887 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.416 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -135.22 65.73 64.65 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.594 0.712 . . . . 72.430000000000007 111.107 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -34.92 13.54 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.65 2.234 . . . . 73.310000000000002 112.37 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -39.55 91.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 75.540000000000006 110.909 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.5 m -87.96 -40.4 13.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 72.439999999999998 111.139 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.4 95.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 73.129999999999995 111.061 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -51.75 -35.78 44.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 65.140000000000001 110.87 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -61.37 -54.53 42.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 45.240000000000002 110.874 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -65.76 -45.65 81.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 73.450000000000003 110.879 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.97 -38.7 86.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 72.430000000000007 110.828 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.36 -44.28 97.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 61.240000000000002 111.093 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.5 mt -74.03 -47.21 38.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 62.100000000000001 110.933 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.1 m -51.92 -44.94 64.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 60.109999999999999 110.838 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.6 p -71.75 -34.4 69.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 61.100000000000001 111.144 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.59 -6.41 41.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.738 -0.744 . . . . 71.040000000000006 112.462 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.75 -25.09 17.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 54.43 110.856 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.582 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -65.63 -32.97 74.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 60.210000000000001 110.897 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.54 -28.88 4.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 73.310000000000002 112.487 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -141.51 -39.97 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.885 0.374 . . . . 74.109999999999999 110.91 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.13 -163.91 52.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 61.539999999999999 112.467 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.54 45.83 1.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.914 0.388 . . . . 71.140000000000001 110.937 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 74.33 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 74.150000000000006 110.865 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.67 -59.38 0.33 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 73.140000000000001 112.49 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 45.8 -163.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.774 0.321 . . . . 60.520000000000003 110.909 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.2 p 179.11 116.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 60.130000000000003 110.89 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.628 ' HE1' HD11 ' A' ' 158' ' ' ILE . 72.3 m-85 -97.37 75.35 2.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 71.420000000000002 110.867 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -73.15 -21.27 60.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 62.520000000000003 110.826 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.18 122.51 46.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 65.409999999999997 110.887 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.434 ' HB ' HG21 ' A' ' 152' ' ' THR . 29.0 mt -150.29 111.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 64.420000000000002 111.125 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.4 ' O ' HG22 ' A' ' 57' ' ' ILE . 42.8 mt -105.78 103.0 41.82 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.615 0.722 . . . . 75.430000000000007 111.179 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 83.11 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.706 2.271 . . . . 72.150000000000006 112.341 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 153.19 -20.63 0.75 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 74.340000000000003 112.525 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.21 -59.33 1.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.866 0.365 . . . . 64.329999999999998 110.859 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -178.14 175.59 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 73.140000000000001 110.866 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.4 m -120.47 -170.13 1.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 73.120000000000005 110.893 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -177.67 144.13 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 71.439999999999998 110.938 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.705 -0.76 . . . . 63.32 112.512 -179.956 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.582 HG22 ' HD2' ' A' ' 44' ' ' LYS . 1.5 pp . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.836 0.35 . . . . 65.439999999999998 111.152 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -82.89 -50.49 8.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.454 . . . . 71.299999999999997 110.884 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.76 -125.79 0.87 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.786 -0.721 . . . . 43.25 112.517 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -72.46 -33.2 66.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.885 0.374 . . . . 73.150000000000006 110.861 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.52 174.94 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 72.319999999999993 110.887 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.74 -168.52 1.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 72.109999999999999 110.85 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.28 162.67 14.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 72.230000000000004 110.902 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -54.33 115.83 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 73.299999999999997 110.881 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -93.85 -74.72 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 75.439999999999998 110.878 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -174.88 174.76 2.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 74.140000000000001 110.847 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.82 37.94 3.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 63.210000000000001 110.887 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -49.6 -30.13 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 73.310000000000002 111.131 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.432 HD13 ' CD1' ' A' ' 25' ' ' PHE . 10.1 mt -112.56 78.18 1.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.168 -0.469 . . . . 62.210000000000001 110.886 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 93' ' ' THR . 4.1 mtpt -70.55 151.55 44.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 72.140000000000001 110.864 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -49.81 102.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 72.400000000000006 110.898 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 91' ' ' LYS . 25.2 p -113.81 26.94 9.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 64.420000000000002 111.098 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.69 -177.78 24.78 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 44.420000000000002 112.54 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 174.14 9.94 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.655 2.237 . . . . 63.439999999999998 112.372 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.13 44.4 97.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 73.439999999999998 112.485 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 115' ' ' CYS . 14.0 mm -110.86 140.4 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.844 0.354 . . . . 55.329999999999998 111.122 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 98' ' ' LEU . 2.8 mt -108.29 155.68 20.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 44.039999999999999 110.943 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 6.8 t -167.29 -134.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 61.109999999999999 110.884 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 9.7 mmt -153.78 143.38 21.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 71.439999999999998 110.902 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -128.37 139.8 52.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 65.209999999999994 111.095 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 168.5 -31.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 74.299999999999997 110.858 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.732 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -175.95 -41.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 74.109999999999999 111.097 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.84 -77.47 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 70.329999999999998 112.484 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 112.0 2.96 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.636 2.224 . . . . 63.340000000000003 112.331 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.436 ' O ' HG23 ' A' ' 107' ' ' THR . 1.3 p-10 39.71 61.15 1.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 64.409999999999997 110.909 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.732 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 10.3 p -156.17 52.92 0.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 70.409999999999997 111.142 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.82 124.94 42.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 71.310000000000002 110.876 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.19 -103.48 1.97 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 73.540000000000006 112.5 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.19 30.49 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 64.319999999999993 110.858 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.633 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 6.3 mm-40 -112.5 40.48 2.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 72.549999999999997 110.933 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' A' ' 99' ' ' SER . 5.7 p90 -58.21 -170.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 73.010000000000005 110.89 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -148.58 146.54 28.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 74.450000000000003 110.895 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.45 HG21 HG13 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -74.79 -15.3 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 74.219999999999999 111.119 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER 49.17 93.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 52.0 110.913 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.549 HG22 ' CG1' ' A' ' 139' ' ' VAL . 82.3 p -91.17 26.75 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 62.329999999999998 111.118 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.621 ' O ' HG23 ' A' ' 119' ' ' THR . . . 178.26 151.76 0.28 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 62.009999999999998 111.129 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.74 97.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 44.299999999999997 110.881 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.699 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 26.5 p -104.11 46.5 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 52.310000000000002 111.148 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -25.38 68.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 71.030000000000001 110.842 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.699 ' CZ2' HG22 ' A' ' 119' ' ' THR . 5.4 p90 -47.32 -28.61 2.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.155 -0.475 . . . . 75.230000000000004 110.938 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.6 mt -46.74 -32.82 3.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 64.209999999999994 110.865 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 62.52 77.44 0.33 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 72.040000000000006 110.869 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 36.54 43.43 0.77 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 60.240000000000002 112.45 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -80.85 -13.6 58.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 74.140000000000001 110.916 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -144.05 -169.15 3.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 110.859 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.1 t -120.69 117.39 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 72.340000000000003 111.173 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 98' ' ' LEU . 2.6 t -88.83 134.14 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 72.150000000000006 111.119 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.445 ' O ' HD23 ' A' ' 24' ' ' LEU . 19.9 p90 -156.09 37.6 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 74.430000000000007 110.839 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -175.4 173.55 46.3 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.772 -0.728 . . . . 70.200000000000003 112.486 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 8.0 pttt -175.59 139.3 0.42 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.797 0.332 . . . . 75.340000000000003 110.926 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.654 HG11 ' HG2' ' A' ' 136' ' ' MET . 55.1 t -41.17 110.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 73.129999999999995 111.132 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.406 ' CE ' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -73.0 -59.29 2.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 71.109999999999999 110.868 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -152.12 157.14 41.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 42.130000000000003 110.897 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.09 35.54 17.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.742 . . . . 32.439999999999998 112.508 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.654 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -56.13 -31.38 63.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.751 0.31 . . . . 71.239999999999995 110.909 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.59 -30.23 20.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 71.040000000000006 110.887 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.443 HG21 ' CG2' ' A' ' 20' ' ' VAL . 41.4 mm -66.27 -41.29 88.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 75.430000000000007 111.092 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.549 ' CG1' HG22 ' A' ' 116' ' ' THR . 59.1 t -62.02 -28.29 44.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 53.240000000000002 111.152 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -79.34 -28.64 42.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 64.040000000000006 110.857 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.32 -38.46 63.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 35.5 111.112 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.569 ' SD ' HG21 ' A' ' 156' ' ' ILE . 28.6 mtm -59.78 -51.8 68.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 72.109999999999999 110.894 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.02 -24.69 25.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 73.120000000000005 110.903 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.43 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -72.71 -24.11 60.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 73.230000000000004 110.925 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.43 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 62.1 m-85 -108.27 16.86 22.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 65.510000000000005 110.879 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.98 178.66 17.62 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 61.229999999999997 112.491 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -141.3 132.59 26.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 45.25 110.865 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -64.58 84.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 62.509999999999998 110.855 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 179.74 -33.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 71.299999999999997 110.865 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.21 -92.49 0.15 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.8 -0.714 . . . . 73.010000000000005 112.488 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -51.17 156.53 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 73.310000000000002 110.895 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.434 HG21 ' HB ' ' A' ' 56' ' ' ILE . 39.1 p -131.66 156.02 46.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 111.145 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.63 -35.21 78.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 73.129999999999995 110.863 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.467 ' HG2' HG12 ' A' ' 12' ' ' VAL . 2.1 mttp -101.23 -179.59 4.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 75.519999999999996 110.859 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.8 104.55 7.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 62.409999999999997 110.846 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.841 HG23 HG23 ' A' ' 10' ' ' ILE . 4.8 mp -90.63 105.56 16.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 71.109999999999999 111.081 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.95 166.02 13.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 70.299999999999997 111.132 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.628 HD11 ' HE1' ' A' ' 53' ' ' PHE . 6.5 mm -98.4 119.51 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 72.319999999999993 111.118 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -82.96 -50.56 8.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 65.129999999999995 111.117 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -142.81 155.58 44.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 73.040000000000006 110.862 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -163.44 148.87 11.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 73.319999999999993 110.89 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 172.96 167.64 33.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.783 -0.722 . . . . 55.219999999999999 112.511 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -61.83 134.8 57.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.789 0.328 . . . . 61.420000000000002 110.927 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.577 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -85.7 -59.3 2.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 74.129999999999995 110.938 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 75.129999999999995 110.855 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.822 0.344 . . . . 74.5 111.162 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.46 142.96 29.58 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 74.409999999999997 110.889 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 146.84 61.47 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.687 2.258 . . . . 65.109999999999999 112.356 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -129.52 135.66 48.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 74.420000000000002 111.167 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -133.13 160.56 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 61.350000000000001 111.122 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 1.7 p90 -143.36 -179.29 6.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 73.409999999999997 110.879 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -155.89 92.99 1.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 74.230000000000004 110.896 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.58 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.8 OUTLIER -44.05 104.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 74.540000000000006 110.925 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.672 HG22 HD12 ' A' ' 17' ' ' LEU . 26.1 mm -77.18 134.79 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 73.329999999999998 111.083 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -127.66 154.12 45.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 43.329999999999998 111.068 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.53 HG13 ' HB3' ' A' ' 154' ' ' LYS . 33.2 t -134.02 95.91 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 64.340000000000003 111.106 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.37 31.52 10.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 71.329999999999998 110.861 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.63 -23.39 34.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.788 -0.72 . . . . 74.530000000000001 112.471 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -92.25 115.09 64.1 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.607 0.718 . . . . 60.039999999999999 110.891 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.9 Cg_endo -69.73 123.0 9.69 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.69 2.26 . . . . 75.400000000000006 112.374 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.672 HD12 HG22 ' A' ' 10' ' ' ILE . 13.1 mt -66.66 -38.66 87.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 73.230000000000004 110.909 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.65 -122.95 1.19 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.756 -0.735 . . . . 42.109999999999999 112.458 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.05 141.13 46.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 73.329999999999998 110.91 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.539 HG21 HG13 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -143.53 103.99 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 55.450000000000003 111.136 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.8 t -110.28 172.95 6.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 71.099999999999994 110.834 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.418 ' N ' ' OG ' ' A' ' 21' ' ' SER . 10.1 m-85 -146.29 131.61 18.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 73.140000000000001 110.906 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -85.98 98.07 10.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 61.310000000000002 110.884 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 129' ' ' PHE . 3.6 mt -83.12 136.39 34.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 73.299999999999997 110.888 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -96.27 63.75 2.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 65.209999999999994 110.85 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.19 -24.02 16.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 71.519999999999996 111.072 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.36 -31.19 70.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 74.209999999999994 110.887 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.5 -27.07 13.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 73.319999999999993 110.831 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.451 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -136.61 63.52 47.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.577 0.703 . . . . 71.239999999999995 111.088 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -41.82 3.89 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.679 2.253 . . . . 73.030000000000001 112.354 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -55.32 -37.46 67.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 73.409999999999997 110.922 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.424 HG21 ' CD1' ' A' ' 129' ' ' PHE . 16.0 m -89.19 -53.36 4.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 62.530000000000001 111.141 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.26 -36.37 41.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 44.399999999999999 111.123 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -49.74 -32.35 13.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 72.219999999999999 110.876 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.475 ' ND2' HG23 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -66.48 -63.84 0.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 75.040000000000006 110.926 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.37 -34.29 68.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 74.519999999999996 110.893 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.5 ' HE ' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -65.05 -49.48 69.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.487 . . . . 70.310000000000002 110.871 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.87 -31.46 72.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 70.120000000000005 111.113 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.9 mt -75.43 -55.95 5.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 62.350000000000001 110.96 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.0 m -49.37 -48.92 46.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 71.120000000000005 110.873 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.5 HG23 ' HE ' ' A' ' 37' ' ' ARG . 17.2 p -69.05 -28.08 66.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 71.340000000000003 111.132 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.3 -14.51 65.16 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.728 . . . . 75.540000000000006 112.459 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -52.29 -25.29 9.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 73.239999999999995 110.938 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.785 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -50.3 -28.26 7.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 75.140000000000001 110.868 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.69 -26.08 4.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.766 -0.731 . . . . 43.420000000000002 112.501 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -165.45 -47.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 74.420000000000002 110.849 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.61 177.72 0.38 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.774 -0.727 . . . . 61.409999999999997 112.488 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -94.7 26.71 3.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.004 0.43 . . . . 75.099999999999994 110.919 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.19 126.92 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 73.120000000000005 110.902 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.18 39.6 92.47 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.763 -0.732 . . . . 73.109999999999999 112.484 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -92.02 -178.66 5.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.888 0.375 . . . . 73.219999999999999 110.853 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 22.6 m -117.73 153.39 33.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 73.0 110.891 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -101.61 143.54 31.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 71.140000000000001 110.888 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -145.25 45.01 1.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 73.540000000000006 110.827 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -171.38 70.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 72.140000000000001 110.885 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 56' ' ' ILE . 11.2 mt -117.39 109.46 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 71.519999999999996 111.091 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.6 mt -106.82 102.67 43.51 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.65 0.738 . . . . 71.430000000000007 111.148 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.5 Cg_endo -69.82 79.67 0.95 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.683 2.255 . . . . 73.010000000000005 112.309 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.19 -25.62 0.54 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 73.120000000000005 112.491 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.43 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.3 OUTLIER -117.95 -59.17 1.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.332 . . . . 74.510000000000005 110.865 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.43 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.2 OUTLIER 176.91 162.63 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 75.340000000000003 110.815 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.9 m -104.59 -169.05 1.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 110.909 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.497 HE21 ' HB1' ' A' ' 101' ' ' ALA . 3.4 tt0 -178.72 146.91 0.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 75.420000000000002 110.939 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.728 . . . . 71.239999999999995 112.472 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.785 HG22 ' HD2' ' A' ' 44' ' ' LYS . 3.9 pt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.857 0.361 . . . . 45.210000000000001 111.144 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -135.42 -67.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 63.340000000000003 110.933 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.16 -142.65 3.49 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 60.399999999999999 112.517 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -50.23 -32.94 17.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.856 0.36 . . . . 74.299999999999997 110.889 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.427 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.69 -175.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 60.32 110.883 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -147.32 161.01 41.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 72.200000000000003 110.871 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -60.73 166.0 3.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 65.510000000000005 110.899 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -82.12 174.94 10.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 75.519999999999996 110.852 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -120.09 -76.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 73.019999999999996 110.871 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.5 p30 -158.89 176.04 12.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 74.010000000000005 110.89 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.03 37.66 3.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 75.430000000000007 110.844 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.54 -30.08 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 71.030000000000001 111.141 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 20.9 mt -109.99 82.56 1.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 65.310000000000002 110.92 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.93 150.48 46.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 63.219999999999999 110.875 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -58.03 97.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.5 110.841 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.0 p -104.06 24.09 11.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 53.25 111.122 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 147.19 -178.89 24.52 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.739 -0.743 . . . . 70.25 112.5 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 172.62 12.33 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.651 2.234 . . . . 75.25 112.327 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.92 29.56 72.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 75.450000000000003 112.473 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.5 mm -103.07 139.97 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.877 0.37 . . . . 54.32 111.119 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.48 HD21 ' CD2' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -108.86 145.97 34.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 65.230000000000004 110.935 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.95 -167.99 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 53.409999999999997 110.891 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.579 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -98.38 113.71 25.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 74.400000000000006 110.859 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.886 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -94.03 130.45 40.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 62.109999999999999 111.077 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.562 ' CG ' ' HA3' ' A' ' 109' ' ' GLY . 0.6 OUTLIER 175.5 -70.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 65.219999999999999 110.915 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.833 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -146.85 -50.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 70.140000000000001 111.07 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.35 -70.27 0.51 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.759 -0.734 . . . . 71.439999999999998 112.522 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 110.23 2.5 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.672 2.248 . . . . 71.030000000000001 112.358 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 39.52 45.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 71.109999999999999 110.865 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.833 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 22.1 p -153.77 53.33 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 65.340000000000003 111.164 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -50.43 -37.16 36.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 73.209999999999994 110.909 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.562 ' HA3' ' CG ' ' A' ' 102' ' ' ASN . . . 77.34 -56.39 3.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 72.099999999999994 112.484 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.579 ' HA ' ' HE2' ' A' ' 100' ' ' MET . 1.0 OUTLIER 85.73 41.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 54.32 110.839 -179.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 25.5 mm-40 -104.45 -14.91 15.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 75.239999999999995 110.925 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.566 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER 72.91 150.94 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.540000000000006 110.876 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.886 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -159.23 131.11 6.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 73.340000000000003 110.849 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 mt -87.85 126.93 41.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 73.530000000000001 111.139 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.94 101.02 13.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.349999999999994 110.823 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 68.4 p -86.24 20.45 2.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 74.349999999999994 111.101 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.718 ' O ' HG23 ' A' ' 119' ' ' THR . . . 176.25 146.21 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 74.5 111.071 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -56.01 94.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 62.520000000000003 110.926 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.811 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 33.8 p -100.7 56.64 0.89 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 54.450000000000003 111.126 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.04 -26.17 67.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 75.109999999999999 110.904 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.811 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.8 p90 -49.17 -26.4 2.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 71.530000000000001 110.908 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.7 mt -45.83 -34.16 3.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.26 -0.427 . . . . 75.219999999999999 110.926 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.6 m-20 61.93 72.5 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 71.200000000000003 110.916 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.65 42.74 0.71 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.691 -0.766 . . . . 75.109999999999999 112.519 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.78 -28.47 36.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 63.200000000000003 110.885 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -124.83 -173.22 2.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 75.109999999999999 110.845 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.11 116.86 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 60.219999999999999 111.143 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.34 135.03 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 35.149999999999999 111.137 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.485 ' O ' HD23 ' A' ' 24' ' ' LEU . 16.4 p90 -160.79 34.82 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 65.230000000000004 110.872 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -172.49 176.39 45.43 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.764 -0.731 . . . . 53.119999999999997 112.497 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -174.14 136.98 0.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.803 0.335 . . . . 65.019999999999996 110.905 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.664 HG11 ' HG2' ' A' ' 136' ' ' MET . 79.6 t -40.95 108.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 73.439999999999998 111.159 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -57.96 4.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 72.120000000000005 110.921 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -157.18 156.83 33.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.540000000000006 110.893 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.07 32.61 16.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.789 -0.719 . . . . 61.130000000000003 112.505 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.664 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -55.89 -26.22 46.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 74.540000000000006 110.888 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -32.39 59.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 55.140000000000001 110.867 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.603 HD12 ' HB3' ' A' ' 17' ' ' LEU . 40.1 mm -65.29 -37.06 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 72.219999999999999 111.126 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.1 t -66.31 -28.19 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 72.319999999999993 111.104 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.21 -28.64 38.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 72.519999999999996 110.901 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.99 -40.0 60.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 54.210000000000001 111.112 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 34.6 mtm -61.27 -53.1 61.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 74.140000000000001 110.908 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.448 ' OE1' HG23 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -54.87 -24.73 24.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 75.109999999999999 110.896 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.43 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.66 -24.31 61.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 73.430000000000007 110.857 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.43 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 64.0 m-85 -107.7 13.94 26.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 73.019999999999996 110.878 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.1 169.08 13.64 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.732 -0.746 . . . . 72.549999999999997 112.482 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.5 p -114.08 146.71 39.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 72.310000000000002 110.859 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -73.73 72.92 1.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 73.430000000000007 110.888 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -179.53 -34.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 73.329999999999998 110.886 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 154.5 -61.3 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.775 -0.726 . . . . 74.140000000000001 112.516 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -58.31 174.37 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.35 . . . . 52.219999999999999 110.918 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.6 p -146.49 179.84 7.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 75.319999999999993 111.133 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.51 -65.19 1.03 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 40.030000000000001 110.872 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.53 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -78.96 -175.7 4.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 75.109999999999999 110.881 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -115.07 107.06 14.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 71.349999999999994 110.874 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.41 HG23 HG23 ' A' ' 10' ' ' ILE . 4.0 mp -84.85 111.36 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 71.400000000000006 111.162 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.49 165.48 17.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 72.140000000000001 111.161 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.3 mt -104.44 127.78 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 74.340000000000003 111.111 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.58 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -88.77 -50.38 6.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 41.43 111.085 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -148.73 150.86 33.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 63.149999999999999 110.907 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -156.87 149.54 23.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 73.530000000000001 110.835 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 164.49 170.5 29.51 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.809 -0.71 . . . . 53.119999999999997 112.535 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.28 127.53 27.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.808 0.337 . . . . 73.099999999999994 110.921 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.55 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.0 mm? -78.31 -47.7 17.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 72.219999999999999 110.974 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 53.109999999999999 110.929 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.6 t . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.809 0.338 . . . . 44.299999999999997 111.172 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -111.81 146.8 35.49 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.613 0.721 . . . . 74.319999999999993 110.899 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 146.1 58.67 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.64 2.227 . . . . 64.230000000000004 112.37 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -133.94 140.76 46.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 65.310000000000002 111.135 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.495 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.7 m -134.97 142.24 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 74.530000000000001 111.142 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 11.7 p90 -102.7 170.88 7.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 74.510000000000005 110.917 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.409 ' HA ' ' HB3' ' A' ' 161' ' ' CYS . 6.9 m-85 -151.18 88.51 1.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 74.140000000000001 110.888 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.644 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 3.0 t70 -50.08 105.6 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 72.319999999999993 110.869 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.683 HG22 HD12 ' A' ' 17' ' ' LEU . 35.9 mm -84.97 122.12 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 62.100000000000001 111.123 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -113.76 150.99 32.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 72.120000000000005 111.097 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.433 HG13 ' HB3' ' A' ' 154' ' ' LYS . 21.1 t -132.39 95.9 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 74.129999999999995 111.119 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.66 33.97 8.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 63.049999999999997 110.896 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.47 -19.13 55.91 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.719 -0.753 . . . . 71.349999999999994 112.516 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -97.01 113.23 62.66 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.629 0.728 . . . . 72.120000000000005 110.896 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.72 126.5 13.41 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.72 2.28 . . . . 71.340000000000003 112.322 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.683 HD12 HG22 ' A' ' 10' ' ' ILE . 13.6 mt -69.18 -40.02 78.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.439 . . . . 44.219999999999999 110.899 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.7 -125.51 1.61 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.785 -0.721 . . . . 55.100000000000001 112.542 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -123.36 135.91 54.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 72.420000000000002 110.874 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.509 HG21 HG13 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -146.64 103.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 72.209999999999994 111.093 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.5 t -113.47 174.59 5.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 53.200000000000003 110.881 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.439 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -145.3 126.14 14.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 75.540000000000006 110.906 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -80.59 100.0 8.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 73.549999999999997 110.862 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.463 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 1.4 mt -83.14 120.4 25.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 73.510000000000005 110.916 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -75.94 68.29 2.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 72.310000000000002 110.899 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.2 -22.73 42.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 50.340000000000003 111.088 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -67.24 -36.72 82.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 75.120000000000005 110.885 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -97.19 -27.28 14.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 72.239999999999995 110.86 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.426 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -138.92 67.24 41.43 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.6 0.714 . . . . 73.310000000000002 111.146 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -36.05 11.39 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.673 2.249 . . . . 64.310000000000002 112.314 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.57 -37.75 82.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 75.239999999999995 110.86 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.41 HG21 ' CD1' ' A' ' 129' ' ' PHE . 58.0 m -88.85 -44.05 10.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 34.409999999999997 111.169 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.77 -46.69 89.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 70.239999999999995 111.108 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -51.03 -29.47 12.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 72.420000000000002 110.896 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.14 -64.64 0.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 75.5 110.891 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -59.05 -30.97 68.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 63.450000000000003 110.923 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.482 ' O ' HG23 ' A' ' 41' ' ' THR . 0.8 OUTLIER -72.54 -51.63 19.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 71.430000000000007 110.897 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.63 -33.31 68.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 73.140000000000001 111.112 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.522 HD23 ' HG2' ' A' ' 44' ' ' LYS . 31.0 mt -76.38 -51.86 11.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 75.450000000000003 110.921 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.1 m -61.66 -37.05 82.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 72.519999999999996 110.863 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 37' ' ' ARG . 26.9 p -65.81 -34.64 78.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 72.310000000000002 111.125 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.28 -15.8 53.84 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.693 -0.765 . . . . 43.240000000000002 112.489 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.89 -27.36 29.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.905 0.383 . . . . 72.010000000000005 110.899 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.522 ' HG2' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -72.91 -29.29 63.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 64.239999999999995 110.862 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.31 -15.37 60.28 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.706 -0.759 . . . . 51.299999999999997 112.451 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -157.63 -165.41 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 64.219999999999999 110.857 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.05 -136.05 5.4 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 71.299999999999997 112.507 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.49 30.61 6.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.932 0.396 . . . . 73.140000000000001 110.924 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -87.37 96.44 10.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 70.239999999999995 110.945 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 134.47 -38.89 1.77 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.762 -0.733 . . . . 71.519999999999996 112.44 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.13 -169.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 63.240000000000002 110.848 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.9 p -141.73 175.5 9.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 63.229999999999997 110.87 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.444 ' CZ ' HD11 ' A' ' 158' ' ' ILE . 9.4 m-85 -107.55 142.72 37.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 75.319999999999993 110.897 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -143.46 45.89 1.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 74.140000000000001 110.827 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -161.98 60.83 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 75.310000000000002 110.889 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 19.0 mt -104.21 108.86 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 73.030000000000001 111.127 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.6 mt -102.0 101.7 20.08 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.635 0.731 . . . . 72.129999999999995 111.126 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 89.85 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.245 . . . . 75.310000000000002 112.377 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.83 -17.6 1.99 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 42.329999999999998 112.497 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.58 -53.11 1.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 74.099999999999994 110.834 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.413 ' HB3' ' HA ' ' A' ' 115' ' ' CYS . 0.0 OUTLIER 172.89 166.04 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.120000000000005 110.843 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 4.8 m -101.33 -173.35 2.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 70.140000000000001 110.897 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 174.1 150.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 72.349999999999994 110.941 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.713 -0.756 . . . . 72.019999999999996 112.506 179.993 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.501 HG13 ' CD2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.804 0.335 . . . . 64.109999999999999 111.121 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.501 ' CD2' HG13 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -164.59 37.82 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 74.230000000000004 110.922 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.15 149.79 6.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.712 -0.756 . . . . 63.219999999999999 112.481 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -44.47 -33.53 1.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 63.109999999999999 110.876 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.465 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.73 166.08 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 63.439999999999998 110.874 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -132.13 177.17 7.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 75.450000000000003 110.873 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.08 157.15 28.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 73.420000000000002 110.876 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -49.94 153.75 1.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 74.219999999999999 110.852 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -104.41 -76.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.457 . . . . 73.319999999999993 110.903 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.467 ' O ' HG22 ' A' ' 127' ' ' VAL . 47.4 p30 -159.32 177.45 10.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 61.439999999999998 110.917 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.29 35.59 3.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 63.299999999999997 110.895 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.65 -31.86 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 75.400000000000006 111.097 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 mt -102.79 101.79 11.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 72.030000000000001 110.884 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.671 ' O ' HG23 ' A' ' 93' ' ' THR . 1.6 mtpt -90.93 138.79 31.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 74.5 110.899 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -47.35 105.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 73.510000000000005 110.876 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.671 HG23 ' O ' ' A' ' 91' ' ' LYS . 43.8 p -114.95 30.04 7.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 65.439999999999998 111.134 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 144.68 176.45 18.7 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 53.32 112.507 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 178.01 5.0 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.663 2.242 . . . . 55.109999999999999 112.347 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.82 21.81 63.65 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 71.530000000000001 112.514 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.0 mm -91.75 140.37 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 74.019999999999996 111.125 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -109.64 149.1 30.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 72.120000000000005 110.926 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.68 -164.55 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 72.239999999999995 110.892 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.495 ' HE2' ' HB ' ' A' ' 127' ' ' VAL . 2.0 mtm -98.71 96.6 8.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 74.400000000000006 110.892 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -72.45 62.09 0.51 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 51.530000000000001 111.105 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -125.15 -158.3 0.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 73.340000000000003 110.875 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.662 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -76.39 53.25 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 62.109999999999999 111.079 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.19 -106.07 0.14 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.713 -0.756 . . . . 62.229999999999997 112.509 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 116.65 4.66 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.707 2.271 . . . . 73.25 112.361 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.489 ' C ' HG23 ' A' ' 107' ' ' THR . 1.1 m-20 66.52 174.13 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 70.120000000000005 110.901 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.662 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.3 p 67.69 32.98 5.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 73.420000000000002 111.15 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.96 146.22 31.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 62.43 110.93 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -148.35 53.79 0.52 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 54.520000000000003 112.46 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.0 t 68.83 33.79 3.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 74.230000000000004 110.869 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -59.89 -168.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 74.299999999999997 110.933 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.436 ' HE2' HD12 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -175.72 155.42 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 73.329999999999998 110.912 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -168.53 68.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 71.340000000000003 110.879 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 113' ' ' PHE . 6.9 mt -33.73 107.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 65.219999999999999 111.164 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.413 ' HA ' ' HB3' ' A' ' 61' ' ' MET . 33.6 m -84.6 139.23 32.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 63.5 110.899 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.1 p -105.01 27.12 8.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.172 -0.467 . . . . 72.219999999999999 111.17 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.665 ' O ' HG23 ' A' ' 119' ' ' THR . . . 178.65 142.94 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 71.049999999999997 111.094 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -52.36 98.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 55.229999999999997 110.888 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.709 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 33.9 p -96.13 44.78 1.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 72.420000000000002 111.197 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -26.54 65.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 70.329999999999998 110.925 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.709 ' CZ2' HG22 ' A' ' 119' ' ' THR . 7.3 p90 -49.68 -27.42 4.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.129 -0.487 . . . . 64.519999999999996 110.943 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 23.6 mt -47.02 -34.71 5.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 61.119999999999997 110.9 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 61.4 77.95 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 71.409999999999997 110.846 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 39.11 44.42 2.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.724 . . . . 52.399999999999999 112.436 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -81.69 -25.56 35.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 72.120000000000005 110.903 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -136.34 -169.35 2.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.848 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.495 ' HB ' ' HE2' ' A' ' 100' ' ' MET . 79.4 t -123.79 112.25 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 111.158 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.5 t -79.95 131.04 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 71.209999999999994 111.138 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.459 ' O ' HD23 ' A' ' 24' ' ' LEU . 30.5 p90 -150.26 37.39 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 75.25 110.909 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -175.13 173.57 46.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.707 -0.759 . . . . 70.340000000000003 112.46 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 132' ' ' VAL . 6.6 pttp -175.9 134.3 0.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 73.099999999999994 110.915 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.761 HG11 ' HG2' ' A' ' 136' ' ' MET . 54.0 t -37.02 105.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 111.127 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -59.31 3.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 63.299999999999997 110.921 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -154.84 158.65 39.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 110.893 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.29 36.3 15.06 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.731 -0.747 . . . . 73.230000000000004 112.5 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.761 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -55.33 -25.23 33.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 74.030000000000001 110.87 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.16 -34.19 65.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 75.409999999999997 110.866 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.547 HD12 ' HB3' ' A' ' 17' ' ' LEU . 37.9 mm -66.31 -40.02 85.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 64.409999999999997 111.139 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.2 t -63.67 -27.59 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 74.450000000000003 111.145 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.57 -30.1 52.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 51.140000000000001 110.926 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.01 -45.94 59.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 73.109999999999999 111.135 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.3 mtm -57.75 -42.02 83.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 62.530000000000001 110.875 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -53.77 -27.53 29.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 73.230000000000004 110.918 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -28.9 52.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 73.310000000000002 110.917 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -100.2 29.38 4.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 72.230000000000004 110.921 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.18 155.66 16.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.752 -0.737 . . . . 61.130000000000003 112.477 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.7 t -110.65 149.81 29.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 35.43 110.872 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -76.05 59.83 1.35 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 72.230000000000004 110.873 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -176.72 -34.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 74.310000000000002 110.889 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.83 -43.23 0.76 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 50.409999999999997 112.485 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.75 165.04 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 72.209999999999994 110.89 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 27.7 p -147.82 149.21 31.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 75.109999999999999 111.129 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.9 m -69.82 -46.08 66.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 63.439999999999998 110.828 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.433 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -104.12 -176.22 3.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.082 -0.508 . . . . 74.030000000000001 110.904 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -115.09 107.95 16.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 73.409999999999997 110.928 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.98 122.12 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 70.230000000000004 111.114 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.89 168.43 18.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 30.52 111.159 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.444 HD11 ' CZ ' ' A' ' 53' ' ' PHE . 41.0 mm -105.43 114.22 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 42.210000000000001 111.084 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -73.58 -47.8 37.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 35.329999999999998 111.122 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -157.44 160.23 38.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.230000000000004 110.849 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -164.05 146.09 9.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 62.210000000000001 110.875 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.95 173.18 44.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 73.310000000000002 112.493 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -63.7 139.55 58.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 65.120000000000005 110.902 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.553 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -92.18 -56.84 2.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 74.209999999999994 110.901 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 72.349999999999994 110.901 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.826 0.346 . . . . 75.329999999999998 111.156 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -51.65 152.66 4.7 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 73.019999999999996 110.905 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 146.03 58.89 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.732 2.288 . . . . 51.210000000000001 112.327 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -135.22 141.69 45.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 73.030000000000001 111.159 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.481 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.5 m -134.48 143.8 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 73.329999999999998 111.101 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 19.0 p90 -102.03 160.77 14.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 65.209999999999994 110.856 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -140.42 95.51 2.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 71.439999999999998 110.936 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.6 t70 -58.77 113.84 2.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 65.25 110.847 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.874 HG23 HG23 ' A' ' 156' ' ' ILE . 14.8 mm -86.05 124.45 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 73.540000000000006 111.112 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -117.25 123.28 46.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 72.219999999999999 111.085 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.661 HG23 HD13 ' A' ' 17' ' ' LEU . 11.5 t -106.6 94.51 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 62.32 111.162 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 62.18 44.56 7.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 72.519999999999996 110.857 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.6 -1.58 88.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 73.120000000000005 112.523 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 8.5 mm-40 -110.05 98.68 35.9 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.627 0.727 . . . . 71.299999999999997 110.896 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.4 Cg_endo -69.81 103.98 1.26 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.737 2.292 . . . . 43.340000000000003 112.31 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.661 HD13 HG23 ' A' ' 12' ' ' VAL . 7.7 mp -65.74 -34.95 79.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 64.140000000000001 110.856 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.76 -143.09 7.94 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 63.130000000000003 112.484 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.08 154.06 47.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 71.209999999999994 110.838 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.441 HG21 HG13 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -144.91 97.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 62.25 111.094 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -91.2 172.46 8.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 74.340000000000003 110.832 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.404 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -145.6 123.48 11.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 74.150000000000006 110.89 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.418 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 23.4 tt0 -73.7 97.48 2.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 62.210000000000001 110.857 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.7 mt -85.09 118.17 24.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 60.439999999999998 110.882 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.423 ' CD1' HD13 ' A' ' 90' ' ' LEU . 52.5 m-85 -79.38 68.98 5.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 73.209999999999994 110.887 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.62 -22.22 21.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 72.010000000000005 111.122 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -69.59 -28.35 65.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 32.240000000000002 110.871 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.91 -29.57 11.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 110.927 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.416 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -139.18 66.42 38.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.62 0.724 . . . . 73.349999999999994 111.122 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -35.21 13.17 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.698 2.265 . . . . 73.010000000000005 112.332 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.86 -36.41 72.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 71.200000000000003 110.895 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.402 HG22 ' CE2' ' A' ' 129' ' ' PHE . 63.5 m -94.22 -43.02 8.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 75.209999999999994 111.139 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.33 91.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.415 . . . . 73.25 111.085 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -50.42 -35.53 28.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 74.140000000000001 110.873 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -64.54 -64.19 0.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 110.926 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -56.35 -34.15 66.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 75.439999999999998 110.913 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.517 ' O ' HG23 ' A' ' 41' ' ' THR . 0.3 OUTLIER -69.87 -53.26 18.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 72.439999999999998 110.904 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 44' ' ' LYS . . . -56.74 -35.42 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 55.219999999999999 111.125 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.7 mt -72.09 -58.68 3.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 73.150000000000006 110.941 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.9 m -51.4 -41.01 60.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 72.400000000000006 110.877 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 37' ' ' ARG . 63.9 p -72.23 -28.31 63.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 74.120000000000005 111.138 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.64 12.75 71.56 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 72.230000000000004 112.465 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.39 -18.42 49.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 73.409999999999997 110.861 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.572 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -90.98 29.78 1.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 75.329999999999998 110.867 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.04 -22.92 16.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.759 -0.734 . . . . 75.319999999999993 112.491 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -179.02 -169.53 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 35.420000000000002 110.914 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.4 -135.84 2.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.801 -0.714 . . . . 72.439999999999998 112.547 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.83 57.49 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.937 0.399 . . . . 74.409999999999997 110.951 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -87.17 48.8 1.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 64.400000000000006 110.876 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 174.48 54.7 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 63.340000000000003 112.492 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.83 131.14 46.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.869 0.366 . . . . 74.409999999999997 110.82 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.8 p -96.69 121.26 38.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 61.340000000000003 110.912 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -80.99 117.21 21.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 73.340000000000003 110.87 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -114.03 29.75 7.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 74.109999999999999 110.874 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.54 91.6 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 54.240000000000002 110.849 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.471 ' O ' HG22 ' A' ' 56' ' ' ILE . 3.1 mt -128.68 116.29 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 63.439999999999998 111.166 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.2 mt -107.89 104.47 53.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.567 0.699 . . . . 74.450000000000003 111.169 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 79.47 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.7 2.267 . . . . 70.209999999999994 112.332 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.7 -24.42 0.56 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.707 -0.759 . . . . 54.450000000000003 112.515 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.64 -58.98 1.97 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.86 0.362 . . . . 55.25 110.848 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.33 157.28 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 61.299999999999997 110.906 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.418 ' HB3' HG12 ' A' ' 56' ' ' ILE . 34.7 m -90.7 -167.31 1.79 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 63.420000000000002 110.865 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 174.69 142.09 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 62.350000000000001 110.937 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 74.209999999999994 112.469 -179.928 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.559 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.7 pp . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.866 0.365 . . . . 53.130000000000003 111.119 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.85 -65.44 1.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 72.209999999999994 110.952 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.82 -33.17 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 43.030000000000001 112.486 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -141.11 -54.92 0.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.93 0.395 . . . . 71.239999999999995 110.908 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.19 -177.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 71.340000000000003 110.895 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.89 -167.67 1.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.439999999999998 110.872 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -133.37 162.76 30.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 71.319999999999993 110.871 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -47.76 104.34 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 74.239999999999995 110.854 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -80.79 -67.38 0.78 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 75.340000000000003 110.882 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -177.68 173.45 1.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 110.92 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.19 35.54 4.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 74.109999999999999 110.885 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -49.94 -28.91 4.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 74.439999999999998 111.153 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.423 HD13 ' CD1' ' A' ' 25' ' ' PHE . 16.0 mt -117.38 68.69 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 74.239999999999995 110.854 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -62.28 166.53 4.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 73.450000000000003 110.863 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -68.72 83.67 0.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 64.510000000000005 110.832 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.4 p -99.86 24.54 8.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 72.510000000000005 111.12 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 155.65 177.47 28.91 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.782 -0.723 . . . . 70.120000000000005 112.496 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 170.13 17.29 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.704 2.269 . . . . 45.210000000000001 112.354 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.12 40.04 96.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 61.530000000000001 112.474 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.3 mm -108.9 136.06 45.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.832 0.348 . . . . 74.510000000000005 111.144 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.505 HD21 ' CD1' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -103.62 157.39 17.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.446 . . . . 72.25 110.899 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 3.6 t -162.19 -139.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 41.049999999999997 110.883 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 13.7 mmt -152.91 147.42 25.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 72.430000000000007 110.853 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -123.19 151.34 42.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 75.310000000000002 111.074 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 167.71 -50.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 74.450000000000003 110.915 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -174.63 29.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 73.019999999999996 111.136 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.55 -116.66 4.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 31.440000000000001 112.472 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 125.09 11.76 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.661 2.241 . . . . 65.400000000000006 112.355 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.488 ' C ' HG23 ' A' ' 107' ' ' THR . 1.3 m-20 70.54 165.76 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 73.030000000000001 110.888 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.488 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.3 p 67.13 29.22 7.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 73.040000000000006 111.175 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -65.24 90.38 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 74.239999999999995 110.898 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -66.52 -131.78 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.743 -0.742 . . . . 72.420000000000002 112.477 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.0 p -133.23 24.2 4.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.833 0.349 . . . . 51.310000000000002 110.861 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.532 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 2.1 pt20 -106.56 55.76 0.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 75.129999999999995 110.939 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.505 ' CD1' HD21 ' A' ' 98' ' ' LEU . 4.6 p90 -58.65 -168.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 60.450000000000003 110.843 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -152.73 160.63 43.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.827 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 114' ' ' ILE . 2.4 mp -105.1 91.17 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 73.439999999999998 111.13 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.5 m -64.28 90.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 75.430000000000007 110.896 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.6 p -63.93 -12.89 41.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 65.120000000000005 111.141 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.688 ' O ' HG23 ' A' ' 119' ' ' THR . . . -143.22 156.7 44.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 62.219999999999999 111.096 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -56.41 95.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 61.509999999999998 110.892 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 117' ' ' ALA . 23.1 p -97.83 50.11 1.03 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 45.420000000000002 111.136 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -24.37 66.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 74.25 110.89 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.687 ' CZ2' HG22 ' A' ' 119' ' ' THR . 5.9 p90 -48.29 -30.49 4.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 74.099999999999994 110.933 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.5 mt -47.44 -34.65 7.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 65.120000000000005 110.922 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 124' ' ' GLY . 3.6 m-20 59.03 81.18 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 74.540000000000006 110.848 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.61 43.63 0.8 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.709 -0.758 . . . . 74.140000000000001 112.47 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -81.66 -16.64 50.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 74.549999999999997 110.871 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -144.75 -168.55 2.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 55.509999999999998 110.802 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.7 t -120.75 120.97 64.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 64.109999999999999 111.125 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 98' ' ' LEU . 20.4 t -93.26 136.15 25.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 74.349999999999994 111.112 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.481 ' O ' HD23 ' A' ' 24' ' ' LEU . 13.3 p90 -156.2 37.54 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 72.099999999999994 110.854 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -177.51 174.49 46.97 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 50.240000000000002 112.528 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 132' ' ' VAL . 5.1 pttp -172.94 132.96 0.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.347 . . . . 73.010000000000005 110.9 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.749 HG11 ' HG2' ' A' ' 136' ' ' MET . 38.2 t -36.44 107.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 45.520000000000003 111.149 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.418 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -72.27 -58.92 3.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 70.150000000000006 110.903 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -155.86 154.89 31.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 72.140000000000001 110.876 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.07 28.79 11.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 45.329999999999998 112.512 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.749 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -57.33 -24.04 52.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 63.420000000000002 110.881 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.06 -36.94 73.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 75.010000000000005 110.932 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.466 HD12 ' HB3' ' A' ' 17' ' ' LEU . 27.4 mm -67.6 -39.57 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 63.530000000000001 111.093 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.407 HG11 HG21 ' A' ' 114' ' ' ILE . 75.9 t -63.01 -29.49 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 65.129999999999995 111.083 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -74.71 -30.55 61.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 71.299999999999997 110.897 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.74 -37.98 70.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 73.219999999999999 111.09 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.576 ' SD ' HG21 ' A' ' 156' ' ' ILE . 17.5 mtm -58.71 -53.44 58.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 71.510000000000005 110.85 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.85 -26.06 32.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 73.519999999999996 110.868 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.445 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.81 -23.74 63.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 63.109999999999999 110.9 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.445 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 59.8 m-85 -109.16 17.32 21.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 72.329999999999998 110.87 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -107.7 170.33 15.31 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.796 -0.716 . . . . 72.319999999999993 112.489 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 t -134.55 142.69 47.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.899 0.381 . . . . 55.420000000000002 110.837 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -69.03 82.73 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 74.409999999999997 110.846 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -179.33 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 110.885 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.75 -84.67 0.16 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 61.450000000000003 112.506 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.68 175.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 75.409999999999997 110.877 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.6 p -143.49 168.99 18.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 72.450000000000003 111.184 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.65 -48.08 35.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 70.329999999999998 110.842 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.405 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -92.29 -179.66 5.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 71.219999999999999 110.886 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -124.51 108.32 11.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.841 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.874 HG23 HG23 ' A' ' 10' ' ' ILE . 4.8 mp -94.53 109.41 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 71.340000000000003 111.123 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.14 161.89 22.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 63.229999999999997 111.159 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.0 mm -92.85 120.07 41.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 63.539999999999999 111.134 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -86.15 -56.99 3.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 61.439999999999998 111.088 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -137.71 157.37 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 74.099999999999994 110.894 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -165.91 146.98 6.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 75.0 110.9 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.11 172.42 44.54 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 64.099999999999994 112.472 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -66.2 137.37 56.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.899 0.38 . . . . 62.509999999999998 110.871 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.564 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.3 mm? -88.76 -58.68 2.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 73.219999999999999 110.908 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 62.200000000000003 110.906 179.918 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.89 0.376 . . . . 54.329999999999998 111.125 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -87.14 144.84 36.85 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.669 0.747 . . . . 62.299999999999997 110.879 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 145.01 55.52 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.662 2.241 . . . . 70.340000000000003 112.347 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.4 m -130.95 129.75 42.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 55.119999999999997 111.14 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.07 170.56 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 73.319999999999993 111.141 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.599 ' HB3' HD21 ' A' ' 164' ' ' LEU . 1.5 p90 -153.92 179.5 8.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 75.219999999999999 110.949 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.423 ' HA ' ' HB3' ' A' ' 161' ' ' CYS . 97.9 m-85 -155.79 97.37 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 70.409999999999997 110.888 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.64 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 5.9 t0 -47.73 106.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 65.25 110.875 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.87 HG23 HG23 ' A' ' 156' ' ' ILE . 43.3 mm -79.03 124.27 37.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 62.420000000000002 111.138 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -116.65 134.87 54.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.340000000000003 111.085 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.504 HG13 ' HB3' ' A' ' 154' ' ' LYS . 5.0 t -116.49 96.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 63.009999999999998 111.11 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.57 35.52 22.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 61.240000000000002 110.85 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.36 -15.78 60.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 71.0 112.517 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.6 tt0 -103.32 108.09 57.9 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.663 0.744 . . . . 54.210000000000001 110.865 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.75 126.49 13.38 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.698 2.265 . . . . 72.209999999999994 112.39 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.1 -38.25 82.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 72.450000000000003 110.902 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.96 -138.64 5.89 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.77 -0.729 . . . . 73.439999999999998 112.53 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.94 140.36 48.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.811 0.339 . . . . 64.239999999999995 110.894 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.474 ' CG2' HG21 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -143.87 97.8 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 72.420000000000002 111.117 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 2.4 t -103.69 174.33 5.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 72.319999999999993 110.848 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.427 ' N ' ' OG ' ' A' ' 21' ' ' SER . 26.6 m-85 -148.12 132.1 17.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 74.019999999999996 110.891 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -88.08 98.79 11.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 71.340000000000003 110.889 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.5 mt -80.8 133.43 35.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 74.109999999999999 110.896 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -91.25 65.42 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 71.409999999999997 110.888 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.26 -23.58 23.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 32.439999999999998 111.119 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.77 -40.89 96.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 75.010000000000005 110.851 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -95.07 -26.8 15.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 70.519999999999996 110.906 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.442 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -137.78 67.44 50.28 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.615 0.721 . . . . 63.439999999999998 111.16 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -38.51 7.63 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.655 2.237 . . . . 44.399999999999999 112.326 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -38.99 90.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 61.210000000000001 110.925 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.7 m -84.76 -42.23 15.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 63.030000000000001 111.131 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.99 -48.46 78.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 62.299999999999997 111.076 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -53.88 -33.13 55.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 64.030000000000001 110.898 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.681 ' O ' HD12 ' A' ' 39' ' ' LEU . 1.3 t30 -60.92 -61.71 2.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 73.140000000000001 110.888 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -63.96 -41.3 97.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 70.230000000000004 110.898 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.481 ' O ' HG23 ' A' ' 41' ' ' THR . 1.1 ttp180 -63.48 -31.14 72.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 75.430000000000007 110.858 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.91 67.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 71.109999999999999 111.127 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.681 HD12 ' O ' ' A' ' 35' ' ' ASN . 1.2 mp -67.6 -36.76 81.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 62.25 110.937 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.2 m -69.02 -51.19 41.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 61.420000000000002 110.881 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 37' ' ' ARG . 73.5 p -64.88 -32.95 74.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 71.299999999999997 111.173 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.02 -13.48 55.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 71.049999999999997 112.462 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.77 -33.45 23.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.951 0.405 . . . . 72.430000000000007 110.913 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -53.45 -27.87 27.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 72.230000000000004 110.929 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.46 -5.71 80.48 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.737 -0.744 . . . . 72.439999999999998 112.484 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -168.65 -167.58 0.79 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 73.519999999999996 110.935 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.26 -137.86 6.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.705 -0.759 . . . . 24.34 112.449 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -151.54 47.15 0.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.001 0.429 . . . . 74.299999999999997 110.925 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 139.47 58.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 74.049999999999997 110.882 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.03 -22.01 39.69 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.763 -0.732 . . . . 61.140000000000001 112.482 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.45 173.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 71.540000000000006 110.854 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.509 ' HB3' HG23 ' A' ' 157' ' ' THR . 17.6 p -122.1 179.68 4.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 74.409999999999997 110.862 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -104.47 136.09 44.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 71.530000000000001 110.841 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.21 37.16 3.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 70.099999999999994 110.856 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -166.95 77.21 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 75.329999999999998 110.881 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.446 HG23 ' OE1' ' A' ' 143' ' ' GLU . 11.9 mt -120.52 111.29 31.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 44.450000000000003 111.139 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.4 mt -108.21 103.5 50.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.646 0.736 . . . . 62.030000000000001 111.135 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 54.2 Cg_endo -69.75 76.25 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 54.219999999999999 112.361 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.99 -26.77 0.25 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.722 -0.751 . . . . 73.030000000000001 112.495 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.69 -55.33 2.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.86 0.362 . . . . 74.239999999999995 110.88 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.442 ' HE3' ' O ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER 171.98 175.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 71.120000000000005 110.871 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.442 ' O ' ' HE3' ' A' ' 61' ' ' MET . 5.3 m -111.83 -168.11 1.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 72.230000000000004 110.887 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -173.15 141.98 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 110.941 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.791 -0.719 . . . . 74.530000000000001 112.45 -179.955 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.42 HG22 ' HD2' ' A' ' 44' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.878 0.371 . . . . 71.329999999999998 111.156 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -79.89 -37.48 34.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 75.150000000000006 110.912 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.95 -151.08 13.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.8 -0.714 . . . . 71.549999999999997 112.499 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -51.03 -40.14 57.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.948 0.404 . . . . 73.510000000000005 110.882 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.436 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.5 167.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 72.140000000000001 110.885 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.35 167.17 19.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 73.230000000000004 110.898 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.17 150.8 48.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 74.329999999999998 110.865 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -52.47 161.03 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 75.010000000000005 110.881 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -110.99 -70.77 0.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.858 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -170.55 173.54 5.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 63.420000000000002 110.908 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.46 37.34 3.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 74.540000000000006 110.831 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.99 -30.28 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 73.109999999999999 111.187 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.1 mt -108.79 80.01 1.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 54.140000000000001 110.888 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.65 154.06 34.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 75.239999999999995 110.901 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -64.13 88.42 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 75.409999999999997 110.831 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.1 p -78.57 -54.29 6.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 74.230000000000004 111.134 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.05 -165.94 11.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 72.430000000000007 112.468 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 177.91 5.08 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.633 2.222 . . . . 75.010000000000005 112.351 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.24 31.13 78.03 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.742 -0.742 . . . . 73.329999999999998 112.482 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.2 mm -107.01 140.98 23.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 60.229999999999997 111.094 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.815 HD11 ' CE2' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -108.26 144.9 35.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 73.420000000000002 110.895 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.25 146.61 22.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 75.230000000000004 110.903 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -69.74 82.83 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 55.229999999999997 110.838 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.858 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -57.44 142.86 42.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 72.120000000000005 111.069 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 170.59 -167.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 71.299999999999997 110.866 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.682 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -50.46 -51.46 46.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 53.240000000000002 111.102 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.14 -69.91 0.37 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 42.119999999999997 112.52 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.477 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 54.0 Cg_endo -69.76 99.26 0.73 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.725 2.283 . . . . 45.340000000000003 112.327 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.529 ' O ' HG23 ' A' ' 107' ' ' THR . 0.4 OUTLIER 37.87 55.35 1.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 74.230000000000004 110.874 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.682 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.2 p -159.97 53.33 0.35 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 64.510000000000005 111.168 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.28 152.47 31.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 32.229999999999997 110.891 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.59 5.37 2.87 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 75.209999999999994 112.498 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 74.2 51.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.793 0.33 . . . . 72.239999999999995 110.881 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.697 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 0.6 OUTLIER -70.21 -31.64 69.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 71.239999999999995 110.935 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.815 ' CE2' HD11 ' A' ' 98' ' ' LEU . 30.6 t80 99.66 145.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 62.340000000000003 110.878 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.858 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -169.86 114.62 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 72.019999999999996 110.91 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.3 mt -80.94 129.07 38.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 63.210000000000001 111.119 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -91.34 92.77 8.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.447 . . . . 64.129999999999995 110.856 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 45.2 p -79.23 14.16 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 74.219999999999999 111.18 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.809 ' O ' HG23 ' A' ' 119' ' ' THR . . . 178.65 143.77 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.466 . . . . 74.120000000000005 111.052 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -50.56 98.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 61.539999999999999 110.937 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 117' ' ' ALA . 35.0 p -104.16 48.93 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 43.439999999999998 111.092 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -24.86 67.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 71.0 110.868 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.8 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.2 p90 -50.03 -26.96 4.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 74.519999999999996 110.901 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.6 mt -45.63 -35.52 4.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 73.299999999999997 110.94 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.7 m-20 61.6 80.2 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 110.819 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 35.98 43.17 0.62 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.741 -0.742 . . . . 51.210000000000001 112.497 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.46 -19.28 33.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.753 0.311 . . . . 74.540000000000006 110.908 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -142.86 -165.15 1.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 73.430000000000007 110.865 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.7 t -131.29 125.64 57.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 74.150000000000006 111.123 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.51 133.2 33.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 73.109999999999999 111.162 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.48 ' O ' HD23 ' A' ' 24' ' ' LEU . 23.0 p90 -155.3 36.53 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 74.049999999999997 110.925 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -171.72 173.9 45.08 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.705 -0.76 . . . . 64.25 112.446 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -175.88 133.54 0.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 74.120000000000005 110.913 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.698 HG11 ' HG2' ' A' ' 136' ' ' MET . 76.8 t -39.73 107.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 54.409999999999997 111.144 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -58.08 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 72.310000000000002 110.922 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -154.75 163.05 40.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 71.540000000000006 110.873 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.5 32.67 46.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.69 -0.766 . . . . 54.539999999999999 112.471 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.698 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -50.89 -34.05 26.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.744 0.307 . . . . 75.209999999999994 110.827 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.6 -32.24 12.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 74.409999999999997 110.847 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.474 HG21 ' CG2' ' A' ' 20' ' ' VAL . 41.8 mm -66.31 -43.35 91.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 72.340000000000003 111.135 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.75 -26.33 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 41.119999999999997 111.113 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.32 -29.73 38.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 73.25 110.864 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.31 -37.61 66.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 60.200000000000003 111.08 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 24.4 mtm -57.3 -54.25 48.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 61.399999999999999 110.912 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.446 ' OE1' HG23 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -55.32 -25.5 34.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 60.43 110.873 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.424 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.91 -23.74 63.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 75.349999999999994 110.846 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.424 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 57.1 m-85 -108.79 17.13 22.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 75.549999999999997 110.88 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.34 168.37 12.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 62.409999999999997 112.5 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.6 m -113.76 148.22 36.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 75.239999999999995 110.892 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 -75.24 67.46 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.898 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -175.11 -35.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 71.450000000000003 110.872 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.78 -45.34 0.62 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.728 -0.749 . . . . 60.119999999999997 112.442 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.71 171.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 74.200000000000003 110.933 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.4 p -145.04 139.58 27.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 74.319999999999993 111.134 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.39 -39.89 77.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 73.150000000000006 110.826 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.504 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -107.39 -174.93 2.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 74.439999999999998 110.885 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.57 107.59 13.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 110.941 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.87 HG23 HG23 ' A' ' 10' ' ' ILE . 3.9 mp -89.68 102.34 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 75.439999999999998 111.131 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.509 HG23 ' HB3' ' A' ' 52' ' ' CYS . 0.0 OUTLIER -109.93 163.86 13.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 65.439999999999998 111.165 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.2 mt -102.94 116.47 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 72.109999999999999 111.131 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -81.72 -52.34 7.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 63.539999999999999 111.159 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -148.17 153.75 39.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 62.009999999999998 110.865 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -160.84 149.74 16.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 110.889 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.84 166.38 27.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.798 -0.715 . . . . 31.539999999999999 112.505 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -59.4 109.24 0.84 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 74.219999999999999 110.876 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.599 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.6 mm? -53.2 -48.19 68.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 73.239999999999995 110.934 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 75.319999999999993 110.913 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.83 0.348 . . . . 71.239999999999995 111.143 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -118.04 146.92 40.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.595 0.712 . . . . 75.239999999999995 110.889 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 149.34 66.58 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.676 2.25 . . . . 72.420000000000002 112.355 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -136.02 137.7 41.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 55.119999999999997 111.181 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.568 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.9 m -131.61 145.64 34.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 55.439999999999998 111.113 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.837 ' HB3' HD21 ' A' ' 164' ' ' LEU . 8.2 p90 -101.93 168.04 9.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 110.923 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -147.81 88.9 1.71 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 73.129999999999995 110.893 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.709 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -51.86 105.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 72.150000000000006 110.882 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.575 HG13 HG21 ' A' ' 20' ' ' VAL . 38.2 mm -83.97 126.95 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 75.120000000000005 111.105 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -121.04 149.54 42.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 35.229999999999997 111.077 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 t -130.04 94.94 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 62.350000000000001 111.123 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.02 32.66 10.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 71.109999999999999 110.893 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.18 -21.59 42.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 62.020000000000003 112.489 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -94.18 113.07 59.82 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.644 0.735 . . . . 74.319999999999993 110.882 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.7 Cg_endo -69.81 123.32 9.97 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.649 2.233 . . . . 53.109999999999999 112.357 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.56 ' HB3' HD12 ' A' ' 138' ' ' ILE . 12.0 mt -68.71 -37.83 79.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 63.030000000000001 110.916 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.13 -125.98 1.67 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.75 -0.738 . . . . 43.0 112.497 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.51 138.48 52.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 61.310000000000002 110.895 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.575 HG21 HG13 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -145.71 101.16 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 74.310000000000002 111.15 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -108.23 172.77 6.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 45.229999999999997 110.829 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.403 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -143.54 133.03 23.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 74.409999999999997 110.871 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -85.4 97.38 9.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 74.219999999999999 110.926 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 129' ' ' PHE . 3.2 mt -81.78 117.61 22.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 52.450000000000003 110.889 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -78.7 64.96 3.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 73.439999999999998 110.827 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.79 -24.05 14.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 20.030000000000001 111.111 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -67.96 -35.14 77.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 64.310000000000002 110.849 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -95.78 -29.2 14.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 70.099999999999994 110.908 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.404 HG21 ' HA ' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -136.58 65.82 55.77 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.641 0.734 . . . . 73.400000000000006 111.129 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -29.32 23.96 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.618 2.212 . . . . 44.25 112.355 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -41.23 96.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 74.400000000000006 110.932 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.8 m -88.55 -45.31 10.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 72.340000000000003 111.143 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.98 -46.07 82.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 73.140000000000001 111.101 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -47.01 -33.66 4.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 72.439999999999998 110.911 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.487 ' HA ' HD13 ' A' ' 78' ' ' ILE . 2.6 t30 -64.57 -65.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 54.109999999999999 110.854 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -59.04 -28.58 66.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 73.310000000000002 110.887 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -50.6 65.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 72.340000000000003 110.847 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.54 -31.71 72.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 62.409999999999997 111.069 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.876 HD21 HG22 ' A' ' 78' ' ' ILE . 75.1 mt -73.67 -54.54 7.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 75.400000000000006 110.927 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.9 m -48.28 -43.94 33.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 61.140000000000001 110.844 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.777 HG22 ' HG3' ' A' ' 163' ' ' GLN . 40.3 p -63.34 -38.42 91.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 72.299999999999997 111.186 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.06 -10.84 44.34 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.702 -0.761 . . . . 52.350000000000001 112.496 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -28.89 27.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.399 . . . . 51.210000000000001 110.893 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.695 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -63.83 -29.05 70.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 63.340000000000003 110.915 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.35 1.38 90.04 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 74.510000000000005 112.508 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -174.89 -165.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.915 0.388 . . . . 75.340000000000003 110.865 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.67 -96.22 0.63 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 61.229999999999997 112.506 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.67 ' O ' ' C ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -119.19 -70.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.958 0.409 . . . . 73.239999999999995 110.894 -179.82 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.67 ' C ' ' O ' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -6.44 96.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 60.340000000000003 110.922 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 120.45 -30.61 5.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.695 -0.764 . . . . 53.100000000000001 112.498 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.37 -168.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.808 0.337 . . . . 62.539999999999999 110.875 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.1 p -142.84 171.94 13.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 45.340000000000003 110.94 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.655 ' HE1' HD11 ' A' ' 158' ' ' ILE . 8.8 m-85 -92.82 139.97 29.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 74.140000000000001 110.909 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -123.45 32.57 5.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 73.319999999999993 110.821 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.99 114.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.423 . . . . 73.129999999999995 110.905 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.46 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.2 mt -144.96 112.47 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 70.329999999999998 111.125 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.478 HD12 ' HE2' ' A' ' 61' ' ' MET . 38.5 mt -105.42 105.07 50.99 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.622 0.725 . . . . 62.530000000000001 111.165 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.8 Cg_endo -69.79 56.9 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.644 2.229 . . . . 72.099999999999994 112.336 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.16 33.33 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.71 -0.757 . . . . 50.299999999999997 112.476 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.419 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.0 OUTLIER -177.12 -59.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.838 0.352 . . . . 75.120000000000005 110.882 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.478 ' HE2' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER 174.65 157.92 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 64.409999999999997 110.885 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.5 m -97.04 -161.88 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 33.530000000000001 110.927 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 177.01 137.96 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 74.109999999999999 110.892 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 62.149999999999999 112.449 -179.946 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.876 HG22 HD21 ' A' ' 39' ' ' LEU . 18.8 pt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.844 0.354 . . . . 74.230000000000004 111.098 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -155.12 -66.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 64.120000000000005 110.939 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -132.32 -88.3 0.39 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.709 -0.758 . . . . 73.519999999999996 112.486 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -130.91 -37.39 1.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 75.510000000000005 110.884 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.422 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.27 170.04 0.31 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 71.340000000000003 110.898 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -130.99 179.7 5.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 62.009999999999998 110.852 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.1 169.01 19.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 63.310000000000002 110.879 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -63.34 156.75 24.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 72.030000000000001 110.884 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -108.26 -68.91 0.88 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 64.010000000000005 110.853 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -175.94 178.09 1.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 73.219999999999999 110.893 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.94 36.5 2.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 74.140000000000001 110.901 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -50.61 -29.78 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 72.040000000000006 111.101 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 18.8 mt -111.61 74.79 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 71.439999999999998 110.896 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.73 153.51 41.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.120000000000005 110.859 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -52.87 101.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.129999999999995 110.866 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.5 p -116.03 29.15 8.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 75.319999999999993 111.126 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 151.8 174.15 22.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 62.149999999999999 112.438 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 171.33 14.73 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.638 2.225 . . . . 74.230000000000004 112.308 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.63 39.7 98.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 45.409999999999997 112.479 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.436 ' HA ' HD13 ' A' ' 97' ' ' ILE . 14.7 mm -106.13 135.28 45.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.88 0.371 . . . . 74.420000000000002 111.085 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 98' ' ' LEU . 1.1 mt -101.05 149.07 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 74.230000000000004 110.924 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.455 ' HB2' ' HA ' ' A' ' 128' ' ' VAL . 0.2 OUTLIER 178.81 131.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 63.439999999999998 110.833 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.74 162.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 73.319999999999993 110.891 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.471 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . . . -156.22 36.8 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 52.219999999999999 111.128 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -68.18 -35.71 78.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 71.420000000000002 110.928 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.706 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -174.61 32.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 71.310000000000002 111.06 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.04 -114.34 6.31 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.686 -0.769 . . . . 75.510000000000005 112.484 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 114.75 3.81 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.658 2.239 . . . . 64.430000000000007 112.34 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.529 ' C ' HG23 ' A' ' 107' ' ' THR . 3.4 m-20 71.19 171.86 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 74.430000000000007 110.867 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.706 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.0 OUTLIER 66.66 25.68 9.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 75.310000000000002 111.143 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -80.3 130.53 35.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 65.019999999999996 110.909 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.01 -74.85 0.11 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.774 -0.727 . . . . 61.420000000000002 112.489 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.8 p -166.43 43.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 73.439999999999998 110.857 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.436 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 42.8 mm-40 -118.36 54.97 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 74.519999999999996 110.945 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -77.9 -165.91 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 73.140000000000001 110.887 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -154.44 174.58 14.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 72.219999999999999 110.837 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 114' ' ' ILE . 3.0 mt -111.26 90.93 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.496 . . . . 73.340000000000003 111.15 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 55.8 m -65.55 93.13 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 53.350000000000001 110.899 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.2 p -65.8 -11.26 44.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.46 . . . . 74.450000000000003 111.191 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 119' ' ' THR . . . -145.5 154.95 42.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 65.310000000000002 111.096 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -55.64 94.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 70.140000000000001 110.915 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 117' ' ' ALA . 25.7 p -96.74 49.56 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 74.510000000000005 111.097 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -26.01 68.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 65.239999999999995 110.863 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.695 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.6 p90 -48.11 -29.6 3.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 73.109999999999999 110.886 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 19.0 mt -46.92 -33.51 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 65.319999999999993 110.925 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.4 OUTLIER 60.54 78.17 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.847 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.94 43.81 0.9 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 62.329999999999998 112.467 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -16.27 49.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 72.25 110.87 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -141.41 -168.19 2.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 75.329999999999998 110.877 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 51.0 t -122.01 124.22 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 75.230000000000004 111.12 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.455 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 2.3 t -93.21 135.67 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.209999999999994 111.127 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.446 ' O ' HD23 ' A' ' 24' ' ' LEU . 14.1 p90 -160.69 35.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 74.310000000000002 110.887 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -174.08 174.9 46.54 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.73 -0.748 . . . . 64.540000000000006 112.499 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -176.1 137.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 64.25 110.877 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.725 HG11 ' HG2' ' A' ' 136' ' ' MET . 54.1 t -40.73 107.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 70.400000000000006 111.092 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -59.82 2.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.040000000000006 110.928 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -153.78 157.13 38.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 72.530000000000001 110.935 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.11 32.9 19.34 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.737 -0.744 . . . . 44.140000000000001 112.487 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.725 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -55.01 -29.19 56.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 71.219999999999999 110.93 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.26 -31.19 42.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 74.099999999999994 110.896 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 17' ' ' LEU . 43.8 mm -65.58 -40.71 88.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 62.420000000000002 111.147 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.4 t -63.03 -27.36 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 62.340000000000003 111.096 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.91 -27.76 36.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 74.140000000000001 110.893 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.91 -38.68 61.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 62.310000000000002 111.097 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.8 mtm -61.42 -52.18 65.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 73.439999999999998 110.859 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -54.05 -29.61 44.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 74.040000000000006 110.904 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.452 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -65.8 -23.37 66.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 64.040000000000006 110.906 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.452 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 62.2 m-85 -108.95 18.63 20.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 72.519999999999996 110.849 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -114.03 168.46 12.58 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.693 -0.765 . . . . 73.310000000000002 112.484 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 m -113.07 146.76 38.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 53.43 110.865 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -76.01 64.45 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 75.340000000000003 110.873 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -165.48 -38.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 64.409999999999997 110.918 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 157.75 -71.39 0.25 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 74.219999999999999 112.501 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 170.4 4.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.817 0.341 . . . . 74.340000000000003 110.921 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.8 p -145.39 -173.9 4.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 72.5 111.113 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.74 -67.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 72.319999999999993 110.841 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -59.93 -179.22 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 70.409999999999997 110.903 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.62 107.07 9.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 71.129999999999995 110.913 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 4.1 mp -86.99 116.41 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 75.540000000000006 111.156 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.44 169.58 13.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 111.126 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.655 HD11 ' HE1' ' A' ' 53' ' ' PHE . 11.6 mm -104.83 109.25 27.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 73.209999999999994 111.112 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.709 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -68.68 -45.15 72.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 73.129999999999995 111.108 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -161.76 160.03 27.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 73.349999999999994 110.856 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.9 146.66 9.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 71.129999999999995 110.862 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.97 178.81 48.14 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.684 -0.77 . . . . 51.229999999999997 112.452 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.777 ' HG3' HG22 ' A' ' 41' ' ' THR . 3.6 mt-30 -63.98 146.24 54.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.854 0.359 . . . . 72.0 110.922 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.837 HD21 ' HB3' ' A' ' 7' ' ' PHE . 3.5 mm? -102.4 -55.66 2.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 75.5 110.904 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 64.25 110.944 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.838 0.352 . . . . 63.130000000000003 111.133 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -123.48 156.26 64.43 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.661 0.744 . . . . 74.209999999999994 110.855 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 145.83 58.52 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.694 2.263 . . . . 62.340000000000003 112.399 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.1 m -129.71 126.88 39.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 73.439999999999998 111.106 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.9 m -121.27 170.51 11.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 65.5 111.139 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.669 ' HB3' HD21 ' A' ' 164' ' ' LEU . 0.6 OUTLIER -158.52 176.37 12.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 63.43 110.882 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -153.13 96.21 2.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 63.149999999999999 110.864 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.6 t70 -43.22 106.63 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 74.349999999999994 110.867 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.708 HG22 HD12 ' A' ' 17' ' ' LEU . 34.1 mm -78.74 137.63 21.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 63.240000000000002 111.114 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -131.25 160.42 34.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 64.299999999999997 111.112 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -143.33 103.6 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 62.439999999999998 111.119 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.96 24.98 9.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 73.450000000000003 110.902 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.11 -25.29 25.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 33.509999999999998 112.512 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -90.28 125.17 60.96 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.672 0.748 . . . . 72.219999999999999 110.886 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.5 Cg_endo -69.76 124.49 11.14 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.653 2.235 . . . . 43.240000000000002 112.328 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.708 HD12 HG22 ' A' ' 10' ' ' ILE . 9.7 mt -68.25 -38.15 81.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 75.040000000000006 110.941 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.93 -131.17 2.86 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.669 -0.777 . . . . 65.319999999999993 112.434 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.67 136.66 53.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 52.439999999999998 110.9 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.584 HG21 HG13 ' A' ' 10' ' ' ILE . 1.3 t -142.4 99.46 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 65.150000000000006 111.137 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 22' ' ' PHE . 1.5 t -106.36 174.01 6.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 61.520000000000003 110.839 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.474 ' CZ ' HD11 ' A' ' 114' ' ' ILE . 48.2 m-85 -144.81 132.97 21.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 71.450000000000003 110.863 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -89.43 95.95 10.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 71.230000000000004 110.893 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.4 mt -81.06 134.61 35.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 54.310000000000002 110.896 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -92.18 66.87 4.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 110.852 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.91 -22.81 27.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 74.200000000000003 111.129 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -65.22 -39.44 92.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 61.32 110.813 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -96.58 -27.84 14.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 74.140000000000001 110.882 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.458 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -135.54 66.2 63.75 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.612 0.72 . . . . 71.519999999999996 111.112 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -45.91 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.703 2.268 . . . . 64.319999999999993 112.348 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -54.41 -34.71 61.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.434 . . . . 63.520000000000003 110.912 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.428 HG21 ' CD1' ' A' ' 129' ' ' PHE . 32.5 m -89.64 -54.11 4.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 65.049999999999997 111.109 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.92 -42.27 62.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 54.530000000000001 111.116 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -56.04 -27.18 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 71.510000000000005 110.925 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -66.68 -65.68 0.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 74.400000000000006 110.901 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.94 -34.66 70.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 73.439999999999998 110.888 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.485 ' O ' HG23 ' A' ' 41' ' ' THR . 3.5 ttp180 -70.22 -48.27 57.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 74.340000000000003 110.894 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.92 -37.18 66.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 73.329999999999998 111.118 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.5 HD22 ' HA2' ' A' ' 47' ' ' GLY . 3.1 mt -76.92 -56.06 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 72.230000000000004 110.934 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.0 m -53.6 -32.75 52.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 73.310000000000002 110.886 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 37' ' ' ARG . 30.6 p -73.42 -53.41 10.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 74.150000000000006 111.142 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.54 -13.92 6.49 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 74.109999999999999 112.455 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -53.63 -31.01 45.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.373 . . . . 73.409999999999997 110.877 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -27.9 60.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 72.450000000000003 110.925 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.04 -17.12 53.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 54.119999999999997 112.515 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -154.85 -165.18 1.98 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.907 0.385 . . . . 71.319999999999993 110.865 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA2' HD22 ' A' ' 39' ' ' LEU . . . 152.05 -123.41 1.47 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 73.299999999999997 112.473 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -121.7 31.72 6.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.934 0.397 . . . . 74.349999999999994 110.905 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.67 114.34 20.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 71.5 110.882 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.48 41.26 94.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 63.119999999999997 112.484 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 m -121.45 138.24 54.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.827 0.346 . . . . 72.040000000000006 110.845 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 55.9 m -56.34 150.57 14.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 72.329999999999998 110.859 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -69.37 -179.86 1.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 73.510000000000005 110.89 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -110.9 -72.62 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.150000000000006 110.854 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -143.34 157.81 44.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 73.329999999999998 110.818 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.515 HD12 HD13 ' A' ' 156' ' ' ILE . 44.9 mt -147.03 111.89 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 64.400000000000006 111.105 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.3 mt -109.76 102.28 49.67 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.682 0.753 . . . . 73.230000000000004 111.108 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 53.9 Cg_endo -69.77 88.53 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.714 2.276 . . . . 62.200000000000003 112.339 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.89 -20.33 1.61 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 50.0 112.46 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.54 -54.38 1.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 70.209999999999994 110.865 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.416 ' HB3' ' HA ' ' A' ' 115' ' ' CYS . 0.0 OUTLIER 171.03 166.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 110.914 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.6 m -91.7 -162.08 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 72.109999999999999 110.87 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -165.4 112.84 0.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 73.540000000000006 110.961 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 72.129999999999995 112.506 -179.958 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 78' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.875 0.369 . . . . 70.040000000000006 111.123 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -135.9 34.63 2.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 73.400000000000006 110.946 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.26 -109.73 2.48 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.752 -0.737 . . . . 55.119999999999997 112.516 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -111.12 -30.76 7.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.38 . . . . 70.019999999999996 110.873 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.401 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.3 179.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 71.120000000000005 110.913 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -148.15 164.98 32.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 73.329999999999998 110.838 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.61 171.31 15.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 64.010000000000005 110.865 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.76 153.88 40.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 75.319999999999993 110.877 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -106.63 -78.46 0.58 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 63.0 110.873 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.5 p30 -155.1 172.89 17.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 71.340000000000003 110.895 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.9 39.27 3.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 61.329999999999998 110.877 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -49.92 -30.26 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 75.140000000000001 111.104 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.6 mt -108.05 91.63 3.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 75.409999999999997 110.959 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.11 150.87 43.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 53.439999999999998 110.867 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -63.42 89.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 53.229999999999997 110.858 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.39 -55.3 5.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 62.109999999999999 111.102 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . -145.66 -166.73 12.05 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.719 -0.753 . . . . 41.329999999999998 112.512 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 172.17 13.17 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.686 2.257 . . . . 74.129999999999995 112.3 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.5 12.67 77.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.732 -0.747 . . . . 50.310000000000002 112.471 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.7 mm -89.05 143.39 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 75.519999999999996 111.129 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -114.14 143.14 45.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 62.350000000000001 110.898 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.5 -165.25 2.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 74.219999999999999 110.872 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.426 ' HG3' ' HB ' ' A' ' 127' ' ' VAL . 0.1 OUTLIER -95.53 104.94 16.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 110.856 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.584 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -70.04 77.37 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 43.229999999999997 111.141 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 22.1 p-10 -129.14 -172.28 2.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 65.209999999999994 110.897 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.22 -18.9 64.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 71.030000000000001 111.098 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.5 -82.68 0.33 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.74 -0.743 . . . . 74.420000000000002 112.512 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 96.14 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.728 2.285 . . . . 53.409999999999997 112.329 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.41 ' C ' HG23 ' A' ' 107' ' ' THR . 1.6 m-20 71.92 166.13 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 74.010000000000005 110.874 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.41 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.7 p 66.1 45.48 2.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 61.140000000000001 111.159 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 1.9 m-20 -43.81 -31.76 0.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 74.430000000000007 110.843 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . 70.58 -64.24 0.83 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 73.0 112.52 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 1.2 t 84.72 58.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.85 0.357 . . . . 74.0 110.849 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -109.93 -15.99 13.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 74.319999999999993 110.967 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.613 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER 73.47 154.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 75.140000000000001 110.883 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.584 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -165.08 67.77 0.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 72.200000000000003 110.873 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.563 ' C ' ' O ' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -23.67 123.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 73.129999999999995 111.093 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 61' ' ' MET . 37.2 m -96.28 114.14 25.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 74.319999999999993 110.863 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 68.1 p -93.16 27.39 2.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 53.140000000000001 111.163 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 119' ' ' THR . . . 176.38 142.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 42.509999999999998 111.131 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.415 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 3.6 tttt -53.42 99.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 72.310000000000002 110.893 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.718 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 28.8 p -98.89 48.63 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 73.120000000000005 111.134 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.39 -25.52 68.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 75.150000000000006 110.904 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.718 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.8 p90 -48.99 -28.29 3.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 75.099999999999994 110.915 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.443 HD13 ' HD2' ' A' ' 126' ' ' HIS . 26.1 mt -48.37 -32.12 7.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 72.25 110.913 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.0 m-20 59.77 76.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.310000000000002 110.934 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.98 41.5 0.98 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.74 -0.743 . . . . 61.130000000000003 112.509 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.93 -26.4 36.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.822 0.344 . . . . 74.129999999999995 110.894 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.443 ' HD2' HD13 ' A' ' 122' ' ' LEU . 19.9 m-70 -129.3 -167.76 1.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 73.5 110.89 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.426 ' HB ' ' HG3' ' A' ' 100' ' ' MET . 76.0 t -127.89 118.27 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 51.219999999999999 111.139 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.53 129.94 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 70.219999999999999 111.134 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.469 ' O ' HD23 ' A' ' 24' ' ' LEU . 35.4 p90 -151.2 33.49 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 72.519999999999996 110.894 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -172.68 175.28 45.77 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 43.210000000000001 112.477 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 2.1 pttt -175.75 137.28 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.813 0.34 . . . . 54.520000000000003 110.938 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.686 HG11 ' HG2' ' A' ' 136' ' ' MET . 53.8 t -41.63 105.73 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 73.430000000000007 111.142 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -59.95 3.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 70.450000000000003 110.898 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -154.28 161.91 41.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 73.430000000000007 110.921 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.05 33.66 28.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.721 -0.752 . . . . 11.44 112.498 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.686 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -55.06 -29.45 57.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 74.25 110.862 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.53 -33.02 53.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 65.120000000000005 110.885 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 17' ' ' LEU . 37.3 mm -65.56 -35.72 75.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 53.350000000000001 111.122 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.3 t -67.09 -26.92 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 72.340000000000003 111.139 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -82.27 -27.81 32.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 54.420000000000002 110.869 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.74 -41.28 60.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.488 . . . . 45.229999999999997 111.083 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.3 mtm -62.27 -51.73 66.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 63.310000000000002 110.91 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -54.06 -26.01 24.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.452 . . . . 72.340000000000003 110.899 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.447 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.34 -24.59 62.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 72.150000000000006 110.84 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.447 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 67.6 m-85 -107.58 12.12 27.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 72.140000000000001 110.902 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.39 171.64 17.7 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 63.530000000000001 112.487 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.68 131.09 55.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.849 0.357 . . . . 73.239999999999995 110.876 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -54.56 -28.07 43.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 63.350000000000001 110.813 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -72.53 -29.68 63.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 71.530000000000001 110.854 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.83 -42.45 1.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 30.109999999999999 112.49 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.27 -177.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.873 0.368 . . . . 54.409999999999997 110.881 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.5 p -144.78 138.41 27.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.207 -0.451 . . . . 72.010000000000005 111.148 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.69 -44.84 63.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 73.519999999999996 110.842 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.42 -177.68 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 73.239999999999995 110.925 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.78 109.13 18.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 74.230000000000004 110.911 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.515 HD13 HD12 ' A' ' 56' ' ' ILE . 5.1 mp -93.46 118.24 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 74.019999999999996 111.142 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.26 162.58 26.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 111.157 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 20.0 mm -101.29 117.16 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 75.030000000000001 111.098 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -77.65 -47.07 20.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 65.019999999999996 111.112 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -153.74 157.49 39.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 72.25 110.848 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -160.32 147.48 16.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 75.109999999999999 110.904 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.19 161.73 21.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.7 -0.762 . . . . 63.149999999999999 112.437 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.62 108.58 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.37 . . . . 54.310000000000002 110.933 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.669 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.1 mm? -50.78 -49.86 57.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.409999999999997 110.892 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 62.039999999999999 110.915 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 C--O 1.23 0.035 0 CA-C-O 120.849 0.357 . . . . 71.439999999999998 111.116 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -106.52 155.83 38.13 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.721 . . . . 74.329999999999998 110.884 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 146.95 61.54 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.629 2.22 . . . . 73.319999999999993 112.375 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -135.39 142.35 45.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 61.439999999999998 111.164 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.465 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.3 m -133.12 143.4 39.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 73.319999999999993 111.094 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 16.1 p90 -104.13 164.12 11.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 71.349999999999994 110.861 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.693 ' CD2' HD13 ' A' ' 158' ' ' ILE . 5.2 m-85 -147.4 85.07 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 65.319999999999993 110.836 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.673 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.8 OUTLIER -49.66 106.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 60.009999999999998 110.846 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.661 HG22 HD12 ' A' ' 17' ' ' LEU . 34.7 mm -85.01 134.58 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 71.540000000000006 111.095 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -124.07 158.65 31.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 53.329999999999998 111.11 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 154' ' ' LYS . 40.5 t -137.84 94.45 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 74.329999999999998 111.17 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.21 32.19 8.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 72.400000000000006 110.851 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.23 -24.0 32.55 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.759 -0.734 . . . . 71.439999999999998 112.51 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -91.74 115.01 63.74 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.633 0.73 . . . . 52.420000000000002 110.902 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.6 Cg_endo -69.76 122.59 9.27 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.682 2.254 . . . . 70.230000000000004 112.335 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.661 HD12 HG22 ' A' ' 10' ' ' ILE . 14.6 mt -66.64 -37.86 85.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 64.540000000000006 110.964 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.41 -122.29 1.2 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.72 -0.752 . . . . 61.340000000000003 112.48 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -130.12 138.22 50.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.853 0.359 . . . . 73.5 110.873 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.562 HG21 HG13 ' A' ' 10' ' ' ILE . 1.6 t -145.14 99.56 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 73.230000000000004 111.114 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.1 t -108.16 174.91 5.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 62.229999999999997 110.823 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.445 ' N ' ' OG ' ' A' ' 21' ' ' SER . 2.1 m-85 -144.92 131.81 20.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.493 . . . . 75.129999999999995 110.909 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.45 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 60.0 tt0 -86.4 97.04 10.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 71.439999999999998 110.933 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.7 mt -77.39 124.43 27.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 52.340000000000003 110.925 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -80.64 64.31 5.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 65.409999999999997 110.89 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.41 -22.38 12.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 55.450000000000003 111.12 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.32 -48.96 77.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 71.219999999999999 110.847 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -90.1 -29.64 18.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 70.510000000000005 110.892 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.446 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -130.89 67.84 81.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.618 0.723 . . . . 73.25 111.064 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -41.01 4.59 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.713 2.275 . . . . 34.240000000000002 112.316 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -35.27 79.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 72.430000000000007 110.936 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 48.5 m -84.63 -44.23 13.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 74.340000000000003 111.112 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.18 -47.05 78.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 65.209999999999994 111.089 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -50.96 -27.03 6.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 72.010000000000005 110.889 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.469 ' HA ' HD13 ' A' ' 78' ' ' ILE . 1.9 t30 -65.81 -63.39 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 75.530000000000001 110.892 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -61.11 -34.78 75.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 72.409999999999997 110.867 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.516 ' O ' HG23 ' A' ' 41' ' ' THR . 0.7 OUTLIER -69.78 -47.06 64.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 54.420000000000002 110.87 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.87 -39.84 72.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 52.420000000000002 111.132 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.506 HD22 ' HA2' ' A' ' 47' ' ' GLY . 4.1 mt -79.34 -49.46 12.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 74.049999999999997 110.957 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.7 m -55.69 -37.84 68.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 71.150000000000006 110.846 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 37' ' ' ARG . 73.9 p -74.91 -47.14 31.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 73.219999999999999 111.126 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.55 -11.95 13.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.738 -0.744 . . . . 62.0 112.505 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -52.07 -37.78 54.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 65.019999999999996 110.843 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -58.85 -27.48 65.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 73.530000000000001 110.905 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.76 -14.79 56.11 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.718 -0.754 . . . . 75.230000000000004 112.46 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -158.68 -166.07 1.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.885 0.374 . . . . 70.150000000000006 110.879 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.506 ' HA2' HD22 ' A' ' 39' ' ' LEU . . . 163.23 -133.2 2.98 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.681 -0.771 . . . . 34.530000000000001 112.446 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -149.72 48.35 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.933 0.397 . . . . 75.120000000000005 110.923 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -58.7 125.73 24.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 70.25 110.924 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.11 43.15 17.53 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.776 -0.726 . . . . 65.200000000000003 112.478 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.466 ' O ' HG22 ' A' ' 157' ' ' THR . 0.7 OUTLIER -60.47 -169.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.831 0.348 . . . . 74.140000000000001 110.903 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.0 p -125.17 132.29 53.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 62.439999999999998 110.886 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -110.7 108.91 18.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 74.109999999999999 110.869 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -133.45 37.75 3.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 110.848 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.46 77.96 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 65.239999999999995 110.851 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.548 HD12 HD13 ' A' ' 156' ' ' ILE . 13.6 mt -117.87 109.56 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 62.439999999999998 111.15 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 30.2 mt -97.77 104.51 21.8 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.606 0.717 . . . . 73.239999999999995 111.155 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.4 Cg_endo -69.76 85.94 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.687 2.258 . . . . 51.240000000000002 112.351 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.71 -19.88 1.82 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 65.200000000000003 112.489 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.9 -56.6 1.93 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.857 0.36 . . . . 70.239999999999995 110.846 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.624 ' HE3' ' O ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER 171.1 165.21 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 62.439999999999998 110.862 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.624 ' O ' ' HE3' ' A' ' 61' ' ' MET . 15.6 m -99.79 -161.85 0.9 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.445 . . . . 75.510000000000005 110.934 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.4 145.87 22.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 74.040000000000006 110.916 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 51.140000000000001 112.454 -179.965 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.469 HD13 ' HA ' ' A' ' 35' ' ' ASN . 11.3 pt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.884 0.373 . . . . 62.210000000000001 111.162 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -161.34 -64.29 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 110.952 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -132.15 166.68 23.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.706 -0.759 . . . . 53.100000000000001 112.492 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.14 -26.0 2.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.917 0.389 . . . . 74.0 110.899 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.41 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 176.13 173.47 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 75.120000000000005 110.928 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -149.76 167.82 25.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 71.349999999999994 110.891 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.75 167.63 20.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 74.519999999999996 110.912 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.13 135.02 57.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 73.230000000000004 110.852 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -83.33 -77.31 0.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 110.885 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.1 p30 -156.25 174.42 15.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 75.319999999999993 110.939 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.52 36.93 3.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 65.120000000000005 110.821 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.09 -32.13 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 73.150000000000006 111.117 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 21.8 mt -109.99 86.96 2.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 72.540000000000006 110.932 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.726 ' O ' HG23 ' A' ' 93' ' ' THR . 5.7 mtpt -75.1 145.83 41.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 73.129999999999995 110.946 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.52 ' CE1' HD12 ' A' ' 122' ' ' LEU . 16.9 m80 -49.85 103.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 70.510000000000005 110.857 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 91' ' ' LYS . 79.2 p -114.4 28.4 8.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 72.439999999999998 111.117 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.17 175.76 21.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.685 -0.769 . . . . 61.509999999999998 112.469 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 175.96 7.35 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.7 2.267 . . . . 74.109999999999999 112.34 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.13 26.63 69.43 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 74.329999999999998 112.45 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.2 mm -95.9 140.34 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.828 0.347 . . . . 61.43 111.166 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.445 HD21 ' HD2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -109.34 139.25 44.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 73.450000000000003 110.861 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.13 156.71 39.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 72.219999999999999 110.842 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.474 ' HE1' ' HB3' ' A' ' 110' ' ' SER . 1.0 OUTLIER -59.95 96.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 74.439999999999998 110.837 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.4 ' HB3' ' HG2' ' A' ' 111' ' ' GLN . . . -63.99 89.65 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 71.219999999999999 111.133 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 107' ' ' THR . 0.8 OUTLIER -134.71 173.55 11.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 74.010000000000005 110.882 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.93 -23.06 6.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 72.510000000000005 111.074 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 122.44 -82.16 0.35 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 62.140000000000001 112.52 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 91.91 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.696 2.264 . . . . 65.150000000000006 112.359 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.446 ' C ' HG23 ' A' ' 107' ' ' THR . 2.3 m-20 73.66 171.8 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 72.040000000000006 110.889 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.446 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.3 p 66.0 39.07 4.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 111.098 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -45.36 -30.48 1.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.838 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.436 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . 51.92 -118.47 7.3 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.777 -0.725 . . . . 62.420000000000002 112.491 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.474 ' HB3' ' HE1' ' A' ' 100' ' ' MET . 1.5 p 165.4 67.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 72.140000000000001 110.882 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.4 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 2.4 tt0 -102.79 -27.51 12.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 63.210000000000001 110.923 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.602 ' HZ ' HD12 ' A' ' 114' ' ' ILE . 0.0 OUTLIER 68.09 151.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.230000000000004 110.861 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -164.39 85.81 0.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 65.420000000000002 110.927 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.602 HD12 ' HZ ' ' A' ' 112' ' ' PHE . 2.2 mt -42.06 114.44 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 71.120000000000005 111.135 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.8 m -85.87 122.44 29.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 62.119999999999997 110.9 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.2 p -91.73 24.04 3.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 73.349999999999994 111.139 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 119' ' ' THR . . . 179.34 154.61 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 51.109999999999999 111.053 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.2 86.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 74.049999999999997 110.91 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.736 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 32.6 p -84.16 53.4 2.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 61.340000000000003 111.093 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -66.8 -23.14 66.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 74.120000000000005 110.909 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.736 ' CZ2' HG22 ' A' ' 119' ' ' THR . 11.6 p90 -53.75 -25.69 20.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 70.450000000000003 110.963 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.545 HD22 ' HE2' ' A' ' 126' ' ' HIS . 38.2 mt -45.6 -33.48 2.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 74.409999999999997 110.933 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 124' ' ' GLY . 1.6 m-20 61.95 76.18 0.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 62.200000000000003 110.838 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.6 41.54 0.85 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 70.230000000000004 112.478 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.67 -21.89 37.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.835 0.35 . . . . 74.140000000000001 110.938 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.545 ' HE2' HD22 ' A' ' 122' ' ' LEU . 9.7 m-70 -137.43 -167.23 2.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 74.049999999999997 110.861 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.9 t -127.06 122.07 59.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 73.129999999999995 111.161 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 t -88.1 133.3 30.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 61.420000000000002 111.106 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.451 ' O ' HD23 ' A' ' 24' ' ' LEU . 19.0 p90 -156.97 32.55 0.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 74.129999999999995 110.852 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -169.44 172.1 43.4 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.727 -0.749 . . . . 54.119999999999997 112.47 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 131' ' ' LYS . 1.6 pttt -176.11 132.41 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 63.43 110.916 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.654 HG11 ' HG2' ' A' ' 136' ' ' MET . 97.4 t -37.97 105.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.510000000000005 111.163 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.45 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -67.31 -58.69 4.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 75.140000000000001 110.94 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -150.99 170.29 19.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 72.219999999999999 110.87 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.13 31.0 64.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.735 . . . . 72.430000000000007 112.502 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.654 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -52.21 -26.38 11.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.771 0.32 . . . . 72.25 110.893 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.18 -31.89 54.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 74.540000000000006 110.886 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.632 HD12 ' HB3' ' A' ' 17' ' ' LEU . 43.4 mm -64.96 -40.26 88.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 71.239999999999995 111.107 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.43 -28.67 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 72.430000000000007 111.162 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -78.01 -29.02 49.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 73.420000000000002 110.885 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.96 57.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 71.319999999999993 111.132 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.487 ' SD ' HG21 ' A' ' 156' ' ' ILE . 35.9 mtm -61.38 -41.9 97.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 74.530000000000001 110.844 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -53.47 -30.57 41.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 72.420000000000002 110.89 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.43 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -73.55 -27.23 61.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 72.319999999999993 110.875 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.43 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 61.4 m-85 -105.44 30.01 6.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 75.519999999999996 110.81 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.0 151.69 17.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.766 -0.73 . . . . 75.230000000000004 112.51 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.5 m -114.37 140.52 48.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 63.219999999999999 110.854 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -74.11 70.18 1.55 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.340000000000003 110.886 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -179.93 -33.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 63.130000000000003 110.88 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 153.96 -100.61 0.2 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.773 -0.727 . . . . 70.140000000000001 112.468 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.32 169.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 55.420000000000002 110.912 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.6 p -143.65 -171.04 3.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 65.099999999999994 111.093 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.1 p -78.39 -55.31 5.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 63.109999999999999 110.847 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.456 ' HB3' HG13 ' A' ' 12' ' ' VAL . 3.7 mttp -81.54 166.66 20.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 74.420000000000002 110.877 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -111.95 110.08 20.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.310000000000002 110.888 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.548 HD13 HD12 ' A' ' 56' ' ' ILE . 4.8 mp -89.46 118.18 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 71.030000000000001 111.132 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -129.67 164.36 24.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 111.127 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.693 HD13 ' CD2' ' A' ' 8' ' ' PHE . 6.8 mt -98.44 123.04 50.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 73.400000000000006 111.073 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.673 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -81.53 -49.05 11.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 63.420000000000002 111.118 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -153.4 155.96 37.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 73.25 110.875 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.56 148.97 18.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 73.230000000000004 110.902 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 172.42 172.28 38.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.703 -0.76 . . . . 61.130000000000003 112.495 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.406 ' OE1' HG21 ' A' ' 41' ' ' THR . 2.7 mt-30 -64.67 142.36 58.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.363 . . . . 60.210000000000001 110.867 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -94.86 -59.58 1.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 72.299999999999997 110.903 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 110.913 179.955 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.458 -0.049 0 CA-C-O 120.839 0.352 . . . . 53.399999999999999 111.083 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -70.63 117.51 56.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.615 0.721 . . . . 64.409999999999997 110.861 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 152.6 69.31 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.653 2.235 . . . . 72.140000000000001 112.337 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -137.78 139.64 40.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 61.210000000000001 111.145 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.492 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.4 m -127.38 142.5 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 75.310000000000002 111.142 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.6 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 7.3 p90 -106.1 155.45 19.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 73.209999999999994 110.872 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.593 ' CE2' HD13 ' A' ' 158' ' ' ILE . 3.9 m-85 -143.8 86.72 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 73.129999999999995 110.847 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.736 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 4.0 t70 -47.75 125.91 9.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 72.129999999999995 110.846 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.67 HG23 HG23 ' A' ' 156' ' ' ILE . 17.5 mm -97.61 111.36 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 111.168 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -104.62 126.04 51.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 70.430000000000007 111.082 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.634 HG23 HD13 ' A' ' 17' ' ' LEU . 11.9 t -111.13 101.28 12.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 54.149999999999999 111.103 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 t0 59.87 43.55 14.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 73.150000000000006 110.87 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.58 0.83 88.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.747 -0.739 . . . . 73.109999999999999 112.511 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 10.2 mm-40 -113.22 102.4 54.74 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.628 0.728 . . . . 72.430000000000007 110.91 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.6 Cg_endo -69.81 110.88 2.67 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.626 2.217 . . . . 70.140000000000001 112.361 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.634 HD13 HG23 ' A' ' 12' ' ' VAL . 6.3 mp -65.45 -35.27 80.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 75.340000000000003 110.915 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.36 -133.72 3.04 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.731 . . . . 60.530000000000001 112.499 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -128.36 146.75 50.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 44.100000000000001 110.861 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.52 HG21 HG13 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -143.7 101.44 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 75.25 111.17 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -107.52 170.94 7.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 40.25 110.833 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -143.35 138.05 29.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 74.519999999999996 110.858 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.465 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 19.7 tt0 -91.17 99.94 12.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 74.420000000000002 110.865 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 129' ' ' PHE . 5.5 mt -82.56 123.13 28.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 72.540000000000006 110.923 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.464 ' CD1' HD13 ' A' ' 90' ' ' LEU . 40.6 m-85 -79.04 63.5 3.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 73.140000000000001 110.86 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.13 -22.32 16.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 74.409999999999997 111.062 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.17 -36.27 74.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 75.140000000000001 110.868 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.37 -25.31 15.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 53.409999999999997 110.919 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.444 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -139.44 65.51 34.04 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.625 0.726 . . . . 75.430000000000007 111.107 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -35.77 11.95 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.698 2.265 . . . . 71.420000000000002 112.339 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -39.82 89.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 75.319999999999993 110.859 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 98.6 m -87.28 -45.3 10.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 71.230000000000004 111.165 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.73 91.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 73.019999999999996 111.1 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -47.42 -35.15 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 74.319999999999993 110.874 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -62.64 -68.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 52.130000000000003 110.906 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -56.21 -23.44 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 71.540000000000006 110.903 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.485 ' NH2' ' HG2' ' A' ' 163' ' ' GLN . 0.0 OUTLIER -68.17 -54.21 19.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 75.340000000000003 110.854 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.57 -26.46 66.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 52.509999999999998 111.103 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.502 HD13 ' HE2' ' A' ' 48' ' ' TYR . 97.5 mt -79.0 -56.45 4.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 73.420000000000002 110.925 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.9 m -49.38 -46.13 46.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 65.439999999999998 110.834 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.3 p -72.44 -27.27 62.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 75.230000000000004 111.166 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.5 -8.81 74.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.726 -0.75 . . . . 73.109999999999999 112.475 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -18.55 50.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 72.209999999999994 110.883 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.737 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -50.36 -30.59 12.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 74.409999999999997 110.928 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.64 -23.97 6.57 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.763 -0.732 . . . . 70.219999999999999 112.509 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -160.59 -50.84 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 72.129999999999995 110.867 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.97 163.18 0.17 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.718 -0.753 . . . . 72.340000000000003 112.499 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.502 ' HE2' HD13 ' A' ' 39' ' ' LEU . 44.8 p90 -96.48 26.67 4.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.0 0.429 . . . . 74.349999999999994 110.934 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.17 142.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 72.209999999999994 110.904 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.83 27.05 74.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.706 -0.759 . . . . 53.32 112.487 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.712 ' O ' HG22 ' A' ' 157' ' ' THR . 0.4 OUTLIER -66.37 -176.46 0.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.827 0.346 . . . . 64.319999999999993 110.844 -179.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.9 p -126.06 122.47 35.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 72.140000000000001 110.856 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -86.98 130.61 34.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 75.230000000000004 110.877 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -147.33 46.82 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 110.889 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -158.94 61.59 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 75.239999999999995 110.905 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 13.7 mt -107.92 109.25 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 71.219999999999999 111.127 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.401 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 26.6 mt -100.2 103.78 25.23 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.604 0.716 . . . . 73.420000000000002 111.093 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.8 Cg_endo -69.75 85.01 0.63 Allowed 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.722 2.281 . . . . 73.530000000000001 112.34 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.37 -20.46 1.19 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.731 . . . . 71.430000000000007 112.479 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.89 -57.93 1.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.915 0.388 . . . . 64.340000000000003 110.911 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 174.19 164.48 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 62.009999999999998 110.827 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 10.1 m -100.81 -168.45 1.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 73.530000000000001 110.931 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 177.24 146.21 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 70.230000000000004 110.887 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.756 . . . . 72.329999999999998 112.497 179.991 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.737 HG22 ' HD2' ' A' ' 44' ' ' LYS . 5.2 pt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.829 0.347 . . . . 74.010000000000005 111.145 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -155.88 46.4 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 72.319999999999993 110.918 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.34 -133.98 11.51 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 65.150000000000006 112.479 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -79.23 -38.94 34.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.939 0.399 . . . . 60.119999999999997 110.88 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.41 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.2 176.63 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 73.239999999999995 110.893 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.75 -178.18 3.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 71.239999999999995 110.858 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -95.34 167.88 11.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.109 -0.496 . . . . 74.209999999999994 110.872 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -60.63 154.93 20.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 61.240000000000002 110.836 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -112.23 -67.44 1.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.019999999999996 110.881 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -176.45 178.11 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 75.430000000000007 110.871 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.46 35.99 3.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 63.140000000000001 110.918 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.51 -30.16 7.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 64.230000000000004 111.123 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 25' ' ' PHE . 12.9 mt -111.41 79.52 1.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 61.149999999999999 110.916 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -69.89 152.05 44.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 72.540000000000006 110.897 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -56.73 97.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 74.299999999999997 110.898 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.1 p -108.93 26.31 10.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 72.340000000000003 111.145 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.58 178.64 25.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.719 -0.753 . . . . 44.32 112.496 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 171.57 14.16 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.736 2.291 . . . . 74.109999999999999 112.335 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.9 37.64 94.54 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 64.239999999999995 112.468 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 97' ' ' ILE . 21.5 mm -108.62 136.99 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.884 0.373 . . . . 43.119999999999997 111.163 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' A' ' 112' ' ' PHE . 4.2 mt -103.1 162.18 13.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 72.230000000000004 110.92 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.16 -160.15 0.31 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 75.430000000000007 110.786 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.3 mmt -121.93 138.15 54.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 73.540000000000006 110.903 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -119.05 148.22 43.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 44.420000000000002 111.1 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 2.4 m-20 163.73 -50.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 75.019999999999996 110.88 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -178.11 30.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 75.129999999999995 111.101 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.33 -120.89 5.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 35.43 112.509 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 126.35 13.17 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.629 2.219 . . . . 74.109999999999999 112.337 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.494 ' C ' HG23 ' A' ' 107' ' ' THR . 4.0 m-20 69.11 173.02 0.3 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 65.519999999999996 110.898 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.494 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.3 p 67.07 26.38 8.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 73.409999999999997 111.142 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -72.25 146.63 47.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 71.219999999999999 110.853 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.89 -106.88 0.9 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 72.450000000000003 112.518 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.6 p -151.43 33.74 0.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.81 0.338 . . . . 70.120000000000005 110.9 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.668 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 3.7 pt20 -114.42 51.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 72.219999999999999 110.902 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.539 ' HB2' HD22 ' A' ' 98' ' ' LEU . 5.4 p90 -56.85 -169.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 62.340000000000003 110.892 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.452 ' O ' HD23 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -151.87 164.27 37.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 74.049999999999997 110.894 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 114' ' ' ILE . 3.4 mt -108.66 90.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 71.420000000000002 111.145 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 57.3 m -63.41 91.29 0.05 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 72.040000000000006 110.89 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.2 p -61.68 -15.16 37.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 42.509999999999998 111.111 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 119' ' ' THR . . . -143.89 156.4 44.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 71.219999999999999 111.08 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -56.06 94.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 75.420000000000002 110.864 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 117' ' ' ALA . 23.7 p -95.49 46.11 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 54.219999999999999 111.151 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -23.88 67.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 74.450000000000003 110.853 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.687 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.0 p90 -49.54 -28.16 5.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 72.200000000000003 110.896 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.9 mt -46.77 -34.06 4.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.227 -0.442 . . . . 54.520000000000003 110.912 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.4 OUTLIER 63.01 75.18 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 64.040000000000006 110.889 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.11 43.71 0.7 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.732 -0.747 . . . . 51.329999999999998 112.495 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -80.34 -27.42 38.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 64.430000000000007 110.91 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -127.18 -168.65 1.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 52.219999999999999 110.856 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.7 t -121.43 110.22 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 62.310000000000002 111.114 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 98' ' ' LEU . 16.4 t -83.84 134.57 26.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 72.439999999999998 111.166 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.444 ' CB ' HG21 ' A' ' 29' ' ' VAL . 12.5 p90 -158.24 44.85 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 74.140000000000001 110.902 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . 179.02 175.25 45.89 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.772 -0.728 . . . . 75.430000000000007 112.525 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.2 pttp -174.9 145.19 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 71.120000000000005 110.927 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.761 HG11 ' HG2' ' A' ' 136' ' ' MET . 32.7 t -44.73 113.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 61.149999999999999 111.155 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.465 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -78.14 -61.24 2.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 61.219999999999999 110.929 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -152.35 151.42 30.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 54.439999999999998 110.881 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.77 30.44 9.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.733 . . . . 42.240000000000002 112.529 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.761 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -54.02 -26.41 26.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.782 0.325 . . . . 73.230000000000004 110.886 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.19 -34.1 68.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 71.150000000000006 110.841 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.503 HD12 ' HB3' ' A' ' 17' ' ' LEU . 23.5 mm -69.39 -38.27 76.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 62.399999999999999 111.101 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.21 -28.66 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.530000000000001 111.152 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -75.75 -31.31 59.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.887 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.07 -41.41 70.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 45.350000000000001 111.093 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 21.4 mtm -58.04 -45.36 87.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 72.209999999999994 110.902 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 11.3 tm-20 -54.59 -25.3 25.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 62.420000000000002 110.909 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.405 ' HG3' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -78.99 -28.87 43.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 71.310000000000002 110.9 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.405 ' CG ' ' HG3' ' A' ' 144' ' ' ARG . 46.9 m-85 -105.26 34.27 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.310000000000002 110.865 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -113.58 161.01 12.84 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 73.230000000000004 112.466 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 t -117.75 143.64 46.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.89 0.376 . . . . 64.519999999999996 110.852 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -74.76 63.85 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 73.219999999999999 110.906 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -175.45 -34.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 70.109999999999999 110.893 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.59 -44.81 0.74 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.746 -0.74 . . . . 10.41 112.478 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -62.65 -169.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 75.540000000000006 110.902 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.82 147.97 4.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 64.239999999999995 111.167 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.97 -39.61 90.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 51.210000000000001 110.864 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.408 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -101.32 171.56 7.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 73.109999999999999 110.894 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -114.85 108.72 17.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 72.310000000000002 110.924 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.67 HG23 HG23 ' A' ' 10' ' ' ILE . 4.8 mp -93.39 119.52 41.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 75.329999999999998 111.121 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.712 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -127.71 163.09 25.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 70.519999999999996 111.122 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.593 HD13 ' CE2' ' A' ' 8' ' ' PHE . 8.5 mt -91.28 109.37 21.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 72.329999999999998 111.123 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.736 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -73.03 -43.47 62.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 71.409999999999997 111.07 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -162.61 155.0 19.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 75.439999999999998 110.864 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.56 148.44 16.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.211 -0.449 . . . . 71.549999999999997 110.956 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.26 -174.65 44.72 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.739 -0.743 . . . . 75.200000000000003 112.489 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.485 ' HG2' ' NH2' ' A' ' 37' ' ' ARG . 3.1 mt-30 -82.03 131.22 35.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.351 . . . . 65.420000000000002 110.897 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.581 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.2 mm? -86.92 -60.79 1.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 73.040000000000006 110.945 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 75.329999999999998 110.911 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.888 0.375 . . . . 45.140000000000001 111.138 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -94.29 154.81 40.35 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.596 0.712 . . . . 60.439999999999998 110.883 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 146.09 59.05 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 62.130000000000003 112.374 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -133.98 142.97 47.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 43.130000000000003 111.15 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.487 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.8 m -134.23 141.73 42.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 74.239999999999995 111.136 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 13.6 p90 -101.49 168.54 9.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 74.420000000000002 110.876 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.635 ' CD2' HD13 ' A' ' 158' ' ' ILE . 5.4 m-85 -148.44 88.9 1.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 70.439999999999998 110.87 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.697 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.7 t70 -51.25 102.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 60.100000000000001 110.873 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.665 HG22 HD12 ' A' ' 17' ' ' LEU . 34.5 mm -80.3 135.95 24.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 74.340000000000003 111.164 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -127.71 155.41 44.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 111.142 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.426 HG13 ' HB3' ' A' ' 154' ' ' LYS . 48.9 t -136.0 94.09 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 65.209999999999994 111.139 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.61 32.01 7.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 75.540000000000006 110.873 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.55 -23.63 33.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.753 -0.737 . . . . 42.219999999999999 112.481 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -92.3 115.62 65.04 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.615 0.721 . . . . 61.299999999999997 110.922 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.4 Cg_endo -69.76 121.26 7.95 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.703 2.269 . . . . 71.430000000000007 112.319 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.665 HD12 HG22 ' A' ' 10' ' ' ILE . 14.1 mt -65.64 -37.58 86.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 73.409999999999997 110.927 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.43 -125.6 1.69 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 70.299999999999997 112.509 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -128.44 136.95 51.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 74.25 110.853 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.572 HG21 HG13 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -145.24 103.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 70.329999999999998 111.146 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -109.42 173.25 6.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 71.310000000000002 110.885 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.413 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -143.8 127.9 17.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 74.319999999999993 110.87 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -82.89 99.59 9.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 75.030000000000001 110.913 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.4 mt -83.18 122.79 28.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 63.350000000000001 110.889 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -77.48 67.25 3.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 75.140000000000001 110.903 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.45 -20.89 33.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 75.430000000000007 111.105 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -68.57 -38.48 80.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 72.209999999999994 110.859 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.48 -28.07 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 72.129999999999995 110.925 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.427 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -136.68 67.9 58.79 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.627 0.727 . . . . 34.140000000000001 111.105 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -36.91 9.89 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.705 2.27 . . . . 74.400000000000006 112.338 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.68 -37.68 82.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 72.329999999999998 110.907 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.4 m -88.53 -43.21 11.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 65.549999999999997 111.173 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.42 -49.38 77.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 50.020000000000003 111.136 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -51.29 -27.67 10.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 110.903 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.0 -63.83 0.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.329999999999998 110.897 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -59.94 -32.75 71.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 74.209999999999994 110.883 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.47 ' O ' HG23 ' A' ' 41' ' ' THR . 1.6 ttp180 -71.72 -47.8 51.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 75.230000000000004 110.903 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.3 -36.94 69.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 64.430000000000007 111.097 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.5 mt -77.65 -50.69 11.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 75.030000000000001 110.9 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.5 m -58.68 -38.13 77.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 73.140000000000001 110.873 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 37' ' ' ARG . 46.5 p -71.37 -38.6 71.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 72.239999999999995 111.144 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.81 -10.8 45.27 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.732 -0.746 . . . . 73.099999999999994 112.467 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -30.72 39.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 64.040000000000006 110.854 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -65.69 -28.71 69.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 63.240000000000002 110.927 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.28 -15.98 58.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.734 . . . . 61.210000000000001 112.516 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -155.11 -167.39 2.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.895 0.379 . . . . 75.409999999999997 110.866 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.56 -158.43 28.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.749 . . . . 44.219999999999999 112.492 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -112.42 21.09 16.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.929 0.395 . . . . 73.540000000000006 110.864 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.51 121.43 5.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 74.129999999999995 110.919 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.37 44.73 9.3 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.761 -0.733 . . . . 24.420000000000002 112.458 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.613 ' O ' HG22 ' A' ' 157' ' ' THR . 9.7 t -92.59 -169.38 2.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.824 0.345 . . . . 54.43 110.873 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 8.1 p -121.14 143.43 49.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 74.319999999999993 110.889 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -99.98 141.28 33.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 74.310000000000002 110.871 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -151.87 48.26 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 73.019999999999996 110.807 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.1 tpp85 -172.95 68.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 75.5 110.894 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 56' ' ' ILE . 4.7 mt -116.11 113.3 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 73.299999999999997 111.127 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.5 mt -110.26 103.16 53.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.629 0.728 . . . . 73.340000000000003 111.156 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 86.24 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.671 2.247 . . . . 74.409999999999997 112.353 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.57 -20.77 1.5 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.737 -0.744 . . . . 64.099999999999994 112.485 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.87 -52.47 1.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 73.409999999999997 110.869 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.51 166.46 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 73.409999999999997 110.876 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.7 m -107.34 -169.4 1.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 73.120000000000005 110.918 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 173.85 149.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 71.230000000000004 110.891 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.67 -0.776 . . . . 71.030000000000001 112.497 -179.945 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.873 0.368 . . . . 74.150000000000006 111.125 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -127.79 -77.8 0.57 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 110.951 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -151.24 -76.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.67 -0.776 . . . . 45.049999999999997 112.464 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 4.7 mm-40 -117.55 -52.58 2.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.919 0.39 . . . . 75.099999999999994 110.909 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER 179.04 152.24 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 110.908 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -117.32 167.62 11.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 72.219999999999999 110.885 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.49 161.53 16.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.494 . . . . 73.329999999999998 110.881 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -48.28 151.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 73.439999999999998 110.848 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -102.78 -76.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 61.210000000000001 110.899 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -158.25 172.8 17.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 71.349999999999994 110.934 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.13 38.02 3.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 73.549999999999997 110.901 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.31 -31.53 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 62.409999999999997 111.156 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.8 mt -107.42 91.94 3.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 71.519999999999996 110.908 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -73.36 148.2 43.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 72.219999999999999 110.903 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -57.5 96.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 75.310000000000002 110.855 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -85.19 -57.93 2.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 75.030000000000001 111.129 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -143.26 -164.88 10.46 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.774 -0.727 . . . . 75.319999999999993 112.484 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 175.31 8.3 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.667 2.244 . . . . 73.120000000000005 112.359 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.07 21.19 69.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.785 -0.721 . . . . 62.450000000000003 112.512 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.1 mm -96.19 142.54 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.381 . . . . 64.140000000000001 111.144 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -114.49 143.71 44.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 64.540000000000006 110.929 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.98 -165.24 2.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 73.439999999999998 110.882 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 35.5 mtm -92.22 99.02 11.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 71.439999999999998 110.878 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -73.07 60.33 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.427 . . . . 65.109999999999999 111.096 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -118.7 -179.17 3.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.040000000000006 110.922 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.07 -24.49 3.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 65.0 111.121 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.96 -80.84 0.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.759 -0.734 . . . . 64.510000000000005 112.502 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 89.56 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.664 2.243 . . . . 71.329999999999998 112.322 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.505 ' C ' HG23 ' A' ' 107' ' ' THR . 40.6 m-20 66.26 -170.37 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 75.140000000000001 110.883 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.505 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.2 p 67.32 34.42 4.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 61.520000000000003 111.154 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.83 148.47 23.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 55.119999999999997 110.913 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.65 59.2 0.44 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.73 -0.747 . . . . 63.439999999999998 112.462 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 65.2 36.2 7.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.836 0.35 . . . . 73.019999999999996 110.89 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -59.66 -169.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 70.200000000000003 110.909 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 177.43 149.05 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 73.129999999999995 110.92 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -165.49 73.2 0.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 71.030000000000001 110.884 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.506 ' C ' ' O ' ' A' ' 113' ' ' PHE . 19.1 mt -28.4 106.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 72.439999999999998 111.126 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 35.7 m -80.5 117.84 21.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 73.510000000000005 110.888 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 60.5 p -94.84 26.36 3.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 61.25 111.154 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.683 ' O ' HG23 ' A' ' 119' ' ' THR . . . 176.7 145.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 55.25 111.123 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -54.83 100.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 64.340000000000003 110.9 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.695 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 27.9 p -101.19 47.61 0.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 75.209999999999994 111.147 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -26.25 68.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 63.549999999999997 110.852 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.695 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.6 p90 -48.41 -28.62 3.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 73.030000000000001 110.942 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 26.0 mt -47.4 -35.82 8.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 74.109999999999999 110.914 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 124' ' ' GLY . 1.8 m-20 61.24 81.43 0.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 62.119999999999997 110.884 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.05 43.27 0.87 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 74.329999999999998 112.497 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.98 -17.86 39.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.785 0.326 . . . . 74.409999999999997 110.885 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -143.59 -168.1 2.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 74.219999999999999 110.851 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.4 t -126.26 119.32 53.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 51.539999999999999 111.115 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.8 t -83.23 129.89 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 53.43 111.107 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.492 ' O ' HD23 ' A' ' 24' ' ' LEU . 31.9 p90 -153.86 33.83 0.44 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.340000000000003 110.862 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -171.96 172.85 44.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.722 . . . . 70.409999999999997 112.486 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -175.81 135.18 0.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 73.439999999999998 110.914 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.741 HG11 ' HG2' ' A' ' 136' ' ' MET . 58.7 t -39.69 104.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 64.030000000000001 111.13 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.75 -60.0 2.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 73.510000000000005 110.899 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -154.56 160.22 41.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 74.040000000000006 110.882 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.59 32.03 28.61 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 74.349999999999994 112.528 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.741 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -52.62 -29.59 26.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.747 0.308 . . . . 73.310000000000002 110.871 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.44 -32.4 49.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 71.400000000000006 110.907 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.54 HD12 ' HB3' ' A' ' 17' ' ' LEU . 44.0 mm -65.74 -38.85 83.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 71.349999999999994 111.091 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.9 t -64.39 -27.22 42.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 73.299999999999997 111.163 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.24 -28.49 38.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 55.43 110.876 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.82 -43.2 59.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 51.409999999999997 111.096 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 40.7 mtm -60.73 -51.29 69.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 75.319999999999993 110.851 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.423 ' OE1' HG23 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -55.94 -23.2 30.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 75.200000000000003 110.881 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -23.97 61.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 75.439999999999998 110.883 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -109.73 19.85 18.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 71.120000000000005 110.885 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.5 167.37 12.35 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.773 -0.727 . . . . 72.140000000000001 112.47 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.5 m -109.8 148.15 31.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 53.210000000000001 110.851 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.4 mmm-85 -76.53 64.21 2.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 72.230000000000004 110.875 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -174.13 -36.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 73.430000000000007 110.902 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 156.76 -47.65 0.48 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 72.420000000000002 112.525 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 168.11 9.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.84 0.352 . . . . 73.349999999999994 110.935 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.3 p -144.91 -174.24 4.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 72.049999999999997 111.157 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.84 -68.3 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 31.219999999999999 110.852 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.426 ' HB3' HG13 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -79.28 -176.06 4.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 74.329999999999998 110.924 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.85 109.73 18.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 71.120000000000005 110.921 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mp -85.04 118.34 31.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 64.099999999999994 111.18 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.613 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -129.72 162.34 28.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 53.409999999999997 111.15 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.635 HD13 ' CD2' ' A' ' 8' ' ' PHE . 7.6 mt -101.34 120.89 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 64.219999999999999 111.12 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.697 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -79.98 -48.83 12.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 62.039999999999999 111.119 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -156.95 158.31 36.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 61.530000000000001 110.828 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.89 146.91 13.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 73.230000000000004 110.887 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.68 174.04 45.29 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.747 -0.74 . . . . 74.329999999999998 112.471 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -65.0 140.57 58.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.853 0.359 . . . . 61.219999999999999 110.924 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.569 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -93.41 -59.39 2.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 110.923 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 54.200000000000003 110.871 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.7 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.834 0.349 . . . . 74.040000000000006 111.147 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -123.51 154.19 66.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.605 0.717 . . . . 73.329999999999998 110.902 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 145.49 57.11 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.709 2.273 . . . . 53.32 112.341 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.9 m -128.84 128.96 44.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 61.299999999999997 111.165 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.403 HG13 ' CD1' ' A' ' 24' ' ' LEU . 2.4 m -124.52 172.71 11.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 51.340000000000003 111.18 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.666 ' HB3' HD21 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -162.0 174.26 13.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 71.549999999999997 110.905 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -153.05 97.85 2.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 63.200000000000003 110.958 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.9 OUTLIER -45.34 108.96 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 62.109999999999999 110.861 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.818 HG22 HD12 ' A' ' 17' ' ' LEU . 42.2 mm -80.11 133.64 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 73.409999999999997 111.136 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -125.82 156.37 39.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 74.150000000000006 111.086 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 154' ' ' LYS . 42.5 t -134.81 96.39 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 64.010000000000005 111.171 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.56 30.56 10.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 72.109999999999999 110.883 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.31 -23.8 32.11 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 45.399999999999999 112.495 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -91.79 116.03 65.68 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.658 0.742 . . . . 74.120000000000005 110.872 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.2 Cg_endo -69.77 126.09 12.9 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.687 2.258 . . . . 62.520000000000003 112.324 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.818 HD12 HG22 ' A' ' 10' ' ' ILE . 12.1 mt -70.32 -40.93 73.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 73.310000000000002 110.938 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.26 -122.13 1.09 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.729 -0.748 . . . . 65.109999999999999 112.493 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -134.32 143.12 47.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 74.049999999999997 110.908 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.47 HG21 HG13 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -146.26 100.31 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 70.200000000000003 111.156 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 2.1 t -104.52 173.78 6.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 73.400000000000006 110.854 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.556 ' CZ ' HD11 ' A' ' 114' ' ' ILE . 63.9 m-85 -145.18 130.74 18.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 61.439999999999998 110.88 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -86.28 95.2 9.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 71.409999999999997 110.878 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.1 mt -80.1 134.07 36.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 73.040000000000006 110.872 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -93.1 66.58 4.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 72.200000000000003 110.849 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.67 -22.71 36.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 60.420000000000002 111.086 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -65.68 -35.65 81.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 55.310000000000002 110.865 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -99.61 -29.24 12.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 71.439999999999998 110.922 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.425 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -134.86 66.06 67.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 74.019999999999996 111.106 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -35.32 12.7 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.688 2.259 . . . . 73.340000000000003 112.321 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.06 -39.39 81.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 64.200000000000003 110.895 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.401 HG21 ' CD1' ' A' ' 129' ' ' PHE . 31.7 m -89.84 -49.25 6.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 74.040000000000006 111.135 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.26 -42.16 63.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 63.420000000000002 111.094 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.75 -25.18 62.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 75.25 110.919 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.7 -65.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 73.129999999999995 110.85 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -31.14 66.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 73.439999999999998 110.891 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.557 ' O ' HG23 ' A' ' 41' ' ' THR . 1.3 ttp180 -73.15 -52.91 12.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 75.099999999999994 110.856 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.05 -33.52 57.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 54.020000000000003 111.095 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.5 HD22 ' HA2' ' A' ' 47' ' ' GLY . 12.6 mt -80.59 -56.07 4.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 74.219999999999999 110.914 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.1 m -54.38 -36.05 63.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 44.32 110.83 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 37' ' ' ARG . 69.9 p -73.9 -45.29 51.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 75.430000000000007 111.147 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.7 -14.93 19.76 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.728 -0.749 . . . . 64.420000000000002 112.477 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -32.77 46.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 75.230000000000004 110.901 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -63.23 -28.77 70.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 64.409999999999997 110.892 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.86 -16.52 50.8 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.785 -0.721 . . . . 64.010000000000005 112.518 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -156.35 -165.91 2.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.923 0.392 . . . . 74.549999999999997 110.871 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA2' HD22 ' A' ' 39' ' ' LEU . . . 157.44 -164.75 33.14 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.721 -0.752 . . . . 52.539999999999999 112.452 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -105.74 26.78 9.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.911 0.386 . . . . 64.310000000000002 110.929 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.38 129.84 16.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 71.010000000000005 110.893 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.95 37.71 88.15 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.786 -0.721 . . . . 63.530000000000001 112.483 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.4 p -71.92 -172.56 0.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 50.039999999999999 110.819 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 8.1 p -131.45 127.33 37.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 61.420000000000002 110.858 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -86.0 115.56 23.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 73.140000000000001 110.863 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -124.08 32.55 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 61.310000000000002 110.878 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.71 83.04 0.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 72.209999999999994 110.865 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 56' ' ' ILE . 10.0 mt -123.24 110.67 26.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 64.5 111.153 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.4 mt -104.17 104.24 42.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.676 0.75 . . . . 71.310000000000002 111.097 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 81.95 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.684 2.256 . . . . 75.530000000000001 112.367 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.77 -21.89 0.8 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 74.400000000000006 112.508 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.42 -54.95 2.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 75.329999999999998 110.892 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 171.58 168.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 72.439999999999998 110.867 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 113' ' ' PHE . 34.7 m -106.4 -165.65 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 70.310000000000002 110.864 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.62 130.55 9.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 72.140000000000001 110.925 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.721 -0.752 . . . . 73.439999999999998 112.457 -179.969 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.515 ' O ' HD12 ' A' ' 78' ' ' ILE . 1.2 pp . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.878 0.371 . . . . 63.420000000000002 111.142 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -140.83 35.54 1.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 63.109999999999999 110.911 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.97 -140.51 15.04 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.75 -0.738 . . . . 63.530000000000001 112.496 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -78.17 -31.28 49.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.892 0.377 . . . . 72.219999999999999 110.891 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.47 -179.56 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 74.329999999999998 110.894 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.66 162.7 35.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 61.100000000000001 110.892 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -78.78 167.96 20.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 74.140000000000001 110.877 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -59.35 146.02 41.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 74.409999999999997 110.85 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -102.59 -77.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 64.319999999999993 110.889 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -152.24 171.44 17.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 63.399999999999999 110.905 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.55 38.36 3.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 70.439999999999998 110.901 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mt -50.42 -30.48 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 73.109999999999999 111.131 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.6 mt -108.42 93.33 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.952 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -73.03 148.94 43.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 64.030000000000001 110.876 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -59.76 94.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.887 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.04 -59.28 2.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 71.310000000000002 111.149 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . -142.83 -166.02 10.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 73.120000000000005 112.523 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 172.24 12.98 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.676 2.251 . . . . 75.140000000000001 112.331 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.15 20.12 76.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.695 -0.764 . . . . 71.530000000000001 112.499 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.2 mm -96.21 142.52 13.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.853 0.359 . . . . 73.530000000000001 111.11 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.438 HD21 ' CD2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -112.52 141.04 46.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 71.310000000000002 110.891 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.22 165.86 32.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 53.520000000000003 110.862 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 11.8 mtm -71.92 87.19 1.01 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 72.019999999999996 110.922 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.792 ' HB3' ' CG ' ' A' ' 111' ' ' GLN . . . -48.35 124.6 8.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 62.450000000000003 111.127 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 24.1 p-10 -170.6 -174.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 72.140000000000001 110.912 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.03 -12.53 60.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 74.420000000000002 111.171 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.12 -83.3 0.34 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 61.299999999999997 112.51 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 96.28 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.666 2.244 . . . . 54.450000000000003 112.341 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 71.27 178.38 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 55.130000000000003 110.875 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.2 p 58.53 40.13 24.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 75.409999999999997 111.139 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 4.2 m120 -43.19 -35.3 1.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 72.540000000000006 110.894 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . 69.83 -62.83 0.69 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.8 -0.714 . . . . 71.329999999999998 112.46 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 0.6 OUTLIER 81.96 44.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.844 0.354 . . . . 34.539999999999999 110.858 -179.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.792 ' CG ' ' HB3' ' A' ' 101' ' ' ALA . 24.5 pt20 -92.95 -7.63 45.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 71.030000000000001 110.88 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.553 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER 69.16 149.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 72.030000000000001 110.931 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.587 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -163.29 70.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 72.200000000000003 110.842 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.556 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -27.48 124.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 53.030000000000001 111.154 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.6 m -96.0 114.08 25.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 72.049999999999997 110.909 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 45.9 p -92.56 28.47 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 72.219999999999999 111.114 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.697 ' O ' HG23 ' A' ' 119' ' ' THR . . . 175.95 141.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 63.520000000000003 111.062 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.418 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 2.1 tttt -50.63 99.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 71.299999999999997 110.905 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.798 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 49.6 p -98.99 55.67 1.02 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.218 -0.446 . . . . 61.020000000000003 111.125 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -23.87 61.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 73.120000000000005 110.882 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.798 ' CZ2' HG22 ' A' ' 119' ' ' THR . 8.1 p90 -49.88 -29.6 8.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 74.430000000000007 110.95 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.707 HD22 ' NE2' ' A' ' 126' ' ' HIS . 32.0 mt -49.45 -32.52 12.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 62.329999999999998 110.931 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.3 m-20 60.13 76.6 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 73.140000000000001 110.814 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.46 42.15 0.89 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.717 -0.754 . . . . 70.219999999999999 112.444 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.67 -21.93 32.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.831 0.348 . . . . 72.340000000000003 110.914 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.707 ' NE2' HD22 ' A' ' 122' ' ' LEU . 5.6 m-70 -129.18 -166.72 1.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 74.329999999999998 110.844 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 79.1 t -128.99 118.76 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 65.439999999999998 111.152 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.82 132.57 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 41.109999999999999 111.103 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.425 ' CB ' HG21 ' A' ' 29' ' ' VAL . 22.7 p90 -155.13 30.1 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 64.209999999999994 110.878 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -168.39 173.99 43.14 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.717 -0.754 . . . . 63.100000000000001 112.476 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 7.2 pttt -175.49 135.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 63.329999999999998 110.892 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' ' 136' ' ' MET . 71.2 t -40.58 105.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 75.140000000000001 111.114 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -59.36 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 71.329999999999998 110.903 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -154.19 -178.72 7.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 64.109999999999999 110.887 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.91 31.13 60.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 73.310000000000002 112.514 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.503 ' HB2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -57.09 -24.63 55.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 72.010000000000005 110.867 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.41 -30.63 19.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 74.120000000000005 110.859 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.642 HD12 ' HB3' ' A' ' 17' ' ' LEU . 40.0 mm -65.15 -38.85 83.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 65.140000000000001 111.113 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 74.6 t -63.44 -30.4 49.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 65.230000000000004 111.179 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -76.49 -28.83 56.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 74.099999999999994 110.841 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.48 -41.3 60.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 54.450000000000003 111.102 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.417 ' SD ' HG21 ' A' ' 10' ' ' ILE . 33.8 mtm -61.35 -51.28 69.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 53.229999999999997 110.831 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.66 -25.52 27.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 72.239999999999995 110.951 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.418 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.84 -25.07 61.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 73.310000000000002 110.868 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.418 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 70.9 m-85 -105.98 10.47 32.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 72.439999999999998 110.895 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.8 165.18 13.32 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.792 -0.718 . . . . 62.439999999999998 112.452 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.0 m -108.67 148.02 31.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 74.239999999999995 110.841 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 -75.95 60.73 1.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 72.239999999999995 110.843 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -163.38 -38.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 74.540000000000006 110.875 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 158.38 -50.99 0.41 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.789 -0.72 . . . . 30.41 112.492 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.03 174.14 7.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 55.0 110.886 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.8 p -144.36 -170.39 3.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 54.240000000000002 111.181 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 63.4 m -98.23 -67.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 52.5 110.843 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.492 ' HB3' HG13 ' A' ' 12' ' ' VAL . 1.4 mttp -76.89 -175.88 3.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 73.340000000000003 110.896 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.52 109.8 18.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.433 . . . . 75.439999999999998 110.879 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.495 HG23 HG23 ' A' ' 10' ' ' ILE . 4.2 mp -86.37 114.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 73.030000000000001 111.098 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.41 164.4 20.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 64.129999999999995 111.173 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.4 mt -103.89 125.65 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 64.409999999999997 111.099 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -87.93 -54.51 4.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 73.450000000000003 111.144 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -142.2 150.73 41.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 75.310000000000002 110.851 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -156.88 146.75 20.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 22.440000000000001 110.878 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.66 164.18 24.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.767 -0.73 . . . . 43.149999999999999 112.518 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.409 ' HB2' HG22 ' A' ' 41' ' ' THR . 1.3 tt0 -57.68 111.43 1.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 64.310000000000002 110.882 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.666 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.1 mm? -54.36 -51.22 65.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 72.25 110.93 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 71.010000000000005 110.872 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.458 -0.031 0 CA-C-O 120.861 0.362 . . . . 52.229999999999997 111.151 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -106.08 141.53 22.93 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.608 0.718 . . . . 61.310000000000002 110.906 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 147.19 62.49 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.686 2.257 . . . . 74.319999999999993 112.322 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -130.96 140.85 50.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 71.099999999999994 111.174 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.509 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.5 m -135.14 142.47 39.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 62.420000000000002 111.114 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.558 ' HB3' HD21 ' A' ' 164' ' ' LEU . 11.7 p90 -103.37 161.71 13.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 74.109999999999999 110.923 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.745 ' CD2' HD13 ' A' ' 158' ' ' ILE . 4.6 m-85 -144.45 89.18 1.98 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 110.889 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.6 OUTLIER -51.17 103.24 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 61.109999999999999 110.838 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.513 HG13 HG21 ' A' ' 20' ' ' VAL . 29.8 mm -75.85 136.75 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 62.509999999999998 111.126 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -128.16 152.98 47.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.040000000000006 111.131 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 t -135.97 94.98 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.438 . . . . 62.409999999999997 111.116 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.74 31.27 4.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.439999999999998 110.859 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.02 -22.18 40.48 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.714 -0.755 . . . . 75.209999999999994 112.492 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -94.23 117.41 67.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.676 0.751 . . . . 55.219999999999999 110.859 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.75 124.56 11.2 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.683 2.255 . . . . 64.219999999999999 112.364 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.522 ' HB3' HD12 ' A' ' 138' ' ' ILE . 8.9 mt -68.87 -39.13 80.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 63.130000000000003 110.953 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.52 -135.93 4.62 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 64.340000000000003 112.433 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.32 134.33 55.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 53.140000000000001 110.917 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.513 HG21 HG13 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -145.79 102.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 73.209999999999994 111.137 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -111.44 172.36 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 64.409999999999997 110.852 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.41 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -143.97 130.95 20.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 64.310000000000002 110.894 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.403 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 25.9 tt0 -84.42 100.38 11.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.519999999999996 110.896 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.459 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 1.7 mt -84.99 127.77 34.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 70.340000000000003 110.911 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.42 ' CD1' HD13 ' A' ' 90' ' ' LEU . 46.7 m-85 -86.79 68.55 10.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 75.019999999999996 110.865 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.76 -23.9 32.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 70.409999999999997 111.077 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.5 -34.86 78.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 72.340000000000003 110.833 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 -27.45 14.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 75.230000000000004 110.901 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.422 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -139.42 66.78 37.18 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.636 0.732 . . . . 71.109999999999999 111.096 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -36.66 10.39 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.687 2.258 . . . . 73.329999999999998 112.3 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -37.56 80.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 74.450000000000003 110.834 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.7 m -88.53 -45.65 9.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 54.539999999999999 111.116 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.76 -38.66 82.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 72.310000000000002 111.11 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -51.22 -35.26 35.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 75.340000000000003 110.917 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -64.21 -63.18 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 75.430000000000007 110.888 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -56.93 -39.82 75.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 73.340000000000003 110.892 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.51 -47.29 76.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 72.530000000000001 110.856 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.68 74.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 75.109999999999999 111.129 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.2 mt -77.26 -54.8 6.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 72.329999999999998 110.904 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.0 m -51.67 -41.97 61.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 61.020000000000003 110.861 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -76.24 -34.44 59.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 73.329999999999998 111.103 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.26 -11.45 56.97 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.699 -0.762 . . . . 73.150000000000006 112.46 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -59.82 -18.77 46.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 62.200000000000003 110.905 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.614 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -49.23 -28.35 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 70.239999999999995 110.859 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.52 -26.03 5.26 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.798 -0.715 . . . . 53.219999999999999 112.518 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -158.67 -46.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 74.129999999999995 110.862 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.92 -149.8 43.99 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.775 -0.726 . . . . 75.040000000000006 112.498 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -179.45 92.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.954 0.407 . . . . 73.219999999999999 110.94 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.86 82.64 6.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 72.420000000000002 110.946 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 179.06 -68.34 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.71 -0.757 . . . . 41.130000000000003 112.511 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.463 ' O ' HG22 ' A' ' 157' ' ' THR . 0.7 OUTLIER 48.36 -166.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 54.130000000000003 110.839 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.1 p -176.86 122.56 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 52.229999999999997 110.875 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.406 ' CD1' HG22 ' A' ' 156' ' ' ILE . 24.7 m-85 -84.13 128.81 34.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 74.140000000000001 110.846 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -129.57 35.55 4.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 74.540000000000006 110.84 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.19 100.74 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 74.409999999999997 110.87 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.7 mt -140.65 113.98 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.478 . . . . 62.229999999999997 111.141 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.412 ' O ' HG22 ' A' ' 57' ' ' ILE . 6.8 mt -113.9 113.02 47.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.592 0.711 . . . . 74.239999999999995 111.091 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 81.28 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.67 2.247 . . . . 44.409999999999997 112.388 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.38 -25.73 0.29 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 73.209999999999994 112.461 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.43 -57.37 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.884 0.373 . . . . 62.399999999999999 110.914 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 170.0 169.32 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 53.240000000000002 110.877 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.0 m -92.51 -165.78 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 63.509999999999998 110.893 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 176.49 142.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 61.409999999999997 110.968 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.739 . . . . 53.299999999999997 112.488 -179.97 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.614 HG22 ' HD2' ' A' ' 44' ' ' LYS . 5.9 pt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.807 0.337 . . . . 71.010000000000005 111.114 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -170.92 55.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 72.099999999999994 110.912 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.03 177.83 51.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.744 . . . . 43.509999999999998 112.476 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -52.23 -28.3 18.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.954 0.407 . . . . 73.439999999999998 110.86 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.555 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 179.84 -175.58 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 74.129999999999995 110.905 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.431 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -142.38 -179.06 6.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 75.349999999999994 110.935 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.2 168.07 20.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 51.030000000000001 110.86 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -70.87 132.45 45.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 74.530000000000001 110.899 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -89.39 -70.11 0.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 75.409999999999997 110.886 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -172.01 172.79 4.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 73.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.9 36.78 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 73.329999999999998 110.829 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -49.64 -30.73 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 73.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.42 HD13 ' CD1' ' A' ' 25' ' ' PHE . 20.6 mt -110.42 68.13 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 74.439999999999998 110.893 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.67 156.19 14.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 62.140000000000001 110.913 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -61.76 92.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 72.140000000000001 110.8 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.4 p -105.35 24.82 11.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 62.200000000000003 111.121 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.39 177.93 27.41 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.704 -0.76 . . . . 73.0 112.478 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 172.9 11.74 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.674 2.249 . . . . 73.349999999999994 112.357 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.17 38.1 95.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.723 -0.751 . . . . 43.43 112.473 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 97' ' ' ILE . 24.1 mm -110.69 134.37 53.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.868 0.366 . . . . 72.109999999999999 111.155 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.518 HD22 ' CG ' ' A' ' 112' ' ' PHE . 1.6 mt -100.81 156.6 17.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 72.140000000000001 110.921 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 t 175.85 126.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 65.450000000000003 110.883 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.437 ' HE3' ' HA ' ' A' ' 110' ' ' SER . 3.7 mmt -50.55 162.06 0.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 73.030000000000001 110.888 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.447 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . . . -158.0 95.12 1.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 75.209999999999994 111.108 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -118.07 -21.94 8.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 51.009999999999998 110.884 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.84 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -179.0 -32.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 64.239999999999995 111.112 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.09 -82.36 0.33 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.705 -0.759 . . . . 71.239999999999995 112.478 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 117.32 5.01 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.638 2.225 . . . . 72.319999999999993 112.368 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.424 ' O ' HG23 ' A' ' 107' ' ' THR . 5.6 m-80 40.22 41.79 1.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 75.25 110.936 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.84 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 7.2 p -155.73 56.0 0.61 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.165 -0.471 . . . . 74.239999999999995 111.075 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 100' ' ' MET . 1.5 m-20 -66.1 -42.56 89.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 75.319999999999993 110.948 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.78 -152.91 52.82 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.737 -0.744 . . . . 74.310000000000002 112.459 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.437 ' HA ' ' HE3' ' A' ' 100' ' ' MET . 0.3 OUTLIER -130.17 21.42 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.859 0.362 . . . . 53.039999999999999 110.877 -179.703 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.439 ' O ' ' CG ' ' A' ' 111' ' ' GLN . 5.2 tt0 -116.26 87.94 2.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 73.420000000000002 110.908 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.518 ' CG ' HD22 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -84.88 -165.15 1.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.43 . . . . 72.439999999999998 110.834 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -153.36 165.69 34.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 70.310000000000002 110.896 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.57 HG21 ' CG1' ' A' ' 139' ' ' VAL . 2.4 mp -100.06 90.88 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 72.310000000000002 111.124 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 53.2 m -66.08 89.96 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 52.229999999999997 110.889 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.3 p -67.68 -8.11 32.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 74.349999999999994 111.099 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.704 ' O ' HG23 ' A' ' 119' ' ' THR . . . -145.9 153.3 40.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 111.138 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -56.57 94.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 63.530000000000001 110.918 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 117' ' ' ALA . 24.2 p -96.73 45.99 1.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 71.209999999999994 111.148 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -24.66 67.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 64.340000000000003 110.842 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.686 ' CZ2' HG22 ' A' ' 119' ' ' THR . 5.9 p90 -48.51 -27.62 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 72.329999999999998 110.929 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.6 mt -45.83 -34.42 3.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 72.010000000000005 110.919 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 124' ' ' GLY . 1.7 m-20 62.17 78.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 62.009999999999998 110.834 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.07 43.07 0.63 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 60.399999999999999 112.494 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 -17.28 43.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.773 0.321 . . . . 74.109999999999999 110.875 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -143.24 -165.48 2.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 71.439999999999998 110.897 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.0 t -126.21 130.22 72.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.432 . . . . 73.329999999999998 111.114 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.9 135.86 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 65.129999999999995 111.15 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.452 ' O ' HD23 ' A' ' 24' ' ' LEU . 12.8 p90 -159.33 38.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 74.209999999999994 110.865 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -178.12 173.77 46.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.73 -0.748 . . . . 51.140000000000001 112.459 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -174.99 140.0 0.51 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.854 0.359 . . . . 74.219999999999999 110.887 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.695 HG11 ' HG2' ' A' ' 136' ' ' MET . 42.0 t -40.65 107.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 65.109999999999999 111.151 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.403 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -72.15 -59.96 2.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 64.420000000000002 110.849 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -154.43 152.33 30.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 63.25 110.911 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.37 41.86 6.39 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.742 -0.742 . . . . 73.019999999999996 112.493 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.695 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -60.08 -33.7 72.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.838 0.351 . . . . 63.140000000000001 110.902 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -36.31 31.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.439 . . . . 75.150000000000006 110.91 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.522 HD12 ' HB3' ' A' ' 17' ' ' LEU . 38.3 mm -63.86 -38.97 83.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 54.509999999999998 111.088 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.57 ' CG1' HG21 ' A' ' 114' ' ' ILE . 76.2 t -66.63 -24.34 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 61.009999999999998 111.139 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.08 -27.33 30.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 73.319999999999993 110.902 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.17 59.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 53.329999999999998 111.112 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 31.7 mtm -60.0 -54.11 49.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 73.040000000000006 110.888 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.48 ' OE1' ' HA ' ' A' ' 143' ' ' GLU . 10.4 mm-40 -54.84 -28.89 53.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 55.25 110.899 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.451 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -64.22 -24.3 67.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 64.239999999999995 110.83 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.451 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 69.0 m-85 -106.85 32.5 4.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 110.863 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.65 170.63 15.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 73.430000000000007 112.471 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.5 t -127.37 146.97 50.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.887 0.375 . . . . 71.349999999999994 110.861 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.1 mmm-85 -72.83 77.29 1.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 73.230000000000004 110.897 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -174.45 -35.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 60.130000000000003 110.891 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.89 -77.5 0.24 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.705 -0.759 . . . . 73.230000000000004 112.5 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.17 168.94 9.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 71.319999999999993 110.882 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.9 p -144.16 -173.76 4.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 60.210000000000001 111.182 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.0 p -86.85 -63.03 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 72.549999999999997 110.834 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -66.2 173.54 3.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 72.230000000000004 110.86 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -122.79 109.65 14.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 75.349999999999994 110.886 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 156' ' ' ILE . 4.2 mp -85.86 119.59 34.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 73.239999999999995 111.124 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -132.83 163.61 28.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 60.32 111.156 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.745 HD13 ' CD2' ' A' ' 8' ' ' PHE . 5.1 mt -102.45 128.35 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 75.099999999999994 111.14 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -91.65 -59.55 2.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 64.310000000000002 111.109 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -134.59 155.77 49.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 63.439999999999998 110.894 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.66 143.93 4.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 64.019999999999996 110.859 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.89 173.23 43.15 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 53.409999999999997 112.483 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -64.59 140.63 58.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 65.099999999999994 110.888 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.558 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -93.28 -57.68 2.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 75.109999999999999 110.938 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 65.219999999999999 110.886 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.816 0.341 . . . . 64.129999999999995 110.885 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.5 t -140.39 131.94 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 55.420000000000002 111.126 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -103.75 152.15 38.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.659 0.742 . . . . 74.519999999999996 110.839 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 146.7 60.82 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.661 2.24 . . . . 74.019999999999996 112.359 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -131.89 141.28 49.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 70.230000000000004 111.178 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.498 ' HA ' HD23 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -135.69 144.26 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 74.540000000000006 111.14 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 18.7 p90 -101.94 165.22 11.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 75.129999999999995 110.873 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.674 ' CD2' HD13 ' A' ' 158' ' ' ILE . 7.2 m-85 -146.95 91.99 2.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 70.549999999999997 110.873 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.6 OUTLIER -54.99 101.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 72.530000000000001 110.888 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.462 ' CG1' HG21 ' A' ' 20' ' ' VAL . 49.7 mm -82.07 119.17 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 53.25 111.078 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -107.71 157.79 17.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 55.240000000000002 111.144 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.413 HG13 ' HB3' ' A' ' 154' ' ' LYS . 42.2 t -137.26 95.98 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 70.510000000000005 111.08 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.49 31.48 10.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 73.0 110.872 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.57 -22.6 38.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.711 -0.757 . . . . 33.409999999999997 112.469 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -94.7 115.41 65.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.638 0.732 . . . . 72.140000000000001 110.902 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.72 123.62 10.3 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.656 2.238 . . . . 71.329999999999998 112.381 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.467 ' HB3' HG23 ' A' ' 138' ' ' ILE . 13.8 mt -67.07 -39.54 86.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 64.420000000000002 110.953 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.4 -131.15 2.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.825 -0.702 . . . . 73.340000000000003 112.522 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.54 137.04 54.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.818 0.342 . . . . 63.340000000000003 110.867 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.537 ' CG2' HG21 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -146.1 99.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 73.219999999999999 111.132 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -107.87 173.28 6.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 64.450000000000003 110.844 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.42 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -145.94 134.47 22.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 75.209999999999994 110.892 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 49.2 tt0 -83.78 98.47 9.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 71.510000000000005 110.879 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.618 HD23 ' O ' ' A' ' 129' ' ' PHE . 4.3 mt -79.63 115.88 19.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 72.200000000000003 110.942 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -76.0 64.97 1.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 74.129999999999995 110.855 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.63 -22.54 23.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 50.240000000000002 111.103 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -66.5 -35.68 80.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 70.099999999999994 110.886 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.62 -28.87 12.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 74.329999999999998 110.926 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.14 66.52 60.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.616 0.722 . . . . 65.430000000000007 111.111 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -37.2 9.56 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.737 2.291 . . . . 70.040000000000006 112.335 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -63.48 -38.17 90.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 65.019999999999996 110.882 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 m -85.9 -41.29 15.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 75.340000000000003 111.153 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.22 -44.78 82.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 75.140000000000001 111.139 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -49.55 -30.23 8.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.010000000000005 110.881 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -67.68 -68.92 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 73.420000000000002 110.88 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -55.27 -25.62 34.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 75.430000000000007 110.94 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.476 ' O ' HG23 ' A' ' 41' ' ' THR . 0.8 OUTLIER -78.52 -55.57 5.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 74.329999999999998 110.885 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.76 -34.66 28.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 63.100000000000001 111.12 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 mt -75.8 -61.98 1.74 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 55.020000000000003 110.91 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.0 m -51.92 -33.92 39.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 53.32 110.858 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 37' ' ' ARG . 73.3 p -76.51 -31.99 58.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 65.049999999999997 111.113 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.01 -15.55 60.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 72.340000000000003 112.528 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -19.16 45.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.869 0.366 . . . . 60.509999999999998 110.888 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.776 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -51.41 -28.94 14.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 71.430000000000007 110.941 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.05 -25.25 6.13 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.739 -0.743 . . . . 54.229999999999997 112.453 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -158.08 -47.68 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.894 0.378 . . . . 72.340000000000003 110.907 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.61 -145.88 47.13 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.72 -0.752 . . . . 75.209999999999994 112.467 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -179.75 92.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.925 0.393 . . . . 73.019999999999996 110.956 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.22 85.45 6.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 74.129999999999995 110.911 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.2 -66.14 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.736 -0.745 . . . . 62.310000000000002 112.523 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.427 ' O ' HG22 ' A' ' 157' ' ' THR . 1.3 m 49.05 -166.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 75.400000000000006 110.9 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.8 147.64 16.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 64.019999999999996 110.892 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -128.73 120.58 26.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 61.25 110.876 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -144.61 42.98 1.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 73.310000000000002 110.864 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.413 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.69 72.88 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 75.540000000000006 110.88 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.697 ' CD1' HD13 ' A' ' 156' ' ' ILE . 4.8 mt -112.59 113.35 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 54.32 111.134 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.405 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 28.9 mt -104.58 103.05 37.81 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.712 . . . . 60.240000000000002 111.121 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 53.4 Cg_endo -69.85 89.56 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.691 2.261 . . . . 71.129999999999995 112.329 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.92 -19.45 1.97 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.71 -0.757 . . . . 53.350000000000001 112.445 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.78 -54.08 1.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 73.519999999999996 110.841 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.446 ' HE1' ' O ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER 173.27 171.35 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 73.540000000000006 110.883 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.446 ' O ' ' HE1' ' A' ' 61' ' ' MET . 7.1 m -111.28 -154.16 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 72.239999999999995 110.846 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 55' ' ' ARG . 54.6 tp60 -134.68 163.38 29.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 70.540000000000006 110.893 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.71 -103.24 2.83 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.757 -0.735 . . . . 70.120000000000005 112.488 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.05 139.21 5.76 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 75.319999999999993 112.5 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.69 146.06 52.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 64.019999999999996 110.807 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -167.77 121.58 0.95 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 55.25 110.887 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.38 -57.72 0.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 74.400000000000006 111.173 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.43 35.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 74.310000000000002 110.917 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.05 -35.77 10.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 75.25 110.802 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -116.62 -35.6 4.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 74.129999999999995 110.851 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 132.55 144.0 5.19 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.741 . . . . 51.450000000000003 112.494 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.4 p 62.92 30.21 16.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.321 . . . . 71.420000000000002 111.143 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.4 -165.54 0.33 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 72.319999999999993 112.46 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -151.23 -131.62 1.81 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.698 -0.763 . . . . 43.039999999999999 112.481 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -175.11 -167.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.349 . . . . 74.510000000000005 110.887 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.404 ' O ' ' CG1' ' A' ' 78' ' ' ILE . 7.3 p -90.16 42.61 1.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.436 . . . . 60.219999999999999 110.905 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.776 HG22 ' HD2' ' A' ' 44' ' ' LYS . 4.1 pt 44.51 28.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 62.409999999999997 111.085 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -174.31 58.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 74.319999999999993 110.892 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.54 -160.41 53.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.784 -0.722 . . . . 61.329999999999998 112.51 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.26 -40.88 59.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 73.450000000000003 110.902 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.532 ' HG2' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER 173.45 -177.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 74.120000000000005 110.878 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.35 -165.94 1.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 72.109999999999999 110.869 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.83 165.51 12.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 65.5 110.884 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -51.44 119.38 4.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.927 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -91.59 -69.16 0.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 72.010000000000005 110.857 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -177.25 177.14 1.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 74.519999999999996 110.909 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.42 36.89 3.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 110.892 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 mt -48.15 -33.63 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 60.240000000000002 111.128 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 22.1 mt -106.83 89.28 2.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 72.510000000000005 110.901 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.698 ' O ' HG23 ' A' ' 93' ' ' THR . 0.1 OUTLIER -79.25 139.23 37.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 73.409999999999997 110.911 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -49.71 101.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 74.349999999999994 110.851 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 91' ' ' LYS . 74.2 p -115.88 28.38 8.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 72.530000000000001 111.121 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.32 178.01 24.81 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 74.329999999999998 112.5 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 173.5 10.81 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.677 2.251 . . . . 75.239999999999995 112.338 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.12 32.8 85.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 75.340000000000003 112.496 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.5 mm -105.91 137.55 35.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.84 0.352 . . . . 54.439999999999998 111.159 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.519 HD21 ' CD1' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -105.16 144.86 31.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 73.329999999999998 110.958 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.58 -163.05 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 74.230000000000004 110.846 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.491 ' HE2' ' HB ' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -123.12 140.92 52.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.497 . . . . 72.200000000000003 110.859 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.794 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -139.55 34.85 2.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 45.439999999999998 111.083 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 1.1 t-20 -70.43 -19.08 63.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 62.549999999999997 110.923 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.74 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . 176.64 -31.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 43.100000000000001 111.101 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.63 -89.28 0.49 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 60.210000000000001 112.495 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 117.24 4.97 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.638 2.226 . . . . 75.099999999999994 112.353 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.493 ' O ' HG23 ' A' ' 107' ' ' THR . 82.9 m-20 45.11 54.61 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 63.130000000000003 110.867 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.74 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 11.1 p -157.96 60.46 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.209999999999994 111.123 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.48 ' O ' ' C ' ' A' ' 109' ' ' GLY . 2.1 m-20 -66.05 -30.71 71.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 70.439999999999998 110.887 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 30.52 -116.14 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.749 . . . . 74.340000000000003 112.519 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.0 p -167.17 40.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.837 0.351 . . . . 62.43 110.85 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.794 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 3.5 mm-40 -108.86 50.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 72.109999999999999 110.916 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.519 ' CD1' HD21 ' A' ' 98' ' ' LEU . 34.6 p90 -54.49 -176.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 75.510000000000005 110.857 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.726 ' CE2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -160.87 91.7 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 63.240000000000002 110.951 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 113' ' ' PHE . 3.0 mt -33.28 105.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 74.209999999999994 111.116 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.452 ' SG ' HG23 ' A' ' 119' ' ' THR . 41.8 t -69.59 100.51 1.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 52.219999999999999 110.914 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 13.1 p -83.94 11.31 7.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 74.439999999999998 111.146 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.49 ' O ' ' C ' ' A' ' 118' ' ' LYS . . . 177.37 124.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 73.230000000000004 111.072 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 117' ' ' ALA . 1.0 OUTLIER -30.22 105.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 71.400000000000006 110.879 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.836 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 71.0 p -87.75 73.51 9.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.5 111.144 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -69.8 -27.09 64.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 63.240000000000002 110.889 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.836 ' CZ2' HG22 ' A' ' 119' ' ' THR . 17.6 p90 -55.86 -22.47 25.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 70.5 110.906 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.682 HD12 ' OG1' ' A' ' 119' ' ' THR . 83.2 mt -77.95 -55.91 4.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 74.439999999999998 110.878 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 53.48 95.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 71.420000000000002 110.827 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 43.17 37.78 3.34 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 32.210000000000001 112.517 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.62 -11.48 48.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 63.310000000000002 110.863 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -148.46 -163.79 1.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 73.540000000000006 110.838 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.491 ' HB ' ' HE2' ' A' ' 100' ' ' MET . 25.0 t -122.09 116.03 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 73.439999999999998 111.139 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.19 134.48 27.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 71.510000000000005 111.149 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.618 ' O ' HD23 ' A' ' 24' ' ' LEU . 15.7 p90 -157.2 54.79 0.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 63.009999999999998 110.891 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.458 ' C ' ' HB2' ' A' ' 98' ' ' LEU . . . 169.92 176.29 39.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.764 -0.731 . . . . 72.340000000000003 112.486 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 132' ' ' VAL . 10.1 pttt -178.89 131.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.792 0.329 . . . . 53.539999999999999 110.905 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.724 HG11 ' HG2' ' A' ' 136' ' ' MET . 48.0 t -36.08 108.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 75.230000000000004 111.13 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.405 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -72.46 -59.33 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 64.530000000000001 110.897 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -152.93 158.35 41.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 65.120000000000005 110.896 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.16 30.94 24.11 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 73.010000000000005 112.475 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.724 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -50.93 -29.42 12.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 62.219999999999999 110.853 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.67 -33.8 35.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 62.329999999999998 110.876 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.537 HG21 ' CG2' ' A' ' 20' ' ' VAL . 44.5 mm -66.06 -44.34 92.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 62.030000000000001 111.131 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.9 t -63.96 -26.34 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 63.229999999999997 111.129 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.5 -30.72 47.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 73.420000000000002 110.857 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.92 -43.39 68.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 60.140000000000001 111.103 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 27.9 mtm -58.58 -43.98 89.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 73.140000000000001 110.859 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 8.7 tm-20 -54.25 -26.65 30.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 64.420000000000002 110.897 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -28.45 52.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 62.340000000000003 110.893 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -103.16 31.61 4.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 73.340000000000003 110.862 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -120.05 152.86 16.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 70.430000000000007 112.499 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.3 t -103.03 144.29 31.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.886 0.374 . . . . 73.0 110.865 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -73.57 65.28 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 62.240000000000002 110.832 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -175.35 -34.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 61.229999999999997 110.883 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.21 -70.9 0.34 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 61.149999999999999 112.482 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.21 170.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 75.109999999999999 110.882 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.4 t -159.48 158.85 32.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 62.509999999999998 111.113 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 86.0 p -75.38 -53.92 7.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.010000000000005 110.859 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.413 ' HB3' HG13 ' A' ' 12' ' ' VAL . 5.9 mttp -73.01 155.52 39.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 75.010000000000005 110.924 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -109.2 109.36 20.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 61.409999999999997 110.921 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.697 HD13 ' CD1' ' A' ' 56' ' ' ILE . 3.6 mp -90.81 123.06 42.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.447 . . . . 74.340000000000003 111.155 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -135.77 162.53 32.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 61.299999999999997 111.123 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.674 HD13 ' CD2' ' A' ' 8' ' ' PHE . 8.4 mt -95.69 120.76 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 70.140000000000001 111.142 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -85.32 -49.39 8.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 62.409999999999997 111.087 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -146.23 156.31 43.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 62.049999999999997 110.88 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.408 ' HA ' ' CE1' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -165.55 144.95 6.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 54.439999999999998 110.901 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.46 171.68 42.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 60.130000000000003 112.493 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -65.35 141.74 58.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 71.120000000000005 110.864 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.554 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.1 mm? -93.48 -56.47 2.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 63.109999999999999 110.892 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 75.430000000000007 110.874 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.865 0.364 . . . . 71.109999999999999 110.875 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 2' ' ' VAL . 3.9 t 61.7 106.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 75.310000000000002 111.125 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 -103.13 152.67 38.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.629 0.728 . . . . 63.310000000000002 110.911 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 146.54 60.22 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.641 2.227 . . . . 73.340000000000003 112.356 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -133.05 141.58 48.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 62.439999999999998 111.165 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.504 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.0 OUTLIER -134.24 143.21 38.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 74.230000000000004 111.16 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 16.6 p90 -100.94 166.37 10.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 75.400000000000006 110.871 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.588 ' CE2' HD13 ' A' ' 158' ' ' ILE . 5.9 m-85 -146.67 87.29 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 73.010000000000005 110.895 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.743 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.7 t0 -50.59 102.45 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 75.409999999999997 110.834 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.663 HG22 HD12 ' A' ' 17' ' ' LEU . 45.9 mm -80.59 128.89 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 55.399999999999999 111.121 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -122.39 154.24 37.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 111.129 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.476 HG13 ' HB3' ' A' ' 154' ' ' LYS . 41.5 t -132.44 94.24 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 63.310000000000002 111.109 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.15 31.37 13.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 65.5 110.905 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.88 -24.77 27.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.754 . . . . 51.140000000000001 112.513 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -91.44 114.57 62.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.62 0.724 . . . . 54.240000000000002 110.916 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.71 122.91 9.59 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.729 2.286 . . . . 62.509999999999998 112.34 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.663 HD12 HG22 ' A' ' 10' ' ' ILE . 12.4 mt -68.26 -38.7 82.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 73.329999999999998 110.949 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.97 -128.21 2.11 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.727 -0.749 . . . . 71.450000000000003 112.49 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.47 136.86 53.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 74.010000000000005 110.861 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.465 HG21 HG13 ' A' ' 10' ' ' ILE . 0.9 OUTLIER -146.35 102.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 64.109999999999999 111.18 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.0 OUTLIER -109.06 174.77 5.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 64.519999999999996 110.841 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.438 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.9 OUTLIER -144.85 132.66 21.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 71.349999999999994 110.924 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.4 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 60.1 tt0 -86.63 97.35 10.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 74.209999999999994 110.878 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.404 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.6 mt -80.69 119.74 23.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 74.120000000000005 110.91 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -78.35 65.19 3.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 74.099999999999994 110.868 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.45 -23.49 10.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 111.1 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -66.85 -31.92 72.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 72.25 110.827 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -101.82 -31.63 10.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 71.439999999999998 110.871 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.48 66.27 69.69 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.588 0.709 . . . . 61.039999999999999 111.169 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -39.85 6.1 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.669 2.246 . . . . 72.519999999999996 112.348 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -36.45 70.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 75.340000000000003 110.942 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.2 m -91.33 -47.91 7.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 71.040000000000006 111.151 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.4 -46.66 80.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 52.530000000000001 111.085 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -54.66 -26.05 30.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 61.130000000000003 110.864 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.569 ' HA ' HD13 ' A' ' 78' ' ' ILE . 0.8 OUTLIER -69.48 -65.31 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 64.129999999999995 110.931 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.95 -24.38 64.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 71.219999999999999 110.918 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.503 ' O ' HG23 ' A' ' 41' ' ' THR . 2.3 ttp180 -80.34 -53.15 6.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 75.219999999999999 110.858 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.04 -34.79 22.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 71.530000000000001 111.075 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 35' ' ' ASN . 3.0 mt -79.52 -59.5 2.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 65.450000000000003 110.944 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.6 m -52.65 -32.16 40.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 43.140000000000001 110.907 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 37' ' ' ARG . 71.3 p -77.51 -52.65 8.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 74.439999999999998 111.19 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.23 -17.86 7.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.741 . . . . 70.340000000000003 112.497 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -33.83 37.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.923 0.392 . . . . 72.150000000000006 110.869 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -58.52 -29.42 66.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 71.340000000000003 110.908 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.16 -13.18 60.36 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.781 -0.723 . . . . 64.040000000000006 112.486 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -160.05 -166.03 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.887 0.375 . . . . 64.150000000000006 110.903 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.54 -140.97 7.05 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 74.420000000000002 112.468 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -157.73 50.77 0.43 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.971 0.415 . . . . 72.219999999999999 110.912 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 142.16 21.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 72.409999999999997 110.899 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.86 21.22 73.12 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.71 -0.757 . . . . 71.450000000000003 112.464 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.11 -26.68 28.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.829 0.347 . . . . 71.329999999999998 110.85 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 0.1 OUTLIER 68.38 155.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 75.230000000000004 110.915 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -95.18 138.65 32.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 72.129999999999995 110.916 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -119.38 30.46 7.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 63.030000000000001 110.842 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -176.34 117.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 44.420000000000002 110.897 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.3 mt -146.11 114.1 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 51.049999999999997 111.135 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.6 mt -106.59 103.05 44.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.69 0.757 . . . . 74.400000000000006 111.149 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.8 Cg_endo -69.74 76.71 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.672 2.248 . . . . 55.310000000000002 112.374 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.04 -26.47 0.32 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.755 -0.736 . . . . 53.030000000000001 112.483 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.408 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -117.56 -57.47 2.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 73.510000000000005 110.853 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.449 ' C ' ' HE3' ' A' ' 61' ' ' MET . 0.0 OUTLIER 176.24 170.55 0.43 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 63.119999999999997 110.851 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 13.2 m -112.98 -177.51 3.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 64.219999999999999 110.869 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -170.6 140.39 1.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 52.509999999999998 110.922 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.52 -144.93 4.13 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.752 -0.737 . . . . 71.109999999999999 112.482 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 52.46 32.63 38.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.727 -0.749 . . . . 71.239999999999995 112.479 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -92.28 113.17 25.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.827 0.346 . . . . 64.319999999999993 110.866 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.497 ' O ' HG23 ' A' ' 68' ' ' THR . 13.8 p90 -167.52 28.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 73.510000000000005 110.885 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER 179.62 107.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 64.340000000000003 111.201 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 70' ' ' HIS . 3.6 mmm180 -116.8 -76.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 74.430000000000007 110.888 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.477 ' CB ' ' O ' ' A' ' 69' ' ' ARG . 1.9 t-80 81.43 -25.51 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 65.349999999999994 110.889 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -179.38 36.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 74.109999999999999 110.919 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.44 106.38 0.29 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.692 -0.766 . . . . 73.109999999999999 112.464 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.6 t 177.46 -48.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.846 0.355 . . . . 74.010000000000005 111.132 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.0 134.58 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.719 -0.753 . . . . 45.43 112.494 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.43 169.27 0.46 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.76 -0.733 . . . . 74.209999999999994 112.476 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -147.1 169.14 19.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.736 0.303 . . . . 72.439999999999998 110.874 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.0 p -83.84 -170.71 3.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 51.140000000000001 110.882 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 35' ' ' ASN . 41.8 pt -107.01 31.54 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 75.409999999999997 111.07 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -130.77 -67.49 0.72 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 110.903 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -137.81 -65.25 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.749 . . . . 43.130000000000003 112.503 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -145.21 -40.06 0.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.887 0.375 . . . . 61.43 110.918 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.408 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.58 179.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 75.140000000000001 110.899 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.61 177.73 8.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 61.32 110.891 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.04 169.47 17.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 72.230000000000004 110.908 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -49.94 163.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 71.540000000000006 110.852 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -120.94 -74.5 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 54.140000000000001 110.854 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -165.22 169.4 16.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 63.219999999999999 110.902 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.42 37.63 3.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 73.209999999999994 110.883 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -50.22 -29.37 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.488 . . . . 65.349999999999994 111.111 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 34.7 mt -111.97 80.52 1.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 75.140000000000001 110.898 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.76 153.16 43.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 74.109999999999999 110.915 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -60.44 94.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 70.310000000000002 110.848 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 p -105.75 25.12 11.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 74.329999999999998 111.134 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.66 179.48 24.62 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.761 -0.733 . . . . 61.530000000000001 112.499 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 171.09 15.11 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.681 2.254 . . . . 62.0 112.351 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.23 29.28 70.46 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.687 -0.768 . . . . 61.32 112.499 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.1 mm -102.82 138.38 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.861 0.362 . . . . 71.319999999999993 111.137 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -109.32 144.2 37.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 73.349999999999994 110.926 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.84 -168.75 2.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 65.439999999999998 110.828 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.41 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 1.8 mtp -105.81 99.97 9.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.497 . . . . 75.420000000000002 110.854 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.721 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -87.64 50.11 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 61.229999999999997 111.082 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -86.59 -78.28 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 75.099999999999994 110.886 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.693 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -146.53 34.01 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 73.109999999999999 111.108 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.36 -111.7 4.39 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.788 -0.72 . . . . 74.420000000000002 112.466 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 111.43 2.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.701 2.267 . . . . 70.109999999999999 112.339 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.536 ' C ' HG23 ' A' ' 107' ' ' THR . 1.7 m-20 72.09 163.72 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 71.450000000000003 110.867 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.693 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.1 p 67.27 29.57 7.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 74.340000000000003 111.125 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.37 78.29 8.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 73.409999999999997 110.849 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -72.35 -71.97 1.0 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 62.009999999999998 112.526 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.41 ' HA ' ' HE2' ' A' ' 100' ' ' MET . 2.7 p 177.29 49.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.783 0.325 . . . . 74.040000000000006 110.86 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.482 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 1.8 mm-40 -64.02 -31.1 72.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 71.140000000000001 110.922 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.482 ' HB3' ' O ' ' A' ' 111' ' ' GLN . 8.2 t80 67.71 139.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 74.219999999999999 110.877 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.721 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -161.08 123.14 3.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 73.299999999999997 110.894 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.9 mt -86.4 126.59 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 74.129999999999995 111.094 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.05 101.07 13.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 62.240000000000002 110.897 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 73.9 p -86.99 20.98 2.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 64.019999999999996 111.151 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.762 ' O ' HG23 ' A' ' 119' ' ' THR . . . 175.59 146.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 72.209999999999994 111.092 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 98.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 63.439999999999998 110.851 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.762 HG23 ' O ' ' A' ' 117' ' ' ALA . 32.8 p -106.51 46.69 0.91 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 74.340000000000003 111.163 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -26.51 64.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 65.549999999999997 110.88 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.738 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.3 p90 -49.5 -25.42 2.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 70.150000000000006 110.951 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 18.1 mt -45.72 -32.19 2.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 70.530000000000001 110.936 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.5 m-20 59.47 77.21 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 75.230000000000004 110.848 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.15 42.23 0.78 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.793 -0.718 . . . . 63.210000000000001 112.46 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -80.59 -26.39 37.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.831 0.348 . . . . 74.010000000000005 110.906 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -136.21 169.03 18.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.409999999999997 110.853 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 50.0 t -102.43 118.53 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 44.240000000000002 111.155 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.02 133.72 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 72.310000000000002 111.129 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.404 ' O ' HD23 ' A' ' 24' ' ' LEU . 21.2 p90 -156.25 33.91 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 62.119999999999997 110.918 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.89 176.11 44.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.712 -0.756 . . . . 73.049999999999997 112.471 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -175.71 135.06 0.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.833 0.349 . . . . 63.109999999999999 110.913 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.682 HG11 ' HG2' ' A' ' 136' ' ' MET . 70.2 t -39.7 107.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 72.239999999999995 111.15 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.4 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -69.62 -59.13 3.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 74.040000000000006 110.908 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -152.78 157.79 41.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 51.0 110.879 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.64 42.95 9.52 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.731 -0.747 . . . . 73.409999999999997 112.472 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.682 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -62.41 -29.04 70.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.328 . . . . 61.109999999999999 110.882 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.86 -31.95 42.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 53.25 110.867 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.545 HD12 ' HB3' ' A' ' 17' ' ' LEU . 45.9 mm -65.21 -40.0 87.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 53.340000000000003 111.099 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.49 -27.75 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 73.450000000000003 111.129 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -80.13 -28.46 38.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 110.868 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.02 -38.72 63.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 74.420000000000002 111.122 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 28.2 mtm -60.7 -52.63 64.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 72.239999999999995 110.894 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -54.51 -26.32 30.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 44.329999999999998 110.95 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.433 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.37 -23.98 63.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 62.32 110.857 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.433 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 64.8 m-85 -107.66 16.11 24.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 75.129999999999995 110.839 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -110.67 168.55 13.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 61.310000000000002 112.497 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.8 m -113.71 146.71 39.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 43.210000000000001 110.847 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -75.72 66.43 2.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.091 -0.504 . . . . 72.319999999999993 110.883 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -171.11 -37.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 70.420000000000002 110.863 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 159.13 -63.15 0.3 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 63.229999999999997 112.472 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.49 175.52 0.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.377 . . . . 72.150000000000006 110.879 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.7 p -145.12 176.69 9.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 65.340000000000003 111.127 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.24 -60.66 1.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.329999999999998 110.853 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.476 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.7 OUTLIER -86.21 -175.77 5.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 75.219999999999999 110.918 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.96 108.73 15.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 53.439999999999998 110.901 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 4.1 mp -83.74 117.96 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 74.129999999999995 111.103 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER -126.12 165.87 18.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 43.350000000000001 111.186 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.588 HD13 ' CE2' ' A' ' 8' ' ' PHE . 4.0 mt -103.87 106.08 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 73.530000000000001 111.142 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.743 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -65.49 -44.96 85.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 73.439999999999998 111.144 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -161.45 158.04 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 74.299999999999997 110.845 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.2 148.27 16.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 72.099999999999994 110.876 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.09 171.77 41.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.713 -0.756 . . . . 73.510000000000005 112.466 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -65.19 142.45 58.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.871 0.367 . . . . 74.409999999999997 110.888 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.576 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -94.54 -58.75 2.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 72.430000000000007 110.918 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 70.409999999999997 110.932 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.5 mtp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.803 0.335 . . . . 71.219999999999999 110.868 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.3 t -137.2 134.69 47.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 111.136 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -108.62 146.31 33.42 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.621 0.724 . . . . 65.239999999999995 110.885 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 146.45 60.42 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.673 2.249 . . . . 74.450000000000003 112.373 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 m -133.19 140.22 47.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 62.409999999999997 111.139 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.493 ' HA ' HD23 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -134.21 144.67 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 70.150000000000006 111.108 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.598 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 17.8 p90 -103.13 168.43 9.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 71.510000000000005 110.897 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.595 ' CE2' HD13 ' A' ' 158' ' ' ILE . 4.6 m-85 -148.22 87.71 1.61 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 72.519999999999996 110.891 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.713 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.4 t70 -51.34 103.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 74.439999999999998 110.888 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.598 HG22 HD12 ' A' ' 17' ' ' LEU . 40.7 mm -81.96 135.81 24.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 51.149999999999999 111.099 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -128.19 155.05 45.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.010000000000005 111.084 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' A' ' 154' ' ' LYS . 22.2 t -135.54 96.17 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 65.329999999999998 111.092 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 66.86 30.76 7.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 72.129999999999995 110.908 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.57 -23.74 33.09 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 73.109999999999999 112.517 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -91.99 117.3 67.65 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.639 0.733 . . . . 54.219999999999999 110.922 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.4 Cg_endo -69.79 124.45 11.08 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.661 2.241 . . . . 72.439999999999998 112.324 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.615 ' HB3' HD12 ' A' ' 138' ' ' ILE . 12.0 mt -68.98 -38.82 79.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 52.25 110.878 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.96 -129.38 2.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 75.239999999999995 112.447 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.41 137.05 54.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 74.340000000000003 110.891 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.506 HG21 HG13 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -146.26 100.21 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 74.140000000000001 111.128 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.4 t -108.67 175.26 5.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 73.219999999999999 110.811 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.442 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -146.34 130.47 17.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 71.439999999999998 110.874 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -83.5 100.78 10.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 73.010000000000005 110.892 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.9 mt -82.84 123.57 29.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 74.299999999999997 110.907 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -82.26 63.55 6.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 75.150000000000006 110.911 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.86 -23.44 12.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 54.020000000000003 111.079 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -64.48 -37.95 89.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 70.299999999999997 110.854 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.59 -29.06 13.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 72.200000000000003 110.875 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.429 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -132.7 64.92 73.14 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.6 0.714 . . . . 61.439999999999998 111.181 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -38.18 8.14 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.664 2.243 . . . . 74.219999999999999 112.344 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.36 -37.98 79.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 72.25 110.903 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.5 m -88.61 -45.07 10.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 70.319999999999993 111.137 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.03 -47.01 86.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 75.030000000000001 111.147 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -50.56 -31.08 14.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 74.109999999999999 110.891 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.81 -62.85 1.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 74.349999999999994 110.907 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.19 -22.61 61.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 71.319999999999993 110.865 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 41' ' ' THR . 1.8 ttp180 -83.08 -56.94 3.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.493 . . . . 73.040000000000006 110.875 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.35 -29.69 10.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 73.439999999999998 111.156 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.452 HD21 HG22 ' A' ' 78' ' ' ILE . 37.9 mt -80.13 -60.89 2.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 72.329999999999998 110.908 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.0 m -55.3 -36.01 65.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 73.140000000000001 110.831 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 37' ' ' ARG . 69.1 p -69.23 -31.97 70.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 72.230000000000004 111.135 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.15 -18.11 58.03 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.775 -0.726 . . . . 51.450000000000003 112.492 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.54 -32.33 40.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 63.420000000000002 110.871 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -60.78 -28.22 68.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 73.319999999999993 110.923 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.19 -15.17 56.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.749 . . . . 62.420000000000002 112.478 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -158.31 -165.4 1.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.877 0.37 . . . . 74.310000000000002 110.927 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.424 ' HA2' HD22 ' A' ' 39' ' ' LEU . . . 156.62 -166.74 33.42 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.723 -0.751 . . . . 70.310000000000002 112.468 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -103.73 15.06 29.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.974 0.416 . . . . 74.319999999999993 110.955 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.53 140.05 2.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 63.350000000000001 110.913 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.64 28.85 60.5 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.699 -0.762 . . . . 40.43 112.483 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.68 ' O ' HG22 ' A' ' 157' ' ' THR . 2.8 m -79.45 -177.16 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.383 . . . . 55.420000000000002 110.814 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.0 p -139.73 127.76 22.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 70.129999999999995 110.846 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -75.66 128.77 35.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 74.109999999999999 110.856 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -128.8 37.3 4.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 73.430000000000007 110.872 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.04 81.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 73.019999999999996 110.918 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.469 HD12 HD13 ' A' ' 156' ' ' ILE . 2.6 mt -117.9 117.97 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 75.120000000000005 111.127 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.406 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 28.8 mt -112.27 103.88 55.65 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.613 0.72 . . . . 72.030000000000001 111.104 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.2 Cg_endo -69.79 92.0 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.678 2.252 . . . . 53.210000000000001 112.304 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.74 -17.4 2.81 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 71.510000000000005 112.505 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.9 -53.96 1.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 74.040000000000006 110.874 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.65 174.21 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 73.420000000000002 110.911 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 9.3 m -113.04 -162.4 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 73.420000000000002 110.881 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 174.51 143.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 72.230000000000004 110.941 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.51 169.42 41.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 61.219999999999999 112.485 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.94 89.87 1.79 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.788 -0.72 . . . . 51.340000000000003 112.487 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -155.09 100.3 2.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.863 0.363 . . . . 73.329999999999998 110.824 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -129.06 36.78 4.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 70.030000000000001 110.901 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -92.05 66.26 4.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 54.420000000000002 111.133 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.24 -35.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 75.040000000000006 110.888 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -48.48 -35.53 13.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 50.009999999999998 110.826 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -137.14 24.52 3.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 71.219999999999999 110.893 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.416 ' C ' HG23 ' A' ' 73' ' ' THR . . . 65.35 114.22 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.722 -0.752 . . . . 73.0 112.456 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.416 HG23 ' C ' ' A' ' 72' ' ' GLY . 1.4 p 63.71 30.64 14.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.34 . . . . 75.019999999999996 111.155 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -51.83 -87.89 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.732 -0.747 . . . . 73.099999999999994 112.505 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -49.52 130.92 26.25 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 51.340000000000003 112.498 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -173.51 151.99 2.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 73.299999999999997 110.898 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.404 ' HG ' ' C ' ' A' ' 80' ' ' GLY . 59.0 p -51.62 150.0 4.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 63.240000000000002 110.857 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.452 HG22 HD21 ' A' ' 39' ' ' LEU . 2.1 pp -61.55 -33.45 57.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 71.409999999999997 111.143 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -76.2 -34.64 59.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 64.219999999999999 110.969 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.404 ' C ' ' HG ' ' A' ' 77' ' ' SER . . . 170.16 -113.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 72.430000000000007 112.487 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -78.95 -44.18 23.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.91 0.386 . . . . 72.010000000000005 110.907 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.432 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.4 170.29 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 73.140000000000001 110.925 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.73 166.25 13.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 75.120000000000005 110.913 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.75 166.34 18.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 71.140000000000001 110.875 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -54.23 145.73 16.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 74.200000000000003 110.833 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -104.91 -69.98 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 72.239999999999995 110.922 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -176.38 177.35 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 71.239999999999995 110.918 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.28 37.11 3.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 71.129999999999995 110.892 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.22 -34.61 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 74.239999999999995 111.132 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.7 mt -112.02 78.03 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 72.099999999999994 110.904 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.455 ' O ' HG23 ' A' ' 93' ' ' THR . 2.0 mtpm? -70.1 144.16 52.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 72.120000000000005 110.936 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -51.03 99.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 50.509999999999998 110.816 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 91' ' ' LYS . 25.7 p -111.8 28.96 8.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 74.200000000000003 111.138 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.45 179.64 26.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.701 -0.762 . . . . 65.200000000000003 112.507 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 163.99 36.22 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.653 2.235 . . . . 64.5 112.384 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.29 37.85 54.13 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 54.200000000000003 112.466 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.2 mm -110.19 139.9 31.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.914 0.388 . . . . 75.430000000000007 111.071 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -107.66 146.09 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 73.310000000000002 110.87 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.81 -158.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 75.319999999999993 110.865 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.413 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 0.9 OUTLIER -130.4 136.83 49.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 74.519999999999996 110.89 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -120.52 100.4 7.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 54.32 111.069 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -151.16 -41.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 71.5 110.928 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.722 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -178.86 34.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 63.200000000000003 111.078 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.13 -109.99 1.77 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 72.109999999999999 112.492 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 115.19 3.98 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.708 2.272 . . . . 63.009999999999998 112.313 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.557 ' C ' HG23 ' A' ' 107' ' ' THR . 1.7 m-20 73.24 169.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 71.120000000000005 110.921 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.722 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 0.7 OUTLIER 65.86 27.16 11.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 61.219999999999999 111.187 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -75.78 144.37 41.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 74.040000000000006 110.871 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.32 -100.33 0.63 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.731 -0.747 . . . . 74.420000000000002 112.471 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.413 ' HA ' ' HE2' ' A' ' 100' ' ' MET . 21.9 p -158.09 37.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.839 0.352 . . . . 73.450000000000003 110.873 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.677 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -110.22 58.71 0.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 73.420000000000002 110.854 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.431 ' CD2' HD21 ' A' ' 98' ' ' LEU . 45.5 p90 -58.19 -171.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 74.299999999999997 110.88 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.549 ' O ' ' C ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -160.88 78.36 0.6 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 74.349999999999994 110.874 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.549 ' C ' ' O ' ' A' ' 113' ' ' PHE . 4.9 mt -25.1 105.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 54.329999999999998 111.119 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 37.3 t -70.29 101.57 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 71.430000000000007 110.89 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 47.9 p -90.53 21.98 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 72.129999999999995 111.185 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 116' ' ' THR . . . 173.25 127.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 73.140000000000001 111.16 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 117' ' ' ALA . 2.1 tttt -36.77 108.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 72.219999999999999 110.956 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.812 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 61.4 p -95.06 71.33 3.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 72.349999999999994 111.155 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -68.62 -26.61 65.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 72.25 110.873 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.812 ' CZ2' HG22 ' A' ' 119' ' ' THR . 17.9 p90 -56.28 -19.99 16.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 74.409999999999997 110.907 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.649 HD12 ' OG1' ' A' ' 119' ' ' THR . 82.9 mt -80.81 -54.66 5.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 52.549999999999997 110.897 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 52.47 95.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 65.230000000000004 110.88 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 42.29 41.91 4.12 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.768 -0.73 . . . . 54.240000000000002 112.478 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -91.21 -9.95 43.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.828 0.347 . . . . 70.099999999999994 110.898 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -146.73 -169.99 3.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 65.230000000000004 110.827 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.6 t -115.56 109.83 29.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 60.140000000000001 111.085 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 t -88.64 136.05 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 74.530000000000001 111.112 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.464 ' O ' HD23 ' A' ' 24' ' ' LEU . 13.5 p90 -157.93 40.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 72.409999999999997 110.878 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -176.32 175.47 47.48 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.701 -0.761 . . . . 62.009999999999998 112.465 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 6.4 pttt -176.1 136.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.79 0.329 . . . . 74.310000000000002 110.929 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.698 HG11 ' HG2' ' A' ' 136' ' ' MET . 53.3 t -38.62 108.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 62.420000000000002 111.155 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.69 -58.88 3.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.867 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -153.51 158.76 41.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 73.030000000000001 110.919 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.63 31.94 28.75 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.737 -0.744 . . . . 72.510000000000005 112.522 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.698 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -52.07 -33.51 39.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.775 0.322 . . . . 60.329999999999998 110.901 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.63 -34.29 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 62.119999999999997 110.876 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.615 HD12 ' HB3' ' A' ' 17' ' ' LEU . 40.2 mm -63.81 -41.63 93.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 72.129999999999995 111.135 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 72.8 t -64.48 -24.87 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 54.119999999999997 111.175 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -81.62 -28.85 33.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 63.039999999999999 110.855 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.68 -38.9 64.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 74.200000000000003 111.094 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.0 mtm -59.04 -52.9 63.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 72.230000000000004 110.892 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -55.42 -25.51 36.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 63.420000000000002 110.92 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.438 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -70.02 -23.76 63.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 72.299999999999997 110.833 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.438 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 62.1 m-85 -108.24 20.8 18.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 70.049999999999997 110.879 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.01 164.96 12.35 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.789 -0.719 . . . . 62.399999999999999 112.499 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.1 m -107.41 146.93 31.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.86 0.362 . . . . 60.119999999999997 110.855 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.7 mmm-85 -74.28 69.93 1.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 72.120000000000005 110.861 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -174.44 -36.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 74.409999999999997 110.914 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 150.58 -52.22 0.51 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 65.349999999999994 112.433 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.45 -176.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.912 0.387 . . . . 72.010000000000005 110.89 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -164.93 155.97 14.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.445 . . . . 73.319999999999993 111.127 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 80.7 p -82.49 -54.75 4.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 75.310000000000002 110.905 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.486 ' HB3' HG13 ' A' ' 12' ' ' VAL . 1.4 mttp -79.12 177.34 8.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 74.510000000000005 110.908 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -121.41 108.55 13.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 72.019999999999996 110.882 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.469 HD13 HD12 ' A' ' 56' ' ' ILE . 4.2 mp -86.01 116.65 29.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 73.120000000000005 111.139 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -126.67 162.72 25.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 74.239999999999995 111.092 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.595 HD13 ' CE2' ' A' ' 8' ' ' PHE . 5.7 mt -101.86 116.02 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 61.130000000000003 111.109 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -74.88 -47.91 27.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 31.329999999999998 111.105 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -159.69 157.08 28.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 71.450000000000003 110.837 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.0 146.83 17.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 62.310000000000002 110.873 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.4 172.98 44.17 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.801 -0.714 . . . . 52.43 112.533 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -64.97 142.51 58.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 63.439999999999998 110.938 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -93.22 -59.93 1.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 72.230000000000004 110.883 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 74.540000000000006 110.909 179.951 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.3 mtp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.867 0.365 . . . . 50.329999999999998 110.839 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.0 t -140.86 134.84 33.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 54.409999999999997 111.119 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -110.63 154.0 43.34 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.615 0.721 . . . . 63.409999999999997 110.885 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 146.35 60.02 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.719 2.279 . . . . 72.420000000000002 112.316 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.6 m -128.6 127.8 42.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 45.0 111.179 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.415 HG13 ' CD1' ' A' ' 24' ' ' LEU . 3.3 m -123.63 177.84 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 74.329999999999998 111.164 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.673 ' HB3' HD21 ' A' ' 164' ' ' LEU . 2.2 p90 -160.61 178.27 9.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 75.120000000000005 110.867 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -155.96 95.25 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 73.099999999999994 110.901 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 3.5 t70 -45.37 108.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 71.109999999999999 110.839 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.644 HG23 HG23 ' A' ' 156' ' ' ILE . 22.9 mm -79.38 129.34 37.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 72.109999999999999 111.097 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -121.96 137.46 54.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 73.5 111.133 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -120.73 93.25 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 41.399999999999999 111.1 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.46 36.3 6.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 73.549999999999997 110.908 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.91 -16.4 61.24 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.71 -0.757 . . . . 64.209999999999994 112.474 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -102.33 109.56 60.68 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.646 0.736 . . . . 61.020000000000003 110.904 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.7 Cg_endo -69.78 127.03 13.99 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.653 2.235 . . . . 74.299999999999997 112.324 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.461 ' HB3' HD12 ' A' ' 138' ' ' ILE . 9.9 mt -67.34 -39.03 85.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 73.129999999999995 110.913 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.45 -120.82 0.97 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 21.440000000000001 112.44 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -134.91 140.86 46.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 75.010000000000005 110.907 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.523 HG21 HG13 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -142.43 93.12 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 72.329999999999998 111.124 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.4 t -95.35 174.19 7.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 71.019999999999996 110.833 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.434 ' N ' ' OG ' ' A' ' 21' ' ' SER . 56.5 m-85 -147.33 143.21 27.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 73.099999999999994 110.856 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -96.5 95.74 8.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 72.430000000000007 110.863 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 129' ' ' PHE . 2.0 mt -78.85 124.93 28.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 75.5 110.906 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -84.91 63.11 7.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 71.420000000000002 110.872 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.39 -23.65 10.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 71.040000000000006 111.098 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -62.68 -39.89 95.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 55.240000000000002 110.846 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -98.27 -28.7 13.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 71.129999999999995 110.887 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.467 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -131.05 63.89 71.88 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.64 0.733 . . . . 44.420000000000002 111.1 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -36.55 10.73 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.707 2.272 . . . . 54.229999999999997 112.385 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -38.73 92.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 74.310000000000002 110.918 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.5 m -85.22 -42.3 14.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 72.430000000000007 111.13 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.67 -42.84 95.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 74.150000000000006 111.097 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -49.36 -30.59 7.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 61.149999999999999 110.922 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.529 ' HA ' HD13 ' A' ' 78' ' ' ILE . 4.1 t30 -68.58 -70.4 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 74.219999999999999 110.905 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.09 -32.12 21.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 62.340000000000003 110.862 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.521 ' O ' HG23 ' A' ' 41' ' ' THR . 0.1 OUTLIER -75.36 -54.51 6.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 73.439999999999998 110.856 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.93 -37.3 43.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 74.530000000000001 111.115 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 mt -79.19 -58.54 3.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 55.420000000000002 110.919 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.8 m -50.13 -35.22 24.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 60.149999999999999 110.857 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 37' ' ' ARG . 80.4 p -79.07 -54.39 6.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 75.510000000000005 111.145 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.28 -16.14 7.18 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.748 . . . . 74.420000000000002 112.453 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -53.86 -27.43 29.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 62.509999999999998 110.907 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HE2' HG21 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -60.28 -17.38 41.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 64.019999999999996 110.939 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.07 -11.93 70.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 62.420000000000002 112.53 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -163.34 -168.33 1.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 63.340000000000003 110.907 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.51 -137.51 5.38 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 32.140000000000001 112.476 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -168.07 88.59 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.909 0.385 . . . . 75.530000000000001 110.949 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -79.98 82.87 5.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.079 -0.51 . . . . 71.120000000000005 110.884 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.58 -62.02 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 23.52 112.488 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.459 ' O ' HG22 ' A' ' 157' ' ' THR . 20.3 m 51.11 -169.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.816 0.341 . . . . 73.319999999999993 110.889 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.6 p -176.09 122.75 0.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 71.420000000000002 110.882 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -91.4 108.19 19.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 72.540000000000006 110.936 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -113.68 28.25 8.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.140000000000001 110.822 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.04 95.39 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 72.319999999999993 110.875 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 56' ' ' ILE . 3.7 mt -126.29 116.38 45.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 45.200000000000003 111.127 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.408 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 26.6 mt -108.57 104.84 55.57 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.616 0.722 . . . . 62.229999999999997 111.129 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.8 Cg_endo -69.82 88.31 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.661 2.24 . . . . 71.040000000000006 112.356 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.98 -18.67 1.96 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 70.140000000000001 112.491 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.0 -55.18 1.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 74.200000000000003 110.846 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 173.4 172.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 64.239999999999995 110.907 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 11.4 m -108.57 -160.46 0.72 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 75.109999999999999 110.918 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 176.49 140.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 51.240000000000002 110.913 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.75 137.02 2.16 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.813 -0.708 . . . . 71.549999999999997 112.54 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.58 39.41 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.692 -0.766 . . . . 64.230000000000004 112.432 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -96.94 124.53 40.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.842 0.353 . . . . 73.209999999999994 110.882 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -150.7 72.61 1.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 65.099999999999994 110.868 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.55 -42.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 64.549999999999997 111.113 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -179.48 173.51 1.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 73.329999999999998 110.893 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -108.06 36.22 2.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 73.450000000000003 110.87 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -113.01 -70.05 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 73.530000000000001 110.879 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.18 46.12 0.22 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.793 -0.717 . . . . 54.32 112.532 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.8 p -100.92 -55.05 2.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.788 0.327 . . . . 55.229999999999997 111.156 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.08 30.62 38.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.757 -0.735 . . . . 35.439999999999998 112.487 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.75 -148.33 31.87 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 45.310000000000002 112.5 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.06 155.03 11.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.816 0.341 . . . . 73.120000000000005 110.879 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.441 ' HG ' ' HE1' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -95.94 58.42 1.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 75.310000000000002 110.859 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 35' ' ' ASN . 40.4 pt 40.54 34.41 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 74.120000000000005 111.166 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -165.72 51.27 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 71.219999999999999 110.892 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.54 -173.24 55.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.751 -0.738 . . . . 72.510000000000005 112.481 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -53.41 -24.67 13.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.398 . . . . 62.299999999999997 110.921 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.521 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -174.7 176.97 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 74.010000000000005 110.861 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.441 ' HE1' ' HG ' ' A' ' 77' ' ' SER . 4.4 p90 -151.83 179.95 7.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 62.439999999999998 110.904 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.79 171.02 11.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 74.420000000000002 110.895 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -87.55 171.85 10.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 74.5 110.854 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -119.7 -59.45 1.81 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.468 . . . . 73.310000000000002 110.839 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.4 p30 -177.45 177.01 1.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 64.5 110.852 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.3 35.27 3.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 75.200000000000003 110.892 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mt -50.48 -32.64 10.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 73.430000000000007 111.133 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.3 mt -111.03 74.95 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 75.409999999999997 110.922 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.665 ' O ' HG23 ' A' ' 93' ' ' THR . 10.9 mtpp -70.32 147.02 50.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 63.450000000000003 110.874 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -50.88 99.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.449 . . . . 75.439999999999998 110.819 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.665 HG23 ' O ' ' A' ' 91' ' ' LYS . 77.0 p -112.66 27.62 9.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 62.140000000000001 111.125 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 147.85 -179.26 24.86 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.714 -0.755 . . . . 40.310000000000002 112.467 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 170.48 16.53 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.657 2.238 . . . . 71.319999999999993 112.337 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.4 34.28 79.35 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.74 . . . . 75.140000000000001 112.494 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.5 mm -106.49 139.43 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.915 0.388 . . . . 74.409999999999997 111.083 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -106.85 146.57 30.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 61.530000000000001 110.915 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.402 ' HG ' ' C ' ' A' ' 127' ' ' VAL . 0.1 OUTLIER -164.06 -156.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 72.120000000000005 110.852 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.4 mmt -131.73 127.61 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.077 -0.51 . . . . 72.349999999999994 110.898 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -86.88 129.35 34.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 54.229999999999997 111.145 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 172.23 -168.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 71.239999999999995 110.888 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.756 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -47.47 -50.58 22.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 64.439999999999998 111.113 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 123.53 -66.89 0.5 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 55.240000000000002 112.447 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.529 ' O ' HG23 ' A' ' 107' ' ' THR . 53.8 Cg_endo -69.75 112.84 3.18 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.62 2.214 . . . . 64.450000000000003 112.39 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.8 OUTLIER 36.88 47.3 0.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 72.400000000000006 110.857 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.756 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 21.3 p -144.54 39.31 1.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 70.129999999999995 111.132 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -76.64 140.38 40.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 74.209999999999994 110.88 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.32 -131.06 3.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 42.240000000000002 112.485 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 p -138.07 29.92 2.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.805 0.336 . . . . 74.219999999999999 110.839 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.533 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 9.3 mm-40 -116.83 72.69 0.83 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 72.299999999999997 110.939 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.416 ' HB2' ' CD2' ' A' ' 98' ' ' LEU . 34.7 p90 -57.24 -174.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 75.510000000000005 110.897 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.552 ' O ' ' C ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -159.54 78.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 72.439999999999998 110.858 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.552 ' C ' ' O ' ' A' ' 113' ' ' PHE . 3.0 mt -23.38 107.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.492 . . . . 63.200000000000003 111.171 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 34.9 t -73.01 99.4 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 64.340000000000003 110.875 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 48.9 p -88.55 20.66 3.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 63.25 111.171 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 116' ' ' THR . . . 174.17 127.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 74.140000000000001 111.13 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 117' ' ' ALA . 3.4 tttt -36.35 107.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 61.030000000000001 110.912 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.812 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 49.5 p -94.36 72.86 3.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 75.230000000000004 111.135 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -71.45 -26.92 62.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 74.329999999999998 110.876 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.812 ' CZ2' HG22 ' A' ' 119' ' ' THR . 15.7 p90 -54.35 -22.02 11.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.168 -0.469 . . . . 63.329999999999998 110.913 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.605 HD12 ' OG1' ' A' ' 119' ' ' THR . 64.1 mt -78.66 -53.12 7.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 54.450000000000003 110.881 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 54.43 95.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 61.219999999999999 110.862 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 40.43 39.88 1.81 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.76 -0.733 . . . . 41.420000000000002 112.493 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -87.07 -12.15 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 74.329999999999998 110.903 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -145.17 -164.88 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 62.149999999999999 110.82 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.402 ' C ' ' HG ' ' A' ' 99' ' ' SER . 85.8 t -121.6 111.67 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 64.400000000000006 111.104 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.1 136.85 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 70.209999999999994 111.13 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.529 ' O ' HD23 ' A' ' 24' ' ' LEU . 12.6 p90 -159.48 42.43 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 61.350000000000001 110.856 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.405 ' C ' ' HB2' ' A' ' 98' ' ' LEU . . . -175.03 178.17 46.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.81 -0.71 . . . . 71.530000000000001 112.547 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -179.39 135.35 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.82 0.343 . . . . 72.140000000000001 110.906 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.702 HG11 ' HG2' ' A' ' 136' ' ' MET . 42.7 t -40.63 111.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 61.030000000000001 111.166 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.14 -59.93 2.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 64.150000000000006 110.878 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -151.05 165.9 32.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 74.239999999999995 110.9 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.76 34.53 48.4 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 60.43 112.485 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.702 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -54.43 -23.3 15.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 71.140000000000001 110.869 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.96 -31.2 62.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.433 . . . . 73.329999999999998 110.865 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' A' ' 17' ' ' LEU . 37.4 mm -65.89 -38.3 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 75.549999999999997 111.1 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.3 t -66.58 -27.83 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 70.310000000000002 111.089 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -80.88 -30.64 35.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 73.120000000000005 110.88 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.15 -38.52 69.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 74.129999999999995 111.088 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.527 ' SD ' HG21 ' A' ' 156' ' ' ILE . 38.9 mtm -62.66 -54.0 46.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 71.319999999999993 110.894 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -55.52 -24.57 32.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 71.120000000000005 110.87 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.431 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.77 -25.04 61.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 71.120000000000005 110.867 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.431 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 72.0 m-85 -108.34 19.96 19.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 53.420000000000002 110.919 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.48 163.4 12.17 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.758 -0.734 . . . . 34.43 112.449 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.3 t -112.01 146.59 37.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.882 0.372 . . . . 73.450000000000003 110.845 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -75.06 67.96 1.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 72.430000000000007 110.856 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -172.68 -36.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 75.530000000000001 110.88 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 156.11 -93.74 0.14 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.715 -0.755 . . . . 44.32 112.461 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -51.85 165.51 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.808 0.337 . . . . 52.450000000000003 110.919 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.5 p -143.53 -171.7 3.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 71.140000000000001 111.115 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.5 p -88.44 -62.64 1.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 75.140000000000001 110.838 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -66.06 178.06 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 74.409999999999997 110.885 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.76 107.58 10.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 110.834 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.644 HG23 HG23 ' A' ' 10' ' ' ILE . 4.9 mp -91.36 108.46 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 74.049999999999997 111.118 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -125.24 162.87 23.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 74.109999999999999 111.115 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 19.9 mt -97.58 128.38 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 72.030000000000001 111.092 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -93.85 -56.13 2.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 75.319999999999993 111.076 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -135.11 155.15 51.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 70.25 110.854 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.83 146.11 11.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 63.100000000000001 110.944 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.39 165.83 31.49 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.72 -0.752 . . . . 64.510000000000005 112.444 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.469 ' HB2' HG22 ' A' ' 41' ' ' THR . 1.4 mt-30 -61.33 107.87 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 72.340000000000003 110.934 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.673 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.7 mm? -49.75 -49.7 47.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 64.510000000000005 110.922 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 51.229999999999997 110.877 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 mtm . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.869 0.366 . . . . 71.140000000000001 110.844 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.568 ' O ' HG22 ' A' ' 2' ' ' VAL . 9.6 p -177.31 32.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 72.25 111.13 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 62.42 157.64 0.12 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.619 0.723 . . . . 75.129999999999995 110.921 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 146.4 59.99 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.679 2.253 . . . . 71.519999999999996 112.373 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -132.7 141.78 48.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 72.049999999999997 111.155 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.476 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.1 m -133.21 143.52 38.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 71.510000000000005 111.133 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.575 ' HB3' HD21 ' A' ' 164' ' ' LEU . 15.4 p90 -103.13 159.79 15.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 62.130000000000003 110.872 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.737 ' CD2' HD13 ' A' ' 158' ' ' ILE . 4.5 m-85 -143.52 87.94 1.97 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 70.430000000000007 110.847 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.7 t0 -50.95 106.09 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 74.25 110.857 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.569 HG13 HG21 ' A' ' 20' ' ' VAL . 37.5 mm -81.18 130.57 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 71.299999999999997 111.133 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -121.28 146.89 46.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 72.209999999999994 111.102 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.0 t -130.59 94.4 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 75.530000000000001 111.128 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 67.44 32.95 5.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 75.109999999999999 110.865 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.76 -19.02 56.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.707 -0.759 . . . . 71.219999999999999 112.475 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -99.28 113.68 64.97 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.63 0.729 . . . . 70.209999999999994 110.884 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.6 Cg_endo -69.81 127.01 13.93 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.67 2.247 . . . . 51.009999999999998 112.328 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.53 ' HB3' HD12 ' A' ' 138' ' ' ILE . 11.3 mt -68.4 -38.28 81.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 63.119999999999997 110.949 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.78 -125.32 1.49 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.755 -0.736 . . . . 73.299999999999997 112.497 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.92 136.42 53.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 73.319999999999993 110.908 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.569 HG21 HG13 ' A' ' 10' ' ' ILE . 1.1 t -144.81 99.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 63.219999999999999 111.145 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -109.95 172.58 6.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 64.510000000000005 110.84 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -144.48 142.56 30.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 64.109999999999999 110.901 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.463 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 47.6 tt0 -98.22 99.58 10.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 71.239999999999995 110.9 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.5 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 2.2 mt -80.25 122.46 26.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 71.230000000000004 110.936 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.41 ' O ' HG23 ' A' ' 29' ' ' VAL . 55.2 m-85 -75.59 65.53 1.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 63.130000000000003 110.911 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.55 -22.6 13.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 72.209999999999994 111.102 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -63.61 -46.21 86.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 60.329999999999998 110.883 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -91.06 -30.38 16.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.430000000000007 110.88 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.468 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -131.03 67.11 80.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.653 0.74 . . . . 64.010000000000005 111.14 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -39.61 6.28 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.652 2.234 . . . . 74.450000000000003 112.346 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -37.05 85.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.878 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 m -85.15 -40.81 16.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 41.539999999999999 111.168 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.9 -48.59 68.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 63.009999999999998 111.088 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -49.52 -32.91 13.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 75.439999999999998 110.854 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.04 -50.62 69.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 72.140000000000001 110.902 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.417 ' HD2' HD11 ' A' ' 24' ' ' LEU . 4.0 t80 -69.55 -44.29 71.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 71.450000000000003 110.829 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.412 ' O ' HG23 ' A' ' 41' ' ' THR . 1.7 ttp180 -63.96 -35.47 80.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.898 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.97 92.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 44.020000000000003 111.107 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.424 HD11 HG23 ' A' ' 78' ' ' ILE . 3.2 mt -74.39 -45.94 43.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 63.219999999999999 110.903 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 m -57.49 -45.31 85.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 75.409999999999997 110.855 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.479 HG22 ' HB2' ' A' ' 163' ' ' GLN . 74.8 p -72.15 -48.64 41.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.104 -0.498 . . . . 64.349999999999994 111.11 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.74 -13.67 10.72 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.707 -0.759 . . . . 63.299999999999997 112.52 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -50.46 -34.57 25.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.856 0.36 . . . . 72.319999999999993 110.88 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -53.36 -27.97 26.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 74.400000000000006 110.882 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.87 -11.29 60.76 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 52.340000000000003 112.488 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -162.36 -165.79 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 71.439999999999998 110.88 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.95 -133.57 3.65 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.696 -0.764 . . . . 43.119999999999997 112.435 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -175.33 91.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.955 0.407 . . . . 74.129999999999995 110.906 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -80.68 78.02 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 75.420000000000002 110.864 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 158' ' ' ILE . . . 179.39 -66.66 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 51.240000000000002 112.502 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.483 ' O ' HG22 ' A' ' 157' ' ' THR . 1.3 m 49.19 -167.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 73.430000000000007 110.818 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.46 129.36 1.03 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 53.009999999999998 110.857 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -94.52 106.84 18.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.447 . . . . 53.049999999999997 110.864 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.0 27.29 9.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 73.120000000000005 110.856 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.97 91.71 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 75.430000000000007 110.909 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.0 mt -125.86 113.04 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 52.310000000000002 111.123 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.1 mt -105.12 102.36 35.83 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.596 0.712 . . . . 74.5 111.094 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 79.32 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.665 2.244 . . . . 63.200000000000003 112.35 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.45 -25.56 0.52 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 32.229999999999997 112.477 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.33 -57.67 2.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.809 0.338 . . . . 74.329999999999998 110.867 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.44 156.77 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 73.540000000000006 110.851 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.9 m -93.11 -167.81 1.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 74.109999999999999 110.915 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 177.61 146.93 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 63.399999999999999 110.887 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.41 163.43 36.12 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.721 -0.752 . . . . 72.319999999999993 112.451 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.28 126.58 0.83 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.721 -0.752 . . . . 54.210000000000001 112.492 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -157.41 70.32 0.6 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.889 0.375 . . . . 74.010000000000005 110.883 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -74.72 -75.59 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 63.530000000000001 110.865 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 t -147.82 69.08 1.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 70.430000000000007 111.144 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -125.57 -36.8 2.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 62.329999999999998 110.875 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.4 m170 63.72 56.24 1.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 74.25 110.86 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -167.01 -42.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 74.319999999999993 110.899 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 126.48 33.57 0.66 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.71 -0.757 . . . . 62.409999999999997 112.431 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.5 p -145.41 37.62 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.81 0.338 . . . . 61.409999999999997 111.147 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.77 -167.09 43.31 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.725 -0.75 . . . . 62.140000000000001 112.519 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.81 113.35 3.8 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.775 -0.726 . . . . 72.439999999999998 112.547 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.28 178.92 6.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 63.210000000000001 110.9 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.38 150.41 20.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 53.520000000000003 110.886 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.424 HG23 HD11 ' A' ' 39' ' ' LEU . 1.2 pp -53.01 -32.27 18.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 73.5 111.16 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -72.37 -34.28 67.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 74.329999999999998 110.879 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.25 -140.72 6.44 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.763 -0.732 . . . . 63.549999999999997 112.49 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -64.26 -35.27 80.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.935 0.398 . . . . 73.439999999999998 110.882 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.457 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.5 168.0 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 75.430000000000007 110.909 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -141.12 179.81 6.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 73.140000000000001 110.859 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.07 160.09 33.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 72.409999999999997 110.902 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.9 152.64 45.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 72.129999999999995 110.894 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -100.24 -75.81 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 70.120000000000005 110.913 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.4 p30 -166.91 173.94 8.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 52.200000000000003 110.919 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.86 34.75 3.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 72.400000000000006 110.908 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -51.03 -29.41 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 70.510000000000005 111.14 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 24.6 mt -99.99 91.7 4.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 74.409999999999997 110.878 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.9 mppp? -80.96 140.16 35.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 64.530000000000001 110.878 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -50.33 101.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 70.140000000000001 110.883 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.7 p -111.01 25.39 11.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 72.120000000000005 111.146 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 151.38 178.74 26.45 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 72.540000000000006 112.453 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 175.91 7.46 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.662 2.241 . . . . 74.230000000000004 112.332 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.86 37.11 93.81 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.69 -0.767 . . . . 70.439999999999998 112.474 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.1 mm -109.51 134.91 50.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.849 0.357 . . . . 65.010000000000005 111.118 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.537 HD22 ' CG ' ' A' ' 112' ' ' PHE . 2.8 mt -99.69 165.17 11.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 43.420000000000002 110.959 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 9.8 t -163.73 -128.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 63.210000000000001 110.83 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.599 ' HE2' ' HB ' ' A' ' 127' ' ' VAL . 28.8 mtm -150.24 143.15 24.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 52.5 110.844 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -93.58 104.13 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 63.130000000000003 111.06 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 179.8 174.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 75.200000000000003 110.896 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -50.57 -26.27 5.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 71.109999999999999 111.098 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.59 -82.93 0.33 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.709 -0.758 . . . . 64.349999999999994 112.499 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 95.06 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.687 2.258 . . . . 71.319999999999993 112.386 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.502 ' C ' HG23 ' A' ' 107' ' ' THR . 2.7 m-20 72.73 171.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 63.240000000000002 110.923 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.502 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.2 p 66.46 28.9 9.41 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 64.010000000000005 111.106 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -96.57 160.64 14.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 75.450000000000003 110.902 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.88 -132.42 3.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 45.119999999999997 112.488 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.9 t -104.48 -47.13 4.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.833 0.349 . . . . 64.5 110.86 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 2.3 pt20 -47.36 109.28 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 73.299999999999997 110.906 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.537 ' CG ' HD22 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -111.04 -164.1 0.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 74.540000000000006 110.898 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -143.81 153.0 41.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 72.540000000000006 110.859 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.0 mt -98.09 120.36 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 73.420000000000002 111.148 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 17.4 m -89.51 95.77 10.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 64.409999999999997 110.88 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 p -68.14 -8.46 38.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 71.209999999999994 111.135 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.687 ' O ' HG23 ' A' ' 119' ' ' THR . . . -147.33 154.03 40.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 40.140000000000001 111.05 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -56.66 93.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 72.219999999999999 110.894 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.69 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 26.2 p -95.74 45.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 64.200000000000003 111.114 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -25.75 67.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 64.129999999999995 110.888 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.69 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.4 p90 -48.18 -29.75 3.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.119 -0.491 . . . . 75.019999999999996 110.864 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.8 mt -45.51 -36.41 4.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 60.340000000000003 110.891 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.32 80.47 0.21 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 63.409999999999997 110.866 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 37.95 42.11 1.07 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.701 -0.762 . . . . 51.43 112.507 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.69 -14.66 47.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.824 0.345 . . . . 62.530000000000001 110.905 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -146.43 -176.47 5.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 70.329999999999998 110.871 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.599 ' HB ' ' HE2' ' A' ' 100' ' ' MET . 55.4 t -113.91 115.86 50.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 75.450000000000003 111.107 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 98' ' ' LEU . 22.4 t -92.27 132.26 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 74.319999999999993 111.133 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.468 ' CB ' HG21 ' A' ' 29' ' ' VAL . 20.2 p90 -157.1 44.78 0.38 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 110.94 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -179.34 174.76 46.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.724 -0.751 . . . . 75.129999999999995 112.474 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.02 143.43 0.55 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 72.329999999999998 110.886 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.741 HG11 ' HG2' ' A' ' 136' ' ' MET . 45.5 t -44.3 113.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 52.439999999999998 111.12 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.463 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -77.43 -59.82 2.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 63.530000000000001 110.906 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -152.53 155.23 37.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 64.420000000000002 110.902 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.99 36.91 10.56 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.739 . . . . 72.400000000000006 112.472 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.741 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -57.27 -27.52 62.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.785 0.326 . . . . 75.540000000000006 110.87 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.85 -32.22 60.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 60.130000000000003 110.866 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 17' ' ' LEU . 43.2 mm -66.17 -39.19 83.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 74.140000000000001 111.153 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.1 t -64.71 -26.62 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 72.409999999999997 111.165 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -81.04 -29.36 35.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 64.510000000000005 110.875 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.2 -39.5 65.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 61.140000000000001 111.092 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 35.0 mtm -61.22 -53.5 56.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 73.219999999999999 110.876 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.45 -25.41 36.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 72.420000000000002 110.934 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.435 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -70.23 -23.81 62.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 62.020000000000003 110.882 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.435 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 66.7 m-85 -108.89 20.73 18.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.400000000000006 110.863 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -111.3 171.74 14.57 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 52.32 112.482 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 t -127.9 143.29 51.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 75.319999999999993 110.868 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -71.48 79.22 0.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 64.109999999999999 110.933 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -178.91 -34.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 74.420000000000002 110.89 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.92 -83.1 0.18 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.741 . . . . 74.329999999999998 112.504 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.44 169.22 3.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 71.310000000000002 110.941 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.9 p -144.61 -171.58 3.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 72.019999999999996 111.146 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.8 p -88.64 -63.79 1.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 110.83 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -64.6 -179.68 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 74.430000000000007 110.916 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -127.71 108.81 11.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 73.099999999999994 110.899 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.14 116.54 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 74.109999999999999 111.16 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -131.69 164.93 24.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 65.099999999999994 111.112 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.737 HD13 ' CD2' ' A' ' 8' ' ' PHE . 3.7 mt -102.75 126.48 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.434 . . . . 45.049999999999997 111.123 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -90.76 -57.67 2.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 64.340000000000003 111.085 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -135.79 152.86 51.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.442 . . . . 50.210000000000001 110.849 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.32 144.38 10.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.198 -0.456 . . . . 75.430000000000007 110.924 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.18 171.28 40.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.71 -0.757 . . . . 52.049999999999997 112.518 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.479 ' HB2' HG22 ' A' ' 41' ' ' THR . 2.1 mt-30 -63.56 141.96 58.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 74.299999999999997 110.872 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.575 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.1 mm? -94.82 -59.61 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 65.219999999999999 110.906 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 73.129999999999995 110.872 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.1 mtm . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.855 0.36 . . . . 51.210000000000001 110.864 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.6 t -145.05 134.91 18.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 74.230000000000004 111.177 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -122.45 156.06 61.48 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.627 0.727 . . . . 74.120000000000005 110.891 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 146.14 59.21 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.674 2.249 . . . . 72.209999999999994 112.322 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -134.12 104.37 6.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 74.209999999999994 111.133 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -100.38 172.28 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.192 -0.458 . . . . 72.310000000000002 111.134 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.657 ' HB3' HD21 ' A' ' 164' ' ' LEU . 0.5 OUTLIER -160.16 172.98 16.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 71.209999999999994 110.9 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.41 ' HA ' ' HB3' ' A' ' 161' ' ' CYS . 32.1 m-85 -153.39 95.29 1.91 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 75.329999999999998 110.926 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.676 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.9 OUTLIER -45.2 104.59 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 70.219999999999999 110.884 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.735 HG22 HD12 ' A' ' 17' ' ' LEU . 29.7 mm -76.17 138.21 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 65.140000000000001 111.188 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.11 168.81 16.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 71.310000000000002 111.148 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.471 HG23 ' HG ' ' A' ' 17' ' ' LEU . 91.5 t -144.82 99.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 63.009999999999998 111.154 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.42 25.01 7.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 54.229999999999997 110.846 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.42 -28.3 12.0 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.725 -0.75 . . . . 60.32 112.479 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.64 125.79 70.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.73 . . . . 75.329999999999998 110.894 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 120.4 7.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.641 2.228 . . . . 74.409999999999997 112.358 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.735 HD12 HG22 ' A' ' 10' ' ' ILE . 6.5 mt -66.2 -42.02 89.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 65.25 110.922 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.88 -130.99 2.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 61.409999999999997 112.478 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.26 136.55 52.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 71.530000000000001 110.893 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.52 HG21 HG13 ' A' ' 10' ' ' ILE . 0.6 OUTLIER -143.01 100.53 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 64.340000000000003 111.179 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.435 ' HB2' ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -109.51 172.84 6.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 71.230000000000004 110.872 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.407 ' N ' ' OG ' ' A' ' 21' ' ' SER . 43.6 m-85 -145.64 144.56 30.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 110.902 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -100.28 97.89 8.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 75.319999999999993 110.865 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.515 HD23 ' O ' ' A' ' 129' ' ' PHE . 2.3 mt -82.37 128.65 34.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 70.430000000000007 110.924 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.406 ' CD1' HD13 ' A' ' 90' ' ' LEU . 38.2 m-85 -87.16 67.3 9.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 75.420000000000002 110.932 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.57 -22.48 33.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 74.040000000000006 111.117 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -65.08 -34.16 77.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 74.310000000000002 110.882 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.2 mmtp -101.46 -31.27 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 75.420000000000002 110.927 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.406 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -132.78 65.64 74.72 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.588 0.708 . . . . 65.400000000000006 111.105 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -37.49 9.03 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.669 2.246 . . . . 74.430000000000007 112.321 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.15 -36.5 77.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 72.219999999999999 110.891 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.9 m -90.59 -41.32 11.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 65.040000000000006 111.143 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.69 -48.9 75.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 74.120000000000005 111.131 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -49.86 -34.29 19.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 74.150000000000006 110.922 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -65.25 -65.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 64.209999999999994 110.915 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -55.38 -36.51 66.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 75.540000000000006 110.875 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.475 ' O ' HG23 ' A' ' 41' ' ' THR . 2.2 ttp180 -68.61 -49.61 57.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 73.540000000000006 110.906 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.29 -25.15 32.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 40.329999999999998 111.084 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.24 -58.3 3.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 73.120000000000005 110.96 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.41 -38.4 83.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 72.040000000000006 110.872 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.487 HG22 ' HB2' ' A' ' 163' ' ' GLN . 42.8 p -62.59 -39.36 93.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 74.519999999999996 111.146 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.32 -19.52 31.74 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 74.150000000000006 112.493 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.71 -30.58 22.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.929 0.395 . . . . 75.129999999999995 110.905 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.567 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -59.53 -31.35 69.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 74.150000000000006 110.909 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.64 -8.97 68.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 44.25 112.458 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -169.81 -165.68 0.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.963 0.411 . . . . 73.200000000000003 110.834 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.37 -142.37 12.0 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.75 -0.738 . . . . 55.100000000000001 112.46 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -115.12 21.61 14.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.896 0.379 . . . . 74.109999999999999 110.875 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.4 125.26 12.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 75.420000000000002 110.86 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.05 36.96 93.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 75.319999999999993 112.53 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -117.3 141.11 48.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.36 . . . . 73.439999999999998 110.823 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.5 p -51.99 170.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 73.0 110.88 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.24 -173.77 4.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 75.439999999999998 110.885 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -106.56 -69.75 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 64.530000000000001 110.826 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.0 ttm-85 -137.26 160.72 38.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 71.230000000000004 110.884 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.563 HD12 HD13 ' A' ' 156' ' ' ILE . 40.5 mt -148.49 107.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 75.019999999999996 111.16 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.1 mt -106.08 104.78 51.16 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.624 0.726 . . . . 63.43 111.077 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.42 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 54.1 Cg_endo -69.77 79.29 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.67 2.247 . . . . 60.43 112.351 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.45 -26.53 0.27 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.749 . . . . 75.400000000000006 112.477 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.1 OUTLIER -120.61 -59.1 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 74.099999999999994 110.879 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.435 ' HB3' ' HA ' ' A' ' 115' ' ' CYS . 0.0 OUTLIER 170.91 156.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 73.209999999999994 110.9 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 6.6 m -85.78 -166.72 1.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 72.430000000000007 110.879 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -162.97 118.34 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 75.109999999999999 110.866 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.67 165.96 54.47 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.739 . . . . 52.310000000000002 112.495 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.34 169.1 27.4 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.737 . . . . 61.130000000000003 112.507 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.55 -175.86 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 73.420000000000002 110.857 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -132.37 -42.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.129999999999995 110.89 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.5 m -79.4 -69.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 70.439999999999998 111.092 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.24 159.18 39.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 53.439999999999998 110.915 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -123.29 -83.0 0.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 74.120000000000005 110.803 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.66 ' O ' HG22 ' A' ' 73' ' ' THR . 8.6 t-20 48.69 30.78 2.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 74.030000000000001 110.879 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 53.24 22.24 13.97 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 63.420000000000002 112.481 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 71' ' ' ASN . 6.3 t 179.22 53.53 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 72.010000000000005 111.128 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.0 -148.09 6.89 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.758 -0.734 . . . . 71.5 112.485 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.07 141.24 2.54 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.752 . . . . 70.299999999999997 112.479 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.84 161.48 35.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.784 0.326 . . . . 42.229999999999997 110.909 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.428 ' O ' ' CG1' ' A' ' 78' ' ' ILE . 59.6 p -97.89 59.41 1.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 52.350000000000001 110.89 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.567 HG22 ' HD2' ' A' ' 44' ' ' LYS . 14.8 pt 43.9 30.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 74.299999999999997 111.108 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.36 26.73 9.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 73.430000000000007 110.931 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.18 -70.07 2.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 32.100000000000001 112.476 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -125.42 -56.2 1.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.403 . . . . 74.549999999999997 110.909 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.437 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.36 -178.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 72.129999999999995 110.907 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -146.25 179.78 7.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 72.200000000000003 110.877 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.7 166.74 11.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 73.219999999999999 110.908 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -45.51 148.32 0.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 73.200000000000003 110.881 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -107.96 -74.66 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 75.450000000000003 110.856 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -162.11 170.47 19.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 70.409999999999997 110.89 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.22 37.95 3.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 75.420000000000002 110.925 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.37 -30.13 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 73.140000000000001 111.152 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.406 HD13 ' CD1' ' A' ' 25' ' ' PHE . 13.6 mt -110.02 84.59 1.95 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 73.150000000000006 110.92 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.467 ' O ' HG23 ' A' ' 93' ' ' THR . 23.6 mttp -71.77 146.83 47.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 64.030000000000001 110.926 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -51.69 103.23 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 73.25 110.862 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 91' ' ' LYS . 44.2 p -124.87 38.92 4.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 64.329999999999998 111.156 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.85 166.65 12.44 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.752 . . . . 71.25 112.49 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 160.11 50.91 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.698 2.265 . . . . 64.010000000000005 112.324 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.419 ' HA2' HG23 ' A' ' 132' ' ' VAL . . . 87.95 -14.53 58.53 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.69 -0.767 . . . . 65.319999999999993 112.465 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.6 mm -55.36 134.73 18.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.838 0.351 . . . . 72.340000000000003 111.131 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.664 HD22 ' HB2' ' A' ' 112' ' ' PHE . 3.8 mt -102.07 167.46 10.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 65.019999999999996 110.945 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.24 -147.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 62.299999999999997 110.878 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.407 ' HG3' ' HB3' ' A' ' 108' ' ' ASN . 6.3 mmt -145.17 124.88 13.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 71.510000000000005 110.902 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -115.31 76.36 1.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 63.520000000000003 111.109 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -114.12 -40.75 3.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 72.299999999999997 110.894 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.25 25.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 70.439999999999998 111.121 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.71 -140.82 16.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.728 -0.748 . . . . 61.310000000000002 112.505 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 106' ' ' ASN . 54.0 Cg_endo -69.73 59.32 1.6 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.668 2.245 . . . . 72.200000000000003 112.355 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER 166.02 160.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 62.109999999999999 110.885 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.2 p 56.71 34.19 24.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 70.439999999999998 111.185 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.407 ' HB3' ' HG3' ' A' ' 100' ' ' MET . 1.0 OUTLIER -75.17 64.83 1.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 70.519999999999996 110.889 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -62.82 -77.85 0.2 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.748 -0.739 . . . . 75.109999999999999 112.434 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 44.0 t -164.43 43.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.342 . . . . 71.549999999999997 110.868 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -101.39 39.46 1.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 74.120000000000005 110.903 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.664 ' HB2' HD22 ' A' ' 98' ' ' LEU . 32.3 p90 -55.29 -178.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 74.420000000000002 110.84 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.519 ' O ' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -157.58 -175.88 5.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.118 -0.492 . . . . 71.099999999999994 110.834 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 114' ' ' ILE . 2.8 mt -121.73 93.5 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 72.439999999999998 111.151 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 61' ' ' MET . 43.9 m -69.94 87.64 0.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 61.509999999999998 110.866 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.0 p -60.91 -14.88 25.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 71.310000000000002 111.118 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 119' ' ' THR . . . -143.26 153.16 42.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 70.420000000000002 111.103 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -54.51 93.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 42.229999999999997 110.862 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.71 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 24.9 p -93.82 52.74 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 72.219999999999999 111.149 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -24.24 65.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 110.862 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.71 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.6 p90 -48.95 -29.91 5.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 72.420000000000002 110.883 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 17.9 mt -47.2 -33.52 5.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 60.329999999999998 110.924 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.5 m-20 57.85 80.36 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 74.230000000000004 110.903 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.23 43.44 0.7 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 73.109999999999999 112.502 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.72 -16.29 51.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.849 0.357 . . . . 71.329999999999998 110.956 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -143.02 -167.75 2.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 73.200000000000003 110.884 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.2 t -120.34 115.14 46.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 63.200000000000003 111.142 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 98' ' ' LEU . 27.4 t -86.91 133.76 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 74.230000000000004 111.078 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.515 ' O ' HD23 ' A' ' 24' ' ' LEU . 16.7 p90 -154.82 41.42 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.510000000000005 110.906 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . 179.38 175.99 46.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.803 -0.713 . . . . 35.340000000000003 112.507 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -175.2 142.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 73.109999999999999 110.946 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.639 HG11 ' HG2' ' A' ' 136' ' ' MET . 34.5 t -45.61 112.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 73.230000000000004 111.128 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.13 -61.02 2.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 73.439999999999998 110.893 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -155.68 147.14 22.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 63.229999999999997 110.883 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.82 38.57 4.88 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.728 -0.749 . . . . 65.420000000000002 112.495 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.639 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -61.17 -30.36 70.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.805 0.336 . . . . 64.430000000000007 110.878 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.47 -37.57 49.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 63.399999999999999 110.881 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 17' ' ' LEU . 33.0 mm -61.89 -38.54 80.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 65.430000000000007 111.091 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.437 ' CG1' HG21 ' A' ' 114' ' ' ILE . 74.6 t -67.11 -24.21 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 73.040000000000006 111.109 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.72 -28.77 28.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 72.530000000000001 110.869 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.13 -39.01 63.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 71.510000000000005 111.108 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 28.1 mtm -58.95 -52.42 65.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 70.120000000000005 110.866 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -54.26 -26.69 30.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 54.409999999999997 110.886 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.45 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.81 -24.46 63.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 72.319999999999993 110.873 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.45 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 63.1 m-85 -107.78 14.07 25.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 73.219999999999999 110.853 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -113.61 167.52 12.34 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.763 -0.732 . . . . 52.219999999999999 112.505 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.55 133.95 51.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 75.109999999999999 110.867 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -54.38 -22.69 13.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.496 . . . . 65.140000000000001 110.873 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -31.27 64.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.452 . . . . 65.129999999999995 110.895 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 141.49 -40.69 1.3 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.749 -0.739 . . . . 75.450000000000003 112.53 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.57 -177.43 0.43 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 74.310000000000002 110.909 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.3 p -146.27 159.63 43.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 72.540000000000006 111.117 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.69 -58.47 2.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 65.439999999999998 110.844 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -89.48 -177.17 5.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 72.409999999999997 110.846 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -112.21 108.17 17.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 54.310000000000002 110.87 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.563 HD13 HD12 ' A' ' 56' ' ' ILE . 5.0 mp -84.65 117.73 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 64.430000000000007 111.165 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.12 164.18 22.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 74.430000000000007 111.2 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.2 mt -101.32 130.74 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 64.430000000000007 111.08 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -89.17 -53.45 4.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 74.120000000000005 111.098 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -148.33 145.69 28.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 74.010000000000005 110.847 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -149.93 146.57 27.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 71.420000000000002 110.886 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.52 161.81 21.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.714 -0.755 . . . . 73.319999999999993 112.472 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.487 ' HB2' HG22 ' A' ' 41' ' ' THR . 1.1 mt-30 -58.13 107.1 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 71.219999999999999 110.908 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.657 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.2 mm? -49.04 -54.88 13.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 71.019999999999996 110.921 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 55.240000000000002 110.864 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.827 0.346 . . . . 73.219999999999999 110.877 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.7 p -177.95 144.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 70.030000000000001 111.101 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -100.73 146.07 31.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.69 0.757 . . . . 65.219999999999999 110.854 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 152.48 69.17 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.702 2.268 . . . . 75.409999999999997 112.328 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -135.92 135.15 39.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 70.430000000000007 111.15 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.503 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.4 m -129.43 143.2 41.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 72.200000000000003 111.133 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 7.0 p90 -104.66 165.21 11.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 71.319999999999993 110.889 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.566 ' HE2' HD13 ' A' ' 158' ' ' ILE . 5.5 m-85 -147.29 86.4 1.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 72.120000000000005 110.896 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.776 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 2.1 t70 -46.76 107.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 74.439999999999998 110.855 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.557 HG13 HG21 ' A' ' 20' ' ' VAL . 46.3 mm -85.38 119.78 34.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 54.329999999999998 111.115 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -113.43 149.85 33.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 72.439999999999998 111.095 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 154' ' ' LYS . 18.2 t -133.28 98.42 2.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.451 . . . . 73.219999999999999 111.147 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.69 32.93 10.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 75.519999999999996 110.875 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.46 -18.59 57.11 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.717 -0.754 . . . . 73.140000000000001 112.486 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -98.5 114.84 65.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.651 0.739 . . . . 71.409999999999997 110.862 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.53 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.75 125.36 12.06 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.68 2.253 . . . . 73.510000000000005 112.337 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.513 HD12 HG22 ' A' ' 10' ' ' ILE . 12.6 mt -67.91 -39.05 83.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 70.519999999999996 110.873 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.19 -129.31 2.28 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.761 -0.733 . . . . 62.409999999999997 112.476 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -121.36 134.74 55.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 74.129999999999995 110.92 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.557 HG21 HG13 ' A' ' 10' ' ' ILE . 1.7 t -145.11 103.19 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 75.200000000000003 111.086 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -114.73 173.75 6.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 75.120000000000005 110.864 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.425 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.8 OUTLIER -143.57 136.8 27.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 75.109999999999999 110.922 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -91.52 98.28 11.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 75.040000000000006 110.855 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 129' ' ' PHE . 2.9 mt -80.15 125.87 30.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 64.140000000000001 110.906 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CD1' HD13 ' A' ' 90' ' ' LEU . 46.3 m-85 -83.58 63.17 7.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 62.240000000000002 110.933 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.64 -23.73 7.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 74.400000000000006 111.105 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.6 -35.1 76.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 63.409999999999997 110.855 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.51 -30.87 13.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 71.239999999999995 110.868 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.414 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -135.04 66.58 68.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.656 0.741 . . . . 73.230000000000004 111.126 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -32.71 18.04 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.664 2.243 . . . . 63.200000000000003 112.351 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -40.62 95.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 64.420000000000002 110.893 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.438 HG21 ' CD1' ' A' ' 129' ' ' PHE . 86.4 m -86.83 -44.91 11.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 73.040000000000006 111.157 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.26 82.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 63.030000000000001 111.074 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -47.62 -40.66 20.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 73.530000000000001 110.87 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.448 ' OD1' HG23 ' A' ' 78' ' ' ILE . 2.8 t30 -64.01 -63.33 1.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 74.310000000000002 110.882 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.43 -23.32 24.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 71.040000000000006 110.865 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.505 ' NH2' ' HG2' ' A' ' 163' ' ' GLN . 0.0 OUTLIER -74.54 -59.31 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 71.230000000000004 110.894 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.43 -30.3 62.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 73.099999999999994 111.126 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.3 mt -75.75 -58.29 3.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 74.030000000000001 110.869 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.6 m -49.64 -46.69 49.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 75.310000000000002 110.863 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.6 p -74.69 -28.81 60.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 54.240000000000002 111.172 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.58 -8.44 76.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.775 -0.726 . . . . 74.340000000000003 112.457 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -63.23 -15.82 58.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.874 0.368 . . . . 75.310000000000002 110.866 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HE3' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -49.48 -28.84 5.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 64.409999999999997 110.859 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.29 -25.83 5.64 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.696 -0.764 . . . . 73.129999999999995 112.431 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -160.25 -46.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 75.340000000000003 110.861 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.52 -146.22 21.48 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.766 -0.731 . . . . 53.130000000000003 112.466 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -175.44 92.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.99 0.424 . . . . 74.340000000000003 110.884 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.47 141.02 29.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 72.420000000000002 110.922 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.91 39.66 74.92 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.754 -0.736 . . . . 71.310000000000002 112.479 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.09 28.83 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 64.329999999999998 110.848 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 3.9 m 51.16 -170.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 61.140000000000001 110.885 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -105.06 -174.27 2.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 62.25 110.875 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -120.3 -72.78 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 74.019999999999996 110.808 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 45.2 ttm-85 -138.91 156.41 47.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 75.319999999999993 110.815 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.558 HD12 HD13 ' A' ' 156' ' ' ILE . 38.0 mt -147.87 113.27 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 74.140000000000001 111.143 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.5 mt -113.12 104.13 55.71 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.601 0.715 . . . . 63.119999999999997 111.178 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.4 Cg_endo -69.77 77.35 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.729 2.286 . . . . 70.209999999999994 112.327 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.01 -27.1 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.741 . . . . 64.209999999999994 112.46 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.01 -54.67 2.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 74.319999999999993 110.869 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 168.87 165.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 110.834 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.6 m -92.45 -161.25 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 52.32 110.861 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -179.57 129.58 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 72.010000000000005 110.919 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.62 75.77 0.29 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.677 -0.773 . . . . 72.430000000000007 112.43 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.45 85.81 0.41 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.717 -0.754 . . . . 51.210000000000001 112.466 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.43 111.1 16.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 75.450000000000003 110.848 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -126.76 -74.63 0.59 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 63.049999999999997 110.864 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.6 p -143.5 -41.9 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 74.010000000000005 111.165 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.78 -81.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 71.329999999999998 110.86 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.7 m170 50.0 30.33 4.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 74.299999999999997 110.853 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 t30 177.99 -74.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 73.430000000000007 110.874 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 163.9 53.72 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 74.150000000000006 112.534 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.7 t -177.79 54.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 72.409999999999997 111.17 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.57 176.0 8.98 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 73.230000000000004 112.501 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.39 110.92 1.67 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 41.119999999999997 112.47 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.52 156.18 40.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.749 0.309 . . . . 72.400000000000006 110.932 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.9 p -93.88 56.48 2.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 74.140000000000001 110.841 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.448 HG23 ' OD1' ' A' ' 35' ' ' ASN . 31.1 pt 40.23 37.11 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 63.5 111.103 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -157.38 47.79 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 63.310000000000002 110.927 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.95 -128.29 8.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.711 -0.757 . . . . 64.5 112.508 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -118.52 -27.0 6.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.908 0.385 . . . . 72.510000000000005 110.855 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.456 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 177.32 167.58 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 74.400000000000006 110.893 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -139.6 177.51 7.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 73.400000000000006 110.894 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.16 157.17 37.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.878 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -52.73 136.24 33.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 61.020000000000003 110.899 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -91.18 -76.27 0.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 54.539999999999999 110.888 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -165.49 167.89 17.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 70.310000000000002 110.91 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.55 37.76 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 70.099999999999994 110.913 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.38 -29.91 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 71.340000000000003 111.169 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.419 HD13 ' CD1' ' A' ' 25' ' ' PHE . 13.8 mt -108.95 79.17 1.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 74.430000000000007 110.914 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 150.33 47.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 71.439999999999998 110.896 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -59.31 96.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 62.530000000000001 110.829 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.9 p -104.53 25.53 10.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 41.030000000000001 111.167 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 144.93 -179.08 22.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 43.240000000000002 112.487 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 171.82 13.75 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.715 2.277 . . . . 73.200000000000003 112.339 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.78 23.0 78.6 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 43.030000000000001 112.464 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.1 mm -99.04 142.7 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.891 0.377 . . . . 75.129999999999995 111.14 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.409 ' HB2' ' C ' ' A' ' 130' ' ' GLY . 0.2 OUTLIER -113.36 140.91 47.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 110.943 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.14 -167.15 2.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 110.858 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -100.24 104.95 16.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 74.409999999999997 110.863 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.976 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -78.42 52.37 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 74.329999999999998 111.117 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.34 -169.14 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 72.439999999999998 110.854 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.793 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -46.45 -47.59 19.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 45.009999999999998 111.074 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.67 -74.79 0.31 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.761 -0.733 . . . . 61.32 112.495 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.411 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.4 Cg_endo -69.81 111.32 2.79 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.659 2.239 . . . . 71.310000000000002 112.311 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 41.35 56.64 3.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 73.349999999999994 110.924 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.793 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 11.0 p -153.68 44.8 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 62.009999999999998 111.178 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.33 125.15 28.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 65.209999999999994 110.893 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.24 -91.84 0.52 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.74 . . . . 72.140000000000001 112.492 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.7 t -178.73 49.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.816 0.341 . . . . 73.540000000000006 110.814 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.671 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 3.8 mm-40 -74.69 -40.26 61.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 74.200000000000003 110.936 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 66.25 141.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 73.439999999999998 110.873 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.976 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.2 OUTLIER -161.99 135.85 6.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 74.200000000000003 110.912 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.417 HG21 ' CG1' ' A' ' 139' ' ' VAL . 2.8 mt -85.9 119.32 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 63.43 111.134 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.08 98.97 10.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 73.400000000000006 110.899 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 76.7 p -86.1 18.48 3.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 64.099999999999994 111.145 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.768 ' O ' HG23 ' A' ' 119' ' ' THR . . . 177.31 142.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 71.310000000000002 111.071 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -51.65 99.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 72.109999999999999 110.919 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.777 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 41.4 p -104.12 53.62 0.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 62.549999999999997 111.111 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.67 -27.32 68.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 73.329999999999998 110.894 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.777 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.6 p90 -48.29 -26.74 2.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 74.230000000000004 110.947 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 23.8 mt -44.48 -37.41 3.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 75.200000000000003 110.923 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 124' ' ' GLY . 5.5 m-20 59.16 80.98 0.17 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 62.020000000000003 110.857 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.63 41.67 0.88 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.742 -0.742 . . . . 70.109999999999999 112.473 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.12 -21.4 36.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.85 0.357 . . . . 73.439999999999998 110.909 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -144.75 -169.44 3.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 74.010000000000005 110.832 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.8 t -124.58 123.46 66.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 64.299999999999997 111.099 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 t -88.84 132.58 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 71.019999999999996 111.096 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.438 ' CD1' HG21 ' A' ' 32' ' ' THR . 23.9 p90 -154.93 36.64 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 72.430000000000007 110.889 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -174.12 177.77 46.22 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.753 -0.736 . . . . 62.43 112.509 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -177.9 138.81 0.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.861 0.362 . . . . 75.409999999999997 110.905 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.54 HG11 ' HG2' ' A' ' 136' ' ' MET . 77.2 t -41.94 106.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 73.340000000000003 111.123 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -59.91 2.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 71.319999999999993 110.878 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -153.46 150.0 28.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 65.129999999999995 110.91 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.8 48.25 4.23 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.729 . . . . 63.140000000000001 112.496 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.54 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -66.45 -32.01 73.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.719 0.295 . . . . 75.099999999999994 110.849 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.99 -33.22 37.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 71.219999999999999 110.916 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 17' ' ' LEU . 45.2 mm -64.92 -36.47 77.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 71.200000000000003 111.077 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.417 ' CG1' HG21 ' A' ' 114' ' ' ILE . 63.5 t -65.8 -27.59 41.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 50.509999999999998 111.144 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -81.03 -27.51 35.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 73.349999999999994 110.827 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.04 -39.89 60.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 74.510000000000005 111.116 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 33.9 mtm -60.69 -52.92 63.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 110.886 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.443 ' OE1' HG23 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -53.55 -27.6 27.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 74.530000000000001 110.889 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.447 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.28 -24.48 63.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 74.230000000000004 110.896 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.447 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 59.7 m-85 -109.08 21.47 17.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 73.099999999999994 110.892 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -114.54 168.14 12.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 60.039999999999999 112.466 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 m -104.73 129.84 52.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 72.519999999999996 110.891 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -54.97 -26.12 34.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 72.129999999999995 110.89 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -77.71 -28.81 51.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.882 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.27 -39.43 1.24 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.765 -0.731 . . . . 54.409999999999997 112.47 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -178.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 75.019999999999996 110.876 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 10.6 p -144.64 133.58 22.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 54.420000000000002 111.161 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.7 m -69.09 -41.17 77.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 65.310000000000002 110.889 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.514 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -105.5 -177.15 3.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 74.530000000000001 110.899 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.55 ' HD2' HG22 ' A' ' 157' ' ' THR . 2.0 tppp? -115.92 108.54 16.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 73.230000000000004 110.885 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.558 HD13 HD12 ' A' ' 56' ' ' ILE . 4.9 mp -92.0 119.2 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 64.209999999999994 111.12 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.55 HG22 ' HD2' ' A' ' 155' ' ' LYS . 0.6 OUTLIER -129.0 163.7 24.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 55.350000000000001 111.145 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.566 HD13 ' HE2' ' A' ' 8' ' ' PHE . 7.5 mt -96.23 105.56 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 111.106 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.776 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -69.31 -41.7 76.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 71.510000000000005 111.083 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -162.98 160.95 25.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 71.430000000000007 110.87 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -167.98 148.16 4.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 71.420000000000002 110.882 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.5 -173.02 44.27 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.739 -0.743 . . . . 75.239999999999995 112.492 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.505 ' HG2' ' NH2' ' A' ' 37' ' ' ARG . 3.8 mt-30 -80.93 129.59 34.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 75.099999999999994 110.91 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.555 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -83.87 -57.78 3.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 75.439999999999998 110.972 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 71.219999999999999 110.871 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.802 0.334 . . . . 65.450000000000003 110.868 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.3 t -141.02 136.4 33.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 64.299999999999997 111.121 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -72.09 149.8 92.19 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.646 0.736 . . . . 73.010000000000005 110.876 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 146.32 59.61 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.689 2.259 . . . . 64.219999999999999 112.351 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -136.29 140.53 43.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 72.450000000000003 111.127 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.5 ' HA ' HD23 ' A' ' 164' ' ' LEU . 0.9 OUTLIER -132.84 147.62 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 71.329999999999998 111.136 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.588 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 16.5 p90 -106.64 166.48 10.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 74.120000000000005 110.849 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.618 ' CE2' HD13 ' A' ' 158' ' ' ILE . 6.3 m-85 -144.47 90.38 2.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.400000000000006 110.914 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.551 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 2.1 t0 -51.04 117.69 2.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 64.209999999999994 110.892 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.421 HG23 HG23 ' A' ' 156' ' ' ILE . 22.2 mm -90.43 116.65 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 65.439999999999998 111.134 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -113.47 124.26 51.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 70.340000000000003 111.093 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.619 HG23 HD13 ' A' ' 17' ' ' LEU . 12.9 t -109.22 101.34 12.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 72.230000000000004 111.158 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.31 44.26 25.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 73.310000000000002 110.833 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.08 -2.0 87.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.734 . . . . 73.299999999999997 112.491 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.413 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 10.3 mm-40 -109.56 99.49 37.71 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.677 0.751 . . . . 63.420000000000002 110.883 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.71 101.29 0.89 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.703 2.269 . . . . 65.519999999999996 112.378 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.619 HD13 HG23 ' A' ' 12' ' ' VAL . 8.4 mp -65.11 -35.73 82.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 62.109999999999999 110.89 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.59 -145.1 9.04 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.745 -0.741 . . . . 73.150000000000006 112.497 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.56 153.2 51.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 73.040000000000006 110.89 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.468 HG11 ' CG2' ' A' ' 139' ' ' VAL . 5.8 t -144.89 101.46 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 72.230000000000004 111.116 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 2.4 t -92.33 176.44 6.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 62.310000000000002 110.83 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.455 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -146.26 116.2 7.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 74.120000000000005 110.882 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -67.64 96.99 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 63.32 110.88 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.8 mt -80.16 134.32 36.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 75.030000000000001 110.885 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -94.4 66.93 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 71.140000000000001 110.849 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.95 -23.65 33.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 75.420000000000002 111.089 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -68.39 -29.16 67.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 63.140000000000001 110.888 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -103.11 -30.13 10.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 73.140000000000001 110.885 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.86 63.89 60.18 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.609 0.719 . . . . 62.310000000000002 111.131 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -5.85 17.19 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.689 2.259 . . . . 61.409999999999997 112.388 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.72 -45.25 11.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 74.549999999999997 110.907 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.432 HG23 ' HE1' ' A' ' 100' ' ' MET . 44.2 m -92.76 -48.8 6.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 53.240000000000002 111.126 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.99 -41.89 68.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 73.329999999999998 111.109 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -58.88 -44.52 91.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 71.439999999999998 110.933 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.468 ' OD1' HG23 ' A' ' 78' ' ' ILE . 3.0 t30 -54.2 -50.03 68.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 72.400000000000006 110.922 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -61.53 -43.61 98.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 64.0 110.856 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -63.06 -44.01 97.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 73.519999999999996 110.907 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.85 -37.75 66.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 52.530000000000001 111.089 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.422 HD23 ' HG2' ' A' ' 44' ' ' LYS . 28.8 mt -71.97 -54.7 9.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 54.399999999999999 110.903 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -44.7 81.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 64.5 110.857 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.404 HG22 ' HB2' ' A' ' 163' ' ' GLN . 40.1 p -65.32 -47.0 78.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 65.430000000000007 111.118 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.09 -18.28 16.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 72.239999999999995 112.484 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -52.89 -29.06 26.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.914 0.388 . . . . 72.200000000000003 110.881 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.804 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -58.83 -19.0 37.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 72.010000000000005 110.894 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.2 -13.07 40.52 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.683 -0.77 . . . . 62.310000000000002 112.476 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -176.78 -170.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.869 0.366 . . . . 73.409999999999997 110.855 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -177.83 173.15 45.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 62.520000000000003 112.466 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -117.93 60.29 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.961 0.41 . . . . 73.239999999999995 110.931 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -78.01 57.56 1.8 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.491 . . . . 71.209999999999994 110.863 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 169.76 59.06 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 54.109999999999999 112.447 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.537 ' O ' HG22 ' A' ' 157' ' ' THR . 0.3 OUTLIER -114.57 151.62 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 75.120000000000005 110.852 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.9 p -96.07 129.23 43.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 53.350000000000001 110.856 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -84.39 133.95 34.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 75.239999999999995 110.885 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -132.62 40.59 3.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 65.400000000000006 110.897 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 tpp85 -162.58 71.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 75.230000000000004 110.882 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.453 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.4 mt -123.66 113.76 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.420000000000002 111.153 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.7 mt -112.91 109.59 52.44 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.618 0.723 . . . . 64.319999999999993 111.12 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.0 Cg_endo -69.76 76.92 1.11 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.67 2.247 . . . . 63.100000000000001 112.319 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.79 -27.15 0.21 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 74.349999999999994 112.457 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.403 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.0 OUTLIER -115.26 -60.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 74.030000000000001 110.858 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.411 ' HE3' ' O ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER 172.68 173.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 55.100000000000001 110.866 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.411 ' O ' ' HE3' ' A' ' 61' ' ' MET . 7.2 m -108.83 -177.71 3.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.248 -0.433 . . . . 75.209999999999994 110.866 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.545 ' CG ' ' HB1' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -150.92 154.63 37.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 53.310000000000002 110.894 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.22 -28.69 61.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.746 -0.74 . . . . 64.140000000000001 112.499 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.61 -87.11 0.54 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.752 -0.737 . . . . 64.239999999999995 112.48 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -155.43 149.9 26.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.861 0.362 . . . . 75.549999999999997 110.828 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -71.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 64.450000000000003 110.869 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.6 t -154.95 -42.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 72.510000000000005 111.176 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.2 -170.35 2.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 75.040000000000006 110.854 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -118.84 -77.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 74.329999999999998 110.882 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 50.28 29.65 3.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 65.239999999999995 110.876 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 57.73 54.7 35.23 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.701 -0.761 . . . . 33.340000000000003 112.48 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.409 HG23 ' N ' ' A' ' 74' ' ' GLY . 1.8 t 177.65 -49.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.828 0.347 . . . . 54.149999999999999 111.173 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.409 ' N ' HG23 ' A' ' 73' ' ' THR . . . 107.21 -146.23 16.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.707 -0.759 . . . . 71.109999999999999 112.487 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.29 -123.44 2.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.756 -0.735 . . . . 74.209999999999994 112.499 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? 179.73 145.08 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.338 . . . . 73.230000000000004 110.884 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.1 m -76.41 65.73 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 52.100000000000001 110.876 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.804 HG22 ' HD2' ' A' ' 44' ' ' LYS . 16.4 pt 41.7 34.17 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 60.219999999999999 111.144 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -164.74 -64.6 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 72.25 110.91 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -136.61 161.85 25.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 70.25 112.509 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -47.84 -32.1 5.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.904 0.383 . . . . 64.530000000000001 110.863 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.427 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.31 170.22 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 74.099999999999994 110.864 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.46 -179.9 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 63.450000000000003 110.886 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.85 160.0 26.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 74.200000000000003 110.888 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -52.1 151.67 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 63.130000000000003 110.823 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -100.62 -78.34 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 71.420000000000002 110.861 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -158.01 172.49 18.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 52.109999999999999 110.888 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.8 37.48 4.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 65.109999999999999 110.898 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mt -50.61 -29.35 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 64.349999999999994 111.089 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 15.1 mt -108.87 88.33 2.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 72.540000000000006 110.874 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -71.6 151.97 43.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 64.439999999999998 110.921 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -64.85 87.39 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 75.230000000000004 110.842 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.21 -51.38 11.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 75.030000000000001 111.154 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . -147.86 -164.46 11.31 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.772 -0.728 . . . . 63.43 112.477 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 173.8 10.44 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.659 2.24 . . . . 62.229999999999997 112.331 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.52 28.09 73.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.777 -0.725 . . . . 63.43 112.472 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.8 mm -100.85 140.69 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.893 0.377 . . . . 75.140000000000001 111.145 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -111.45 138.97 47.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 110.93 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.62 -168.1 3.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 71.519999999999996 110.863 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.432 ' HE1' HG23 ' A' ' 32' ' ' THR . 0.5 OUTLIER -94.23 103.91 15.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 64.549999999999997 110.902 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.937 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -75.64 69.77 2.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 64.319999999999993 111.115 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -131.71 -175.17 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 74.129999999999995 110.896 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.93 -27.15 2.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 64.329999999999998 111.112 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.4 -89.23 0.49 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.715 -0.755 . . . . 64.540000000000006 112.506 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 90.86 0.52 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.737 2.292 . . . . 73.530000000000001 112.316 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.561 ' C ' HG23 ' A' ' 107' ' ' THR . 2.9 m-20 76.07 168.53 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 64.400000000000006 110.897 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.561 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.1 p 69.86 28.96 4.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 73.530000000000001 111.174 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -109.28 106.65 16.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 64.400000000000006 110.879 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -90.23 -65.58 1.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 50.439999999999998 112.457 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.5 p 179.64 49.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.806 0.336 . . . . 73.239999999999995 110.836 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.686 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 3.4 mm-40 -62.39 -34.95 77.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 71.329999999999998 110.963 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 68.58 137.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 62.009999999999998 110.89 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.937 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -154.06 127.55 8.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 74.230000000000004 110.849 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.7 mt -83.95 125.32 40.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 73.329999999999998 111.164 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -91.15 103.48 16.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 73.319999999999993 110.894 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 69.4 p -88.42 20.75 3.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 111.117 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.732 ' O ' HG23 ' A' ' 119' ' ' THR . . . 174.87 146.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 52.310000000000002 111.13 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.425 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 1.2 tttt -54.43 99.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 65.219999999999999 110.906 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.732 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 42.2 p -105.87 46.66 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 72.209999999999994 111.125 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -25.73 65.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 75.140000000000001 110.879 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.732 ' CZ2' HG22 ' A' ' 119' ' ' THR . 5.6 p90 -50.12 -25.46 3.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.474 . . . . 72.329999999999998 110.905 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.9 mt -45.04 -35.72 3.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 73.409999999999997 110.888 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.0 m-20 60.74 80.45 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 65.329999999999998 110.853 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.3 42.66 0.9 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 63.200000000000003 112.52 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? -82.23 -25.49 34.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.834 0.35 . . . . 73.319999999999993 110.897 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -141.46 179.23 6.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 63.310000000000002 110.876 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.4 t -114.8 124.31 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 62.240000000000002 111.096 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.45 131.92 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 74.299999999999997 111.119 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.459 ' O ' HD23 ' A' ' 24' ' ' LEU . 43.3 p90 -149.23 31.58 0.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 62.25 110.911 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -175.8 175.69 47.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.804 -0.713 . . . . 73.030000000000001 112.494 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' A' ' 132' ' ' VAL . 1.5 pttp -173.12 127.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.81 0.338 . . . . 75.450000000000003 110.885 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.761 HG11 ' HG2' ' A' ' 136' ' ' MET . 53.8 t -32.12 106.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 64.430000000000007 111.107 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -57.16 4.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 70.510000000000005 110.895 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -157.06 157.51 34.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 75.409999999999997 110.905 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.33 32.05 10.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 65.299999999999997 112.507 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.761 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -61.16 -24.23 66.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 64.0 110.848 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -39.4 79.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 71.439999999999998 110.893 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.477 HD12 ' HB3' ' A' ' 17' ' ' LEU . 25.9 mm -66.56 -37.7 80.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 54.439999999999998 111.134 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.468 ' CG2' HG11 ' A' ' 20' ' ' VAL . 69.0 t -64.17 -30.54 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 73.230000000000004 111.129 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -73.09 -30.86 63.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 74.430000000000007 110.898 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.79 -37.19 70.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 61.119999999999997 111.111 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 16.0 mtm -57.97 -53.79 54.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 51.25 110.869 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.453 ' OE1' HG23 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -53.87 -28.12 34.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 61.140000000000001 110.866 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.44 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -67.81 -24.44 65.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 64.299999999999997 110.854 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.44 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 58.5 m-85 -108.71 20.68 18.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 70.109999999999999 110.915 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.41 166.25 12.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 52.119999999999997 112.514 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.5 t -123.34 148.79 45.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.864 0.364 . . . . 62.200000000000003 110.866 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.9 mmm-85 -75.34 70.51 2.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 61.009999999999998 110.92 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -174.79 -35.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.299999999999997 110.889 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 147.42 -42.72 0.88 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 70.040000000000006 112.483 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.38 165.63 20.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.864 0.364 . . . . 73.349999999999994 110.854 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.8 p -145.67 154.5 42.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 75.010000000000005 111.133 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.9 m -71.32 -48.16 52.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 75.329999999999998 110.849 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.413 ' HB3' HG13 ' A' ' 12' ' ' VAL . 6.0 mttt -96.87 -178.53 4.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 70.420000000000002 110.921 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -124.05 108.86 12.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 63.119999999999997 110.887 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.421 HG23 HG23 ' A' ' 10' ' ' ILE . 4.7 mp -92.76 123.12 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 70.430000000000007 111.126 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -131.83 158.57 40.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 64.129999999999995 111.136 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.618 HD13 ' CE2' ' A' ' 8' ' ' PHE . 9.7 mt -91.1 108.44 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 63.0 111.15 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -73.85 -48.4 31.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 63.039999999999999 111.099 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -151.93 162.74 40.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 54.409999999999997 110.872 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.11 148.19 4.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 74.310000000000002 110.901 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 176.81 172.51 41.52 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 74.329999999999998 112.498 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.404 ' HB2' HG22 ' A' ' 41' ' ' THR . 2.4 mt-30 -63.84 140.4 58.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.836 0.351 . . . . 74.140000000000001 110.91 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -92.49 -56.19 3.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 55.539999999999999 110.894 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 63.329999999999998 110.864 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mtp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.853 0.358 . . . . 75.319999999999993 110.875 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.6 t -140.35 130.31 28.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 51.539999999999999 111.159 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -102.44 153.51 38.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.617 0.722 . . . . 70.299999999999997 110.877 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 146.72 61.0 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.672 2.248 . . . . 75.319999999999993 112.316 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -133.28 140.05 47.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 74.120000000000005 111.18 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.458 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.6 m -133.3 143.02 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 64.209999999999994 111.14 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.577 ' HB3' HD21 ' A' ' 164' ' ' LEU . 15.7 p90 -103.4 161.07 14.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 71.099999999999994 110.92 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -142.55 88.08 2.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 72.540000000000006 110.868 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.493 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 2.3 t70 -52.13 107.49 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 60.130000000000003 110.888 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.841 HG23 HG23 ' A' ' 156' ' ' ILE . 32.3 mm -78.9 131.39 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 50.399999999999999 111.117 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -126.87 123.58 37.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 62.32 111.102 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.467 HG12 ' HG2' ' A' ' 154' ' ' LYS . 1.9 t -108.28 94.55 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 73.530000000000001 111.156 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.1 t0 58.96 46.76 13.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 73.040000000000006 110.899 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.34 -4.37 84.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.738 -0.744 . . . . 65.129999999999995 112.477 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.441 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -111.28 102.63 53.5 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.681 0.753 . . . . 72.439999999999998 110.87 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.82 124.34 10.96 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.628 2.218 . . . . 74.010000000000005 112.33 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.429 ' HB3' HD12 ' A' ' 138' ' ' ILE . 11.1 mt -70.14 -38.76 75.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 70.340000000000003 110.926 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.39 -127.17 1.7 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.76 -0.733 . . . . 72.019999999999996 112.534 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.49 138.37 54.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.856 0.36 . . . . 75.219999999999999 110.851 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.561 HG21 HG13 ' A' ' 10' ' ' ILE . 1.4 t -145.04 100.05 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 64.129999999999995 111.083 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -108.78 175.24 5.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 53.310000000000002 110.885 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.454 ' N ' ' OG ' ' A' ' 21' ' ' SER . 1.8 m-85 -146.23 137.2 24.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 74.409999999999997 110.827 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.406 ' HB2' ' CE ' ' A' ' 133' ' ' LYS . 16.2 tt0 -92.12 101.55 14.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 71.299999999999997 110.892 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.7 mt -83.15 119.06 24.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 63.240000000000002 110.939 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.432 ' CD1' HD13 ' A' ' 90' ' ' LEU . 58.3 m-85 -76.55 65.68 2.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 74.120000000000005 110.88 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.7 -22.77 25.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 44.130000000000003 111.099 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -65.87 -33.94 76.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 71.049999999999997 110.881 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -101.56 -29.19 12.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 51.439999999999998 110.887 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.416 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -135.22 65.73 64.65 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.594 0.712 . . . . 72.430000000000007 111.107 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -34.92 13.54 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.65 2.234 . . . . 73.310000000000002 112.37 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -39.55 91.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 75.540000000000006 110.909 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.5 m -87.96 -40.4 13.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 72.439999999999998 111.139 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.4 95.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 73.129999999999995 111.061 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -51.75 -35.78 44.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 65.140000000000001 110.87 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -61.37 -54.53 42.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 45.240000000000002 110.874 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -65.76 -45.65 81.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 73.450000000000003 110.879 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.97 -38.7 86.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 72.430000000000007 110.828 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.36 -44.28 97.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 61.240000000000002 111.093 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.5 mt -74.03 -47.21 38.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 62.100000000000001 110.933 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.1 m -51.92 -44.94 64.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 60.109999999999999 110.838 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.6 p -71.75 -34.4 69.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 61.100000000000001 111.144 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.59 -6.41 41.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.738 -0.744 . . . . 71.040000000000006 112.462 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.75 -25.09 17.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 54.43 110.856 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.582 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -65.63 -32.97 74.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 60.210000000000001 110.897 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.54 -28.88 4.38 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 73.310000000000002 112.487 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -141.51 -39.97 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.885 0.374 . . . . 74.109999999999999 110.91 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.13 -163.91 52.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 61.539999999999999 112.467 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.54 45.83 1.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.914 0.388 . . . . 71.140000000000001 110.937 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 74.33 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 74.150000000000006 110.865 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.67 -59.38 0.33 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 73.140000000000001 112.49 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 45.8 -163.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.774 0.321 . . . . 60.520000000000003 110.909 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.2 p 179.11 116.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 60.130000000000003 110.89 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.628 ' HE1' HD11 ' A' ' 158' ' ' ILE . 72.3 m-85 -97.37 75.35 2.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 71.420000000000002 110.867 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -73.15 -21.27 60.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 62.520000000000003 110.826 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.18 122.51 46.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 65.409999999999997 110.887 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.434 ' HB ' HG21 ' A' ' 152' ' ' THR . 29.0 mt -150.29 111.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 64.420000000000002 111.125 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.4 ' O ' HG22 ' A' ' 57' ' ' ILE . 42.8 mt -105.78 103.0 41.82 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.615 0.722 . . . . 75.430000000000007 111.179 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 83.11 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.706 2.271 . . . . 72.150000000000006 112.341 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 153.19 -20.63 0.75 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 74.340000000000003 112.525 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.21 -59.33 1.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.866 0.365 . . . . 64.329999999999998 110.859 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -178.14 175.59 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 73.140000000000001 110.866 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.4 m -120.47 -170.13 1.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 73.120000000000005 110.893 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -177.67 144.13 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 71.439999999999998 110.938 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.95 124.27 1.03 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.705 -0.76 . . . . 63.32 112.512 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.72 106.64 0.19 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.728 -0.749 . . . . 73.040000000000006 112.503 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.42 145.82 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.339 . . . . 75.200000000000003 110.88 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -163.09 44.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 73.230000000000004 110.879 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.3 p -119.19 -37.34 3.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 74.420000000000002 111.137 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.89 -172.38 3.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 75.430000000000007 110.852 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -77.82 -35.86 50.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 65.319999999999993 110.851 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -153.18 65.0 0.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 70.030000000000001 110.916 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.09 -146.22 8.3 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 64.450000000000003 112.466 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.9 p -145.84 38.93 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.794 0.33 . . . . 71.239999999999995 111.122 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.61 -113.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.728 -0.748 . . . . 75.409999999999997 112.489 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 51.55 88.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 43.039999999999999 112.474 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.88 152.25 25.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 55.240000000000002 110.88 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.9 p -61.63 157.38 17.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 63.009999999999998 110.852 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.582 HG22 ' HD2' ' A' ' 44' ' ' LYS . 1.5 pp -56.84 -29.47 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 65.439999999999998 111.152 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -82.89 -50.49 8.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.454 . . . . 71.299999999999997 110.884 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.76 -125.79 0.87 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.786 -0.721 . . . . 43.25 112.517 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -72.46 -33.2 66.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.885 0.374 . . . . 73.150000000000006 110.861 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.52 174.94 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 72.319999999999993 110.887 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.74 -168.52 1.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 72.109999999999999 110.85 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.28 162.67 14.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 72.230000000000004 110.902 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -54.33 115.83 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 73.299999999999997 110.881 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -93.85 -74.72 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 75.439999999999998 110.878 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -174.88 174.76 2.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 74.140000000000001 110.847 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.82 37.94 3.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 63.210000000000001 110.887 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -49.6 -30.13 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 73.310000000000002 111.131 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.432 HD13 ' CD1' ' A' ' 25' ' ' PHE . 10.1 mt -112.56 78.18 1.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.168 -0.469 . . . . 62.210000000000001 110.886 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 93' ' ' THR . 4.1 mtpt -70.55 151.55 44.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 72.140000000000001 110.864 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -49.81 102.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 72.400000000000006 110.898 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 91' ' ' LYS . 25.2 p -113.81 26.94 9.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 64.420000000000002 111.098 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.69 -177.78 24.78 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 44.420000000000002 112.54 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 174.14 9.94 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.655 2.237 . . . . 63.439999999999998 112.372 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.13 44.4 97.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 73.439999999999998 112.485 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 115' ' ' CYS . 14.0 mm -110.86 140.4 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.844 0.354 . . . . 55.329999999999998 111.122 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 98' ' ' LEU . 2.8 mt -108.29 155.68 20.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 44.039999999999999 110.943 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 6.8 t -167.29 -134.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 61.109999999999999 110.884 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 9.7 mmt -153.78 143.38 21.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 71.439999999999998 110.902 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -128.37 139.8 52.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 65.209999999999994 111.095 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 168.5 -31.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 74.299999999999997 110.858 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.732 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -175.95 -41.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 74.109999999999999 111.097 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.84 -77.47 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 70.329999999999998 112.484 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 112.0 2.96 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.636 2.224 . . . . 63.340000000000003 112.331 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.436 ' O ' HG23 ' A' ' 107' ' ' THR . 1.3 p-10 39.71 61.15 1.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 64.409999999999997 110.909 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.732 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 10.3 p -156.17 52.92 0.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 70.409999999999997 111.142 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.82 124.94 42.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 71.310000000000002 110.876 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.19 -103.48 1.97 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 73.540000000000006 112.5 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.19 30.49 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 64.319999999999993 110.858 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.633 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 6.3 mm-40 -112.5 40.48 2.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 72.549999999999997 110.933 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' A' ' 99' ' ' SER . 5.7 p90 -58.21 -170.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 73.010000000000005 110.89 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -148.58 146.54 28.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 74.450000000000003 110.895 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.45 HG21 HG13 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -74.79 -15.3 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 74.219999999999999 111.119 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER 49.17 93.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 52.0 110.913 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.549 HG22 ' CG1' ' A' ' 139' ' ' VAL . 82.3 p -91.17 26.75 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 62.329999999999998 111.118 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.621 ' O ' HG23 ' A' ' 119' ' ' THR . . . 178.26 151.76 0.28 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 62.009999999999998 111.129 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.74 97.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 44.299999999999997 110.881 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.699 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 26.5 p -104.11 46.5 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 52.310000000000002 111.148 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -25.38 68.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 71.030000000000001 110.842 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.699 ' CZ2' HG22 ' A' ' 119' ' ' THR . 5.4 p90 -47.32 -28.61 2.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.155 -0.475 . . . . 75.230000000000004 110.938 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.6 mt -46.74 -32.82 3.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 64.209999999999994 110.865 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 62.52 77.44 0.33 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 72.040000000000006 110.869 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 36.54 43.43 0.77 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 60.240000000000002 112.45 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -80.85 -13.6 58.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 74.140000000000001 110.916 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -144.05 -169.15 3.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 110.859 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.1 t -120.69 117.39 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 72.340000000000003 111.173 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 98' ' ' LEU . 2.6 t -88.83 134.14 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 72.150000000000006 111.119 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.445 ' O ' HD23 ' A' ' 24' ' ' LEU . 19.9 p90 -156.09 37.6 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 74.430000000000007 110.839 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -175.4 173.55 46.3 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.772 -0.728 . . . . 70.200000000000003 112.486 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 8.0 pttt -175.59 139.3 0.42 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.797 0.332 . . . . 75.340000000000003 110.926 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.654 HG11 ' HG2' ' A' ' 136' ' ' MET . 55.1 t -41.17 110.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 73.129999999999995 111.132 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.406 ' CE ' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -73.0 -59.29 2.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 71.109999999999999 110.868 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -152.12 157.14 41.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 42.130000000000003 110.897 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.09 35.54 17.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.742 . . . . 32.439999999999998 112.508 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.654 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -56.13 -31.38 63.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.751 0.31 . . . . 71.239999999999995 110.909 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.59 -30.23 20.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 71.040000000000006 110.887 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.443 HG21 ' CG2' ' A' ' 20' ' ' VAL . 41.4 mm -66.27 -41.29 88.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 75.430000000000007 111.092 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.549 ' CG1' HG22 ' A' ' 116' ' ' THR . 59.1 t -62.02 -28.29 44.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 53.240000000000002 111.152 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -79.34 -28.64 42.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 64.040000000000006 110.857 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.32 -38.46 63.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 35.5 111.112 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.569 ' SD ' HG21 ' A' ' 156' ' ' ILE . 28.6 mtm -59.78 -51.8 68.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 72.109999999999999 110.894 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.02 -24.69 25.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 73.120000000000005 110.903 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.43 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -72.71 -24.11 60.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 73.230000000000004 110.925 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.43 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 62.1 m-85 -108.27 16.86 22.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 65.510000000000005 110.879 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.98 178.66 17.62 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 61.229999999999997 112.491 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -141.3 132.59 26.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 45.25 110.865 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -64.58 84.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 62.509999999999998 110.855 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 179.74 -33.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 71.299999999999997 110.865 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.21 -92.49 0.15 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.8 -0.714 . . . . 73.010000000000005 112.488 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -51.17 156.53 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 73.310000000000002 110.895 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.434 HG21 ' HB ' ' A' ' 56' ' ' ILE . 39.1 p -131.66 156.02 46.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 111.145 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.63 -35.21 78.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 73.129999999999995 110.863 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.467 ' HG2' HG12 ' A' ' 12' ' ' VAL . 2.1 mttp -101.23 -179.59 4.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 75.519999999999996 110.859 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.8 104.55 7.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 62.409999999999997 110.846 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.841 HG23 HG23 ' A' ' 10' ' ' ILE . 4.8 mp -90.63 105.56 16.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 71.109999999999999 111.081 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.95 166.02 13.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 70.299999999999997 111.132 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.628 HD11 ' HE1' ' A' ' 53' ' ' PHE . 6.5 mm -98.4 119.51 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 72.319999999999993 111.118 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -82.96 -50.56 8.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 65.129999999999995 111.117 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -142.81 155.58 44.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 73.040000000000006 110.862 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -163.44 148.87 11.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 73.319999999999993 110.89 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 172.96 167.64 33.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.783 -0.722 . . . . 55.219999999999999 112.511 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -61.83 134.8 57.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.789 0.328 . . . . 61.420000000000002 110.927 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.577 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -85.7 -59.3 2.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 74.129999999999995 110.938 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 75.129999999999995 110.855 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.783 0.325 . . . . 74.5 110.882 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.7 t -149.87 136.32 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 74.5 111.162 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -115.46 142.96 29.58 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 74.409999999999997 110.889 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 146.84 61.47 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.687 2.258 . . . . 65.109999999999999 112.356 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -129.52 135.66 48.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 74.420000000000002 111.167 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -133.13 160.56 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 61.350000000000001 111.122 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 1.7 p90 -143.36 -179.29 6.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 73.409999999999997 110.879 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -155.89 92.99 1.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 74.230000000000004 110.896 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.58 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.8 OUTLIER -44.05 104.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 74.540000000000006 110.925 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.672 HG22 HD12 ' A' ' 17' ' ' LEU . 26.1 mm -77.18 134.79 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 73.329999999999998 111.083 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -127.66 154.12 45.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 43.329999999999998 111.068 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.53 HG13 ' HB3' ' A' ' 154' ' ' LYS . 33.2 t -134.02 95.91 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 64.340000000000003 111.106 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.37 31.52 10.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 71.329999999999998 110.861 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.63 -23.39 34.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.788 -0.72 . . . . 74.530000000000001 112.471 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -92.25 115.09 64.1 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.607 0.718 . . . . 60.039999999999999 110.891 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.9 Cg_endo -69.73 123.0 9.69 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.69 2.26 . . . . 75.400000000000006 112.374 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.672 HD12 HG22 ' A' ' 10' ' ' ILE . 13.1 mt -66.66 -38.66 87.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 73.230000000000004 110.909 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.65 -122.95 1.19 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.756 -0.735 . . . . 42.109999999999999 112.458 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.05 141.13 46.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 73.329999999999998 110.91 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.539 HG21 HG13 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -143.53 103.99 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 55.450000000000003 111.136 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.8 t -110.28 172.95 6.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 71.099999999999994 110.834 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.418 ' N ' ' OG ' ' A' ' 21' ' ' SER . 10.1 m-85 -146.29 131.61 18.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 73.140000000000001 110.906 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -85.98 98.07 10.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 61.310000000000002 110.884 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 129' ' ' PHE . 3.6 mt -83.12 136.39 34.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 73.299999999999997 110.888 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -96.27 63.75 2.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 65.209999999999994 110.85 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.19 -24.02 16.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 71.519999999999996 111.072 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.36 -31.19 70.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 74.209999999999994 110.887 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.5 -27.07 13.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 73.319999999999993 110.831 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.451 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -136.61 63.52 47.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.577 0.703 . . . . 71.239999999999995 111.088 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -41.82 3.89 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.679 2.253 . . . . 73.030000000000001 112.354 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -55.32 -37.46 67.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 73.409999999999997 110.922 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.424 HG21 ' CD1' ' A' ' 129' ' ' PHE . 16.0 m -89.19 -53.36 4.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 62.530000000000001 111.141 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.26 -36.37 41.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 44.399999999999999 111.123 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -49.74 -32.35 13.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 72.219999999999999 110.876 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.475 ' ND2' HG23 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -66.48 -63.84 0.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 75.040000000000006 110.926 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.37 -34.29 68.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 74.519999999999996 110.893 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.5 ' HE ' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -65.05 -49.48 69.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.487 . . . . 70.310000000000002 110.871 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.87 -31.46 72.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 70.120000000000005 111.113 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.9 mt -75.43 -55.95 5.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 62.350000000000001 110.96 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.0 m -49.37 -48.92 46.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 71.120000000000005 110.873 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.5 HG23 ' HE ' ' A' ' 37' ' ' ARG . 17.2 p -69.05 -28.08 66.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 71.340000000000003 111.132 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.3 -14.51 65.16 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.728 . . . . 75.540000000000006 112.459 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -52.29 -25.29 9.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.959 0.409 . . . . 73.239999999999995 110.938 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.785 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -50.3 -28.26 7.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 75.140000000000001 110.868 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.69 -26.08 4.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.766 -0.731 . . . . 43.420000000000002 112.501 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -165.45 -47.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 74.420000000000002 110.849 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.61 177.72 0.38 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.774 -0.727 . . . . 61.409999999999997 112.488 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -94.7 26.71 3.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.004 0.43 . . . . 75.099999999999994 110.919 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.19 126.92 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 73.120000000000005 110.902 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.18 39.6 92.47 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.763 -0.732 . . . . 73.109999999999999 112.484 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -92.02 -178.66 5.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.888 0.375 . . . . 73.219999999999999 110.853 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 22.6 m -117.73 153.39 33.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 73.0 110.891 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -101.61 143.54 31.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 71.140000000000001 110.888 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -145.25 45.01 1.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 73.540000000000006 110.827 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -171.38 70.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 72.140000000000001 110.885 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 56' ' ' ILE . 11.2 mt -117.39 109.46 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 71.519999999999996 111.091 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.6 mt -106.82 102.67 43.51 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.65 0.738 . . . . 71.430000000000007 111.148 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.5 Cg_endo -69.82 79.67 0.95 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.683 2.255 . . . . 73.010000000000005 112.309 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.19 -25.62 0.54 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 73.120000000000005 112.491 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.43 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.3 OUTLIER -117.95 -59.17 1.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.332 . . . . 74.510000000000005 110.865 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.43 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.2 OUTLIER 176.91 162.63 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 75.340000000000003 110.815 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.9 m -104.59 -169.05 1.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 110.909 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.497 HE21 ' HB1' ' A' ' 101' ' ' ALA . 3.4 tt0 -178.72 146.91 0.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 75.420000000000002 110.939 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.38 176.67 18.02 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.728 . . . . 71.239999999999995 112.472 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.13 120.31 4.33 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.756 -0.735 . . . . 55.329999999999998 112.493 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -179.83 38.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.772 0.32 . . . . 74.409999999999997 110.836 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -128.86 35.0 4.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 72.439999999999998 110.907 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.52 -35.33 40.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 74.510000000000005 111.157 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? 63.55 160.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 71.319999999999993 110.815 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -52.14 -35.91 49.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 74.409999999999997 110.863 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.01 -39.41 59.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 63.530000000000001 110.85 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.36 48.57 5.01 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.74 . . . . 52.32 112.489 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.8 t -165.94 48.25 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.846 0.355 . . . . 72.349999999999994 111.161 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.96 -81.01 1.5 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 64.129999999999995 112.443 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.88 94.88 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.762 -0.732 . . . . 71.230000000000004 112.471 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -174.74 167.02 3.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.75 0.31 . . . . 71.010000000000005 110.916 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.25 -165.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 74.319999999999993 110.86 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.785 HG22 ' HD2' ' A' ' 44' ' ' LYS . 3.9 pt -94.95 28.43 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 45.210000000000001 111.144 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -135.42 -67.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 63.340000000000003 110.933 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.16 -142.65 3.49 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 60.399999999999999 112.517 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -50.23 -32.94 17.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.856 0.36 . . . . 74.299999999999997 110.889 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.427 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.69 -175.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 60.32 110.883 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -147.32 161.01 41.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 72.200000000000003 110.871 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -60.73 166.0 3.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 65.510000000000005 110.899 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -82.12 174.94 10.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 75.519999999999996 110.852 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -120.09 -76.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 73.019999999999996 110.871 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.5 p30 -158.89 176.04 12.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 74.010000000000005 110.89 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.03 37.66 3.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 75.430000000000007 110.844 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.54 -30.08 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 71.030000000000001 111.141 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 20.9 mt -109.99 82.56 1.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 65.310000000000002 110.92 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.93 150.48 46.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 63.219999999999999 110.875 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -58.03 97.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.5 110.841 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.0 p -104.06 24.09 11.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 53.25 111.122 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 147.19 -178.89 24.52 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.739 -0.743 . . . . 70.25 112.5 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 172.62 12.33 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.651 2.234 . . . . 75.25 112.327 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.92 29.56 72.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 75.450000000000003 112.473 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.5 mm -103.07 139.97 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.877 0.37 . . . . 54.32 111.119 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.48 HD21 ' CD2' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -108.86 145.97 34.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 65.230000000000004 110.935 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.95 -167.99 2.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 53.409999999999997 110.891 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.579 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -98.38 113.71 25.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 74.400000000000006 110.859 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.886 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -94.03 130.45 40.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 62.109999999999999 111.077 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.562 ' CG ' ' HA3' ' A' ' 109' ' ' GLY . 0.6 OUTLIER 175.5 -70.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 65.219999999999999 110.915 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.833 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -146.85 -50.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 70.140000000000001 111.07 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.35 -70.27 0.51 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.759 -0.734 . . . . 71.439999999999998 112.522 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 110.23 2.5 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.672 2.248 . . . . 71.030000000000001 112.358 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 39.52 45.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 71.109999999999999 110.865 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.833 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 22.1 p -153.77 53.33 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 65.340000000000003 111.164 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -50.43 -37.16 36.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 73.209999999999994 110.909 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.562 ' HA3' ' CG ' ' A' ' 102' ' ' ASN . . . 77.34 -56.39 3.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 72.099999999999994 112.484 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.579 ' HA ' ' HE2' ' A' ' 100' ' ' MET . 1.0 OUTLIER 85.73 41.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 54.32 110.839 -179.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 25.5 mm-40 -104.45 -14.91 15.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 75.239999999999995 110.925 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.566 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER 72.91 150.94 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.540000000000006 110.876 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.886 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -159.23 131.11 6.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 73.340000000000003 110.849 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 mt -87.85 126.93 41.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 73.530000000000001 111.139 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.94 101.02 13.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.349999999999994 110.823 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 68.4 p -86.24 20.45 2.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 74.349999999999994 111.101 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.718 ' O ' HG23 ' A' ' 119' ' ' THR . . . 176.25 146.21 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 74.5 111.071 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -56.01 94.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 62.520000000000003 110.926 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.811 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 33.8 p -100.7 56.64 0.89 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 54.450000000000003 111.126 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -66.04 -26.17 67.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 75.109999999999999 110.904 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.811 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.8 p90 -49.17 -26.4 2.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 71.530000000000001 110.908 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.7 mt -45.83 -34.16 3.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.26 -0.427 . . . . 75.219999999999999 110.926 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.6 m-20 61.93 72.5 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 71.200000000000003 110.916 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.65 42.74 0.71 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.691 -0.766 . . . . 75.109999999999999 112.519 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.78 -28.47 36.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 63.200000000000003 110.885 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -124.83 -173.22 2.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 75.109999999999999 110.845 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.11 116.86 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 60.219999999999999 111.143 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.34 135.03 26.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 35.149999999999999 111.137 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.485 ' O ' HD23 ' A' ' 24' ' ' LEU . 16.4 p90 -160.79 34.82 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 65.230000000000004 110.872 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -172.49 176.39 45.43 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.764 -0.731 . . . . 53.119999999999997 112.497 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -174.14 136.98 0.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.803 0.335 . . . . 65.019999999999996 110.905 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.664 HG11 ' HG2' ' A' ' 136' ' ' MET . 79.6 t -40.95 108.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 73.439999999999998 111.159 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -57.96 4.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 72.120000000000005 110.921 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -157.18 156.83 33.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.540000000000006 110.893 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.07 32.61 16.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.789 -0.719 . . . . 61.130000000000003 112.505 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.664 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -55.89 -26.22 46.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 74.540000000000006 110.888 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -32.39 59.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 55.140000000000001 110.867 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.603 HD12 ' HB3' ' A' ' 17' ' ' LEU . 40.1 mm -65.29 -37.06 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 72.219999999999999 111.126 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.1 t -66.31 -28.19 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 72.319999999999993 111.104 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.21 -28.64 38.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 72.519999999999996 110.901 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.99 -40.0 60.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 54.210000000000001 111.112 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 34.6 mtm -61.27 -53.1 61.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 74.140000000000001 110.908 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.448 ' OE1' HG23 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -54.87 -24.73 24.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 75.109999999999999 110.896 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.43 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.66 -24.31 61.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 73.430000000000007 110.857 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.43 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 64.0 m-85 -107.7 13.94 26.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 73.019999999999996 110.878 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.1 169.08 13.64 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.732 -0.746 . . . . 72.549999999999997 112.482 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 53.5 p -114.08 146.71 39.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 72.310000000000002 110.859 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -73.73 72.92 1.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 73.430000000000007 110.888 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -179.53 -34.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 73.329999999999998 110.886 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 154.5 -61.3 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.775 -0.726 . . . . 74.140000000000001 112.516 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -58.31 174.37 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.35 . . . . 52.219999999999999 110.918 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.6 p -146.49 179.84 7.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 75.319999999999993 111.133 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.51 -65.19 1.03 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 40.030000000000001 110.872 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.53 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -78.96 -175.7 4.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 75.109999999999999 110.881 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -115.07 107.06 14.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 71.349999999999994 110.874 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.41 HG23 HG23 ' A' ' 10' ' ' ILE . 4.0 mp -84.85 111.36 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 71.400000000000006 111.162 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.49 165.48 17.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 72.140000000000001 111.161 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.3 mt -104.44 127.78 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 74.340000000000003 111.111 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.58 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -88.77 -50.38 6.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 41.43 111.085 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -148.73 150.86 33.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 63.149999999999999 110.907 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -156.87 149.54 23.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 73.530000000000001 110.835 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 164.49 170.5 29.51 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.809 -0.71 . . . . 53.119999999999997 112.535 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.28 127.53 27.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.808 0.337 . . . . 73.099999999999994 110.921 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.55 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.0 mm? -78.31 -47.7 17.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 72.219999999999999 110.974 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 53.109999999999999 110.929 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.777 0.322 . . . . 64.319999999999993 110.883 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.6 t -140.08 136.84 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 44.299999999999997 111.172 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -111.81 146.8 35.49 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.613 0.721 . . . . 74.319999999999993 110.899 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 146.1 58.67 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.64 2.227 . . . . 64.230000000000004 112.37 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -133.94 140.76 46.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 65.310000000000002 111.135 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.495 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.7 m -134.97 142.24 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 74.530000000000001 111.142 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 11.7 p90 -102.7 170.88 7.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 74.510000000000005 110.917 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.409 ' HA ' ' HB3' ' A' ' 161' ' ' CYS . 6.9 m-85 -151.18 88.51 1.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 74.140000000000001 110.888 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.644 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 3.0 t70 -50.08 105.6 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 72.319999999999993 110.869 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.683 HG22 HD12 ' A' ' 17' ' ' LEU . 35.9 mm -84.97 122.12 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 62.100000000000001 111.123 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -113.76 150.99 32.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 72.120000000000005 111.097 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.433 HG13 ' HB3' ' A' ' 154' ' ' LYS . 21.1 t -132.39 95.9 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 74.129999999999995 111.119 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.66 33.97 8.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 63.049999999999997 110.896 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.47 -19.13 55.91 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.719 -0.753 . . . . 71.349999999999994 112.516 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -97.01 113.23 62.66 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.629 0.728 . . . . 72.120000000000005 110.896 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.72 126.5 13.41 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.72 2.28 . . . . 71.340000000000003 112.322 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.683 HD12 HG22 ' A' ' 10' ' ' ILE . 13.6 mt -69.18 -40.02 78.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.439 . . . . 44.219999999999999 110.899 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.7 -125.51 1.61 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.785 -0.721 . . . . 55.100000000000001 112.542 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -123.36 135.91 54.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 72.420000000000002 110.874 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.509 HG21 HG13 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -146.64 103.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 72.209999999999994 111.093 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.5 t -113.47 174.59 5.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 53.200000000000003 110.881 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.439 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -145.3 126.14 14.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 75.540000000000006 110.906 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -80.59 100.0 8.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 73.549999999999997 110.862 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.463 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 1.4 mt -83.14 120.4 25.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 73.510000000000005 110.916 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -75.94 68.29 2.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 72.310000000000002 110.899 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.2 -22.73 42.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 50.340000000000003 111.088 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -67.24 -36.72 82.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 75.120000000000005 110.885 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -97.19 -27.28 14.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 72.239999999999995 110.86 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.426 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -138.92 67.24 41.43 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.6 0.714 . . . . 73.310000000000002 111.146 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -36.05 11.39 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.673 2.249 . . . . 64.310000000000002 112.314 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.57 -37.75 82.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 75.239999999999995 110.86 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.41 HG21 ' CD1' ' A' ' 129' ' ' PHE . 58.0 m -88.85 -44.05 10.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 34.409999999999997 111.169 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.77 -46.69 89.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 70.239999999999995 111.108 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -51.03 -29.47 12.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 72.420000000000002 110.896 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.14 -64.64 0.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 75.5 110.891 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -59.05 -30.97 68.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 63.450000000000003 110.923 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.482 ' O ' HG23 ' A' ' 41' ' ' THR . 0.8 OUTLIER -72.54 -51.63 19.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 71.430000000000007 110.897 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.63 -33.31 68.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 73.140000000000001 111.112 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.522 HD23 ' HG2' ' A' ' 44' ' ' LYS . 31.0 mt -76.38 -51.86 11.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 75.450000000000003 110.921 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.1 m -61.66 -37.05 82.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 72.519999999999996 110.863 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 37' ' ' ARG . 26.9 p -65.81 -34.64 78.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 72.310000000000002 111.125 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.28 -15.8 53.84 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.693 -0.765 . . . . 43.240000000000002 112.489 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.89 -27.36 29.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.905 0.383 . . . . 72.010000000000005 110.899 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.522 ' HG2' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -72.91 -29.29 63.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 64.239999999999995 110.862 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.31 -15.37 60.28 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.706 -0.759 . . . . 51.299999999999997 112.451 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -157.63 -165.41 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 64.219999999999999 110.857 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.05 -136.05 5.4 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 71.299999999999997 112.507 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.49 30.61 6.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.932 0.396 . . . . 73.140000000000001 110.924 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -87.37 96.44 10.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 70.239999999999995 110.945 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 134.47 -38.89 1.77 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.762 -0.733 . . . . 71.519999999999996 112.44 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.13 -169.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 63.240000000000002 110.848 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.9 p -141.73 175.5 9.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 63.229999999999997 110.87 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.444 ' CZ ' HD11 ' A' ' 158' ' ' ILE . 9.4 m-85 -107.55 142.72 37.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 75.319999999999993 110.897 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -143.46 45.89 1.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 74.140000000000001 110.827 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -161.98 60.83 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.449 . . . . 75.310000000000002 110.889 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 19.0 mt -104.21 108.86 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 73.030000000000001 111.127 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.6 mt -102.0 101.7 20.08 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.635 0.731 . . . . 72.129999999999995 111.126 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 89.85 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.245 . . . . 75.310000000000002 112.377 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.83 -17.6 1.99 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 42.329999999999998 112.497 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.58 -53.11 1.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 74.099999999999994 110.834 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.413 ' HB3' ' HA ' ' A' ' 115' ' ' CYS . 0.0 OUTLIER 172.89 166.04 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.120000000000005 110.843 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 4.8 m -101.33 -173.35 2.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 70.140000000000001 110.897 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 174.1 150.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 72.349999999999994 110.941 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.09 -51.3 0.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.713 -0.756 . . . . 72.019999999999996 112.506 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.99 -158.27 20.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.784 -0.722 . . . . 42.200000000000003 112.462 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -107.35 164.82 11.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.378 . . . . 73.349999999999994 110.832 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -138.58 36.02 2.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 63.109999999999999 110.871 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.07 -73.92 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 73.340000000000003 111.144 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.25 161.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 74.439999999999998 110.941 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -134.71 37.87 3.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 64.019999999999996 110.843 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -115.17 -36.05 4.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 71.409999999999997 110.916 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 164.02 76.33 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.708 -0.758 . . . . 53.439999999999998 112.474 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.6 t 177.52 -48.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 70.540000000000006 111.136 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.02 169.6 0.42 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.676 -0.773 . . . . 71.329999999999998 112.536 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.54 135.61 6.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 41.109999999999999 112.485 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -172.65 -178.84 2.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 52.049999999999997 110.878 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.517 ' O ' ' CG1' ' A' ' 78' ' ' ILE . 3.1 p -91.35 39.58 1.0 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 74.040000000000006 110.84 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.517 ' CG1' ' O ' ' A' ' 77' ' ' SER . 0.7 OUTLIER 59.55 6.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 64.109999999999999 111.121 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.501 ' CD2' HG13 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -164.59 37.82 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 74.230000000000004 110.922 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.15 149.79 6.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.712 -0.756 . . . . 63.219999999999999 112.481 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -44.47 -33.53 1.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 63.109999999999999 110.876 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.465 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.73 166.08 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 63.439999999999998 110.874 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -132.13 177.17 7.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 75.450000000000003 110.873 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.08 157.15 28.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 73.420000000000002 110.876 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -49.94 153.75 1.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 74.219999999999999 110.852 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -104.41 -76.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.457 . . . . 73.319999999999993 110.903 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.467 ' O ' HG22 ' A' ' 127' ' ' VAL . 47.4 p30 -159.32 177.45 10.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 61.439999999999998 110.917 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.29 35.59 3.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 63.299999999999997 110.895 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.65 -31.86 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 75.400000000000006 111.097 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 mt -102.79 101.79 11.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 72.030000000000001 110.884 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.671 ' O ' HG23 ' A' ' 93' ' ' THR . 1.6 mtpt -90.93 138.79 31.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 74.5 110.899 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -47.35 105.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 73.510000000000005 110.876 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.671 HG23 ' O ' ' A' ' 91' ' ' LYS . 43.8 p -114.95 30.04 7.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 65.439999999999998 111.134 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 144.68 176.45 18.7 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 53.32 112.507 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 178.01 5.0 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.663 2.242 . . . . 55.109999999999999 112.347 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.82 21.81 63.65 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 71.530000000000001 112.514 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.0 mm -91.75 140.37 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 74.019999999999996 111.125 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -109.64 149.1 30.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 72.120000000000005 110.926 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.68 -164.55 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 72.239999999999995 110.892 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.495 ' HE2' ' HB ' ' A' ' 127' ' ' VAL . 2.0 mtm -98.71 96.6 8.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 74.400000000000006 110.892 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -72.45 62.09 0.51 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 51.530000000000001 111.105 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -125.15 -158.3 0.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 73.340000000000003 110.875 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.662 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -76.39 53.25 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 62.109999999999999 111.079 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.19 -106.07 0.14 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.713 -0.756 . . . . 62.229999999999997 112.509 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 116.65 4.66 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.707 2.271 . . . . 73.25 112.361 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.489 ' C ' HG23 ' A' ' 107' ' ' THR . 1.1 m-20 66.52 174.13 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 70.120000000000005 110.901 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.662 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.3 p 67.69 32.98 5.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 73.420000000000002 111.15 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.96 146.22 31.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 62.43 110.93 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -148.35 53.79 0.52 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 54.520000000000003 112.46 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.0 t 68.83 33.79 3.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 74.230000000000004 110.869 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -59.89 -168.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 74.299999999999997 110.933 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.436 ' HE2' HD12 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -175.72 155.42 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 73.329999999999998 110.912 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -168.53 68.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 71.340000000000003 110.879 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 113' ' ' PHE . 6.9 mt -33.73 107.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 65.219999999999999 111.164 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.413 ' HA ' ' HB3' ' A' ' 61' ' ' MET . 33.6 m -84.6 139.23 32.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 63.5 110.899 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.1 p -105.01 27.12 8.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.172 -0.467 . . . . 72.219999999999999 111.17 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.665 ' O ' HG23 ' A' ' 119' ' ' THR . . . 178.65 142.94 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 71.049999999999997 111.094 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -52.36 98.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 55.229999999999997 110.888 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.709 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 33.9 p -96.13 44.78 1.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 72.420000000000002 111.197 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -26.54 65.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 70.329999999999998 110.925 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.709 ' CZ2' HG22 ' A' ' 119' ' ' THR . 7.3 p90 -49.68 -27.42 4.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.129 -0.487 . . . . 64.519999999999996 110.943 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 23.6 mt -47.02 -34.71 5.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 61.119999999999997 110.9 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 61.4 77.95 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 71.409999999999997 110.846 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 39.11 44.42 2.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.724 . . . . 52.399999999999999 112.436 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -81.69 -25.56 35.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 72.120000000000005 110.903 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -136.34 -169.35 2.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.848 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.495 ' HB ' ' HE2' ' A' ' 100' ' ' MET . 79.4 t -123.79 112.25 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 111.158 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.5 t -79.95 131.04 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 71.209999999999994 111.138 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.459 ' O ' HD23 ' A' ' 24' ' ' LEU . 30.5 p90 -150.26 37.39 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 75.25 110.909 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -175.13 173.57 46.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.707 -0.759 . . . . 70.340000000000003 112.46 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 132' ' ' VAL . 6.6 pttp -175.9 134.3 0.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 73.099999999999994 110.915 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.761 HG11 ' HG2' ' A' ' 136' ' ' MET . 54.0 t -37.02 105.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 111.127 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -59.31 3.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 63.299999999999997 110.921 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -154.84 158.65 39.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 110.893 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.29 36.3 15.06 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.731 -0.747 . . . . 73.230000000000004 112.5 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.761 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -55.33 -25.23 33.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 74.030000000000001 110.87 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.16 -34.19 65.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 75.409999999999997 110.866 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.547 HD12 ' HB3' ' A' ' 17' ' ' LEU . 37.9 mm -66.31 -40.02 85.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 64.409999999999997 111.139 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.2 t -63.67 -27.59 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 74.450000000000003 111.145 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.57 -30.1 52.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 51.140000000000001 110.926 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.01 -45.94 59.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 73.109999999999999 111.135 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.3 mtm -57.75 -42.02 83.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 62.530000000000001 110.875 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -53.77 -27.53 29.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 73.230000000000004 110.918 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -28.9 52.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 73.310000000000002 110.917 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -100.2 29.38 4.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 72.230000000000004 110.921 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.18 155.66 16.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.752 -0.737 . . . . 61.130000000000003 112.477 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.7 t -110.65 149.81 29.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 35.43 110.872 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -76.05 59.83 1.35 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 72.230000000000004 110.873 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -176.72 -34.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 74.310000000000002 110.889 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.83 -43.23 0.76 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 50.409999999999997 112.485 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.75 165.04 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 72.209999999999994 110.89 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 27.7 p -147.82 149.21 31.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 75.109999999999999 111.129 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.9 m -69.82 -46.08 66.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 63.439999999999998 110.828 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.433 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -104.12 -176.22 3.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.082 -0.508 . . . . 74.030000000000001 110.904 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -115.09 107.95 16.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 73.409999999999997 110.928 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.98 122.12 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 70.230000000000004 111.114 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.89 168.43 18.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 30.52 111.159 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.444 HD11 ' CZ ' ' A' ' 53' ' ' PHE . 41.0 mm -105.43 114.22 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 42.210000000000001 111.084 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -73.58 -47.8 37.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 35.329999999999998 111.122 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -157.44 160.23 38.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.230000000000004 110.849 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -164.05 146.09 9.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 62.210000000000001 110.875 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.95 173.18 44.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 73.310000000000002 112.493 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -63.7 139.55 58.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 65.120000000000005 110.902 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.553 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -92.18 -56.84 2.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 74.209999999999994 110.901 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 72.349999999999994 110.901 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.828 0.347 . . . . 44.210000000000001 110.881 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 p -178.15 156.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 75.329999999999998 111.156 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -51.65 152.66 4.7 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 73.019999999999996 110.905 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 146.03 58.89 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.732 2.288 . . . . 51.210000000000001 112.327 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -135.22 141.69 45.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 73.030000000000001 111.159 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.481 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.5 m -134.48 143.8 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 73.329999999999998 111.101 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 19.0 p90 -102.03 160.77 14.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 65.209999999999994 110.856 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -140.42 95.51 2.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 71.439999999999998 110.936 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.6 t70 -58.77 113.84 2.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 65.25 110.847 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.874 HG23 HG23 ' A' ' 156' ' ' ILE . 14.8 mm -86.05 124.45 40.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 73.540000000000006 111.112 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -117.25 123.28 46.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 72.219999999999999 111.085 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.661 HG23 HD13 ' A' ' 17' ' ' LEU . 11.5 t -106.6 94.51 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 62.32 111.162 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 62.18 44.56 7.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 72.519999999999996 110.857 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.6 -1.58 88.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 73.120000000000005 112.523 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 8.5 mm-40 -110.05 98.68 35.9 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.627 0.727 . . . . 71.299999999999997 110.896 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.4 Cg_endo -69.81 103.98 1.26 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.737 2.292 . . . . 43.340000000000003 112.31 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.661 HD13 HG23 ' A' ' 12' ' ' VAL . 7.7 mp -65.74 -34.95 79.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 64.140000000000001 110.856 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.76 -143.09 7.94 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.737 -0.744 . . . . 63.130000000000003 112.484 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.08 154.06 47.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 71.209999999999994 110.838 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.441 HG21 HG13 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -144.91 97.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 62.25 111.094 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -91.2 172.46 8.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 74.340000000000003 110.832 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.404 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -145.6 123.48 11.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 74.150000000000006 110.89 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.418 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 23.4 tt0 -73.7 97.48 2.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 62.210000000000001 110.857 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.7 mt -85.09 118.17 24.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 60.439999999999998 110.882 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.423 ' CD1' HD13 ' A' ' 90' ' ' LEU . 52.5 m-85 -79.38 68.98 5.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 73.209999999999994 110.887 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.62 -22.22 21.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 72.010000000000005 111.122 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -69.59 -28.35 65.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 32.240000000000002 110.871 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.91 -29.57 11.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 110.927 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.416 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -139.18 66.42 38.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.62 0.724 . . . . 73.349999999999994 111.122 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -35.21 13.17 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.698 2.265 . . . . 73.010000000000005 112.332 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.86 -36.41 72.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 71.200000000000003 110.895 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.402 HG22 ' CE2' ' A' ' 129' ' ' PHE . 63.5 m -94.22 -43.02 8.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 75.209999999999994 111.139 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.33 91.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.415 . . . . 73.25 111.085 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -50.42 -35.53 28.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 74.140000000000001 110.873 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -64.54 -64.19 0.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 110.926 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -56.35 -34.15 66.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 75.439999999999998 110.913 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.517 ' O ' HG23 ' A' ' 41' ' ' THR . 0.3 OUTLIER -69.87 -53.26 18.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 72.439999999999998 110.904 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 44' ' ' LYS . . . -56.74 -35.42 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 55.219999999999999 111.125 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.7 mt -72.09 -58.68 3.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 73.150000000000006 110.941 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.9 m -51.4 -41.01 60.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 72.400000000000006 110.877 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 37' ' ' ARG . 63.9 p -72.23 -28.31 63.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 74.120000000000005 111.138 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.64 12.75 71.56 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 72.230000000000004 112.465 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.39 -18.42 49.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 73.409999999999997 110.861 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.572 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -90.98 29.78 1.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 75.329999999999998 110.867 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.04 -22.92 16.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.759 -0.734 . . . . 75.319999999999993 112.491 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -179.02 -169.53 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 35.420000000000002 110.914 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.4 -135.84 2.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.801 -0.714 . . . . 72.439999999999998 112.547 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.614 ' HH ' ' HD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -148.83 57.49 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.937 0.399 . . . . 74.409999999999997 110.951 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -87.17 48.8 1.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 64.400000000000006 110.876 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 174.48 54.7 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 63.340000000000003 112.492 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.83 131.14 46.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.869 0.366 . . . . 74.409999999999997 110.82 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.8 p -96.69 121.26 38.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 61.340000000000003 110.912 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -80.99 117.21 21.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 73.340000000000003 110.87 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -114.03 29.75 7.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 74.109999999999999 110.874 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.54 91.6 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 54.240000000000002 110.849 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.471 ' O ' HG22 ' A' ' 56' ' ' ILE . 3.1 mt -128.68 116.29 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 63.439999999999998 111.166 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.2 mt -107.89 104.47 53.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.567 0.699 . . . . 74.450000000000003 111.169 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 79.47 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.7 2.267 . . . . 70.209999999999994 112.332 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.7 -24.42 0.56 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.707 -0.759 . . . . 54.450000000000003 112.515 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.64 -58.98 1.97 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.86 0.362 . . . . 55.25 110.848 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.33 157.28 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 61.299999999999997 110.906 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.418 ' HB3' HG12 ' A' ' 56' ' ' ILE . 34.7 m -90.7 -167.31 1.79 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 63.420000000000002 110.865 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 174.69 142.09 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 62.350000000000001 110.937 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -178.71 148.1 8.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 74.209999999999994 112.469 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.82 112.84 1.23 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.772 -0.727 . . . . 75.219999999999999 112.505 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -179.32 116.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 70.140000000000001 110.864 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.614 ' HD1' ' HH ' ' A' ' 48' ' ' TYR . 2.3 p90 -151.73 159.3 44.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.261 -0.427 . . . . 74.230000000000004 110.931 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.51 105.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 63.140000000000001 111.099 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.89 -169.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 73.239999999999995 110.843 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -102.8 34.43 2.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 74.030000000000001 110.857 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.36 -37.29 3.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 53.240000000000002 110.869 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.99 37.36 2.73 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.78 -0.724 . . . . 50.450000000000003 112.49 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.7 p -145.43 37.94 1.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.34 . . . . 74.230000000000004 111.129 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -129.59 -178.74 15.56 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.698 -0.763 . . . . 64.540000000000006 112.483 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 56.34 39.14 82.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.713 -0.756 . . . . 52.520000000000003 112.469 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.29 159.21 43.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.789 0.328 . . . . 73.109999999999999 110.903 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.2 p -59.15 -175.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 72.120000000000005 110.852 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.559 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.7 pp -90.75 16.88 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 53.130000000000003 111.119 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.85 -65.44 1.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 72.209999999999994 110.952 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.82 -33.17 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 43.030000000000001 112.486 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -141.11 -54.92 0.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.93 0.395 . . . . 71.239999999999995 110.908 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.19 -177.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 71.340000000000003 110.895 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.89 -167.67 1.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.439999999999998 110.872 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -133.37 162.76 30.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 71.319999999999993 110.871 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -47.76 104.34 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 74.239999999999995 110.854 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -80.79 -67.38 0.78 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 75.340000000000003 110.882 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -177.68 173.45 1.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 110.92 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.19 35.54 4.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 74.109999999999999 110.885 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -49.94 -28.91 4.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 74.439999999999998 111.153 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.423 HD13 ' CD1' ' A' ' 25' ' ' PHE . 16.0 mt -117.38 68.69 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 74.239999999999995 110.854 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -62.28 166.53 4.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 73.450000000000003 110.863 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -68.72 83.67 0.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 64.510000000000005 110.832 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.4 p -99.86 24.54 8.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 72.510000000000005 111.12 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 155.65 177.47 28.91 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.782 -0.723 . . . . 70.120000000000005 112.496 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 170.13 17.29 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.704 2.269 . . . . 45.210000000000001 112.354 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.12 40.04 96.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 61.530000000000001 112.474 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.3 mm -108.9 136.06 45.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.832 0.348 . . . . 74.510000000000005 111.144 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.505 HD21 ' CD1' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -103.62 157.39 17.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.446 . . . . 72.25 110.899 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 3.6 t -162.19 -139.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 41.049999999999997 110.883 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 13.7 mmt -152.91 147.42 25.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 72.430000000000007 110.853 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -123.19 151.34 42.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 75.310000000000002 111.074 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 167.71 -50.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 74.450000000000003 110.915 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -174.63 29.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 73.019999999999996 111.136 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.55 -116.66 4.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 31.440000000000001 112.472 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 125.09 11.76 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.661 2.241 . . . . 65.400000000000006 112.355 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.488 ' C ' HG23 ' A' ' 107' ' ' THR . 1.3 m-20 70.54 165.76 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 73.030000000000001 110.888 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.488 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.3 p 67.13 29.22 7.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 73.040000000000006 111.175 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -65.24 90.38 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 74.239999999999995 110.898 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -66.52 -131.78 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.743 -0.742 . . . . 72.420000000000002 112.477 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.0 p -133.23 24.2 4.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.833 0.349 . . . . 51.310000000000002 110.861 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.532 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 2.1 pt20 -106.56 55.76 0.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 75.129999999999995 110.939 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.505 ' CD1' HD21 ' A' ' 98' ' ' LEU . 4.6 p90 -58.65 -168.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 60.450000000000003 110.843 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -152.73 160.63 43.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.827 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 114' ' ' ILE . 2.4 mp -105.1 91.17 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 73.439999999999998 111.13 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.5 m -64.28 90.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 75.430000000000007 110.896 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.6 p -63.93 -12.89 41.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 65.120000000000005 111.141 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.688 ' O ' HG23 ' A' ' 119' ' ' THR . . . -143.22 156.7 44.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 62.219999999999999 111.096 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -56.41 95.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 61.509999999999998 110.892 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 117' ' ' ALA . 23.1 p -97.83 50.11 1.03 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 45.420000000000002 111.136 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -24.37 66.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 74.25 110.89 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.687 ' CZ2' HG22 ' A' ' 119' ' ' THR . 5.9 p90 -48.29 -30.49 4.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 74.099999999999994 110.933 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.5 mt -47.44 -34.65 7.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 65.120000000000005 110.922 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 124' ' ' GLY . 3.6 m-20 59.03 81.18 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 74.540000000000006 110.848 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.61 43.63 0.8 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.709 -0.758 . . . . 74.140000000000001 112.47 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -81.66 -16.64 50.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 74.549999999999997 110.871 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -144.75 -168.55 2.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 55.509999999999998 110.802 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.7 t -120.75 120.97 64.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 64.109999999999999 111.125 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 98' ' ' LEU . 20.4 t -93.26 136.15 25.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 74.349999999999994 111.112 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.481 ' O ' HD23 ' A' ' 24' ' ' LEU . 13.3 p90 -156.2 37.54 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 72.099999999999994 110.854 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -177.51 174.49 46.97 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 50.240000000000002 112.528 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 132' ' ' VAL . 5.1 pttp -172.94 132.96 0.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.347 . . . . 73.010000000000005 110.9 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.749 HG11 ' HG2' ' A' ' 136' ' ' MET . 38.2 t -36.44 107.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 45.520000000000003 111.149 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.418 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -72.27 -58.92 3.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 70.150000000000006 110.903 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -155.86 154.89 31.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 72.140000000000001 110.876 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.07 28.79 11.22 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 45.329999999999998 112.512 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.749 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -57.33 -24.04 52.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 63.420000000000002 110.881 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.06 -36.94 73.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 75.010000000000005 110.932 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.466 HD12 ' HB3' ' A' ' 17' ' ' LEU . 27.4 mm -67.6 -39.57 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 63.530000000000001 111.093 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.407 HG11 HG21 ' A' ' 114' ' ' ILE . 75.9 t -63.01 -29.49 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 65.129999999999995 111.083 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -74.71 -30.55 61.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 71.299999999999997 110.897 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.74 -37.98 70.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 73.219999999999999 111.09 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.576 ' SD ' HG21 ' A' ' 156' ' ' ILE . 17.5 mtm -58.71 -53.44 58.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 71.510000000000005 110.85 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.85 -26.06 32.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 73.519999999999996 110.868 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.445 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.81 -23.74 63.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 63.109999999999999 110.9 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.445 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 59.8 m-85 -109.16 17.32 21.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 72.329999999999998 110.87 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -107.7 170.33 15.31 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.796 -0.716 . . . . 72.319999999999993 112.489 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 t -134.55 142.69 47.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.899 0.381 . . . . 55.420000000000002 110.837 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -69.03 82.73 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 74.409999999999997 110.846 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -179.33 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 110.885 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.75 -84.67 0.16 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 61.450000000000003 112.506 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.68 175.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 75.409999999999997 110.877 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.6 p -143.49 168.99 18.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 72.450000000000003 111.184 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.65 -48.08 35.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 70.329999999999998 110.842 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.405 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -92.29 -179.66 5.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 71.219999999999999 110.886 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -124.51 108.32 11.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.841 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.874 HG23 HG23 ' A' ' 10' ' ' ILE . 4.8 mp -94.53 109.41 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 71.340000000000003 111.123 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.14 161.89 22.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 63.229999999999997 111.159 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.0 mm -92.85 120.07 41.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 63.539999999999999 111.134 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -86.15 -56.99 3.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 61.439999999999998 111.088 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -137.71 157.37 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 74.099999999999994 110.894 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -165.91 146.98 6.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 75.0 110.9 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.11 172.42 44.54 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 64.099999999999994 112.472 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -66.2 137.37 56.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.899 0.38 . . . . 62.509999999999998 110.871 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.564 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.3 mm? -88.76 -58.68 2.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 73.219999999999999 110.908 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 62.200000000000003 110.906 179.918 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 mtm . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.859 0.361 . . . . 75.129999999999995 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.2 t -145.72 127.41 8.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 54.329999999999998 111.125 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -87.14 144.84 36.85 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.669 0.747 . . . . 62.299999999999997 110.879 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 145.01 55.52 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.662 2.241 . . . . 70.340000000000003 112.347 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.4 m -130.95 129.75 42.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 55.119999999999997 111.14 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.07 170.56 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 73.319999999999993 111.141 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.599 ' HB3' HD21 ' A' ' 164' ' ' LEU . 1.5 p90 -153.92 179.5 8.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 75.219999999999999 110.949 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.423 ' HA ' ' HB3' ' A' ' 161' ' ' CYS . 97.9 m-85 -155.79 97.37 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 70.409999999999997 110.888 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.64 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 5.9 t0 -47.73 106.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 65.25 110.875 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.87 HG23 HG23 ' A' ' 156' ' ' ILE . 43.3 mm -79.03 124.27 37.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 62.420000000000002 111.138 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -116.65 134.87 54.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.340000000000003 111.085 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.504 HG13 ' HB3' ' A' ' 154' ' ' LYS . 5.0 t -116.49 96.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 63.009999999999998 111.11 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.57 35.52 22.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 61.240000000000002 110.85 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.36 -15.78 60.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 71.0 112.517 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.6 tt0 -103.32 108.09 57.9 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.663 0.744 . . . . 54.210000000000001 110.865 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.75 126.49 13.38 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.698 2.265 . . . . 72.209999999999994 112.39 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.1 -38.25 82.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 72.450000000000003 110.902 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.96 -138.64 5.89 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.77 -0.729 . . . . 73.439999999999998 112.53 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.94 140.36 48.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.811 0.339 . . . . 64.239999999999995 110.894 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.474 ' CG2' HG21 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -143.87 97.8 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 72.420000000000002 111.117 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 2.4 t -103.69 174.33 5.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 72.319999999999993 110.848 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.427 ' N ' ' OG ' ' A' ' 21' ' ' SER . 26.6 m-85 -148.12 132.1 17.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 74.019999999999996 110.891 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -88.08 98.79 11.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 71.340000000000003 110.889 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.5 mt -80.8 133.43 35.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 74.109999999999999 110.896 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -91.25 65.42 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 71.409999999999997 110.888 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.26 -23.58 23.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 32.439999999999998 111.119 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.77 -40.89 96.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 75.010000000000005 110.851 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -95.07 -26.8 15.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 70.519999999999996 110.906 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.442 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -137.78 67.44 50.28 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.615 0.721 . . . . 63.439999999999998 111.16 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -38.51 7.63 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.655 2.237 . . . . 44.399999999999999 112.326 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -38.99 90.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 61.210000000000001 110.925 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.7 m -84.76 -42.23 15.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 63.030000000000001 111.131 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.99 -48.46 78.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 62.299999999999997 111.076 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -53.88 -33.13 55.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 64.030000000000001 110.898 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.681 ' O ' HD12 ' A' ' 39' ' ' LEU . 1.3 t30 -60.92 -61.71 2.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 73.140000000000001 110.888 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -63.96 -41.3 97.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 70.230000000000004 110.898 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.481 ' O ' HG23 ' A' ' 41' ' ' THR . 1.1 ttp180 -63.48 -31.14 72.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 75.430000000000007 110.858 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.56 -49.91 67.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 71.109999999999999 111.127 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.681 HD12 ' O ' ' A' ' 35' ' ' ASN . 1.2 mp -67.6 -36.76 81.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 62.25 110.937 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.2 m -69.02 -51.19 41.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 61.420000000000002 110.881 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 37' ' ' ARG . 73.5 p -64.88 -32.95 74.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 71.299999999999997 111.173 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.02 -13.48 55.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 71.049999999999997 112.462 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.77 -33.45 23.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.951 0.405 . . . . 72.430000000000007 110.913 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -53.45 -27.87 27.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 72.230000000000004 110.929 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.46 -5.71 80.48 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.737 -0.744 . . . . 72.439999999999998 112.484 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -168.65 -167.58 0.79 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 73.519999999999996 110.935 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.26 -137.86 6.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.705 -0.759 . . . . 24.34 112.449 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -151.54 47.15 0.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.001 0.429 . . . . 74.299999999999997 110.925 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 139.47 58.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 74.049999999999997 110.882 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.03 -22.01 39.69 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.763 -0.732 . . . . 61.140000000000001 112.482 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.45 173.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 71.540000000000006 110.854 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.509 ' HB3' HG23 ' A' ' 157' ' ' THR . 17.6 p -122.1 179.68 4.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 74.409999999999997 110.862 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -104.47 136.09 44.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 71.530000000000001 110.841 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -130.21 37.16 3.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 70.099999999999994 110.856 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -166.95 77.21 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 75.329999999999998 110.881 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.446 HG23 ' OE1' ' A' ' 143' ' ' GLU . 11.9 mt -120.52 111.29 31.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 44.450000000000003 111.139 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.4 mt -108.21 103.5 50.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.646 0.736 . . . . 62.030000000000001 111.135 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 54.2 Cg_endo -69.75 76.25 1.15 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 54.219999999999999 112.361 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.99 -26.77 0.25 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.722 -0.751 . . . . 73.030000000000001 112.495 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.69 -55.33 2.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.86 0.362 . . . . 74.239999999999995 110.88 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.442 ' HE3' ' O ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER 171.98 175.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 71.120000000000005 110.871 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.442 ' O ' ' HE3' ' A' ' 61' ' ' MET . 5.3 m -111.83 -168.11 1.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 72.230000000000004 110.887 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -173.15 141.98 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 110.941 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -58.23 -46.45 92.82 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.791 -0.719 . . . . 74.530000000000001 112.45 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.95 125.88 5.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.737 . . . . 61.130000000000003 112.444 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.08 136.48 50.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.369 . . . . 73.349999999999994 110.835 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -121.96 -48.49 2.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 65.239999999999995 110.876 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.8 p 47.02 90.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 74.129999999999995 111.143 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -48.14 -68.27 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 74.349999999999994 110.825 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -114.76 -75.64 0.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 71.349999999999994 110.856 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -125.42 35.99 4.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 70.129999999999995 110.883 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.57 122.26 0.1 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.778 -0.725 . . . . 72.239999999999995 112.516 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.401 HG23 ' N ' ' A' ' 74' ' ' GLY . 1.7 t 177.66 -48.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.841 0.353 . . . . 74.239999999999995 111.099 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.401 ' N ' HG23 ' A' ' 73' ' ' THR . . . -51.97 -54.77 24.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.77 -0.728 . . . . 52.200000000000003 112.501 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.38 -125.06 5.51 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.719 -0.753 . . . . 73.340000000000003 112.483 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 44.7 -164.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.721 0.296 . . . . 74.349999999999994 110.912 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.15 125.88 28.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 45.130000000000003 110.896 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.42 HG22 ' HD2' ' A' ' 44' ' ' LYS . 1.0 OUTLIER -50.74 -28.14 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 71.329999999999998 111.156 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -79.89 -37.48 34.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 75.150000000000006 110.912 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.95 -151.08 13.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.8 -0.714 . . . . 71.549999999999997 112.499 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -51.03 -40.14 57.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.948 0.404 . . . . 73.510000000000005 110.882 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.436 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.5 167.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 72.140000000000001 110.885 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.35 167.17 19.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 73.230000000000004 110.898 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.17 150.8 48.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 74.329999999999998 110.865 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -52.47 161.03 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 75.010000000000005 110.881 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -110.99 -70.77 0.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.858 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -170.55 173.54 5.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 63.420000000000002 110.908 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.46 37.34 3.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 74.540000000000006 110.831 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.99 -30.28 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 73.109999999999999 111.187 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.1 mt -108.79 80.01 1.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 54.140000000000001 110.888 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.65 154.06 34.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 75.239999999999995 110.901 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -64.13 88.42 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 75.409999999999997 110.831 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.1 p -78.57 -54.29 6.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 74.230000000000004 111.134 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.05 -165.94 11.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 72.430000000000007 112.468 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 177.91 5.08 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.633 2.222 . . . . 75.010000000000005 112.351 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.24 31.13 78.03 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.742 -0.742 . . . . 73.329999999999998 112.482 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.2 mm -107.01 140.98 23.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 60.229999999999997 111.094 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.815 HD11 ' CE2' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -108.26 144.9 35.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 73.420000000000002 110.895 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.25 146.61 22.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 75.230000000000004 110.903 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -69.74 82.83 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 55.229999999999997 110.838 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.858 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -57.44 142.86 42.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 72.120000000000005 111.069 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 170.59 -167.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 71.299999999999997 110.866 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.682 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -50.46 -51.46 46.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 53.240000000000002 111.102 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.14 -69.91 0.37 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 42.119999999999997 112.52 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.477 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 54.0 Cg_endo -69.76 99.26 0.73 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.725 2.283 . . . . 45.340000000000003 112.327 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.529 ' O ' HG23 ' A' ' 107' ' ' THR . 0.4 OUTLIER 37.87 55.35 1.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 74.230000000000004 110.874 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.682 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.2 p -159.97 53.33 0.35 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 64.510000000000005 111.168 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.28 152.47 31.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 32.229999999999997 110.891 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.59 5.37 2.87 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 75.209999999999994 112.498 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 74.2 51.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.793 0.33 . . . . 72.239999999999995 110.881 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.697 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 0.6 OUTLIER -70.21 -31.64 69.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 71.239999999999995 110.935 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.815 ' CE2' HD11 ' A' ' 98' ' ' LEU . 30.6 t80 99.66 145.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 62.340000000000003 110.878 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.858 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -169.86 114.62 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 72.019999999999996 110.91 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.3 mt -80.94 129.07 38.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 63.210000000000001 111.119 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -91.34 92.77 8.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.447 . . . . 64.129999999999995 110.856 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 45.2 p -79.23 14.16 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 74.219999999999999 111.18 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.809 ' O ' HG23 ' A' ' 119' ' ' THR . . . 178.65 143.77 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.466 . . . . 74.120000000000005 111.052 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -50.56 98.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 61.539999999999999 110.937 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 117' ' ' ALA . 35.0 p -104.16 48.93 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 43.439999999999998 111.092 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -24.86 67.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 71.0 110.868 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.8 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.2 p90 -50.03 -26.96 4.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 74.519999999999996 110.901 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.6 mt -45.63 -35.52 4.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 73.299999999999997 110.94 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.7 m-20 61.6 80.2 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 110.819 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 35.98 43.17 0.62 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.741 -0.742 . . . . 51.210000000000001 112.497 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.46 -19.28 33.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.753 0.311 . . . . 74.540000000000006 110.908 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -142.86 -165.15 1.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 73.430000000000007 110.865 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.7 t -131.29 125.64 57.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 74.150000000000006 111.123 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.51 133.2 33.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 73.109999999999999 111.162 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.48 ' O ' HD23 ' A' ' 24' ' ' LEU . 23.0 p90 -155.3 36.53 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 74.049999999999997 110.925 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -171.72 173.9 45.08 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.705 -0.76 . . . . 64.25 112.446 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -175.88 133.54 0.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 74.120000000000005 110.913 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.698 HG11 ' HG2' ' A' ' 136' ' ' MET . 76.8 t -39.73 107.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 54.409999999999997 111.144 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -58.08 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 72.310000000000002 110.922 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -154.75 163.05 40.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 71.540000000000006 110.873 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.5 32.67 46.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.69 -0.766 . . . . 54.539999999999999 112.471 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.698 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -50.89 -34.05 26.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.744 0.307 . . . . 75.209999999999994 110.827 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.6 -32.24 12.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 74.409999999999997 110.847 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.474 HG21 ' CG2' ' A' ' 20' ' ' VAL . 41.8 mm -66.31 -43.35 91.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 72.340000000000003 111.135 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.75 -26.33 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 41.119999999999997 111.113 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.32 -29.73 38.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 73.25 110.864 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.31 -37.61 66.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 60.200000000000003 111.08 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 24.4 mtm -57.3 -54.25 48.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 61.399999999999999 110.912 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.446 ' OE1' HG23 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -55.32 -25.5 34.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 60.43 110.873 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.424 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -69.91 -23.74 63.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 75.349999999999994 110.846 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.424 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 57.1 m-85 -108.79 17.13 22.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 75.549999999999997 110.88 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.34 168.37 12.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 62.409999999999997 112.5 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.6 m -113.76 148.22 36.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 75.239999999999995 110.892 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 -75.24 67.46 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.898 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -175.11 -35.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 71.450000000000003 110.872 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.78 -45.34 0.62 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.728 -0.749 . . . . 60.119999999999997 112.442 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.71 171.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 74.200000000000003 110.933 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.4 p -145.04 139.58 27.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 74.319999999999993 111.134 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.39 -39.89 77.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 73.150000000000006 110.826 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.504 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -107.39 -174.93 2.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 74.439999999999998 110.885 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.57 107.59 13.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 110.941 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.87 HG23 HG23 ' A' ' 10' ' ' ILE . 3.9 mp -89.68 102.34 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 75.439999999999998 111.131 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.509 HG23 ' HB3' ' A' ' 52' ' ' CYS . 0.0 OUTLIER -109.93 163.86 13.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 65.439999999999998 111.165 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.2 mt -102.94 116.47 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 72.109999999999999 111.131 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -81.72 -52.34 7.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 63.539999999999999 111.159 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -148.17 153.75 39.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 62.009999999999998 110.865 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -160.84 149.74 16.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 110.889 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.84 166.38 27.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.798 -0.715 . . . . 31.539999999999999 112.505 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -59.4 109.24 0.84 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 74.219999999999999 110.876 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.599 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.6 mm? -53.2 -48.19 68.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 73.239999999999995 110.934 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 75.319999999999993 110.913 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.9 mtm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.824 0.345 . . . . 61.539999999999999 110.879 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.4 t -149.32 127.5 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 71.239999999999995 111.143 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -118.04 146.92 40.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.595 0.712 . . . . 75.239999999999995 110.889 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 149.34 66.58 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.676 2.25 . . . . 72.420000000000002 112.355 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -136.02 137.7 41.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 55.119999999999997 111.181 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.568 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.9 m -131.61 145.64 34.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 55.439999999999998 111.113 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.837 ' HB3' HD21 ' A' ' 164' ' ' LEU . 8.2 p90 -101.93 168.04 9.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 110.923 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -147.81 88.9 1.71 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 73.129999999999995 110.893 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.709 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -51.86 105.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 72.150000000000006 110.882 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.575 HG13 HG21 ' A' ' 20' ' ' VAL . 38.2 mm -83.97 126.95 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 75.120000000000005 111.105 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -121.04 149.54 42.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 35.229999999999997 111.077 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 t -130.04 94.94 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 62.350000000000001 111.123 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.02 32.66 10.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 71.109999999999999 110.893 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.18 -21.59 42.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 62.020000000000003 112.489 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -94.18 113.07 59.82 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.644 0.735 . . . . 74.319999999999993 110.882 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.7 Cg_endo -69.81 123.32 9.97 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.649 2.233 . . . . 53.109999999999999 112.357 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.56 ' HB3' HD12 ' A' ' 138' ' ' ILE . 12.0 mt -68.71 -37.83 79.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 63.030000000000001 110.916 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.13 -125.98 1.67 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.75 -0.738 . . . . 43.0 112.497 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.51 138.48 52.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 61.310000000000002 110.895 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.575 HG21 HG13 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -145.71 101.16 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 74.310000000000002 111.15 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -108.23 172.77 6.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 45.229999999999997 110.829 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.403 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -143.54 133.03 23.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 74.409999999999997 110.871 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -85.4 97.38 9.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 74.219999999999999 110.926 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 129' ' ' PHE . 3.2 mt -81.78 117.61 22.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 52.450000000000003 110.889 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -78.7 64.96 3.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 73.439999999999998 110.827 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.79 -24.05 14.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 20.030000000000001 111.111 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -67.96 -35.14 77.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 64.310000000000002 110.849 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -95.78 -29.2 14.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 70.099999999999994 110.908 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.404 HG21 ' HA ' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -136.58 65.82 55.77 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.641 0.734 . . . . 73.400000000000006 111.129 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -29.32 23.96 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.618 2.212 . . . . 44.25 112.355 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -41.23 96.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 74.400000000000006 110.932 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.8 m -88.55 -45.31 10.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 72.340000000000003 111.143 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.98 -46.07 82.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 73.140000000000001 111.101 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -47.01 -33.66 4.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 72.439999999999998 110.911 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.487 ' HA ' HD13 ' A' ' 78' ' ' ILE . 2.6 t30 -64.57 -65.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 54.109999999999999 110.854 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -59.04 -28.58 66.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 73.310000000000002 110.887 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -50.6 65.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 72.340000000000003 110.847 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.54 -31.71 72.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 62.409999999999997 111.069 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.876 HD21 HG22 ' A' ' 78' ' ' ILE . 75.1 mt -73.67 -54.54 7.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 75.400000000000006 110.927 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.9 m -48.28 -43.94 33.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 61.140000000000001 110.844 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.777 HG22 ' HG3' ' A' ' 163' ' ' GLN . 40.3 p -63.34 -38.42 91.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 72.299999999999997 111.186 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.06 -10.84 44.34 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.702 -0.761 . . . . 52.350000000000001 112.496 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -28.89 27.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.399 . . . . 51.210000000000001 110.893 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.695 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -63.83 -29.05 70.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 63.340000000000003 110.915 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.35 1.38 90.04 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 74.510000000000005 112.508 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -174.89 -165.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.915 0.388 . . . . 75.340000000000003 110.865 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.67 -96.22 0.63 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 61.229999999999997 112.506 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.67 ' O ' ' C ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -119.19 -70.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.958 0.409 . . . . 73.239999999999995 110.894 -179.82 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.67 ' C ' ' O ' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -6.44 96.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 60.340000000000003 110.922 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 120.45 -30.61 5.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.695 -0.764 . . . . 53.100000000000001 112.498 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.37 -168.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.808 0.337 . . . . 62.539999999999999 110.875 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.1 p -142.84 171.94 13.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 45.340000000000003 110.94 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.655 ' HE1' HD11 ' A' ' 158' ' ' ILE . 8.8 m-85 -92.82 139.97 29.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 74.140000000000001 110.909 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -123.45 32.57 5.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 73.319999999999993 110.821 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.99 114.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.423 . . . . 73.129999999999995 110.905 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.46 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.2 mt -144.96 112.47 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 70.329999999999998 111.125 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.478 HD12 ' HE2' ' A' ' 61' ' ' MET . 38.5 mt -105.42 105.07 50.99 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.622 0.725 . . . . 62.530000000000001 111.165 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 53.8 Cg_endo -69.79 56.9 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.644 2.229 . . . . 72.099999999999994 112.336 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.16 33.33 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.71 -0.757 . . . . 50.299999999999997 112.476 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.419 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.0 OUTLIER -177.12 -59.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.838 0.352 . . . . 75.120000000000005 110.882 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.478 ' HE2' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER 174.65 157.92 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 64.409999999999997 110.885 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.5 m -97.04 -161.88 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 33.530000000000001 110.927 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 177.01 137.96 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 74.109999999999999 110.892 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.2 166.83 40.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 62.149999999999999 112.449 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.48 -151.49 2.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.694 -0.765 . . . . 71.239999999999995 112.452 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.19 168.38 19.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.812 0.339 . . . . 64.120000000000005 110.884 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -154.1 38.3 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 62.140000000000001 110.852 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 93.4 m -158.66 98.73 1.53 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 111.159 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? 63.09 162.08 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 64.450000000000003 110.845 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -112.66 36.4 3.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 65.549999999999997 110.838 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -98.89 -74.66 0.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 75.400000000000006 110.899 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.59 32.74 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.775 -0.726 . . . . 72.430000000000007 112.509 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.0 p -101.8 -55.45 2.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.795 0.331 . . . . 51.399999999999999 111.121 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.24 107.37 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.693 -0.765 . . . . 60.310000000000002 112.472 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 51.84 -170.37 0.43 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.685 -0.769 . . . . 31.5 112.516 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.79 -171.51 3.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 63.420000000000002 110.862 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.9 p -104.44 52.64 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 45.149999999999999 110.879 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.876 HG22 HD21 ' A' ' 39' ' ' LEU . 18.8 pt 42.24 33.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 74.230000000000004 111.098 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -155.12 -66.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 64.120000000000005 110.939 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -132.32 -88.3 0.39 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.709 -0.758 . . . . 73.519999999999996 112.486 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -130.91 -37.39 1.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 75.510000000000005 110.884 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.422 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.27 170.04 0.31 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 71.340000000000003 110.898 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -130.99 179.7 5.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 62.009999999999998 110.852 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.1 169.01 19.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 63.310000000000002 110.879 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -63.34 156.75 24.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 72.030000000000001 110.884 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -108.26 -68.91 0.88 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 64.010000000000005 110.853 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -175.94 178.09 1.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 73.219999999999999 110.893 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.94 36.5 2.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 74.140000000000001 110.901 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -50.61 -29.78 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 72.040000000000006 111.101 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 18.8 mt -111.61 74.79 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 71.439999999999998 110.896 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.73 153.51 41.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.120000000000005 110.859 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -52.87 101.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.129999999999995 110.866 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.5 p -116.03 29.15 8.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 75.319999999999993 111.126 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 151.8 174.15 22.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 62.149999999999999 112.438 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 171.33 14.73 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.638 2.225 . . . . 74.230000000000004 112.308 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.63 39.7 98.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 45.409999999999997 112.479 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.436 ' HA ' HD13 ' A' ' 97' ' ' ILE . 14.7 mm -106.13 135.28 45.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.88 0.371 . . . . 74.420000000000002 111.085 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 98' ' ' LEU . 1.1 mt -101.05 149.07 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 74.230000000000004 110.924 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.455 ' HB2' ' HA ' ' A' ' 128' ' ' VAL . 0.2 OUTLIER 178.81 131.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 63.439999999999998 110.833 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.74 162.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 73.319999999999993 110.891 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.471 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . . . -156.22 36.8 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 52.219999999999999 111.128 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -68.18 -35.71 78.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 71.420000000000002 110.928 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.706 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -174.61 32.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 71.310000000000002 111.06 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.04 -114.34 6.31 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.686 -0.769 . . . . 75.510000000000005 112.484 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 114.75 3.81 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.658 2.239 . . . . 64.430000000000007 112.34 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.529 ' C ' HG23 ' A' ' 107' ' ' THR . 3.4 m-20 71.19 171.86 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 74.430000000000007 110.867 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.706 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.0 OUTLIER 66.66 25.68 9.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 75.310000000000002 111.143 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -80.3 130.53 35.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 65.019999999999996 110.909 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.01 -74.85 0.11 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.774 -0.727 . . . . 61.420000000000002 112.489 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.8 p -166.43 43.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 73.439999999999998 110.857 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.436 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 42.8 mm-40 -118.36 54.97 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 74.519999999999996 110.945 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -77.9 -165.91 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 73.140000000000001 110.887 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -154.44 174.58 14.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 72.219999999999999 110.837 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 114' ' ' ILE . 3.0 mt -111.26 90.93 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.496 . . . . 73.340000000000003 111.15 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 55.8 m -65.55 93.13 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 53.350000000000001 110.899 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.2 p -65.8 -11.26 44.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.46 . . . . 74.450000000000003 111.191 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.705 ' O ' HG23 ' A' ' 119' ' ' THR . . . -145.5 154.95 42.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 65.310000000000002 111.096 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -55.64 94.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 70.140000000000001 110.915 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 117' ' ' ALA . 25.7 p -96.74 49.56 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.25 -0.432 . . . . 74.510000000000005 111.097 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -26.01 68.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 65.239999999999995 110.863 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.695 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.6 p90 -48.11 -29.6 3.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 73.109999999999999 110.886 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 19.0 mt -46.92 -33.51 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 65.319999999999993 110.925 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.4 OUTLIER 60.54 78.17 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.847 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.94 43.81 0.9 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 62.329999999999998 112.467 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -16.27 49.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 72.25 110.87 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -141.41 -168.19 2.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 75.329999999999998 110.877 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 51.0 t -122.01 124.22 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 75.230000000000004 111.12 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.455 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 2.3 t -93.21 135.67 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.209999999999994 111.127 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.446 ' O ' HD23 ' A' ' 24' ' ' LEU . 14.1 p90 -160.69 35.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 74.310000000000002 110.887 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -174.08 174.9 46.54 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.73 -0.748 . . . . 64.540000000000006 112.499 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -176.1 137.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 64.25 110.877 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.725 HG11 ' HG2' ' A' ' 136' ' ' MET . 54.1 t -40.73 107.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 70.400000000000006 111.092 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -59.82 2.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.040000000000006 110.928 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -153.78 157.13 38.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 72.530000000000001 110.935 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.11 32.9 19.34 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.737 -0.744 . . . . 44.140000000000001 112.487 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.725 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -55.01 -29.19 56.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 71.219999999999999 110.93 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.26 -31.19 42.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 74.099999999999994 110.896 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 17' ' ' LEU . 43.8 mm -65.58 -40.71 88.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 62.420000000000002 111.147 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.4 t -63.03 -27.36 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 62.340000000000003 111.096 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.91 -27.76 36.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 74.140000000000001 110.893 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.91 -38.68 61.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 62.310000000000002 111.097 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.8 mtm -61.42 -52.18 65.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 73.439999999999998 110.859 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -54.05 -29.61 44.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 74.040000000000006 110.904 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.452 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -65.8 -23.37 66.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 64.040000000000006 110.906 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.452 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 62.2 m-85 -108.95 18.63 20.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 72.519999999999996 110.849 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -114.03 168.46 12.58 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.693 -0.765 . . . . 73.310000000000002 112.484 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 m -113.07 146.76 38.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 53.43 110.865 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -76.01 64.45 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 75.340000000000003 110.873 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -165.48 -38.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 64.409999999999997 110.918 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 157.75 -71.39 0.25 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 74.219999999999999 112.501 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 170.4 4.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.817 0.341 . . . . 74.340000000000003 110.921 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.8 p -145.39 -173.9 4.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 72.5 111.113 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.74 -67.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 72.319999999999993 110.841 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -59.93 -179.22 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 70.409999999999997 110.903 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.62 107.07 9.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 71.129999999999995 110.913 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 4.1 mp -86.99 116.41 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 75.540000000000006 111.156 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.44 169.58 13.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 111.126 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.655 HD11 ' HE1' ' A' ' 53' ' ' PHE . 11.6 mm -104.83 109.25 27.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 73.209999999999994 111.112 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.709 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -68.68 -45.15 72.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 73.129999999999995 111.108 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -161.76 160.03 27.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 73.349999999999994 110.856 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.9 146.66 9.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 71.129999999999995 110.862 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.97 178.81 48.14 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.684 -0.77 . . . . 51.229999999999997 112.452 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.777 ' HG3' HG22 ' A' ' 41' ' ' THR . 3.6 mt-30 -63.98 146.24 54.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.854 0.359 . . . . 72.0 110.922 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.837 HD21 ' HB3' ' A' ' 7' ' ' PHE . 3.5 mm? -102.4 -55.66 2.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 75.5 110.904 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 64.25 110.944 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 mtt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.837 0.351 . . . . 60.329999999999998 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.5 t -140.55 131.99 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 63.130000000000003 111.133 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -123.48 156.26 64.43 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.661 0.744 . . . . 74.209999999999994 110.855 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 145.83 58.52 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.694 2.263 . . . . 62.340000000000003 112.399 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.1 m -129.71 126.88 39.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 73.439999999999998 111.106 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.9 m -121.27 170.51 11.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 65.5 111.139 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.669 ' HB3' HD21 ' A' ' 164' ' ' LEU . 0.6 OUTLIER -158.52 176.37 12.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 63.43 110.882 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -153.13 96.21 2.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 63.149999999999999 110.864 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.6 t70 -43.22 106.63 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 74.349999999999994 110.867 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.708 HG22 HD12 ' A' ' 17' ' ' LEU . 34.1 mm -78.74 137.63 21.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 63.240000000000002 111.114 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -131.25 160.42 34.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 64.299999999999997 111.112 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -143.33 103.6 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 62.439999999999998 111.119 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.96 24.98 9.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 73.450000000000003 110.902 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.11 -25.29 25.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 33.509999999999998 112.512 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -90.28 125.17 60.96 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.672 0.748 . . . . 72.219999999999999 110.886 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.5 Cg_endo -69.76 124.49 11.14 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.653 2.235 . . . . 43.240000000000002 112.328 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.708 HD12 HG22 ' A' ' 10' ' ' ILE . 9.7 mt -68.25 -38.15 81.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 75.040000000000006 110.941 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.93 -131.17 2.86 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.669 -0.777 . . . . 65.319999999999993 112.434 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.67 136.66 53.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 52.439999999999998 110.9 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.584 HG21 HG13 ' A' ' 10' ' ' ILE . 1.3 t -142.4 99.46 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 65.150000000000006 111.137 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 22' ' ' PHE . 1.5 t -106.36 174.01 6.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 61.520000000000003 110.839 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.474 ' CZ ' HD11 ' A' ' 114' ' ' ILE . 48.2 m-85 -144.81 132.97 21.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 71.450000000000003 110.863 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -89.43 95.95 10.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 71.230000000000004 110.893 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.4 mt -81.06 134.61 35.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 54.310000000000002 110.896 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -92.18 66.87 4.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 110.852 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.91 -22.81 27.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 74.200000000000003 111.129 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -65.22 -39.44 92.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 61.32 110.813 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -96.58 -27.84 14.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 74.140000000000001 110.882 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.458 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -135.54 66.2 63.75 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.612 0.72 . . . . 71.519999999999996 111.112 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -45.91 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.703 2.268 . . . . 64.319999999999993 112.348 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -54.41 -34.71 61.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.434 . . . . 63.520000000000003 110.912 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.428 HG21 ' CD1' ' A' ' 129' ' ' PHE . 32.5 m -89.64 -54.11 4.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 65.049999999999997 111.109 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.92 -42.27 62.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 54.530000000000001 111.116 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -56.04 -27.18 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 71.510000000000005 110.925 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -66.68 -65.68 0.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 74.400000000000006 110.901 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.94 -34.66 70.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 73.439999999999998 110.888 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.485 ' O ' HG23 ' A' ' 41' ' ' THR . 3.5 ttp180 -70.22 -48.27 57.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 74.340000000000003 110.894 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.92 -37.18 66.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 73.329999999999998 111.118 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.5 HD22 ' HA2' ' A' ' 47' ' ' GLY . 3.1 mt -76.92 -56.06 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 72.230000000000004 110.934 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.0 m -53.6 -32.75 52.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 73.310000000000002 110.886 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 37' ' ' ARG . 30.6 p -73.42 -53.41 10.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 74.150000000000006 111.142 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.54 -13.92 6.49 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 74.109999999999999 112.455 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -53.63 -31.01 45.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.373 . . . . 73.409999999999997 110.877 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -27.9 60.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 72.450000000000003 110.925 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.04 -17.12 53.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 54.119999999999997 112.515 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -154.85 -165.18 1.98 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.907 0.385 . . . . 71.319999999999993 110.865 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA2' HD22 ' A' ' 39' ' ' LEU . . . 152.05 -123.41 1.47 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 73.299999999999997 112.473 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -121.7 31.72 6.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.934 0.397 . . . . 74.349999999999994 110.905 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.67 114.34 20.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 71.5 110.882 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.48 41.26 94.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 63.119999999999997 112.484 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 m -121.45 138.24 54.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.827 0.346 . . . . 72.040000000000006 110.845 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 55.9 m -56.34 150.57 14.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 72.329999999999998 110.859 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -69.37 -179.86 1.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 73.510000000000005 110.89 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -110.9 -72.62 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.150000000000006 110.854 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -143.34 157.81 44.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 73.329999999999998 110.818 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.515 HD12 HD13 ' A' ' 156' ' ' ILE . 44.9 mt -147.03 111.89 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 64.400000000000006 111.105 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.3 mt -109.76 102.28 49.67 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.682 0.753 . . . . 73.230000000000004 111.108 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 53.9 Cg_endo -69.77 88.53 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.714 2.276 . . . . 62.200000000000003 112.339 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.89 -20.33 1.61 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 50.0 112.46 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.54 -54.38 1.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 70.209999999999994 110.865 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.416 ' HB3' ' HA ' ' A' ' 115' ' ' CYS . 0.0 OUTLIER 171.03 166.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 110.914 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.6 m -91.7 -162.08 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 72.109999999999999 110.87 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -165.4 112.84 0.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 73.540000000000006 110.961 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.09 58.83 0.43 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 72.129999999999995 112.506 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.61 78.85 0.31 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.761 -0.733 . . . . 53.210000000000001 112.468 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -177.04 87.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 65.540000000000006 110.889 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -139.72 31.99 2.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 74.120000000000005 110.916 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.78 34.04 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 71.25 111.163 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.59 55.94 3.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 74.329999999999998 110.865 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -124.59 -36.71 2.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 74.140000000000001 110.869 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -99.97 -35.98 9.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 62.520000000000003 110.897 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 135.35 149.01 5.74 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 73.219999999999999 112.5 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.6 t 41.22 36.72 0.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.842 0.353 . . . . 70.519999999999996 111.143 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -51.48 170.66 0.33 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.726 -0.749 . . . . 64.129999999999995 112.431 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.68 129.06 0.19 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.72 -0.752 . . . . 62.229999999999997 112.48 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -162.35 151.19 15.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 74.310000000000002 110.91 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.8 m -67.49 -176.73 0.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 51.409999999999997 110.86 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 78' ' ' ILE . 1.1 pp -98.93 23.11 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 70.040000000000006 111.123 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -135.9 34.63 2.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 73.400000000000006 110.946 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.26 -109.73 2.48 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.752 -0.737 . . . . 55.119999999999997 112.516 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -111.12 -30.76 7.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.38 . . . . 70.019999999999996 110.873 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.401 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.3 179.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 71.120000000000005 110.913 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -148.15 164.98 32.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 73.329999999999998 110.838 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.61 171.31 15.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 64.010000000000005 110.865 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.76 153.88 40.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 75.319999999999993 110.877 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -106.63 -78.46 0.58 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 63.0 110.873 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 42.5 p30 -155.1 172.89 17.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 71.340000000000003 110.895 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.9 39.27 3.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 61.329999999999998 110.877 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -49.92 -30.26 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 75.140000000000001 111.104 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.6 mt -108.05 91.63 3.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 75.409999999999997 110.959 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.11 150.87 43.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 53.439999999999998 110.867 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -63.42 89.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 53.229999999999997 110.858 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.39 -55.3 5.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 62.109999999999999 111.102 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . -145.66 -166.73 12.05 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.719 -0.753 . . . . 41.329999999999998 112.512 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 172.17 13.17 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.686 2.257 . . . . 74.129999999999995 112.3 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.5 12.67 77.4 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.732 -0.747 . . . . 50.310000000000002 112.471 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.7 mm -89.05 143.39 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 75.519999999999996 111.129 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -114.14 143.14 45.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 62.350000000000001 110.898 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.5 -165.25 2.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 74.219999999999999 110.872 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.426 ' HG3' ' HB ' ' A' ' 127' ' ' VAL . 0.1 OUTLIER -95.53 104.94 16.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 110.856 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.584 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -70.04 77.37 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 43.229999999999997 111.141 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 22.1 p-10 -129.14 -172.28 2.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 65.209999999999994 110.897 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.22 -18.9 64.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 71.030000000000001 111.098 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.5 -82.68 0.33 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.74 -0.743 . . . . 74.420000000000002 112.512 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 96.14 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.728 2.285 . . . . 53.409999999999997 112.329 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.41 ' C ' HG23 ' A' ' 107' ' ' THR . 1.6 m-20 71.92 166.13 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 74.010000000000005 110.874 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.41 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.7 p 66.1 45.48 2.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 61.140000000000001 111.159 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 1.9 m-20 -43.81 -31.76 0.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 74.430000000000007 110.843 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . 70.58 -64.24 0.83 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 73.0 112.52 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 1.2 t 84.72 58.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.85 0.357 . . . . 74.0 110.849 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -109.93 -15.99 13.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 74.319999999999993 110.967 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.613 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER 73.47 154.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 75.140000000000001 110.883 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.584 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -165.08 67.77 0.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 72.200000000000003 110.873 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.563 ' C ' ' O ' ' A' ' 113' ' ' PHE . 1.0 OUTLIER -23.67 123.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 73.129999999999995 111.093 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 61' ' ' MET . 37.2 m -96.28 114.14 25.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 74.319999999999993 110.863 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 68.1 p -93.16 27.39 2.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 53.140000000000001 111.163 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 119' ' ' THR . . . 176.38 142.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 42.509999999999998 111.131 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.415 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 3.6 tttt -53.42 99.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 72.310000000000002 110.893 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.718 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 28.8 p -98.89 48.63 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 73.120000000000005 111.134 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.39 -25.52 68.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 75.150000000000006 110.904 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.718 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.8 p90 -48.99 -28.29 3.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 75.099999999999994 110.915 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.443 HD13 ' HD2' ' A' ' 126' ' ' HIS . 26.1 mt -48.37 -32.12 7.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 72.25 110.913 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.0 m-20 59.77 76.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.310000000000002 110.934 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.98 41.5 0.98 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.74 -0.743 . . . . 61.130000000000003 112.509 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.93 -26.4 36.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.822 0.344 . . . . 74.129999999999995 110.894 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.443 ' HD2' HD13 ' A' ' 122' ' ' LEU . 19.9 m-70 -129.3 -167.76 1.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 73.5 110.89 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.426 ' HB ' ' HG3' ' A' ' 100' ' ' MET . 76.0 t -127.89 118.27 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 51.219999999999999 111.139 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.53 129.94 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 70.219999999999999 111.134 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.469 ' O ' HD23 ' A' ' 24' ' ' LEU . 35.4 p90 -151.2 33.49 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 72.519999999999996 110.894 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -172.68 175.28 45.77 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 43.210000000000001 112.477 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 2.1 pttt -175.75 137.28 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.813 0.34 . . . . 54.520000000000003 110.938 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.686 HG11 ' HG2' ' A' ' 136' ' ' MET . 53.8 t -41.63 105.73 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 73.430000000000007 111.142 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -59.95 3.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 70.450000000000003 110.898 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -154.28 161.91 41.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 73.430000000000007 110.921 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.05 33.66 28.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.721 -0.752 . . . . 11.44 112.498 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.686 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -55.06 -29.45 57.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 74.25 110.862 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.53 -33.02 53.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 65.120000000000005 110.885 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 17' ' ' LEU . 37.3 mm -65.56 -35.72 75.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 53.350000000000001 111.122 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.3 t -67.09 -26.92 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 72.340000000000003 111.139 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -82.27 -27.81 32.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 54.420000000000002 110.869 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.74 -41.28 60.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.488 . . . . 45.229999999999997 111.083 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 30.3 mtm -62.27 -51.73 66.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 63.310000000000002 110.91 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -54.06 -26.01 24.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.452 . . . . 72.340000000000003 110.899 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.447 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.34 -24.59 62.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 72.150000000000006 110.84 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.447 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 67.6 m-85 -107.58 12.12 27.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 72.140000000000001 110.902 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.39 171.64 17.7 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 63.530000000000001 112.487 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.68 131.09 55.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.849 0.357 . . . . 73.239999999999995 110.876 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -54.56 -28.07 43.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 63.350000000000001 110.813 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -72.53 -29.68 63.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 71.530000000000001 110.854 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.83 -42.45 1.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 30.109999999999999 112.49 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.27 -177.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.873 0.368 . . . . 54.409999999999997 110.881 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.5 p -144.78 138.41 27.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.207 -0.451 . . . . 72.010000000000005 111.148 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.69 -44.84 63.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 73.519999999999996 110.842 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.42 -177.68 3.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 73.239999999999995 110.925 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.78 109.13 18.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 74.230000000000004 110.911 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.515 HD13 HD12 ' A' ' 56' ' ' ILE . 5.1 mp -93.46 118.24 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 74.019999999999996 111.142 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.26 162.58 26.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 111.157 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 20.0 mm -101.29 117.16 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 75.030000000000001 111.098 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -77.65 -47.07 20.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 65.019999999999996 111.112 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -153.74 157.49 39.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 72.25 110.848 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -160.32 147.48 16.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 75.109999999999999 110.904 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.19 161.73 21.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.7 -0.762 . . . . 63.149999999999999 112.437 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.62 108.58 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.37 . . . . 54.310000000000002 110.933 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.669 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.1 mm? -50.78 -49.86 57.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.409999999999997 110.892 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 62.039999999999999 110.915 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.837 0.351 . . . . 74.230000000000004 110.893 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 p -178.01 146.3 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 71.439999999999998 111.116 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -106.52 155.83 38.13 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.721 . . . . 74.329999999999998 110.884 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 146.95 61.54 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.629 2.22 . . . . 73.319999999999993 112.375 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -135.39 142.35 45.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 61.439999999999998 111.164 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.465 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.3 m -133.12 143.4 39.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 73.319999999999993 111.094 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 16.1 p90 -104.13 164.12 11.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 71.349999999999994 110.861 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.693 ' CD2' HD13 ' A' ' 158' ' ' ILE . 5.2 m-85 -147.4 85.07 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 65.319999999999993 110.836 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.673 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.8 OUTLIER -49.66 106.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 60.009999999999998 110.846 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.661 HG22 HD12 ' A' ' 17' ' ' LEU . 34.7 mm -85.01 134.58 26.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.446 . . . . 71.540000000000006 111.095 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -124.07 158.65 31.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 53.329999999999998 111.11 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 154' ' ' LYS . 40.5 t -137.84 94.45 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 74.329999999999998 111.17 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.21 32.19 8.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 72.400000000000006 110.851 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.23 -24.0 32.55 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.759 -0.734 . . . . 71.439999999999998 112.51 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -91.74 115.01 63.74 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.633 0.73 . . . . 52.420000000000002 110.902 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.6 Cg_endo -69.76 122.59 9.27 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.682 2.254 . . . . 70.230000000000004 112.335 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.661 HD12 HG22 ' A' ' 10' ' ' ILE . 14.6 mt -66.64 -37.86 85.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 64.540000000000006 110.964 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.41 -122.29 1.2 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.72 -0.752 . . . . 61.340000000000003 112.48 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -130.12 138.22 50.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.853 0.359 . . . . 73.5 110.873 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.562 HG21 HG13 ' A' ' 10' ' ' ILE . 1.6 t -145.14 99.56 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 73.230000000000004 111.114 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.1 t -108.16 174.91 5.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 62.229999999999997 110.823 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.445 ' N ' ' OG ' ' A' ' 21' ' ' SER . 2.1 m-85 -144.92 131.81 20.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.493 . . . . 75.129999999999995 110.909 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.45 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 60.0 tt0 -86.4 97.04 10.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 71.439999999999998 110.933 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.7 mt -77.39 124.43 27.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 52.340000000000003 110.925 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -80.64 64.31 5.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 65.409999999999997 110.89 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.41 -22.38 12.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 55.450000000000003 111.12 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.32 -48.96 77.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 71.219999999999999 110.847 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -90.1 -29.64 18.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 70.510000000000005 110.892 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.446 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -130.89 67.84 81.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.618 0.723 . . . . 73.25 111.064 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -41.01 4.59 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.713 2.275 . . . . 34.240000000000002 112.316 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -35.27 79.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 72.430000000000007 110.936 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 48.5 m -84.63 -44.23 13.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 74.340000000000003 111.112 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.18 -47.05 78.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 65.209999999999994 111.089 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -50.96 -27.03 6.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 72.010000000000005 110.889 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.469 ' HA ' HD13 ' A' ' 78' ' ' ILE . 1.9 t30 -65.81 -63.39 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 75.530000000000001 110.892 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -61.11 -34.78 75.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 72.409999999999997 110.867 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.516 ' O ' HG23 ' A' ' 41' ' ' THR . 0.7 OUTLIER -69.78 -47.06 64.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 54.420000000000002 110.87 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.87 -39.84 72.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 52.420000000000002 111.132 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.506 HD22 ' HA2' ' A' ' 47' ' ' GLY . 4.1 mt -79.34 -49.46 12.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 74.049999999999997 110.957 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.7 m -55.69 -37.84 68.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 71.150000000000006 110.846 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 37' ' ' ARG . 73.9 p -74.91 -47.14 31.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 73.219999999999999 111.126 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.55 -11.95 13.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.738 -0.744 . . . . 62.0 112.505 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -52.07 -37.78 54.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 65.019999999999996 110.843 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -58.85 -27.48 65.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 73.530000000000001 110.905 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.76 -14.79 56.11 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.718 -0.754 . . . . 75.230000000000004 112.46 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -158.68 -166.07 1.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.885 0.374 . . . . 70.150000000000006 110.879 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.506 ' HA2' HD22 ' A' ' 39' ' ' LEU . . . 163.23 -133.2 2.98 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.681 -0.771 . . . . 34.530000000000001 112.446 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -149.72 48.35 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.933 0.397 . . . . 75.120000000000005 110.923 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -58.7 125.73 24.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 70.25 110.924 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.11 43.15 17.53 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.776 -0.726 . . . . 65.200000000000003 112.478 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.466 ' O ' HG22 ' A' ' 157' ' ' THR . 0.7 OUTLIER -60.47 -169.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.831 0.348 . . . . 74.140000000000001 110.903 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.0 p -125.17 132.29 53.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.153 -0.476 . . . . 62.439999999999998 110.886 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -110.7 108.91 18.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 74.109999999999999 110.869 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -133.45 37.75 3.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 110.848 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.46 77.96 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 65.239999999999995 110.851 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.548 HD12 HD13 ' A' ' 156' ' ' ILE . 13.6 mt -117.87 109.56 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 62.439999999999998 111.15 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 30.2 mt -97.77 104.51 21.8 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.606 0.717 . . . . 73.239999999999995 111.155 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.4 Cg_endo -69.76 85.94 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.687 2.258 . . . . 51.240000000000002 112.351 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.71 -19.88 1.82 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 65.200000000000003 112.489 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.9 -56.6 1.93 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.857 0.36 . . . . 70.239999999999995 110.846 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.624 ' HE3' ' O ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER 171.1 165.21 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 62.439999999999998 110.862 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.624 ' O ' ' HE3' ' A' ' 61' ' ' MET . 15.6 m -99.79 -161.85 0.9 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.445 . . . . 75.510000000000005 110.934 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.4 145.87 22.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 74.040000000000006 110.916 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.85 -64.14 1.7 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 51.140000000000001 112.454 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.59 72.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 63.530000000000001 112.536 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -51.65 159.54 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.835 0.35 . . . . 74.230000000000004 110.875 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -157.67 161.58 38.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 73.129999999999995 110.864 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.57 HG22 ' HA2' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -160.9 33.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 75.439999999999998 111.155 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.474 ' HG2' HG23 ' A' ' 73' ' ' THR . 2.5 tpm_? 51.94 32.58 10.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 75.129999999999995 110.903 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.3 m170 50.3 38.78 18.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 73.140000000000001 110.862 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -177.3 -75.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 70.099999999999994 110.906 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.57 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 163.75 54.52 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 42.109999999999999 112.483 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.474 HG23 ' HG2' ' A' ' 69' ' ' ARG . 9.6 t -158.79 44.31 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 54.130000000000003 111.197 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -153.82 -48.43 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.741 -0.742 . . . . 45.420000000000002 112.48 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.17 132.37 10.96 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.737 . . . . 74.430000000000007 112.494 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.73 171.08 5.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 75.120000000000005 110.923 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.406 ' O ' ' CG1' ' A' ' 78' ' ' ILE . 41.2 t -84.44 53.8 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 75.329999999999998 110.856 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.469 HD13 ' HA ' ' A' ' 35' ' ' ASN . 11.3 pt 43.17 30.93 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 62.210000000000001 111.162 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -161.34 -64.29 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 110.952 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -132.15 166.68 23.17 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.706 -0.759 . . . . 53.100000000000001 112.492 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.14 -26.0 2.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.917 0.389 . . . . 74.0 110.899 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.41 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 176.13 173.47 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 75.120000000000005 110.928 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -149.76 167.82 25.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 71.349999999999994 110.891 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.75 167.63 20.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 74.519999999999996 110.912 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.13 135.02 57.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 73.230000000000004 110.852 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -83.33 -77.31 0.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 110.885 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.1 p30 -156.25 174.42 15.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 75.319999999999993 110.939 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.52 36.93 3.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 65.120000000000005 110.821 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.09 -32.13 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 73.150000000000006 111.117 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 21.8 mt -109.99 86.96 2.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 72.540000000000006 110.932 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.726 ' O ' HG23 ' A' ' 93' ' ' THR . 5.7 mtpt -75.1 145.83 41.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 73.129999999999995 110.946 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.52 ' CE1' HD12 ' A' ' 122' ' ' LEU . 16.9 m80 -49.85 103.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 70.510000000000005 110.857 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 91' ' ' LYS . 79.2 p -114.4 28.4 8.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 72.439999999999998 111.117 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.17 175.76 21.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.685 -0.769 . . . . 61.509999999999998 112.469 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 175.96 7.35 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.7 2.267 . . . . 74.109999999999999 112.34 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.13 26.63 69.43 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 74.329999999999998 112.45 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.2 mm -95.9 140.34 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.828 0.347 . . . . 61.43 111.166 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.445 HD21 ' HD2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -109.34 139.25 44.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 73.450000000000003 110.861 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.13 156.71 39.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 72.219999999999999 110.842 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.474 ' HE1' ' HB3' ' A' ' 110' ' ' SER . 1.0 OUTLIER -59.95 96.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 74.439999999999998 110.837 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.4 ' HB3' ' HG2' ' A' ' 111' ' ' GLN . . . -63.99 89.65 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 71.219999999999999 111.133 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 107' ' ' THR . 0.8 OUTLIER -134.71 173.55 11.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 74.010000000000005 110.882 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.93 -23.06 6.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 72.510000000000005 111.074 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 122.44 -82.16 0.35 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 62.140000000000001 112.52 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 91.91 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.696 2.264 . . . . 65.150000000000006 112.359 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.446 ' C ' HG23 ' A' ' 107' ' ' THR . 2.3 m-20 73.66 171.8 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 72.040000000000006 110.889 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.446 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.3 p 66.0 39.07 4.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 111.098 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -45.36 -30.48 1.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.838 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.436 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . 51.92 -118.47 7.3 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.777 -0.725 . . . . 62.420000000000002 112.491 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.474 ' HB3' ' HE1' ' A' ' 100' ' ' MET . 1.5 p 165.4 67.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 72.140000000000001 110.882 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.4 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 2.4 tt0 -102.79 -27.51 12.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 63.210000000000001 110.923 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.602 ' HZ ' HD12 ' A' ' 114' ' ' ILE . 0.0 OUTLIER 68.09 151.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.230000000000004 110.861 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -164.39 85.81 0.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 65.420000000000002 110.927 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.602 HD12 ' HZ ' ' A' ' 112' ' ' PHE . 2.2 mt -42.06 114.44 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 71.120000000000005 111.135 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.8 m -85.87 122.44 29.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 62.119999999999997 110.9 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.2 p -91.73 24.04 3.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 73.349999999999994 111.139 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 119' ' ' THR . . . 179.34 154.61 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 51.109999999999999 111.053 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.2 86.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 74.049999999999997 110.91 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.736 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 32.6 p -84.16 53.4 2.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 61.340000000000003 111.093 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -66.8 -23.14 66.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 74.120000000000005 110.909 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.736 ' CZ2' HG22 ' A' ' 119' ' ' THR . 11.6 p90 -53.75 -25.69 20.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 70.450000000000003 110.963 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.545 HD22 ' HE2' ' A' ' 126' ' ' HIS . 38.2 mt -45.6 -33.48 2.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 74.409999999999997 110.933 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 124' ' ' GLY . 1.6 m-20 61.95 76.18 0.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 62.200000000000003 110.838 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.6 41.54 0.85 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 70.230000000000004 112.478 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.67 -21.89 37.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.835 0.35 . . . . 74.140000000000001 110.938 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.545 ' HE2' HD22 ' A' ' 122' ' ' LEU . 9.7 m-70 -137.43 -167.23 2.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 74.049999999999997 110.861 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.9 t -127.06 122.07 59.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 73.129999999999995 111.161 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 t -88.1 133.3 30.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 61.420000000000002 111.106 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.451 ' O ' HD23 ' A' ' 24' ' ' LEU . 19.0 p90 -156.97 32.55 0.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.473 . . . . 74.129999999999995 110.852 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -169.44 172.1 43.4 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.727 -0.749 . . . . 54.119999999999997 112.47 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 131' ' ' LYS . 1.6 pttt -176.11 132.41 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 63.43 110.916 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.654 HG11 ' HG2' ' A' ' 136' ' ' MET . 97.4 t -37.97 105.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.510000000000005 111.163 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.45 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -67.31 -58.69 4.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 75.140000000000001 110.94 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -150.99 170.29 19.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 72.219999999999999 110.87 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.13 31.0 64.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.735 . . . . 72.430000000000007 112.502 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.654 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -52.21 -26.38 11.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.771 0.32 . . . . 72.25 110.893 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.18 -31.89 54.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 74.540000000000006 110.886 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.632 HD12 ' HB3' ' A' ' 17' ' ' LEU . 43.4 mm -64.96 -40.26 88.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 71.239999999999995 111.107 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.43 -28.67 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 72.430000000000007 111.162 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -78.01 -29.02 49.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 73.420000000000002 110.885 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.96 57.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 71.319999999999993 111.132 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.487 ' SD ' HG21 ' A' ' 156' ' ' ILE . 35.9 mtm -61.38 -41.9 97.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 74.530000000000001 110.844 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -53.47 -30.57 41.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 72.420000000000002 110.89 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.43 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -73.55 -27.23 61.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 72.319999999999993 110.875 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.43 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 61.4 m-85 -105.44 30.01 6.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 75.519999999999996 110.81 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.0 151.69 17.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.766 -0.73 . . . . 75.230000000000004 112.51 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.5 m -114.37 140.52 48.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 63.219999999999999 110.854 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -74.11 70.18 1.55 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.340000000000003 110.886 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -179.93 -33.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 63.130000000000003 110.88 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 153.96 -100.61 0.2 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.773 -0.727 . . . . 70.140000000000001 112.468 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.32 169.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 55.420000000000002 110.912 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.6 p -143.65 -171.04 3.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 65.099999999999994 111.093 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.1 p -78.39 -55.31 5.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 63.109999999999999 110.847 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.456 ' HB3' HG13 ' A' ' 12' ' ' VAL . 3.7 mttp -81.54 166.66 20.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 74.420000000000002 110.877 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -111.95 110.08 20.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.310000000000002 110.888 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.548 HD13 HD12 ' A' ' 56' ' ' ILE . 4.8 mp -89.46 118.18 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 71.030000000000001 111.132 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -129.67 164.36 24.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 111.127 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.693 HD13 ' CD2' ' A' ' 8' ' ' PHE . 6.8 mt -98.44 123.04 50.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 73.400000000000006 111.073 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.673 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -81.53 -49.05 11.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 63.420000000000002 111.118 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -153.4 155.96 37.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 73.25 110.875 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.56 148.97 18.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 73.230000000000004 110.902 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 172.42 172.28 38.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.703 -0.76 . . . . 61.130000000000003 112.495 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.406 ' OE1' HG21 ' A' ' 41' ' ' THR . 2.7 mt-30 -64.67 142.36 58.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.363 . . . . 60.210000000000001 110.867 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -94.86 -59.58 1.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 72.299999999999997 110.903 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 110.913 179.955 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.2 tpt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.844 0.354 . . . . 73.430000000000007 110.894 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.8 t -135.35 109.26 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.447 . . . . 53.399999999999999 111.083 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -70.63 117.51 56.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.615 0.721 . . . . 64.409999999999997 110.861 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 152.6 69.31 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.653 2.235 . . . . 72.140000000000001 112.337 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -137.78 139.64 40.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 61.210000000000001 111.145 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.492 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.4 m -127.38 142.5 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 75.310000000000002 111.142 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.6 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 7.3 p90 -106.1 155.45 19.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 73.209999999999994 110.872 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.593 ' CE2' HD13 ' A' ' 158' ' ' ILE . 3.9 m-85 -143.8 86.72 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 73.129999999999995 110.847 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.736 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 4.0 t70 -47.75 125.91 9.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 72.129999999999995 110.846 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.67 HG23 HG23 ' A' ' 156' ' ' ILE . 17.5 mm -97.61 111.36 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 111.168 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -104.62 126.04 51.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 70.430000000000007 111.082 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.634 HG23 HD13 ' A' ' 17' ' ' LEU . 11.9 t -111.13 101.28 12.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 54.149999999999999 111.103 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 t0 59.87 43.55 14.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 73.150000000000006 110.87 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.58 0.83 88.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.747 -0.739 . . . . 73.109999999999999 112.511 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 10.2 mm-40 -113.22 102.4 54.74 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.628 0.728 . . . . 72.430000000000007 110.91 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.6 Cg_endo -69.81 110.88 2.67 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.626 2.217 . . . . 70.140000000000001 112.361 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.634 HD13 HG23 ' A' ' 12' ' ' VAL . 6.3 mp -65.45 -35.27 80.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 75.340000000000003 110.915 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.36 -133.72 3.04 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.731 . . . . 60.530000000000001 112.499 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -128.36 146.75 50.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 44.100000000000001 110.861 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.52 HG21 HG13 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -143.7 101.44 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 75.25 111.17 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -107.52 170.94 7.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 40.25 110.833 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -143.35 138.05 29.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 74.519999999999996 110.858 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.465 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 19.7 tt0 -91.17 99.94 12.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 74.420000000000002 110.865 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 129' ' ' PHE . 5.5 mt -82.56 123.13 28.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 72.540000000000006 110.923 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.464 ' CD1' HD13 ' A' ' 90' ' ' LEU . 40.6 m-85 -79.04 63.5 3.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 73.140000000000001 110.86 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.13 -22.32 16.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 74.409999999999997 111.062 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.17 -36.27 74.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 75.140000000000001 110.868 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.37 -25.31 15.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 53.409999999999997 110.919 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.444 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -139.44 65.51 34.04 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.625 0.726 . . . . 75.430000000000007 111.107 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -35.77 11.95 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.698 2.265 . . . . 71.420000000000002 112.339 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -39.82 89.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 75.319999999999993 110.859 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 98.6 m -87.28 -45.3 10.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 71.230000000000004 111.165 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.73 91.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 73.019999999999996 111.1 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -47.42 -35.15 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 74.319999999999993 110.874 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -62.64 -68.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 52.130000000000003 110.906 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -56.21 -23.44 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 71.540000000000006 110.903 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.485 ' NH2' ' HG2' ' A' ' 163' ' ' GLN . 0.0 OUTLIER -68.17 -54.21 19.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 75.340000000000003 110.854 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.57 -26.46 66.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 52.509999999999998 111.103 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.502 HD13 ' HE2' ' A' ' 48' ' ' TYR . 97.5 mt -79.0 -56.45 4.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 73.420000000000002 110.925 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.9 m -49.38 -46.13 46.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 65.439999999999998 110.834 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.3 p -72.44 -27.27 62.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 75.230000000000004 111.166 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.5 -8.81 74.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.726 -0.75 . . . . 73.109999999999999 112.475 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -18.55 50.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 72.209999999999994 110.883 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.737 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -50.36 -30.59 12.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 74.409999999999997 110.928 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.64 -23.97 6.57 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.763 -0.732 . . . . 70.219999999999999 112.509 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -160.59 -50.84 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 72.129999999999995 110.867 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.97 163.18 0.17 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.718 -0.753 . . . . 72.340000000000003 112.499 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.502 ' HE2' HD13 ' A' ' 39' ' ' LEU . 44.8 p90 -96.48 26.67 4.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.0 0.429 . . . . 74.349999999999994 110.934 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.17 142.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 72.209999999999994 110.904 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.83 27.05 74.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.706 -0.759 . . . . 53.32 112.487 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.712 ' O ' HG22 ' A' ' 157' ' ' THR . 0.4 OUTLIER -66.37 -176.46 0.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.827 0.346 . . . . 64.319999999999993 110.844 -179.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.9 p -126.06 122.47 35.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 72.140000000000001 110.856 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -86.98 130.61 34.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 75.230000000000004 110.877 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -147.33 46.82 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 110.889 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -158.94 61.59 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 75.239999999999995 110.905 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 13.7 mt -107.92 109.25 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 71.219999999999999 111.127 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.401 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 26.6 mt -100.2 103.78 25.23 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.604 0.716 . . . . 73.420000000000002 111.093 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.8 Cg_endo -69.75 85.01 0.63 Allowed 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.722 2.281 . . . . 73.530000000000001 112.34 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.37 -20.46 1.19 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.731 . . . . 71.430000000000007 112.479 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.89 -57.93 1.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.915 0.388 . . . . 64.340000000000003 110.911 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 174.19 164.48 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 62.009999999999998 110.827 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 10.1 m -100.81 -168.45 1.57 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 73.530000000000001 110.931 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 177.24 146.21 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 70.230000000000004 110.887 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.99 -33.22 7.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.756 . . . . 72.329999999999998 112.497 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.42 173.24 49.57 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.729 . . . . 71.329999999999998 112.496 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.13 -172.49 1.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.833 0.349 . . . . 73.409999999999997 110.839 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -150.99 52.79 0.86 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 74.239999999999995 110.916 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 p -82.6 63.22 6.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 51.409999999999997 111.155 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.44 -179.57 5.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 64.040000000000006 110.818 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -108.92 36.05 3.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 74.519999999999996 110.822 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -111.09 -73.33 0.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 72.409999999999997 110.904 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.51 32.59 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.771 -0.728 . . . . 72.209999999999994 112.5 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.2 p -101.38 -54.88 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 74.109999999999999 111.134 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.26 110.98 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 70.340000000000003 112.479 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.77 108.14 2.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 73.099999999999994 112.468 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -173.6 156.32 2.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 75.209999999999994 110.942 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.1 p -61.22 -169.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 75.140000000000001 110.884 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.737 HG22 ' HD2' ' A' ' 44' ' ' LYS . 5.2 pt -102.29 28.08 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 74.010000000000005 111.145 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -155.88 46.4 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 72.319999999999993 110.918 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.34 -133.98 11.51 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 65.150000000000006 112.479 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -79.23 -38.94 34.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.939 0.399 . . . . 60.119999999999997 110.88 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.41 ' HD2' ' C ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 174.2 176.63 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 73.239999999999995 110.893 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.75 -178.18 3.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 71.239999999999995 110.858 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -95.34 167.88 11.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.109 -0.496 . . . . 74.209999999999994 110.872 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -60.63 154.93 20.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 61.240000000000002 110.836 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -112.23 -67.44 1.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.019999999999996 110.881 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -176.45 178.11 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 75.430000000000007 110.871 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.46 35.99 3.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 63.140000000000001 110.918 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.51 -30.16 7.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 64.230000000000004 111.123 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 25' ' ' PHE . 12.9 mt -111.41 79.52 1.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 61.149999999999999 110.916 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -69.89 152.05 44.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 72.540000000000006 110.897 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -56.73 97.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 74.299999999999997 110.898 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.1 p -108.93 26.31 10.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 72.340000000000003 111.145 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.58 178.64 25.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.719 -0.753 . . . . 44.32 112.496 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 171.57 14.16 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.736 2.291 . . . . 74.109999999999999 112.335 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.9 37.64 94.54 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 64.239999999999995 112.468 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 97' ' ' ILE . 21.5 mm -108.62 136.99 42.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.884 0.373 . . . . 43.119999999999997 111.163 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' A' ' 112' ' ' PHE . 4.2 mt -103.1 162.18 13.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 72.230000000000004 110.92 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.16 -160.15 0.31 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 75.430000000000007 110.786 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.3 mmt -121.93 138.15 54.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 73.540000000000006 110.903 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -119.05 148.22 43.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 44.420000000000002 111.1 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 2.4 m-20 163.73 -50.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 75.019999999999996 110.88 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -178.11 30.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 75.129999999999995 111.101 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.33 -120.89 5.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 35.43 112.509 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 126.35 13.17 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.629 2.219 . . . . 74.109999999999999 112.337 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.494 ' C ' HG23 ' A' ' 107' ' ' THR . 4.0 m-20 69.11 173.02 0.3 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 65.519999999999996 110.898 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.494 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.3 p 67.07 26.38 8.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 73.409999999999997 111.142 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -72.25 146.63 47.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 71.219999999999999 110.853 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.89 -106.88 0.9 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 72.450000000000003 112.518 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.6 p -151.43 33.74 0.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.81 0.338 . . . . 70.120000000000005 110.9 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.668 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 3.7 pt20 -114.42 51.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 72.219999999999999 110.902 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.539 ' HB2' HD22 ' A' ' 98' ' ' LEU . 5.4 p90 -56.85 -169.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 62.340000000000003 110.892 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.452 ' O ' HD23 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -151.87 164.27 37.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 74.049999999999997 110.894 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 114' ' ' ILE . 3.4 mt -108.66 90.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 71.420000000000002 111.145 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 57.3 m -63.41 91.29 0.05 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 72.040000000000006 110.89 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.2 p -61.68 -15.16 37.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 42.509999999999998 111.111 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 119' ' ' THR . . . -143.89 156.4 44.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 71.219999999999999 111.08 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -56.06 94.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 75.420000000000002 110.864 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 117' ' ' ALA . 23.7 p -95.49 46.11 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 54.219999999999999 111.151 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -23.88 67.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 74.450000000000003 110.853 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.687 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.0 p90 -49.54 -28.16 5.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 72.200000000000003 110.896 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.9 mt -46.77 -34.06 4.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.227 -0.442 . . . . 54.520000000000003 110.912 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.4 OUTLIER 63.01 75.18 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 64.040000000000006 110.889 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.11 43.71 0.7 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.732 -0.747 . . . . 51.329999999999998 112.495 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -80.34 -27.42 38.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 64.430000000000007 110.91 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -127.18 -168.65 1.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 52.219999999999999 110.856 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.7 t -121.43 110.22 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 62.310000000000002 111.114 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 98' ' ' LEU . 16.4 t -83.84 134.57 26.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 72.439999999999998 111.166 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.444 ' CB ' HG21 ' A' ' 29' ' ' VAL . 12.5 p90 -158.24 44.85 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 74.140000000000001 110.902 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . 179.02 175.25 45.89 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.772 -0.728 . . . . 75.430000000000007 112.525 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.2 pttp -174.9 145.19 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 71.120000000000005 110.927 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.761 HG11 ' HG2' ' A' ' 136' ' ' MET . 32.7 t -44.73 113.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 61.149999999999999 111.155 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.465 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -78.14 -61.24 2.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 61.219999999999999 110.929 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -152.35 151.42 30.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 54.439999999999998 110.881 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.77 30.44 9.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.733 . . . . 42.240000000000002 112.529 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.761 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -54.02 -26.41 26.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.782 0.325 . . . . 73.230000000000004 110.886 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.19 -34.1 68.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 71.150000000000006 110.841 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.503 HD12 ' HB3' ' A' ' 17' ' ' LEU . 23.5 mm -69.39 -38.27 76.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 62.399999999999999 111.101 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.21 -28.66 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.530000000000001 111.152 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -75.75 -31.31 59.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.887 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.07 -41.41 70.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 45.350000000000001 111.093 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 21.4 mtm -58.04 -45.36 87.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 72.209999999999994 110.902 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 58' ' ' PRO . 11.3 tm-20 -54.59 -25.3 25.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 62.420000000000002 110.909 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.405 ' HG3' ' CG ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -78.99 -28.87 43.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 71.310000000000002 110.9 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.405 ' CG ' ' HG3' ' A' ' 144' ' ' ARG . 46.9 m-85 -105.26 34.27 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.310000000000002 110.865 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -113.58 161.01 12.84 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 73.230000000000004 112.466 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 t -117.75 143.64 46.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.89 0.376 . . . . 64.519999999999996 110.852 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -74.76 63.85 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 73.219999999999999 110.906 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -175.45 -34.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 70.109999999999999 110.893 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.59 -44.81 0.74 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.746 -0.74 . . . . 10.41 112.478 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -62.65 -169.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.369 . . . . 75.540000000000006 110.902 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.82 147.97 4.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 64.239999999999995 111.167 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.97 -39.61 90.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 51.210000000000001 110.864 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.408 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.4 OUTLIER -101.32 171.56 7.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 73.109999999999999 110.894 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -114.85 108.72 17.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 72.310000000000002 110.924 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.67 HG23 HG23 ' A' ' 10' ' ' ILE . 4.8 mp -93.39 119.52 41.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 75.329999999999998 111.121 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.712 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -127.71 163.09 25.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 70.519999999999996 111.122 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.593 HD13 ' CE2' ' A' ' 8' ' ' PHE . 8.5 mt -91.28 109.37 21.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 72.329999999999998 111.123 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.736 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -73.03 -43.47 62.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 71.409999999999997 111.07 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -162.61 155.0 19.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 75.439999999999998 110.864 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.56 148.44 16.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.211 -0.449 . . . . 71.549999999999997 110.956 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.26 -174.65 44.72 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.739 -0.743 . . . . 75.200000000000003 112.489 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.485 ' HG2' ' NH2' ' A' ' 37' ' ' ARG . 3.1 mt-30 -82.03 131.22 35.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.351 . . . . 65.420000000000002 110.897 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.581 HD21 ' HB3' ' A' ' 7' ' ' PHE . 1.2 mm? -86.92 -60.79 1.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 73.040000000000006 110.945 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 75.329999999999998 110.911 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.2 mtp . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.84 0.353 . . . . 75.340000000000003 110.853 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.8 t -141.45 130.43 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 45.140000000000001 111.138 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -94.29 154.81 40.35 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.596 0.712 . . . . 60.439999999999998 110.883 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 146.09 59.05 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 62.130000000000003 112.374 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -133.98 142.97 47.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 43.130000000000003 111.15 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.487 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.8 m -134.23 141.73 42.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 74.239999999999995 111.136 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 13.6 p90 -101.49 168.54 9.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 74.420000000000002 110.876 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.635 ' CD2' HD13 ' A' ' 158' ' ' ILE . 5.4 m-85 -148.44 88.9 1.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 70.439999999999998 110.87 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.697 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.7 t70 -51.25 102.99 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 60.100000000000001 110.873 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.665 HG22 HD12 ' A' ' 17' ' ' LEU . 34.5 mm -80.3 135.95 24.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 74.340000000000003 111.164 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -127.71 155.41 44.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 111.142 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.426 HG13 ' HB3' ' A' ' 154' ' ' LYS . 48.9 t -136.0 94.09 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 65.209999999999994 111.139 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.61 32.01 7.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 75.540000000000006 110.873 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.55 -23.63 33.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.753 -0.737 . . . . 42.219999999999999 112.481 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -92.3 115.62 65.04 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.615 0.721 . . . . 61.299999999999997 110.922 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.4 Cg_endo -69.76 121.26 7.95 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.703 2.269 . . . . 71.430000000000007 112.319 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.665 HD12 HG22 ' A' ' 10' ' ' ILE . 14.1 mt -65.64 -37.58 86.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 73.409999999999997 110.927 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.43 -125.6 1.69 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 70.299999999999997 112.509 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -128.44 136.95 51.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 74.25 110.853 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.572 HG21 HG13 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -145.24 103.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 70.329999999999998 111.146 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -109.42 173.25 6.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 71.310000000000002 110.885 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.413 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -143.8 127.9 17.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 74.319999999999993 110.87 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -82.89 99.59 9.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 75.030000000000001 110.913 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.4 mt -83.18 122.79 28.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 63.350000000000001 110.889 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -77.48 67.25 3.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 75.140000000000001 110.903 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.45 -20.89 33.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 75.430000000000007 111.105 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -68.57 -38.48 80.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 72.209999999999994 110.859 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.48 -28.07 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 72.129999999999995 110.925 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.427 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -136.68 67.9 58.79 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.627 0.727 . . . . 34.140000000000001 111.105 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -36.91 9.89 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.705 2.27 . . . . 74.400000000000006 112.338 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.68 -37.68 82.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 72.329999999999998 110.907 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.4 m -88.53 -43.21 11.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 65.549999999999997 111.173 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.42 -49.38 77.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 50.020000000000003 111.136 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -51.29 -27.67 10.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 110.903 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.0 -63.83 0.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.329999999999998 110.897 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -59.94 -32.75 71.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 74.209999999999994 110.883 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.47 ' O ' HG23 ' A' ' 41' ' ' THR . 1.6 ttp180 -71.72 -47.8 51.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 75.230000000000004 110.903 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.3 -36.94 69.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 64.430000000000007 111.097 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.5 mt -77.65 -50.69 11.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 75.030000000000001 110.9 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.5 m -58.68 -38.13 77.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 73.140000000000001 110.873 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 37' ' ' ARG . 46.5 p -71.37 -38.6 71.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 72.239999999999995 111.144 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.81 -10.8 45.27 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.732 -0.746 . . . . 73.099999999999994 112.467 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -30.72 39.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 64.040000000000006 110.854 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -65.69 -28.71 69.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 63.240000000000002 110.927 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 100.28 -15.98 58.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.734 . . . . 61.210000000000001 112.516 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -155.11 -167.39 2.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.895 0.379 . . . . 75.409999999999997 110.866 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.56 -158.43 28.72 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.749 . . . . 44.219999999999999 112.492 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -112.42 21.09 16.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.929 0.395 . . . . 73.540000000000006 110.864 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.51 121.43 5.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 74.129999999999995 110.919 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.37 44.73 9.3 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.761 -0.733 . . . . 24.420000000000002 112.458 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.613 ' O ' HG22 ' A' ' 157' ' ' THR . 9.7 t -92.59 -169.38 2.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.824 0.345 . . . . 54.43 110.873 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 8.1 p -121.14 143.43 49.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 74.319999999999993 110.889 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -99.98 141.28 33.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.467 . . . . 74.310000000000002 110.871 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -151.87 48.26 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 73.019999999999996 110.807 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.1 tpp85 -172.95 68.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 75.5 110.894 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 56' ' ' ILE . 4.7 mt -116.11 113.3 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 73.299999999999997 111.127 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.5 mt -110.26 103.16 53.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.629 0.728 . . . . 73.340000000000003 111.156 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 86.24 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.671 2.247 . . . . 74.409999999999997 112.353 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.57 -20.77 1.5 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.737 -0.744 . . . . 64.099999999999994 112.485 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.87 -52.47 1.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 73.409999999999997 110.869 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 172.51 166.46 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 73.409999999999997 110.876 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.7 m -107.34 -169.4 1.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 73.120000000000005 110.918 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 173.85 149.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 71.230000000000004 110.891 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.94 172.09 22.29 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.67 -0.776 . . . . 71.030000000000001 112.497 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.33 165.18 46.41 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.73 . . . . 72.310000000000002 112.488 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.15 -170.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.86 0.362 . . . . 74.430000000000007 110.862 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -171.97 35.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 62.549999999999997 110.88 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.92 51.72 2.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 74.150000000000006 111.151 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.11 34.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 73.329999999999998 110.878 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.92 -57.46 3.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 71.200000000000003 110.863 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -107.4 37.91 2.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 70.209999999999994 110.868 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.41 -32.59 5.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.753 -0.737 . . . . 30.129999999999999 112.486 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.5 t -160.04 45.63 0.23 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.83 0.348 . . . . 75.040000000000006 111.118 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.9 -141.74 0.34 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.757 -0.735 . . . . 54.030000000000001 112.468 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.53 174.92 21.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.73 -0.748 . . . . 73.430000000000007 112.462 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.49 ' HE2' ' N ' ' A' ' 77' ' ' SER . 0.0 OUTLIER 56.54 174.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.789 0.328 . . . . 73.310000000000002 110.889 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.49 ' N ' ' HE2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -59.61 -153.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 63.149999999999999 110.841 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.71 47.3 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 74.150000000000006 111.125 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -127.79 -77.8 0.57 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 110.951 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.452 ' H ' ' NZ ' ' A' ' 76' ' ' LYS . . . -151.24 -76.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.67 -0.776 . . . . 45.049999999999997 112.464 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 4.7 mm-40 -117.55 -52.58 2.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.919 0.39 . . . . 75.099999999999994 110.909 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER 179.04 152.24 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 110.908 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -117.32 167.62 11.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 72.219999999999999 110.885 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.49 161.53 16.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.494 . . . . 73.329999999999998 110.881 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -48.28 151.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 73.439999999999998 110.848 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -102.78 -76.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 61.210000000000001 110.899 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -158.25 172.8 17.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 71.349999999999994 110.934 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.13 38.02 3.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 73.549999999999997 110.901 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mt -49.31 -31.53 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 62.409999999999997 111.156 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.8 mt -107.42 91.94 3.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 71.519999999999996 110.908 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -73.36 148.2 43.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 72.219999999999999 110.903 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -57.5 96.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 75.310000000000002 110.855 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -85.19 -57.93 2.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 75.030000000000001 111.129 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -143.26 -164.88 10.46 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.774 -0.727 . . . . 75.319999999999993 112.484 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 175.31 8.3 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.667 2.244 . . . . 73.120000000000005 112.359 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.07 21.19 69.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.785 -0.721 . . . . 62.450000000000003 112.512 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.1 mm -96.19 142.54 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.381 . . . . 64.140000000000001 111.144 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -114.49 143.71 44.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 64.540000000000006 110.929 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.98 -165.24 2.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 73.439999999999998 110.882 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 35.5 mtm -92.22 99.02 11.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 71.439999999999998 110.878 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -73.07 60.33 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.427 . . . . 65.109999999999999 111.096 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -118.7 -179.17 3.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.040000000000006 110.922 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.07 -24.49 3.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 65.0 111.121 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.96 -80.84 0.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.759 -0.734 . . . . 64.510000000000005 112.502 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 89.56 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.664 2.243 . . . . 71.329999999999998 112.322 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.505 ' C ' HG23 ' A' ' 107' ' ' THR . 40.6 m-20 66.26 -170.37 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 75.140000000000001 110.883 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.505 HG23 ' C ' ' A' ' 106' ' ' ASN . 1.2 p 67.32 34.42 4.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 61.520000000000003 111.154 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.83 148.47 23.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 55.119999999999997 110.913 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.65 59.2 0.44 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.73 -0.747 . . . . 63.439999999999998 112.462 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 65.2 36.2 7.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.836 0.35 . . . . 73.019999999999996 110.89 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -59.66 -169.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 70.200000000000003 110.909 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 177.43 149.05 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 73.129999999999995 110.92 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -165.49 73.2 0.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 71.030000000000001 110.884 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.506 ' C ' ' O ' ' A' ' 113' ' ' PHE . 19.1 mt -28.4 106.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 72.439999999999998 111.126 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 35.7 m -80.5 117.84 21.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 73.510000000000005 110.888 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 60.5 p -94.84 26.36 3.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 61.25 111.154 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.683 ' O ' HG23 ' A' ' 119' ' ' THR . . . 176.7 145.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 55.25 111.123 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -54.83 100.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 64.340000000000003 110.9 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.695 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 27.9 p -101.19 47.61 0.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 75.209999999999994 111.147 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -26.25 68.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 63.549999999999997 110.852 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.695 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.6 p90 -48.41 -28.62 3.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 73.030000000000001 110.942 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 26.0 mt -47.4 -35.82 8.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 74.109999999999999 110.914 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 124' ' ' GLY . 1.8 m-20 61.24 81.43 0.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 62.119999999999997 110.884 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.05 43.27 0.87 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 74.329999999999998 112.497 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.98 -17.86 39.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.785 0.326 . . . . 74.409999999999997 110.885 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -143.59 -168.1 2.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 74.219999999999999 110.851 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.4 t -126.26 119.32 53.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 51.539999999999999 111.115 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.8 t -83.23 129.89 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 53.43 111.107 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.492 ' O ' HD23 ' A' ' 24' ' ' LEU . 31.9 p90 -153.86 33.83 0.44 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.340000000000003 110.862 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -171.96 172.85 44.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.722 . . . . 70.409999999999997 112.486 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -175.81 135.18 0.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 73.439999999999998 110.914 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.741 HG11 ' HG2' ' A' ' 136' ' ' MET . 58.7 t -39.69 104.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 64.030000000000001 111.13 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.75 -60.0 2.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 73.510000000000005 110.899 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -154.56 160.22 41.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 74.040000000000006 110.882 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.59 32.03 28.61 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 74.349999999999994 112.528 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.741 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -52.62 -29.59 26.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.747 0.308 . . . . 73.310000000000002 110.871 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.44 -32.4 49.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 71.400000000000006 110.907 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.54 HD12 ' HB3' ' A' ' 17' ' ' LEU . 44.0 mm -65.74 -38.85 83.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 71.349999999999994 111.091 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.9 t -64.39 -27.22 42.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 73.299999999999997 111.163 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.24 -28.49 38.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 55.43 110.876 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.82 -43.2 59.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 51.409999999999997 111.096 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 40.7 mtm -60.73 -51.29 69.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 75.319999999999993 110.851 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.423 ' OE1' HG23 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -55.94 -23.2 30.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 75.200000000000003 110.881 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -23.97 61.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 75.439999999999998 110.883 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -109.73 19.85 18.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 71.120000000000005 110.885 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.5 167.37 12.35 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.773 -0.727 . . . . 72.140000000000001 112.47 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.5 m -109.8 148.15 31.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 53.210000000000001 110.851 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.4 mmm-85 -76.53 64.21 2.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 72.230000000000004 110.875 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -174.13 -36.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 73.430000000000007 110.902 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 156.76 -47.65 0.48 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 72.420000000000002 112.525 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 168.11 9.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.84 0.352 . . . . 73.349999999999994 110.935 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.3 p -144.91 -174.24 4.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 72.049999999999997 111.157 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.84 -68.3 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 31.219999999999999 110.852 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.426 ' HB3' HG13 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -79.28 -176.06 4.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 74.329999999999998 110.924 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.85 109.73 18.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 71.120000000000005 110.921 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mp -85.04 118.34 31.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 64.099999999999994 111.18 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.613 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -129.72 162.34 28.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 53.409999999999997 111.15 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.635 HD13 ' CD2' ' A' ' 8' ' ' PHE . 7.6 mt -101.34 120.89 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 64.219999999999999 111.12 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.697 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -79.98 -48.83 12.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 62.039999999999999 111.119 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -156.95 158.31 36.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 61.530000000000001 110.828 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.89 146.91 13.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 73.230000000000004 110.887 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.68 174.04 45.29 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.747 -0.74 . . . . 74.329999999999998 112.471 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -65.0 140.57 58.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.853 0.359 . . . . 61.219999999999999 110.924 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.569 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -93.41 -59.39 2.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 110.923 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 54.200000000000003 110.871 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.5 mtm . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.824 0.345 . . . . 75.319999999999993 110.893 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.7 t -144.3 136.55 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 74.040000000000006 111.147 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -123.51 154.19 66.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.605 0.717 . . . . 73.329999999999998 110.902 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 145.49 57.11 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.709 2.273 . . . . 53.32 112.341 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.9 m -128.84 128.96 44.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 61.299999999999997 111.165 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.403 HG13 ' CD1' ' A' ' 24' ' ' LEU . 2.4 m -124.52 172.71 11.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 51.340000000000003 111.18 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.666 ' HB3' HD21 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -162.0 174.26 13.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 71.549999999999997 110.905 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -153.05 97.85 2.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 63.200000000000003 110.958 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.9 OUTLIER -45.34 108.96 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 62.109999999999999 110.861 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.818 HG22 HD12 ' A' ' 17' ' ' LEU . 42.2 mm -80.11 133.64 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 73.409999999999997 111.136 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -125.82 156.37 39.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 74.150000000000006 111.086 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 154' ' ' LYS . 42.5 t -134.81 96.39 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 64.010000000000005 111.171 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.56 30.56 10.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 72.109999999999999 110.883 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.31 -23.8 32.11 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 45.399999999999999 112.495 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -91.79 116.03 65.68 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.658 0.742 . . . . 74.120000000000005 110.872 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.2 Cg_endo -69.77 126.09 12.9 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.687 2.258 . . . . 62.520000000000003 112.324 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.818 HD12 HG22 ' A' ' 10' ' ' ILE . 12.1 mt -70.32 -40.93 73.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 73.310000000000002 110.938 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.26 -122.13 1.09 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.729 -0.748 . . . . 65.109999999999999 112.493 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -134.32 143.12 47.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 74.049999999999997 110.908 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.47 HG21 HG13 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -146.26 100.31 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 70.200000000000003 111.156 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 2.1 t -104.52 173.78 6.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 73.400000000000006 110.854 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.556 ' CZ ' HD11 ' A' ' 114' ' ' ILE . 63.9 m-85 -145.18 130.74 18.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 61.439999999999998 110.88 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -86.28 95.2 9.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 71.409999999999997 110.878 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 129' ' ' PHE . 1.1 mt -80.1 134.07 36.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 73.040000000000006 110.872 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -93.1 66.58 4.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 72.200000000000003 110.849 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.67 -22.71 36.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 60.420000000000002 111.086 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -65.68 -35.65 81.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 55.310000000000002 110.865 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -99.61 -29.24 12.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 71.439999999999998 110.922 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.425 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -134.86 66.06 67.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 74.019999999999996 111.106 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -35.32 12.7 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.688 2.259 . . . . 73.340000000000003 112.321 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.06 -39.39 81.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 64.200000000000003 110.895 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.401 HG21 ' CD1' ' A' ' 129' ' ' PHE . 31.7 m -89.84 -49.25 6.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 74.040000000000006 111.135 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.26 -42.16 63.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 63.420000000000002 111.094 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.75 -25.18 62.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 75.25 110.919 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.7 -65.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 73.129999999999995 110.85 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -31.14 66.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 73.439999999999998 110.891 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.557 ' O ' HG23 ' A' ' 41' ' ' THR . 1.3 ttp180 -73.15 -52.91 12.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 75.099999999999994 110.856 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.05 -33.52 57.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 54.020000000000003 111.095 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.5 HD22 ' HA2' ' A' ' 47' ' ' GLY . 12.6 mt -80.59 -56.07 4.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 74.219999999999999 110.914 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.1 m -54.38 -36.05 63.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 44.32 110.83 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 37' ' ' ARG . 69.9 p -73.9 -45.29 51.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 75.430000000000007 111.147 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.7 -14.93 19.76 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.728 -0.749 . . . . 64.420000000000002 112.477 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -32.77 46.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 75.230000000000004 110.901 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -63.23 -28.77 70.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 64.409999999999997 110.892 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.86 -16.52 50.8 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.785 -0.721 . . . . 64.010000000000005 112.518 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -156.35 -165.91 2.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.923 0.392 . . . . 74.549999999999997 110.871 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA2' HD22 ' A' ' 39' ' ' LEU . . . 157.44 -164.75 33.14 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.721 -0.752 . . . . 52.539999999999999 112.452 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -105.74 26.78 9.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.911 0.386 . . . . 64.310000000000002 110.929 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.38 129.84 16.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 71.010000000000005 110.893 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.95 37.71 88.15 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.786 -0.721 . . . . 63.530000000000001 112.483 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.4 p -71.92 -172.56 0.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 50.039999999999999 110.819 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 8.1 p -131.45 127.33 37.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 61.420000000000002 110.858 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -86.0 115.56 23.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 73.140000000000001 110.863 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -124.08 32.55 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 61.310000000000002 110.878 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.71 83.04 0.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 72.209999999999994 110.865 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 56' ' ' ILE . 10.0 mt -123.24 110.67 26.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 64.5 111.153 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.4 mt -104.17 104.24 42.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.676 0.75 . . . . 71.310000000000002 111.097 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 81.95 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.684 2.256 . . . . 75.530000000000001 112.367 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.77 -21.89 0.8 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 74.400000000000006 112.508 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -120.42 -54.95 2.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 75.329999999999998 110.892 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 171.58 168.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 72.439999999999998 110.867 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 113' ' ' PHE . 34.7 m -106.4 -165.65 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 70.310000000000002 110.864 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.62 130.55 9.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 72.140000000000001 110.925 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -51.37 -32.48 30.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.721 -0.752 . . . . 73.439999999999998 112.457 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.0 139.91 10.71 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.748 . . . . 51.130000000000003 112.53 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -69.55 139.31 53.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.831 0.348 . . . . 72.319999999999993 110.873 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -131.59 47.76 2.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 73.319999999999993 110.878 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.27 -34.49 42.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 74.109999999999999 111.155 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -143.18 166.6 24.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 64.439999999999998 110.844 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 67.78 71.23 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.510000000000005 110.855 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 67.74 39.69 2.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 63.109999999999999 110.873 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -124.83 -32.3 0.82 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.789 -0.72 . . . . 53.219999999999999 112.518 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.4 p 63.43 31.02 15.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.757 0.313 . . . . 62.149999999999999 111.092 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.37 151.03 26.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.739 . . . . 62.439999999999998 112.493 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.51 114.82 2.66 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.786 -0.721 . . . . 63.130000000000003 112.498 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -174.63 151.14 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.817 0.342 . . . . 65.150000000000006 110.899 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.0 m -60.04 -173.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 73.230000000000004 110.877 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.515 ' O ' HD12 ' A' ' 78' ' ' ILE . 1.2 pp -95.14 22.56 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 63.420000000000002 111.142 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -140.83 35.54 1.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 63.109999999999999 110.911 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.97 -140.51 15.04 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.75 -0.738 . . . . 63.530000000000001 112.496 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -78.17 -31.28 49.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.892 0.377 . . . . 72.219999999999999 110.891 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 175.47 -179.56 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 74.329999999999998 110.894 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.66 162.7 35.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 61.100000000000001 110.892 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -78.78 167.96 20.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 74.140000000000001 110.877 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -59.35 146.02 41.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 74.409999999999997 110.85 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -102.59 -77.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 64.319999999999993 110.889 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -152.24 171.44 17.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 63.399999999999999 110.905 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -133.55 38.36 3.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 70.439999999999998 110.901 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mt -50.42 -30.48 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 73.109999999999999 111.131 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.6 mt -108.42 93.33 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.952 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -73.03 148.94 43.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 64.030000000000001 110.876 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -59.76 94.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.887 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.04 -59.28 2.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 71.310000000000002 111.149 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . -142.83 -166.02 10.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 73.120000000000005 112.523 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 172.24 12.98 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.676 2.251 . . . . 75.140000000000001 112.331 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.15 20.12 76.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.695 -0.764 . . . . 71.530000000000001 112.499 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.2 mm -96.21 142.52 13.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.853 0.359 . . . . 73.530000000000001 111.11 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.438 HD21 ' CD2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -112.52 141.04 46.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 71.310000000000002 110.891 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.22 165.86 32.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 53.520000000000003 110.862 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 11.8 mtm -71.92 87.19 1.01 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 72.019999999999996 110.922 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.792 ' HB3' ' CG ' ' A' ' 111' ' ' GLN . . . -48.35 124.6 8.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 62.450000000000003 111.127 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 24.1 p-10 -170.6 -174.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 72.140000000000001 110.912 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.03 -12.53 60.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 74.420000000000002 111.171 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.12 -83.3 0.34 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 61.299999999999997 112.51 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 96.28 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.666 2.244 . . . . 54.450000000000003 112.341 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 71.27 178.38 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 55.130000000000003 110.875 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.2 p 58.53 40.13 24.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 75.409999999999997 111.139 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 4.2 m120 -43.19 -35.3 1.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 72.540000000000006 110.894 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . 69.83 -62.83 0.69 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.8 -0.714 . . . . 71.329999999999998 112.46 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 0.6 OUTLIER 81.96 44.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.844 0.354 . . . . 34.539999999999999 110.858 -179.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.792 ' CG ' ' HB3' ' A' ' 101' ' ' ALA . 24.5 pt20 -92.95 -7.63 45.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 71.030000000000001 110.88 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.553 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER 69.16 149.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 72.030000000000001 110.931 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.587 ' O ' ' CD1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -163.29 70.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 72.200000000000003 110.842 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.556 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -27.48 124.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 53.030000000000001 111.154 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 33.6 m -96.0 114.08 25.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 72.049999999999997 110.909 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 45.9 p -92.56 28.47 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 72.219999999999999 111.114 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.697 ' O ' HG23 ' A' ' 119' ' ' THR . . . 175.95 141.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 63.520000000000003 111.062 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.418 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 2.1 tttt -50.63 99.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 71.299999999999997 110.905 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.798 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 49.6 p -98.99 55.67 1.02 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.218 -0.446 . . . . 61.020000000000003 111.125 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -23.87 61.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 73.120000000000005 110.882 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.798 ' CZ2' HG22 ' A' ' 119' ' ' THR . 8.1 p90 -49.88 -29.6 8.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 74.430000000000007 110.95 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.707 HD22 ' NE2' ' A' ' 126' ' ' HIS . 32.0 mt -49.45 -32.52 12.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 62.329999999999998 110.931 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 124' ' ' GLY . 2.3 m-20 60.13 76.6 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 73.140000000000001 110.814 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.46 42.15 0.89 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.717 -0.754 . . . . 70.219999999999999 112.444 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.67 -21.93 32.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.831 0.348 . . . . 72.340000000000003 110.914 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.707 ' NE2' HD22 ' A' ' 122' ' ' LEU . 5.6 m-70 -129.18 -166.72 1.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 74.329999999999998 110.844 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 79.1 t -128.99 118.76 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 65.439999999999998 111.152 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.82 132.57 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 41.109999999999999 111.103 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.425 ' CB ' HG21 ' A' ' 29' ' ' VAL . 22.7 p90 -155.13 30.1 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 64.209999999999994 110.878 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -168.39 173.99 43.14 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.717 -0.754 . . . . 63.100000000000001 112.476 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 7.2 pttt -175.49 135.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 63.329999999999998 110.892 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' ' 136' ' ' MET . 71.2 t -40.58 105.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 75.140000000000001 111.114 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -59.36 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 71.329999999999998 110.903 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -154.19 -178.72 7.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 64.109999999999999 110.887 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.91 31.13 60.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 73.310000000000002 112.514 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.503 ' HB2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -57.09 -24.63 55.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 72.010000000000005 110.867 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.41 -30.63 19.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 74.120000000000005 110.859 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.642 HD12 ' HB3' ' A' ' 17' ' ' LEU . 40.0 mm -65.15 -38.85 83.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 65.140000000000001 111.113 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 74.6 t -63.44 -30.4 49.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 65.230000000000004 111.179 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -76.49 -28.83 56.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 74.099999999999994 110.841 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.48 -41.3 60.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 54.450000000000003 111.102 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.417 ' SD ' HG21 ' A' ' 10' ' ' ILE . 33.8 mtm -61.35 -51.28 69.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 53.229999999999997 110.831 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.66 -25.52 27.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 72.239999999999995 110.951 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.418 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -71.84 -25.07 61.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 73.310000000000002 110.868 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.418 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 70.9 m-85 -105.98 10.47 32.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 72.439999999999998 110.895 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.8 165.18 13.32 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.792 -0.718 . . . . 62.439999999999998 112.452 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.0 m -108.67 148.02 31.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 74.239999999999995 110.841 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.4 mmm-85 -75.95 60.73 1.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 72.239999999999995 110.843 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -163.38 -38.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 74.540000000000006 110.875 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 158.38 -50.99 0.41 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.789 -0.72 . . . . 30.41 112.492 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.03 174.14 7.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 55.0 110.886 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.8 p -144.36 -170.39 3.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 54.240000000000002 111.181 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 63.4 m -98.23 -67.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 52.5 110.843 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.492 ' HB3' HG13 ' A' ' 12' ' ' VAL . 1.4 mttp -76.89 -175.88 3.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 73.340000000000003 110.896 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.52 109.8 18.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.433 . . . . 75.439999999999998 110.879 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.495 HG23 HG23 ' A' ' 10' ' ' ILE . 4.2 mp -86.37 114.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 73.030000000000001 111.098 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.41 164.4 20.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 64.129999999999995 111.173 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.4 mt -103.89 125.65 58.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 64.409999999999997 111.099 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -87.93 -54.51 4.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 73.450000000000003 111.144 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -142.2 150.73 41.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 75.310000000000002 110.851 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -156.88 146.75 20.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 22.440000000000001 110.878 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.66 164.18 24.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.767 -0.73 . . . . 43.149999999999999 112.518 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.409 ' HB2' HG22 ' A' ' 41' ' ' THR . 1.3 tt0 -57.68 111.43 1.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 64.310000000000002 110.882 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.666 HD21 ' HB3' ' A' ' 7' ' ' PHE . 2.1 mm? -54.36 -51.22 65.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 72.25 110.93 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 71.010000000000005 110.872 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.871 0.367 . . . . 72.129999999999995 110.831 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t -137.32 133.7 46.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 52.229999999999997 111.151 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -106.08 141.53 22.93 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.608 0.718 . . . . 61.310000000000002 110.906 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 147.19 62.49 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.686 2.257 . . . . 74.319999999999993 112.322 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -130.96 140.85 50.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 71.099999999999994 111.174 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.509 ' HA ' HD23 ' A' ' 164' ' ' LEU . 1.5 m -135.14 142.47 39.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 62.420000000000002 111.114 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.558 ' HB3' HD21 ' A' ' 164' ' ' LEU . 11.7 p90 -103.37 161.71 13.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 74.109999999999999 110.923 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.745 ' CD2' HD13 ' A' ' 158' ' ' ILE . 4.6 m-85 -144.45 89.18 1.98 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 110.889 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.6 OUTLIER -51.17 103.24 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 61.109999999999999 110.838 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.513 HG13 HG21 ' A' ' 20' ' ' VAL . 29.8 mm -75.85 136.75 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 62.509999999999998 111.126 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -128.16 152.98 47.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.040000000000006 111.131 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 t -135.97 94.98 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.438 . . . . 62.409999999999997 111.116 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.74 31.27 4.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.439999999999998 110.859 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.02 -22.18 40.48 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.714 -0.755 . . . . 75.209999999999994 112.492 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -94.23 117.41 67.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.676 0.751 . . . . 55.219999999999999 110.859 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.75 124.56 11.2 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.683 2.255 . . . . 64.219999999999999 112.364 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.522 ' HB3' HD12 ' A' ' 138' ' ' ILE . 8.9 mt -68.87 -39.13 80.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 63.130000000000003 110.953 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.52 -135.93 4.62 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 64.340000000000003 112.433 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.32 134.33 55.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 53.140000000000001 110.917 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.513 HG21 HG13 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -145.79 102.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 73.209999999999994 111.137 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 1.2 t -111.44 172.36 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 64.409999999999997 110.852 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.41 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -143.97 130.95 20.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 64.310000000000002 110.894 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.403 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 25.9 tt0 -84.42 100.38 11.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.519999999999996 110.896 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.459 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 1.7 mt -84.99 127.77 34.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 70.340000000000003 110.911 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.42 ' CD1' HD13 ' A' ' 90' ' ' LEU . 46.7 m-85 -86.79 68.55 10.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 75.019999999999996 110.865 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.76 -23.9 32.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 70.409999999999997 111.077 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.5 -34.86 78.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 72.340000000000003 110.833 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 -27.45 14.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 75.230000000000004 110.901 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.422 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -139.42 66.78 37.18 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.636 0.732 . . . . 71.109999999999999 111.096 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -36.66 10.39 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.687 2.258 . . . . 73.329999999999998 112.3 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -37.56 80.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 74.450000000000003 110.834 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.7 m -88.53 -45.65 9.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 54.539999999999999 111.116 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.76 -38.66 82.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 72.310000000000002 111.11 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -51.22 -35.26 35.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 75.340000000000003 110.917 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -64.21 -63.18 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 75.430000000000007 110.888 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -56.93 -39.82 75.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 73.340000000000003 110.892 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.51 -47.29 76.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 72.530000000000001 110.856 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.68 74.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 75.109999999999999 111.129 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.2 mt -77.26 -54.8 6.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 72.329999999999998 110.904 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.0 m -51.67 -41.97 61.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 61.020000000000003 110.861 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -76.24 -34.44 59.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 73.329999999999998 111.103 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.26 -11.45 56.97 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.699 -0.762 . . . . 73.150000000000006 112.46 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -59.82 -18.77 46.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 62.200000000000003 110.905 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.614 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -49.23 -28.35 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 70.239999999999995 110.859 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.52 -26.03 5.26 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.798 -0.715 . . . . 53.219999999999999 112.518 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -158.67 -46.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 74.129999999999995 110.862 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.92 -149.8 43.99 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.775 -0.726 . . . . 75.040000000000006 112.498 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -179.45 92.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.954 0.407 . . . . 73.219999999999999 110.94 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.86 82.64 6.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 72.420000000000002 110.946 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 179.06 -68.34 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.71 -0.757 . . . . 41.130000000000003 112.511 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.463 ' O ' HG22 ' A' ' 157' ' ' THR . 0.7 OUTLIER 48.36 -166.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 54.130000000000003 110.839 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.1 p -176.86 122.56 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 52.229999999999997 110.875 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.406 ' CD1' HG22 ' A' ' 156' ' ' ILE . 24.7 m-85 -84.13 128.81 34.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 74.140000000000001 110.846 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -129.57 35.55 4.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 74.540000000000006 110.84 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.19 100.74 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 74.409999999999997 110.87 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.7 mt -140.65 113.98 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.478 . . . . 62.229999999999997 111.141 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.412 ' O ' HG22 ' A' ' 57' ' ' ILE . 6.8 mt -113.9 113.02 47.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.592 0.711 . . . . 74.239999999999995 111.091 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 81.28 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.67 2.247 . . . . 44.409999999999997 112.388 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.38 -25.73 0.29 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.748 -0.739 . . . . 73.209999999999994 112.461 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.43 -57.37 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.884 0.373 . . . . 62.399999999999999 110.914 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 170.0 169.32 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 53.240000000000002 110.877 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.0 m -92.51 -165.78 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 63.509999999999998 110.893 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 176.49 142.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 61.409999999999997 110.968 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 150.51 112.84 0.59 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.739 . . . . 53.299999999999997 112.488 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.62 109.09 0.27 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.772 -0.728 . . . . 73.140000000000001 112.494 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -174.35 151.85 1.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.901 0.381 . . . . 71.219999999999999 110.832 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -125.16 -38.4 2.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 75.329999999999998 110.881 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 87.2 m -52.3 -36.18 52.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 71.129999999999995 111.137 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -144.86 146.78 32.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 74.439999999999998 110.907 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -116.45 39.3 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 65.219999999999999 110.834 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -127.28 -42.76 1.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 72.049999999999997 110.885 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 137.99 40.47 0.11 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.734 -0.746 . . . . 61.210000000000001 112.497 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.2 t -161.71 46.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.36 . . . . 75.219999999999999 111.127 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.15 168.76 41.88 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.706 -0.759 . . . . 73.099999999999994 112.444 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.54 103.74 1.94 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 42.530000000000001 112.468 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.89 155.96 19.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.807 0.337 . . . . 54.140000000000001 110.885 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 p -92.22 57.15 2.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 61.409999999999997 110.838 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.614 HG22 ' HD2' ' A' ' 44' ' ' LYS . 5.9 pt 42.78 30.58 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 71.010000000000005 111.114 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -170.92 55.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 72.099999999999994 110.912 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.03 177.83 51.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.744 . . . . 43.509999999999998 112.476 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -52.23 -28.3 18.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.954 0.407 . . . . 73.439999999999998 110.86 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.555 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 179.84 -175.58 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 74.129999999999995 110.905 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.431 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -142.38 -179.06 6.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 75.349999999999994 110.935 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.2 168.07 20.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 51.030000000000001 110.86 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -70.87 132.45 45.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 74.530000000000001 110.899 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -89.39 -70.11 0.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 75.409999999999997 110.886 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -172.01 172.79 4.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 73.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.9 36.78 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 73.329999999999998 110.829 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -49.64 -30.73 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 73.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.42 HD13 ' CD1' ' A' ' 25' ' ' PHE . 20.6 mt -110.42 68.13 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 74.439999999999998 110.893 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.67 156.19 14.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 62.140000000000001 110.913 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -61.76 92.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 72.140000000000001 110.8 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.4 p -105.35 24.82 11.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 62.200000000000003 111.121 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.39 177.93 27.41 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.704 -0.76 . . . . 73.0 112.478 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 172.9 11.74 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.674 2.249 . . . . 73.349999999999994 112.357 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.17 38.1 95.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.723 -0.751 . . . . 43.43 112.473 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 97' ' ' ILE . 24.1 mm -110.69 134.37 53.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.868 0.366 . . . . 72.109999999999999 111.155 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.518 HD22 ' CG ' ' A' ' 112' ' ' PHE . 1.6 mt -100.81 156.6 17.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 72.140000000000001 110.921 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 t 175.85 126.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 65.450000000000003 110.883 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.437 ' HE3' ' HA ' ' A' ' 110' ' ' SER . 3.7 mmt -50.55 162.06 0.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 73.030000000000001 110.888 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.447 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . . . -158.0 95.12 1.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 75.209999999999994 111.108 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -118.07 -21.94 8.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 51.009999999999998 110.884 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.84 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -179.0 -32.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 64.239999999999995 111.112 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.09 -82.36 0.33 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.705 -0.759 . . . . 71.239999999999995 112.478 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 117.32 5.01 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.638 2.225 . . . . 72.319999999999993 112.368 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.424 ' O ' HG23 ' A' ' 107' ' ' THR . 5.6 m-80 40.22 41.79 1.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 75.25 110.936 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.84 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 7.2 p -155.73 56.0 0.61 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.165 -0.471 . . . . 74.239999999999995 111.075 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 100' ' ' MET . 1.5 m-20 -66.1 -42.56 89.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 75.319999999999993 110.948 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.78 -152.91 52.82 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.737 -0.744 . . . . 74.310000000000002 112.459 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.437 ' HA ' ' HE3' ' A' ' 100' ' ' MET . 0.3 OUTLIER -130.17 21.42 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.859 0.362 . . . . 53.039999999999999 110.877 -179.703 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.439 ' O ' ' CG ' ' A' ' 111' ' ' GLN . 5.2 tt0 -116.26 87.94 2.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 73.420000000000002 110.908 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.518 ' CG ' HD22 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -84.88 -165.15 1.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.43 . . . . 72.439999999999998 110.834 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -153.36 165.69 34.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 70.310000000000002 110.896 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.57 HG21 ' CG1' ' A' ' 139' ' ' VAL . 2.4 mp -100.06 90.88 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 72.310000000000002 111.124 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 53.2 m -66.08 89.96 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 52.229999999999997 110.889 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.3 p -67.68 -8.11 32.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 74.349999999999994 111.099 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.704 ' O ' HG23 ' A' ' 119' ' ' THR . . . -145.9 153.3 40.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 111.138 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -56.57 94.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 63.530000000000001 110.918 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 117' ' ' ALA . 24.2 p -96.73 45.99 1.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 71.209999999999994 111.148 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -24.66 67.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 64.340000000000003 110.842 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.686 ' CZ2' HG22 ' A' ' 119' ' ' THR . 5.9 p90 -48.51 -27.62 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 72.329999999999998 110.929 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.6 mt -45.83 -34.42 3.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 72.010000000000005 110.919 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 124' ' ' GLY . 1.7 m-20 62.17 78.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 62.009999999999998 110.834 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 36.07 43.07 0.63 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 60.399999999999999 112.494 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 -17.28 43.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.773 0.321 . . . . 74.109999999999999 110.875 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -143.24 -165.48 2.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 71.439999999999998 110.897 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.0 t -126.21 130.22 72.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.432 . . . . 73.329999999999998 111.114 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.9 t -96.9 135.86 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 65.129999999999995 111.15 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.452 ' O ' HD23 ' A' ' 24' ' ' LEU . 12.8 p90 -159.33 38.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 74.209999999999994 110.865 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . -178.12 173.77 46.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.73 -0.748 . . . . 51.140000000000001 112.459 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -174.99 140.0 0.51 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.854 0.359 . . . . 74.219999999999999 110.887 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.695 HG11 ' HG2' ' A' ' 136' ' ' MET . 42.0 t -40.65 107.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 65.109999999999999 111.151 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.403 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -72.15 -59.96 2.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 64.420000000000002 110.849 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -154.43 152.33 30.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 63.25 110.911 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.37 41.86 6.39 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.742 -0.742 . . . . 73.019999999999996 112.493 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.695 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -60.08 -33.7 72.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.838 0.351 . . . . 63.140000000000001 110.902 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -36.31 31.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.439 . . . . 75.150000000000006 110.91 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.522 HD12 ' HB3' ' A' ' 17' ' ' LEU . 38.3 mm -63.86 -38.97 83.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 54.509999999999998 111.088 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.57 ' CG1' HG21 ' A' ' 114' ' ' ILE . 76.2 t -66.63 -24.34 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 61.009999999999998 111.139 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.08 -27.33 30.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 73.319999999999993 110.902 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.17 59.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 53.329999999999998 111.112 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 31.7 mtm -60.0 -54.11 49.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 73.040000000000006 110.888 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.48 ' OE1' ' HA ' ' A' ' 143' ' ' GLU . 10.4 mm-40 -54.84 -28.89 53.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 55.25 110.899 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.451 ' HG3' ' CD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -64.22 -24.3 67.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 64.239999999999995 110.83 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.451 ' CD2' ' HG3' ' A' ' 144' ' ' ARG . 69.0 m-85 -106.85 32.5 4.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 110.863 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.65 170.63 15.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 73.430000000000007 112.471 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.5 t -127.37 146.97 50.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.887 0.375 . . . . 71.349999999999994 110.861 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.1 mmm-85 -72.83 77.29 1.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 73.230000000000004 110.897 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -174.45 -35.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 60.130000000000003 110.891 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 148.89 -77.5 0.24 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.705 -0.759 . . . . 73.230000000000004 112.5 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.17 168.94 9.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 71.319999999999993 110.882 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.9 p -144.16 -173.76 4.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 60.210000000000001 111.182 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.0 p -86.85 -63.03 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 72.549999999999997 110.834 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -66.2 173.54 3.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 72.230000000000004 110.86 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -122.79 109.65 14.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 75.349999999999994 110.886 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 156' ' ' ILE . 4.2 mp -85.86 119.59 34.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 73.239999999999995 111.124 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -132.83 163.61 28.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 60.32 111.156 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.745 HD13 ' CD2' ' A' ' 8' ' ' PHE . 5.1 mt -102.45 128.35 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 75.099999999999994 111.14 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -91.65 -59.55 2.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 64.310000000000002 111.109 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -134.59 155.77 49.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 63.439999999999998 110.894 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.66 143.93 4.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 64.019999999999996 110.859 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.89 173.23 43.15 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 53.409999999999997 112.483 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -64.59 140.63 58.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 65.099999999999994 110.888 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.558 HD21 ' HB3' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -93.28 -57.68 2.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 75.109999999999999 110.938 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 65.219999999999999 110.886 179.944 . . . . . . . . 1 1 . 1 stop_ save_